Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,embryonic skeletal system development (GO:0048706),-0.7614000188440718,-2.2708969426239487,0.0,0.0,0.0,18/35,10.85%,SULF1;COL1A1;PDGFRA;HOXC4;OSR1;SULF2;HOXA3;PCSK5;RBP4;DYNC2I1;WNT9A;HOXB4;HOXB3;SIX1;KIAA1217;XYLT1;SLC2A10;FUZ
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.8326394060426878,-2.1287713141089877,0.0,0.0018243980819321903,0.004,9/17,7.48%,ATP1A2;ANK2;CACNA1C;CACNA2D1;CACNA1D;SLC8A1;CACNB2;CACNA1G;KCNJ2
prerank,retinoid metabolic process (GO:0001523),-0.6178269810005561,-2.119923780468683,0.0,0.001520331734943492,0.005,25/71,16.05%,GPC6;ALDH1A1;LRP1;ALDH1A2;SDC2;GPC3;RBP1;HSPG2;ABCA4;RBP4;CYP26B1;AKR1B1;DHRS3;CYP1B1;GPC5;SDC4;APOE;GPC4;STRA6;SCPEP1;SDC1;RDH13;RDH10;RARRES2;GPC1
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.7933443505177851,-2.1175924571334317,0.0,0.001140248801207619,0.005,11/20,12.57%,ATP1A2;ANK2;CACNA1C;DMD;ATP1B1;SLC8A1;PRKACA;ATP2A2;RYR2;SLC9A1;GSTM2
prerank,diterpenoid metabolic process (GO:0016101),-0.6391382120064091,-2.08420667987644,0.0,0.0025541573147050667,0.013,20/55,16.05%,GPC6;ALDH1A1;LRP1;SDC2;GPC3;RBP1;HSPG2;ABCA4;RBP4;AKR1B1;DHRS3;GPC5;SDC4;APOE;GPC4;STRA6;SDC1;RDH10;RARRES2;GPC1
prerank,collagen fibril organization (GO:0030199),-0.5835478693021946,-2.0359785355510787,0.0,0.006081326939773968,0.038,44/88,11.47%,COL1A2;COL3A1;COL4A5;COL1A1;ADAMTS2;COL8A1;COL4A6;COL5A1;COL12A1;COL22A1;COL25A1;COL4A3;LOXL1;COL4A4;COL6A2;COL6A3;COL11A1;PLOD2;COL6A1;COL8A2;TGFBR1;COL26A1;SERPINH1;COL13A1;COL18A1;COL23A1;LOXL3;COL27A1;CYP1B1;COL5A3;NF1;LUM;COL16A1;P4HB;LOX;COL14A1;COL9A2;DPT;DDR2;COL20A1;COL15A1;ADAMTS14;P4HA1;TGFB2
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.7564299193662722,-2.0292720585409465,0.0,0.0058152688861588565,0.047,4/21,1.86%,EYA2;EYA1;BCL2;EYA4
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),-0.7564299193662722,-2.0292720585409465,0.0,0.0058152688861588565,0.047,4/21,1.86%,EYA2;EYA1;BCL2;EYA4
prerank,cotranslational protein targeting to membrane (GO:0006613),0.6926063000719644,2.024215380246639,0.0,0.022078296943507457,0.016,60/91,21.42%,RPS15;RPS19;RPLP1;RPS14;RPSA;RPS16;RPL38;RPL34;RPS20;RPL39;RPS7;RPS24;SEC63;RPL37A;RPL36;RPS18;TRAM1;RPL15;RPS8;RPL14;RPL23;RPL17;RPL9;RPL4;RPL13A;RPS11;RPL32;RPL22;RPS27;RPL31;RPS23;RPL13;RPS12;SRP9;RPL6;RPL10;RPS29;RPS6;RPL29;RPS25;RPL35A;RPS13;RPS21;RPL27;RPL18;RPL27A;RPS10;ARL6IP1;RPL11;RPL8;RPLP2;SEC62;SIL1;RPL18A;SSR1;RPL21;RPL3;RPS3;RPS28;RPL7
prerank,glycosaminoglycan catabolic process (GO:0006027),-0.6202710202161463,-2.018335513856344,0.0,0.005979971490777735,0.054,22/55,11.64%,GPC6;SDC2;DCN;GPC3;OGN;CEMIP;FMOD;HSPG2;BGN;FGF2;CSPG4;PRELP;LUM;VCAN;ARSB;CD44;GPC5;SDC4;OMD;GPC4;SLC9A1;HEXA
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.7934384808875756,-1.9968387349470327,0.0,0.008757110793274514,0.086,7/16,9.11%,ATP1A2;ANK2;CACNA1C;DMD;SLC8A1;PRKACA;RYR2
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.6797750019471696,1.960282095236887,0.0,0.07306864940827468,0.097,56/87,21.42%,RPS15;RPS19;RPLP1;RPS14;RPSA;RPS16;RPL38;RPL34;RPS20;RPL39;RPS7;RPS24;SEC63;RPL37A;RPL36;RPS18;RPL15;RPS8;RPL14;RPL23;RPL17;ZFAND2B;RPL9;RPL4;RPL13A;RPS11;RPL32;RPL22;RPS27;RPL31;RPS23;RPL13;RPS12;SRP9;RPL6;RPL10;RPS29;RPS6;RPL29;RPS25;RPL35A;RPS13;RPS21;RPL27;RPL18;RPL27A;RPS10;RPL11;RPL8;RPLP2;RPL18A;RPL21;RPL3;RPS3;RPS28;RPL7
prerank,membrane lipid biosynthetic process (GO:0046467),0.7082357692844546,1.958649874900131,0.001422475106685633,0.0515160262015174,0.103,17/58,5.72%,ACER2;CERT1;ELOVL7;SPTLC2;SGMS1;DEGS2;PRKD1;SPNS2;PLPP1;SGPP2;PRKD2;PRKD3;CERS4;SPTLC3;ELOVL5;SPTSSA;PPM1L
prerank,positive regulation of acute inflammatory response (GO:0002675),0.883997309846776,1.9525587075110653,0.0,0.04441943075539,0.119,3/14,2.38%,IL6ST;PTGS2;OSMR
prerank,regulation of striated muscle contraction (GO:0006942),-0.6962785897499897,-1.9451673252331367,0.0,0.022307412910898144,0.209,7/27,9.11%,ATP1A2;ANK2;DMD;SLC8A3;P2RX4;PRKACA;RYR2
prerank,protein targeting to ER (GO:0045047),0.6592256572713753,1.9407969767243711,0.0,0.04962360074921676,0.156,61/99,21.42%,RPS15;RPS19;RPLP1;RPS14;RPSA;RPS16;RPL38;RPL34;RPS20;RPL39;RPS7;RPS24;SEC63;RPL37A;RPL36;RPS18;RPL15;RPS8;RPL14;RPL23;RPL17;CHMP4B;CHMP4A;ZFAND2B;RPL9;RPL4;RPL13A;RPS11;RPL32;RPL22;RPS27;RPL31;RPS23;RPL13;RPS12;SRP9;RPL6;RPL10;SPCS1;RPS29;RPS6;RPL29;RPS25;RPL35A;RPS13;RPS21;RPL27;RPL18;RPL27A;RPS10;RPL11;RPL8;RPLP2;SEC62;RPL18A;ZFAND2A;RPL21;RPL3;RPS3;RPS28;RPL7
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.6527205805155017,1.9381512873044076,0.0,0.044156593887014914,0.167,62/110,21.42%,RPS15;RPS19;RPLP1;RPS14;RPSA;RPS16;RPL38;RPL34;RPS20;RPL39;RPS7;RPS24;RPL37A;RPL36;RPS18;RPL15;RPS8;RPL14;RPL23;RPL17;SMG7;RPL9;RPL4;RPL13A;RPS11;RPL32;RPL22;RPS27;RPL31;RPS23;RNPS1;RPL13;RPS12;PNRC2;RPL6;RPL10;UPF2;RPS29;RPS6;RPL29;RPS25;RPL35A;RPS13;RPS21;RPL27;RPL18;RPL27A;RPS10;CTIF;RPL11;RPL8;RPLP2;HELZ2;PPP2R2A;RPL18A;DHX34;PPP2R1A;RPL21;RPL3;RPS3;RPS28;RPL7
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.709613918365094,-1.9341658490243891,0.0024096385542168677,0.02516149021331479,0.25,8/21,9.11%,ATP1A2;ANK2;CACNA1C;DMD;SLC8A1;AKAP6;PRKACA;RYR2
prerank,establishment of endothelial barrier (GO:0061028),0.7945518956326101,1.9306031535229995,0.0,0.04625928883401562,0.198,14/29,7.52%,TJP1;PECAM1;PPP1R16B;ICAM1;F11R;TJP2;PDE2A;MSN;PDE4D;RAP1B;SOX18;ROBO4;RAPGEF2;RAP1A
prerank,cardiac muscle cell action potential (GO:0086001),-0.6721505878427951,-1.9220812093871587,0.0,0.02933070762490983,0.298,11/30,7.48%,ATP1A2;ANK2;CACNA1C;DMD;CACNA2D1;CACNA1D;ATP1B1;SLC8A1;KCND3;CACNA1G;KCNJ2
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.7713815524578264,-1.9179662171494989,0.0,0.029516154682688648,0.317,6/16,3.80%,IGF1;IGFBP2;BMP5;IGFBP5;IGFBP6;IGFBP3
prerank,cytoplasmic translation (GO:0002181),0.6550974177410482,1.9017656845693431,0.0,0.07622269182877574,0.358,54/91,21.42%,RPS15;RPS19;RPLP1;RPS14;RPSA;RPS16;RPL38;RPL34;RPS20;RPL39;RPS7;RPS24;RPL37A;RPL36;RPS18;RPL15;RPS8;RPL14;RPL23;RPL17;RPL9;RPL4;RPL13A;RPS11;RPL32;RPL22;RPS27;DRG2;RPL31;RPS23;RPL13;RPS12;RPL6;RPL10;RPS29;RPS6;RPL29;RPS25;RPL35A;RPS13;RPS21;RPL27;RPL18;RPL27A;RPS10;RPL11;RPL8;RPL18A;RPL21;RPL3;RWDD1;RPS3;RPS28;RPL7
prerank,membrane depolarization during action potential (GO:0086010),-0.682966534181967,-1.9002780236452086,0.0,0.036731214716234764,0.402,7/26,7.48%,ATP1A2;CACNA1C;SCN7A;CACNA1D;SLC8A1;CACNA1G;KCNJ2
prerank,negative regulation of peptidase activity (GO:0010466),-0.6026566450081466,-1.899258047716241,0.0,0.03477758843683238,0.403,13/47,12.41%,LRP1;TIMP3;SERPING1;VTN;TIMP2;SERPINH1;SERPINE2;SERPIND1;ECM1;SERPINF1;SERPINE1;CST3;SPOCK3
prerank,negative regulation of glucose transmembrane transport (GO:0010829),-0.8458593685104343,-1.8838700444703074,0.0,0.04217579095290298,0.477,6/10,4.97%,PID1;PRKCB;APPL2;ENPP1;GRB10;SELENOS
prerank,sphingolipid metabolic process (GO:0006665),0.6293983357510674,1.880607396106742,0.0,0.1094569536299814,0.48,23/108,5.72%,ST6GALNAC3;ACER2;CERT1;ELOVL7;SPTLC2;SGMS1;UGCG;DEGS2;PRKD1;SPNS2;PLPP1;SGPP2;PRKD2;PRKD3;CERS4;ESYT2;SPTLC3;ELOVL5;SPTSSA;GLTP;ENPP2;ASAH2;PPM1L
prerank,embryonic digestive tract development (GO:0048566),-0.7269531891200376,-1.8671292858865929,0.002320185614849188,0.05158992353908249,0.574,12/18,15.45%,GLI3;FGFR2;RARB;GLI2;PDGFRA;PCSK5;SALL1;RBPMS2;TGFB2;STRA6;PKDCC;RARRES2
prerank,sphingolipid biosynthetic process (GO:0030148),0.6518594599874804,1.8600831664182584,0.0,0.1489759369950003,0.616,18/71,5.72%,ACER2;CERT1;ELOVL7;SPTLC2;SGMS1;DEGS2;PRKD1;SPNS2;PLPP1;SGPP2;PRKD2;PRKD3;CERS4;SPTLC3;ELOVL5;SPTSSA;ASAH2;PPM1L
prerank,skeletal system morphogenesis (GO:0048705),-0.6101867044794328,-1.8572861282793673,0.0,0.058140686242628484,0.628,16/42,10.85%,FGFR2;PDGFRA;HOXC4;TGFBR1;HOXA3;WWOX;CYP26B1;DYNC2I1;FBN2;SFRP4;HOXB4;HOXB3;SIX1;LRP6;HHIP;FUZ
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),-0.6616458225247923,-1.8508233442101978,0.0,0.06198392483364617,0.667,10/25,9.95%,ANK2;DMD;ACTN2;SLC6A9;ATP1B1;WNK4;ANK3;TRPC6;ATP1B2;WNK1
prerank,regulation of potassium ion transport (GO:0043266),-0.6322867646522683,-1.84197300335979,0.0027397260273972603,0.06698147243665327,0.713,12/31,9.99%,ANK2;FHL1;KCNIP3;ACTN2;CACNA1D;KCNIP4;ANK3;DLG1;KCNAB1;DPP6;ADRA2A;CD63
prerank,dermatan sulfate biosynthetic process (GO:0030208),-0.7901721940829436,-1.831665175461031,0.0,0.07513203010138929,0.767,7/12,9.72%,UST;DSE;DCN;BGN;CSPG4;VCAN;DSEL
prerank,renal system development (GO:0072001),-0.5709468549324559,-1.8314941386798842,0.0,0.07198440258058535,0.768,28/52,18.47%,SULF1;GLI2;WNT4;GREB1L;SULF2;TGFBR1;BMP4;PCSK5;PKD1;RBP4;SALL1;SIX1;TBX18;IFT88;AGTR1;PYGO1;ARL3;VEGFA;TGFB2;STRA6;PYGO2;TRAF3IP1;PAX8;ITGA8;NPHP3;MYOCD;FOXC1;IFT27
prerank,synaptic membrane adhesion (GO:0099560),-0.759087264443019,-1.8310576499175548,0.0022675736961451248,0.06940314370017041,0.769,7/14,6.10%,GPC6;PTPRS;PTPRF;PTPRD;LRFN5;LRRC4C;NTNG1
prerank,digestive tract development (GO:0048565),-0.6222242635901797,-1.8276442083722746,0.0027247956403269754,0.07034879003930526,0.782,17/33,15.45%,GLI3;FGFR2;CLMP;RARB;GLI2;KIT;PCSK5;PKD1;COBL;SALL1;GLI1;SMO;TGFB2;STRA6;CCDC39;PKDCC;RARRES2
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.7063456555223488,-1.826421894488907,0.0045662100456621,0.06918678879942845,0.79,8/17,9.88%,ATP1A2;CACNA1C;GJA1;ATP1B1;SLC8A1;PRKACA;RYR2;ATP1B2
prerank,dermatan sulfate metabolic process (GO:0030205),-0.7671487147321427,-1.8253495825494335,0.002242152466367713,0.06763786963015268,0.795,7/13,9.72%,UST;DSE;DCN;BGN;CSPG4;VCAN;DSEL
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),-0.6010774583147809,-1.8216846479188442,0.0,0.06916423442753643,0.813,7/37,7.06%,PHLDB2;EPHA3;EFNA5;PHLDB1;BICD1;PRKAA2;MAP6
prerank,external encapsulating structure organization (GO:0045229),-0.44318873681909443,-1.811486558302827,0.0,0.07659326430180834,0.843,77/205,7.60%,LAMA2;COL1A2;COL3A1;COL4A5;FBN1;SMOC1;ADAMTS12;COL1A1;ADAMTS2;THSD4;DCN;COL8A1;COL4A6;ADAMTSL3;COL5A1;NID1;COL22A1;ADAMTS6;VTN;COL4A3;LAMC3;ADAMTSL5;LOXL1;COL4A4;ITGA9;COL6A2;COL6A3;COL11A1;ITGB5;HSPG2;SPARC;COL6A1;NID2;ADAMTS10;ADAMTS5;COL8A2;BGN;MFAP5;COL13A1;VIT;COL18A1;DAG1;ITGA10;FBLN5;COL23A1;ITGA11;ADAMTSL1;THBS1;DDR1;COL27A1;FGF2;SMOC2;CDH1;RECK;MMP14;NDNF;FBN2;ITGA1;ADAMTS17;ADAMTSL4;MMP16;COL5A3;ITGB8;ITGAV;NF1;ADAM19;ADAMTS15;SPP1;LUM;TGFBI;ST7;COL16A1;VCAN;LOX;ADAMTS1;COL14A1;CD44
prerank,negative regulation of blood pressure (GO:0045776),0.8602494070636528,1.809283658685138,0.003656307129798903,0.34388620087766164,0.904,3/13,1.82%,NOS3;BMPR2;PRCP
prerank,ureteric bud development (GO:0001657),-0.7262993969745699,-1.8089347876027253,0.0023923444976076554,0.0767159393452486,0.852,10/17,10.90%,FGFR2;GPC3;BMP7;OSR1;BMP4;ROBO2;SALL1;SIX1;NPNT;SLIT2
prerank,extracellular structure organization (GO:0043062),-0.44567006448929214,-1.8086807622673098,0.0,0.0744766378285544,0.852,78/204,7.60%,LAMA2;COL1A2;COL3A1;COL4A5;FBN1;SMOC1;ADAMTS12;COL1A1;ADAMTS2;THSD4;DCN;COL8A1;COL4A6;ADAMTSL3;COL5A1;NID1;COL22A1;ADAMTS6;VTN;COL4A3;LAMC3;ADAMTSL5;LOXL1;COL4A4;ITGA9;COL6A2;COL6A3;COL11A1;ITGB5;HSPG2;SPARC;COL6A1;NID2;ADAMTS10;ADAMTS5;COL8A2;TGFBR1;BGN;MFAP5;COL13A1;VIT;COL18A1;DAG1;ITGA10;FBLN5;COL23A1;ITGA11;ADAMTSL1;THBS1;DDR1;COL27A1;FGF2;SMOC2;CDH1;RECK;MMP14;NDNF;FBN2;ITGA1;ADAMTS17;ADAMTSL4;MMP16;COL5A3;ITGB8;ITGAV;NF1;ADAM19;ADAMTS15;SPP1;LUM;TGFBI;ST7;COL16A1;VCAN;LOX;ADAMTS1;COL14A1;CD44
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.6397393258869161,-1.806771979811316,0.0024154589371980675,0.07423019695861599,0.861,4/26,1.86%,EYA2;EYA1;BCL2;EYA4
prerank,mesonephric tubule development (GO:0072164),-0.7396384876724593,-1.8023645062502542,0.0,0.07656943465079041,0.876,10/15,10.90%,FGFR2;BMP7;OSR1;BMP4;PKD1;ROBO2;SALL1;SIX1;NPNT;SLIT2
prerank,endodermal cell differentiation (GO:0035987),-0.6299802378075217,-1.798183442493401,0.0,0.07855643505731548,0.894,13/31,9.55%,COL8A1;COL12A1;VTN;COL11A1;ITGB5;COL6A1;MMP14;ITGAV;CTR9;PAF1;MMP2;INHBA;LEO1
prerank,regulation of smoothened signaling pathway (GO:0008589),-0.5695656529210528,-1.7928724615638723,0.006369426751592357,0.08095114917830547,0.908,21/50,14.20%,ZIC1;GLI3;FGFR2;GPC3;DCDC2;IFT81;GAS1;TULP3;RORA;EVC;GLIS2;ARMC9;BTRC;GLI1;SFRP1;HHIP;SMO;FUZ;SUFU;INTU;KIF7
prerank,bile acid and bile salt transport (GO:0015721),0.7683918160067833,1.7894560407698785,0.0015455950540958269,0.4400765299493569,0.958,6/24,5.11%,ABCC4;SLCO2B1;ATP8B1;STARD5;NCOA1;CEACAM1
prerank,embryonic limb morphogenesis (GO:0030326),-0.5938060975299261,-1.7874754048468848,0.0,0.0843277335648657,0.921,12/34,15.44%,CACNA1C;AFF3;GLI3;OSR1;CYP26B1;SALL1;LRP6;TGFB2;TBX2;WDPCP;INTU;TBX3
prerank,regulation of cell junction assembly (GO:1901888),0.7420181860763488,1.7862515859797496,0.00333889816360601,0.4263618369456824,0.962,12/27,11.56%,PRKCH;TJP1;MEF2C;CLDN5;OCLN;F11R;RAP1B;RAPGEF2;RAP1A;APLNR;MYO1C;CBFB
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.8034404113247868,1.784589799257451,0.005128205128205128,0.40506916229006534,0.963,6/18,5.38%,JAM2;SLC39A8;VCAM1;SELE;SELP;CX3CR1
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.6285935030446791,1.779494824525049,0.0,0.41156749095960565,0.972,18/75,6.54%,NRP2;TEK;EGFL7;BMPR2;KDR;PPP1R16B;PRKD1;PLCG1;PDGFB;VEGFC;GATA2;PRKD2;JCAD;HIF1A;FLT4;VEGFD;WNT5A;NRAS
prerank,relaxation of cardiac muscle (GO:0055119),-0.7463770603308262,-1.7791783727638395,0.004434589800443459,0.09156506049048858,0.937,6/13,7.48%,ATP1A2;GSN;ATP1B1;SLC8A1;P2RX4;KCNJ2
prerank,leukocyte cell-cell adhesion (GO:0007159),0.7495278615229005,1.7762114603758858,0.0033277870216306157,0.4037174298241363,0.975,7/24,3.91%,PECAM1;VCAM1;ICAM1;F11R;MSN;SELE;SELP
prerank,granulocyte differentiation (GO:0030851),0.7841595669089324,1.7701411779961922,0.0053475935828877,0.4174467909486703,0.98,4/18,3.41%,LEF1;CBFA2T3;TAL1;LBR
prerank,porphyrin-containing compound catabolic process (GO:0006787),0.8454029876584463,1.7694535855755487,0.003395585738539898,0.37721240667641687,0.981,2/14,0.42%,SLCO2B1;ABCG2
prerank,heme catabolic process (GO:0042167),0.8454029876584463,1.7694535855755487,0.003395585738539898,0.37721240667641687,0.981,2/14,0.42%,SLCO2B1;ABCG2
prerank,regulation of protein neddylation (GO:2000434),0.8640721020974477,1.7669049522125202,0.00558659217877095,0.3744374026871515,0.985,3/10,2.79%,EPAS1;DCUN1D3;HIF1A
prerank,carboxylic acid metabolic process (GO:0019752),0.7058394188063789,1.7637558843940004,0.005917159763313609,0.3732283530926261,0.987,6/33,4.12%,CSGALNACT1;SLC2A1;ST6GAL1;ST3GAL1;PLA2G4A;GLYAT
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.7187095872032969,-1.763331020058195,0.004514672686230248,0.10811959159240243,0.963,4/14,9.88%,ANK2;ACTN2;ATP1B1;ATP1B2
prerank,extracellular matrix organization (GO:0030198),-0.4189491760507677,-1.7620015214184255,0.0,0.10703135414002184,0.964,105/276,10.53%,LAMA2;COL1A2;COL3A1;COL4A5;FBN1;SMOC1;ADAMTS12;COL1A1;ADAMTS2;THSD4;DCN;COL8A1;COL4A6;GSN;ADAMTSL3;COL5A1;NID1;COL12A1;COL22A1;ADAMTS6;VTN;COL25A1;COL4A3;LAMC3;TIMP2;ADAMTSL5;LOXL1;COL4A4;ITGA9;COL6A2;COL6A3;COL11A1;ITGB5;HSPG2;SPARC;PLOD2;COL6A1;NID2;ADAMTS10;ADAMTS5;COL8A2;TGFBR1;BGN;MFAP5;COL26A1;SERPINH1;COL13A1;VIT;COL18A1;DAG1;GPM6B;ITGA10;FBLN5;COL23A1;ITGA11;ADAMTSL1;THBS1;DDR1;LOXL3;COL27A1;FGF2;SMOC2;SH3PXD2B;CDH1;SCUBE1;RECK;MMP14;NDNF;HTRA1;FBN2;ITGA1;ADAMTS17;CYP1B1;ADAMTSL4;MMP16;COL5A3;ITGB8;ITGAV;NF1;ADAM19;ADAMTS15;SPP1;LUM;TGFBI;ST7;COL16A1;VCAN;P4HB;LOX;ADAMTS1;COL14A1;CD44;FLRT2;KLK2;COL9A2;TNC;MMP2;NPNT;ADAM12;DPT;DDR2;COL20A1;SERPINE1;COL15A1;ADAMTS14
prerank,relaxation of muscle (GO:0090075),-0.7368437487334636,-1.7606729924138338,0.006622516556291391,0.10617996836845348,0.967,6/13,7.48%,ATP1A2;GSN;ATP1B1;SLC8A1;P2RX4;KCNJ2
prerank,striated muscle cell development (GO:0055002),0.819314881225579,1.7583254756709288,0.0017667844522968198,0.38684808172660795,0.991,3/14,3.98%,PGM5;FLII;TMOD3
prerank,cell-substrate junction assembly (GO:0007044),0.7079676771471255,1.7533775128313185,0.00631911532385466,0.39809500637889533,0.992,10/33,5.16%,THSD1;ITGA6;PEAK1;BCR;DST;TAOK2;LAMA3;SORBS1;ACTN1;PTPRK
prerank,negative regulation of endopeptidase activity (GO:0010951),-0.5478056326808157,-1.7522654032158462,0.003105590062111801,0.11544880057495288,0.978,12/47,12.41%,TIMP3;SERPING1;VTN;TIMP2;SERPINH1;RECK;SERPINE2;SERPIND1;SERPINF1;BIN1;SERPINE1;SPOCK3
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.6624674237279434,1.7516592413292158,0.002793296089385475,0.39092603556321537,0.993,18/48,7.97%,NOS3;HDAC9;KDR;PTGS2;PRKD1;PLCG1;PDGFB;GATA2;PRKD2;JCAD;HDAC7;HIF1A;PIK3C2A;TMSB4X;RHOJ;CD40;TGFB1;MAP3K3
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.7363349946632243,1.7504825078693684,0.006359300476947536,0.38226994136472914,0.993,6/26,5.50%,NOS3;ACER2;SPTLC2;GCH1;SPTLC3;ASAH2
prerank,regulation of smooth muscle cell migration (GO:0014910),-0.6636033372263757,-1.7501400466453307,0.0024154589371980675,0.11604474942575824,0.984,11/20,10.90%,IGF1;LRP1;BMPR1A;PDGFRB;VTN;NRP1;IGFBP5;IGFBP3;CCN4;SERPINE1;SLIT2
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.7076933940561636,1.7482588125985214,0.0032102728731942215,0.3780807260472431,0.993,13/34,5.62%,SEMA6A;FLT1;KDR;ERN1;PRKD1;VEGFC;DAB2IP;PRKD2;NOTCH1;FLT4;VEGFD;DLL4;RAMP2
prerank,sulfur compound catabolic process (GO:0044273),-0.5812036591145633,-1.7477328282563365,0.0,0.11684633296840122,0.986,14/38,11.64%,DCN;OGN;FMOD;BGN;CSPG4;GGT5;PRELP;LUM;VCAN;ARSB;OMD;NUDT7;ACAT1;HEXA
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.7180965102305416,1.745905189626004,0.0032520325203252032,0.37599300755997883,0.995,6/30,3.69%,NOS3;TNFSF10;ICAM1;ARHGEF2;FAS;CASP8
prerank,T cell proliferation (GO:0042098),0.7956161345177893,1.7419912362567598,0.016216216216216217,0.3841924053162726,0.997,5/13,7.41%,CADM1;CTPS1;MSN;PPP3CB;PIK3CG
prerank,regulation of gastrulation (GO:0010470),-0.7318270531190609,-1.7418406416391985,0.009324009324009324,0.12281516178825336,0.992,4/14,3.02%,PHLDB2;OSR1;PHLDB1;DAG1
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.6234963129160593,1.741525408806497,0.0014044943820224719,0.37326460645378123,0.997,19/67,5.07%,NRP2;CLEC14A;FLT1;KDR;PRKD1;VEGFC;DOCK1;ELMO1;WASF2;DAB2IP;PRKD2;PTK2B;FYN;NCK1;PXN;FLT4;PAK2;NCKAP1;VEGFD
prerank,regulation of endothelial cell proliferation (GO:0001936),0.6013349568224698,1.7410667678127372,0.0013531799729364006,0.3634508215890727,0.997,20/88,6.54%,NRP2;TEK;EGFL7;BMPR2;KDR;CAV1;TIE1;PPP1R16B;ACVRL1;PRKD1;PTPRM;PDGFB;VEGFC;PRKD2;HIF1A;FLT4;CAV2;VEGFD;WNT5A;NRAS
prerank,dicarboxylic acid transport (GO:0006835),-0.6048222950720852,-1.73669075897176,0.0053475935828877,0.12799166099244277,0.994,13/28,15.93%,SLC1A3;SLC13A3;PDPN;SLC26A7;GJA1;SLC22A6;SLC1A2;SLC25A12;SLC25A13;SLC19A1;SLC26A6;SLC1A1;SLC25A18
prerank,intestinal absorption (GO:0050892),0.8230093767758135,1.7340117458146231,0.0038022813688212928,0.38784547441774386,0.998,4/13,2.39%,UGCG;F11R;TJP2;KCNQ1
prerank,actomyosin structure organization (GO:0031032),0.6073467599125218,1.731485139471686,0.0040650406504065045,0.3891628382378658,0.998,12/75,5.44%,PGM5;FRMD5;FLII;TJP1;FAM171A1;EPB41;F11R;MYH9;TMOD3;SORBS1;PDLIM1;CDC42BPB
prerank,filopodium assembly (GO:0046847),0.779757201468742,1.7299646412495544,0.010657193605683837,0.384602021215039,0.998,6/16,4.52%,FGD5;DNM3;FGD6;SRGAP2;SPATA13;PPP1R9B
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.7654949485218954,1.729162793321313,0.010221465076660987,0.37690806924987724,0.998,6/19,4.81%,PRKCH;TJP1;CLDN5;OCLN;F11R;IKBKB
prerank,embryonic eye morphogenesis (GO:0048048),-0.7521483598718798,-1.7251946002116059,0.0023094688221709007,0.14505947792754317,0.996,7/11,14.84%,FBN1;EFEMP1;MFAP5;FBN2;LRP6;TBX2;MFAP2
prerank,odontogenesis (GO:0042476),-0.5767632590243671,-1.7210747540171263,0.0027397260273972603,0.14890193707004007,0.997,13/35,11.47%,COL1A2;FGFR2;GLI2;EDA;OSR1;WNT6;BMP4;LRP6;AXIN2;BCOR;INHBA;TGFB3;TGFB2
prerank,amino sugar metabolic process (GO:0006040),0.8601217269023828,1.7169301397240713,0.003898635477582846,0.4280786527101017,0.999,3/10,1.50%,CSGALNACT1;ST6GAL1;ST3GAL1
prerank,skeletal system development (GO:0001501),-0.4466673811523671,-1.713905701526027,0.0,0.15819051702087034,0.997,40/148,7.60%,BMP6;COL1A2;SOX5;IGF1;SULF1;FBN1;FGFR2;COL1A1;GLI2;CDH11;AKAP13;TRPS1;BMP5;BMP7;GJA1;SULF2;NPR3;TGFBR1;COL13A1;WWOX;PCSK5;PKD1;RBP4;SOX6;SH3PXD2B;EXT1;MMP14;GNAS;MMP16;TNFRSF11B;ITGB8;IGF2;EVC;ALPL;PRELP;PAPSS2;KIAA1217;VCAN;NOTUM;CD44
prerank,keratan sulfate catabolic process (GO:0042340),-0.7501643229426972,-1.7129161182913981,0.008620689655172414,0.1567865372044174,0.997,6/11,11.64%,OGN;FMOD;PRELP;LUM;OMD;HEXA
prerank,amide transport (GO:0042886),0.7054792266916594,1.712490357147465,0.006546644844517185,0.4390543865723427,1.0,7/26,5.77%,ABCG2;CERT1;PLTP;SLC38A5;AQP11;GLTP;TAP2
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.632180222342594,1.712157715028312,0.006915629322268326,0.4290350135778881,1.0,15/54,7.32%,NOS3;KDR;MEF2C;ACVRL1;PRKD1;PRCP;PLCG1;PDGFB;GATA2;PRKD2;HIF1A;TMSB4X;ATP2B4;CD40;TGFB1
prerank,cellular response to increased oxygen levels (GO:0036295),0.841506425977512,1.71174380415745,0.005385996409335727,0.4199303145470628,1.0,3/11,2.42%,FOXO1;CAV1;FAS
prerank,positive regulation of dendrite morphogenesis (GO:0050775),-0.6526234759028487,-1.710806775739881,0.0024813895781637717,0.15731784660501277,0.998,10/19,13.90%,OBSL1;CUX2;CAPRIN2;PTPRD;IL1RAPL1;CUX1;FBXW8;DBN1;CDKL3;CAMK2B
prerank,tight junction assembly (GO:0120192),0.6425557920922382,1.710789166282845,0.005822416302765648,0.4143926503242938,1.0,9/49,5.62%,PECAM1;ESAM;LSR;CLDN5;OCLN;F11R;PARD3;PAK2;RAMP2
prerank,lipid transport (GO:0006869),0.5798584480233985,1.7098272501035436,0.0039164490861618795,0.4091581529995007,1.0,17/97,5.76%,ABCC4;SLCO2B1;ATP8B1;CERT1;PPARD;PLTP;ATP8A1;UGCG;SPNS2;SLCO2A1;SCARB1;PRELID2;STARD5;NCOA1;GLTP;CEACAM1;ABCA3
prerank,modulation by symbiont of entry into host (GO:0052372),0.7733457847793714,1.7093866221047616,0.010101010101010102,0.4014352365280014,1.0,6/16,7.85%,CAV1;TRIM14;NECTIN2;FUCA2;TRIM68;TRIM25
prerank,regulation of Notch signaling pathway (GO:0008593),0.6058326239442957,1.7073949649375846,0.004048582995951417,0.40176492737334996,1.0,18/76,7.33%,EGFL7;NOS3;IL6ST;LFNG;MAML2;EPN2;GATA2;STAT3;PRAG1;MFNG;FBXW7;NOTCH1;TSPAN5;DLL1;DLL4;TSPAN14;ARRB1;ARRDC1
prerank,response to lipid (GO:0033993),0.5688797745431171,1.7073290159863352,0.0012626262626262627,0.3927149562642489,1.0,32/105,15.63%,FOXO1;NOS3;ACER2;ESR1;PPARD;GCH1;FOXP1;SOCS2;STAT3;TNFRSF11A;SELE;SELP;TIRAP;RPS6KA3;PELI1;IFNAR1;WNT9B;HNRNPA0;TGFB1;CITED1;MAPKAPK3;OVCA2;CYP27B1;ASXL1;TRIB1;ADAM17;ABCG1;S100A9;PAQR8;STRN3;TRIM16;IRAK3
prerank,translation (GO:0006412),0.5330763732606599,1.7055445486347836,0.0,0.39251102152705303,1.0,83/208,17.73%,GARS1;RPS15;IGF2BP3;RPS19;RPLP1;RPS14;RPSA;RPS16;RPL38;FARS2;RPL34;RPS20;RPL39;IARS1;RPS7;RPS24;RPL37A;SRBD1;RPL36;RPS18;RSL24D1;RPL15;RPS8;RPL14;RPL23;RPL17;MRPS18A;NDUFA7;RPL9;DHPS;RPL4;RPL13A;LARS1;RPS11;RPL32;TNIP1;RPL22;RPS27;DRG2;RPL31;RPS23;MRPL13;RPL13;MRPS12;RPS12;EEF2K;MRPL35;APEH;HBS1L;RPL6;RPL10;FASTKD2;WARS1;MRRF;MRPL41;RPS29;RPS6;MRPL52;RARS1;RPL29;QRSL1;RPS25;RPL35A;RPS13;RPS21;MRPS16;RPL27;RPL18;AIMP1;MRPL23;RPL27A;MRPS5;KARS1;RPS10;MRPL37;EEFSEC;RPL11;RPL8;EEF2;WARS2;PTCD3;RPLP2;MRPL11
prerank,regulation of extracellular matrix disassembly (GO:0010715),-0.6960281120248912,-1.704773313156333,0.016055045871559634,0.165090140159158,0.998,8/15,11.31%,LRP1;PDPN;DPP4;DDR1;FAP;DDR2;FGFR4;CST3
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.6984761639643553,-1.7036014973024391,0.009779951100244499,0.16437125026639063,0.998,5/15,6.10%,PIEZO2;ADGRV1;COL11A1;KIT;WHRN
prerank,heart contraction (GO:0060047),-0.5428740634895103,-1.7018025516231754,0.006006006006006006,0.1645916873350711,0.999,9/41,9.11%,ATP1A2;DMD;SGCD;ATP1B1;SLC8A1;TPM1;GAA;SGCZ;RYR2
prerank,neurotransmitter uptake (GO:0001504),-0.7482733101780173,-1.7014941319237686,0.004464285714285714,0.1620166852204781,0.999,4/12,4.31%,ATP1A2;SLC1A3;GLUL;SNAP25
prerank,apical junction assembly (GO:0043297),0.6286924393371142,1.7013276756612248,0.007122507122507123,0.4039510625960253,1.0,10/53,5.62%,PECAM1;ESAM;CLDN5;OCLN;F11R;PARD3;PKN2;PAK2;CTNNA1;RAMP2
prerank,kidney development (GO:0001822),-0.5060181200850015,-1.6988819259933654,0.0033444816053511705,0.1642124128110056,0.999,31/65,18.47%,SULF1;GLI2;WNT4;BMP7;OSR1;GREB1L;SULF2;TGFBR1;BMP4;PCSK5;PKD1;ROBO2;KANK2;SALL1;NF1;SIX1;IFT88;AGTR1;PYGO1;ARL3;VEGFA;TGFB2;STRA6;PYGO2;TRAF3IP1;PAX8;ITGA8;NPHP3;FGF10;FOXC1;IFT27
prerank,positive regulation of endothelial cell migration (GO:0010595),0.588420572815026,1.6976288621707185,0.005141388174807198,0.413682375442531,1.0,23/84,7.41%,NRP2;TEK;NOS3;BMPR2;KDR;PRKD1;PLCG1;PDGFB;FOXP1;GATA2;SCARB1;EDN1;PRKD2;PTK2B;HIF1A;FLT4;TMSB4X;WNT5A;CD40;RAC1;SASH1;TGFB1;PIK3CG
prerank,ceramide metabolic process (GO:0006672),0.6357819640642938,1.690884811069303,0.004392386530014641,0.43883690925808433,1.0,10/49,5.50%,ST6GALNAC3;ACER2;SPTLC2;SGMS1;DEGS2;PLPP1;CERS4;SPTLC3;SPTSSA;ASAH2
prerank,blood vessel morphogenesis (GO:0048514),0.6166387646939121,1.6890819833935375,0.010115606936416185,0.4389813763311274,1.0,18/54,7.50%,EGFL7;FLT1;KDR;ENG;CAV1;TBX1;RASIP1;LRP5;SOX17;SOX18;FLT4;CDH2;ID1;SMAD7;LAMA1;RAMP2;TGFB1;RASA1
prerank,leukocyte tethering or rolling (GO:0050901),0.7645969661240056,1.6870834566601152,0.011986301369863013,0.4399996456953424,1.0,5/17,5.38%,JAM2;VCAM1;SELE;SELP;CX3CR1
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),-0.6352057379483458,-1.6857321272231212,0.010554089709762533,0.18507866970458525,1.0,11/21,10.63%,SULF1;SULF2;EXT1;HS3ST3B1;HS6ST3;HS2ST1;HS3ST4;HS6ST2;XYLT1;HS3ST5;HS6ST1
prerank,T-helper cell differentiation (GO:0042093),0.7908146904425228,1.6800437275126414,0.017605633802816902,0.46719779027408775,1.0,4/14,9.03%,LEF1;FOXP1;TMEM98;ZFPM1
prerank,intraciliary transport involved in cilium assembly (GO:0035735),-0.561951069348434,-1.6792609367127225,0.0,0.19425038524993796,1.0,21/37,20.43%,DYNC2H1;IFT81;WDR35;DYNC2I1;KIF3C;KIF3A;IFT80;IFT88;IFT20;IFT46;DYNC2LI1;IFT43;IFT22;PCM1;TRAF3IP1;KIFAP3;IFT74;IFT140;IFT27;IFT57;TTC21B
prerank,regulation of hydrolase activity (GO:0051336),0.5932093264134516,1.6781529786346245,0.0027359781121751026,0.4684474507416091,1.0,11/71,4.33%,PRKG1;CHN2;FGD5;PLXNA4;CAV1;RASIP1;DAB2IP;FGD6;PLXND1;ARHGAP27;TBC1D15
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.8017527067541627,1.6775221618308078,0.016483516483516484,0.4626131065608004,1.0,7/12,11.39%,ERN1;DAB2IP;XBP1;BOK;BCL2L11;PTPN1;ATF6
prerank,cardiac muscle contraction (GO:0060048),-0.5690608213157834,-1.6771056193333655,0.008620689655172414,0.1950533190700261,1.0,8/34,9.11%,ATP1A2;DMD;GSN;ATP1B1;SLC8A1;TPM1;GAA;RYR2
prerank,monocyte chemotaxis (GO:0002548),0.6791761025807627,1.6759998891292143,0.004862236628849271,0.46172007156970307,1.0,5/32,4.40%,FLT1;PDGFB;IL6R;TNFRSF11A;RPS19
prerank,adenine nucleotide transport (GO:0051503),0.7468695858978012,1.6757941981051696,0.021885521885521887,0.4542989249380978,1.0,2/17,0.57%,ABCC4;LRRC8C
prerank,regulation of plasminogen activation (GO:0010755),-0.7137689384543021,-1.6757394009491524,0.013793103448275862,0.19463853774105377,1.0,8/12,24.81%,CLEC3B;THBS1;SERPINE2;RUNX1;SERPINE1;CTSZ;PLGRKT;ENO1
prerank,regulation of GTPase activity (GO:0043087),0.5346281373972661,1.672858120146983,0.002430133657351154,0.4616180025010922,1.0,39/177,10.81%,PRKG1;CHN2;LRCH1;FGD5;DOCK9;PKP4;PLXNA4;TGM2;NET1;ITGA6;F11R;TBC1D30;RASIP1;SH3BP4;DAB2IP;FGD6;SRGAP2;PLXND1;ARHGAP27;CAV2;ADRB1;TBC1D15;RAP1GDS1;RAPGEF2;CD40;BCAR3;PTK2;RAP1A;TBC1D2;AGRN;RASA4;RSU1;ARHGEF7;CRK;OCRL;LARS1;CCL14;SEMA4D;EPHA4
prerank,organic hydroxy compound transport (GO:0015850),0.6742330909155193,1.6715667884108651,0.005979073243647235,0.45988942340829814,1.0,6/36,5.11%,ABCC4;SLCO2B1;ATP8B1;STARD5;NCOA1;CEACAM1
prerank,protein localization to synapse (GO:0035418),-0.7380037032437953,-1.665036052245411,0.008403361344537815,0.21430596135763463,1.0,8/12,15.54%,NLGN2;DLG4;PCLO;NRXN1;NLGN1;SHANK1;NRXN2;BSN
prerank,lymphocyte differentiation (GO:0030098),0.593636326859311,1.662974136410927,0.00846262341325811,0.4968077929602116,1.0,22/68,13.42%,HDAC9;PBX1;LFNG;VCAM1;HHEX;TPD52;PTPRJ;ADGRG3;CHD7;PLCG2;TOX;JAK3;DLL4;LYL1;LCK;TCF3;SOX4;RELB;JAG2;DCAF1;KLF6;ADAM17
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),-0.6624322850041656,-1.6610091641915932,0.0045871559633027525,0.21957079538533072,1.0,7/16,9.25%,FOXD1;FGF1;BMP4;FGF2;SALL1;SIX1;NPNT
prerank,actin filament depolymerization (GO:0030042),-0.7389895328319974,-1.6598732472567579,0.011286681715575621,0.21858937341343992,1.0,3/11,1.04%,MICAL3;GSN;MICAL2
prerank,negative regulation of protein processing (GO:0010955),-0.7211157025942477,-1.6582332630517498,0.017467248908296942,0.21897120788143265,1.0,6/12,14.28%,GAS1;THBS1;SERPINE2;LRRK2;SERPINE1;CTSZ
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.5342853423080994,1.6551733213638953,0.004790419161676647,0.531166120965188,1.0,29/151,8.78%,ACER2;CERT1;ELOVL7;SPTLC2;SGMS1;DEGS2;PRKD1;GCH1;SPNS2;PLA2G4A;PLPP1;SGPP2;PRKD2;PRKD3;CERS4;ALAS1;LPCAT3;SPTLC3;ELOVL5;GPHN;SPTSSA;CEPT1;LPIN3;PPM1L;PAM;B4GALT5;GSTO2;GSTA4;B3GNT6
prerank,hemopoiesis (GO:0030097),0.5710206171786066,1.6541134813064349,0.004092769440654843,0.5281862790173564,1.0,20/87,7.32%,MECOM;TEK;FLT1;KDR;SNRK;ZBTB16;ETV6;KITLG;PDGFB;TAL1;CD34;FLT4;TOX;TIRAP;DLL1;HIPK1;WNT5A;LYL1;LCK;TGFB1
prerank,diol biosynthetic process (GO:0034312),0.7605289640742917,1.6540263274825697,0.015873015873015872,0.5199263705617089,1.0,5/15,5.50%,ACER2;SPTLC2;GCH1;SPTLC3;ASAH2
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.6553998126125261,1.653860896500537,0.007898894154818325,0.5122475124574435,1.0,11/36,6.09%,LEF1;NFATC1;FZD6;FZD4;PPP3CA;GNB1;PLCB1;TCF7L2;TNRC6C;PPP3CB;WNT5A
prerank,regulation of transferase activity (GO:0051338),0.7375554931791171,1.6525348438329788,0.02555366269165247,0.5111922731635758,1.0,4/17,8.82%,LDB2;NLRC5;HMBOX1;PINX1
prerank,angiogenesis involved in wound healing (GO:0060055),0.8035720506507036,1.6523659457383186,0.02185792349726776,0.5038624486888289,1.0,5/11,3.79%,ADIPOR2;KDR;PRCP;GATA2;CD34
prerank,positive regulation of angiogenesis (GO:0045766),0.5538849269665806,1.6521094164974557,0.0012453300124533001,0.49713950922720695,1.0,26/108,8.09%,TEK;TJP1;NOS3;FLT1;KDR;TIE1;PRKD1;SMAD1;PLCG1;VEGFC;GATA2;PRKD2;HIF1A;CD34;PIK3R6;DLL1;HIPK1;XBP1;VEGFD;RAMP2;WNT5A;CD40;SASH1;JAK1;ITGA5;GAB1
prerank,purine ribonucleotide transport (GO:0015868),0.7481653220896212,1.6515812971994543,0.02218430034129693,0.4922894108224124,1.0,2/16,0.57%,ABCC4;LRRC8C
prerank,regulation of cation transmembrane transport (GO:1904062),-0.5782834743682259,-1.6497135393440496,0.012987012987012988,0.23439239419824118,1.0,13/29,16.38%,SNTA1;KCNIP3;CACNA1D;KCNIP4;DLG1;SLMAP;KCNAB1;DPP6;WNK1;CD63;KCNN2;WNK3;DPP10
prerank,regulation of lymphocyte migration (GO:2000401),0.8164648975674984,1.647757461455759,0.021778584392014518,0.5041689020649429,1.0,3/10,2.80%,JAM2;STK10;MSN
prerank,modified amino acid transport (GO:0072337),-0.68594804468788,-1.6477102809788098,0.009111617312072893,0.23510877743546144,1.0,3/15,1.60%,SLC6A13;SLC16A12;PDPN
prerank,calcium ion transmembrane transport (GO:0070588),-0.4688437776447536,-1.6475487926430785,0.0,0.2319611591596057,1.0,23/86,11.67%,SLC24A3;TRPM3;CACNA1C;NALCN;SLC8A3;CACNA2D1;CACNA1D;PKD1;SLC8A1;P2RX4;MCU;SLC35G1;CACNA1G;ITGAV;TRPC3;TRPC6;TRPC1;ATP2A2;SLC24A2;TRPC4;GRIN2A;MICU1;YME1L1
prerank,embryonic skeletal system morphogenesis (GO:0048704),-0.568972934858163,-1.64656058683342,0.014450867052023121,0.23050044423217897,1.0,10/31,5.77%,FGFR2;PDGFRA;HOXC4;OSR1;TGFBR1;HOXA3;DYNC2I1;HOXB4;HOXB3;SIX1
prerank,regulation of macrophage migration (GO:1905521),0.8088710057320958,1.6456951752281526,0.02099236641221374,0.5077851379473357,1.0,6/10,11.15%,MTUS1;CD200;PTK2B;CX3CR1;CSF1;P2RY12
prerank,bicellular tight junction assembly (GO:0070830),0.6227789364602105,1.6444079005850207,0.011816838995568686,0.5075998368013258,1.0,8/46,5.62%,PECAM1;ESAM;CLDN5;OCLN;F11R;PARD3;PAK2;RAMP2
prerank,regulation of microtubule-based process (GO:0032886),-0.5438845852221859,-1.6441917369201207,0.02046783625730994,0.23202050900808208,1.0,8/36,7.06%,PHLDB2;EPHA3;EFNA5;PHLDB1;BICD1;PRKAA2;ATF5;MAP6
prerank,growth hormone receptor signaling pathway (GO:0060396),0.7755638386972354,1.6438353183334151,0.01936619718309859,0.5032754644886482,1.0,8/14,9.42%,SOCS2;LYN;STAT3;PXN;JAK3;GHR;PTK2;PTPN1
prerank,response to interleukin-4 (GO:0070670),0.8165325789368078,1.6436690010585822,0.019927536231884056,0.4969268929747535,1.0,5/10,8.35%,LEF1;JAK3;XBP1;DCSTAMP;CITED1
prerank,L-serine metabolic process (GO:0006563),0.8208637503296938,1.6436231213642767,0.017509727626459144,0.49009080747100353,1.0,2/10,2.40%,SERINC3;SERINC5
prerank,maintenance of blood-brain barrier (GO:0035633),0.6695579259136211,1.6433362242048133,0.015503875968992248,0.48467118528366365,1.0,9/30,1.93%,TJP1;PECAM1;JAM2;ESAM;LSR;CLDN5;OCLN;F11R;TJP2
prerank,positive regulation of epithelial cell migration (GO:0010634),0.5691572569030094,1.6402575616758797,0.00510204081632653,0.49344201557628997,1.0,23/92,7.41%,NRP2;TEK;BMPR2;KDR;PRKD1;PLCG1;DOCK1;FOXP1;RAB11A;SCARB1;EDN1;PRKD2;PTK2B;HIF1A;PPM1F;RREB1;FLT4;PLCG2;ENPP2;WNT5A;RAC1;SASH1;PIK3CG
prerank,positive regulation of smooth muscle cell migration (GO:0014911),-0.6638653460460228,-1.6375402752689596,0.012195121951219513,0.24343816145434313,1.0,7/17,1.52%,IGF1;DOCK7;DOCK5;PDGFRB;VTN;NRP1;IGFBP5
prerank,peripheral nervous system development (GO:0007422),0.6971217452968776,1.6369092588295762,0.014634146341463415,0.5036948915947038,1.0,1/23,0.01%,ADGRG6
prerank,inositol lipid-mediated signaling (GO:0048017),-0.51673739224663,-1.6368482695234337,0.0,0.241784871515499,1.0,15/50,7.82%,PLCL1;IGF1;PLCE1;PDGFRB;PDGFRA;ADAP2;IRS1;PI4KA;GAB2;OGT;PLCD3;NGF;PLCB3;PLCD1;EZR
prerank,regulation of sprouting angiogenesis (GO:1903670),0.6667414648874048,1.635813201058363,0.011661807580174927,0.5022356970742763,1.0,11/33,7.98%,SEMA6A;TJP1;PPP1R16B;EPN2;SMAD1;DLL1;RHOJ;KLF2;CEACAM1;JAK1;ITGA5
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.6993346097116026,1.6353471447114605,0.024350649350649352,0.49777152814425357,1.0,4/23,3.88%,CADM1;NECTIN2;PVR;PIK3R6
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.5363606504963315,1.6350041709627614,0.003703703703703704,0.4929454264387444,1.0,40/149,14.56%,PRKCH;RPS6KA5;NOD1;CAV1;APP;PRKD1;ARHGEF2;PRKD2;STAT3;AIM2;TNFRSF11A;TRIM14;NFKBIA;TRAF1;TIRAP;IKBKB;CX3CR1;TRIM68;WNT5A;MID2;CD40;TRIM25;NFKB1;MALT1;IKBKG;PSMA6;MAP3K13;RIPK1;CARD16;RELA;RIPK2;RNF25;MTPN;RAB7B;IL1RAP;NPM1;TRAF6;S100A9;ERC1;NFKB2
prerank,sulfation (GO:0051923),-0.7310197203568182,-1.6347866568015679,0.006928406466512702,0.24282481513041126,1.0,1/11,0.08%,UST
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.5838869719263055,1.634122880874631,0.0055248618784530384,0.490655778594358,1.0,23/70,13.98%,WIPF3;PLCG1;DOCK1;ELMO1;WASF2;LYN;YES1;FYN;NCK1;PLCG2;ARPC3;NCKAP1;ARPC1B;RAC1;PTK2;CRK;FCGR1A;MYO1C;CYFIP1;ACTR2;HSP90AB1;PLD2;ACTR3
prerank,hematopoietic stem cell proliferation (GO:0071425),0.808038675634411,1.6308843631141425,0.018148820326678767,0.5002284662522956,1.0,4/11,6.09%,MECOM;ETV6;CD34;WNT5A
prerank,glycosaminoglycan metabolic process (GO:0030203),-0.5117240592310264,-1.6286338948729073,0.009708737864077669,0.25414878835805377,1.0,25/54,18.87%,GPC6;SDC2;GPC3;HSPG2;HS3ST3A1;EXT1;PXYLP1;HS3ST3B1;HS2ST1;GPC5;HS6ST2;GCNT2;SDC4;XYLT1;HS3ST5;HS6ST1;GPC4;HEXA;B4GALT7;SDC1;GPC1;HGSNAT;UGDH;B3GAT2;IDUA
prerank,regulation of T cell migration (GO:2000404),0.7350682916396734,1.6280567554852616,0.019963702359346643,0.5082213686900717,1.0,3/18,1.49%,LRCH1;APP;CD200
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.7826816102418742,1.6272979206929854,0.023465703971119134,0.5055293999739733,1.0,6/13,9.42%,EPN2;MMRN2;DAB2IP;HHEX;NEDD4;PTPN1
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.5602369070757025,1.6265725568344886,0.001321003963011889,0.5030569447592674,1.0,27/94,18.42%,IL1R1;RPS6KA5;NOD1;NFKBIA;PLCB1;IKBKB;PELI1;PSMA2;NFKB1;MAP3K3;IKBKG;PSMA8;PSMA6;CUL1;IRAK4;RELA;RIPK2;IL1RAP;TRAF6;PSME1;IRAK3;RPS6KA4;TAB3;IRAK2;MAP3K8;PSMA4;PSMF1
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.6691341537807923,1.6263927812383674,0.013996889580093312,0.4978320289579633,1.0,12/32,5.27%,HDAC9;KDR;PTGS2;MMRN2;GATA2;JCAD;HDAC7;NOTCH1;PIK3C2A;CARD10;RHOJ;DLL4
prerank,regulation of endothelial cell migration (GO:0010594),0.5665180108953629,1.6256380720193342,0.006587615283267457,0.49529730439082803,1.0,23/85,7.46%,NRP2;TEK;BMPR2;KDR;ACVRL1;PRKD1;PTPRM;PRCP;FOXP1;DAB2IP;SCARB1;EDN1;PRKD2;PTK2B;FLT4;RHOJ;CEACAM1;DLL4;WNT5A;RAC1;SASH1;PIK3CG;PTK2
prerank,aminoglycan catabolic process (GO:0006026),-0.5677990981273133,-1.6246283301857785,0.013623978201634877,0.2599892225526106,1.0,10/28,16.74%,GPC6;SDC2;GPC3;HSPG2;GPC5;SDC4;GPC4;SDC1;GPC1;HGSNAT
prerank,protein localization to endoplasmic reticulum (GO:0070972),-0.652400884059193,-1.62397798947886,0.016055045871559634,0.25797975039646537,1.0,8/16,18.28%,ANK2;LRRK2;RYR2;SEC16B;GBF1;MIA3;DDRGK1;SEC16A
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.6859528031320349,-1.623837998933942,0.014423076923076924,0.25480759877652925,1.0,7/14,16.58%,SULF1;SULF2;THBS1;FGF2;FUZ;GPC1;CREB3L1
prerank,lipid translocation (GO:0034204),0.7042361487358539,1.6234170821113718,0.019834710743801654,0.499785851314457,1.0,5/21,2.88%,ATP8B1;ATP8A1;ATP10A;ATP11C;ATP11B
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.5802753495937569,1.6231713924373385,0.004149377593360996,0.49502573540058,1.0,23/71,13.98%,WIPF3;PLCG1;DOCK1;ELMO1;WASF2;LYN;YES1;FYN;NCK1;PLCG2;ARPC3;NCKAP1;ARPC1B;RAC1;PTK2;CRK;FCGR1A;MYO1C;CYFIP1;ACTR2;HSP90AB1;PLD2;ACTR3
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.7331304939195658,1.6221695310255972,0.02195945945945946,0.49421790372119556,1.0,3/16,3.16%,CADM1;NECTIN2;PVR
prerank,vasculogenesis (GO:0001570),0.6407909649167796,1.6214762655872306,0.021604938271604937,0.4920425647285469,1.0,11/32,7.50%,EGFL7;KDR;ENG;CAV1;RASIP1;NOTCH1;SOX17;SOX18;RAMP2;TGFB1;RASA1
prerank,regulation of cellular component biogenesis (GO:0044087),0.6221995778500793,1.6202404360665823,0.0218408736349454,0.4927748298546889,1.0,9/39,7.52%,TJP1;TIE1;DAB2IP;NOTCH1;MSN;RAP1B;RAPGEF2;SNCAIP;RAP1A
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),-0.5002206065236289,-1.6195673539532451,0.0058823529411764705,0.26165709332974835,1.0,9/53,4.96%,EYA2;EGFR;EYA1;DDX5;EYA4;PLA2R1;PRKCD;SPRED1;FXR2
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.5807110135098578,1.6190884994508346,0.012711864406779662,0.49297683032431644,1.0,14/63,11.13%,CD38;IL6ST;MEF2C;VCAM1;IL15;BST1;NCK1;TIRAP;JAK3;CD40;TNFRSF13C;IL23A;CD320;IL7
prerank,phosphorylation (GO:0016310),0.48777062425522033,1.6186811587287846,0.0,0.4898354964996489,1.0,93/385,11.79%,PRKG1;PRKCH;ERG;RPS6KA5;CDK17;BMPR2;APP;SNRK;ERN1;ACVRL1;PRKD1;CDK6;INSR;DAPK1;NEK7;PDGFB;PEAK1;DGKZ;LYN;PIM3;PRKD2;BCR;ADAM10;STAT3;PRAG1;PTK2B;FNIP2;STK10;MAP4K3;SIK1;FYN;TAOK2;STK24;STK3;PKN3;LIPE;PKN2;PAK2;PKN1;STK4;LMTK2;MARK3;JAK3;MAP3K9;IKBKB;HIPK1;DGKH;ACVR2A;CDC42BPB;MAPK8;RET;PLK2;MAST2;ULK1;LIMK2;PPP3CB;AURKA;SIK3;ACVR1;TSSK6;DYRK1A;STK26;BMX;TNIK;LCK;JAK1;TGFB1;PIK3CG;CERKL;CTBP1;HASPIN;CREB1;SGK3;NEK6;PXK;MAP3K11;AURKC;PANK2;CDK2;COPS2;CDK18;NUAK1;PRKAB1;GAS6;AKT3;GK5;DGKE;GMFG;PICK1;MAP3K13;SIK2;STK38;PIM1
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.7247744315107854,1.6179753907381667,0.018487394957983194,0.4876309569753658,1.0,3/17,3.16%,CADM1;NECTIN2;PVR
prerank,lung development (GO:0030324),-0.54575801210629,-1.6177475035151168,0.015625,0.26197882586914584,1.0,18/33,17.19%,FGFR2;GLI2;FGF1;PDPN;ERRFI1;BMP4;PKD1;RBP4;LOXL3;FGF2;RCN3;VEGFA;STRA6;FGF7;CCDC39;WNT11;NPHP3;FGF10
prerank,hemidesmosome assembly (GO:0031581),0.7928104841396171,1.617679714154244,0.016423357664233577,0.48394767734491073,1.0,3/11,3.59%,ITGA6;DST;LAMA3
prerank,negative regulation of amyloid-beta formation (GO:1902430),-0.6475379745289336,-1.6176376033018078,0.014778325123152709,0.2588657150228784,1.0,8/17,18.44%,IGF1;NTRK2;RTN1;BIN1;APOE;RTN4;ABCA7;CHRNA7
prerank,hippo signaling (GO:0035329),0.6939789731038166,1.6164998644758268,0.023026315789473683,0.4842014342848656,1.0,7/26,5.84%,TJP1;TEAD4;TJP2;WWTR1;STK3;STK4;TEAD2
prerank,cytosolic calcium ion transport (GO:0060401),-0.5803526769770685,-1.6164021951353096,0.005305039787798408,0.2579560325972477,1.0,15/28,18.74%,CACNA1C;CACNA2D1;JPH1;SLC8A1;MCU;SLC35G1;ATP2A2;RYR2;MICU1;ADRA1A;JPH2;SLC25A23;CACNB3;SLC8A2;ATP2A3
prerank,glucosamine-containing compound metabolic process (GO:1901071),-0.6839662957497145,-1.6158146577460968,0.02517162471395881,0.25613408821526745,1.0,6/13,9.50%,MGAT3;LARGE1;RENBP;PGM3;NAGK;CHST3
prerank,endothelial cell development (GO:0001885),0.6950438432466521,1.6154386885186756,0.030716723549488054,0.48399610953752126,1.0,11/25,7.52%,PECAM1;PPP1R16B;ICAM1;PDE2A;MSN;PDE4D;RAP1B;SOX18;ROBO4;RAPGEF2;RAP1A
prerank,homeostasis of number of cells (GO:0048872),0.7646571721954722,1.6145999928482218,0.031078610603290677,0.4829627456392256,1.0,4/12,5.38%,NOS3;NOTCH1;LPCAT3;CX3CR1
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.6256473016991033,1.612687802287187,0.016923076923076923,0.4870990392430871,1.0,11/38,8.08%,CAV1;PTGS2;INSR;EDN1;CD34;KLF2;CX3CR1;ATP2B4;RAC1;NOS1AP;PKD2
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.5728332818022369,1.6112439512902947,0.009628610729023384,0.48911259195743045,1.0,23/73,13.98%,WIPF3;PLCG1;DOCK1;ELMO1;WASF2;LYN;YES1;FYN;NCK1;PLCG2;ARPC3;NCKAP1;ARPC1B;RAC1;PTK2;CRK;FCGR1A;MYO1C;CYFIP1;ACTR2;HSP90AB1;PLD2;ACTR3
prerank,regulation of glucose import (GO:0046324),-0.5471521139784421,-1.6093294971192924,0.014778325123152709,0.2682203031936974,1.0,10/30,6.44%,PID1;IGF1;APPL2;IRS1;RHOQ;ENPP1;GRB10;SELENOS;OSBPL8;PRKAG2
prerank,cellular response to interleukin-4 (GO:0071353),0.799768611277907,1.6091861785524495,0.03502626970227671,0.493411174886601,1.0,4/10,6.49%,LEF1;JAK3;XBP1;DCSTAMP
prerank,regulation of T cell proliferation (GO:0042129),0.5740848922320857,1.6088451498649476,0.016483516483516484,0.4898333013785504,1.0,10/61,9.60%,IL6ST;VCAM1;IL15;TNFRSF1B;NCK1;JAK3;TNFSF8;PLA2G2D;TNFRSF13C;IL23A
prerank,receptor clustering (GO:0043113),-0.5684890303800886,-1.6072139140744133,0.020512820512820513,0.27016665742564133,1.0,14/27,20.54%,MAGI2;PTN;DLG2;DLG4;DLG1;NRXN1;NLGN1;DLG3;NRXN2;DVL1;LRRC7;ITGA4;MUSK;ITGB2
prerank,regulation of actomyosin structure organization (GO:0110020),-0.6784651689138257,-1.6071865815888842,0.02112676056338028,0.2669775795560046,1.0,6/13,11.27%,ROCK2;AKAP13;ALMS1;FHOD1;ASAP3;SLC9A1
prerank,B cell activation (GO:0042113),0.5675019467859611,1.6064983401967368,0.016783216783216783,0.4955489883510683,1.0,15/68,8.24%,HDAC9;MEF2C;VCAM1;HHEX;CTPS1;TPD52;PTPRJ;ADGRG3;CASP8;PLCG2;JAK3;CD40;LYL1;TCF3;MALT1
prerank,regulation of neurotransmitter transport (GO:0051588),0.7308325188959885,1.606168888326091,0.03595890410958904,0.4922367641615976,1.0,6/16,13.54%,MCTP1;MEF2C;KCNMB4;SNCAIP;MCTP2;FMR1
prerank,positive regulation of Wnt signaling pathway (GO:0030177),-0.4045547482436538,-1.605325256806201,0.0,0.2682408156059942,1.0,32/152,11.62%,RNF220;ZEB2;SULF1;EGFR;WLS;LGR4;FGFR2;COL1A1;GPC3;PTK7;SULF2;SEMA5A;DAAM2;RSPO3;RSPO2;DACT1;CAPRIN2;LYPD6;LRRK1;PLEKHA4;SALL1;SFRP4;PSME4;AXIN2;LRRK2;GPC5;SFRP1;WNK1;SMARCA4;DKK2;SCEL;GPRC5B
prerank,protein autophosphorylation (GO:0046777),0.509937990811466,1.6047976672031694,0.002421307506053269,0.4940312399749241,1.0,43/157,12.04%,TEK;FLT1;KDR;EPHB4;ERN1;PRKD1;INSR;DAPK1;PEAK1;LYN;PIM3;PRKD2;PTK2B;STK10;SIK1;TAOK2;STK24;SRMS;FLT4;PAK2;STK4;LMTK2;MARK3;MAP3K9;ULK1;AURKA;DYRK1A;STK26;BMX;TNIK;PTK2;MAP3K3;NEK6;MAP3K11;SLK;MAPKAPK3;EPHA4;MAP3K13;SIK2;PIM1;EEF2K;RIPK1;MKNK2
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.7025417730933126,1.6047479428182128,0.026755852842809364,0.48950334001763646,1.0,4/21,2.31%,PRKCH;FOXP1;ELF2;LYN
prerank,mRNA splice site selection (GO:0006376),-0.5548290249095587,-1.6031478217127313,0.023809523809523808,0.2700753066465029,1.0,7/30,12.29%,CELF2;SRSF5;CELF4;LUC7L3;PSIP1;CELF1;SF1
prerank,positive regulation of neuron migration (GO:2001224),0.7726605069977481,1.6017020235947388,0.03102189781021898,0.4989795237563494,1.0,4/11,6.11%,SEMA6A;DAB2IP;ARHGEF2;RAPGEF2
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.6278117208011196,1.60151120250677,0.0182370820668693,0.49522433350823325,1.0,6/38,3.69%,NOS3;TNFSF10;ICAM1;ARHGEF2;FAS;CASP8
prerank,regulation of angiogenesis (GO:0045765),0.5078714202515917,1.6012643367087553,0.003484320557491289,0.4916965445692035,1.0,37/192,6.84%,SEMA6A;TEK;NOS3;FLT1;KDR;TIE1;PPP1R16B;CLDN5;PRKD1;PTPRM;PLCG1;VEGFC;ECSCR;GATA2;DAB2IP;HHEX;STAB1;PRKD2;NPR1;ADGRA2;HIF1A;PLXND1;CD34;PIK3R6;GTF2I;RHOJ;TSPAN12;HIPK1;XBP1;VEGFD;CEACAM1;ATP2B4;RAMP2;WNT5A;CD40;SASH1;EGLN1
prerank,aminoglycan biosynthetic process (GO:0006023),-0.5042442567557971,-1.5994806479649213,0.015015015015015015,0.27549471733735337,1.0,21/49,13.10%,GPC6;SDC2;B3GALT1;GPC3;HSPG2;HS3ST3A1;EXT1;PXYLP1;HS3ST3B1;HS2ST1;GPC5;HS6ST2;GCNT2;SDC4;XYLT1;HS3ST5;HS6ST1;GPC4;HEXA;B3GALT5;B4GALT7
prerank,regulation of B cell proliferation (GO:0030888),0.6080055906400497,1.5988850910158459,0.0182648401826484,0.4979979879801636,1.0,11/44,11.13%,CD38;MEF2C;AHR;LYN;BST1;TIRAP;CD40;TNFRSF13C;CD320;RC3H1;IL7
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.7161645679552565,1.595998906115708,0.02364864864864865,0.5070581346964557,1.0,4/18,7.77%,GNAQ;GNB1;PLCB1;AGRN
prerank,determination of bilateral symmetry (GO:0009855),0.6783164246206624,1.5959196180705906,0.02843601895734597,0.5028021503493925,1.0,6/25,8.36%,TBX1;ZIC3;NOTCH1;DLL1;PKD2;CFAP53
prerank,ceramide biosynthetic process (GO:0046513),0.6109482276298561,1.5943370031035902,0.02245508982035928,0.505546589171905,1.0,9/40,6.92%,ST6GALNAC3;SPTLC2;SGMS1;DEGS2;CERS4;SPTLC3;SPTSSA;ASAH2;ST8SIA4
prerank,cellular response to sterol (GO:0036315),-0.6808992080415119,-1.593440189884036,0.024943310657596373,0.2875314287403819,1.0,9/13,20.55%,GRAMD1B;GRAMD1C;INSIG2;RORA;LRP6;SMO;INSIG1;GPLD1;PTCH1
prerank,embryonic organ morphogenesis (GO:0048562),-0.508103321324692,-1.5930660617355303,0.01948051948051948,0.28504146850551915,1.0,16/42,10.85%,FBN1;FGFR2;PDGFRA;HOXC4;EFEMP1;MFAP5;HOXA3;RBP4;DYNC2I1;FBN2;HOXB4;HOXB3;SIX1;RBPMS2;RYR2;FUZ
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.757219037751721,1.590848688645546,0.027624309392265192,0.5167748313494781,1.0,1/12,0.05%,IL1R1
prerank,sequestering of extracellular ligand from receptor (GO:0035581),-0.6654256152897678,-1.590341768082532,0.032188841201716736,0.28834714179212534,1.0,6/13,4.62%,FSTL1;FBN1;LTBP1;NBL1;GREM2;FBN2
prerank,nitric oxide metabolic process (GO:0046209),0.7493553790118326,1.589856566965816,0.039383561643835614,0.5164069926474664,1.0,2/14,1.55%,NOS3;GCH1
prerank,cardiac conduction system development (GO:0003161),-0.5845688792777358,-1.5888294953312274,0.014669926650366748,0.28929885806994726,1.0,7/24,5.92%,NOTCH2;BMPR1A;GJB6;GJA1;BMP4;CACNA1G;TBX18
prerank,rRNA metabolic process (GO:0016072),0.5121378725454896,1.5882492520340556,0.001201923076923077,0.5190520921363769,1.0,82/160,26.57%,DDX54;RPS15;IMP3;RPS19;RPLP1;RPS14;RPS16;RPL38;RPL34;RPL39;RPS7;RPS24;MTREX;FCF1;RPL37A;RPF1;RPL36;RPL15;RPL14;RPL23;RPL17;NIFK;RPL9;RPL4;RPL13A;RPL32;RPL22;RPS27;RPL31;EXOSC1;RPL13;NOP53;UTP4;RPL6;RPL10;RPS6;RPL29;RRP9;TRIR;PELP1;RPS25;RPL35A;RPL27;RPL18;XRN2;EMG1;RPL27A;RRP1B;UTP6;PIH1D1;PDCD11;RPL11;WDR18;HEATR1;ESF1;RPL8;NOP14;RPLP2;RPL18A;RPL21;RPL3;DIS3L;SBDS;RPS28;DDX47;RPL7;RPL26;NOL6;TEX10;RRP12;LAS1L;LYAR;NOLC1;RPS17;RPL28;WDR46;WDR74;RPL41;DIS3;EXOSC4;RPS2;RPS9
prerank,L-glutamate transmembrane transport (GO:0015813),-0.7287623921384657,-1.5875085478698918,0.023109243697478993,0.28937760345724434,1.0,7/10,18.51%,SLC1A3;SLC1A2;SLC25A12;SLC25A13;SLC1A1;SLC25A18;PRAF2
prerank,inner ear receptor cell stereocilium organization (GO:0060122),-0.7122401248984491,-1.5873112069125541,0.0423728813559322,0.28665854862359547,1.0,5/10,16.84%,ADGRV1;IFT88;WHRN;PLS1;TSKU
prerank,positive regulation of vasculature development (GO:1904018),0.539048320938031,1.5872814643968594,0.01019108280254777,0.5188719757042274,1.0,20/94,6.62%,TEK;NOS3;FLT1;KDR;TIE1;PRKD1;PLCG1;VEGFC;GATA2;PRKD2;HIF1A;CD34;PIK3R6;HIPK1;XBP1;VEGFD;RAMP2;WNT5A;CD40;SASH1
prerank,glycerophospholipid catabolic process (GO:0046475),0.6622843491068348,1.586706449511184,0.021406727828746176,0.51707262681611,1.0,8/27,15.02%,GPCPD1;PLA2G4A;ENPP6;ENPP2;INPP5F;GDPD1;PNPLA6;PNPLA8
prerank,regulation of response to external stimulus (GO:0032101),0.5247564412742536,1.5863002413892073,0.00625,0.5145402365820839,1.0,30/121,11.15%,IL1R1;CAV1;PTGS2;SEMA7A;FOXP1;NMT2;SAMHD1;ADGRA2;CASP4;CNGB1;NLRP6;BST1;SELE;STK24;CASP8;TMSB4X;TIRAP;N4BP1;SBNO2;XIAP;WNT5A;GNAT1;ERAP1;CASP1;GUCA1B;BRD4;CYRIB;PSMA6;CXCR4;P2RY12
prerank,spermatid development (GO:0007286),0.6273066524598104,1.5858777953819654,0.04134762633996937,0.5117121986910668,1.0,7/32,11.22%,JAM2;GALNTL5;NECTIN2;CDYL;CEP57;TTC21A;TDRD5
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.7209881758194181,1.5842110664931095,0.028960817717206135,0.5153811333331363,1.0,8/18,4.39%,HDAC9;KDR;PTGS2;GATA2;JCAD;HDAC7;PIK3C2A;RHOJ
prerank,heart morphogenesis (GO:0003007),0.6010966179260657,1.5840045648226961,0.01447178002894356,0.5118660399315396,1.0,12/50,7.46%,NOS3;ENG;TBX1;EPHB4;ACVRL1;INSR;NOTCH1;SOX17;CHD7;FKBP1A;ACVR1;PTK2
prerank,regulation of cell killing (GO:0031341),0.7258562832038717,1.5836960132446767,0.03052064631956912,0.5091128418370232,1.0,6/16,7.48%,CFH;ICAM1;MAPK8;WNT5A;RAC1;CR1L
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.724719065899926,1.5833948417821728,0.035842293906810034,0.5062755141038717,1.0,2/15,2.18%,PLTP;SCARB1
prerank,platelet degranulation (GO:0002576),0.5341236327657465,1.5832246583491527,0.005050505050505051,0.502945826733613,1.0,23/118,9.13%,VWF;ABCC4;PECAM1;PCDH7;APP;PDGFB;VEGFC;LYN;ACTN4;SELP;SELENOP;TMSB4X;ACTN1;PROS1;VEGFD;QSOX1;TAGLN2;PPBP;SRGN;TGFB1;APOOL;TMX3;APLP2
prerank,regulation of collagen biosynthetic process (GO:0032965),-0.618518556606458,-1.5829093794741649,0.020642201834862386,0.2944833527626352,1.0,6/19,10.18%,WNT4;BMP4;LARP6;RUNX1;RGCC;TGFB3
prerank,cardiac muscle cell contraction (GO:0086003),-0.6136953830337314,-1.5824256614175258,0.03357314148681055,0.29264121573801666,1.0,6/19,7.48%,CACNA1C;GSN;CACNA2D1;CACNA1D;CACNA1G;KCNJ2
prerank,nuclear migration (GO:0007097),-0.6628601498939463,-1.5807505597114986,0.030373831775700934,0.29345923252637685,1.0,6/13,17.24%,DOCK7;CLMN;SYNE3;PCM1;SYNE2;DYNC1H1
prerank,endothelial cell proliferation (GO:0001935),0.708274053584089,1.5799508991543427,0.03076923076923077,0.5136425910655242,1.0,5/17,3.79%,TEK;BMPR2;ERN1;ACVRL1;CD34
prerank,metanephros development (GO:0001656),-0.5723233372541484,-1.5792486623867201,0.02349869451697128,0.29436473010509023,1.0,8/26,5.77%,FOXD1;BMP7;OSR1;BMP4;PKD1;ROBO2;NF1;SIX1
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),0.5101846525635015,1.5789780575669499,0.0012106537530266344,0.5137640725703655,1.0,76/168,20.56%,CNOT6;PAN3;CNOT6L;RPS15;RPS19;RPLP1;RPS14;RPSA;RPS16;RPL38;RPL34;RPS20;RPL39;RPS7;RPS24;RPL37A;RPL36;RPS18;RPL15;RPS8;RPL14;RPL23;RPL17;SMG7;RPL9;RPL4;RPL13A;CNOT1;RPS11;RPL32;NBDY;RC3H1;RPL22;RPS27;RPL31;RPS23;CNOT2;DCP2;RNPS1;RPL13;RPS12;PNRC2;RPL6;ZFP36;RPL10;CNOT7;UPF2;MTPAP;RPS29;RPS6;RPL29;RPS25;RPL35A;RPS13;RPS21;RPL27;RPL18;XRN2;RPL27A;RPS10;ZFP36L1;CTIF;RPL11;CSDE1;RPL8;RPLP2;HELZ2;PPP2R2A;RPL18A;DHX34;PPP2R1A;RPL21;LSM1;RPL3;PAN2;RPS3
prerank,focal adhesion assembly (GO:0048041),0.6896825651553472,1.5776762767468053,0.04222972972972973,0.5159863207443528,1.0,7/21,5.16%,THSD1;PEAK1;BCR;TAOK2;SORBS1;ACTN1;PTPRK
prerank,positive regulation of keratinocyte differentiation (GO:0045618),0.782700332966629,1.5771442327873244,0.03896103896103896,0.5142744810729335,1.0,1/10,0.04%,PRKCH
prerank,positive regulation of cellular senescence (GO:2000774),0.7804716617166689,1.5768746115447203,0.036328871892925434,0.511472332205786,1.0,2/10,1.56%,ABI3;B2M
prerank,negative regulation of sprouting angiogenesis (GO:1903671),0.7982593999759074,1.5762355460583686,0.02491103202846975,0.5105555230808507,1.0,3/11,4.42%,SEMA6A;EPN2;KLF2
prerank,regulation of chemokine production (GO:0032642),0.6261576575442189,1.5746981800556759,0.03260869565217391,0.5137692484348504,1.0,10/36,13.42%,APP;FOXP1;IL6R;HIF1A;ACKR1;SIGIRR;WNT5A;LPL;IL7;ADAM17
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.607013744684487,-1.5745973156300808,0.0275,0.30316041735694854,1.0,9/19,18.44%,IGF1;NTRK2;RTN1;BIN1;APOE;FLOT2;RTN4;ABCA7;CHRNA7
prerank,apical protein localization (GO:0045176),0.7763457146796945,1.5744394257041767,0.03564727954971857,0.5110511787599665,1.0,4/10,4.28%,ATP8B1;CELSR1;SHROOM2;MAL
prerank,brain morphogenesis (GO:0048854),0.7741672631314902,1.5740305641830072,0.030303030303030304,0.5090433312602628,1.0,1/12,0.09%,SHANK3
prerank,regulation of immune response (GO:0050776),0.5172574324271434,1.5728559264274922,0.007334963325183374,0.5104568654231987,1.0,22/135,6.59%,CLEC2D;VCAM1;IL15;ICAM1;CD200;B2M;AHR;FOXP1;LYN;SAMHD1;NECTIN2;ICAM2;DENND1B;PVR;CASP8;FKBP1A;CD34;TIRAP;SPPL2A;N4BP1;XIAP;CD40
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.7104093811442374,1.5717837586661687,0.045936395759717315,0.5112059401745458,1.0,5/18,2.34%,RPS6KA5;PRKD1;CRTC1;CD200;PRKD2
prerank,cAMP-mediated signaling (GO:0019933),0.6587510276348751,1.5707705710331497,0.04390243902439024,0.5118348888952877,1.0,5/24,2.87%,ADGRG6;AHR;PDE2A;PDE7B;PDE4D
prerank,cellular response to fluid shear stress (GO:0071498),0.7438831914093742,1.5707643744795123,0.05714285714285714,0.5080868580574326,1.0,6/12,16.94%,MEF2C;MTSS1;KLF2;PKD2;HAS2;MAP2K5
prerank,energy reserve metabolic process (GO:0006112),-0.5954739252431976,-1.5703250591935418,0.04009433962264151,0.3106037734489554,1.0,9/19,12.04%,PID1;LEPR;PHKB;PYGM;PRKAG2;GFPT1;PPP1R3C;GFPT2;UGP2
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.6761574376992118,-1.568962179265675,0.04008438818565401,0.31090323273008064,1.0,8/12,14.95%,DMD;ATP1B1;WNK4;ANK3;ATP1B2;WNK1;FXYD1;WNK3
prerank,protein hydroxylation (GO:0018126),-0.6299785858398104,-1.56892115772577,0.021377672209026127,0.3079857622013827,1.0,7/15,19.25%,PLOD2;ASPH;P3H3;EGLN3;P3H4;P3H1;VIPAS39
prerank,atrial cardiac muscle cell action potential (GO:0086014),-0.6784074182632278,-1.5687914726309997,0.021052631578947368,0.30532476018712684,1.0,4/13,5.06%,ANK2;CACNA1C;GJA1;CACNB2
prerank,regulation of defense response (GO:0031347),0.5556353609312126,1.5681944281168227,0.018867924528301886,0.515329091536466,1.0,19/76,9.15%,IL1R1;PTGS2;SEMA7A;FOXP1;SAMHD1;CASP4;NLRP6;BST1;SELE;CASP8;TMSB4X;TIRAP;N4BP1;SBNO2;XIAP;WNT5A;ERAP1;CASP1;BRD4
prerank,endocardial cushion development (GO:0003197),0.6826343266718033,1.5675982368486039,0.022617124394184167,0.5141698622212968,1.0,7/21,6.27%,NOS3;BMPR2;ENG;ACVRL1;NOTCH1;FOXF1;ACVR1
prerank,monocarboxylic acid transport (GO:0015718),0.5847404306291988,1.5667243187180682,0.015558698727015558,0.5142753148612205,1.0,10/51,5.11%,ABCC4;SLCO2B1;ABCG2;ATP8B1;SLCO2A1;STARD5;SLC16A9;SLC16A2;NCOA1;CEACAM1
prerank,negative regulation of wound healing (GO:0061045),-0.5568887463449752,-1.5666560460563987,0.011695906432748537,0.30767042751329976,1.0,11/28,10.33%,PHLDB2;VTN;TFPI;SLC12A2;FGF2;SERPINE2;CD109;CASK;APOE;AJAP1;SERPINE1
prerank,positive regulation of biomineral tissue development (GO:0070169),-0.5010642061497601,-1.5665328968087824,0.030120481927710843,0.30493131242236526,1.0,12/40,4.62%,BMP6;BMPR1A;PTN;WNT4;BMP7;ADGRV1;OSR1;WNT6;BMP4;GPM6B;SLC8A1;FBN2
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.616054049452243,1.56536975595332,0.03255813953488372,0.5162942153615923,1.0,6/35,2.59%,TEK;TJP1;ABI3;ESAM;F11R;PTK2B
prerank,glial cell differentiation (GO:0010001),0.6524146515791194,1.564857431481725,0.03577235772357724,0.5148098128573405,1.0,7/28,11.51%,ADGRG6;STAT3;CDH2;EIF2B5;SOX4;NFIB;PICK1
prerank,aspartate family amino acid metabolic process (GO:0009066),-0.6246200790160255,-1.5638989238306231,0.02544529262086514,0.30841098729278693,1.0,8/18,13.26%,ASPA;NAALAD2;SMS;ASPG;SLC25A12;GOT1;MTHFD1;SLC25A13
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.5929200863118878,1.5635960049607602,0.032448377581120944,0.5165818022610337,1.0,9/42,6.61%,TEK;KDR;UTRN;CDK6;PTK2B;PTPRJ;PPM1F;SKAP1;RAC1
prerank,nitric oxide biosynthetic process (GO:0006809),0.754241767948637,1.5634598098686308,0.045454545454545456,0.5136677897276175,1.0,2/13,1.55%,NOS3;GCH1
prerank,neuron projection regeneration (GO:0031102),-0.7068633708010917,-1.5630774220816825,0.029953917050691243,0.30767170510299297,1.0,3/10,11.38%,PTN;NREP;GAP43
prerank,sphingosine biosynthetic process (GO:0046512),0.7639997651867286,1.562655681135248,0.038181818181818185,0.5099107753199031,1.0,4/11,5.50%,ACER2;SPTLC2;SPTLC3;ASAH2
prerank,sphingoid biosynthetic process (GO:0046520),0.7639997651867286,1.562655681135248,0.038181818181818185,0.5099107753199031,1.0,4/11,5.50%,ACER2;SPTLC2;SPTLC3;ASAH2
prerank,positive regulation of collagen biosynthetic process (GO:0032967),-0.6378664230326295,-1.5624110922101555,0.03811659192825112,0.3064214269026392,1.0,6/16,10.18%,WNT4;BMP4;LARP6;RUNX1;RGCC;TGFB3
prerank,regulation of platelet activation (GO:0010543),0.6732364788323149,1.5622236591565823,0.036243822075782535,0.5082832973768668,1.0,5/21,3.91%,NOS3;PLA2G4A;PDGFB;LYN;SELP
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),-0.5593568956782264,-1.562097036026981,0.018229166666666668,0.3044698742903096,1.0,10/28,9.16%,PID1;PRKCB;APPL2;IRS1;ENPP1;GRB10;PRKCD;TNS2;PRKCZ;TSC2
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.7529635976951743,1.5593940818684326,0.04085257548845471,0.5173130211275795,1.0,3/12,7.32%,ESR1;STAT3;TGFB1
prerank,regulation of trophoblast cell migration (GO:1901163),-0.6557480828474634,-1.5593882706505084,0.043478260869565216,0.30824725925979296,1.0,10/14,28.86%,GJA1;VEGFA;SYDE1;ACVR1B;ARHGDIB;SMURF2;TIMP1;CALR;C1QBP;ACVR1C
prerank,myeloid leukocyte differentiation (GO:0002573),0.5611366412708702,1.55937442112998,0.02109704641350211,0.5138958035673153,1.0,12/65,9.45%,LEF1;CBFA2T3;IL15;PIR;FOXP1;MYH9;TNFRSF11A;CASP8;SBNO2;DCSTAMP;CDK2;CSF1
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.4026415797243842,-1.5589708825827728,0.0,0.306490508966067,1.0,26/129,11.62%,RNF220;ZEB2;EGFR;WLS;LGR4;FGFR2;COL1A1;GPC3;PTK7;SEMA5A;DAAM2;DACT1;CAPRIN2;LYPD6;LRRK1;PLEKHA4;SFRP4;PSME4;AXIN2;LRRK2;GPC5;SFRP1;WNK1;DKK2;SCEL;GPRC5B
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.7325669234424347,1.5589057512838354,0.043936731107205626,0.5124366370167099,1.0,5/13,10.01%,NECTIN2;PVR;STX7;IL23A;CYRIB
prerank,positive regulation of developmental growth (GO:0048639),0.5844534190163894,1.5586776436977745,0.035036496350364967,0.5100086593950223,1.0,14/49,12.83%,NTN1;INSR;SEMA7A;SMURF1;NEDD4L;ITSN2;PLCB1;DLL1;GHR;AGRN;TWF2;SEMA4D;MAP3K13;DBNL
prerank,regulation of integrin activation (GO:0033623),0.7225800457932356,1.5579509562515228,0.03327495621716287,0.5097642733266787,1.0,5/15,6.14%,PIEZO1;RASIP1;RAP1B;SELP;SKAP1
prerank,cellular response to drug (GO:0035690),0.6517540522440936,1.5571826063966958,0.04186795491143317,0.5095922704614385,1.0,7/25,7.06%,ACER2;MEF2C;KCNQ1;AIM2;PPM1F;FBP1;KCNE2
prerank,protein localization to cell-cell junction (GO:0150105),0.7115244857731244,1.5566470967753738,0.0415944540727903,0.5083368107655932,1.0,7/15,9.62%,TJP1;LSR;F11R;TJP2;PAK2;JAK1;TJP3
prerank,neuron projection organization (GO:0106027),0.713981852097157,1.5566443754026815,0.051188299817184646,0.5050427493156445,1.0,7/15,11.84%,APP;INSR;ATP1A3;PSEN1;PICK1;LGMN;ABCD1
prerank,regulation of cell morphogenesis (GO:0022604),-0.5382606623432027,-1.556333947627897,0.04216867469879518,0.31024718655112316,1.0,13/30,16.13%,EFNA5;PDPN;SPARC;NTNG1;CD44;ZMYM6;ZMYM3;ZMYM4;MOV10;MFSD2A;CAPZB;MACF1;MYO9A
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.7720800138395759,1.5558935753957268,0.035781544256120526,0.5048502738879447,1.0,4/11,7.26%,IL6ST;STAT3;IL27RA;JAK1
prerank,cellular biogenic amine biosynthetic process (GO:0042401),-0.6258439503507728,-1.5549728667202096,0.03587443946188341,0.31093660282876734,1.0,6/15,28.58%,MOXD1;SAT1;ASMT;DDC;SRM;SAT2
prerank,regulation of phospholipase activity (GO:0010517),-0.7161070659836383,-1.554506764407596,0.023157894736842106,0.3092110409846232,1.0,2/10,0.68%,LRP1;FGFR2
prerank,interleukin-15-mediated signaling pathway (GO:0035723),0.7315219921481013,1.5536895190016284,0.046263345195729534,0.5076401141633211,1.0,5/13,7.26%,IL15;STAT3;PLCB1;JAK3;JAK1
prerank,cellular response to interleukin-15 (GO:0071350),0.7315219921481013,1.5536895190016284,0.046263345195729534,0.5076401141633211,1.0,5/13,7.26%,IL15;STAT3;PLCB1;JAK3;JAK1
prerank,stress-activated MAPK cascade (GO:0051403),0.5619779346315185,1.5531912588770007,0.014164305949008499,0.5064234314284273,1.0,27/61,18.73%,NOD1;TNFRSF19;MAP4K3;TAOK2;SH2D3C;IKBKB;MAPK8;NFKB1;MAP3K11;IKBKG;MAP2K3;MAPK11;CCM2;MAP3K13;CUL1;RIPK2;ZFP36;TRIB1;TRAF6;MAP3K20;MAP4K2;TAB3;ZFP36L1;IRAK2;MAP3K8;MAP2K4;MINK1
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.5831994832417577,-1.553181164266721,0.019753086419753086,0.31001851300231786,1.0,8/22,13.36%,ANK2;ATP1B1;AKAP6;RYR2;SLC9A1;GSTM2;HTT;JPH2
prerank,lamellipodium assembly (GO:0030032),0.6459809083372104,1.5530265124626925,0.02773246329526917,0.5039855624540696,1.0,10/26,11.69%,PARVB;ABLIM1;SRGAP2;S1PR1;SPATA13;CCDC88A;RAC1;ARHGEF7;P2RY12;CYFIP1
prerank,peptide biosynthetic process (GO:0043043),0.5007307861423147,1.5527772738343233,0.0048134777376654635,0.5019132838490695,1.0,66/153,17.73%,RPS15;IGF2BP3;RPS19;RPLP1;RPS14;RPSA;RPS16;RPL38;RPL34;RPS20;RPL39;RPS7;RPS24;RPL37A;SRBD1;RPL36;RPS18;RSL24D1;RPL15;RPS8;RPL14;RPL23;RPL17;MRPS18A;RPL9;DHPS;RPL4;RPL13A;RPS11;RPL32;TNIP1;RPL22;RPS27;RPL31;RPS23;MRPL13;RPL13;MRPS12;RPS12;MRPL35;HBS1L;RPL6;RPL10;WARS1;MRRF;MRPL41;RPS29;RPS6;MRPL52;RPL29;RPS25;RPL35A;RPS13;RPS21;MRPS16;RPL27;RPL18;MRPL23;RPL27A;MRPS5;RPS10;MRPL37;RPL11;RPL8;RPLP2;MRPL11
prerank,positive regulation of lymphocyte migration (GO:2000403),0.7415499930307828,1.5526319599737832,0.06690777576853527,0.4994292305638549,1.0,2/12,1.06%,JAM2;APP
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.7172176069133652,1.5522649311961032,0.03873239436619718,0.49769621231647365,1.0,10/18,16.67%,RNF125;SEC14L1;USP15;PUM1;PUM2;OASL;NOP53;BIRC3;GPATCH3;BIRC2
prerank,establishment of endothelial intestinal barrier (GO:0090557),0.758085746018461,1.5511647916146682,0.04854368932038835,0.49905465071866856,1.0,5/11,9.62%,TJP1;F11R;TJP2;RAPGEF2;TJP3
prerank,sodium ion transmembrane transport (GO:0035725),-0.44159174622915187,-1.5496699892335013,0.004,0.31621299737629954,1.0,13/84,3.39%,ATP1A2;SLC24A3;NALCN;SLC6A13;SLC8A3;SLC12A2;SLC6A1;SCN7A;SLC9A9;SLC6A12;SLC6A9;ATP1B1;SLC8A1
prerank,phospholipid transport (GO:0015914),0.5639004642838364,1.548740202222433,0.027377521613832854,0.5062045765244423,1.0,12/52,10.69%,ATP8B1;PLTP;ATP8A1;SCARB1;PRELID2;ATP10A;ATP11C;ATP11B;ABCA3;ATP11A;PITPNC1;SCARB2
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.6761257567645532,1.5483259647940908,0.03496503496503497,0.5047296207174765,1.0,4/20,7.77%,GNAQ;GNB1;PLCB1;AGRN
prerank,lung epithelium development (GO:0060428),-0.7096942871816216,-1.5463562337534824,0.029661016949152543,0.32134789171842126,1.0,6/10,17.19%,ERRFI1;BMP4;PKD1;RCN3;STRA6;FGF10
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),0.7562834333228852,1.545655694563366,0.051330798479087454,0.5128422308386611,1.0,2/10,1.06%,SHANK3;APP
prerank,myeloid cell differentiation (GO:0030099),0.5900248701779425,1.543127300483612,0.020618556701030927,0.5201840661101038,1.0,10/47,5.14%,SNRK;ZBTB16;LYN;TAL1;MFHAS1;TIRAP;RPS19;JAK3;RPS14;KMT2E
prerank,response to lipopolysaccharide (GO:0032496),0.5031160222142437,1.5424711858674045,0.006313131313131313,0.520010228038762,1.0,36/138,14.35%,NOS3;MEF2C;GCH1;FOXP1;DAB2IP;SCARB1;TNFRSF11A;TNFRSF1B;SELE;SELP;TIRAP;RPS6KA3;XBP1;CX3CR1;SBNO2;MAPK8;PELI1;IFNAR1;WNT5A;IL36G;PPBP;HNRNPA0;NFKB1;CASP1;CITED1;DEFA6;MAPKAPK3;CYP27B1;CARD16;RELA;GSTP1;ZFP36;TRIB1;ADAM17;TRAF6;S100A9
prerank,acidic amino acid transport (GO:0015800),-0.617125616085053,-1.5408480775769124,0.03294117647058824,0.3334087494731078,1.0,10/17,18.51%,SLC6A13;SLC1A3;GJA1;SLC6A1;SLC1A2;SLC25A12;SLC25A13;SLC1A1;SLC25A18;PRAF2
prerank,embryonic digit morphogenesis (GO:0042733),-0.5962350987534106,-1.5405642378619342,0.03836930455635491,0.33136214906068384,1.0,7/18,15.44%,GLI3;OSR1;SALL1;TBX2;WDPCP;INTU;TBX3
prerank,negative regulation of GTPase activity (GO:0034260),0.6586181817974976,1.5400615244881646,0.034482758620689655,0.5269614818804412,1.0,4/22,2.14%,LRCH1;F11R;SH3BP4;DAB2IP
prerank,chordate embryonic development (GO:0043009),-0.47504672637534084,-1.5395931368554454,0.00909090909090909,0.3311746348727756,1.0,18/55,10.18%,SULF1;ALDH1A2;FGFR2;COL1A1;ARNT2;BMP5;BMP7;SULF2;TGFBR1;PCSK5;PKD1;RBP4;DACT1;IGF2;KIAA1217;VEGFA;XYLT1;TGFB3
prerank,protein phosphorylation (GO:0006468),0.45787957094650095,1.5394589059658932,0.0,0.5264158643785307,1.0,107/479,11.86%,PRKG1;PRKCH;ERG;TEK;RPS6KA5;CDK17;FLT1;BMPR2;ABI3;KDR;APP;SNRK;EPHB4;ERN1;ACVRL1;PRKD1;CDK6;INSR;DAPK1;NEK7;PDGFB;PEAK1;DAB2IP;LYN;PIM3;PRKD2;BCR;ADAM10;PRAG1;PTK2B;FNIP2;STK10;MAP4K3;SIK1;FYN;TAOK2;STK24;STK3;PKN3;SRMS;FLT4;LIPE;PKN2;PAK2;PKN1;RPS6KA3;STK4;LMTK2;MARK3;JAK3;MAP3K9;IKBKB;RPS6KA1;HIPK1;SMAD7;ACVR2A;CDC42BPB;MAPK8;RET;PLK2;MAST2;USP15;ULK1;LIMK2;PPP3CB;AURKA;SIK3;ACVR1;TSSK6;DYRK1A;STK26;BMX;TNIK;LCK;JAK1;TGFB1;PTK2;MAP3K3;CTBP1;HASPIN;CREB1;SGK3;AKT2;NEK6;PXK;MAP3K11;AURKC;SLK;CDK2;RICTOR;MAPKAPK3;COPS2;CDK18;NUAK1;PRKAB1;GAS6;EPHA4;AKT3;ABL2;GMFG;PICK1;MAP3K13;SIK2;STK38;PIM1;EEF2K;RIPK1
prerank,tetrahydrobiopterin metabolic process (GO:0046146),0.751952443547161,1.5393498777895458,0.03163444639718805,0.5237247475741564,1.0,2/11,1.55%,NOS3;GCH1
prerank,regulation of cardiac conduction (GO:1903779),-0.4632696738750847,-1.5381668685748666,0.010676156583629894,0.332209092751165,1.0,15/54,9.88%,ATP1A2;ANK2;SLC8A3;ATP1B1;SLC8A1;ASPH;DMPK;ABCC9;STIM1;PRKACA;TRPC1;ATP2A2;RYR2;TMEM65;ATP1B2
prerank,regulation of adenylate cyclase activity (GO:0045761),-0.5818217142712501,-1.538072799767571,0.030612244897959183,0.3296155217944238,1.0,7/22,6.34%,CACNA1C;ADGRV1;CACNA1D;NF1;CAP2;GRM3;STIM1
prerank,glucose transmembrane transport (GO:1904659),0.6857457965755485,1.537790925349732,0.04452054794520548,0.5270062585479861,1.0,4/18,6.84%,SLC2A1;PPARD;SLC2A9;PPBP
prerank,membrane fusion (GO:0061025),0.616852105420661,1.5374315117323816,0.04354587869362364,0.5255278850775532,1.0,2/33,0.33%,DNM3;MYOF
prerank,positive regulation of stem cell differentiation (GO:2000738),-0.6240545353827702,-1.5371313796484192,0.04096385542168675,0.329318931458859,1.0,9/16,23.08%,SOX5;PTN;SOX6;HOXB4;TGFB2;FOXC1;LTBP3;SP7;RBM24
prerank,heterochromatin organization (GO:0070828),0.7266061219900589,1.536492752755804,0.04827586206896552,0.5261873260332093,1.0,3/14,8.56%,MECOM;SMCHD1;EZH1
prerank,ceramide transport (GO:0035627),0.7482983274392485,1.53421495145819,0.0300187617260788,0.5325225145775512,1.0,4/12,9.21%,CERT1;PLTP;GLTP;PLEKHA8
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.634577845058756,-1.5337879891882154,0.02733485193621868,0.3352032393897624,1.0,2/15,1.21%,IGF1;PRKN
prerank,regulation of neuron migration (GO:2001222),0.6326618313162224,1.5329652956971265,0.05,0.534705767317976,1.0,7/26,6.11%,SEMA6A;NEXMIF;DAB2IP;ARHGEF2;SRGAP2;ADGRG1;RAPGEF2
prerank,regulation of cellular protein metabolic process (GO:0032268),0.5741188002941426,1.5328690505779974,0.032116788321167884,0.5321303169970413,1.0,13/47,13.02%,NANOS3;APP;EDN1;NFKBIA;EIF4E;TGFB1;PM20D2;NFKB1;CSF1;RBM3;CYFIP1;RPL10;MTPN
prerank,innate immune response (GO:0045087),0.4810560085794745,1.5326169700379506,0.0023094688221709007,0.530263045665401,1.0,41/217,12.40%,SERINC3;APP;GCH1;B2M;NLRC5;NRROS;LYN;SERINC5;MFHAS1;PTK2B;TRIM14;YES1;FYN;SRMS;PLCG2;LCN2;IKBKB;CX3CR1;TRIM68;RPL39;PTX3;MID2;ADAM15;PGLYRP2;CD40;CFB;LCK;PIK3CG;PTK2;TRIM25;MALT1;CITED1;ANG;DEFA6;RELB;IKBKG;CYP27B1;ADAR;IRAK4;RELA;RIPK2
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.666647046284956,-1.5314468056730468,0.045454545454545456,0.3386186667599263,1.0,6/11,15.31%,BMPR1A;BMP4;ZFPM2;JAG1;TGFB2;HEY2
prerank,camera-type eye development (GO:0043010),-0.5508797636539369,-1.5308666712634682,0.032432432432432434,0.33760927892787906,1.0,10/25,12.99%,CACNA1C;FBN1;EFEMP1;TENM3;FBN2;CYP1B1;NF1;VEGFA;STRA6;NES
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.6199421368107174,1.530592079856494,0.04489164086687306,0.5356468541244994,1.0,6/29,10.01%,CADM1;NECTIN2;PVR;STX7;IL23A;CYRIB
prerank,ribosome assembly (GO:0042255),0.5700707455938202,1.5304093291491387,0.02976190476190476,0.5333310508488384,1.0,18/47,21.07%,RPS15;RPS19;RPS14;RPSA;RSL24D1;RRS1;EIF6;RPS27;NOP53;RPL6;RPL10;NPM1;RPL11;MTERF3;RPL3;TRAF7;SBDS;RPS28
prerank,regulation of mitochondrial fusion (GO:0010635),-0.6838752526727239,-1.5279897815063372,0.061224489795918366,0.3422935681321176,1.0,2/11,1.21%,PID1;PRKN
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.68953165238709,1.5275315575801476,0.04745166959578207,0.5423210398388627,1.0,2/17,1.15%,PRKG1;MEF2C
prerank,B cell differentiation (GO:0030183),0.5776659351947855,1.5272902299015605,0.0381791483113069,0.5404099312825917,1.0,10/46,7.69%,HDAC9;VCAM1;HHEX;TPD52;PTPRJ;ADGRG3;PLCG2;JAK3;LYL1;TCF3
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),-0.5681154476927482,-1.5264205022605204,0.029891304347826088,0.34350809599808957,1.0,9/23,16.94%,GJA1;BMP4;FGF2;SIX1;VEGFA;SMO;PIK3CD;PAX8;MDK
prerank,striated muscle contraction (GO:0006941),-0.46530689378905976,-1.5252461458058513,0.022292993630573247,0.3437194717038702,1.0,8/53,9.11%,ATP1A2;DMD;ATP1B1;SLC8A1;TPM1;DTNA;GAA;RYR2
prerank,negative regulation of DNA metabolic process (GO:0051053),0.6529041393721096,1.524955641408991,0.046511627906976744,0.5475337211035591,1.0,3/24,1.39%,DACH1;BMPR2;ACVRL1
prerank,cation transmembrane transport (GO:0098655),-0.4773567196500058,-1.5245161487128027,0.018633540372670808,0.34300821906827444,1.0,7/44,4.22%,ATP1A2;TRPM3;SLC7A2;SLC6A9;ATP1B1;SFXN2;ABCC9
prerank,alpha-amino acid catabolic process (GO:1901606),-0.5488536211107817,-1.5242459753149233,0.034574468085106384,0.3410210151134179,1.0,13/29,24.83%,DDO;ACADSB;ALDH4A1;PRODH;FAH;ACAT1;CBS;HOGA1;BLMH;GSTZ1;GOT2;KYAT1;MTRR
prerank,cardiac myofibril assembly (GO:0055003),-0.6208120908309309,-1.5226473091781987,0.03571428571428571,0.34260792595546585,1.0,4/15,10.83%,PDGFRB;PDGFRA;OBSL1;FHOD3
prerank,neuron cell-cell adhesion (GO:0007158),-0.6461411948795681,-1.522468555937666,0.03286384976525822,0.3404103993638819,1.0,9/14,12.64%,NLGN2;NRXN1;NLGN1;NRXN3;NCAM2;ASTN1;NLGN3;CNTN4;NRXN2
prerank,striated muscle tissue development (GO:0014706),0.6247398647089097,1.5221910923294715,0.04897314375987362,0.5563285149856634,1.0,4/29,1.15%,PGM5;BMPR2;CAV1;MEF2C
prerank,phospholipid catabolic process (GO:0009395),0.6496418724432922,1.5215157183913153,0.0463258785942492,0.556350351139123,1.0,5/24,9.99%,GPCPD1;PLA2G4A;ENPP6;ENPP2;GDPD1
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.7051926376820666,1.5202863421882384,0.04638218923933209,0.5583898613556617,1.0,4/15,9.45%,PRKCH;NFKB1;LPL;CSF1
prerank,glycerolipid catabolic process (GO:0046503),0.6808436775967301,1.520174692534791,0.05546218487394958,0.5558929488895594,1.0,5/19,9.99%,GPCPD1;PLA2G4A;ABHD2;ENPP6;GDPD1
prerank,cellular response to mechanical stimulus (GO:0071260),0.5733053274655517,1.5201524955564405,0.027314112291350532,0.5530087710611867,1.0,13/46,10.76%,PIEZO1;F11R;PDE2A;FAS;CASP8;MAPK8;CD40;TNFRSF1A;NFKB1;CASP1;CRADD;TNFRSF8;BNIP3
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.6659926208995256,1.5196840117857544,0.06228956228956229,0.5521576802493054,1.0,7/21,9.42%,PRKCH;FOXP1;PRKD2;NECTIN2;TESPA1;LCK;IKBKG
prerank,protein depolymerization (GO:0051261),-0.5386601029535903,-1.5189710338240687,0.02956989247311828,0.34604823466952433,1.0,3/27,1.04%,MICAL3;GSN;MICAL2
prerank,presynapse assembly (GO:0099054),-0.6197803972881879,-1.518110633104337,0.053811659192825115,0.34561369829565786,1.0,10/16,15.82%,NLGN2;LRRTM3;PTPRD;IL1RAPL1;PCLO;NLGN1;NLGN3;FZD1;BSN;DVL1
prerank,lymphocyte proliferation (GO:0046651),0.6485384336452782,1.5169468640335033,0.06283662477558348,0.5605674060548786,1.0,6/22,7.41%,MEF2C;CTPS1;MSN;PPP3CB;CD40;PIK3CG
prerank,cytokine-mediated signaling pathway (GO:0019221),0.45196480898275054,1.516493312922845,0.0,0.5595975821909246,1.0,107/532,12.73%,IL1R1;RPS6KA5;FOXO1;ADIPOR2;NOD1;IL6ST;LIFR;INPP5D;MAOA;PTGS2;UGCG;LCP1;VCAM1;IL15;ICAM1;STX3;B2M;PDGFB;IRF2;IL6R;SOCS2;OSMR;STAT3;AIM2;TNFRSF11A;SAMHD1;PTK2B;S1PR1;HIF1A;MSN;PTPRJ;TNFRSF1B;NFKBIA;RAP1B;FYN;ACTN4;PLCB1;TRAF1;TMSB4X;PAK2;TNFRSF25;LCN2;JAK3;EDAR;IKBKB;ISG20;CEACAM1;GHR;CSF2RB;IL27RA;TRIM68;PELI1;IFNAR1;HNRNPF;CISH;IFNAR2;TNFSF8;CA1;IL36G;MTAP;CD40;CDKN1B;JUNB;BCL2L11;PPBP;LCK;JAK1;TNFRSF1A;TGFB1;STX1A;PSMA2;TRIM25;NFKB1;MAP3K3;TNFRSF13C;CASP1;IL7R;CRK;IKBKG;CSF1;TNFRSF8;IL23A;BCL2L1;PSMA8;TNFRSF9;FCGR1A;CCL14;PSMA6;FSCN1;POU2F1;IL4R;CBL;ABL2;IL7;ADAR;CUL1;CEBPD;IL17RB;IRAK4;PIM1;RIPK1;MUC1;OASL;RELA;RIPK2;ADIPOR1;BIRC3
prerank,negative regulation of cytoskeleton organization (GO:0051494),0.6343648085859253,1.5163747844957163,0.0425531914893617,0.557170354810459,1.0,5/29,3.66%,SHANK3;TJP1;KANK3;HIP1R;SSH2
prerank,negative regulation of platelet activation (GO:0010544),0.6981989705260875,1.5149231654631552,0.044722719141323794,0.560504388281583,1.0,4/16,5.11%,PRKG1;NOS3;PDGFB;CEACAM1
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.5451950035460761,1.5148379891332115,0.029166666666666667,0.5579674460006343,1.0,18/67,7.46%,TEK;FLT1;ABI3;KDR;IL15;INSR;PDGFB;LYN;PTK2B;FYN;SRMS;FLT4;JAK3;GHR;DYRK1A;BMX;LCK;PTK2
prerank,response to molecule of bacterial origin (GO:0002237),0.5325980135451331,1.5141890989968898,0.02695035460992908,0.5579204507963602,1.0,15/69,10.25%,NOS3;GCH1;FOXP1;TNFRSF11A;SELE;SELP;TIRAP;RPS6KA3;PELI1;IFNAR1;HNRNPA0;CITED1;MAPKAPK3;CYRIB;CYP27B1
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.6433973019370862,1.51211398644278,0.050793650793650794,0.5634900616898586,1.0,5/23,8.49%,PLA2G4A;LPCAT3;PLA2G2D;MBOAT1;PLAAT3
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.5945014392178103,1.5117415296906054,0.038109756097560975,0.562188048494794,1.0,9/36,7.93%,NOS3;CAV1;GCH1;SCARB1;HIF1A;NOSTRIN;ATP2B4;NOSIP;NOS1AP
prerank,myeloid cell development (GO:0061515),0.665664961990252,1.5117343523688902,0.07291666666666667,0.5593752640951611,1.0,4/18,2.95%,APP;FOXP1;NRROS;ALAS1
prerank,"phototransduction, visible light (GO:0007603)",0.7061318083951237,1.51149357358632,0.053604436229205174,0.5575998311339093,1.0,4/14,6.95%,GNAQ;GNB1;CNGB1;GNAT1
prerank,hexose biosynthetic process (GO:0019319),-0.47788466299608284,-1.5114712679767024,0.015384615384615385,0.3602981988150188,1.0,17/42,18.71%,RBP4;AKR1B1;PPARGC1A;SLC39A14;CHST15;PER2;ENO2;SLC25A12;GOT1;TPI1;SLC25A13;G6PC3;ENO3;PFKFB1;MDH1;CRY1;PCK2
prerank,regulation of heart contraction (GO:0008016),-0.42240281974478405,-1.5102718438855038,0.009174311926605505,0.3609537819953173,1.0,22/90,12.08%,CELF2;ATP1A2;ANK2;SLC8A3;ATP1B1;SLC8A1;P2RX4;ASPH;DMPK;ABCC9;TPM1;STIM1;PRKACA;TRPC1;ATP2A2;RYR2;TMEM65;ATP1B2;DES;TGFB2;S100A1;TBX2
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.71847284190743,1.5098448923007932,0.05912162162162162,0.5619347111112047,1.0,2/14,2.21%,NOS3;EDN1
prerank,diol metabolic process (GO:0034311),0.6780256915172534,1.5091351680792706,0.05454545454545454,0.5619949151381698,1.0,6/19,5.50%,NOS3;DEGS2;GCH1;PLPP1;SGPP2;ASAH2
prerank,glycolipid metabolic process (GO:0006664),0.5743558625036274,1.5089961673189463,0.050746268656716415,0.5598060968056989,1.0,6/47,4.86%,ST3GAL6;ST6GALNAC3;UGCG;PGAP1;ESYT2;GLTP
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.5072431101413977,1.5089340098284494,0.020486555697823303,0.5572245190583753,1.0,14/110,6.11%,ADGRG6;ADGRL4;CALCRL;GNAQ;ADGRL2;ADCY4;S1PR1;GNB1;ADGRG3;ADGRE5;ADGRG1;ADRB1;RAMP2;RAPGEF2
prerank,regulation of cell adhesion (GO:0030155),0.4940096642300882,1.5088119684743841,0.006305170239596469,0.5549826244060427,1.0,33/129,11.11%,FRMD5;PKP4;PLXNA4;TGM2;STX3;ACVRL1;PODXL;CYTH1;LYN;PRKD2;ADAM10;EFNA1;PTK2B;PPP3CA;PLXND1;PTPRJ;PPP1R12A;ADGRG1;DLL1;RET;CBLL1;ADAMDEC1;ATXN3;PIK3CG;PTK2;RASA1;RSU1;DSCAM;SEMA4D;CXCR4;NUAK1;EPHA4;ABL2
prerank,positive regulation of cell migration (GO:0030335),0.46522822594131347,1.5080894436459715,0.002290950744558992,0.555219165017668,1.0,50/253,8.74%,SEMA6A;LEF1;TJP1;PECAM1;FLT1;BMPR2;KDR;CAV1;ITGA6;SEMA5B;PODXL;INSR;SEMA7A;PLCG1;PDGFB;NEDD9;DOCK1;DAB2IP;RAB11A;EDN1;ARHGEF2;ADAM10;STAT3;PDGFD;PTK2B;PPP3CA;NOTCH1;HIF1A;PPM1F;RREB1;ACTN4;PLCG2;NUMB;F7;SDCBP;XBP1;ENPP2;SEMA6B;RET;RAPGEF2;CBLL1;ACVR1;PDGFC;TGFB1;PTK2;GRB7;GAB1;SEMA6D;AKT2;ARHGEF7
prerank,regulation of inflammatory response (GO:0050727),0.47739003956905457,1.5068601225524942,0.006936416184971098,0.5575816222080621,1.0,31/190,10.61%,IL1R1;TEK;PTGS2;APP;PPARD;IL15;CD200;SEMA7A;FOXP1;PDE2A;MFHAS1;CASP4;NFKBIZ;TNFRSF1B;NFKBIA;NLRP6;BST1;SELE;LPCAT3;TMSB4X;SBNO2;XIAP;WNT5A;TNFRSF1A;LPL;CASP1;BRD4;IL23A;TNIP1;PSMA6;NMI
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.5793061202913753,1.5068278994672053,0.045662100456621,0.5549844916756391,1.0,9/45,8.27%,APP;STAT3;GBP5;AIM2;CASP8;WNT5A;LPL;MALT1;CASP1
prerank,negative regulation of lymphocyte migration (GO:2000402),0.7480339454724498,1.50618200646396,0.06513409961685823,0.5549295020223893,1.0,2/10,1.49%,LRCH1;CD200
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.6419591089091305,-1.5058822650431818,0.043668122270742356,0.36932658671114776,1.0,8/13,23.98%,DDX5;PLA2R1;SPRED1;SPRED2;SPRED3;ATR;MSX1;ATM
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.7533638223555935,1.5043287692021703,0.0703125,0.5597142551864306,1.0,2/10,2.20%,RNF125;SEC14L1
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.6105325325823698,-1.5041823115846324,0.045563549160671464,0.37101199096110793,1.0,5/15,15.87%,BMP4;SIX1;VEGFA;SMO;PAX8
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.6671061577524283,1.5031588453901406,0.05601317957166392,0.5617800128401039,1.0,11/20,14.18%,ADAM10;SPPL2A;TGFB1;NFKB1;PSEN1;RHBDD1;MBTPS2;APH1A;RELA;ADAM17;TRAF6
prerank,positive regulation of cell motility (GO:2000147),0.4722991230213959,1.5028429750146508,0.00351288056206089,0.5603283418601063,1.0,37/205,7.59%,SEMA6A;LEF1;TJP1;PECAM1;FLT1;NTN1;KDR;CAV1;ITGA6;SEMA5B;PODXL;INSR;SEMA7A;PDGFB;NEDD9;EDN1;ADAM10;STAT3;PDGFD;PTK2B;PPP3CA;NOTCH1;PPM1F;ACTN4;NUMB;F7;SDCBP;XBP1;CAVIN1;SEMA6B;RET;CBLL1;ACVR1;PDGFC;TGFB1;PTK2;GRB7
prerank,negative regulation of RNA metabolic process (GO:0051253),0.6645520692994276,1.502782076205039,0.06734006734006734,0.5579183653949855,1.0,7/18,14.67%,ESR1;TMBIM6;PTBP3;TGFB1;NUDT16;RPS13;KAT2B
prerank,calcium ion transport into cytosol (GO:0060402),-0.5519439676998458,-1.5023342591197035,0.056372549019607844,0.3732943220324514,1.0,9/21,13.74%,CACNA1C;CACNA2D1;JPH1;SLC8A1;RYR2;GRIN2A;ADRA1A;JPH2;GRIN2D
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.7502873773969755,1.5021343555284485,0.06296296296296296,0.5579298669817494,1.0,3/11,5.17%,AHR;CEACAM1;SMAD7
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.616541749790123,1.5007530302720926,0.05846153846153846,0.5607710561459089,1.0,8/28,7.33%,EGFL7;LFNG;GATA2;FBXW7;DLL1;DLL4;ARRB1;ARRDC1
prerank,heart trabecula morphogenesis (GO:0061384),0.6671875016173014,1.4999682163139818,0.055062166962699825,0.5613804309431989,1.0,7/18,5.27%,ADGRG6;TEK;ENG;S1PR1;NOTCH1;FKBP1A;DLL4
prerank,peptidyl-tyrosine modification (GO:0018212),0.5481793458848377,1.4997614921699995,0.031473533619456366,0.5595602233729066,1.0,16/56,7.46%,TEK;FLT1;ABI3;KDR;INSR;PDGFB;LYN;TPST2;PTK2B;FYN;SRMS;FLT4;JAK3;DYRK1A;LCK;PTK2
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),-0.6786863285495193,-1.4995003169369923,0.05982905982905983,0.37809665860590363,1.0,4/10,9.55%,CPEB1;CPEB3;PAF1;LEO1
prerank,2-oxoglutarate metabolic process (GO:0006103),-0.6242126593449534,-1.4994412656485037,0.05555555555555555,0.37553931375087046,1.0,5/13,10.45%,ADHFE1;IDH2;GPT2;IDH1;GOT1
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.6009283968406041,1.4989376479580678,0.05443234836702955,0.5602809948295002,1.0,8/35,6.61%,NRP2;SEMA6A;PLXNA4;SEMA5B;SEMA7A;PLXND1;SEMA6B;RAC1
prerank,positive regulation of Notch signaling pathway (GO:0045747),0.5813781277325584,1.4985994251625556,0.04978038067349927,0.5590708984657278,1.0,10/39,5.39%,NOS3;IL6ST;MAML2;EPN2;STAT3;NOTCH1;TSPAN5;DLL1;DLL4;TSPAN14
prerank,sodium ion import across plasma membrane (GO:0098719),-0.5880126233201685,-1.4982780243731473,0.033185840707964605,0.37591657783245336,1.0,4/17,3.39%,SLC12A2;SLC6A1;SLC9A9;SLC8A1
prerank,sodium ion transport (GO:0006814),-0.4256281470361332,-1.4969275798234376,0.01195219123505976,0.3767831714773548,1.0,12/85,3.39%,ATP1A2;SLC24A3;NALCN;SLC6A13;SLC8A3;SLC12A2;SLC6A1;SCN7A;SLC6A12;SLC6A9;ATP1B1;SLC8A1
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),-0.5364994113098057,-1.4963912578788114,0.037940379403794036,0.37567928754976393,1.0,13/30,15.26%,ANK2;CACNA1C;SNTA1;CACNA2D1;GJA1;CACNA1D;CACNA1G;KCNJ2;RYR2;GPD1L;SCN2B;SCN1A;GJC1
prerank,glycosaminoglycan biosynthetic process (GO:0006024),-0.41315362213018075,-1.496317767292364,0.0,0.3732541103597518,1.0,35/95,10.70%,GPC6;UST;DSE;SDC2;DCN;ANGPT1;GPC3;OGN;CEMIP;FMOD;HSPG2;HS3ST3A1;BGN;EXT1;CSPG4;PRELP;CHST15;PXYLP1;HS3ST3B1;LUM;CHSY3;HS2ST1;VCAN;GPC5;CHSY1;HS6ST2;GCNT2;SDC4;CHST3;DSEL;OMD;XYLT1;HS3ST5;HS6ST1;GPC4
prerank,plasma membrane tubulation (GO:0097320),0.688515764274561,1.4962523359446234,0.07246376811594203,0.5660377986551592,1.0,4/13,9.19%,FNBP1L;CAVIN2;EHD2;CHMP4A
prerank,regulation of platelet aggregation (GO:0090330),0.6664633117367262,1.4960972079048305,0.07388316151202749,0.5642104005061178,1.0,4/17,5.11%,PRKG1;F11R;LYN;CEACAM1
prerank,respiratory tube development (GO:0030323),-0.5328129769880962,-1.4955848514769878,0.045454545454545456,0.3725861255256344,1.0,13/28,12.70%,FGFR2;GLI2;FGF1;PDPN;BMP4;PCSK5;RBP4;LOXL3;FGF2;VEGFA;STRA6;FGF7;CCDC39
prerank,positive regulation of collagen metabolic process (GO:0010714),-0.5957979768923948,-1.4953005671910484,0.040268456375838924,0.3707089431345296,1.0,6/17,10.18%,WNT4;BMP4;LARP6;RUNX1;RGCC;TGFB3
prerank,cellular response to cytokine stimulus (GO:0071345),0.44940828013069595,1.495031390206467,0.0,0.5658009581935055,1.0,82/416,11.86%,IL1R1;LEF1;ST3GAL6;LRCH1;FOXO1;PTPN14;IL6ST;LIFR;INPP5D;MAOA;PTGS2;VCAM1;ICAM1;STX3;DAPK1;PTPN12;IL6R;DAB2IP;ARHGEF2;PDE2A;SOCS2;OSMR;STAT3;GBP5;AIM2;GBP4;S1PR1;HIF1A;PTPRJ;TNFRSF1B;FYN;SIGIRR;LCN2;JAK3;GBP7;IKBKB;XBP1;GHR;CSF2RB;IL27RA;SBNO2;MAPK8;ASAH2;IFNAR1;WNT5A;IFNAR2;IL36G;DCSTAMP;CD40;INPP5K;CDKN1B;JUNB;BCL2L11;LCK;JAK1;TNFRSF1A;TGFB1;STX1A;NFKB1;CASP1;CRK;YBX3;CSF1;IL23A;BCL2L1;MAPK11;RPL13A;CCL14;CXCR4;GAS6;FSCN1;POU2F1;RC3H1;IL4R;CBL;RO60;ABL2;IL7;CEBPD;IRAK4;PIM1;RIPK1
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.6173094612987279,1.4942831810079482,0.06270096463022508,0.5662926884628466,1.0,8/28,8.17%,CTSC;SMURF1;ECSCR;DAB2IP;FBXW7;KCNE2;PTK2;RNF139
prerank,sphingosine metabolic process (GO:0006670),0.6843456157937368,1.4939824024421142,0.0576271186440678,0.564880039842684,1.0,6/17,5.50%,ACER2;SPTLC2;PLPP1;SGPP2;SPTLC3;ASAH2
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.7402677404079575,1.4937095414158903,0.07945736434108527,0.5634377625170698,1.0,4/10,13.09%,GNB1;CNGB1;GNAT1;PDE6B
prerank,regulation of programmed cell death (GO:0043067),0.4797250827522566,1.4930667689924288,0.009626955475330927,0.5632979583351768,1.0,36/161,14.20%,MECOM;ACER2;TGM2;PPP1R13B;DAPK1;HIP1;FAS;ANP32A;GLS2;ACTN4;AMIGO2;TNFRSF25;ACTN1;JAK3;TOX3;STK26;BCL2L11;TIGAR;BCL3;MALT1;CASP1;CRADD;NF2;CITED1;RBM25;TRIM24;SLK;BNIP3;RIPK1;BID;NOP53;PRDX2;BIRC3;OMA1;ASAH1;BCL2L14
prerank,inorganic cation transmembrane transport (GO:0098662),-0.364399095517118,-1.4928333281074178,0.0,0.3748951895301066,1.0,44/268,8.00%,ATP1A2;SLC24A3;TRPM3;CACNA1C;KCNK2;NALCN;SLC6A13;SLC1A3;SLC8A3;SLC41A1;SLC12A2;SLC6A1;SCN7A;KCNB2;SCARA5;CACNA1D;SLC9A9;SLC30A10;KCNK5;SLC6A12;SLC6A9;PKD1;ATP1B1;SLC8A1;P2RX4;KCNQ3;ABCC9;KCND2;ATP6V0A4;SLC39A14;KCND3;CACNA1G;ITGAV;TRPC3;SLC39A13;KCNC2;SLC6A15;KCNS3;TRPC6;KCNJ2;KCNQ4;TRPC1;ATP2A2;KCNAB1
prerank,regulation of leukocyte activation (GO:0002694),0.6886494448355664,1.492625332150654,0.08347529812606473,0.5624941582225461,1.0,4/14,7.19%,CD200;LYN;MFHAS1;LCK
prerank,rRNA processing (GO:0006364),0.47441852558168024,1.4925599506210325,0.005917159763313609,0.5602292587756672,1.0,88/172,26.57%,DDX54;RPS15;IMP3;RPS19;RPLP1;RPS14;RPS16;RPL38;RPL34;RPL39;RPS7;RPS24;MTREX;FCF1;RPL37A;RPF1;RPL36;RPL15;RPL14;RPL23;RPL17;RPL9;RPL4;RPL13A;RPL32;EIF6;RPL22;RPS27;RPL31;EXOSC1;RPL13;NOP53;UTP4;RPL6;RPL10;RPS6;RIOK1;RPL29;RRP9;PELP1;RPS25;SRFBP1;RPL35A;RPL27;RPL18;XRN2;EMG1;RPL27A;RRP1B;UTP6;PIH1D1;PDCD11;MAK16;RPL11;WDR18;HEATR1;ESF1;RPL8;NOP14;RPLP2;RPL18A;RPL21;SART1;RPL3;SBDS;RIOK2;RPS28;DDX47;RPL7;THUMPD1;RPL26;MRPL1;NOL6;RIOK3;TEX10;RRP12;LAS1L;LYAR;NOLC1;RPS17;RPL28;WDR46;WDR74;RPL41;DIS3;EXOSC4;RPS2;RPS9
prerank,positive regulation of bone mineralization (GO:0030501),-0.49816518992166786,-1.4925057474165417,0.03903903903903904,0.3733359480364751,1.0,11/35,4.62%,BMP6;BMPR1A;PTN;WNT4;BMP7;ADGRV1;OSR1;BMP4;GPM6B;SLC8A1;FBN2
prerank,ribosomal small subunit biogenesis (GO:0042274),0.581875618232803,1.4920688947170653,0.038523274478330656,0.5595289698661406,1.0,19/39,21.07%,RPS15;RPS19;RPS14;RPSA;RPS16;RPS7;RPS24;RPS27;UTP4;RPS6;NPM1;RIOK1;RPS25;SRFBP1;EMG1;NOP14;NOM1;RIOK2;RPS28
prerank,amino sugar biosynthetic process (GO:0046349),-0.646069818026424,-1.491932449759578,0.058823529411764705,0.3724037279391047,1.0,6/12,12.48%,RENBP;PGM3;NAGK;GFPT1;GFPT2;GNPDA1
prerank,positive regulation of T cell cytokine production (GO:0002726),0.6625310837746444,1.491684770838953,0.061258278145695365,0.5584629230197825,1.0,3/20,3.15%,IL1R1;B2M;DENND1B
prerank,actin filament polymerization (GO:0030041),-0.525430842621332,-1.4904660662404563,0.030054644808743168,0.3736732151413512,1.0,5/29,3.85%,ARHGAP6;GAS7;GSN;SPIRE1;COBL
prerank,positive regulation of vasculogenesis (GO:2001214),0.73930854232712,1.4902628713017452,0.06395348837209303,0.5615978228120875,1.0,5/10,7.52%,KDR;CD34;CEACAM1;RAPGEF2;RAP1A
prerank,positive regulation of integrin activation (GO:0033625),0.7391943084922696,1.489882746485256,0.06355140186915888,0.560677690943646,1.0,5/11,11.15%,PIEZO1;RASIP1;RAP1B;SKAP1;P2RY12
prerank,myelination in peripheral nervous system (GO:0022011),0.7074833540944203,1.489695026831419,0.06569343065693431,0.5590540190338138,1.0,2/13,1.92%,ADGRG6;PARD3
prerank,receptor metabolic process (GO:0043112),0.5501341009595495,1.4892360269291867,0.03550295857988166,0.5583783139515963,1.0,16/53,13.42%,DNM3;CALCRL;CAV1;SMURF1;LMTK2;RAMP2;SH3GLB1;SNX25;TGFB1;NEDD4;EHD3;PICALM;LGMN;RAB11B;KIF16B;RAB31
prerank,cellular response to fatty acid (GO:0071398),-0.6486778396013064,-1.486509077886052,0.05417607223476298,0.38152875914738216,1.0,2/12,1.40%,PID1;IRS1
prerank,nuclear transport (GO:0051169),0.6745891241989328,1.48649399097039,0.07104795737122557,0.5666538235270866,1.0,7/16,14.04%,ANP32A;RSRC1;XPO1;CITED1;NUP98;NUP205;NPM1
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.64942461834099,1.4856115331765611,0.06218487394957983,0.5676739498617577,1.0,5/19,6.61%,TEK;KDR;PTPRJ;PPM1F;RAC1
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.6018577840942837,1.4851856741915703,0.07582938388625593,0.5670950452612211,1.0,10/30,16.50%,DACH1;BMPR2;ACVRL1;PINX1;ACD;DCP2;HNRNPC;ERCC4;NIBAN2;TERF1
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),-0.5698616755706584,-1.4850926323251032,0.04938271604938271,0.3830395788730394,1.0,4/21,2.57%,ANK2;SNTA1;CACNA2D1;CACNA1D
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.5851211197950573,1.4850373531124041,0.04791344667697063,0.5651458456919757,1.0,8/39,6.59%,TEK;KDR;ICAM1;PLCG1;ECSCR;GATA2;RAMP2;CD40
prerank,regulated exocytosis (GO:0045055),0.47983996105640137,1.4848671400303544,0.00954653937947494,0.563389723005413,1.0,36/173,12.21%,VWF;ABCC4;PECAM1;PCDH7;APP;PDGFB;VEGFC;MYH9;LYN;ACTN4;RAB11FIP1;SELP;SELENOP;TMSB4X;ACTN1;PROS1;VEGFD;QSOX1;RAB11FIP5;ARHGAP17;TAGLN2;PPP3CB;PPBP;SRGN;TGFB1;STX1A;APOOL;TMX3;APLP2;CYRIB;GAS6;SYT15;ITGB3;RAB26;MMRN1;RAB11B
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.6264364875828989,1.4844324946654734,0.06862745098039216,0.5627788243609536,1.0,5/24,5.62%,TEK;KDR;ICAM1;GATA2;RAMP2
prerank,negative regulation of cell activation (GO:0050866),0.6775061868589782,1.4838352524948308,0.07944732297063903,0.5627074515042275,1.0,3/14,1.89%,NOS3;CD200;PDGFB
prerank,regulation of interleukin-13 production (GO:0032656),0.704179958378205,1.4831070326354119,0.0659536541889483,0.5633651980408126,1.0,1/13,0.13%,LEF1
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.6628372125357394,1.4805469388391455,0.060658578856152515,0.5707861010676473,1.0,6/18,6.83%,ERN1;NCK1;XBP1;BOK;ATXN3;BCL2L11
prerank,regulation of fatty acid metabolic process (GO:0019217),0.6605473488588011,1.4803940393673054,0.07130730050933787,0.5689823302058917,1.0,3/17,1.07%,ADIPOR2;CAV1;PPARD
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.7220463373659406,1.4797771306132979,0.07806691449814127,0.569227098480266,1.0,5/11,13.54%,STAT3;PUM1;PUM2;ZFP36;FMR1
prerank,regulation of epithelial cell migration (GO:0010632),0.5590542061884843,1.478821061356027,0.04978038067349927,0.5706242052600395,1.0,16/51,7.46%,PTPRG;BMPR2;PLCG1;DOCK1;DAB2IP;RAB11A;HIF1A;PPM1F;RREB1;PLCG2;EVL;RHOJ;CEACAM1;ENPP2;SASH1;PTK2
prerank,regulation of blood circulation (GO:1903522),-0.5055138458607458,-1.478307801179504,0.04473684210526316,0.3990185164424633,1.0,10/34,12.08%,CELF2;DMPK;TPM1;PER2;AGTR1;KCNMB2;BDKRB2;DES;S100A1;TBX2
prerank,regulation of DNA biosynthetic process (GO:2000278),0.6164781062754938,1.4780850268145418,0.05714285714285714,0.571185115796134,1.0,6/27,4.03%,DACH1;BMPR2;ACVRL1;PDGFB;PRKD2;HMBOX1
prerank,ethanol metabolic process (GO:0006067),-0.6515004902257803,-1.4780432847417813,0.05919661733615222,0.39717975515519205,1.0,2/12,6.08%,ALDH1A1;ALDH2
prerank,regulation of steroid biosynthetic process (GO:0050810),-0.6389256035496653,-1.4777553837732702,0.04935622317596566,0.3953470643547056,1.0,5/11,16.86%,WNT4;BMP5;FGFR4;DGKQ;NR1H4
prerank,regulation of acute inflammatory response (GO:0002673),0.6583041515566718,1.4775644316108996,0.06788079470198675,0.5707539840855712,1.0,3/18,6.32%,IL6ST;OSMR;PLA2G2D
prerank,cellular response to interleukin-1 (GO:0071347),0.4832388093877607,1.477453595060634,0.008674101610904586,0.5689188802065369,1.0,34/143,17.82%,IL1R1;RPS6KA5;NOD1;DAB2IP;HIF1A;NFKBIA;PLCB1;IKBKB;PELI1;CD40;PSMA2;NFKB1;MAP3K3;IKBKG;MAPK11;PSMA8;CCL14;PSMA6;RC3H1;CUL1;IRAK4;RELA;RIPK2;HAS2;GBP3;IL1RAP;TRAF6;PSME1;IRAK3;RPS6KA4;TAB3;IRAK2;MAP3K8;PSMA4
prerank,positive regulation of cell aging (GO:0090343),0.7171471047051143,1.47739149948009,0.07210626185958255,0.5668831798881835,1.0,2/11,1.56%,ABI3;B2M
prerank,cellular response to interferon-gamma (GO:0071346),0.499250764024076,1.4768483420689393,0.04768041237113402,0.5667898337438294,1.0,16/88,10.40%,VCAM1;ICAM1;B2M;DAPK1;IRF2;GBP5;GBP4;GBP7;TRIM68;WNT5A;JAK1;TRIM25;CASP1;RPL13A;FCGR1A;CCL14
prerank,negative regulation of smoothened signaling pathway (GO:0045879),-0.5530849368135988,-1.4766561088891266,0.03617571059431524,0.39593531578753377,1.0,12/23,20.55%,GLI3;GPC3;ENPP1;TULP3;GLIS2;BTRC;HHIP;SUFU;KIF7;PTCH2;ULK3;PTCH1
prerank,ncRNA processing (GO:0034470),0.46625922420137506,1.4764631757310014,0.012895662368112544,0.5659474656653405,1.0,77/200,21.42%,SMAD1;DDX54;RPS15;IMP3;RPS19;RPLP1;RPS14;RPS16;RPL38;FARS2;RPL34;RPL39;DROSHA;RPS7;RPS24;MTREX;FCF1;RPL37A;RPF1;RPL36;RPL15;RPL14;RPL23;RPL17;DICER1;RPL9;RPL4;RPL13A;RPL32;INTS11;RPL22;RPS27;RPL31;EXOSC1;ADAR;RPL13;RPP30;NOP53;UTP4;RPL6;RPL10;INTS12;RPS6;RPL29;RRP9;ADAT1;PELP1;RPS25;RPL35A;RPL27;RPL18;XRN2;EMG1;RPL27A;RRP1B;KARS1;UTP6;PIH1D1;PDCD11;RPL11;WDR18;HEATR1;ESF1;RPL8;NOP14;RPLP2;RPL18A;SMAD2;RPL21;RPL3;MRPL44;SBDS;INTS8;RPS28;DDX47;PRKRA;RPL7
prerank,positive regulation of B cell proliferation (GO:0030890),0.5974609823101689,1.475758514758652,0.07580645161290323,0.566463515513721,1.0,8/29,11.13%,CD38;MEF2C;BST1;TIRAP;CD40;TNFRSF13C;CD320;IL7
prerank,regulation of cell migration (GO:0030334),0.4430087170998914,1.4754932838721038,0.001072961373390558,0.5653340540904438,1.0,72/382,8.62%,FRMD5;SEMA6A;LEF1;TJP1;LIMCH1;PECAM1;MCTP1;FLT1;DACH1;ABI3;PLXNA4;LDB2;KDR;ENG;CAV1;ITGA6;SEMA5B;ACVRL1;CLDN5;PODXL;INSR;SEMA7A;PDGFB;NEDD9;ADARB1;EDN1;ADAM10;STAT3;PDGFD;PTK2B;SRGAP3;SRGAP2;PPP3CA;NOTCH1;PLXND1;PTPRJ;PPM1F;ADGRG3;SPATA13;ACTN4;STK24;SRGAP1;ROBO4;NUMB;TMSB4X;FGF23;F7;SDCBP;XBP1;CEACAM1;PTPRK;SMAD7;ENPP2;SEMA6B;RET;PRR5L;DUSP22;ADAM15;CBLL1;ACVR1;RAC1;SASH1;STK26;PDGFC;TGFB1;PTK2;GRB7;NF2;SEMA6D;GNA12;SGK3;AKT2
prerank,regulation of calcium ion transmembrane transport (GO:1903169),-0.5444404806481093,-1.4753599679802283,0.06766917293233082,0.3969053559648146,1.0,5/23,8.65%,ATP1A2;ANK2;CACNA2D1;UBASH3B;CACNB1
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),-0.5311114631889744,-1.47510580370196,0.03836317135549872,0.3950572390897911,1.0,9/27,9.16%,PID1;PRKCB;IRS1;ENPP1;GRB10;PRKCD;TNS2;PRKCZ;TSC2
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.5150070820316812,-1.475100225794075,0.05472636815920398,0.3925783394668425,1.0,8/26,9.88%,ANK2;FHL1;ACTN2;CACNA1D;ATP1B1;DLG1;KCNAB1;ATP1B2
prerank,neuron projection morphogenesis (GO:0048812),-0.38212986312470837,-1.4736638011148946,0.005154639175257732,0.39420111430949206,1.0,41/137,11.40%,ALCAM;DCLK1;GAS7;DOCK7;SDC2;FGFR2;NBL1;CTNND2;EPB41L3;BMP7;DCDC2;DLG4;NRK;MAP2;BRSK1;ALS2;IMPACT;FARP1;CNTNAP2;S100A6;ANK3;TAOK3;SHTN1;DOCK10;RYK;NGF;NLGN1;NTNG1;MAP6;S100B;LRRK2;CTNNA2;FLRT1;DCC;PLXNB1;NRCAM;DTNBP1;SHANK1;BAIAP2;RAB10;CNTN4
prerank,muscle tissue development (GO:0060537),0.6971762696536311,1.4732493280878591,0.0975177304964539,0.5715811967052659,1.0,3/13,5.60%,PGM5;ENG;SRPK3
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.7322924942851448,1.4724185807922843,0.0712979890310786,0.57263392389986,1.0,1/10,0.83%,KDR
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.7331488751723511,1.4722157853509135,0.07334525939177101,0.5711609422833414,1.0,4/10,4.99%,PLPP1;PARD3;PRKD3;DGKH
prerank,bone development (GO:0060348),-0.4797294834318495,-1.4709901851303284,0.03987730061349693,0.39922589332020497,1.0,12/39,7.11%,RANBP3L;SULF1;FGFR2;AKAP13;GJA1;SULF2;CYP26B1;SH3PXD2B;GNAS;SFRP4;LRP6;NOTUM
prerank,regulation of epithelial cell differentiation (GO:0030856),0.6858443679229229,1.4706278708270955,0.06303236797274275,0.5749357066952798,1.0,6/17,5.11%,CAV1;APOLD1;KLF7;MAFF;DLL1;CEACAM1
prerank,axonal fasciculation (GO:0007413),-0.6408118655218416,-1.4706070703803837,0.07964601769911504,0.39774693615260537,1.0,7/12,17.34%,EPHA3;SEMA5A;NRCAM;CNTN4;RTN4;ARHGAP35;EPHB3
prerank,positive regulation of T cell activation (GO:0050870),0.526501273160339,1.4696183429601972,0.056708160442600276,0.5766926141463963,1.0,12/62,11.30%,IL6ST;VCAM1;IL15;NCK1;JAK3;XBP1;LCK;TNFRSF13C;IL23A;CYRIB;IL7;ZMIZ1
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.6768869504704923,1.469161411244316,0.07570422535211267,0.5740640260400959,1.0,8/15,19.01%,NANOS3;NANOS2;TNRC6C;CNOT1;ZFP36;CNOT7;ZFP36L1;DHX36
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.6768869504704923,1.469161411244316,0.07570422535211267,0.5740640260400959,1.0,8/15,19.01%,NANOS3;NANOS2;TNRC6C;CNOT1;ZFP36;CNOT7;ZFP36L1;DHX36
prerank,negative regulation of locomotion (GO:0040013),0.7042654157537005,1.4688864085626208,0.0859106529209622,0.5728917255791858,1.0,2/12,2.30%,FRMD5;CCDC125
prerank,O-glycan processing (GO:0016266),0.5384999304859642,1.4688561095546409,0.0420899854862119,0.5708174736848302,1.0,12/54,12.16%,ST6GAL1;ST3GAL1;GALNT14;GALNT15;B3GNT3;B3GNT4;ST6GALNAC2;B4GALT5;B3GNT6;ST6GALNAC4;C1GALT1;MUC1
prerank,positive regulation of ion transport (GO:0043270),-0.46010971984028937,-1.4683069093073853,0.041916167664670656,0.40126124807552144,1.0,10/48,8.32%,ANK2;FHL1;ACTN2;CACNA1D;P2RX4;ANK3;DLG1;CACNB2;TRPC6;ADRA2A
prerank,positive regulation of signaling receptor activity (GO:2000273),0.5883377339760064,1.4681473930788587,0.04434250764525994,0.5714053530879876,1.0,6/36,7.47%,SHANK3;EDN1;FBXW7;HIF1A;GREM1;TGFA
prerank,regulation of adaptive immune response (GO:0002819),0.6474917780133504,1.4673506783626682,0.07445008460236886,0.5725184349728467,1.0,4/18,8.07%,IL6ST;AHR;SKAP1;SAMSN1
prerank,T cell activation involved in immune response (GO:0002286),0.7127869029387601,1.4664042496749305,0.0922242314647378,0.5741785450936316,1.0,2/12,1.30%,LCP1;ICAM1
prerank,regulation of osteoblast proliferation (GO:0033688),-0.5866900841332069,-1.4652058210825338,0.05924170616113744,0.4069297672992654,1.0,6/17,8.67%,FGFR2;NPR3;MN1;CCN1;SFRP1;PLXNB1
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.7003222062153401,1.4648770725130211,0.07977736549165121,0.5778616767505484,1.0,2/12,2.87%,CAV1;PDE4D
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.7351950506594968,1.4640533010024914,0.06844106463878327,0.5787175637746093,1.0,3/11,4.28%,LYN;MFHAS1;TIRAP
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.6168017627449066,1.463906172418017,0.07628524046434494,0.5771113041850158,1.0,6/25,8.08%,PTGS2;INSR;EDN1;KLF2;NOS1AP;PKD2
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.6197420516195556,1.4634718293320028,0.07881773399014778,0.5765566094546427,1.0,5/24,6.61%,TEK;KDR;PTPRJ;PPM1F;RAC1
prerank,positive regulation of cell projection organization (GO:0031346),-0.3969397623335014,-1.4632990901391878,0.0,0.4098150939923315,1.0,44/115,14.96%,ROBO1;PLXNA2;NTRK3;MAGI2;ROR1;DPYSL3;CAMK1D;EPHA3;PTN;PTK7;GRIP1;TIAM2;DLG4;TENM3;OBSL1;NDNF;CARMIL1;CUX2;CAPRIN2;PTPRD;NTRK2;ROR2;ROBO2;IL1RAPL1;NGF;CUX1;KIDINS220;MAP6;ARSB;PLXNB1;APOE;ATP1B2;FBXW8;FZD1;SLIT2;CAMK1;PLK5;CDKL3;PRKCI;CAMK2B;FUT9;P3H1;PLPPR5;CBFA2T2
prerank,apoptotic process (GO:0006915),0.46674806759231025,1.4622424392728788,0.012746234067207415,0.5792496252238493,1.0,46/203,12.98%,SEMA6A;FOXO1;TBX1;APP;PPARD;ZBTB16;TNFRSF19;DAPK1;AHR;ELMO1;HIP1;FAS;PAEP;PTK2B;DDIT4;CASP4;BIK;NFKBIA;TAOK2;STK3;CASP8;TNFRSF25;MAL;STK4;IER3;NCKAP1;BOK;ADAM15;JADE1;BCL2L11;CASP7;BNIP2;CASP1;IKBKG;BCL2L1;SIAH1;CXCR4;BNIP3;CSRNP1;RIPK1;BID;RHOB;GLRX2;FASTKD2;TGFBR2;MAGI3
prerank,protein localization to cilium (GO:0061512),-0.4990279441157598,-1.4607038425679741,0.058823529411764705,0.4144131233458861,1.0,19/32,29.87%,TULP3;WDR35;INVS;ARL3;IFT20;RAB29;EHD1;BBS9;TCTN1;IFT140;TULP1;TCTN2;TTC21B;TULP2;IFT122;BBS1;ARL6;ODAD4;NPHP4
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.6315925231364943,-1.460420843542712,0.06944444444444445,0.4127782594417176,1.0,6/13,12.48%,RENBP;PGM3;NAGK;GFPT1;GFPT2;GNPDA1
prerank,regulation of cellular amide metabolic process (GO:0034248),0.5803354015930638,1.4597082413880968,0.06055900621118013,0.5873579612101614,1.0,9/32,13.02%,NANOS3;APP;EIF4E;TIGAR;RBM3;CYFIP1;PICALM;RPL10;MTPN
prerank,protein localization to chromatin (GO:0071168),0.6455402364917117,1.4591087386902777,0.09747899159663866,0.5873283086244575,1.0,9/18,22.92%,ESR1;TASOR;PPHLN1;MCM9;PIH1D1;RAD21;MSH2;PLK1;NIPBL
prerank,adherens junction organization (GO:0034332),0.5510945262250705,1.4576116339124987,0.044709388971684055,0.5909458551690696,1.0,11/48,8.76%,TJP1;CADM1;NECTIN2;PVR;PAK2;CDH2;SMAD7;CTNNA1;RAMP2;CDH15;ANG
prerank,dephosphorylation (GO:0016311),0.4729070154379129,1.457320911180968,0.015625,0.5899901102932905,1.0,26/147,8.36%,PTPRB;PTPRG;PTPN14;CTTNBP2NL;PTPRM;PLPP1;PTPN12;PPP2R5A;SGPP2;PPP3CA;PTPRJ;PPM1F;MTM1;SSH2;PPP1R12A;PTPRK;PPM1L;PPP3CB;MTMR6;FBP1;INPP5K;PPM1D;DUSP23;DUSP16;PPP2R5E;PPP2R5B
prerank,mesoderm development (GO:0007498),0.6434374119414876,1.4566077126795953,0.0945945945945946,0.5905858413049503,1.0,5/18,9.32%,TBX1;TIE1;MESD;BMX;TCF15
prerank,receptor catabolic process (GO:0032801),0.6229381386404286,1.4565107131009218,0.07109004739336493,0.5888231512997749,1.0,11/24,12.64%,SMURF1;ZNRF3;AP2B1;SH3GLB1;SNX25;TGFB1;AP2A1;NEDD4;LGMN;KIF16B;MYLIP
prerank,positive regulation of cell adhesion (GO:0045785),0.5143523227493996,1.4564957749857064,0.039030955585464336,0.5867429816910466,1.0,17/74,11.15%,FRMD5;TGM2;STX3;MAGI1;PDGFB;PRKD2;PPP3CA;PTPRJ;PPM1F;ADGRG1;SMAD7;RET;RAC1;RSU1;SFRP2;EPHA4;P2RY12
prerank,aortic valve development (GO:0003176),0.5782654565860075,1.4563914453894193,0.06045751633986928,0.5849992324940627,1.0,11/34,7.32%,NOS3;BMPR2;TIE1;NFATC1;EFNA1;NOTCH1;TNFRSF1B;ELN;DLL4;TNFRSF1A;TGFB1
prerank,regulation of cardiac muscle cell action potential (GO:0098901),-0.5316281390356417,-1.4559772984044441,0.03980099502487562,0.4223915940168719,1.0,8/25,10.19%,ANK2;CACNA1C;CXADR;DLG1;TBX18;ATP2A2;RYR2;CTNNA3
prerank,negative regulation of cell junction assembly (GO:1901889),-0.51855787135185,-1.455648268549123,0.05789473684210526,0.4206910843366713,1.0,6/25,4.96%,ARHGAP6;PHLDB2;ROCK2;THBS1;APOD;ROBO2
prerank,endothelial cell differentiation (GO:0045446),0.7096533101890866,1.4555369472966084,0.08860759493670886,0.5861695515873627,1.0,5/12,3.69%,BMPR2;KDR;TIE1;ACVRL1;SOX18
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.646753380130265,-1.4553244173400641,0.07205240174672489,0.41917692283076696,1.0,6/11,12.48%,RENBP;PGM3;NAGK;GFPT1;GFPT2;GNPDA1
prerank,positive regulation of cytokine production (GO:0001819),0.4437193562636611,1.4545880156444482,0.008639308855291577,0.5875417807532681,1.0,42/292,10.01%,IL1R1;NOD1;IL6ST;CADM1;PTGS2;APP;IL15;SPTBN1;CD200;LRRFIP1;FOXP1;IL6R;ARHGEF2;PRKD2;STAT3;GBP5;PAEP;HIF1A;PDE4D;AFAP1L2;PLCB1;CD34;FLT4;PLCG2;TIRAP;XBP1;WNT5A;TIGIT;CD40;TGFB1;PIK3CG;AGPAT1;NFKB1;LPL;MALT1;ZFPM1;G3BP1;CGAS;RFTN1;IL23A;MAPK11;CYRIB
prerank,regulation of cell communication (GO:0010646),-0.4866954739755428,-1.454271573530472,0.044444444444444446,0.4194355204329892,1.0,13/35,9.28%,ANK2;CXADR;GRK3;SLC8A1;ANXA1;IGFBP7;YWHAG;MTCH1;TBX18;MGLL;RYR2;SCG5;GRK5
prerank,negative regulation of cartilage development (GO:0061037),-0.6109154313695726,-1.454271306104653,0.05592841163310962,0.4169969418258207,1.0,4/13,4.01%,ADAMTS12;EFEMP1;TGFBR1;WNT9A
prerank,copper ion homeostasis (GO:0055070),0.6684973927628448,1.4541257063381439,0.08139534883720931,0.5872168491758265,1.0,4/17,10.24%,APP;SLC31A1;XIAP;ATP7B
prerank,organic anion transport (GO:0015711),0.5135759000133766,1.453859632514415,0.04755434782608696,0.5861784110318699,1.0,6/76,1.65%,ABCC4;SLCO2B1;ABCG2;LRRC8C;SLC39A8;SLCO2A1
prerank,hexose transmembrane transport (GO:0008645),0.6328562120253433,1.4536234290010963,0.0702054794520548,0.5850581514636163,1.0,4/21,6.84%,SLC2A1;PPARD;SLC2A9;PPBP
prerank,potassium ion transport (GO:0006813),-0.3924187132218684,-1.4534626402482573,0.013392857142857142,0.41674314105084564,1.0,31/120,16.32%,ATP1A2;SLC24A3;KCNK2;NALCN;SLC1A3;KCNB2;SLC9A9;KCNK5;KCNMA1;KCNQ3;ABCC9;KCND2;KCND3;KCNC2;KCNMB2;KCNS3;KCNJ2;KCNQ4;KCNJ13;KCNAB1;SLC24A2;KCNQ5;SLC9A1;KCNA6;ABCB8;KCNJ10;KCNN2;CCDC51;KCNJ8;KCNJ15;LRRC38
prerank,glial cell development (GO:0021782),0.6122777447527176,1.452885921957236,0.08196721311475409,0.5857560237040887,1.0,11/25,14.35%,APP;CDK6;NRROS;DLL1;EIF2B5;PRDM8;SOX4;PICK1;CSPG5;EIF2B2;S100A9
prerank,N-acetylglucosamine metabolic process (GO:0006044),-0.5879220911192815,-1.4520423603494061,0.06937799043062201,0.4185892668157349,1.0,6/15,12.48%,MGAT3;LARGE1;RENBP;NAGK;CHST3;GNPDA1
prerank,establishment of epithelial cell polarity (GO:0090162),0.648497337494583,1.4520249367607,0.09473684210526316,0.5871609637266824,1.0,5/19,5.93%,PARD3;CYTH1;MSN;SIPA1L3;OPHN1
prerank,smoothened signaling pathway (GO:0007224),-0.5065492495628774,-1.4511841917272812,0.05026455026455026,0.4186472341439539,1.0,20/32,25.55%,GLI3;GLI2;EVC2;CC2D2A;GLI1;HIPK2;SMO;TMEM231;DISP2;TTBK2;DISP3;PTCH2;IFT27;TCTN2;ULK3;TMEM17;PTCH1;STK36;STIL;MAP3K10
prerank,positive regulation of cholesterol transport (GO:0032376),0.594739923743154,1.4511086572662604,0.0707395498392283,0.5885854873148106,1.0,6/27,5.76%,CAV1;PLTP;NFKBIA;LPCAT3;EEPD1;ABCA3
prerank,heart looping (GO:0001947),0.5679536600817292,1.4510892161697664,0.05752212389380531,0.5866409005183532,1.0,13/40,14.03%,ENG;MEF2C;ZIC3;NOTCH1;SOX17;SOX18;DLL1;PKD2;IHH;APLNR;VANGL2;TGFBR2;SETDB2
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),-0.5449212647782948,-1.450931181422074,0.06175771971496437,0.4169112423651803,1.0,5/20,3.90%,SULF1;SULF2;THBS1;FGF2;SMOC2
prerank,serine family amino acid biosynthetic process (GO:0009070),0.688736688007737,1.4507517842503674,0.11423220973782772,0.5858013209030398,1.0,2/12,2.40%,SERINC3;SERINC5
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.5239306943121496,-1.450696049523482,0.051490514905149054,0.4151948663127205,1.0,14/27,23.98%,DDX5;PLA2R1;SPRED1;KMT5A;CD44;MDM2;SPRED2;SPRED3;SNAI1;ATR;CD74;MSX1;TWIST1;ATM
prerank,negative regulation of angiogenesis (GO:0016525),0.505132047505578,1.4505090567563168,0.04979811574697174,0.5847201756511612,1.0,13/84,5.48%,SEMA6A;TEK;CLDN5;EPN2;PTPRM;ECSCR;DAB2IP;HHEX;STAB1;NPR1;GTF2I;KLF2;ATP2B4
prerank,myelination (GO:0042552),0.5535765459961426,1.4501432601030597,0.05555555555555555,0.584092402915642,1.0,13/46,13.78%,ADGRG6;MPZ;PARD3;MAL;MALL;B4GALT5;EIF2B5;PLLP;CXCR4;DEGS1;ABCD1;CMTM8;EIF2B2
prerank,regulation of metal ion transport (GO:0010959),-0.5842295436742224,-1.4500198033586356,0.08018867924528301,0.4147738290990555,1.0,7/16,6.34%,ANK2;BCL2;CACNA2D1;SLC30A10;IL16;DLG1;STIM1
prerank,negative regulation of potassium ion transport (GO:0043267),0.6946859978174161,1.449874675435033,0.08876811594202899,0.5831979789256849,1.0,3/13,2.59%,CAV1;NEDD4L;PTK2B
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.6630651975197145,1.4496912346880442,0.09302325581395349,0.581989236178325,1.0,2/15,1.44%,STOX2;NR5A2
prerank,icosanoid biosynthetic process (GO:0046456),0.7190740389458542,1.449470805876555,0.11131386861313869,0.5808461557008309,1.0,3/10,8.63%,PLA2G4A;ALOX5AP;LTC4S
prerank,limb morphogenesis (GO:0035108),-0.5596453975592601,-1.4494559732885852,0.06015037593984962,0.41398548207777486,1.0,9/20,20.55%,GLI3;PCSK5;CYP26B1;LRP6;TGFB2;TBX3;IQCE;SKI;PTCH1
prerank,long-term memory (GO:0007616),-0.5590370933772754,-1.4491716686972127,0.06845965770171149,0.41246599969016934,1.0,9/19,24.12%,RASGRF1;CPEB3;LDLR;APOE;SHANK1;NFATC4;PJA2;CAMK4;CALB1
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.6077524898624787,1.4487807638279273,0.07425742574257425,0.5814201849283986,1.0,6/26,8.08%,PTGS2;INSR;EDN1;KLF2;NOS1AP;PKD2
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.602114510231849,-1.4487711223355488,0.06921241050119331,0.41127073335932707,1.0,6/15,8.61%,GPC3;DAAM2;RSPO3;DACT1;SFRP4;SFRP1
prerank,protein oxidation (GO:0018158),-0.6376308800899962,-1.4474539467559595,0.08849557522123894,0.41268987271487534,1.0,3/11,6.86%,LOXL1;LOXL3;LOX
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.6125675941395655,-1.4472990055372168,0.06802721088435375,0.4109232368312677,1.0,8/13,22.67%,SLC4A10;GRIK2;SHISA7;SYP;SLC8A2;PPFIA3;RAB3GAP1;CLN3
prerank,negative regulation of cell adhesion (GO:0007162),0.509972409909614,1.44722534200164,0.04576976421636616,0.5850659592785958,1.0,17/72,9.24%,SEMA6A;ACER2;PLXNA4;NEXMIF;ACVRL1;PODXL;FZD4;ADAM10;NOTCH1;PLXND1;CBLL1;ADAMDEC1;TGFB1;PTK2;RASA1;NF2;DSCAM
prerank,regulation of protein localization to membrane (GO:1905475),-0.501601615280558,-1.4471099015826323,0.06504065040650407,0.4092005915290299,1.0,8/28,7.81%,GPC6;GSN;PRKN;GPC3;AR;MMP14;SLC5A3;GPC5
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.5474674957796295,1.4469371973732381,0.0401854714064915,0.5841371807157716,1.0,11/45,13.02%,NANOS3;APP;EIF4E;PUM1;RBM3;YTHDC1;RC3H1;CYFIP1;PUM2;RPL10;MTPN
prerank,regulation of insulin receptor signaling pathway (GO:0046626),-0.4695292814225999,-1.4455125997314922,0.052941176470588235,0.4110812651099641,1.0,12/43,9.16%,PID1;PRKCB;IRS1;ENPP1;GRB10;PRKCD;OGT;TNS2;IGF2;PRKCZ;NUCKS1;TSC2
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.5756787079766603,1.4454244574372097,0.07866868381240545,0.5877740354963618,1.0,9/34,7.46%,TEK;FLT1;PRKD1;PDGFB;DAB2IP;PTK2B;PIK3IP1;TGFB1;PTK2
prerank,lipoxygenase pathway (GO:0019372),0.6895427229094783,1.4453150537885986,0.10068259385665529,0.586217944779505,1.0,4/14,8.63%,PTGS2;ALOX5AP;PON2;LTC4S
prerank,organic substance transport (GO:0071702),0.4815514016146851,1.4449732723812698,0.026217228464419477,0.5854739590974034,1.0,28/121,14.27%,CALCRL;SLCO2B1;ABCG2;SLC6A2;PLTP;ATP8A1;SPNS2;SLCO2A1;MYH9;SCAMP1;RAMP2;ABCA3;TAP2;CHMP2B;ARRDC1;RAB38;PLEKHA8;CD320;SLCO1B1;PICK1;ABCD1;RILP;CHKA;RAB7A;ABCG1;TXNIP;TCN2;SLC22A5
prerank,response to axon injury (GO:0048678),-0.5678441234790149,-1.4442057792766172,0.07746478873239436,0.4123679137717859,1.0,5/18,11.38%,DPYSL3;P2RX4;APOD;NREP;GAP43
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.6666595176766331,1.443292244123809,0.08869565217391304,0.5897919146673858,1.0,3/15,2.79%,STAT3;GBP5;HIF1A
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.5665785623418579,1.4430656312374237,0.05819295558958652,0.5886707567902186,1.0,2/36,0.30%,MECOM;FOXO1
prerank,positive regulation of lipid kinase activity (GO:0090218),0.588490147505554,1.442725472692001,0.0724191063174114,0.5879399649323873,1.0,6/29,2.59%,TEK;FLT1;PRKD1;PDGFB;DGKZ;PTK2B
prerank,Golgi localization (GO:0051645),-0.6308545512357352,-1.4425975741846513,0.08172043010752689,0.41439690229470993,1.0,3/11,12.73%,ARHGAP21;COPG1;ARCN1
prerank,pteridine-containing compound metabolic process (GO:0042558),0.6935348616024248,1.4423896191342664,0.09608540925266904,0.587231345751398,1.0,3/13,5.80%,NOS3;GCH1;MTHFD1L
prerank,lipoprotein transport (GO:0042953),-0.6612961275911995,-1.4416150409828163,0.10082304526748971,0.4147060629379319,1.0,4/10,15.05%,LRP1;PRKCB;MIA3;UNC119B
prerank,energy derivation by oxidation of organic compounds (GO:0015980),-0.5334456318462296,-1.4415686743049858,0.05570291777188329,0.4126276857635682,1.0,10/24,20.33%,PID1;LEPR;PPARGC1A;GFPT1;GFPT2;SLC25A13;MT3;SDHAF4;NR4A3;MRAP2
prerank,hydrogen peroxide catabolic process (GO:0042744),0.7135742967489981,1.4413960140316755,0.1033210332103321,0.58876496029974,1.0,4/11,16.67%,PXDN;CAT;PRDX2;PRDX1
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.5841233765009926,-1.4400071708676343,0.08333333333333333,0.414407223263313,1.0,7/17,14.52%,FSTL1;SULF1;TWSG1;SFRP4;CASK;SLIT2;PCSK6
prerank,stabilization of membrane potential (GO:0030322),-0.5720254945515072,-1.4393680090703447,0.0705596107055961,0.41380882672516917,1.0,2/16,2.75%,KCNK2;KCNK5
prerank,positive regulation of hydrolase activity (GO:0051345),0.4681944773206921,1.4389010571428549,0.030376670716889428,0.596155381965462,1.0,27/137,10.42%,DOCK9;PKP4;TGM2;NET1;ITGA6;F11R;CD200;TBC1D30;SRGAP2;ARHGAP27;CAV2;ADRB1;PLIN5;MAPK8;RAP1GDS1;CHP2;RAPGEF2;CD40;BCAR3;RAP1A;TBC1D2;AGRN;RSU1;ARHGEF7;LARS1;CCL14;SEMA4D
prerank,macromolecule catabolic process (GO:0009057),0.6103626104263189,1.4384289749850552,0.08814102564102565,0.5959594075521277,1.0,11/26,12.55%,SMURF1;SH3GLB1;SNX25;TGFB1;NEDD4;CTRL;TRIM24;SIAH1;LGMN;CLN6;KIF16B
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),0.6924651079210398,1.4377481770390073,0.10344827586206896,0.5967475656264849,1.0,2/13,1.06%,SHANK3;APP
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.4778665677681465,1.4373954334964014,0.028967254408060455,0.5961344982696397,1.0,18/113,8.40%,UNC13B;ESR1;PIEZO1;LCP1;RASIP1;DAB2IP;TAL1;GBP5;FNIP2;BIK;RAP1B;TIRAP;SKAP1;SH3GLB1;BCL2L11;RPA1;TGFB1;CDT1
prerank,vesicle transport along actin filament (GO:0030050),0.6241348059507789,1.4373859265058126,0.08506944444444445,0.5942528942772751,1.0,5/19,10.60%,FNBP1L;MYO1D;ACTN4;MYO1E;MYO1C
prerank,cellular potassium ion homeostasis (GO:0030007),-0.6006549723259846,-1.4372785867840292,0.08240534521158129,0.4171695259951508,1.0,6/13,9.88%,ATP1A2;SLC12A2;ATP1B1;KCNMA1;KCNJ2;ATP1B2
prerank,ribosome biogenesis (GO:0042254),0.4549919292204734,1.4367387865619543,0.012850467289719626,0.5946997855506703,1.0,71/187,21.42%,DDX54;RPS15;IMP3;RPS19;RPLP1;RPS14;RPS16;RPL38;RPL34;RPL39;RPS7;RPS24;MTREX;FCF1;RPL37A;RPF1;RPL36;RPL15;XPO1;RRS1;RPL14;RPL23;RPL17;RPL9;RPL4;RPL13A;RPL32;EIF6;RPL22;RPS27;RPL31;EXOSC1;RPL13;NOP53;UTP4;RPL6;RPL10;NOP16;RPS6;NPM1;RIOK1;RPL29;RRP9;PELP1;RPS25;RPL35A;RPL27;RPL18;XRN2;EMG1;RPL27A;RRP1B;UTP6;PIH1D1;PDCD11;RPL11;WDR18;HEATR1;ESF1;RPL8;NOP14;RPLP2;RPL18A;NOM1;RPL21;RPL3;SBDS;RIOK2;RPS28;DDX47;RPL7
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.6489898798502034,1.4365468433925024,0.10178571428571428,0.5935076222912005,1.0,4/17,2.82%,PBX1;MAML2;NOTCH1;PLXND1
prerank,mesenchyme morphogenesis (GO:0072132),0.6575828456423083,1.4365298694793216,0.08774834437086093,0.5916525301192062,1.0,5/17,6.27%,NOS3;ENG;ACVRL1;NOTCH1;ACVR1
prerank,positive regulation of protein binding (GO:0032092),0.5219907192163591,1.4364648166002396,0.053237410071942444,0.5899940331401401,1.0,15/56,6.76%,CAV1;APP;EPB41;CLDN5;B2M;HIP1R;STK3;FKBP1A;STK4;MARK3;RALB;DTX3L;TCF7L2;RAPGEF2;TRIB3
prerank,gluconeogenesis (GO:0006094),-0.46414594592307556,-1.4352329305559297,0.03592814371257485,0.42029688973010365,1.0,20/39,28.10%,RBP4;PPARGC1A;SLC39A14;PER2;ENO2;SLC25A12;GOT1;TPI1;SLC25A13;G6PC3;ENO3;PFKFB1;MDH1;CRY1;PCK2;ALDOA;GOT2;ENO1;ALDOC;MDH2
prerank,intraciliary retrograde transport (GO:0035721),-0.629701693824883,-1.4346959688728866,0.06881720430107527,0.41961626090131593,1.0,7/12,20.43%,DYNC2H1;WDR35;DYNC2I1;DYNC2LI1;IFT43;IFT140;TTC21B
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.6967867566551433,1.4335433086193685,0.08029197080291971,0.5987524308795367,1.0,2/12,3.85%,RAB27A;PLCG2
prerank,embryonic hemopoiesis (GO:0035162),0.6794982828461058,1.4334850125936878,0.10505836575875487,0.5969984843968524,1.0,3/12,2.32%,KDR;KITLG;TAL1
prerank,vasodilation (GO:0042311),0.6897400471689068,1.4327390271580729,0.09430604982206406,0.5976777304890847,1.0,3/13,4.42%,NOS3;ADRB1;KLF2
prerank,negative regulation of reproductive process (GO:2000242),-0.5665645023958916,-1.4323742312633354,0.07616707616707617,0.4234755404230602,1.0,3/17,2.01%,IGF1;SULF1;GJA1
prerank,JNK cascade (GO:0007254),0.560263456030895,1.432174549341467,0.06153846153846154,0.5977457618184305,1.0,16/40,18.73%,NOD1;TNFRSF19;MAP4K3;SH2D3C;MAPK8;MAP3K11;IKBKG;MAP3K13;RIPK2;TRIB1;TRAF6;MAP4K2;TAB3;IRAK2;MAP2K4;MINK1
prerank,positive regulation of interleukin-1 production (GO:0032732),0.5428552896593509,1.4320324574110244,0.061285500747384154,0.5963024665501401,1.0,9/51,8.27%,APP;STAT3;GBP5;AIM2;CASP8;WNT5A;LPL;MALT1;CASP1
prerank,regulation of fatty acid oxidation (GO:0046320),-0.5732029109548473,-1.4318243581176782,0.07226107226107226,0.4226227464949398,1.0,4/16,6.44%,APPL2;PPARA;PPARGC1A;PRKAG2
prerank,regulation of vasculogenesis (GO:2001212),0.6754379090200548,1.4313218183529026,0.08941605839416059,0.5969676193419007,1.0,7/14,13.26%,KDR;CD34;CEACAM1;RAPGEF2;RAP1A;XDH;ASB4
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.6980882479693489,1.431283682153327,0.08587786259541985,0.5952367994264994,1.0,5/11,18.15%,NFKBIZ;MALT1;IL23A;NFKBID;CARD9
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.7146268158596316,1.4312807886996999,0.09269162210338681,0.5934054057594838,1.0,4/11,8.71%,FOXO1;NOTCH1;ATP2B4;GLRX3
prerank,smooth muscle cell differentiation (GO:0051145),0.7088773464271739,1.4312432147828758,0.10554561717352415,0.5916702786193163,1.0,3/12,4.27%,MRTFB;MEF2C;MRTFA
prerank,negative regulation of cell death (GO:0060548),0.48817603425514045,1.4310023324695744,0.04155495978552279,0.5907596317350478,1.0,19/88,10.76%,MECOM;PDE8A;PRKD1;CD200;SRGAP2;TNFRSF1B;FYN;NCK1;CD34;AMIGO2;TIGAR;CHMP4B;CHMP4A;SOX4;IKBKG;CSF1;BTBD10;RAD18;BNIP3
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),0.6985897683119469,1.4296225427949276,0.10412573673870335,0.593910730639804,1.0,3/11,6.11%,MEF2C;LYN;RAPGEF2
prerank,epithelial structure maintenance (GO:0010669),-0.6416266960890424,-1.4289847571993703,0.0899581589958159,0.4284788743949118,1.0,2/11,3.26%,CXADR;RBP4
prerank,cardiac muscle tissue development (GO:0048738),-0.4462968189796474,-1.4289667264610293,0.03857566765578635,0.4263931597954244,1.0,12/50,5.92%,NOTCH2;BMPR1A;GJB6;AKAP13;BMP5;SGCD;BMP7;GJA1;BMP4;RBP4;CACNA1G;TBX18
prerank,regulation of endopeptidase activity (GO:0052548),-0.42600542588813517,-1.428709175514014,0.026143790849673203,0.42498849087984714,1.0,11/59,12.41%,TIMP3;SERPING1;VTN;TIMP2;SERPINH1;SERPINE2;SERPIND1;SERPINF1;APH1B;SERPINE1;SPOCK3
prerank,phospholipid translocation (GO:0045332),0.5966242023568393,1.427786181443234,0.0768,0.5986243117498898,1.0,5/28,2.88%,ATP8B1;ATP8A1;ATP10A;ATP11C;ATP11B
prerank,positive regulation of DNA repair (GO:0045739),-0.4527704846996855,-1.4276182243425009,0.05029585798816568,0.4259148542174795,1.0,5/46,2.95%,EYA2;EGFR;EYA1;EYA4;SPIRE1
prerank,aspartate family amino acid catabolic process (GO:0009068),-0.5605125387536353,-1.4275775397986035,0.06954436450839328,0.4239047941317367,1.0,5/19,10.45%,DDO;ASPA;ALDH7A1;PHYKPL;GOT1
prerank,regulation of water loss via skin (GO:0033561),0.6689140146103837,1.426766538838408,0.10101010101010101,0.598496428721991,1.0,5/15,15.25%,UGCG;LSR;SFN;MET;FA2H
prerank,establishment of skin barrier (GO:0061436),0.6689140146103837,1.426766538838408,0.10101010101010101,0.598496428721991,1.0,5/15,15.25%,UGCG;LSR;SFN;MET;FA2H
prerank,cell junction assembly (GO:0034329),0.48644406949333335,1.4266761918968265,0.036458333333333336,0.5969634293054257,1.0,10/100,4.22%,SHANK3;DNM3;TJP1;PKP4;ITGA6;CLDN5;LIMS2;PLXND1;PCDHB4;CDH2
prerank,cellular protein modification process (GO:0006464),0.4175678034469927,1.426120759793315,0.0,0.5973027751043126,1.0,178/983,11.79%,PTPRB;PRKG1;PRKCH;ERG;ST3GAL6;RPS6KA5;PTPRG;EPAS1;CDK17;PTPN14;BMPR2;TGM2;DCUN1D3;KLHL3;APP;SNRK;KLHL5;UGCG;ZBTB16;ERN1;ACVRL1;PRKD1;CTTNBP2NL;ST3GAL1;CDK6;INSR;MGAT4A;STT3B;PTPRM;DAPK1;GALNTL5;NEK7;PDGFB;PTPN12;PPP2R5A;PEAK1;RAB11A;SOCS2;LYN;PIM3;PRKD2;BCR;KLHL2;ADAM10;PRAG1;PTK2B;FNIP2;STK10;PPP3CA;NEURL2;YES1;FBXW7;HIF1A;PTPRJ;MAP4K3;PPM1F;SIK1;PGAP1;MTM1;MAN2A1;FYN;BTBD1;TAOK2;B3GNT3;FUCA2;STK24;STK3;SSH2;PKN3;LIPE;PPP1R12A;PKN2;PAK2;FGF23;CPE;UBA7;PTP4A2;CDH2;PKN1;STK4;LMTK2;MARK3;JAK3;MAP3K9;IKBKB;PADI4;HIPK1;PTPRK;ACVR2A;QSOX1;ALG10B;CDC42BPB;MAPK8;SPARCL1;FBXL4;RET;PLK2;MAST2;PPM1L;ULK1;LIMK2;KCTD6;PPP3CB;AURKA;MTMR6;VWA1;CISH;SIK3;ACVR1;TSSK6;B3GNT4;DYRK1A;STK26;ST8SIA4;BMX;TNIK;PPM1D;LCK;GOLM1;RNF7;JAK1;SIRT5;ST6GALNAC2;TGFB1;B4GALT5;PSMA2;FBXL7;PIGU;DUSP16;PPP2R5E;RAB2A;CTBP1;PPP2R5B;RAB38;HASPIN;CREB1;SGK3;AKT2;NEK6;PXK;PGGT1B;B3GNT6;MAP3K11;AURKC;RHBDD1;APLP2;FBXL2;CDK2;FBXW2;PTPN1;CSF1;ERO1A;COPS2;PARP2;PSMA8;PTAR1;ASB10;UBE2D3;PSMA6;CDK18;NUAK1;PRKAB1;ICMT;GAS6;COPS4;FBXO30;PPP2R3A;AKT3;ABL2;PIGK;GMFG;PICK1;MAP3K13;CUL1;SIK2;STK38;NUS1;PIM1
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),-0.5267604629348561,-1.425878929751581,0.07556675062972293,0.4259337304154559,1.0,12/22,24.15%,DMD;CACNB2;GNB5;CACNB1;AHNAK;PDE4B;CACNB3;STAC3;CBARP;HPCA;CACNB4;GPR35
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.6214979943292465,1.4251637365188525,0.09666666666666666,0.5989877005689357,1.0,8/21,6.60%,CAV1;CNKSR3;DDIT4;PDE4D;PPM1F;NCK1;SMAD7;INPP5K
prerank,regulation of cytokine production (GO:0001817),0.4716751616044534,1.4248626828843005,0.035758323057953144,0.598258004014317,1.0,18/126,8.30%,RPS6KA5;HDAC9;CADM1;IL15;FOXP1;LYN;TNFRSF1B;AFAP1L2;ACKR1;CASP8;IGF2BP3;N4BP1;MAST2;BTN2A2;SRGN;PIK3CG;AGPAT1;POLA1
prerank,regulation of Rac protein signal transduction (GO:0035020),-0.5744351877441606,-1.4246595614496569,0.08571428571428572,0.4270754140515205,1.0,6/16,10.30%,OGT;ARHGAP24;RASGRF1;AUTS2;ALS2;CADM4
prerank,embryonic heart tube morphogenesis (GO:0003143),0.5530999926442324,1.4245380456988057,0.07091172214182344,0.5976055375349985,1.0,14/44,14.03%,ENG;MEF2C;ZIC3;NOTCH1;SOX17;SOX18;DLL1;ACVR1;PKD2;IHH;APLNR;VANGL2;TGFBR2;SETDB2
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.5813497232837225,1.4240083412326294,0.08346709470304976,0.5976768312866613,1.0,5/29,6.76%,DCUN1D3;FBXW7;DTX3L;SMAD7;TRIB3
prerank,clathrin coat assembly (GO:0048268),0.6595369209593739,1.4231779027240257,0.10338983050847457,0.5989343987209778,1.0,4/15,3.93%,HIP1;HIP1R;PIK3C2A;FCHO2
prerank,determination of heart left/right asymmetry (GO:0061371),0.556376937972964,1.4227513871463882,0.06835066864784546,0.5985619309950901,1.0,13/43,14.03%,ENG;MEF2C;ZIC3;NOTCH1;SOX17;SOX18;DLL1;PKD2;IHH;APLNR;VANGL2;TGFBR2;SETDB2
prerank,ATP transport (GO:0015867),-0.6449630002504031,-1.4226548673840056,0.09381663113006397,0.4303611985232395,1.0,4/10,19.24%,ABCC6;SLC25A42;SLC17A9;SLC25A4
prerank,amide biosynthetic process (GO:0043604),0.5333331592507313,1.4226449822999896,0.07456140350877193,0.5971778809895529,1.0,8/47,5.89%,SPTLC2;SGMS1;DEGS2;CERS4;SPTLC3;SPTSSA;ASAH2;PAM
prerank,regulation of heart rate by cardiac conduction (GO:0086091),-0.46971611569815835,-1.4224217124013343,0.05070422535211268,0.42897383583070947,1.0,10/38,10.19%,ANK2;CACNA1C;CACNA2D1;CACNA1D;KCND3;CACNB2;CACNA1G;KCNJ2;BIN1;CTNNA3
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.4552126270175766,1.4211579243437116,0.019024970273483946,0.6007592886558348,1.0,41/163,16.37%,CD38;INPP5D;MEF2C;PLCG1;PRKD2;PDE4D;PTPRJ;NFKBIZ;DENND1B;FYN;NCK1;PLCG2;PAK2;SH2B2;IKBKB;SKAP1;BTN2A2;BMX;LCK;PSMA2;NFKB1;MALT1;EIF2B5;IKBKG;ICOSLG;RFTN1;PSMA8;PSMA6;RC3H1;CUL1;RELA;RIPK2;BTN3A3;EIF2B2;SLA2;TRAF6;PSME1;SPPL3;ERMAP;LAT;NFKBID
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.604320593387881,1.4209621404322268,0.08362369337979095,0.5996506508397009,1.0,8/23,18.66%,NMT2;CNGB1;GNAT1;GUCA1B;PDE6B;CALM1;FNTA;CAMKMT
prerank,regulation of ruffle assembly (GO:1900027),0.6046954589272526,1.4209011985425397,0.09598603839441536,0.5980771530225648,1.0,4/23,4.23%,ABI3;CAV1;EPS8;EVL
prerank,lamellipodium organization (GO:0097581),0.5807355845641996,1.4202360111654768,0.08225806451612903,0.598878442890317,1.0,9/29,11.69%,PARVB;ABLIM1;S1PR1;SPATA13;CCDC88A;RAC1;ARHGEF7;P2RY12;CYFIP1
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.7020667411892356,1.4199484383211733,0.12589928057553956,0.5980533065093985,1.0,2/10,2.14%,SEMA6A;DAB2IP
prerank,positive regulation of neuroinflammatory response (GO:0150078),-0.6106134007749335,-1.4198260568540138,0.0659090909090909,0.43410046788343803,1.0,2/12,2.50%,NUPR1;IL18
prerank,activation of adenylate cyclase activity (GO:0007190),-0.4855400688522777,-1.4191069084412706,0.06948640483383686,0.43390267715287256,1.0,8/35,5.97%,LGR4;ADCY5;ADCY1;ADCY2;EDNRA;ADCY7;ADCY6;CAP2
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),0.6353226953642168,1.419023503044422,0.09326424870466321,0.5995908420142595,1.0,5/19,7.85%,APP;PDGFB;KLF2;MAPK8;NFKB1
prerank,cation transport (GO:0006812),-0.3680322986564015,-1.4182198923692582,0.006211180124223602,0.43411903205361463,1.0,26/167,8.00%,ATP1A2;TRPM3;PIEZO2;SLC47A1;SLC8A3;SLC41A1;SLC12A2;SCN7A;KCNB2;KCNK5;SLC6A9;ATP1B1;SLC8A1;SLC22A4;KCNMA1;ANO1;ABCC9;KCND3;KCNMB2;KCNS3;TRPC6;KCNJ2;KCNQ4;SLC5A5;KCNJ13;KCNAB1
prerank,positive regulation of protein phosphorylation (GO:0001934),0.42562290340839,1.4180391835482216,0.004324324324324324,0.6014688397376899,1.0,59/348,7.98%,TEK;RPS6KA5;LIMCH1;PECAM1;BMPR2;KDR;ENG;CAV1;TBX1;APP;PDE8A;RBPMS;IL15;ACVRL1;PRKD1;INSR;PDGFB;VEGFC;IQGAP1;IL6R;ARHGEF2;LYN;PRKD2;FAS;EFNA1;PDGFD;PTK2B;FNIP2;PTPRJ;TAOK2;FLT4;PLCG2;PAK2;FGF23;SH2D3C;STK4;RALB;SDCBP;VEGFD;GHR;ACVR2A;CX3CR1;ENPP2;ATP2B4;LIMK2;RAPGEF2;ACVR1;KRAS;CD40;RAC1;BCAR3;PDGFC;ARRB1;TNIK;TGFB1;PTK2;RAP1A;NIBAN1;ITGA5
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.6290745111063784,1.417790376121688,0.11703958691910499,0.6005272318692783,1.0,5/18,10.89%,IL6ST;IL6R;STAT3;JAK1;CBL
prerank,urogenital system development (GO:0001655),-0.6259601238195953,-1.4172419518848594,0.10526315789473684,0.4345995564840094,1.0,7/11,30.15%,OSR1;ANXA1;PAX8;EPHB3;EPHB2;LHX1;SHH
prerank,regulation of phagocytosis (GO:0050764),0.5236099543314552,1.4167834026510908,0.059854014598540145,0.6021082217656439,1.0,5/53,2.18%,RAB27A;TGM2;IL15;GATA2;SCARB1
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.5862636447362051,1.416410647669226,0.09484193011647254,0.601756654059355,1.0,7/26,6.60%,PDE8A;PLCG1;PTPN12;IQGAP1;DAB2IP;DUSP22;INPP5K
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),0.6983227053308352,1.4162435049284579,0.12727272727272726,0.6005890613316467,1.0,2/10,5.11%,PRKG1;CEACAM1
prerank,regulation of protein import into nucleus (GO:0042306),-0.47314594582681674,-1.4162316547192746,0.062111801242236024,0.43527966332423573,1.0,15/36,21.71%,ZIC1;PRKCD;BMP4;CDH1;APOD;SMAD3;SUFU;RAB23;MAVS;PIK3R2;TRIM28;UBR5;HDAC3;JUP;BAG3
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.6396910688373306,1.4160899501846826,0.11073253833049404,0.5994674533815558,1.0,10/16,25.22%,CAV1;BCL3;NF2;INPP5F;ADIPOR1;PPP2R1A;PIBF1;LEPROT;VHL;PPP2CA
prerank,triglyceride biosynthetic process (GO:0019432),-0.5502944718791374,-1.4160757306796639,0.06880733944954129,0.4335842000785385,1.0,5/18,6.99%,AGMO;MOGAT3;LPGAT1;GK;LPIN1
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.42670056325564665,1.4152786322815394,0.004223864836325237,0.6005995658645065,1.0,64/417,11.57%,MECOM;LEF1;ELK3;RPS6KA5;FOXO1;CD38;HDAC9;ATP8B1;DACH1;ZHX3;SMARCA2;PPARD;CBFA2T3;ZBTB16;SOX7;AHR;PDGFB;FOXP1;DAB2IP;SOX13;HHEX;NR3C1;NOTCH1;PPM1F;PLCB1;SOX18;HMBOX1;VGLL4;SCMH1;FOXL2;ID1;EPC1;PTPRK;SBNO2;TCF7L2;WNT5A;ATF7IP;RCOR1;KLF10;INPP5K;CDKN1B;TRIB3;TGFB1;BCL3;GATAD2A;CTBP1;CITED1;KAT6B;FOXK1;MYBBP1A;YEATS2;COPS2;SFRP2;FOXN3;SMARCE1;TFAP4;GAS6;POU2F1;SPEN;RBM15;RB1;ZMYND11;EID1;SP3
prerank,ganglion development (GO:0061548),0.6881234274012235,1.4144602884199469,0.12030075187969924,0.6017462360827389,1.0,1/11,0.07%,NRP2
prerank,response to interleukin-1 (GO:0070555),0.4935644136391261,1.4139424958675832,0.053763440860215055,0.6018829497651905,1.0,16/73,14.18%,IL1R1;APP;DAB2IP;TNFRSF11A;HIF1A;SELE;CD40;NFKB1;CITED1;MAPK11;CCL14;RC3H1;RELA;HAS2;GBP3;TRAF6
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.5233569847162943,1.4137354063103171,0.059490084985835696,0.6008749489314046,1.0,13/57,8.27%,NOD1;TNFSF10;SOX7;DAPK1;AIM2;PPM1F;FYN;CASP8;FOXL2;CYCS;GRAMD4;MALT1;CASP1
prerank,anion transport (GO:0006820),0.57404059221419,1.4130343135657628,0.08294209702660407,0.6016924135593079,1.0,4/33,2.47%,SLCO2B1;ABCG2;LRRC8C;LRRC8B
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.4574958723735703,1.4127687898969665,0.03366583541147132,0.6010173357762523,1.0,24/138,5.59%,TEK;PTPRG;FLT1;BMPR2;KDR;IL6ST;TIE1;LIFR;EPHB4;INSR;NEDD9;LYN;NPR1;PTK2B;YES1;MPZL1;MTSS1;FYN;SRMS;FLT4;LMTK2;JAK3;ACVR2A;RET
prerank,phosphatidylinositol-mediated signaling (GO:0048015),-0.41696748284903656,-1.4127224993043481,0.028169014084507043,0.44039420680603697,1.0,16/69,7.82%,PLCL1;IGF1;PLCE1;PDGFRB;PDGFRA;IRS1;PI4KA;GAB2;OGT;PLCD3;SIRT2;NF1;NGF;PLCB3;PLCD1;EZR
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.42135920824413936,1.4124766777102533,0.003131524008350731,0.6002690611516619,1.0,82/476,9.80%,MECOM;LEF1;FLI1;FOXO1;CD38;TBX1;ESR1;SMARCA2;PPARD;MEF2C;ZBTB16;ACVRL1;NR5A2;AHR;ZIC3;NFATC1;PDGFB;ELF2;MLLT3;FZD4;HHEX;LRP5;TAL1;STAT3;NOTCH1;HIF1A;RREB1;AFAP1L2;KDM3A;SOX17;PLCB1;SOX18;NCOA1;KLF2;FOXF1;IKBKB;RPS6KA1;DTX3L;FOXL2;EPC1;KMT2E;SPIN1;FOXF2;ARID1B;RET;TCF4;TEAD2;PITX3;PPP3CB;ESRRG;WNT5A;CNBP;SKAP1;ATF7IP;ATMIN;ACVR1;SOST;INPP5K;HNF1B;DYRK1A;ETS2;LYL1;TGFB1;BCL3;TCF3;HNRNPD;NFKB1;PCBD2;ARID1A;NEUROD1;CITED1;KAT6B;PSEN1;CREB1;FOXK1;BRD4;SOX4;MAP2K3;MAFB;RNF4;EDRF1;NFIB
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),-0.5978231749387369,-1.411696431254836,0.11279826464208242,0.4411445953607302,1.0,5/12,13.81%,NINL;BICD1;KIF3A;PCM1;BICD2
prerank,signal release from synapse (GO:0099643),-0.45761501731940024,-1.4113996105739397,0.05309734513274336,0.43990585619972894,1.0,16/43,16.69%,SYT1;BRSK1;SNAP25;NAAA;PCLO;NRXN1;LIN7A;SNPH;PTPRN2;NRXN2;GAD2;SNCA;RIMS1;DVL1;SYN1;PDZD11
prerank,regulation of AMPA receptor activity (GO:2000311),0.6085158485493831,1.4113063791995872,0.08373590982286634,0.6028178342298862,1.0,2/25,1.15%,SHANK3;MEF2C
prerank,positive regulation of chromatin organization (GO:1905269),0.698477098193211,1.4111036882274357,0.11731843575418995,0.6018596166926262,1.0,6/12,16.50%,TAL1;H3-3A;ACD;MIER1;ATRX;TERF1
prerank,regulation of anoikis (GO:2000209),0.6325061700688903,1.410424238817411,0.10401459854014598,0.6027451420421981,1.0,6/19,9.01%,CAV1;NOTCH1;SIK1;PTK2;ITGA5;MYBBP1A
prerank,chondroitin sulfate catabolic process (GO:0030207),-0.6093782046489886,-1.4103518572642124,0.10574712643678161,0.4406897208700762,1.0,8/13,18.87%,DCN;BGN;CSPG4;VCAN;ARSB;HEXA;HYAL1;IDUA
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.6583917707627207,1.4102148003925328,0.12126537785588752,0.6018568932282784,1.0,7/14,19.50%,ENTPD1;NUDT16;NUDT15;ENTPD3;NUDT1;ADPRM;NUDT9
prerank,neurotransmitter secretion (GO:0007269),-0.4566762390650653,-1.4098103236469823,0.057057057057057055,0.44010225211647547,1.0,16/44,16.69%,SYT1;BRSK1;SNAP25;NAAA;PCLO;NRXN1;LIN7A;SNPH;PTPRN2;NRXN2;GAD2;SNCA;RIMS1;DVL1;SYN1;PDZD11
prerank,positive regulation of cholesterol efflux (GO:0010875),0.5971421845904425,1.4089910908695629,0.09333333333333334,0.6043612543223819,1.0,5/21,5.76%,CAV1;PLTP;NFKBIA;EEPD1;ABCA3
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.6671491795405731,1.4088813931041149,0.10619469026548672,0.6030366018085249,1.0,2/13,2.21%,KDR;EDN1
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.5765626044208312,1.4086328318961168,0.08850931677018634,0.602247845828383,1.0,11/28,18.28%,NOD1;CASP8;IKBKG;RELA;RIPK2;TRAF6;OTULIN;TAB3;IRGM;IRAK2;AAMP
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.5955218633609727,1.4082410304732702,0.09060955518945635,0.6020166239512681,1.0,10/26,18.28%,NOD1;CASP8;IKBKG;RIPK2;IFIH1;TRAF6;TAB3;IRAK2;TIFA;AAMP
prerank,positive regulation of nervous system process (GO:0031646),0.6144400775115033,1.4082281571028175,0.12658227848101267,0.6004002802512796,1.0,3/18,3.04%,UNC13B;PARD3;TNFRSF1B
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.5267813538536203,1.408140484693482,0.06797583081570997,0.599121159289316,1.0,10/47,7.85%,CAV1;FBXW7;SIK1;FYN;CD34;CEACAM1;ATP2B4;RAPGEF2;TRIB3;NFKB1
prerank,substrate-dependent cell migration (GO:0006929),0.6584727666742232,1.407861731155614,0.1273996509598604,0.5984867306252786,1.0,8/14,11.16%,NTN1;ANKS1A;CD2AP;VEGFC;SDCBP;OPHN1;P2RY12;ITGA2
prerank,eye morphogenesis (GO:0048592),-0.5359923626815603,-1.4061249350935583,0.07341772151898734,0.4478855254321362,1.0,8/19,9.30%,FBN1;COL5A1;EFEMP1;MFAP5;TENM3;FBN2;NF1;VEGFA
prerank,metanephric mesenchyme development (GO:0072075),-0.646727991014451,-1.4059412117379029,0.08067940552016985,0.4463540545820841,1.0,3/10,5.77%,WNT4;OSR1;SIX1
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.5518448017129292,1.404968551146152,0.08892355694227769,0.6070170923633726,1.0,5/35,2.87%,ADGRG6;AHR;PDE2A;PDE7B;PDE4D
prerank,regulation of cell motility (GO:2000145),0.4713905559699868,1.404721530883484,0.03530895334174023,0.6061989538373542,1.0,28/121,10.01%,FRMD5;ABI3;PLXNA4;NTN1;LDB2;CDK6;CCDC125;PRAG1;PLXND1;ADGRG3;SPATA13;ROBO4;TMSB4X;PKN2;FGF23;PKN1;CAVIN1;CEACAM1;ENPP2;RAC1;TGFB1;SGK3;AKT2;SLK;CRK;SST;INPP5F;CYRIB
prerank,peptidyl-serine phosphorylation (GO:0018105),0.44911957772708616,1.4038902469350272,0.02181818181818182,0.6076190069001605,1.0,38/153,13.03%,PRKCH;RPS6KA5;ERN1;PRKD1;PDGFB;PRKD2;PKN3;PKN2;PAK2;PKN1;RPS6KA3;STK4;LMTK2;MARK3;IKBKB;RPS6KA1;HIPK1;MAPK8;PLK2;MAST2;ULK1;AURKA;DYRK1A;SGK3;AKT2;NEK6;CDK2;RICTOR;MAPKAPK3;GAS6;AKT3;MAP3K13;STK38;RIPK1;MKNK2;TGFBR2;TOP1;UHMK1
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.5515906321349053,1.4038781670602585,0.09186746987951808,0.6060250985221857,1.0,15/37,19.50%,ENTPD1;ISG20;RNASEH2A;MTREX;HNRNPD;NUDT16;RNASEH2C;RNASEH2B;NUDT15;XRN2;PNPT1;ENTPD3;NUDT1;ADPRM;NUDT9
prerank,regulation of cellular localization (GO:0060341),-0.44121718783660685,-1.403678433527222,0.02564102564102564,0.4503014334281398,1.0,10/46,7.58%,ADCY5;GSN;EFNA5;PRKN;PARD6G;MAP2;BRSK1;HSP90AA1;STXBP4;LRRK2
prerank,ribosomal small subunit assembly (GO:0000028),0.6357926364900124,1.4027025351084672,0.10877192982456141,0.6083702919299279,1.0,5/16,10.96%,RPS15;RPS19;RPS14;RPSA;RPS27
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.5398597214887215,1.4023203677784306,0.07526881720430108,0.6080716818843249,1.0,8/41,7.26%,TJP1;PIEZO1;PODXL;MAGI1;SMAD7;SKAP1;LCK;JAK1
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),-0.5504024995464303,-1.402259335053474,0.09004739336492891,0.4519821857208688,1.0,11/19,8.79%,BMPR1A;FGFR2;TGFBR3;TGFBR1;RBP4;ERBB4;FGF2;ZFPM2;RBPJ;GLI1;RUNX1
prerank,establishment of vesicle localization (GO:0051650),0.6249980825030387,1.4022271250400848,0.11694915254237288,0.606726144117406,1.0,6/18,12.50%,RAB27A;RAB11A;LIMK2;SYNJ1;IKBKG;CCDC186
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.5384402813354618,1.4019651541771723,0.09956076134699854,0.6059162865658665,1.0,16/40,18.25%,SMURF1;PTK2B;FBXW7;FOXF2;RPS7;PTK2;RNF139;XPO1;GNA12;RPL23;RAD23A;UBE3A;RPL11;DESI1;CSNK2A2;CSNK2A1
prerank,regulation of muscle contraction (GO:0006937),-0.5109225058945143,-1.4015224679732008,0.0859375,0.451860477880911,1.0,7/26,9.29%,ATP1A2;PLCE1;KCNB2;TPM1;ANXA6;MYL9;PPP1R12B
prerank,regulation of cellular senescence (GO:2000772),0.5823180512899545,1.4011189878397248,0.1,0.607207836015077,1.0,12/28,18.43%,ABI3;B2M;CDK6;MAP3K3;NEK6;CGAS;NUAK1;AKT3;YBX1;PNPT1;RBL1;YPEL3
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.654194907246209,1.4010511614736287,0.1195840554592721,0.6058194086462964,1.0,8/15,21.69%,JMY;ARPC3;ARPC1B;ACTR2;ACTR3;ARPC2;WHAMM;ARPC4
prerank,detection of visible light (GO:0009584),0.6371451308402002,1.4004432486091585,0.11284722222222222,0.6063430427606411,1.0,3/16,6.95%,GNAQ;CNGB1;GNAT1
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.6380223972669864,-1.3995550440091753,0.10869565217391304,0.4552160844749047,1.0,3/10,2.47%,ATP1A2;OSR1;HECW2
prerank,regulation of interleukin-1 beta production (GO:0032651),0.5034978342192428,1.3992369433854432,0.05907172995780591,0.6090083214089543,1.0,16/66,15.21%,APP;FOXP1;STAT3;GBP5;AIM2;CASP8;CX3CR1;WNT5A;LPL;MALT1;CASP1;CARD16;RIPK2;GSTP1;PANX1;TRIM16
prerank,negative regulation of proteolysis (GO:0045861),-0.4770382573522939,-1.3992054933421785,0.043010752688172046,0.4540992275187767,1.0,9/34,11.31%,TIMP3;TIMP2;GAS1;SERPINE2;LRRK2;ECM1;CAMK2N1;PLAT;CST3
prerank,cellular response to nerve growth factor stimulus (GO:1990090),-0.5181154922864453,-1.3990622049514947,0.07416267942583732,0.4524995921249492,1.0,7/22,13.18%,NTRK3;MAGI2;NTRK2;NGF;KIDINS220;WASF1;EHD1
prerank,T cell receptor signaling pathway (GO:0050852),0.45748512077680126,1.3990030488902405,0.03780487804878049,0.6081781603830206,1.0,46/138,21.40%,INPP5D;PLCG1;PRKD2;PDE4D;PTPRJ;NFKBIZ;DENND1B;FYN;NCK1;PLCG2;PAK2;IKBKB;SKAP1;BTN2A2;LCK;PSMA2;NFKB1;MALT1;EIF2B5;IKBKG;ICOSLG;RFTN1;PSMA8;PSMA6;RC3H1;CUL1;RELA;RIPK2;BTN3A3;EIF2B2;TRAF6;PSME1;SPPL3;ERMAP;LAT;NFKBID;PSMA4;PSMF1;PAK1;BCAR1;CD276;BCL10;PSMB7;PSMB1;PSMD2;BTNL9
prerank,ameboidal-type cell migration (GO:0001667),0.5241088749970367,1.398727476608696,0.07868383404864092,0.6076318057172855,1.0,10/51,5.54%,SEMA6A;TBX1;SEMA5B;SEMA7A;SRGAP2;PKN3;PKN2;PDLIM1;PKN1;SEMA6B
prerank,ganglioside biosynthetic process (GO:0001574),0.6467274646028847,1.3981955712746355,0.11149825783972125,0.6079078733847814,1.0,5/15,10.19%,ST6GALNAC3;ST3GAL1;ST8SIA4;B4GALT5;ST6GALNAC4
prerank,skeletal muscle tissue development (GO:0007519),0.5766209920297569,1.3978787583093002,0.09375,0.6074338922351907,1.0,4/32,4.96%,CAV1;MEF2C;CAV2;FOXL2
prerank,multivesicular body organization (GO:0036257),0.5687854555292985,1.3976576172542927,0.07580645161290323,0.6066576875679516,1.0,6/31,9.88%,RAB27A;RAB11A;CHMP2B;CHMP4B;CHMP4A;VPS28
prerank,lipoprotein localization (GO:0044872),-0.6284986219933661,-1.396920759600515,0.11777301927194861,0.45583599631565735,1.0,8/11,30.45%,LRP1;PRKCB;MIA3;UNC119B;PPARG;ZDHHC3;CD36;UNC119
prerank,actin filament-based transport (GO:0099515),0.597851691915804,1.3967589785434542,0.11892797319932999,0.6081962997678187,1.0,5/21,10.60%,FNBP1L;MYO1D;ACTN4;MYO1E;MYO1C
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.7135856053841615,1.3966789351662259,0.13221601489757914,0.6069169541114997,1.0,5/10,9.42%,LYN;STAT3;JAK3;GHR;PTPN1
prerank,cellular glucose homeostasis (GO:0001678),0.5422757051509095,1.3961620583973557,0.08206686930091185,0.607264837569288,1.0,12/41,13.47%,FOXO1;UNC13B;ERN1;HIF1A;KCNB1;XBP1;FOXA3;FOXK1;SOX4;GAS6;RACK1;IGF1R
prerank,response to muramyl dipeptide (GO:0032495),0.6890680828994046,1.395755037499984,0.11685823754789272,0.6071572409366623,1.0,2/12,2.26%,NOD1;ARHGEF2
prerank,response to estrogen (GO:0043627),0.5657966516393947,1.3957488528797575,0.10474631751227496,0.605622208929631,1.0,10/31,14.57%,CAV1;ESR1;SERPINB9;NCOA4;TRIM25;CITED1;TRIM24;CYP27B1;ASH2L;PELP1
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.5017394625620992,1.395705895621826,0.08659217877094973,0.604203176827366,1.0,15/67,13.54%,TBC1D8;ATP8B1;CAV1;PPP1R16B;PODXL;TBC1D22A;TBC1D15;RAC1;TBC1D2;TWF2;FSCN1;TBC1D5;EVI5;RAB5A;FMR1
prerank,positive regulation of glucose metabolic process (GO:0010907),-0.5856898110749554,-1.395700454028163,0.09134615384615384,0.45706015487132157,1.0,8/14,20.83%,IRS1;PPARGC1A;IRS2;SLC45A3;PTPN2;DDB1;GPLD1;NNMT
prerank,regulation of interleukin-4 production (GO:0032673),0.6097020244008374,1.395600491391002,0.10273972602739725,0.6030313446977832,1.0,1/21,0.13%,LEF1
prerank,cellular copper ion homeostasis (GO:0006878),0.6672681603446835,1.3953876499193942,0.11458333333333333,0.6022177483310844,1.0,3/14,10.24%,APP;SLC31A1;ATP7B
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.41434864007398514,1.395269797781664,0.0,0.6009925915928063,1.0,108/509,12.95%,VWF;TEK;FLT1;NOD1;TNFSF10;TGM2;KDR;ENG;CAV1;TBX1;ESR1;APP;TNFRSF19;PRKD1;INSR;KITLG;PDGFB;HIP1;IQGAP1;DAB2IP;LYN;PRKD2;JCAD;MFHAS1;PDGFD;TRIM14;RASD2;PTPRJ;FYN;ACTN4;CASP8;FKBP1A;FLT4;PLCG2;CAV2;SELP;RPS15;FGF23;PLEKHG5;TIRAP;F7;EDAR;IKBKB;CX3CR1;TRIM68;PELI1;RET;PLK2;TCF7L2;USP15;BOK;RPS20;WNT5A;RAPGEF2;MID2;CD40;RAC1;SASH1;TRIB3;BCL2L11;BCAR3;PDGFC;LCK;TNFRSF1A;TGFB1;ATP2C1;PIK3CG;PTK2;TGFA;NEDD4;TRIM25;NOS1AP;MAP3K3;GAB1;MALT1;CASP1;RPTOR;AKT2;NEK6;RPL23;BRD4;IKBKG;RICTOR;CGAS;PUM1;IL23A;BCL2L1;SIAH1;LARS1;SEMA4D;NMI;GAS6;CBL;MC1R;P2RY12;PUM2;IRAK4;RIPK1;BID;OASL;CARD16;MIER1;RELA;RIPK2;RACK1;BIRC3;MET;HSP90AB1
prerank,epithelial cell-cell adhesion (GO:0090136),-0.6264268243175075,-1.3947621485216988,0.10367170626349892,0.45767477169035464,1.0,4/11,12.35%,ITGB5;KIT;CCN3;PLEKHA7
prerank,positive regulation of locomotion (GO:0040017),0.5820115560283683,1.3934904501923422,0.10989010989010989,0.6057420061696829,1.0,8/27,11.15%,NTN1;STX3;PDGFB;PPM1F;CAVIN1;TGFB1;AKT2;P2RY12
prerank,icosanoid secretion (GO:0032309),0.6611691028951017,1.3928200964745399,0.14695340501792115,0.6065260932147987,1.0,1/12,0.17%,ABCC4
prerank,regulation of intracellular signal transduction (GO:1902531),0.41815490155213203,1.392806509343957,0.007376185458377239,0.6050305087056538,1.0,78/420,10.68%,VWF;CHN2;TEK;ARHGAP31;NET1;SGMS1;PPP1R16B;PPP1R13B;MCF2L;ARHGEF3;ARAP3;RASGRF2;PIP5K1B;DAB2IP;ARHGEF2;PDE2A;LYN;PRKD2;BCR;SRGAP3;SRGAP2;DDIT4;RASD2;NFKBIA;BST1;TAOK2;STK3;SRGAP1;PRKAR2B;TRAF1;JMY;PLCG2;TMSB4X;PAK2;PLEKHG5;RHOJ;KALRN;STK4;ARHGAP8;IER3;PREX1;HIPK1;CEACAM1;ARHGAP17;PHF20;XIAP;OPHN1;AURKA;WNT5A;RAC1;TNIK;RPA1;BCL3;PTPMT1;NF2;WWC2;PPP2R5B;GNA12;SLC15A2;DEPDC1B;TAF3;RRS1;TAF4B;ARHGEF7;CRK;ARHGEF26;FBXL2;CDK2;IKBKG;RICTOR;ARHGAP28;BRIP1;MAPK11;OCRL;ARAP2;NUAK1;PRKAB1;HUS1
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.420719903440731,1.3925428184557924,0.013015184381778741,0.6044159456303468,1.0,94/366,18.00%,RPS6KA5;NANOS3;ENG;SLC39A8;APBB2;ESR1;SMARCA2;APP;MEF2C;SOX7;ACVRL1;NR5A2;INSR;AHR;IRF2;SOX13;STAT3;NR3C1;NOTCH1;HIF1A;RREB1;SOX17;WWTR1;CHD7;SOX18;TCF7L1;LIN54;SPIN1;EIF4E;SBNO2;MTF2;JMJD1C;TEAD2;CCDC88A;PITX3;ESRRG;CNBP;ASCC1;LYL1;FOXN2;TCF3;HNRNPD;WWC2;ZNF2;CREM;KAT6B;PRDM8;MYBBP1A;HINT1;SOX4;MAFB;BACH1;FOXN3;RBM3;BTG1;RB1;SP3;CYFIP1;PRDM2;RELA;UTP4;GLRX2;RPL6;RPL10;MTPN;ESRRB;DMTF1;ZSCAN21;ACVR2B;ERC1;NFKB2;RYBP;ZNF423;ORC5;YBX1;ATRX;HMG20A;DDIT3;RPS6KA4;NR2C2;ZFPL1;GPBP1L1;ORC3;ACTR5;HP1BP3;CHEK2;CASZ1;CXXC1;RFX3;ZSCAN26;PHF19;MLXIPL;MLX;PFDN5
prerank,sensory perception of mechanical stimulus (GO:0050954),-0.3953549973535223,-1.3923047147517067,0.01968503937007874,0.4619688011545268,1.0,19/85,8.32%,EYA1;ROR1;COL1A1;PIEZO2;CEMIP;COL4A3;ADGRV1;COL11A1;EML2;DCDC2;CACNA1D;GRM7;P2RX4;GSDME;ATP6V0A4;PCDH15;WHRN;ALDH7A1;RIPOR2
prerank,defense response to protozoan (GO:0042832),0.6674371989886666,1.3921858601153065,0.14590747330960854,0.6040587087102204,1.0,3/12,6.59%,GBP4;GBP7;CD40
prerank,defense response to bacterium (GO:0042742),0.46513831384205,1.3918911556162925,0.045278137128072445,0.6035764712753006,1.0,16/105,9.60%,NOD1;IL6R;STAB1;GBP4;SELP;TIRAP;RPS19;LCN2;GBP7;RPL39;DROSHA;PGLYRP2;LYG2;ANG;DEFA6;IL23A
prerank,muscle cell migration (GO:0014812),-0.639828228278938,-1.3917923184407262,0.0989010989010989,0.461397445044117,1.0,4/10,8.16%,DDR1;SIX1;CCN3;PLAT
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.6556149153869586,1.3915284044687275,0.14013840830449828,0.603381226326616,1.0,3/14,3.22%,PRKD1;LIMS2;BST1
prerank,cellular metal ion homeostasis (GO:0006875),-0.3852945763187693,-1.3914264516672945,0.017857142857142856,0.46040272030673546,1.0,19/102,9.88%,ATP1A2;SLC24A3;ANK2;ATP13A5;ATP13A3;SLC8A3;SLC41A1;SLC12A2;ATP1B1;SLC8A1;KCNMA1;DMPK;STIM1;KCNJ2;ATP2A2;RYR2;CXCL12;SLC24A2;ATP1B2
prerank,positive regulation of dendrite development (GO:1900006),-0.6258562826709754,-1.3908448882507067,0.1111111111111111,0.4599852514627474,1.0,5/10,10.02%,PTN;BMP5;BMP7;COBL;ALK
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.5891403860859828,-1.390832789276178,0.10666666666666667,0.45803007966026466,1.0,5/13,14.38%,DDO;GLUL;ASPA;GOT1;QPRT
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.4668478876100537,1.3901030357219546,0.04871794871794872,0.6066826879520636,1.0,19/113,6.54%,NRP2;TEK;EGFL7;BMPR2;KDR;TBX1;PPP1R16B;PRKD1;PDGFB;VEGFC;PRKD2;HIF1A;RREB1;FLT4;XBP1;VEGFD;TCF7L2;WNT5A;NRAS
prerank,epithelial tube morphogenesis (GO:0060562),0.5683560027509592,1.389648990455756,0.1064516129032258,0.6067087684483047,1.0,12/32,12.87%,MEF2C;ACVRL1;PODXL;RASIP1;PRKD2;SOX17;MTSS1;ACVR1;PKD2;CCM2;RHOB;MET
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.6300612212544301,-1.3894000764077143,0.1079913606911447,0.459846192080492,1.0,3/11,2.95%,EGFR;DDX5;BMP4
prerank,regulation of erythrocyte differentiation (GO:0045646),0.5518769610798936,1.3889872450096183,0.09076682316118936,0.6073571587398207,1.0,9/35,9.92%,CDK6;LYN;TAL1;STAT3;HIF1A;ACVR2A;ZFPM1;MAFB;MAPK11
prerank,amino acid import (GO:0043090),-0.5170146781050481,-1.388969977697824,0.10232558139534884,0.459101201087936,1.0,6/21,3.63%,SLC6A13;SLC1A3;SLC47A1;SLC6A1;SFXN2;SLC22A4
prerank,presynapse organization (GO:0099172),-0.6367031779162915,-1.388270195413585,0.10845986984815618,0.459123363261399,1.0,6/10,15.82%,NLGN2;LRRTM3;NLGN1;NLGN3;FZD1;DVL1
prerank,response to cytokine (GO:0034097),0.45369628828341196,1.3881518380263054,0.04411764705882353,0.6085945294181894,1.0,30/141,10.51%,IL1R1;LEF1;PTPN14;IL6ST;LIFR;APP;GCH1;PTPN12;IL6R;OSMR;ADAM10;STAT3;TNFRSF11A;MAP4K3;SELE;CASP8;SIGIRR;SELP;JAK3;MAPK8;ASAH2;IFNAR2;CD40;CASP1;CITED1;RELB;BCL2L1;MAPKAPK3;CYP27B1;CXCR4
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.5275110952842632,-1.387938940769758,0.0936768149882904,0.458070798071576,1.0,9/20,20.33%,GRK3;BICD1;GPRASP1;RPGRIP1L;SNCA;PLEK;CRY1;RNF157;MRAP2
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),-0.5252744574449062,-1.3875345824813266,0.0705596107055961,0.4572811454010923,1.0,9/20,11.79%,ATP1A2;SLC12A2;ATP1B1;SLC8A1;KCNMA1;KCNJ2;ATP1B2;SLC9A1;LACC1
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.43728765608499726,1.386341845490899,0.014689265536723164,0.6133623616686625,1.0,34/234,8.26%,PRKCH;RPS6KA5;NOD1;CAV1;ESR1;APP;PRKD1;CRTC1;CD200;FZD4;EDN1;ARHGEF2;PRKD2;STAT3;AIM2;TNFRSF11A;TRIM14;NFKBIA;STK3;TRAF1;JMY;PLCG2;TIRAP;IKBKB;CX3CR1;TRIM68;WNT5A;MID2;CD40;TCF3;TRIM25;NFKB1;MALT1;NEUROD1
prerank,endoderm development (GO:0007492),0.6490126536142351,1.3860998726192133,0.1310592459605027,0.6127149238772563,1.0,4/13,14.85%,SOX7;SOX17;KIF16B;DUSP2
prerank,positive regulation of DNA replication (GO:0045740),-0.5500926906542761,-1.3858950949859858,0.10629067245119306,0.45953368157844937,1.0,3/16,8.39%,EGFR;GLI2;GLI1
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),-0.4304539104800206,-1.3856681117388479,0.05537459283387622,0.4581834563674304,1.0,19/51,14.50%,DCLK1;GAS7;NBL1;EPB41L3;BMP7;NRK;ALS2;CNTNAP2;TAOK3;SHTN1;NGF;LRRK2;PLXNB1;DTNBP1;WASF1;DBN1;ANKRD27;CTTN;CNTNAP1
prerank,blood circulation (GO:0008015),0.5181469955223794,1.3854609841053065,0.0898876404494382,0.6132981106622588,1.0,7/49,5.27%,TBC1D8;NOS3;MYOF;ACVRL1;NPR1;ELN;DLL4
prerank,cellular response to growth factor stimulus (GO:0071363),0.4465448533457353,1.3851617142068398,0.03402187120291616,0.6128322505176848,1.0,31/151,7.52%,SEMA6A;FLT1;BMPR2;KDR;TBX1;PDE8A;MEF2C;ERN1;ACVRL1;PRKD1;PLCG1;PDGFB;PTPN12;IQGAP1;DAB2IP;PDE2A;PRKD2;NR3C1;NOTCH1;FLT4;SMAD7;ACVR2A;DLL4;RAMP2;DUSP22;WNT5A;RAPGEF2;ACVR1;INPP5K;TGFB1;RAP1A
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.6389574810873306,1.3845855921670072,0.09945750452079566,0.6132860262085404,1.0,2/16,1.82%,BMPR2;PRCP
prerank,cellular response to inorganic substance (GO:0071241),0.6038032275915461,1.3844398547451227,0.12562814070351758,0.6122903735889745,1.0,9/21,16.91%,FOXO1;CDK2;AOC1;FMR1;DDI1;ATRX;MTR;DDI2;SPIDR
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.5034984688807008,1.3841262843333946,0.08131241084165478,0.6118252515482054,1.0,18/55,15.95%,TNFSF10;CAV1;DAB2IP;FAS;TPD52L1;PAK2;BOK;BCL2L11;LCK;CRADD;BCL2L1;SIAH1;RIPK1;BID;RACK1;S100A9;DDIT3;BMF
prerank,negative regulation of cytokine production (GO:0001818),0.44012279996151676,1.3839672452575453,0.029342723004694836,0.6109096227952027,1.0,24/163,7.85%,LEF1;RPS6KA5;HDAC9;RNF125;CD200;NLRC5;HDAC7;CD34;SIGIRR;HOMER2;TMSB4X;UBA7;DLL1;JAK3;CEACAM1;N4BP1;CUEDC2;BTN2A2;TIGIT;RAC1;SRGN;ARRB1;BCL3;TRIM25
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.4156674508237995,1.3833644035747326,0.0031413612565445027,0.6115448382811495,1.0,75/497,11.57%,MECOM;LEF1;ELK3;RPS6KA5;FOXO1;NANOS3;CD38;HDAC9;ATP8B1;DACH1;ZHX3;BMPR2;SMARCA2;PPARD;CBFA2T3;ZBTB16;SOX7;ACVRL1;DAPK1;AHR;PDGFB;FOXP1;DAB2IP;SOX13;HHEX;NR3C1;NOTCH1;PPM1F;PLCB1;SOX18;HMBOX1;IGF2BP3;VGLL4;SCMH1;FOXL2;ID1;EPC1;PTPRK;NANOS2;SBNO2;TCF7L2;WNT5A;ATF7IP;RCOR1;KLF10;INPP5K;CDKN1B;TRIB3;TGFB1;BCL3;GRB7;GATAD2A;RNF139;CTBP1;CITED1;KAT6B;FOXK1;MYBBP1A;YEATS2;BTG2;RPL13A;CNOT1;SFRP2;FOXN3;SMARCE1;TFAP4;GAS6;POU2F1;SPEN;RBM15;RB1;ZMYND11;MRPL13;EID1;SP3
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.6176737581339332,1.3829246447455084,0.1273996509598604,0.6115456600518421,1.0,7/18,12.87%,HEG1;RASIP1;CCDC125;KCTD10;ITGA3;ABL2;MET
prerank,negative regulation of chondrocyte differentiation (GO:0032331),-0.5774072430635474,-1.382799882517468,0.10204081632653061,0.4640128471634285,1.0,4/14,4.01%,ADAMTS12;EFEMP1;TGFBR1;WNT9A
prerank,morphogenesis of an epithelium (GO:0002009),-0.5036587540000927,-1.3825508987654618,0.09181141439205956,0.4626665965663512,1.0,5/25,6.69%,FGFR2;DAG1;TBX18;LRP6;AHI1
prerank,positive regulation of activated T cell proliferation (GO:0042104),-0.5437805349629927,-1.3822539182569424,0.08292682926829269,0.4615237123010236,1.0,4/18,5.19%,IGF1;IGFBP2;IL18;IGF2
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.5422332419531032,1.3820963304579696,0.10244648318042814,0.6129863667837263,1.0,8/35,7.49%,HEG1;RASIP1;DAB2IP;CCDC125;KCTD10;FBP1;ITGA3;SYNGAP1
prerank,cell-cell junction maintenance (GO:0045217),0.6827734393056841,1.3819375548795176,0.14416058394160583,0.612026098151944,1.0,1/11,0.28%,TJP1
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.680052510360259,1.3816677241981576,0.11720226843100189,0.6113989922817449,1.0,3/10,6.14%,PIEZO1;PODXL;SKAP1
prerank,cellular response to peptide (GO:1901653),0.49798440868843286,1.381544479930796,0.07596685082872928,0.6103412447959543,1.0,17/56,12.40%,NOD1;CAV1;APP;VCAM1;ICAM1;ARHGEF2;CASP4;FYN;XBP1;ATP1A3;CACNA1A;PSEN1;RPL23;EPHA4;GRIN1;LGMN;RIPK2
prerank,regulation of protein kinase A signaling (GO:0010738),-0.5205194600019508,-1.3813675781954606,0.09925558312655088,0.46191056622549825,1.0,9/20,16.60%,ADGRV1;AKAP12;AKAP7;AKAP6;LRRK2;PRKAR1B;PRKAR1A;TCIM;PJA2
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.42348659108418113,1.381190779373857,0.0192090395480226,0.610098447983462,1.0,48/260,11.69%,ABCC4;FGD5;DNM3;PARVB;ABLIM1;FNBP1L;EXOC6;NTN1;EHD4;CD2AP;FGD6;RAB11A;SRGAP2;S1PR1;NOTCH1;CNGB1;SPATA13;RAP1B;MTSS1;SSX2IP;PPP1R9B;DISC1;SDCBP;CEP41;CCDC88A;OPHN1;RAPGEF2;PCNT;INPP5K;RAC1;BBIP1;STK26;TNIK;RAP1A;EHD2;DYNLL1;EXOC5;ARHGEF7;TEKT5;EXOC4;OCRL;CEP83;ANO6;FSCN1;ARL13B;P2RY12;EHD3;CYFIP1
prerank,regulation of supramolecular fiber organization (GO:1902903),-0.5147626151522973,-1.381062440559547,0.10810810810810811,0.4608063179936062,1.0,5/22,9.84%,AEBP1;AKAP13;MAP2;EFEMP2;APOE
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),0.6023969872080261,1.3806328371107186,0.12040133779264214,0.6103461006959281,1.0,6/20,10.42%,SEMA6A;SEMA5B;SEMA7A;SEMA6B;SEMA6D;SEMA4D
prerank,positive regulation by host of viral transcription (GO:0043923),0.64160851524055,1.3803285752354495,0.13120567375886524,0.6098491212535024,1.0,6/15,16.04%,LEF1;CHD1;TFAP4;SNW1;RRP1B;CTDP1
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.673494165286724,1.3802888357751624,0.13186813186813187,0.608527908901709,1.0,5/12,10.94%,SMCHD1;CDYL;PCGF5;YTHDC1;RBM15
prerank,negative regulation of protein kinase activity (GO:0006469),0.480722977270692,1.380255555709462,0.06501950585175553,0.6072029928409338,1.0,23/88,14.04%,PTPRB;GNAQ;CAV1;ADARB1;DAB2IP;LRP5;PPM1F;WWTR1;PAK2;CEACAM1;INPP5K;CDKN1B;TRIB3;PTPN1;SFN;ADAR;RB1;CORO1C;GSTP1;WARS1;TRIB1;GSKIP;NPM1
prerank,cellular response to interleukin-6 (GO:0071354),0.5896483457233622,1.3801421889991912,0.12479201331114809,0.6062074503113087,1.0,7/26,7.85%,ST3GAL6;IL6ST;IL6R;STAT3;SBNO2;JAK1;NFKB1
prerank,glucose import (GO:0046323),0.6597565399099649,1.379960800420267,0.11072056239015818,0.6053852160676678,1.0,1/13,0.52%,SLC2A1
prerank,cartilage development (GO:0051216),-0.43555393399602327,-1.3796082783840855,0.0670926517571885,0.46271947923748724,1.0,14/49,8.79%,SOX5;SULF1;OSR1;SULF2;BMP4;PKD1;SOX6;RUNX2;FGF2;SLC39A14;ITGB8;CCN3;CD44;RUNX1
prerank,neural crest cell development (GO:0014032),0.5247069469996897,1.3794714295275037,0.09037037037037036,0.6055538809073538,1.0,8/44,8.32%,SEMA6A;TBX1;SEMA5B;SEMA7A;CDH2;SEMA6B;CYP26C1;SEMA6D
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.6475869459837162,1.3789751383473292,0.12078152753108348,0.6057291577487797,1.0,1/15,0.04%,PRKCH
prerank,positive regulation of potassium ion transport (GO:0043268),-0.46359635120256065,-1.378705718735168,0.06735751295336788,0.46319316587072296,1.0,16/38,18.62%,ANK2;FHL1;ACTN2;KCNMA1;DLG1;AKAP6;KCNMB2;KCNJ2;ADRA2A;GABBR1;KCNJ10;KCNN2;GNG2;KCNJ15;KCNJ6;KCNN3
prerank,regulation of dendrite development (GO:0050773),-0.4645348673058522,-1.3785839026452162,0.0743801652892562,0.46167242879405096,1.0,9/37,3.85%,CAMK1D;SDC2;PTN;BMP5;BMP7;HECW2;ADGRB3;CSMD3;COBL
prerank,positive regulation of neuron projection development (GO:0010976),-0.3924035198245618,-1.3775228496301595,0.03018867924528302,0.46268721597647605,1.0,32/85,14.96%,NTRK3;MAGI2;ROR1;DPYSL3;CAMK1D;EPHA3;PTN;PTK7;BMP5;BMP7;COBL;TENM3;NDNF;CUX2;CAPRIN2;NTRK2;ROR2;KIDINS220;ARSB;APOE;ATP1B2;ALK;FZD1;CAMK1;PLK5;DBN1;PRKCI;CAMK2B;FUT9;P3H1;PLPPR5;CBFA2T2
prerank,negative regulation of cellular component movement (GO:0051271),0.6257822480421651,1.3767633881181682,0.13898305084745763,0.611473046841669,1.0,3/15,4.26%,FRMD5;CCDC125;ACTN1
prerank,glycoprotein metabolic process (GO:0009100),0.5063821792382285,1.3764545513798458,0.08345752608047691,0.6112283656159342,1.0,11/53,13.20%,ST6GALNAC3;MGAT4A;STT3B;HIF1A;MAN2A1;ST8SIA4;B4GALT5;B3GNT6;TNIP1;OGA;ERP44
prerank,positive regulation of inflammatory response (GO:0050729),0.4697998713734248,1.3763741407619323,0.05810810810810811,0.6101344344814508,1.0,16/86,11.86%,IL6ST;APP;IL15;PDE2A;OSMR;NFKBIZ;NFKBIA;RPS19;WNT5A;TNFRSF1A;LPL;IL23A;TNIP1;VAMP8;NMI;RIPK1
prerank,macrophage activation (GO:0042116),0.5496884278816244,1.3762702809538827,0.10569105691056911,0.6090749313282487,1.0,5/34,5.41%,APP;CD93;FOXP1;PLCG2;SBNO2
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.4862564808178689,1.3761817889197736,0.08356545961002786,0.6080227839842807,1.0,11/75,5.48%,SEMA6A;TEK;CLDN5;PTPRM;ECSCR;DAB2IP;HHEX;STAB1;NPR1;GTF2I;ATP2B4
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.5539247818897018,1.3760288098148539,0.10681114551083591,0.6070898904040685,1.0,8/33,7.32%,MEF2C;ACVRL1;MMRN2;NOTCH1;CARD10;DLL4;ATP2B4;TGFB1
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.4196595121991546,1.3759468503609258,0.014238773274917854,0.6059330687052682,1.0,88/327,18.08%,RPS6KA5;ENG;SLC39A8;APBB2;ESR1;SMARCA2;MEF2C;SOX7;ACVRL1;NR5A2;INSR;AHR;IRF2;SOX13;STAT3;NR3C1;NOTCH1;HIF1A;RREB1;SOX17;ACTN4;WWTR1;CHD7;SOX18;TCF7L1;LIN54;SPIN1;SBNO2;MTF2;JMJD1C;TEAD2;PITX3;ESRRG;CNBP;ASCC1;LYL1;FOXN2;TCF3;HNRNPD;WWC2;ZNF2;CREM;KAT6B;PRDM8;MYBBP1A;HINT1;SOX4;MAFB;BACH1;COPS2;FOXN3;BTG1;ZMIZ1;RB1;SP3;PRDM2;RELA;UTP4;GLRX2;RPL6;ESRRB;DMTF1;ZSCAN21;ACVR2B;ERC1;NFKB2;RYBP;ZNF423;YBX1;ATRX;HMG20A;DDIT3;RPS6KA4;NR2C2;ZFPL1;GPBP1L1;ACTR5;HP1BP3;CHEK2;CASZ1;CXXC1;RFX3;ZSCAN26;PHF19;MLXIPL;MLX;PFDN5;RALY
prerank,electron transport chain (GO:0022900),0.6282845375937732,1.3758151849238824,0.12678571428571428,0.6049850645898125,1.0,6/15,19.20%,PDIA5;CYB561;ENOX2;ETFDH;ETFA;ETFB
prerank,regulation of actin filament-based movement (GO:1903115),-0.6254658252084783,-1.3755516819206721,0.09978308026030369,0.46585895118639564,1.0,2/10,1.60%,ANK2;PDPN
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.5700950415797534,1.3753704354187337,0.11164274322169059,0.6051096848226745,1.0,7/27,7.46%,TEK;FLT1;PRKD1;PDGFB;PTK2B;TGFB1;PTK2
prerank,negative regulation of signaling receptor activity (GO:2000272),-0.4853891089651352,-1.3745018491600944,0.07772020725388601,0.46674670768920384,1.0,5/25,6.95%,ERRFI1;CBLB;SLC6A9;PPARA;SNX6
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.574280251037581,-1.373909774366335,0.1011764705882353,0.46647896455077337,1.0,7/14,14.95%,DMD;ATP1B1;WNK4;ANK3;WNK1;SLC9A1;WNK3
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.4993158874307143,-1.3733535682216165,0.08247422680412371,0.4660902718841048,1.0,9/27,13.36%,ANK2;DMD;JPH1;CACNB2;PRKACA;ADRA2A;CACNB1;AHNAK;JPH2
prerank,negative regulation of peptide hormone secretion (GO:0090278),-0.5345593690548088,-1.373270817689592,0.11804008908685969,0.4644571385737962,1.0,5/18,8.61%,PRKN;IRS1;CCN3;ADRA2A;SFRP1
prerank,replicative senescence (GO:0090399),-0.6013948391403136,-1.3724520012700325,0.09787234042553192,0.46484082940317145,1.0,8/12,23.98%,PLA2R1;SERPINE1;WNT16;ATR;TP53;CHEK1;TERT;ATM
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.5823125203305068,1.372390371844973,0.11726384364820847,0.6135408252521946,1.0,8/24,18.28%,NOD1;CASP8;IKBKG;RIPK2;TRAF6;TAB3;IRAK2;AAMP
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.5662345323075773,1.3723524343713274,0.1116584564860427,0.6122571331433223,1.0,7/27,13.76%,PRKCH;NFKBIA;NFKB1;LPL;CSF1;ITGB3;ABCG1
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.5487709671419381,1.3718576461269465,0.10248447204968944,0.6126139319332434,1.0,11/33,13.83%,DGKZ;PRKD2;NECTIN2;PTPRJ;TESPA1;CEACAM1;LCK;IKBKG;RC3H1;RELA;SLA2
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.5940982659504632,-1.3710438928257502,0.1228813559322034,0.46670964736738263,1.0,6/12,25.98%,INSIG2;KDELR3;GPAA1;INSIG1;RER1;HSPA5
prerank,regulation of myotube differentiation (GO:0010830),0.5788506199286502,1.3706652976439506,0.13432835820895522,0.6151077231975517,1.0,6/24,8.14%,HDAC9;PIEZO1;NOTCH1;SIK1;XBP1;ATP11A
prerank,positive regulation of synapse assembly (GO:0051965),-0.4871719968606308,-1.3704169341883015,0.09975669099756691,0.46655773995662375,1.0,10/27,12.91%,NLGN2;CLSTN2;CUX2;PTPRD;IL1RAPL1;NRXN1;NLGN1;NLGN3;SRPX2;GRID2
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.5314802904227335,1.3699964361400225,0.1126331811263318,0.6159988212803148,1.0,10/36,8.27%,SGMS1;DAB2IP;FAS;TPD52L1;TRAF1;TMBIM6;CX3CR1;ASAH2;PTPMT1;CRADD
prerank,receptor internalization (GO:0031623),0.5265172544386725,1.3696180492838637,0.10510510510510511,0.6158869788017125,1.0,11/44,13.43%,DNM3;CALCRL;CAV1;CEACAM1;RAMP2;ARRB1;NEDD4;SCYL2;PICALM;RAB31;RAB5A
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.5978561188349524,-1.3694375501392904,0.12295081967213115,0.46732986198350174,1.0,4/11,9.35%,CACNA2D1;CACNB2;CACNB1;BIN1
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.5770117591098323,1.3686847810298213,0.13278688524590163,0.6176618834530716,1.0,8/25,11.76%,APP;ANKRD13A;RIN3;SDCBP;RAC1;PSEN1;PICALM;ITGB3
prerank,positive regulation of actin filament depolymerization (GO:0030836),-0.6269158779831338,-1.3679188561307711,0.11563169164882227,0.4695137963025257,1.0,3/10,4.58%,ACTN2;SEMA5A;CARMIL1
prerank,muscle cell differentiation (GO:0042692),0.5596423895659968,1.3668620904321584,0.11043872919818457,0.622490260861796,1.0,5/32,6.81%,MRTFB;TBX1;MEF2C;MRTFA;SYNE1
prerank,response to exogenous dsRNA (GO:0043330),0.6090183630513515,1.3667549709137545,0.13728813559322034,0.6215168456181964,1.0,7/18,15.63%,CAV1;SLC3A2;RALB;CGAS;RFTN1;IFIH1;IRAK3
prerank,modulation by host of symbiont process (GO:0051851),0.5585559792896742,1.3664655680400264,0.10708661417322834,0.6211360873440097,1.0,11/31,19.88%,LEF1;CX3CR1;INPP5K;CHD1;TFAP4;SNW1;RRP1B;CTDP1;CARD9;SAP30BP;SP1
prerank,positive regulation of JNK cascade (GO:0046330),0.4829803573843554,1.3663800215345998,0.08253094910591471,0.6200357084188304,1.0,14/70,6.07%,APP;TNFRSF19;DAB2IP;MFHAS1;PTK2B;TPD52L1;TAOK2;PLCB1;TRAF1;FLT4;TIRAP;EDAR;SDCBP;DUSP22
prerank,cardiac atrium morphogenesis (GO:0003209),0.6096609353015752,1.3658961122251596,0.13523131672597866,0.6202573772408784,1.0,5/16,9.03%,BMPR2;ENG;NOTCH1;DLL4;ZFPM1
prerank,N-acetylneuraminate metabolic process (GO:0006054),0.6787265410025687,1.3656623744741851,0.16387337057728119,0.619593328796958,1.0,2/10,1.50%,ST6GAL1;ST3GAL1
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.5917875006271778,1.3651622874084917,0.131175468483816,0.6198524599832684,1.0,4/19,3.91%,KDR;VCAM1;PTPRJ;SELP
prerank,positive regulation of cell communication (GO:0010647),-0.4759584749554774,-1.3650791676894192,0.08483290488431877,0.47496337400974414,1.0,6/28,6.83%,WLS;CLSTN2;DLG4;SYT1;ANK3;PTPN23
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.4414764729677898,1.3650579228781947,0.04589371980676329,0.618865176801249,1.0,16/152,6.95%,ADGRG6;ADGRL4;CALCRL;GNAQ;ADGRL2;ADCY4;WASF2;PDE2A;S1PR1;ADGRG3;ADGRE5;ADGRG1;GNAI2;RAMP2;MCHR1;GNAT1
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.5160612273272619,1.3649429977856273,0.10058309037900874,0.6178636226360279,1.0,9/46,7.26%,LCP1;MSN;RAP1B;PLCB1;PAK2;HNRNPF;CA1;MTAP;JAK1
prerank,positive regulation of interferon-gamma production (GO:0032729),0.5142508916880328,1.3644129794306,0.10993975903614457,0.618178358478295,1.0,5/48,10.01%,IL1R1;PDE4D;ZFPM1;IL23A;CYRIB
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.5453974403224162,-1.3641555387076032,0.0979498861047836,0.475487258561427,1.0,3/17,1.99%,ANK2;SNTA1;CACNA2D1
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.6290743388568848,1.3641551335888453,0.13937282229965156,0.6176979722286821,1.0,7/15,20.73%,DTX3L;SMAD7;RPS7;RPL23;MAD2L2;RPL11;BAG2
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.5923907005621538,1.3640829965671983,0.13805309734513274,0.6165851885446201,1.0,4/19,2.97%,TJP1;NEXMIF;NOTCH1;PPM1F
prerank,positive regulation of B cell activation (GO:0050871),0.5130696799485226,1.3636547787796476,0.10318664643399089,0.6167504664545511,1.0,11/50,11.13%,CD38;MEF2C;BST1;TIRAP;XBP1;SHLD1;CD40;TNFRSF13C;MAD2L2;CD320;IL7
prerank,COPII-coated vesicle cargo loading (GO:0090110),-0.5699768823288949,-1.363324921921826,0.09579439252336448,0.475986158579205,1.0,5/14,13.22%,SEC24D;SEC31A;SEC23A;MIA3;TBC1D20
prerank,response to interferon-gamma (GO:0034341),0.4765598138323592,1.361882765015121,0.08111888111888112,0.6211895769523106,1.0,12/67,10.40%,GCH1;DAPK1;GBP5;GBP4;GBP7;WNT5A;CD40;CASP1;CITED1;RPL13A;CYP27B1;CCL14
prerank,regulation of Rho protein signal transduction (GO:0035023),0.48482572054195866,1.3615110686973564,0.08321775312066575,0.6210725923981265,1.0,16/72,7.33%,NET1;HEG1;F11R;EPS8;ARHGEF3;RASIP1;ARHGEF2;CCDC125;BCR;PRAG1;ADGRG1;KCTD10;OPHN1;RAC1;ARRB1;ITGA3
prerank,cellular biogenic amine catabolic process (GO:0042402),-0.6154804124066361,-1.361417521616529,0.12704918032786885,0.47925962743154554,1.0,2/10,9.61%,ALDH7A1;HNMT
prerank,endocardial cushion morphogenesis (GO:0003203),0.6151909973407768,1.361365146344349,0.14072847682119205,0.6202077796621679,1.0,5/18,6.27%,NOS3;ENG;ACVRL1;NOTCH1;ACVR1
prerank,negative regulation of cell motility (GO:2000146),0.4548500901325016,1.3609823053222443,0.05505761843790013,0.6200659576280635,1.0,19/108,6.76%,FRMD5;LIMCH1;MCTP1;DACH1;ENG;ACVRL1;CLDN5;ADARB1;CCDC125;SRGAP3;SRGAP2;PTPRJ;STK24;SRGAP1;PTPRK;SMAD7;DUSP22;ADAM15;STK26
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.6157067665528537,1.3602077488086488,0.1404109589041096,0.6213052171549642,1.0,6/17,11.15%,PIEZO1;PODXL;RET;SKAP1;SFRP2;P2RY12
prerank,regulation of monooxygenase activity (GO:0032768),0.5744306299306404,1.3599297985078627,0.13028764805414553,0.6208674349961174,1.0,5/23,7.93%,NOS3;CAV1;NOSTRIN;NOSIP;NOS1AP
prerank,positive regulation of epithelial cell differentiation (GO:0030858),-0.5317984995669822,-1.3590499242182987,0.13010204081632654,0.48384008295318764,1.0,5/17,6.69%,BMP4;FGF2;SFRP4;TMEM100;AHI1
prerank,regulation of cellular component size (GO:0032535),0.5410110532398523,1.3577762907729587,0.12401883830455258,0.6265484787530426,1.0,10/30,16.64%,EPS8;RIN3;MSN;RAC1;RPTOR;LARS1;PICALM;MTPN;RDX;HP1BP3
prerank,positive regulation of GTPase activity (GO:0043547),0.42948075307109546,1.3574176363584434,0.042923433874709975,0.6263465018422687,1.0,36/188,10.42%,TBC1D8;DOCK9;PKP4;TGM2;NET1;ITGA6;RALGAPA2;F11R;TBC1D30;ARHGEF15;TBC1D4;CCDC125;BCR;SRGAP2;RALGAPA1;ARHGAP27;SGSM1;TBC1D22A;CAV2;ADRB1;TBC1D15;SIPA1L3;RAP1GDS1;RAPGEF2;TBC1D12;CD40;BCAR3;RAP1A;TBC1D2;AGRN;RSU1;ARHGEF7;ARHGEF26;LARS1;CCL14;SEMA4D
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.5321430367544668,1.35697978914583,0.11848341232227488,0.6265101949682514,1.0,14/36,14.10%,NLRC5;EDN1;HIF1A;CASP4;WNT5A;AGPAT1;CASP1;CSF1;CXCR4;GAS6;IL7;RIPK1;ADAM17;UBE2K
prerank,cellular response to lectin (GO:1990858),0.4584316676423689,1.3569631138716796,0.07008760951188986,0.6238664322204693,1.0,32/104,21.22%,RPS6KA5;LYN;ICAM2;FYN;PLCG2;PAK2;IKBKB;NRAS;KRAS;PSMA2;NFKB1;MALT1;RELB;IKBKG;PSMA8;PSMA6;CUL1;MUC1;RELA;TRAF6;PSME1;TAB3;PSMA4;CARD9;PRKACB;PSMF1;PAK1;BCL10;PSMB7;PSMB1;MUC6;PSMD2
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.4584316676423689,1.3569631138716796,0.07008760951188986,0.6238664322204693,1.0,32/104,21.22%,RPS6KA5;LYN;ICAM2;FYN;PLCG2;PAK2;IKBKB;NRAS;KRAS;PSMA2;NFKB1;MALT1;RELB;IKBKG;PSMA8;PSMA6;CUL1;MUC1;RELA;TRAF6;PSME1;TAB3;PSMA4;CARD9;PRKACB;PSMF1;PAK1;BCL10;PSMB7;PSMB1;MUC6;PSMD2
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.6440753705705214,1.3569199718361824,0.13358070500927643,0.6226340886477938,1.0,1/15,0.26%,ENTPD1
prerank,regulation of DNA repair (GO:0006282),-0.43693760237068147,-1.3563526524187923,0.05588235294117647,0.4893636877837317,1.0,4/44,1.86%,EYA2;EGFR;EYA1;EYA4
prerank,endocrine system development (GO:0035270),-0.5184850289745953,-1.3563338921385344,0.10406091370558376,0.48756522400557994,1.0,11/21,16.94%,GLI2;WNT4;DKK3;TGFBR1;SALL1;NF1;SIX1;STRA6;WNT11;PAX8;MDK
prerank,ureteric bud morphogenesis (GO:0060675),-0.5333072991108643,-1.3562255816042554,0.12933025404157045,0.48606491604681346,1.0,7/16,15.87%,BMP4;FGF2;SALL1;SIX1;NPNT;WNT11;PAX8
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.6440343648689726,1.355865554673487,0.15371024734982333,0.6248104119757559,1.0,3/13,2.82%,NRP2;PLXNA4;PLXND1
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.45698495440996817,1.3549202222805603,0.06875,0.62674880334433,1.0,32/105,21.22%,RPS6KA5;LYN;ICAM2;FYN;PLCG2;PAK2;IKBKB;NRAS;KRAS;PSMA2;NFKB1;MALT1;RELB;IKBKG;PSMA8;PSMA6;CUL1;MUC1;RELA;TRAF6;PSME1;TAB3;PSMA4;CARD9;PRKACB;PSMF1;PAK1;BCL10;PSMB7;PSMB1;MUC6;PSMD2
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.6711621794435608,1.3534878589655335,0.14076782449725778,0.6287682896399597,1.0,3/10,5.97%,NFATC1;PPP3CA;PPP3CB
prerank,calcineurin-mediated signaling (GO:0097720),0.6711621794435608,1.3534878589655335,0.14076782449725778,0.6287682896399597,1.0,3/10,5.97%,NFATC1;PPP3CA;PPP3CB
prerank,positive regulation of ERAD pathway (GO:1904294),0.6400846389235564,1.3526758969363897,0.1282952548330404,0.630126890187308,1.0,2/13,6.78%,CAV1;ATXN3
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.5464113619964546,1.3520945595996008,0.12908496732026145,0.6307173525010301,1.0,12/29,17.55%,RPS19;RPS14;RPS16;RRS1;RPS8;HELB;UTP4;NOL10;RPS21;UTP6;HEATR1;NOP14
prerank,secondary palate development (GO:0062009),0.6271656821051041,1.351714502297657,0.15985130111524162,0.6305689365746053,1.0,3/14,6.09%,LEF1;CHD7;WNT5A
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.6529147969895762,1.351383683701622,0.1650853889943074,0.6302728502295034,1.0,4/11,12.61%,CAV1;BCL3;NF2;ADIPOR1
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.6524210043875404,1.3509132165815017,0.1691449814126394,0.6305301862395806,1.0,2/11,2.36%,CAV1;NEDD4L
prerank,retinal metabolic process (GO:0042574),-0.5899355470377694,-1.349567064031033,0.12008733624454149,0.5023039393220943,1.0,4/12,15.15%,ABCA4;CYP1B1;RDH13;RDH10
prerank,hydrogen peroxide metabolic process (GO:0042743),0.605274740406318,1.3493704475838733,0.14795918367346939,0.6343504450853599,1.0,5/19,16.67%,MAOB;PXDN;CAT;PRDX2;PRDX1
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.5755070788026782,1.348611217426794,0.12935323383084577,0.6355087551271382,1.0,8/24,14.52%,CTSC;EFNA1;PTK2B;UCHL5;EPHA4;UBE3A;NUDT15;PSME1
prerank,response to muscle stretch (GO:0035994),-0.5535015628245282,-1.3482513336667132,0.14385150812064965,0.5040478335057691,1.0,5/15,11.27%,DMD;GSN;SLC8A1;RYR2;SLC9A1
prerank,regulation of protein transport (GO:0051223),0.5522495167188443,1.3471788950855967,0.13643926788685523,0.6388593035841363,1.0,12/27,18.65%,LCP1;PPM1F;DNAJA1;SNX3;LLGL1;PTPN1;GAPVD1;RHBDF2;NDEL1;CHP1;NDFIP2;STXBP5
prerank,pyroptosis (GO:0070269),0.62120071945601,1.347095204042689,0.16428571428571428,0.637821847871355,1.0,4/15,8.27%,AIM2;CASP4;CASP8;CASP1
prerank,vesicle organization (GO:0016050),0.5071356176632338,1.3470519622052677,0.12369597615499255,0.636611659863505,1.0,7/46,7.02%,FNBP1L;CAV1;CD34;CAV2;ALS2CL;CHMP2B;SRGN
prerank,inorganic anion transport (GO:0015698),-0.41578911091301474,-1.3467610928504576,0.06756756756756757,0.5061653444266291,1.0,9/53,8.64%,SLC4A10;SLC13A4;ENPP1;SLC26A7;ANO1;CLCN2;ANO4;SLC5A5;ENPP3
prerank,positive regulation of cellular process (GO:0048522),0.3973148499608713,1.3465496355689488,0.008238928939237899,0.637005326781156,1.0,110/565,13.64%,FRMD5;LEF1;TJP1;TBC1D8;RAB27A;FLT1;ACER2;TGM2;KDR;IL6ST;CAV1;TBX1;LIFR;IL15;STX3;CLDN5;INSR;KITLG;PDGFB;PARD3;VEGFC;GATA2;IL6R;EDN1;LRP5;LYN;TAL1;PRKD2;OSMR;ADAM10;FASN;PDGFD;TNFRSF11A;PTK2B;PPP3CA;NOTCH1;CNOT6;PTPRJ;ACACB;TNFRSF1B;BST1;AQP11;ACTN4;WWTR1;CNOT6L;FLT4;ADGRG1;FGF23;DLL1;RPS19;RPS6KA3;SLC6A6;SDCBP;RPS6KA1;XBP1;VEGFD;GNAI2;GREM1;MAPK8;H3-3A;CHP2;WNT5A;CNBP;FOSL1;KRAS;RAC1;CDKN1B;PDGFC;TGFB1;PTK2;TGFA;AGPAT1;KDM4C;NEUROD1;RPTOR;AKT2;IL7R;RPL23;CDK2;SOX4;CSF1;DICER1;RAD18;DHPS;RAD23A;SFRP2;CCL14;GAS6;EPHA4;MCTS1;IL7;GRIN1;SINHCAF;LGMN;RPRD1B;RELA;RIPK2;PA2G4;ZFP36;PHIP;TGFBR2;HSP90AB1;MTPN;CNOT7;HAS2;ADAM17;IGF1R;NSMCE4A;FMR1;RPS6
prerank,histone H3 acetylation (GO:0043966),0.5254292673114983,1.3465472323073708,0.11411411411411411,0.6356886518757571,1.0,10/40,15.21%,LEF1;JADE2;JADE1;KAT6B;JADE3;YEATS2;KAT2B;MBIP;KAT6A;TRIM16
prerank,negative regulation of hydrolase activity (GO:0051346),0.5092358950388532,1.34654631454959,0.09781021897810219,0.6343795899812762,1.0,9/49,7.99%,LRCH1;F11R;SH3BP4;DAB2IP;PLIN5;PTX3;EGLN1;GNAT1;RASA4
prerank,steroid hormone mediated signaling pathway (GO:0043401),0.6485348620479043,1.3461457270190929,0.16112084063047286,0.6343917364171121,1.0,4/13,3.07%,ESR1;PLPP1;NR3C1;ABHD2
prerank,lipid oxidation (GO:0034440),0.6532770982622826,1.3455551711188636,0.14690265486725665,0.6350701189207802,1.0,1/12,0.58%,ADIPOR2
prerank,spliceosomal complex assembly (GO:0000245),-0.42736309569016284,-1.3453371999570054,0.0804953560371517,0.5083313618657729,1.0,8/46,12.29%,CELF2;SRSF5;CELF4;DDX39B;LUC7L3;SRPK2;CELF1;SF1
prerank,positive regulation of autophagy (GO:0010508),0.46521222756988756,1.3452439915899748,0.0801068090787717,0.6347807209610768,1.0,16/81,11.39%,FOXO1;KDR;PRKD1;DAPK1;SH3BP4;TRIM14;PIK3C2A;TRIM68;PLK2;ULK1;MID2;SH3GLB1;IKBKG;NPRL2;BNIP3;ATF6
prerank,T cell homeostasis (GO:0043029),0.6756530159165062,1.3447630487413715,0.14754098360655737,0.6351194396216765,1.0,2/10,4.61%,FAS;JAK3
prerank,cellular response to steroid hormone stimulus (GO:0071383),-0.5374606239227732,-1.344431307826506,0.12439024390243902,0.5089633062334997,1.0,5/17,3.81%,ATP1A2;BMP7;TFPI;BMP4;AR
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.5680651990140276,1.3437222281113443,0.12786885245901639,0.6372047187293818,1.0,11/25,18.42%,EFNA1;OPHN1;RPS7;RPL23;EPHA4;HSP90AB1;PRKCG;RPL11;CSNK2A2;CSNK2A1;PSMF1
prerank,regulation of JNK cascade (GO:0046328),0.4474003344458602,1.3427849221649315,0.09090909090909091,0.6390519065352912,1.0,15/101,6.07%,MECOM;APP;TNFRSF19;DAB2IP;MFHAS1;PTK2B;TPD52L1;TAOK2;PLCB1;TRAF1;FLT4;TIRAP;EDAR;SDCBP;DUSP22
prerank,protein localization to phagophore assembly site (GO:0034497),-0.6071500919449397,-1.3427226096015645,0.1425339366515837,0.5117671376925925,1.0,6/11,26.91%,WIPI1;PACS2;ATG9A;STX17;WDR45;WIPI2
prerank,rRNA transcription (GO:0009303),0.6009113385840439,1.34255613095472,0.13932980599647266,0.6385490566393246,1.0,10/17,24.54%,CAVIN1;SPIN1;TAF1B;ANG;NIFK;POLR1G;GTF3C1;TCOF1;SIRT7;BRF1
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),-0.4326917537744452,-1.3422087169483583,0.0625,0.5113092814862812,1.0,18/44,18.62%,ANK2;ACTN2;ATP1B1;KCNMA1;WNK4;AKAP6;KCNMB2;KCNJ2;ATP1B2;WNK1;GABBR1;KCNJ10;KCNN2;GNG2;WNK3;KCNJ15;KCNJ6;KCNN3
prerank,spinal cord development (GO:0021510),-0.5811631600674267,-1.3420043037239726,0.13569937369519833,0.5100657484175746,1.0,5/12,5.63%,GLI2;VIT;PKD1;LOXL3;NF1
prerank,organic acid transport (GO:0015849),0.4559237152347819,1.3419424245707985,0.08290155440414508,0.6393218343734355,1.0,14/94,6.69%,ABCC4;SLCO2B1;ABCG2;ATP8B1;PPARD;SLC7A7;SLC38A5;SLC3A2;STARD5;NCOA1;SLC6A6;CEACAM1;SLC43A2;SLC26A1
prerank,modulation by symbiont of host process (GO:0044003),0.6806697840836164,1.3417138570398257,0.15575221238938053,0.6387735608010727,1.0,1/10,1.56%,B2M
prerank,prostaglandin biosynthetic process (GO:0001516),0.6061879865318209,1.341691276467769,0.15202702702702703,0.6375677544966444,1.0,5/18,7.16%,PTGS2;PLA2G4A;EDN1;PTGS1;CBR1
prerank,prostanoid biosynthetic process (GO:0046457),0.6266909234512166,1.3415214116158416,0.16520210896309315,0.6368468292863979,1.0,4/15,5.09%,PTGS2;PLA2G4A;EDN1;PTGS1
prerank,amino acid import across plasma membrane (GO:0089718),-0.48354891037153924,-1.3411092067152617,0.10501193317422435,0.5105329250730607,1.0,7/24,3.63%,SLC7A2;SLC6A13;SLC1A3;SLC47A1;SLC1A5;SLC6A9;SLC22A4
prerank,regulation of dopamine secretion (GO:0014059),-0.49214226614888545,-1.3409936600621677,0.12781954887218044,0.5090136749970592,1.0,12/25,26.65%,PRKN;SYT1;SYT9;SYT12;SYT11;DTNBP1;SNCA;SYT3;SYT2;SYT6;SYT5;KCNA2
prerank,protein polymerization (GO:0051258),-0.4080415810316086,-1.3408323004481357,0.07120743034055728,0.507670051102286,1.0,6/56,3.85%,ARHGAP6;GAS7;GSN;PRKN;SPIRE1;COBL
prerank,cellular response to alcohol (GO:0097306),-0.43476169444133983,-1.3402451356494132,0.08670520231213873,0.5074484513898044,1.0,13/42,9.48%,ADCY5;ADCY1;ADCY2;GRAMD1B;ADCY7;CDH1;GRAMD1C;ADCY6;LRP6;GNAI1;SFRP1;PTGFR;SMO
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.6487478836504472,1.3395403610318066,0.15101289134438306,0.642051119179741,1.0,4/13,7.26%,IL6ST;STAT3;IL27RA;JAK1
prerank,negative regulation of endothelial cell migration (GO:0010596),0.5380188063335569,1.3385345963677389,0.11446740858505565,0.6441904239741834,1.0,8/36,7.32%,MEF2C;ACVRL1;PTPRM;DAB2IP;NOTCH1;DLL4;ATP2B4;TGFB1
prerank,negative regulation of endocytosis (GO:0045806),0.5600849626536369,1.338374072602419,0.15841584158415842,0.6434183203637023,1.0,3/24,1.41%,MCTP1;CAV1;PRKD1
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.5391178916152958,1.3377049076149248,0.1486697965571205,0.6443474798210813,1.0,2/28,1.06%,SHANK3;APP
prerank,phasic smooth muscle contraction (GO:0014821),0.6708157503197585,1.3373325755612517,0.15682656826568267,0.6442468075064945,1.0,2/10,15.59%,EDN1;HTR1D
prerank,defense response to Gram-positive bacterium (GO:0050830),0.519539234415112,1.3372604319431078,0.1099236641221374,0.6432420844604717,1.0,9/40,9.15%,GBP4;TIRAP;GBP7;RPL39;DROSHA;PGLYRP2;LYG2;ANG;DEFA6
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.5377879673864481,1.3371817301100517,0.1320450885668277,0.6421931949885554,1.0,6/33,5.65%,TEK;KDR;ICAM1;GATA2;RAMP2;TCF7L2
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),-0.5385613754795643,-1.337154685160463,0.13863636363636364,0.5140715677782799,1.0,10/16,8.39%,IGF1;BMPR1A;FGFR2;TGFBR3;ERBB4;FGF2;ZFPM2;AKAP6;RBPJ;GLI1
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.475315435482449,1.3368302639288216,0.10054347826086957,0.6420284308949445,1.0,11/70,6.61%,TEK;PARVB;MEF2C;PEAK1;EFNA1;SRGAP2;PXN;ACTN1;SIPA1L3;OPHN1;RAC1
prerank,phosphatidylcholine catabolic process (GO:0034638),0.6700149726010408,1.3366194804358917,0.16789667896678967,0.6414033131039992,1.0,2/10,5.46%,PLA2G4A;ENPP2
prerank,determination of left/right symmetry (GO:0007368),0.5345500942962778,1.3361696380595094,0.1244309559939302,0.6417071059294692,1.0,6/37,8.36%,TBX1;ZIC3;NOTCH1;DLL1;PKD2;CFAP53
prerank,positive regulation of cartilage development (GO:0061036),0.6073219894673771,1.336023903131648,0.14010507880910683,0.6409521172338667,1.0,3/17,1.39%,BMPR2;ZBTB16;ACVRL1
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.5857302021141871,1.3357967677977054,0.14726027397260275,0.640399178508377,1.0,6/21,8.49%,PLA2G4A;LPCAT3;PLA2G2D;OSBPL10;MBOAT1;PLAAT3
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),-0.5721593044380142,-1.3355620321768122,0.125,0.5163339778702695,1.0,7/12,33.74%,SIX1;VEGFA;SMO;PAX8;LHX1;NOG;SOX8
prerank,regulation of sensory perception of pain (GO:0051930),-0.5882167907611975,-1.3354005255735053,0.15250544662309368,0.5148827953364784,1.0,3/11,6.83%,CCN3;TMEM100;MGLL
prerank,phosphatidylserine metabolic process (GO:0006658),0.5359929776523708,1.3346955305929922,0.11497730711043873,0.6426920218813922,1.0,7/32,8.49%,PLA2G4A;SERINC5;LPCAT3;PLA2G2D;OSBPL10;MBOAT1;PLAAT3
prerank,sympathetic nervous system development (GO:0048485),0.6157097330246167,1.3342940720963574,0.17253521126760563,0.6427017232994569,1.0,1/15,0.07%,NRP2
prerank,negative regulation of oxidoreductase activity (GO:0051354),-0.6065469207255935,-1.33412761635339,0.1864406779661017,0.516424342876582,1.0,3/10,16.20%,PRKN;SNCA;MT3
prerank,cellular component maintenance (GO:0043954),0.6593585207345409,1.3336327223415825,0.1696113074204947,0.6436040012924027,1.0,5/12,13.47%,INSR;FYN;ITGA3;PICK1;IGF1R
prerank,chromatin organization (GO:0006325),0.4405116541272542,1.3333506554296917,0.057001239157372985,0.6431962788907132,1.0,33/132,18.54%,MECOM;ESR1;SMARCA2;BAZ2B;KDM6A;PADI4;TCF7L1;MTF2;CHD1;ARID1A;KDM4C;SMARCA5;EZH1;NPM3;SMARCE1;RB1;PADI1;TOP1;SETDB2;NPM1;KAT2B;ATRX;HMG20A;JARID2;PIH1D1;HP1BP3;KDM5C;BAZ1A;KDM4A;PHF19;EHMT1;CHRAC1;PAK1
prerank,regulation of mast cell activation (GO:0033003),0.6597250759871651,1.333278284239112,0.17290552584670232,0.6421741252444014,1.0,2/10,2.79%,LYN;NECTIN2
prerank,B cell receptor signaling pathway (GO:0050853),0.534403754178516,1.3332133653372755,0.13099041533546327,0.6411662036539573,1.0,7/32,9.58%,CD38;MEF2C;PLCG2;SH2B2;BMX;LCK;RFTN1
prerank,negative regulation of focal adhesion assembly (GO:0051895),-0.5298091895462281,-1.3332115765574089,0.12771084337349398,0.5154181538934767,1.0,4/16,4.51%,ARHGAP6;PHLDB2;THBS1;APOD
prerank,negative regulation of cell-substrate junction organization (GO:0150118),-0.5298091895462281,-1.3332115765574089,0.12771084337349398,0.5154181538934767,1.0,4/16,4.51%,ARHGAP6;PHLDB2;THBS1;APOD
prerank,regulation of fibrinolysis (GO:0051917),-0.5629394687388964,-1.3322631440914168,0.133630289532294,0.5161798299496251,1.0,3/13,10.33%,THBS1;FAP;SERPINE1
prerank,cochlea morphogenesis (GO:0090103),0.6775543053733858,1.3317994628394774,0.18165467625899281,0.6444903192174191,1.0,1/10,0.88%,TBX1
prerank,gliogenesis (GO:0042063),0.6093784105762695,1.330906866946009,0.16724137931034483,0.6460948722197676,1.0,7/15,17.83%,CDK6;CDH2;NFIB;NDUFS2;CD9;MMP24;METTL14
prerank,calcium ion transport (GO:0006816),-0.36087432153883303,-1.3304151171195226,0.038834951456310676,0.5194144266446489,1.0,21/113,7.91%,SLC24A3;TRPM3;ANK2;CACNA1C;NALCN;SLC8A3;CACNA2D1;CACNA1D;PKD1;GRIN3A;SLC8A1;P2RX4;RAMP1;CACNB2;CACNA1G;ITGAV;TRPC3;STIM1;TRPC6;TRPC1;ATP2A2
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.5386844775978398,1.330329332633519,0.13215859030837004,0.6467253958501834,1.0,7/33,7.32%,PDGFB;GATA2;STAT3;NR3C1;HIF1A;FOSL1;TGFB1
prerank,regulation of macrophage cytokine production (GO:0010935),0.6235182310228294,1.3299661064199453,0.16123499142367068,0.6466559712587977,1.0,5/13,7.32%,SEMA7A;PLCG2;CUEDC2;WNT5A;TGFB1
prerank,calcium ion import (GO:0070509),-0.4660912131181985,-1.3297936414088232,0.12885154061624648,0.5193432017274495,1.0,9/28,11.30%,CACNA1C;CACNA1D;SLC8A1;MCU;CACNB2;CACNA1G;ATP2A2;TRPC4;MICU1
prerank,cellular response to interleukin-12 (GO:0071349),0.4993781870484668,1.329433059792605,0.10564399421128799,0.6470861032845235,1.0,9/48,7.26%,LCP1;MSN;RAP1B;PLCB1;PAK2;HNRNPF;CA1;MTAP;JAK1
prerank,negative regulation of epithelial cell migration (GO:0010633),0.5308934140258736,1.3291513567585296,0.13875598086124402,0.6467468307697714,1.0,6/33,5.27%,PTPRG;ACVRL1;PTPRM;DAB2IP;EVL;DLL4
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.5684664603692648,1.32881474704756,0.14743589743589744,0.6466009362454271,1.0,9/24,9.42%,EPN2;MMRN2;DAB2IP;HHEX;PRKD2;HIF1A;NEDD4;ITGA5;PTPN1
prerank,cellular response to cAMP (GO:0071320),0.5342762953533805,1.3287755590625951,0.13700787401574804,0.6454829540182447,1.0,8/30,8.08%,AHR;PDE2A;KCNQ1;RAP1B;RAPGEF2;INPP5K;RAP1A;PKD2
prerank,endoderm formation (GO:0001706),-0.4477799908363701,-1.3286012849652438,0.13005780346820808,0.5208909912538894,1.0,10/35,9.38%,COL8A1;COL12A1;VTN;COL11A1;ITGB5;COL6A1;MMP14;ITGAV;MMP2;INHBA
prerank,regulation of cell cycle (GO:0051726),0.4105914077454079,1.3285536495292796,0.0436241610738255,0.6450479987317217,1.0,53/271,13.03%,MECOM;NANOS3;DCUN1D3;APBB2;ERN1;PPP1R13B;CDK6;NEK7;ADARB1;IQGAP1;DAB2IP;PIM3;ADAM10;STAT3;NOTCH1;SIK1;AFAP1L2;TTC28;JMY;PPP1R9B;SDCBP;UHRF2;LIN54;PTPRK;ASAH2;XIAP;TCF7L2;LIN9;CDKN1B;JUNB;TGFB1;RNF167;PKD2;NF2;CTBP1;AKT2;NEK6;MYBBP1A;RPL23;PUM1;DDIAS;RAD23A;TFAP4;CDC26;RB1;RNF112;RPRD1B;NOP53;RHOB;RACK1;BIRC3;HSP90AB1;UHMK1
prerank,neuronal action potential (GO:0019228),-0.49049139884894627,-1.326880750804073,0.12928759894459102,0.5236937850584418,1.0,12/22,27.56%,SCN7A;ANK3;CACNA1G;KCNMB2;GPER1;SCN1A;SCN8A;SCN2A;SCN5A;KCNA2;SCN9A;CACNA1H
prerank,protein glycosylation (GO:0006486),0.434157923248221,1.3266558369591248,0.07197943444730077,0.6499015974908562,1.0,24/125,12.80%,ST3GAL6;SLC39A8;ST3GAL1;MGAT4A;STT3B;GALNT18;GALNTL5;EOGT;AQP11;B3GNT3;TET3;ALG10B;B3GNT4;ST8SIA4;ST6GALNAC2;B4GALT5;B4GAT1;B3GNT6;NUS1;MGAT5;DPAGT1;TET2;OGA;PMM2
prerank,adipose tissue development (GO:0060612),0.6474474117032054,1.326383236188055,0.1807909604519774,0.6495782467234875,1.0,3/11,4.96%,SPTLC2;LRP5;XBP1
prerank,oogenesis (GO:0048477),0.6119250328643623,1.326367637444386,0.15716753022452504,0.6483910189903714,1.0,4/15,8.15%,NANOS3;NANOS2;TRIP13;MARF1
prerank,"synaptic transmission, GABAergic (GO:0051932)",-0.6087120325145956,-1.3262003894515841,0.12815126050420167,0.5238318720317474,1.0,6/10,22.92%,GABRG2;GABRA2;GABRG3;GABRA1;GABRA5;GABRA3
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),-0.48210083361189343,-1.3261842053620458,0.12345679012345678,0.5220944565980277,1.0,5/25,7.90%,ANK2;CEMIP;CACNB2;AKAP6;TRPC1
prerank,potassium ion transmembrane transport (GO:0071805),-0.3513865164055041,-1.3257437183541523,0.020942408376963352,0.5215498016723649,1.0,26/135,12.44%,ATP1A2;SLC24A3;KCNK2;NALCN;SLC1A3;SLC12A2;KCNB2;SLC9A9;KCNK5;ATP1B1;KCNQ3;ABCC9;KCND2;KCND3;KCNC2;KCNS3;KCNJ2;KCNQ4;KCNJ13;KCNAB1;SLC24A2;ATP1B2;KCNQ5;SLC9A1;KCNA6;ABCB8
prerank,regulation of protein binding (GO:0043393),0.4399843683079977,1.3257075864200085,0.08524173027989822,0.6492830177457715,1.0,25/114,9.03%,CAV1;APP;EPB41;CLDN5;B2M;PDGFB;HIP1R;BTBD1;STK3;FKBP1A;TMBIM6;STK4;MARK3;RALB;DISC1;DTX3L;MAPK8;TCF7L2;AURKA;RAPGEF2;TRIB3;CTNNBIP1;PSEN1;CRK;ZFPM1
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.5901516338792139,-1.3254417390694988,0.14184397163120568,0.5205356418170928,1.0,6/11,11.88%,PDK1;MAP3K5;PRKCD;CYP1B1;PRODH;DIABLO
prerank,regulation of lymphocyte proliferation (GO:0050670),0.6121018333039916,1.3252797279891275,0.15371024734982333,0.649481372813616,1.0,4/16,10.90%,AHR;TNFRSF1B;TNFSF8;LST1
prerank,negative regulation of inflammatory response (GO:0050728),0.42577286370275824,1.3252651022801007,0.053488372093023255,0.6483050565427274,1.0,21/182,5.63%,TEK;CALCRL;CYSLTR1;PPARD;ADCY4;CD200;PLCG1;MYH9;LYN;MFHAS1;YES1;GNB1;TNFRSF1B;LPCAT3;FYN;PRKAR2B;PLCG2;ADRB1;RPS19;RAMP2;PLK2
prerank,positive regulation of protein modification process (GO:0031401),0.4157895676255347,1.3249158873067706,0.060324825986078884,0.6481447865791234,1.0,33/203,7.93%,TEK;LIMCH1;PECAM1;KDR;ENG;TBX1;APP;PDE8A;PPP1R16B;INSR;VEGFC;PPP2R5A;LYN;FAS;EFNA1;FLT4;FGF23;STK4;RALB;VEGFD;ACVR2A;ALG10B;LIMK2;KRAS;CD40;RAC1;DYRK1A;ARRB1;TNIK;TGFB1;PTK2;NIBAN1;NOS1AP
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.40359910881776173,1.3248668105285284,0.030871003307607496,0.647094451567077,1.0,97/306,17.73%,ALAS1;RPS15;IGF2BP3;RPS19;RPLP1;RPS14;RPSA;RPS16;EPC1;RPL38;RPL34;RPS20;RPL39;RPS7;PWP1;RNASEH2A;RPS24;TAF1B;MCM10;RPA1;RPL37A;B4GALT5;BCL3;SRBD1;RPL36;RPS18;RSL24D1;RPL15;POLA1;B3GNT6;RPS8;RPL14;RPL23;RPL17;DUT;CDK2;MRPS18A;BRIP1;RPL9;DHPS;RPL4;RPL13A;HELB;RPS11;RPL32;TNIP1;HUS1;RPL22;RPS27;RPL31;RPS23;MMS19;RNPS1;MRPL13;RPL13;MRPS12;RPS12;MCM9;EEF2K;RMI1;MRPL35;HBS1L;RPL6;RPL10;WARS1;PTMA;TOP1;MRRF;MRPL41;GRWD1;RPS29;RPS6;MEF2A;MRPL52;RPL29;TOPORS;RPS25;RPL35A;RPS13;RPS21;MRPS16;RPL27;RPL18;MRPL23;ORC5;RPL27A;MRPS5;RPS10;MRPL37;ORC3;EEFSEC;RPL11;RPL8;EEF2;RFC3;RPLP2;MRPL11
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.3896140791110397,1.3248099005688456,0.003036437246963563,0.646048072619106,1.0,148/834,12.41%,ERG;LEF1;MRTFB;ELK3;RPS6KA5;FOXO1;EPAS1;PBX1;BMPR2;LDB2;ENG;ITGA6;TBX1;ESR1;SMARCA2;APP;PPARD;MEF2C;LMO2;ACVRL1;PRKD1;NR5A2;CRTC1;MAML2;AHR;SMAD1;ZIC3;NFATC1;PDGFB;NLRC5;IRF2;GATA2;DAB2IP;EDN1;HHEX;ARHGEF2;LRP5;TAL1;PRKD2;STAT3;NR3C1;PPP3CA;NOTCH1;HIF1A;PLXND1;KLF7;RREB1;NFKBIA;CCNK;SOX17;NCK1;WWTR1;SOX18;TCF12;PPP1R12A;FOSL2;MAFF;MRTFA;NCOA1;DLL1;RPS6KA3;KLF2;FOXF1;SS18;ELK4;IKBKB;RPS6KA1;XBP1;TET3;EPC1;SMAD7;ACVR2A;GREM1;FOXF2;SBNO2;HOXA10;MTF2;LPIN3;TCF7L2;TCF4;PPP3CB;CHP2;WNT5A;CNBP;SKAP1;TOX3;ATMIN;KLF10;ACVR1;NR1I3;BTBD18;FOXA3;FOSL1;IRF2BPL;CD40;HNF1B;JUNB;ARRB1;RBM14;TNFRSF1A;TGFB1;HOXD8;TCF3;AGRN;NFKB1;PKD2;NEUROD1;CITED1;NRL;KAT6B;SMARCA5;CREB1;ZFPM1;SUB1;BRD4;PCGF5;IER2;TCF15;SOX4;IKBKG;RNF4;NFIB;CREB3L4;NRIP1;SMAD5;SFRP2;USF2;TNIP1;GLYR1;POU2F1;GABPB1;CSRNP1;MC1R;GLMP;ZMIZ1;ATF6;SP3;GRIN1;RIPK1;PRDM2;ACTR2;RPRD1B;MUC1;ASXL1;RELA;RIPK2;MAX;TET2
prerank,regulation of interleukin-12 production (GO:0032655),0.5031429364927266,1.3247795596342495,0.12661870503597122,0.6449166976590833,1.0,11/47,12.40%,FOXP1;PLCB1;PLCG2;TIRAP;JAK3;MAST2;TIGIT;CD40;IL23A;MAPK11;RIPK2
prerank,regulation of viral entry into host cell (GO:0046596),0.5521062131425962,1.3243367941055455,0.13559322033898305,0.6451269293349956,1.0,8/30,7.85%,LY6E;TRIM14;NECTIN2;TRIM68;PTX3;MID2;SNX3;TRIM25
prerank,regulation of chondrocyte differentiation (GO:0032330),-0.48437073768207173,-1.3243211624119178,0.1172069825436409,0.5217344133830366,1.0,7/24,4.01%,SOX5;ADAMTS12;TRPS1;EFEMP1;TGFBR1;SOX6;WNT9A
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.5838395786894331,1.3241944099225114,0.17222222222222222,0.6444129991599273,1.0,7/18,13.91%,TEK;PTK2B;RAP1B;LLGL1;CYRIB;RACK1;CDH5
prerank,regulation of cell-matrix adhesion (GO:0001952),0.48154133850836,1.323903633974611,0.11716621253405994,0.6440731484854979,1.0,15/64,9.45%,LIMCH1;ACER2;UTRN;NEXMIF;CDK6;PEAK1;PTK2B;BST1;SKAP1;ADAM15;PTK2;RASA1;NF2;SLK;CSF1
prerank,negative regulation of response to stimulus (GO:0048585),0.48036616685449857,1.3238960510366595,0.11218836565096953,0.6428813268229643,1.0,13/60,9.42%,MCTP1;CDK6;LYN;PIM3;KLF7;AQP11;LPCAT3;KIF26A;SRMS;CD34;ACVR1;MAP3K3;PTPN1
prerank,cellular response to hormone stimulus (GO:0032870),0.4760675281270294,1.3238162201398171,0.1056338028169014,0.6419288819577214,1.0,16/69,6.62%,CAV1;MEF2C;LMO2;SOCS2;STAT3;NR3C1;NCOA1;XBP1;GHR;SERPINB9;RAMP2;ATP1A3;ATP1A1;SOST;INPP5K;NCOA4
prerank,positive regulation of monooxygenase activity (GO:0032770),0.5605224866820335,1.323734734854912,0.14353312302839116,0.64098779448955,1.0,7/26,11.69%,GCH1;SCARB1;HIF1A;FGF23;NOS1AP;CYP27B1;NUS1
prerank,myofibril assembly (GO:0030239),0.5100842226847063,1.3234442725343214,0.12063492063492064,0.6407094855389659,1.0,3/42,3.98%,PGM5;FLII;TMOD3
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),0.6677878461987851,1.3232423132914395,0.18114602587800369,0.6401557419155375,1.0,5/10,16.37%,NFKBIZ;SMAD7;MALT1;RC3H1;NFKBID
prerank,membrane protein proteolysis (GO:0033619),0.5274327463410736,1.323196123960776,0.13178294573643412,0.6390890600421446,1.0,15/37,15.14%,MYH9;ADAM10;SPPL2A;RET;TGFB1;NFKB1;ERAP1;PSEN1;RHBDD1;MBTPS2;APH1A;RELA;ADAM17;TRAF6;SPPL3
prerank,regulation of bone mineralization (GO:0030500),-0.4038099648233274,-1.32288346042163,0.06741573033707865,0.5240722639356465,1.0,17/55,7.75%,BMP6;BMPR1A;PTN;WNT4;BMP7;ENPP1;ADGRV1;OSR1;BMP4;GPM6B;SLC8A1;FBN2;BMP2K;CCN1;NOTUM;BCOR;ECM1
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.6339824867430962,1.32244321480772,0.19038817005545286,0.6403346232927595,1.0,4/12,3.19%,PRKG1;MEF2C;PDGFB;DOCK4
prerank,contractile actin filament bundle assembly (GO:0030038),0.6118234587273798,1.3210794403583517,0.16549295774647887,0.6422902034753336,1.0,4/15,7.05%,FAM171A1;SORBS1;PDLIM1;ARRB1
prerank,stress fiber assembly (GO:0043149),0.6118234587273798,1.3210794403583517,0.16549295774647887,0.6422902034753336,1.0,4/15,7.05%,FAM171A1;SORBS1;PDLIM1;ARRB1
prerank,cell-cell junction organization (GO:0045216),0.4652379566811523,1.320412732477415,0.09230769230769231,0.6432491076903117,1.0,16/79,9.62%,TJP1;PKP4;CADM1;CLDN5;OCLN;LIMS2;TJP2;NECTIN2;PVR;CDH2;CTNNA1;TGFB1;TRPV4;CDH15;ANG;TJP3
prerank,regulation of interleukin-10 production (GO:0032653),0.505713014861942,1.320036858444578,0.12917271407837447,0.6432070672171889,1.0,7/44,9.60%,STAT3;CD34;PLCG2;DLL1;JAK3;TIGIT;IL23A
prerank,cellular response to nutrient levels (GO:0031669),0.48173751223587596,1.3193625976458472,0.11267605633802817,0.6441338808712879,1.0,11/62,8.46%,FOXO1;BMPR2;STK24;KCNB1;RALB;XBP1;ULK1;KLF10;STK26;LPL;RPTOR
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),-0.5606973305182485,-1.3191467359760376,0.1476510067114094,0.5324499638612064,1.0,7/13,12.16%,BMP6;BMPR1A;TGFBR1;BMP4;DAB2;TGFB3;NUP93
prerank,sphingoid metabolic process (GO:0046519),0.6521002644104306,1.3188267640551743,0.16576576576576577,0.6446870381573326,1.0,5/12,5.50%,DEGS2;PLPP1;SGPP2;SPTLC3;ASAH2
prerank,regulation of T cell cytokine production (GO:0002724),0.6095936631539279,1.3182778006371931,0.1742957746478873,0.6453358464571778,1.0,4/15,8.24%,B2M;TNFRSF1B;SMAD7;MALT1
prerank,peptidyl-serine modification (GO:0018209),0.4169821603597139,1.3177591129596689,0.056152927120669056,0.6458045221540499,1.0,38/166,13.03%,PRKCH;RPS6KA5;PRKD1;PDGFB;PRKD2;PKN3;PKN2;PAK2;PKN1;RPS6KA3;STK4;LMTK2;MARK3;IKBKB;RPS6KA1;HIPK1;MAPK8;PLK2;MAST2;ULK1;AURKA;DYRK1A;SGK3;AKT2;NEK6;CDK2;RICTOR;MAPKAPK3;PARP2;GAS6;AKT3;MAP3K13;STK38;MKNK2;NAA11;TGFBR2;TOP1;UHMK1
prerank,magnesium ion transport (GO:0015693),-0.5709028850011711,-1.317690337178258,0.16379310344827586,0.5347820626765473,1.0,6/12,19.16%,SLC41A1;TUSC3;MAGT1;CNNM4;MRS2;NIPA1
prerank,regulation of amyloid-beta formation (GO:1902003),-0.44048236651869443,-1.3174250567107206,0.09302325581395349,0.5337558207188492,1.0,8/34,9.84%,IGF1;ROCK2;SLC2A13;LRRTM3;NTRK2;RTN1;BIN1;APOE
prerank,neutrophil mediated immunity (GO:0002446),0.3969945100080755,1.3172825204962972,0.015772870662460567,0.6461131267226201,1.0,83/432,15.52%,PTPRB;CTSC;RAB27A;PECAM1;LRG1;ATP8A1;CD93;B2M;PRCP;OSTF1;IQGAP1;ADAM10;STK10;ATP11B;PTPRJ;STOM;TNFRSF1B;ADGRG3;BST1;RAP1B;ADGRE5;FUCA2;CAT;ENPP4;LCN2;SDCBP;MCEMP1;CEACAM1;KMT2E;QSOX1;TSPAN14;SCAMP1;PTX3;NRAS;RAC1;PPBP;RAP1A;ATP6V0A1;PSMA2;NFKB1;ARMC8;DYNLL1;ATP11A;DYNC1LI1;PSEN1;GDI2;SNAP23;VAMP8;ANO6;SPTAN1;CPPED1;PGM2;GMFG;DEGS1;CYFIP1;IRAK4;ACTR2;APEH;PA2G4;GSTP1;STXBP3;DBNL;HSP90AB1;ACTR10;IMPDH1;PFKL;ERP44;AOC1;RAB31;ADAM17;RAB7A;RAB5B;ASAH1;RAB18;S100A9;HMOX2;SVIP;DGAT1;GGH;RAB6A;ACE;CEP290;APAF1
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.4752568978880434,1.317186280300457,0.11938202247191011,0.6452245149460902,1.0,15/67,9.45%,UTRN;CDK6;LIMS2;PDGFB;NEDD9;DOCK1;PTK2B;PPM1F;RREB1;SKAP1;RAC1;RSU1;ARHGEF7;CRK;CSF1
prerank,negative regulation of growth (GO:0045926),0.4399965493892037,1.3170874996096218,0.08712121212121213,0.6443752392012954,1.0,18/121,7.32%,BMPR2;DCUN1D3;APBB2;SMARCA2;ACVRL1;SH3BP4;NPR1;NOTCH1;PTPRJ;SOX17;PPP1R9B;VGLL4;ADAM15;JADE1;FBP1;DCSTAMP;CDKN1B;TGFB1
prerank,regulation of cation channel activity (GO:2001257),-0.3723424742082464,-1.31689672195491,0.046875,0.5333740673346536,1.0,30/89,15.46%,ANK2;DMD;DLG2;NLGN2;ACTN2;DLG4;FGF14;JPH1;GRIA2;ANK3;DLG1;GRIA3;GRIA1;SLMAP;CACNB2;NLGN1;PRKACA;KCNAB1;CACNB1;DLG3;GRIA4;SHANK1;GRIN2A;PRRT1;AHNAK;JPH2;CAMK2B;CACNG4;SHISA7;NETO1
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.5471297368002953,1.3163655458586827,0.15422077922077923,0.6455425306421927,1.0,9/27,18.41%,CTPS1;GSR;AK4;DCTD;DUT;RRM2B;CMPK1;TXNRD1;GLRX
prerank,positive regulation of cell population proliferation (GO:0008284),0.39524868240931815,1.3163116225049134,0.019128586609989374,0.6445991320409024,1.0,63/423,9.45%,PRKCH;LEF1;TJP1;TBC1D8;FLT1;ACER2;KDR;IL6ST;TBX1;LIFR;MEF2C;IL15;STX3;CLDN5;CDK6;INSR;KITLG;PDGFB;VEGFC;FOXP1;IL6R;EDN1;LRP5;LYN;OSMR;ADAM10;PDGFD;TNFRSF11A;PTK2B;NOTCH1;CNOT6;BST1;AQP11;WWTR1;CNOT6L;FLT4;FGF23;TOX;DLL1;SDCBP;XBP1;VEGFD;GNAI2;GREM1;DLL4;TCF7L2;CHP2;WNT5A;CNBP;FOSL1;KRAS;PDGFC;TGFB1;PTK2;TGFA;MAP3K3;KDM4C;AKT2;IL7R;RPL23;CDK2;SOX4;CSF1
prerank,neural crest cell migration (GO:0001755),0.5154247764967363,1.3160814639475664,0.142433234421365,0.6441715643074558,1.0,4/36,1.68%,SEMA6A;TBX1;SEMA5B;SEMA7A
prerank,positive regulation of extracellular matrix organization (GO:1903055),-0.5090822123250883,-1.3160741387927803,0.13636363636363635,0.5339982779180822,1.0,6/18,9.96%,PDPN;SMAD3;EFEMP2;RUNX1;RGCC;DDR2
prerank,positive regulation of cellular catabolic process (GO:0031331),0.42820815924223016,1.3159519335241037,0.074719800747198,0.6434510790328977,1.0,30/132,11.84%,FOXO1;APP;PRKD1;INSR;DAPK1;SH3BP4;TRIM14;HIF1A;MSN;PFKFB3;TNFRSF1B;PIK3C2A;PLIN5;VGLL4;DTX3L;TRIM68;PLK2;ULK1;PRR5L;MID2;SH3GLB1;PSEN1;AKT2;PTPN1;NPRL2;CNOT1;BNIP3;RC3H1;ATF6;ABCD1
prerank,regulation of interleukin-2 production (GO:0032663),0.5085749463017091,1.3158511452546406,0.125,0.6425937501338057,1.0,7/43,3.95%,SPTBN1;PRKD2;HDAC7;PDE4D;CD34;PLCG2;HOMER2
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.5219084678025206,1.3155895471397943,0.15683229813664595,0.6423187641320953,1.0,10/32,17.07%,CDK17;POLA1;CDT1;BRD4;BACH1;CDK18;RB1;ESRRB;E2F7;KLF11
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),-0.5398191879130362,-1.3151168845486791,0.14651162790697675,0.5347335022636033,1.0,7/15,9.72%,UST;DSE;DCN;BGN;CSPG4;VCAN;DSEL
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.46294469371304453,1.315077381514189,0.11201079622132254,0.6427018523941858,1.0,29/72,19.71%,LIFR;CASP8;TRAF1;SIGIRR;SPPL2A;IKBKB;HIPK1;IFNAR2;JAK1;TNFRSF1A;AGPAT1;PTPN1;IKBKG;GAS6;IL7;CBFB;RIPK1;RACK1;BIRC3;HSP90AB1;IRAK3;OTULIN;BIRC2;IRAK2;STAT1;IFNGR1;CDC37;MADD;TAX1BP1
prerank,regulation of postsynapse organization (GO:0099175),0.5418005382765164,1.314128661268045,0.15445859872611464,0.6444628828380448,1.0,4/28,6.09%,SHANK3;ABI3;PPFIA2;WNT5A
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.5392773272600385,1.3137271051905295,0.15348837209302327,0.6446593323098155,1.0,4/31,3.49%,SHANK3;ABI3;EFNA1;PPFIA2
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.6125202443140462,1.3136199870407117,0.19099099099099098,0.6438392170843792,1.0,7/13,18.14%,KDR;ENG;DLL4;SFRP2;TGFBR2;CTNNB1;NRARP
prerank,regulation of cell differentiation (GO:0045595),-0.3454195595618217,-1.3132139661285922,0.017341040462427744,0.538040366785459,1.0,30/148,11.45%,PHLDB2;SMOC1;FGFR2;EPHA3;ZFHX3;DDX5;PRKCB;TRPS1;CCN2;PHLDB1;TGFBR1;DAG1;RUNX2;AR;IGF2;YWHAG;NF1;NGF;SIX1;DDX17;NLGN1;ST7;PRKACA;BCL6;RUNX1;BIN1;ALK;NREP;FLOT2;CAMK1
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.6353036786873083,1.3123797654414107,0.19005328596802842,0.6464631225442838,1.0,2/12,7.32%,ESR1;TGFB1
prerank,regulation of leukocyte chemotaxis (GO:0002688),0.590106116961727,1.3123310091638132,0.15780141843971632,0.6454808289295055,1.0,5/18,4.50%,MTUS1;IL6R;LYN;PTK2B;F7
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.5868205551709712,1.311894544244268,0.152428810720268,0.6457279592011933,1.0,5/20,10.54%,RPS6KA5;DIP2B;ARRB1;SOX4;GLYR1
prerank,positive regulation of dendrite extension (GO:1903861),0.5843527832128925,1.3113735362666563,0.17277486910994763,0.6461893082495701,1.0,3/17,2.93%,SMURF1;NEDD4L;ITSN2
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.5737762068993352,1.31130291087955,0.1476510067114094,0.6452478531860868,1.0,3/20,2.79%,EPAS1;DCUN1D3;HIF1A
prerank,membrane organization (GO:0061024),0.4102324962090711,1.3106712405678458,0.04880817253121453,0.6461537227072788,1.0,44/227,12.03%,DNM3;MYOF;FNBP1L;CERT1;SPTBN1;EPN2;HIP1;HIP1R;FZD4;REEP1;LPCAT3;PIK3C2A;FCHO2;ARPC3;GLTP;AP2B1;VAMP4;CCDC88A;CHMP2B;WNT5A;DCSTAMP;SH3GLB1;ARRB1;ATP2C1;TGFA;SNX3;AP2A1;IL7R;SYNJ1;CHMP4B;CHMP4A;PLEKHA8;SNAP23;GAPVD1;OCRL;VAMP8;A4GALT;SCARB2;CBL;PICK1;PICALM;M6PR;CORO1C;ACTR2
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.6136004509763893,1.3106082604605132,0.16695957820738136,0.6451990332024056,1.0,6/14,12.35%,PRKD2;NECTIN2;TESPA1;LCK;IKBKG;RELA
prerank,cellular polysaccharide catabolic process (GO:0044247),-0.5380019280977143,-1.3105704815374364,0.13073394495412843,0.5435231110791348,1.0,8/16,20.80%,PYGB;PHKB;PYGM;GAA;AGL;AOAH;PHKA2;PHKG1
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.43661781468432054,1.3104474514775843,0.08816120906801007,0.6445367621429777,1.0,31/114,18.42%,AIM2;TNFRSF11A;PTK2B;TNFRSF1B;NFKBIA;ACTN4;TRAF1;TMSB4X;TNFRSF25;EDAR;IKBKB;TNFSF8;CD40;TNFRSF1A;PSMA2;TNFRSF13C;TNFRSF8;PSMA8;TNFRSF9;PSMA6;RIPK1;RELA;BIRC3;ADAM17;TRAF6;PSME1;BAG4;BIRC2;STAT1;PSMA4;PSMF1
prerank,negative regulation of anoikis (GO:2000811),0.6141639844425177,1.3098558176849133,0.20550458715596331,0.6452295894797302,1.0,4/14,7.98%,CAV1;NOTCH1;PTK2;ITGA5
prerank,sensory perception of sound (GO:0007605),-0.3728923846431252,-1.309816546025563,0.058333333333333334,0.5438326637717538,1.0,18/88,8.32%,EYA1;ROR1;COL1A1;CEMIP;COL4A3;ADGRV1;COL11A1;EML2;DCDC2;KIT;CACNA1D;GRM7;GSDME;ATP6V0A4;PCDH15;WHRN;ALDH7A1;RIPOR2
prerank,regulation of stress fiber assembly (GO:0051492),-0.377312637129482,-1.3087261637421843,0.05862068965517241,0.5449596703392563,1.0,26/74,11.29%,ARHGAP6;PHLDB2;LPAR1;CGNL1;ROCK2;PPM1E;TMEFF2;ARHGEF10L;NRP1;CCN2;TGFBR1;ARAP1;ARHGEF10;TPM1;RHPN2;CARMIL1;ALMS1;SFRP1;FHOD1;ASAP3;RGCC;TGFB3;S100A10;PFN2;SLC9A1;ARHGEF18
prerank,positive regulation of ossification (GO:0045778),-0.42684179685032014,-1.308546142230177,0.0963855421686747,0.5436855336288804,1.0,11/39,4.62%,BMP6;BMPR1A;PTN;WNT4;BMP7;ADGRV1;OSR1;BMP4;GPM6B;SLC8A1;FBN2
prerank,ncRNA transcription (GO:0098781),0.6041368129058391,1.3084748853041361,0.20373831775700935,0.6485089187893194,1.0,7/13,16.49%,CAVIN1;SPIN1;ANG;NIFK;SNAPC3;POLR1G;GTF3C1
prerank,positive regulation of endopeptidase activity (GO:0010950),0.5493407442062151,1.3083656932753815,0.15384615384615385,0.6477362773930532,1.0,11/26,15.09%,LYN;STAT3;EFNA1;AIM2;FYN;APH1A;EPHA4;GRIN1;PICALM;PSME1;VSIR
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.5474384154612696,-1.3079917224878261,0.13286713286713286,0.5435458324557909,1.0,6/15,24.57%,GGT5;ALDH4A1;PRODH;HOGA1;GGT1;GOT2
prerank,glutamine family amino acid catabolic process (GO:0009065),0.6344021793163461,1.307577266980702,0.18629173989455183,0.6489245723914157,1.0,3/13,3.41%,NOS3;GLS2;GLS
prerank,retinol metabolic process (GO:0042572),-0.5441950082902041,-1.3066623910938078,0.14468085106382977,0.5455364900904961,1.0,3/14,4.73%,RBP4;DHRS3;CYP1B1
prerank,keratan sulfate biosynthetic process (GO:0018146),0.5416056361526154,1.306401346673015,0.1791044776119403,0.6514758581322347,1.0,8/26,10.18%,ST3GAL6;ST3GAL1;B3GNT3;B4GALT4;B3GNT4;B4GALT5;B4GAT1;SLC35D2
prerank,plasma membrane repair (GO:0001778),0.6190181315240076,1.3053116522390988,0.2073170731707317,0.6536921460060898,1.0,2/13,2.11%,MYOF;MYH9
prerank,positive regulation of histone deacetylation (GO:0031065),0.6367557280804728,1.3042654836269576,0.18853974121996303,0.6558571104973988,1.0,4/12,10.44%,PRKD1;PRKD2;CTBP1;APLNR
prerank,response to hydroxyurea (GO:0072710),0.6338010717716697,1.3042500638928192,0.18874773139745918,0.6547752117387816,1.0,9/11,29.26%,FMR1;DDI1;ATRX;DDI2;SPIDR;RTF2;TIMELESS;DDX11;KAT7
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),-0.4259958175995594,-1.304146690434168,0.10303030303030303,0.550726148506113,1.0,14/43,9.22%,IGF1;BMPR1A;PDGFRB;IGFBP5;GJA1;IL18;BMP4;CDH13;THBS1;FGF2;ADAMTS1;RBPMS2;CCN4;MMP2
prerank,regulation of dendrite extension (GO:1903859),0.580001253365262,1.3036686628997955,0.17657342657342656,0.6553900756314859,1.0,3/18,2.93%,SMURF1;NEDD4L;ITSN2
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.6627715952664425,1.3036331473174154,0.18018018018018017,0.6543615627836564,1.0,2/10,1.12%,ACER2;NEXMIF
prerank,regulation of membrane repolarization (GO:0060306),0.6123123557379322,1.3034032133367532,0.18233082706766918,0.6539110319328523,1.0,4/13,7.06%,CAV1;NEDD4L;KCNQ1;KCNE2
prerank,positive regulation of fat cell differentiation (GO:0045600),0.5037746175273798,1.30257673266439,0.13446676970633695,0.655382604205512,1.0,13/47,12.67%,PTGS2;PPARD;ZBTB16;SOX13;LRP5;RREB1;XBP1;LPL;CREB1;SFRP2;CCDC71L;PIM1;ZFP36
prerank,regulation of chromatin binding (GO:0035561),0.6562947450629781,1.3022181192327167,0.19157088122605365,0.6553477262428214,1.0,8/10,29.96%,HMBOX1;DTX3L;CDT1;PARP9;MED25;GMNN;DDX11;BTAF1
prerank,glycoprotein biosynthetic process (GO:0009101),0.45507498514984174,1.3021777367354006,0.11804613297150611,0.6543658562072945,1.0,11/79,8.78%,ST3GAL6;CSGALNACT1;BMPR2;GALNTL5;B3GNT3;ALG10B;B3GNT4;ST8SIA4;ST6GALNAC2;B4GALT5;B3GNT6
prerank,positive regulation of programmed cell death (GO:0043068),0.4009880633217781,1.3015879094363028,0.05011135857461024,0.6550092111822032,1.0,54/272,12.70%,FOXO1;TNFSF10;UNC13B;TGM2;NET1;DCUN1D3;ITGA6;MCF2L;DAPK1;ARHGEF3;RASGRF2;HIP1R;DAB2IP;ARHGEF2;FAS;STK3;CASP8;JMY;PLEKHG5;KALRN;STK4;PREX1;FOXL2;MAPK8;BOK;CTNNBL1;DNAJA1;BCL2L11;SPDEF;STPG1;NEUROD1;CRADD;PSEN1;ARHGEF7;MAP3K11;ARHGEF26;SOX4;TNFRSF8;SIAH1;SFRP2;ANO6;TFAP4;APH1A;BNIP3;ATF6;RNPS1;RIPK1;BID;RHOB;TNFAIP8;TRIO;GNA13;ARHGEF9;RACK1
prerank,regulation of cellular component organization (GO:0051128),0.4212327889410246,1.3013877616124474,0.08190709046454768,0.6544843993509816,1.0,27/135,11.71%,TJP1;NET1;HIP1;HIP1R;DAB2IP;MLLT3;SOCS2;RAP1B;TAOK2;CEACAM1;OPHN1;AURKA;WNT5A;RAPGEF2;CISH;SNCAIP;RAP1A;NEDD4;CAMSAP2;RPTOR;SGK3;PTPN1;MAD2L2;SEMA4D;ABL2;IL17RB;PICALM
prerank,regulation of transmembrane transport (GO:0034762),0.5280445470206622,1.3003509213237476,0.14380165289256197,0.656745297791703,1.0,6/31,7.80%,SLC2A1;CTTNBP2NL;OCLN;NEDD4L;TRIB3;NEDD4
prerank,neutrophil activation (GO:0042119),0.6352157371886592,1.3001607859259448,0.2007233273056058,0.656219320488585,1.0,3/12,5.14%,IL15;PREX1;KMT2E
prerank,respiratory system development (GO:0060541),-0.4469355843841594,-1.2996648469518035,0.10880829015544041,0.561284897639093,1.0,12/32,12.70%,FGFR2;GLI2;FGF1;PDPN;BMP4;RBP4;LOXL3;FGF2;VEGFA;STRA6;FGF7;CCDC39
prerank,mesoderm formation (GO:0001707),0.5872746742162501,1.2994896429585892,0.18345323741007194,0.6571189001107771,1.0,4/17,11.76%,BMPR2;ITGA3;ITGA2;ITGB3
prerank,neutrophil degranulation (GO:0043312),0.39203064578666447,1.299439866103275,0.023206751054852322,0.65616356961595,1.0,79/425,15.52%,PTPRB;CTSC;RAB27A;PECAM1;LRG1;ATP8A1;CD93;B2M;PRCP;OSTF1;IQGAP1;ADAM10;STK10;ATP11B;PTPRJ;STOM;TNFRSF1B;ADGRG3;BST1;RAP1B;ADGRE5;FUCA2;CAT;ENPP4;LCN2;SDCBP;MCEMP1;CEACAM1;QSOX1;TSPAN14;SCAMP1;PTX3;NRAS;RAC1;PPBP;RAP1A;ATP6V0A1;PSMA2;NFKB1;ARMC8;DYNLL1;ATP11A;DYNC1LI1;PSEN1;GDI2;SNAP23;VAMP8;ANO6;SPTAN1;CPPED1;PGM2;GMFG;DEGS1;CYFIP1;ACTR2;APEH;PA2G4;GSTP1;STXBP3;DBNL;HSP90AB1;ACTR10;IMPDH1;PFKL;ERP44;AOC1;RAB31;RAB7A;RAB5B;ASAH1;RAB18;S100A9;HMOX2;SVIP;DGAT1;GGH;RAB6A;CEP290;APAF1
prerank,maturation of SSU-rRNA (GO:0030490),0.5164002411567927,1.299250792656131,0.17258064516129032,0.6556803107325989,1.0,18/34,26.02%,RPS19;RPS14;RPS16;RPS8;HELB;UTP4;NOL10;RIOK1;SRFBP1;UTP6;HEATR1;NOP14;RIOK2;RPS28;NGDN;RIOK3;MRPS11;WDR46
prerank,sprouting angiogenesis (GO:0002040),0.49241618482414545,1.2988983162302206,0.13372093023255813,0.655712831419369,1.0,13/51,5.62%,TEK;KDR;ENG;EPHB4;ACVRL1;VEGFC;PTK2B;ADGRA2;FLT4;DLL1;VEGFD;GREM1;RAMP2
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.4312747384085023,1.2985567811654053,0.10211706102117062,0.6556585152920396,1.0,20/117,11.14%,CALCRL;CYSLTR1;ADCY4;PLCG1;MYH9;LYN;YES1;GNB1;FYN;PRKAR2B;PLCG2;ADRB1;RAMP2;PLK2;PLA2G2D;CREB1;INSL3;FCGR1A;MC4R;MC1R
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.6075071997242987,1.2980834458343877,0.19444444444444445,0.656044357405309,1.0,3/14,6.09%,ADAM10;PTK2B;WNT5A
prerank,positive regulation of myelination (GO:0031643),0.626857665411367,1.2980819764929847,0.2159090909090909,0.6549436118391926,1.0,3/11,9.46%,PARD3;TNFRSF1B;DICER1
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.37902029523091796,1.2976002685381154,0.0010070493454179255,0.6553064651787113,1.0,184/1082,12.41%,MECOM;ERG;LEF1;MRTFB;ELK3;FLI1;RPS6KA5;FOXO1;EPAS1;CD38;PBX1;BMPR2;LDB2;ENG;ITGA6;TBX1;ESR1;SMARCA2;APP;PPARD;MEF2C;ZBTB16;LMO2;ACVRL1;PRKD1;NR5A2;CRTC1;MAML2;AHR;SMAD1;ZIC3;NFATC1;PDGFB;NLRC5;IRF2;GATA2;DAB2IP;ELF2;MLLT3;FZD4;EDN1;HHEX;ARHGEF2;LRP5;TAL1;PRKD2;STAT3;NR3C1;PPP3CA;NOTCH1;HIF1A;KLF7;RREB1;AFAP1L2;NFKBIA;CCNK;KDM3A;SOX17;NCK1;WWTR1;PLCB1;SOX18;TCF12;PPP1R12A;FOSL2;MAFF;MRTFA;NCOA1;DLL1;RPS6KA3;KLF2;FOXF1;SS18;ELK4;IKBKB;RPS6KA1;DTX3L;FOXL2;XBP1;TET3;EPC1;KMT2E;SMAD7;ACVR2A;SPIN1;GREM1;FOXF2;SBNO2;ARID1B;HOXA10;RET;MTF2;LPIN3;TCF7L2;TCF4;TEAD2;PITX3;PPP3CB;ESRRG;CHP2;WNT5A;CNBP;SKAP1;ATF7IP;TOX3;ATMIN;KLF10;ACVR1;NR1I3;FOXA3;FOSL1;IRF2BPL;SOST;CD40;INPP5K;HNF1B;DYRK1A;ETS2;JUNB;LYL1;ARRB1;RBM14;TNFRSF1A;TGFB1;HOXD8;BCL3;TCF3;AGRN;HNRNPD;NFKB1;PCBD2;ARID1A;PKD2;NEUROD1;CITED1;NRL;RPTOR;KAT6B;SMARCA5;PSEN1;CREB1;FOXK1;ZFPM1;BRD4;PCGF5;IER2;TCF15;SOX4;IKBKG;MAP2K3;MAFB;RNF4;EDRF1;NFIB;CREB3L4;NRIP1;MAD2L2;SMAD5;SFRP2;USF2;TNIP1;GLYR1;TFAP4;POU2F1;GABPB1;CSRNP1;MC1R;MMS19;GLMP;ZMIZ1;ENY2;ATF6;SP3;GRIN1;PICALM;RIPK1;PRDM2;ACTR2;RPRD1B;ASXL1;RELA;RIPK2;MAX;TET2
prerank,dendritic spine organization (GO:0097061),0.5434096528712417,1.2973156076403842,0.1693548387096774,0.6550932042531568,1.0,7/26,13.47%,SHANK3;INSR;FYN;ITGA3;PICK1;LGMN;IGF1R
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.5710065838326348,1.2972075055802883,0.18871252204585537,0.6543681454304222,1.0,5/17,7.30%,CLDN5;F11R;PPP1R12A;IKBKB;TNFRSF1A
prerank,glycine transport (GO:0015816),0.6439574980707208,1.296549936327299,0.21113243761996162,0.6551997454854213,1.0,2/10,2.68%,SLC6A5;SLC38A5
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.3898336854196842,1.2959005599326021,0.03389830508474576,0.6562454951021575,1.0,74/390,9.65%,NRP2;TEK;FOXO1;PTPRG;FLT1;KDR;TIE1;EPHB4;ANKS1A;PRKD1;INSR;PDGFB;NEDD9;VEGFC;DOCK1;ELMO1;WASF2;SOCS2;LYN;PRKD2;STAT3;EFNA1;PDGFD;PTK2B;DDIT4;YES1;PTPRJ;MPZL1;MTSS1;FYN;PIK3C2A;NCK1;PLCB1;PXN;SRMS;FLT4;CAV2;PAK2;FGF23;SH2B2;SORBS1;KALRN;LMTK2;GRB14;ARPC3;SDCBP;AP2B1;NCKAP1;VEGFD;GHR;RET;ARPC1B;HNRNPF;RAPGEF2;GTF2F2;RAC1;BCAR3;PDGFC;LCK;PTK2;RASA1;AP2A1;GRB7;ATP6V0A1;GAB1;SHOC2;PSEN1;AKT2;ARHGEF7;CRK;ATP6V1G2;CEP57;CSF1;MAPKAPK3
prerank,neutrophil activation involved in immune response (GO:0002283),0.3906918733215917,1.2956039603827418,0.023157894736842106,0.656000655703606,1.0,79/428,15.52%,PTPRB;CTSC;RAB27A;PECAM1;LRG1;ATP8A1;CD93;B2M;PRCP;OSTF1;IQGAP1;ADAM10;STK10;ATP11B;PTPRJ;STOM;TNFRSF1B;ADGRG3;BST1;RAP1B;ADGRE5;FUCA2;CAT;ENPP4;LCN2;SDCBP;MCEMP1;CEACAM1;QSOX1;TSPAN14;SCAMP1;PTX3;NRAS;RAC1;PPBP;RAP1A;ATP6V0A1;PSMA2;NFKB1;ARMC8;DYNLL1;ATP11A;DYNC1LI1;PSEN1;GDI2;SNAP23;VAMP8;ANO6;SPTAN1;CPPED1;PGM2;GMFG;DEGS1;CYFIP1;ACTR2;APEH;PA2G4;GSTP1;STXBP3;DBNL;HSP90AB1;ACTR10;IMPDH1;PFKL;ERP44;AOC1;RAB31;RAB7A;RAB5B;ASAH1;RAB18;S100A9;HMOX2;SVIP;DGAT1;GGH;RAB6A;CEP290;APAF1
prerank,negative regulation of programmed cell death (GO:0043069),0.39136926338000444,1.2953028818935877,0.03488372093023256,0.6558821624027148,1.0,77/355,14.49%,MECOM;LEF1;TEK;TJP1;FOXO1;CD38;KDR;IL6ST;RNF144B;SOCS2;PIM3;ADAM10;FAS;PTK2B;NFKBIA;FLT4;AMIGO2;PAK2;BABAM2;CAT;RPS6KA3;TMBIM6;IKBKB;RPS6KA1;XBP1;GREM1;MAPK8;SERPINB9;PLK2;XIAP;WNT5A;DNAJA1;AVEN;TIGAR;HNRNPK;PTK2;RASA1;BCL3;BNIP2;NFKB1;MALT1;PSEN1;AKT2;RHBDD1;BCL2L1;HIGD2A;EGR3;SEMA4D;GAS6;BNIP3;CBL;IL7;PIM1;THOC6;RIPK1;TMBIM4;TMIGD1;BID;RELA;TNFAIP8;RIPK2;PRDX2;PA2G4;GSTP1;RPL10;BIRC3;PHIP;MET;PTMA;IGF1R;RAB7A;HIGD1A;NPM1;TRAF6;PROC;ERC1;TOPORS
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.5236837173710633,1.2950572933662934,0.16174183514774496,0.6556074037276295,1.0,10/33,12.16%,ACER2;NEXMIF;LYN;EFNA1;RET;PIK3CG;PTK2;SFRP2;P2RY12;MUC1
prerank,positive regulation of cell differentiation (GO:0045597),0.4010350882093794,1.2948909566743003,0.06404494382022471,0.6550607243319007,1.0,47/237,10.35%,PRKCH;LEF1;ZHX3;BMPR2;KDR;IL6ST;PPARD;MEF2C;ZBTB16;ACVRL1;PRKD1;KITLG;IL6R;ARHGEF2;LRP5;WWTR1;PLCB1;CD34;CDH2;RPS6KA3;SLC6A6;SDCBP;RPS6KA1;XBP1;CEACAM1;ACVR2A;CTNNA1;TCF4;RAPGEF2;ACVR1;TGFB1;RAP1A;BRINP2;TCF3;BNIP2;NFKB1;CTNNBIP1;CDH15;LPL;NEUROD1;CREB1;TCF15;CSF1;SPAG9;MAPK11;SFRP2;CCDC71L
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.5489383654933523,1.2940052001302815,0.1783960720130933,0.656674060803871,1.0,7/24,10.42%,SEMA6A;SEMA5B;SEMA7A;SEMA6B;SEMA6D;DSCAM;SEMA4D
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.42466293180615067,1.29391510948397,0.08841843088418432,0.6558502992103746,1.0,34/140,12.57%,CHN2;ARHGAP31;TGM2;NET1;MCF2L;ARHGEF3;ARAP3;CD2AP;RASGRF2;ARHGEF2;BCR;SRGAP3;SRGAP2;SRGAP1;PLEKHG5;RHOJ;KALRN;ARHGAP8;PREX1;ARHGAP17;OPHN1;RAC1;DEPDC1B;ARHGEF7;ARHGEF26;ARHGAP28;OCRL;CYRIB;ARAP2;ARHGAP23;RHOB;TRIO;GNA13;ARHGEF9
prerank,negative regulation of biomineral tissue development (GO:0070168),0.5641106489483404,1.2938667207801704,0.1686143572621035,0.6548943705449275,1.0,7/21,7.32%,NOS3;PTK2B;NOTCH1;FGF23;GREM1;SRGN;TGFB1
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.5989615898663455,1.2932333388028814,0.19889502762430938,0.6558008607403849,1.0,6/15,22.83%,ERN1;TSEN34;RTCB;CPSF1;TSEN2;RTRAF
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.5903538682241954,1.2929261065978885,0.1704745166959578,0.6556047727907862,1.0,2/18,2.59%,SHANK3;PTK2B
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.5969510193260403,1.2928408860499527,0.18198198198198198,0.6548036404307571,1.0,6/15,13.14%,TENT4A;TNRC6C;BTG2;CNOT1;ZFP36;CNOT7
prerank,T cell activation (GO:0042110),0.4587605783241241,1.29249584257231,0.13073713490959665,0.6548520449484334,1.0,16/69,10.70%,LFNG;LCP1;CTPS1;PPP3CA;MSN;NCK1;CHD7;CASP8;FKBP1A;DLL4;PPP3CB;LCK;PIK3CG;SOX4;ICOSLG;JAG2
prerank,negative regulation of DNA binding (GO:0043392),0.5378371464572465,1.2910541674128355,0.16478190630048464,0.658116077041604,1.0,4/28,10.60%,LEF1;NFKBIA;MAD2L2;TFAP4
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.5792588871982957,1.290108472146604,0.19257950530035337,0.6597958804827659,1.0,4/18,5.73%,ELOVL7;ACSL4;ELOVL5;ACSL5
prerank,positive regulation of signaling (GO:0023056),-0.4283830615026813,-1.2899826342143603,0.11452513966480447,0.5875412427428984,1.0,10/37,15.19%,WLS;CLSTN2;DLG4;SYT1;ANXA2;PTPN23;RAB29;GRIK2;SNCA;RIMS1
prerank,transport across blood-brain barrier (GO:0150104),-0.36307164061651015,-1.2898036628196337,0.05555555555555555,0.5861112735397153,1.0,19/83,5.16%,ATP1A2;SLC24A3;SLC7A2;LRP1;SLC6A13;SLCO3A1;SLC1A3;SLC16A12;SLC13A3;LEPR;SLC2A13;SLC22A8;SLC12A2;SLC6A1;SLC1A5;SLC6A9;ABCC9;SLCO1C1;SLC5A3
prerank,protein dephosphorylation (GO:0006470),0.4254419133278651,1.289288336339778,0.09440993788819876,0.6612445660810266,1.0,24/135,8.36%,PTPRB;PTPRG;PTPN14;CTTNBP2NL;PTPRM;PTPN12;PPP2R5A;PPP3CA;PTPRJ;PPM1F;MTM1;NCK1;SSH2;PPP1R12A;PTPRK;PPP2R2C;PPM1L;PPP3CB;MTMR6;DUSP22;PPM1D;DUSP16;PPP2R5E;PPP2R5B
prerank,positive regulation of histone acetylation (GO:0035066),0.5564829164462842,1.2890637529565834,0.1902439024390244,0.66089135839878,1.0,6/23,16.33%,RPS6KA5;ARRB1;GLYR1;MUC1;RPS6KA4;PIH1D1
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.4289062245862462,1.2889601741857513,0.10861423220973783,0.6601405674208534,1.0,14/116,5.63%,CALCRL;CYSLTR1;ADCY4;PLCG1;MYH9;LYN;YES1;GNB1;FYN;PRKAR2B;PLCG2;ADRB1;RAMP2;PLK2
prerank,vascular transport (GO:0010232),-0.3651200854142349,-1.2889123471185036,0.05952380952380952,0.5867217601511,1.0,19/81,5.16%,ATP1A2;SLC24A3;SLC7A2;LRP1;SLC6A13;SLCO3A1;SLC1A3;SLC16A12;SLC13A3;LEPR;SLC2A13;SLC22A8;SLC12A2;SLC6A1;SLC1A5;SLC6A9;ABCC9;SLCO1C1;SLC5A3
prerank,regulation of neurotransmitter secretion (GO:0046928),0.5119021407161972,1.2887665930920944,0.17061611374407584,0.6597120335739525,1.0,10/32,17.27%,MCTP1;MEF2C;KCNMB4;SNCAIP;PNKD;MCTP2;RAB5A;FMR1;RIMS4;CPLX2
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.6004291400953778,1.2886775013433953,0.19197207678883071,0.6589180167115715,1.0,2/15,2.58%,NLRC5;SAMHD1
prerank,positive regulation of cellular component movement (GO:0051272),0.5365961680189547,1.288453095013068,0.21163166397415187,0.6585233600790675,1.0,6/24,8.62%,NTN1;LYN;ACTN4;RPS19;CAVIN1;AKT2
prerank,regulation of actin filament polymerization (GO:0030833),0.4617167226273114,1.2884222940529328,0.12845303867403315,0.6575543575081979,1.0,13/69,10.18%,KANK3;ESAM;HIP1R;PTK2B;NCK1;SSH2;EVL;NCKAP1;CDC42EP3;RASA1;ARHGAP28;CYRIB;TWF2
prerank,negative regulation of protein catabolic process (GO:0042177),-0.41738977798621807,-1.2880438161863235,0.1225071225071225,0.5874038907173966,1.0,15/40,21.74%,EGFR;TIMP3;SNRNP70;TIMP2;SIRT2;MDM4;CST3;RGP1;AZIN1;SNCA;PTPN3;CDK5RAP3;AGAP2;CYP51A1;BANP
prerank,negative regulation of cell growth (GO:0030308),0.43047004156170143,1.287430257112485,0.09898477157360407,0.6595210878499728,1.0,19/121,7.32%,BMPR2;DCUN1D3;APBB2;SMARCA2;ACVRL1;SH3BP4;NPR1;PTPRJ;SOX17;DIP2B;PPP1R9B;VGLL4;ULK1;ADAM15;JADE1;FBP1;DCSTAMP;CDKN1B;TGFB1
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.5992072239276007,1.2873212899006132,0.20257826887661143,0.658796602636334,1.0,8/14,14.62%,KDR;VEGFC;FLT4;VEGFD;GAB1;MYO1C;NUS1;PGF
prerank,axon guidance (GO:0007411),0.40694949266563524,1.2871480395407267,0.08264462809917356,0.6582681974385284,1.0,39/201,10.81%,NRP2;SHANK3;SEMA6A;RPS6KA5;PLXNA4;NTN1;SEMA5B;EPHB4;SPTBN1;PTPRM;SEMA7A;PLCG1;EFNA1;NOTCH1;PLXND1;KLF7;BSG;FYN;LAMA3;ROBO4;EVL;LAMA1;SEMA6B;RET;OPHN1;WNT5A;RAC1;PTK2;GRB7;GAB1;SEMA6D;FEZ2;DSCAM;NFIB;SIAH1;SEMA4D;CXCR4;SPTAN1;EPHA4
prerank,regulation of cholesterol efflux (GO:0010874),0.5159106926429041,1.2868645600634774,0.1497584541062802,0.6580795964848335,1.0,5/30,5.76%,CAV1;PLTP;NFKBIA;EEPD1;ABCA3
prerank,positive regulation of protein import into nucleus (GO:0042307),-0.452681077027243,-1.2858460564033332,0.16231884057971013,0.5920287610668811,1.0,11/28,21.71%,ZIC1;PRKCD;CDH1;SMAD3;MAVS;PIK3R2;TRIM28;UBR5;HDAC3;JUP;BAG3
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.4321876772883896,1.2856777675554285,0.1267605633802817,0.6606509653408326,1.0,19/108,8.27%,ACER2;NOD1;TNFSF10;SOX7;DAPK1;HIP1;HIP1R;FAS;CASP4;PPM1F;CASP8;FOXL2;BOK;CYCS;LCK;GRAMD4;MALT1;CASP1;CRADD
prerank,chondroitin sulfate metabolic process (GO:0030204),-0.44553133013350193,-1.285554742656479,0.1402116402116402,0.5910674513702937,1.0,13/30,11.64%,DSE;DCN;BGN;CSPG4;NDNF;CHST15;CHSY3;VCAN;ARSB;CHSY1;CHST3;DSEL;HEXA
prerank,negative regulation of viral transcription (GO:0032897),0.6083436350466933,1.2852064192129178,0.20987654320987653,0.6609487884641188,1.0,5/13,19.38%,TRIM14;MID2;ZFP36;IFITM3;TRIM62
prerank,positive regulation of MAPK cascade (GO:0043410),0.39525286255188397,1.2851413728666887,0.05649717514124294,0.6600988907823185,1.0,39/245,7.52%,TEK;FLT1;KDR;TBX1;APP;PDE8A;ICAM1;INSR;SEMA7A;PDGFB;HTR2A;IQGAP1;DAB2IP;EDN1;PRKD2;JCAD;MFHAS1;PDGFD;PTK2B;FBXW7;NOTCH1;PTPRJ;TPD52L1;TAOK2;FLT4;PLCG2;CAV2;PIK3R6;TIRAP;ARHGAP8;RET;RAPGEF2;CD40;BCAR3;PDGFC;ARRB1;TGFB1;PIK3CG;RAP1A
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),-0.33825502163097554,-1.2848492247250698,0.05172413793103448,0.5913006553119151,1.0,29/142,13.07%,ATP1A2;CACNA1C;LPAR1;PLCE1;ADCY5;PDGFRA;EDNRA;DLG4;ADRA1B;CCR9;SLC8A1;SLC35G1;CD55;SMAD3;TRPC3;AGTR1;PRKACA;TRPC6;TRPC1;BDKRB2;PTGDR;RYR2;PTGFR;TRPC4;TBXA2R;S1PR3;ADRA1A;TRPC5;GPER1
prerank,ceramide catabolic process (GO:0046514),0.6062574248533532,1.2848177526399507,0.19337979094076654,0.6600021803993501,1.0,2/14,5.50%,ACER2;ASAH2
prerank,response to cAMP (GO:0051591),0.49845129687337697,1.284739628872643,0.17209302325581396,0.6591898594681822,1.0,9/37,8.35%,AHR;PDE2A;KCNQ1;RAP1B;RAPGEF2;INPP5K;RAP1A;PKD2;CITED1
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.455660215085345,1.2844384214208389,0.1440677966101695,0.6590415790898542,1.0,13/73,8.27%,ACER2;NOD1;TNFSF10;HIP1;HIP1R;FAS;CASP4;CASP8;BOK;CYCS;LCK;CASP1;CRADD
prerank,regulation of SMAD protein signal transduction (GO:0060390),-0.4851137805330672,-1.2844231208929262,0.1553398058252427,0.5906746959795363,1.0,9/21,12.16%,BMP6;BMPR1A;TGFBR1;BMP4;CCN3;DAB2;SLC2A10;TGFB3;NUP93
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.4872744524654004,1.2843221457400387,0.12941176470588237,0.6583298331533615,1.0,9/45,12.18%,VCAM1;ICAM1;B2M;IRF2;TRIM68;JAK1;TRIM25;FCGR1A;OASL
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.5559656230381667,1.284053300221064,0.1821247892074199,0.6580770825519173,1.0,6/22,14.18%,B2M;STX7;MALT1;IL23A;CYRIB;TRAF6
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),-0.5834322199276888,-1.2838367157092665,0.1934156378600823,0.5905873985259203,1.0,4/10,13.11%,ATP1A2;ADRA2A;BIN1;VDAC1
prerank,keratan sulfate metabolic process (GO:0042339),0.5130998593081152,1.2836416454941062,0.17412140575079874,0.658259597785268,1.0,8/31,10.18%,ST3GAL6;ST3GAL1;B3GNT3;B4GALT4;B3GNT4;B4GALT5;B4GAT1;SLC35D2
prerank,regulation of cell development (GO:0060284),0.5055899524797103,1.2834179119417142,0.14860681114551083,0.6578802676265191,1.0,6/36,5.38%,FOXO1;HDAC9;ADGRA2;DLL1;RPS19;CX3CR1
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.4199114404530615,1.2832417485035823,0.10401002506265664,0.6573632731164233,1.0,41/136,19.85%,ESR1;CD200;NLRC5;DAB2IP;FZD6;AIM2;SIK1;ADGRG3;NFKBIA;SIGIRR;TMSB4X;ID1;SMAD7;TCF7L2;EGLN1;ARRB1;CTNNBIP1;PKD2;TAF3;MAD2L2;GAS6;RB1;NFKBIE;PIM1;EIF2AK4;TRIB1;LRRC14;PEX14;IRAK3;DDIT3;OTULIN;CHP1;MAP2K5;ERBIN;IRAK2;USP7;KDM1A;NLRP3;HAVCR2;TAX1BP1;HES1
prerank,regulation of fat cell differentiation (GO:0045598),0.4495644635763208,1.2831472478978816,0.1329639889196676,0.6566531467180184,1.0,18/74,12.67%,FOXO1;PPARD;ZBTB16;GATA2;LRP5;WWTR1;XBP1;WNT5A;TRIB3;TGFB1;LPL;CREB1;ZFPM1;SFRP2;CCDC71L;ASXL1;TRIO;ZFP36
prerank,negative regulation of interleukin-10 production (GO:0032693),0.5770666884708476,1.28245396652389,0.20173913043478262,0.6577233089978326,1.0,4/16,15.09%,DLL1;JAK3;IL23A;VSIR
prerank,acylglycerol biosynthetic process (GO:0046463),-0.46132314445373973,-1.28242013974546,0.14797136038186157,0.5929664347140011,1.0,6/23,6.99%,AGMO;PLCE1;MOGAT3;LPGAT1;GK;LPIN1
prerank,positive regulation of defense response (GO:0031349),0.44098954354437864,1.2822451955808276,0.1168289290681502,0.6573175772035584,1.0,14/89,11.86%,APP;MEF2C;IL15;PDE2A;GBP5;NFKBIZ;NFKBIA;WNT5A;TNFRSF1A;LPL;IL23A;TNIP1;NMI;RIPK1
prerank,regulation of lamellipodium assembly (GO:0010591),0.5166413262460606,1.2820728077341852,0.1808,0.6568096213042187,1.0,11/34,15.75%,ABI3;OCLN;WASF2;NCKAP1;RAC1;TWF2;FSCN1;CYFIP1;ACTR2;ACTR3;ARPC2
prerank,regulation of apoptotic process (GO:0042981),0.37870157652433717,1.2818367960295503,0.01015228426395939,0.6564918695721975,1.0,130/676,12.97%,LEF1;TEK;TJP1;FOXO1;CD38;ACER2;TNFSF10;UNC13B;TGM2;NET1;KDR;IL6ST;DCUN1D3;ITGA6;MEF2C;PPP1R13B;MCF2L;DAPK1;ARHGEF3;RASGRF2;RNF144B;HIP1;HIP1R;DAB2IP;ARHGEF2;SOCS2;PIM3;ADAM10;FAS;ANP32A;PTK2B;NFKBIA;GLS2;ACTN4;STK3;CASP8;JMY;FLT4;PAK2;BABAM2;CAT;TNFRSF25;PLEKHG5;ACTN1;RPS6KA3;TMBIM6;KALRN;STK4;JAK3;IKBKB;RPS6KA1;PREX1;FOXL2;XBP1;GREM1;MAPK8;SERPINB9;PLK2;XIAP;BOK;WNT5A;TOX3;CTNNBL1;STK26;DNAJA1;BCL2L11;AVEN;SPDEF;HNRNPK;PTK2;RASA1;BCL3;BNIP2;STPG1;NFKB1;MALT1;NEUROD1;CASP1;CRADD;NF2;CITED1;RBM25;PSEN1;AKT2;TRIM24;ARHGEF7;MAP3K11;SLK;ARHGEF26;RHBDD1;SOX4;TNFRSF8;BCL2L1;HIGD2A;SIAH1;SFRP2;EGR3;SEMA4D;ANO6;TFAP4;GAS6;APH1A;BNIP3;CBL;IL7;ATF6;RNPS1;PIM1;THOC6;RIPK1;TMBIM4;TMIGD1;BID;NOP53;RHOB;RELA;TNFAIP8;RIPK2;TRIO;GNA13;PRDX2;ARHGEF9;PA2G4;GSTP1;RPL10;RACK1;BIRC3;PHIP;PTMA;SIGMAR1
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.5018047553337043,1.2818058236458671,0.1633587786259542,0.6555691909527447,1.0,5/39,9.89%,MYRIP;ACSL4;TCF7L2;SOX4;UCN
prerank,ribosomal large subunit assembly (GO:0000027),0.5417372792007968,1.2817391744149456,0.19262981574539365,0.6547638368751021,1.0,9/24,20.42%,RSL24D1;RRS1;NOP53;RPL6;RPL10;FASTKD2;RPL11;RPL3;TRAF7
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),0.6201723273978287,1.2817234964537876,0.24091778202676864,0.6537879360210065,1.0,5/12,16.23%,INSR;BNIP3;IGF1R;FYCO1;IRGM
prerank,negative regulation of vascular permeability (GO:0043116),0.6251529114955212,1.2814877590317477,0.21328671328671328,0.6534963995787424,1.0,5/12,5.62%,CLDN5;PDE2A;PTPRJ;CEACAM1;RAMP2
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.593768911926441,1.280586724278735,0.21140939597315436,0.6551473408590331,1.0,5/15,7.98%,TJP1;SMAD1;DLL1;JAK1;ITGA5
prerank,regulation of synapse assembly (GO:0051963),-0.4100945739513957,-1.2803166171384848,0.13354037267080746,0.5971720967780004,1.0,15/46,12.91%,GPC6;NLGN2;CLSTN2;CUX2;PTPRD;ROBO2;IL1RAPL1;LRFN5;NRXN1;NLGN1;NLGN3;GPC4;MDGA1;SRPX2;GRID2
prerank,positive regulation of organelle assembly (GO:1902117),0.48782830392551607,1.2800081351786587,0.17087667161961367,0.6559108268678072,1.0,11/44,11.13%,LCP1;CNOT6;CNOT6L;RALB;SDCBP;CCDC88A;SH3GLB1;G3BP1;CNOT1;FSCN1;CNOT2
prerank,cellular response to purine-containing compound (GO:0071415),-0.5703558723836156,-1.2797679149727736,0.17324561403508773,0.5968416340055215,1.0,4/10,18.29%,SLC8A1;RYR2;GSTM2;CASQ2
prerank,eye development (GO:0001654),-0.39283999967639033,-1.279652454007786,0.10238907849829351,0.5953016589636012,1.0,14/54,11.95%,CACNA1C;FBN1;SMOC1;COL5A1;EFEMP1;MEIS1;RBP4;SH3PXD2B;FBN2;HIPK2;PBX4;PBX3;TGFB2;STRA6
prerank,phosphate-containing compound metabolic process (GO:0006796),0.4025492699669448,1.279095245415621,0.08266360505166476,0.6577103243133448,1.0,30/198,9.23%,PTPRB;INPP5D;PLCB4;PLA2G4A;PLPP1;PLCG1;GPD2;STAT3;PPP3CA;PFKFB3;PLCB1;PLCG2;PAK2;LIMK2;PPP3CB;ITPKB;PLA2G2D;FBP1;INPP5K;TIGAR;TGFB1;PIK3CG;AGPAT1;CERKL;DUSP23;DUSP16;LPL;PLAAT3;SYNJ1;PANK2
prerank,regulation of cell population proliferation (GO:0042127),0.37793855823425576,1.278913396226096,0.009174311926605505,0.6572412063268774,1.0,108/691,10.70%,LEF1;TJP1;TBC1D8;NOS3;FLT1;ACER2;PTPN14;BMPR2;KDR;IL6ST;ENG;TBX1;LIFR;SMARCA2;APP;CBFA2T3;IL15;STX3;SOX7;ACVRL1;CLDN5;CD200;CDK6;INSR;KITLG;PLPP1;PDGFB;VEGFC;SH3BP4;ADARB1;IL6R;DAB2IP;EDN1;HHEX;ARHGEF2;LRP5;LYN;OSMR;ADAM10;STAT3;PDGFD;TNFRSF11A;PTK2B;NOTCH1;CNOT6;PTPRJ;BST1;AQP11;WWTR1;CNOT6L;ELN;FLT4;ADGRG1;FGF23;TES;DLL1;PPP1R9B;SDCBP;XBP1;VEGFD;GNAI2;BTG3;PTPRK;GREM1;DLL4;XIAP;TCF7L2;BOK;CCDC88A;DUSP22;CHP2;CNBP;RAPGEF2;KLF10;FOSL1;KRAS;CDKN1B;JUNB;PDGFC;PPM1D;TGFB1;PTK2;TGFA;PKD2;KDM4C;RNF139;NF2;CTBP1;SGK3;AKT2;IL7R;PINX1;RPL23;CDK2;SOX4;CSF1;SST;TNFRSF8;BTG2;TNFRSF9;DHPS;CYP27B1;SFRP2;CCL14;NUAK1;TFAP4;NMI;JAG2
prerank,actin filament capping (GO:0051693),0.5755733156981376,1.2785345731085422,0.21702838063439064,0.6563880426758998,1.0,2/18,1.54%,FLII;EPS8
prerank,barbed-end actin filament capping (GO:0051016),0.5755733156981376,1.2785345731085422,0.21702838063439064,0.6563880426758998,1.0,2/18,1.54%,FLII;EPS8
prerank,regulation of calcium ion transport (GO:0051924),-0.39054374256240265,-1.2785065686195192,0.07718120805369127,0.5967696219732636,1.0,11/54,8.88%,ANK2;BCL2;CACNA2D1;CACNA1D;P2RX4;IL16;CACNB2;STIM1;TRPC6;ADRA2A;EFHB
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.5425699693901879,1.27847033859385,0.180623973727422,0.6555683620995963,1.0,9/26,20.56%,OCLN;RAC1;TRPV4;MET;PAK1;CDK5RAP2;CLIP1;NUMA1;RPS3
prerank,dendritic spine morphogenesis (GO:0060997),0.5787420579741362,1.2784043841466843,0.21043478260869566,0.6547785624853176,1.0,1/15,0.09%,SHANK3
prerank,cellular response to light stimulus (GO:0071482),0.4633185810002645,1.2782916749209057,0.14008321775312066,0.6541406817001887,1.0,20/66,19.01%,POLK;GNB1;CNGB1;PTPRK;N4BP1;OPN4;GNAT1;NEDD4;RHBDD1;OPN5;EIF2AK4;ERCC4;PDE6B;FMR1;NPM1;YY1;BMF;KDM1A;BAK1;DHX36
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.5402771384624243,-1.278185923959644,0.1824175824175824,0.5958512203253332,1.0,8/13,8.39%,BMPR1A;FGFR2;TGFBR3;ERBB4;FGF2;ZFPM2;RBPJ;GLI1
prerank,positive regulation of protein import (GO:1904591),-0.4390834979636735,-1.27771458880946,0.1511627906976744,0.5953134060233702,1.0,11/30,21.71%,ZIC1;PRKCD;CDH1;SMAD3;MAVS;PIK3R2;TRIM28;UBR5;HDAC3;JUP;BAG3
prerank,positive regulation of exocytosis (GO:0045921),0.5185962382772048,1.2776500695185262,0.1719242902208202,0.6550536804165837,1.0,4/35,4.84%,RAB27A;CADPS2;EXPH5;SDCBP
prerank,cellular response to exogenous dsRNA (GO:0071360),0.6155283286588583,1.2776457377051806,0.19144981412639406,0.6540615336322505,1.0,4/12,13.33%,CAV1;RALB;CGAS;IFIH1
prerank,cellular response to hydroxyurea (GO:0072711),0.6426064948201531,1.2769332215382314,0.19360902255639098,0.6551895040488454,1.0,8/10,28.06%,FMR1;DDI1;ATRX;DDI2;SPIDR;RTF2;TIMELESS;DDX11
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),-0.4611065220666274,-1.2769317861114382,0.13903743315508021,0.5957970849280021,1.0,3/27,6.12%,LPAR1;GRM1;AGTR1
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.4697924030001603,1.2768353114924953,0.13333333333333333,0.6545181271994102,1.0,16/54,16.76%,DCUN1D3;CAV1;SMAD7;N4BP1;DNAJA1;ARRB1;PINX1;SOX4;SPOPL;VPS28;NXN;UBXN1;PRKCG;CHP1;CTNNB1;RPL11
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),-0.35115101525586134,-1.2764085164274752,0.05392156862745098,0.5955436055868282,1.0,18/107,9.51%,SLC24A3;ANK2;ATP13A5;ATP13A3;SLC8A3;SLC41A1;SLC30A10;ATP1B1;SLC8A1;DMPK;SLC39A14;SLC39A13;STIM1;ATP2A2;SLC39A10;RYR2;CXCL12;SLC24A2
prerank,negative regulation of T cell differentiation (GO:0045581),-0.5738133240472187,-1.2760257785397624,0.2009132420091324,0.5949423143293034,1.0,2/10,2.95%,GLI3;BMP4
prerank,receptor-mediated endocytosis (GO:0006898),0.41954813809228847,1.2758655157897936,0.1111111111111111,0.6564795496481556,1.0,15/132,5.62%,DNM3;CALCRL;FNBP1L;CAV1;INSR;HIP1R;SCARB1;STAB1;ARHGAP27;CAV2;FCHO2;DLL1;AP2B1;SCARF1;RAMP2
prerank,positive regulation of interleukin-8 production (GO:0032757),0.4768822606630049,1.2750879089602523,0.1565217391304348,0.6578169635141502,1.0,5/49,4.28%,NOD1;PRKD2;STAT3;AFAP1L2;TIRAP
prerank,negative regulation of binding (GO:0051100),0.4490767370965021,1.2749012916084939,0.12855209742895804,0.6573752872013876,1.0,18/81,15.04%,LEF1;CAV1;PDGFB;NFKBIA;TMBIM6;RALB;DISC1;MAPK8;AURKA;CTNNBIP1;ZFPM1;ARHGAP28;TFAP4;CARD16;RACK1;PEX14;ILRUN;STYX
prerank,positive regulation of mRNA metabolic process (GO:1903313),0.6029953796716381,1.2744335112088705,0.21901528013582344,0.6578973569937109,1.0,5/13,16.24%,PRR5L;CNOT1;RC3H1;CNOT7;PNPT1
prerank,sodium-independent organic anion transport (GO:0043252),0.6474783380175744,1.2741196282253584,0.21206581352833637,0.6578723563931701,1.0,3/10,4.03%,SLCO2B1;SLCO2A1;SLC16A2
prerank,B cell proliferation (GO:0042100),0.5686222748789553,1.2739312641643852,0.18439716312056736,0.6573993417357024,1.0,3/17,6.59%,MEF2C;CTPS1;CD40
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),-0.3167760364913013,-1.273883257588893,0.0297029702970297,0.5989913538911092,1.0,41/248,8.61%,RNF220;BICC1;RBMS3;ZEB2;EGFR;WLS;LGR4;GLI3;FGFR2;COL1A1;IGFBP2;PRKN;GPC3;PTK7;CTNND2;DKK3;SEMA5A;IGFBP6;DAAM2;DACT1;CAPRIN2;LYPD6;INVS;LRRK1;LZTS2;PLEKHA4;SFRP4;PSME4;TMEM64;LRP6;SIAH2;AXIN2;NOTUM;AMFR;DAB2;LRRK2;GPC5;BTRC;GLI1;TLE2;SFRP1
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),-0.33196664498085493,-1.2736315534181382,0.0425531914893617,0.5978624167588661,1.0,21/140,9.25%,CACNA1C;LPAR1;PLCE1;ADCY5;PDGFRA;CACNA2D1;EDNRA;DLG4;ADRA1B;CCR9;JPH1;SLC8A1;P2RX4;CD55;TRPC3;GRM1;AGTR1;BDKRB2;PTGDR;RYR2;PTGFR
prerank,defense response to symbiont (GO:0140546),0.4406756356416114,1.2734576475868558,0.11757105943152454,0.6578099329722621,1.0,29/92,19.42%,SERINC3;NLRC5;IRF2;SERINC5;SAMHD1;DDIT4;ISG20;IFNAR2;RNASE1;CD40;MLKL;G3BP1;CGAS;BCL2L1;BNIP3;NT5C3A;ZMYND11;OASL;RELA;CNOT7;IFIH1;IFITM3;STAT1;PLSCR1;BST2;ATG7;IFITM1;EIF2AK2;BNIP3L
prerank,protein-containing complex subunit organization (GO:0043933),0.4297164432265849,1.2733838784803464,0.12628865979381443,0.6570274483455093,1.0,25/109,14.29%,SLC2A1;OCLN;CD2AP;MAGI1;PARD3;FAS;PTK2B;TRAF1;CARD10;TEAD2;CD40;LLGL1;SKAP2;NIFK;IKBKG;TFAP4;PICALM;NUP98;NUP133;NUP205;CAPZA1;PEX14;IL1RAP;NUP54;APC
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.5104172420972168,-1.2727079313655059,0.16363636363636364,0.5986910675584012,1.0,3/17,4.64%,MAGI2;PDGFRB;ITGA1
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.5615547602548137,1.272562762459018,0.1724709784411277,0.6584256641349953,1.0,3/21,3.70%,PPP1R16B;MFHAS1;FKBP1A
prerank,positive regulation of interleukin-6 production (GO:0032755),0.45460522030264044,1.2725240931496458,0.14589235127478753,0.6575580374828658,1.0,9/68,8.23%,APP;IL6R;ARHGEF2;STAT3;PLCG2;TIRAP;XBP1;WNT5A;LPL
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.49044960550526107,1.2722209330828553,0.18222222222222223,0.6575211961399126,1.0,10/43,6.27%,ZHX3;BMPR2;IL6ST;MEF2C;PRKD1;IL6R;LRP5;WWTR1;ACVR2A;ACVR1
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.5097619583535618,1.271779179153595,0.19384615384615383,0.6578720510785125,1.0,7/33,7.47%,HIP1;HIP1R;FBXW7;AFAP1L2;CCDC88A;BCAR3;TGFA
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.5198532046732931,1.271256212785174,0.20991735537190082,0.6583597418856529,1.0,7/29,9.03%,ENG;S1PR1;NOTCH1;FKBP1A;SMAD7;TGFB1;ZFPM1
prerank,neuron remodeling (GO:0016322),0.6340344483884182,1.2712487075681838,0.22532588454376165,0.6573956849404884,1.0,3/10,5.29%,APP;ANKS1A;SCARF1
prerank,regulation of interleukin-6 production (GO:0032675),0.42807463923898464,1.2711667823305999,0.13350785340314136,0.6566766309259074,1.0,12/96,8.23%,APP;CD200;IL6R;ARHGEF2;STAT3;AFAP1L2;PLCG2;TIRAP;XBP1;WNT5A;ARRB1;LPL
prerank,negative regulation of MAPK cascade (GO:0043409),0.43731156893260714,1.2711322731779904,0.1318242343541944,0.655814643369774,1.0,7/87,2.90%,SEMA6A;FOXO1;CAV1;CNKSR3;DAB2IP;LYN;PTPRJ
prerank,positive regulation of signal transduction (GO:0009967),0.40086359200340815,1.271072991869299,0.059684684684684686,0.6550081666124723,1.0,40/238,9.07%,VWF;SHANK3;TEK;NOS3;IL6ST;ERN1;MAML2;EPN2;LIMS2;DAB2IP;HHEX;PRKD2;JCAD;FAS;STAT3;PTK2B;NOTCH1;HIF1A;TSPAN5;TPD52L1;CAV2;SORBS1;DLL1;KLF2;F7;DISC1;XBP1;SPIN1;DLL4;TSPAN14;UCHL5;SASH1;AGPAT1;ITGA5;PKD2;CRADD;DEPDC1B;IL7R;ZRANB1;IHH
prerank,primary alcohol metabolic process (GO:0034308),-0.4596751976788968,-1.2709498993617865,0.1549636803874092,0.6019965803084356,1.0,5/25,4.89%,IGF1;RBP4;DHRS3;CYP1B1;NAAA
prerank,cellular response to interferon-beta (GO:0035458),0.5997499729152721,1.270862101341809,0.20404411764705882,0.6546722054513807,1.0,6/14,17.69%,AIM2;UBE2K;IRGM;PNPT1;CDC34;STAT1
prerank,regulation of presynapse assembly (GO:1905606),-0.48520231223243676,-1.2706480090219994,0.1807511737089202,0.599290263074818,1.0,6/18,11.15%,GPC6;PTPRD;IL1RAPL1;LRFN5;GPC4;MDGA1
prerank,regulation of presynapse organization (GO:0099174),-0.48520231223243676,-1.2706480090219994,0.1807511737089202,0.599290263074818,1.0,6/18,11.15%,GPC6;PTPRD;IL1RAPL1;LRFN5;GPC4;MDGA1
prerank,vitamin D metabolic process (GO:0042359),0.6037437336447375,1.270594323940409,0.19524617996604415,0.6544692375806436,1.0,4/13,11.79%,FGF23;CYP27B1;CYP2R1;LGMN
prerank,sodium ion homeostasis (GO:0055078),-0.4740032802401314,-1.2705268061597654,0.15949367088607594,0.5978405911074489,1.0,4/21,3.39%,ATP1A2;SLC12A2;ATP1B1;SLC8A1
prerank,regulation of amyloid-beta clearance (GO:1900221),-0.5090342502427538,-1.2702325815615074,0.18032786885245902,0.5969381801284687,1.0,7/16,27.26%,LRP1;APOE;ABCA7;MYOCD;CYP51A1;HMGCR;TREM2
prerank,signal transduction by p53 class mediator (GO:0072331),0.5180167591340935,1.2698558184700415,0.17384370015948963,0.6556671144065318,1.0,8/30,9.31%,ACER2;PPP1R13B;JMY;GREM1;BOK;BCL3;MYBBP1A;HINT1
prerank,error-prone translesion synthesis (GO:0042276),0.5613523273831226,1.2698149491183681,0.18072289156626506,0.6548485737520046,1.0,4/21,10.14%,POLK;RPA1;PRIMPOL;MAD2L2
prerank,negative regulation of neuron projection development (GO:0010977),-0.3920224894477836,-1.2695819234168766,0.11347517730496454,0.59715841774392,1.0,17/56,16.84%,LPAR1;DPYSL3;PTPN9;PTPRS;EFNB2;ADCY6;NLGN1;SEMA3A;DCC;RAB29;APOE;NGEF;RTN4;CBFA2T2;STX1B;MT3;TSKU
prerank,protein O-linked glycosylation (GO:0006493),0.4292377400564819,1.2691507059546514,0.13175230566534915,0.6558089085803611,1.0,20/96,12.65%,ST6GAL1;TMTC2;ST3GAL1;GALNT18;GALNT14;GALNT15;EOGT;B3GNT3;TET3;B3GNT4;ST6GALNAC2;B4GALT5;B4GAT1;B3GNT6;RXYLT1;ST6GALNAC4;C1GALT1;MUC1;TET2;OGA
prerank,prostaglandin metabolic process (GO:0006693),0.5289157417497039,1.2689980271554915,0.192,0.655298241768548,1.0,4/26,5.09%,PTGS2;PLA2G4A;EDN1;PTGS1
prerank,endochondral bone morphogenesis (GO:0060350),0.630529056304024,1.268622823787544,0.21731123388581952,0.6554550286842653,1.0,2/11,1.15%,BMPR2;MEF2C
prerank,ion transport (GO:0006811),-0.34498283992144846,-1.2684153018089332,0.07179487179487179,0.598951504809915,1.0,22/111,11.27%,SLC24A3;TRPM3;SLC1A3;PIEZO2;SLC8A3;SLC26A7;SLC12A2;SLC9A9;SLC26A2;SLC8A1;WNK4;GLRB;ANO1;TRPC6;SLC1A2;SLC5A5;SLC20A1;SLC24A2;WNK1;SLC4A2;GABRB1;SLC9A1
prerank,actin polymerization or depolymerization (GO:0008154),-0.39109558789654336,-1.2683750240435938,0.1027190332326284,0.5972945173328201,1.0,9/50,6.67%,ARHGAP6;GAS7;MICAL3;GSN;MICAL2;SPIRE1;COBL;ABI2;VILL
prerank,cellular response to glucose stimulus (GO:0071333),0.5127883218562871,1.2683328180681714,0.1952,0.6553004162391064,1.0,10/30,13.47%,UNC13B;ERN1;KCNB1;XBP1;RAB11FIP5;SOX4;GAS6;RAB11B;RACK1;IGF1R
prerank,negative regulation of heart contraction (GO:0045822),-0.5597848336305047,-1.2678320868496165,0.1788793103448276,0.59709446139859,1.0,1/11,0.03%,ATP1A2
prerank,glucan catabolic process (GO:0009251),-0.5241885017583825,-1.2678209517421068,0.175,0.5953752436471603,1.0,7/15,20.80%,PYGB;PHKB;PYGM;GAA;AGL;PHKA2;PHKG1
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.5264220182513675,1.2674148107064445,0.19834710743801653,0.6570414480332987,1.0,5/25,11.99%,TNFSF10;BIK;BCL2L11;BNIP3;BID
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.5297358428736627,1.26723015809111,0.1856,0.6566102393951246,1.0,9/27,14.48%,ERN1;RNASE1;RNASE4;KHNYN;NUDT16;DICER1;RPP30;ZC3H12C;TRIR
prerank,neuron projection fasciculation (GO:0106030),-0.5733547281591614,-1.2670806863601078,0.2033898305084746,0.5957537363408074,1.0,7/10,23.18%,SEMA5A;NRCAM;CNTN4;RTN4;ARHGAP35;EPHB3;EPHB2
prerank,nucleotide catabolic process (GO:0009166),0.5754608619874659,1.266966435290801,0.2188612099644128,0.6563948486338697,1.0,5/16,14.45%,GDA;SAMHD1;NT5C2;XDH;NUDT15
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),0.5744389398340908,1.2662686959613503,0.22036727879799667,0.6574946518482467,1.0,5/16,11.69%,GCH1;SCARB1;HIF1A;NOS1AP;NUS1
prerank,neurotransmitter biosynthetic process (GO:0042136),-0.5292054195036929,-1.2662015581951025,0.18663594470046083,0.5965092275154742,1.0,5/14,27.01%,MOXD1;DAGLA;SLC22A2;DAGLB;SLC5A7
prerank,positive regulation of lamellipodium organization (GO:1902745),0.5141051729080731,1.2661667810782071,0.18885448916408668,0.6568965714077684,1.0,14/32,15.75%,OCLN;WASF2;RREB1;NCKAP1;ENPP2;RAC1;ARHGEF7;TWF2;FSCN1;CYFIP1;CORO1C;ACTR2;ACTR3;ARPC2
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.4973773351710447,1.265855155315272,0.19148936170212766,0.6568388709658771,1.0,4/37,1.89%,PRKG1;MEF2C;ERN1;PDGFB
prerank,regulation of aerobic respiration (GO:1903715),0.5904494107411343,1.2649560904226946,0.2127659574468085,0.658576246936547,1.0,4/15,12.25%,CBFA2T3;AK4;ABCD1;NOP53
prerank,negative regulation of establishment of protein localization (GO:1904950),0.6340640109920785,1.264885452452273,0.24813432835820895,0.6578468284584978,1.0,5/10,16.57%,PPM1F;DNAJA1;SNX3;TERF1;NDFIP2
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.5964361216826587,1.2648470831135863,0.21062271062271062,0.6569903786245361,1.0,9/14,22.93%,TIRAP;HNRNPA0;YBX3;ANGEL2;HNRNPC;ZFP36;DAZL;ELAVL1;MAPK14
prerank,mitochondrial fission (GO:0000266),0.5683370700675293,1.2646526970948773,0.2283609576427256,0.6566415934490788,1.0,1/16,0.27%,DNM3
prerank,regulation of coagulation (GO:0050818),0.6207467140210707,1.2645444295604327,0.23156089193825044,0.6560423383741257,1.0,3/11,14.28%,CAV1;PROCR;PROC
prerank,muscle contraction (GO:0006936),-0.33374822795933323,-1.26436775049571,0.07373271889400922,0.5999149704431284,1.0,29/126,15.26%,CALD1;DMD;ROCK2;SNTA1;ITGB5;EDNRA;ACTN2;SLC8A1;ASPH;GNAO1;SNTB1;TPM1;DTNA;ITGA1;TMOD2;BDKRB2;MYL9;SSPN;TPM2;MYOM1;ACTA2;DES;ADRA1A;TLN1;LMOD1;TPM4;ARHGEF11;FXYD1;GJC1
prerank,response to progesterone (GO:0032570),0.564462300734147,1.264196519007499,0.20973154362416108,0.6561361254654166,1.0,5/18,11.53%,CAV1;ABHD2;TGFB1;CATSPERD;UBE3A
prerank,positive regulation of interleukin-10 production (GO:0032733),0.5196063580341914,1.2641476602366253,0.19538461538461538,0.6553474779321286,1.0,5/30,9.60%,STAT3;CD34;PLCG2;TIGIT;IL23A
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.41836759785773237,1.2641470920129738,0.13447432762836187,0.6544072376481515,1.0,21/124,10.43%,LEF1;SMURF1;NFATC1;CELSR1;FZD6;FZD4;PPP3CA;GNB1;PLCB1;AP2B1;TCF7L2;TNRC6C;PPP3CB;WNT5A;WNT9B;RAC1;AP2A1;PSMA2;PSMA8;SFRP2;PSMA6
prerank,natural killer cell activation (GO:0030101),0.5288725192644266,1.264088515932594,0.19376026272577998,0.6536504388790566,1.0,3/23,4.17%,PBX1;CASP8;TOX
prerank,smooth muscle contraction (GO:0006939),-0.5423204987460198,-1.2639290929126565,0.18161434977578475,0.5994413177585579,1.0,7/14,16.81%,ROCK2;EDNRA;SLC8A1;BDKRB2;ACTA2;ADRA1A;MYH11
prerank,positive regulation of response to stimulus (GO:0048584),0.48526386358855633,1.2634623191210632,0.167420814479638,0.6545908964764471,1.0,13/40,20.12%,ABI3;IL15;B2M;WNT5A;CGAS;IFIH1;NSMCE4A;FMR1;NSMCE1;YPEL3;IER5;HOMER1;TAF9
prerank,sensory perception (GO:0007600),-0.39543919597278027,-1.2634194338992684,0.1355421686746988,0.5992411630756841,1.0,22/45,32.19%,ADGRV1;P2RX4;GNAS;PCDH15;WHRN;PTGES;ADORA2A;RETREG1;TTC8;CHRNA7;TRPA1;TMEM150C;CCR2;CCL2;KCNA2;SCN9A;GNAL;CHRNB2;ALOXE3;P2RX7;TRPV2;CLRN1
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.570897258200894,1.2628289781075224,0.2030716723549488,0.655510643952585,1.0,3/18,1.87%,FLT1;MEF2C;PLCG1
prerank,synaptic vesicle transport (GO:0048489),0.6154727367194737,1.2627059331551171,0.21611721611721613,0.6549519814303253,1.0,1/11,0.41%,RAB27A
prerank,carbohydrate derivative catabolic process (GO:1901136),0.5525003437639819,1.262642811815453,0.2099827882960413,0.6542062071465037,1.0,2/18,2.58%,STT3B;SAMHD1
prerank,regulation of glucose metabolic process (GO:0010906),-0.42794681447224814,-1.2626301697098572,0.12602739726027398,0.5996974741100723,1.0,6/34,4.97%,PRKN;IRS1;PDK1;OGT;RORA;SELENOS
prerank,positive regulation of lipid transport (GO:0032370),-0.5519749051157592,-1.262287893409832,0.1860986547085202,0.5989802098080091,1.0,3/12,9.84%,LRP1;SPP1;APOE
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.5583436826390286,1.2617710240649327,0.18870967741935485,0.6557850902949917,1.0,6/20,13.78%,ENTPD1;APP;CASP1;ANO6;HSP90AB1;TXNIP
prerank,pancreas development (GO:0031016),0.6074947181514043,1.26163847130243,0.20840950639853748,0.6551761499029194,1.0,3/12,5.65%,ZIC3;FOXF1;TCF7L2
prerank,vasculature development (GO:0001944),0.5758024169375461,1.2610360248406527,0.21551724137931033,0.6559364343533776,1.0,6/16,4.47%,BMPR2;ACVRL1;FBXW7;SOX18;FLT4;FOXF1
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.5092694909436198,1.261017081002893,0.18729641693811075,0.6550639340270881,1.0,17/36,20.12%,AQP11;SDCBP;N4BP1;EIF3H;UCHL5;OPHN1;NOP53;HSP90AB1;UBXN1;GIPC1;RYBP;PRKCG;RPL11;USP7;PSMF1;USP25;TAF9
prerank,glycogen catabolic process (GO:0005980),-0.5153500510716703,-1.2606667800325388,0.2088888888888889,0.6018089827210232,1.0,7/15,20.80%,PYGB;PHKB;PYGM;GAA;AGL;PHKA2;PHKG1
prerank,melanosome localization (GO:0032400),0.5532815429819742,1.260641519597948,0.21775544388609716,0.655242275241775,1.0,3/21,3.64%,RAB27A;RAB11A;SHROOM2
prerank,regulation of Wnt signaling pathway (GO:0030111),-0.3400532886406532,-1.2605269106186006,0.06511627906976744,0.6004218832806834,1.0,30/108,10.26%,TRABD2B;SULF1;WLS;LRP1;FGFR2;PRKN;GPC3;PTK7;CTNND2;RNF43;SULF2;DCDC2;GRB10;WWOX;DAAM2;RSPO3;RSPO2;DACT1;SALL1;SFRP4;CXXC4;NOTUM;LRRK2;FOXL1;BTRC;SFRP1;RUNX1;TSC2;SMARCA4;APCDD1
prerank,actin filament organization (GO:0007015),0.4102634257353573,1.2603224792782461,0.0996309963099631,0.6552092491913963,1.0,24/151,8.54%,FLII;SHROOM4;LCP1;EPS8;MYO1D;CD2AP;NEDD9;ELMO1;HIP1;HIP1R;ARHGEF2;SHROOM2;SHROOM1;TMOD3;EVL;ACTN1;PLS3;PPP1R9B;ARHGAP17;RAC1;TPM3;TRPV4;RHOBTB1;MYO1E
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.5158835153241716,1.2603124074574052,0.196875,0.6543192234406194,1.0,5/30,7.32%,FLT1;KDR;MLLT3;FLT4;TGFB1
prerank,regulation of transforming growth factor beta production (GO:0071634),0.5664227656191693,1.2601292215221171,0.20767888307155322,0.6539277631195948,1.0,4/18,3.79%,PTGS2;CD200;HIF1A;CD34
prerank,regulation of cytoplasmic transport (GO:1903649),-0.5707805940935398,-1.2599183759028194,0.18872017353579176,0.6005016652577997,1.0,5/11,16.44%,ATP9A;LRRK2;SRC;MAP2K2;MAP2K1
prerank,sulfate transport (GO:0008272),-0.5301501211155273,-1.2590375952491402,0.19036144578313252,0.6013433145242385,1.0,3/14,3.03%,SLC13A4;SLC26A7;SLC26A2
prerank,chondrocyte differentiation (GO:0002062),-0.42899989368212077,-1.2588507159336582,0.15426997245179064,0.6001934701208529,1.0,11/32,10.12%,SOX5;SULF1;OSR1;SULF2;BMP4;SOX6;RUNX2;SLC39A14;CCN3;RUNX1;EIF2AK3
prerank,carboxylic acid transport (GO:0046942),-0.38551392367944415,-1.2586563972837834,0.10810810810810811,0.599057812438396,1.0,13/55,11.58%,SLC6A13;SLC16A12;SLC13A3;SLC1A5;SLC6A12;SLC16A6;SLC6A9;SLC16A11;PSAP;SLC6A15;SLC66A1;SLC7A6;SLC6A7
prerank,pyrimidine-containing compound catabolic process (GO:0072529),-0.508891223871542,-1.2581905351558615,0.19866071428571427,0.5986101217791469,1.0,6/16,17.41%,DPYSL3;DPYD;UPB1;NT5E;NT5C1A;DPYSL2
prerank,regulation of sequestering of calcium ion (GO:0051282),-0.5417398715639943,-1.257594088744863,0.1934065934065934,0.5986325370185397,1.0,4/12,9.11%,ANK2;ANXA6;UBASH3B;RYR2
prerank,positive regulation of binding (GO:0051099),0.4319701005384481,1.2574607761740537,0.13956639566395665,0.6604813248185417,1.0,18/84,8.58%,CAV1;APP;EPB41;CLDN5;B2M;HIP1R;STK3;FKBP1A;HMBOX1;STK4;MARK3;RALB;DTX3L;TCF7L2;RAPGEF2;TRIB3;CDT1;PSEN1
prerank,regulation of keratinocyte migration (GO:0051547),-0.5366217202840475,-1.2571549264475381,0.21136363636363636,0.5981961794706347,1.0,11/12,46.22%,IQSEC1;ADAM9;FGF7;FGF10;PTEN;MTOR;EPB41L4B;MAP4K4;ARF6;EPPK1;MMP9
prerank,positive regulation of filopodium assembly (GO:0051491),-0.45951441950315036,-1.2571322693173874,0.18041237113402062,0.5965756318474223,1.0,12/24,15.21%,DPYSL3;DOCK11;NRP1;RHOQ;ARAP1;TENM2;NLGN1;RIPOR2;TGFB3;PALM;PLPPR5;RALA
prerank,regulation of cellular respiration (GO:0043457),0.567681245069883,1.2570754636763033,0.21546052631578946,0.6607394016393313,1.0,4/17,16.24%,CBFA2T3;IFNAR1;NOP53;PNPT1
prerank,aortic valve morphogenesis (GO:0003180),0.5090436890895469,1.2569873671946106,0.19344262295081968,0.6600574721568091,1.0,8/30,7.32%,NOS3;TIE1;NFATC1;EFNA1;NOTCH1;ELN;DLL4;TGFB1
prerank,response to nitric oxide (GO:0071731),0.6050798892959075,1.2568434984012091,0.22702702702702704,0.6595320627634783,1.0,3/13,9.30%,FOXO1;EGLN1;CDK2
prerank,production of siRNA involved in RNA interference (GO:0030422),0.6298681864769987,1.256676473865032,0.21863117870722434,0.6590875255133023,1.0,5/10,21.33%,DROSHA;DICER1;HENMT1;MRPL44;PRKRA
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.4050446108354806,1.2561200572432236,0.1181592039800995,0.6597440334197634,1.0,23/151,7.52%,TEK;KDR;APP;PDE8A;ICAM1;SEMA7A;PDGFB;HTR2A;PRKD2;MFHAS1;PDGFD;TNFRSF11A;PTK2B;FBXW7;NOTCH1;FLT4;TIRAP;ARHGAP8;RAPGEF2;PDGFC;ARRB1;TGFB1;RAP1A
prerank,response to chemokine (GO:1990868),0.6038974775444155,1.2560282430605165,0.2136602451838879,0.6591068870166473,1.0,1/13,0.16%,LRCH1
prerank,regulation of glucose transmembrane transport (GO:0010827),0.5624341374808859,1.2557136963828508,0.2226027397260274,0.6591026167331481,1.0,4/18,6.76%,SLC2A1;OCLN;INPP5K;TRIB3
prerank,regulation of triglyceride biosynthetic process (GO:0010866),0.5691689922951013,1.2553393302377394,0.22758620689655173,0.6591992525918443,1.0,4/15,4.20%,SCARB1;FBXW7;SIK1;PLIN5
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.5047975312886271,-1.2553342964604512,0.18501170960187355,0.599976114219425,1.0,6/16,15.06%,APPL2;PPARA;ADCY7;APOD;CHID1;SIRPA
prerank,neural crest cell differentiation (GO:0014033),0.5648755459104242,1.254629745806846,0.19550173010380623,0.6603513481055729,1.0,3/18,6.56%,MEF2C;CDH2;CYP26C1
prerank,cAMP biosynthetic process (GO:0006171),-0.5671997727298549,-1.254128254103508,0.21535181236673773,0.6016672832309001,1.0,5/10,5.09%,ADCY5;ADCY1;ADCY2;ADCY7;ADCY6
prerank,acylglycerol metabolic process (GO:0006639),0.49475721270910294,1.253537914536883,0.17535545023696683,0.6625078498788874,1.0,10/37,14.99%,CAV1;DGKZ;ABHD2;DGKH;LPL;PLAAT3;GK5;DGKE;PNPLA2;DGAT1
prerank,positive regulation of apoptotic process (GO:0043065),0.38330951606728836,1.2534847423700959,0.07793633369923161,0.6617547950515005,1.0,58/293,12.70%,FOXO1;TNFSF10;UNC13B;TGM2;NET1;DCUN1D3;ITGA6;MCF2L;DAPK1;ARHGEF3;RASGRF2;HIP1R;DAB2IP;ARHGEF2;FAS;SIK1;TPD52L1;STK3;CASP8;JMY;PLEKHG5;KALRN;STK4;PREX1;FOXL2;MAPK8;BOK;CTNNBL1;DNAJA1;BCL2L11;SPDEF;STPG1;NEUROD1;CRADD;PSEN1;ARHGEF7;MAP3K11;MYBBP1A;ARHGEF26;SOX4;TNFRSF8;SIAH1;SFRP2;ANO6;TFAP4;APH1A;BNIP3;BTG1;ATF6;RNPS1;RIPK1;BID;RHOB;TNFAIP8;TRIO;GNA13;ARHGEF9;RACK1
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),-0.49117897165331,-1.2533238991474343,0.18269230769230768,0.6022504380990491,1.0,6/17,7.08%,NOTCH2;BMPR1A;BMP4;JAG1;HEYL;RBPJ
prerank,outflow tract septum morphogenesis (GO:0003148),0.5371183907918958,1.2532670916009858,0.1911532385466035,0.661421163231789,1.0,4/24,0.88%,NRP2;BMPR2;ENG;TBX1
prerank,cellular response to dsRNA (GO:0071359),0.5763423073185624,1.2532190419061988,0.22661870503597123,0.6606542639660319,1.0,5/15,14.04%,CAV1;RALB;CGAS;IFIH1;NPM1
prerank,sphingolipid catabolic process (GO:0030149),0.570699578777564,1.25291220441815,0.22203098106712565,0.6606014962975437,1.0,3/15,5.50%,ACER2;ENPP2;ASAH2
prerank,heterocycle biosynthetic process (GO:0018130),0.5935546622520051,1.252559539835478,0.2277580071174377,0.6606922395591018,1.0,3/14,9.92%,GCH1;GPHN;MOCOS
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),-0.39840451790030074,-1.251068964192604,0.12923076923076923,0.6068234496238338,1.0,10/46,7.08%,PLCL1;ALDH1A1;DOCK7;LGR4;NPR3;ADAMTS5;FOXC2;ACOT11;NOVA1;RBPJ
prerank,positive regulation of transforming growth factor beta production (GO:0071636),0.6207552241355101,1.2510317594493294,0.2413793103448276,0.6641016361427511,1.0,3/11,3.79%,PTGS2;CD200;CD34
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.42436371759740116,1.2504243962286175,0.15535248041775457,0.6648574118237265,1.0,21/100,9.18%,TEK;FLT1;KDR;PPP1R16B;INSR;PDGFB;PIP5K1B;DAB2IP;LYN;PDGFD;SELP;PIK3IP1;IER3;CEACAM1;PDGFC;PIK3CG;PTK2;NEDD4;GAB1;PPP2R5B;FBXL2
prerank,positive regulation of protein ubiquitination (GO:0031398),0.44280985277171125,1.250392660467512,0.15405777166437415,0.6640434669902208,1.0,25/80,21.01%,DCUN1D3;CAV1;FBXW7;FKBP1A;SMAD7;XIAP;MYCBP2;TRIB3;MALT1;UBE3A;RIPK2;PRICKLE1;BIRC3;TRAF6;TOPORS;NDFIP2;BIRC2;CUL3;KDM1A;PTTG1IP;BCL10;PDCD6;UBE2L3;PLK1;PEF1
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.47311458997155736,1.2503564043458981,0.1804733727810651,0.6632504747688007,1.0,9/49,7.30%,IL6ST;IL15;IL6R;LYN;STAT3;GHR;CD40;STAP2;TNFRSF1A
prerank,positive regulation of cation transmembrane transport (GO:1904064),-0.4127406313413384,-1.2489249210060378,0.16853932584269662,0.6111382728687851,1.0,15/41,19.05%,ANK2;ACTN2;KCNMA1;ANK3;AKAP6;KCNMB2;KCNJ2;GABBR1;KCNJ10;KCNN2;GNG2;KCNJ15;KCNJ6;KCNN3;ACE2
prerank,regulation of nervous system process (GO:0031644),0.5591652000196242,1.2489125746659469,0.22030981067125646,0.6664493072750588,1.0,2/18,1.06%,NOS3;APP
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.539796124066213,1.2483931533442927,0.20170940170940171,0.6671000796745394,1.0,7/23,8.58%,APP;INSR;PDGFB;HIF1A;PFKFB3;NFKB1;PSEN1
prerank,positive regulation of cell junction assembly (GO:1901890),0.4608698177882918,1.248037687624087,0.17027417027417027,0.6671753533916203,1.0,6/56,2.97%,TEK;KDR;CAV1;CLDN5;PTPRJ;PPM1F
prerank,positive regulation of brown fat cell differentiation (GO:0090336),0.5802608469050138,1.2474495388789693,0.2508896797153025,0.6679651664027644,1.0,3/13,3.01%,PTGS2;SOX13;RREB1
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.46536754636811845,1.24708998947334,0.18454935622317598,0.6681191609693058,1.0,6/46,3.63%,TEK;PARVB;PEAK1;EFNA1;SRGAP2;PXN
prerank,negative regulation of cellular process (GO:0048523),0.37087314641713204,1.246882484593842,0.03619441571871768,0.6678270571651066,1.0,85/521,10.76%,NOS3;PTPN14;BMPR2;JAM2;PLXNA4;DCUN1D3;TBX1;APBB2;SMARCA2;APP;PDE8A;CBFA2T3;SOX7;ACVRL1;PRKD1;PPP1R13B;CTTNBP2NL;PODXL;CD200;CDK6;PLPP1;SH3BP4;ADARB1;MYH9;DAB2IP;LYN;ADAM10;NPR1;PTK2B;SRGAP2;NOTCH1;PLXND1;PTPRJ;TNFRSF1B;SOX17;AQP11;LPCAT3;NCK1;CD34;ADGRG1;TES;ACTN1;DLL1;TMBIM6;PPP1R9B;VGLL4;BTG3;PTPRK;DLL4;TMEM98;RAPGEF2;ADAM15;CBLL1;JADE1;KLF10;BTN2A2;FBP1;BTBD18;DCSTAMP;ADAMDEC1;CDKN1B;PPM1D;TGFB1;RASA1;SNX3;RNF167;PKD2;RNF139;NF2;CTBP1;PINX1;CHMP4B;DSCAM;SOX4;SST;TNFRSF8;BTG2;RAD18;CYP27B1;SFRP2;SEMA4D;VAMP8;TFAP4;NMI;BNIP3
prerank,defense response to virus (GO:0051607),0.4259228723345878,1.2468808723698013,0.13127413127413126,0.6669237676641322,1.0,30/100,19.42%,SERINC3;NLRC5;IRF2;SERINC5;SAMHD1;DDIT4;ISG20;IFNAR2;RNASE1;CD40;MLKL;G3BP1;CGAS;BCL2L1;BNIP3;NT5C3A;ZMYND11;OASL;RELA;CNOT7;IFIH1;IFITM3;STAT1;PLSCR1;ZDHHC1;BST2;ATG7;IFITM1;EIF2AK2;BNIP3L
prerank,negative regulation of axon extension (GO:0030517),0.5109293474031775,1.246448234547887,0.20447284345047922,0.6672423752042396,1.0,5/30,5.54%,SEMA6A;SEMA5B;SEMA7A;DIP2B;SEMA6B
prerank,carbohydrate derivative transport (GO:1901264),0.5506014262596212,1.246234934156851,0.22181818181818183,0.6669540663183775,1.0,4/18,8.48%,PLTP;SCARB1;SLC10A7;SLC15A2
prerank,positive chemotaxis (GO:0050918),-0.4972835384232356,-1.2461662873873653,0.17906976744186046,0.6173363241185779,1.0,8/17,18.63%,ANGPT1;NRP1;SEMA5A;TSC2;VEGFA;FGF7;FGF10;SCG2
prerank,positive regulation of DNA metabolic process (GO:0051054),-0.3679233006712622,-1.2457495183544693,0.11726384364820847,0.6168384624202782,1.0,8/61,4.55%,EYA2;EGFR;EYA1;PDGFRB;EYA4;FGF2;SMOC2;PARP3
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.5934713286175288,1.2456703369206037,0.23550087873462214,0.6677335122573403,1.0,3/12,5.48%,SEMA6A;DAB2IP;ATP2B4
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.45974608503126196,1.2451815110849456,0.17664233576642335,0.6682753298933627,1.0,23/57,21.42%,RPS15;RPS19;RPS16;RPL38;TGS1;RPS7;RPS24;XPO1;RRS1;RPL14;NOP16;RPS6;NPM1;RIOK1;RPS25;RPL35A;EMG1;RPL11;NOP14;NOM1;RIOK2;RPS28;RPL7
prerank,negative regulation of endothelial cell proliferation (GO:0001937),0.5033084617369419,1.245044146367431,0.18619582664526485,0.6677572550792814,1.0,6/35,5.27%,FLT1;CAV1;MEF2C;PTPRM;CAV2;DLL4
prerank,regulation of dendritic spine development (GO:0060998),0.5575530153415472,1.2449584693259637,0.22372881355932203,0.6670849244476271,1.0,3/19,3.49%,SHANK3;MEF2C;PPFIA2
prerank,supramolecular fiber organization (GO:0097435),-0.2975286170197405,-1.244737643581073,0.0,0.6179365552414765,1.0,93/334,14.82%,COL1A2;COL3A1;CGNL1;COL4A5;COL1A1;ADAMTS2;COL8A1;TNXB;COL4A6;GSN;COL5A1;COL12A1;COL22A1;PRKN;COL25A1;COL4A3;LOXL1;COL4A4;COL6A2;FAT1;COL6A3;CLIP4;COL11A1;HSPG2;PLOD2;COL6A1;COL8A2;TGFBR1;MYO5A;COL26A1;SERPINH1;COL13A1;COL18A1;FBLN5;COL23A1;PPP1R9A;RHOBTB2;LOXL3;COL27A1;RND3;TPM1;CARMIL1;CYP1B1;DLG1;COL5A3;TMOD2;NF1;CLIP3;LUM;TGFBI;COL16A1;P4HB;LOX;SIAH2;COL14A1;SHROOM3;EFEMP2;MPRIP;RHOBTB3;COL9A2;KIF24;GGA2;APH1B;TUBGCP5;MDM2;KATNAL1;DPT;DDR2;COL20A1;TPM2;COL15A1;MYO1B;ADAMTS14;P4HA1;CST3;DES;TGFB2;MAP7D3;MFAP4;LMOD1;WDR73;B4GALT7;TSPAN15;DBN1;PCM1;TPM4;COL19A1;LAMC2;P3H4;GGA1;P3H1;HOOK2;SNCA
prerank,establishment of melanosome localization (GO:0032401),0.5586026943543712,1.244717593058797,0.22530329289428075,0.6668213743719288,1.0,3/19,3.64%,RAB27A;RAB11A;SHROOM2
prerank,glucose homeostasis (GO:0042593),0.43593487343650694,1.2445613583548378,0.15803452855245684,0.6663567295464867,1.0,13/83,9.32%,FOXO1;ADIPOR2;INSR;STAT3;HIF1A;KLF7;KCNB1;TCF7L2;FOXA3;INPP5K;NEUROD1;FOXK1;SOX4
prerank,response to retinoic acid (GO:0032526),0.454214069708099,1.24425343272452,0.1773049645390071,0.666428869345148,1.0,14/59,12.23%,ACER2;TBX1;FZD4;LYN;PTK2B;RET;WNT5A;WNT9B;BRINP2;CREB1;OVCA2;TWF2;ABL2;ASXL1
prerank,mesenchymal to epithelial transition (GO:0060231),-0.5671176234722227,-1.243871065382964,0.23076923076923078,0.6187113935439629,1.0,4/10,15.87%,BMP4;SALL1;FZD7;PAX8
prerank,negative regulation of cell projection organization (GO:0031345),-0.3973698922323159,-1.243404139058523,0.14429530201342283,0.6183794826625036,1.0,10/48,9.84%,LPAR1;DPYSL3;PTPN9;PTPRS;EFNB2;ADCY6;SEMA3A;DCC;RAB29;APOE
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.43589883094777865,1.2430647288708558,0.16622340425531915,0.6690187017147526,1.0,21/73,22.48%,LMO2;KITLG;GATA2;TAL1;TCF12;PSMA2;TCF3;PSMA8;PSMA6;CBFB;PSME1;PSMA4;METTL14;PSMF1;DHX36;EIF2AK2;PSMB7;PSMB1;PSMD2;PSMA5;PSMC3
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.607345581038271,1.2427943804111459,0.26071428571428573,0.6689015579328422,1.0,3/11,7.50%,NOVA2;IGF2BP3;RASA1
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.5241202855196035,1.242704393199384,0.22132471728594508,0.6682597550487617,1.0,6/26,9.68%,HTR2A;PLCG2;LCK;ITPR3;PKD2;ERO1A
prerank,negative regulation of apoptotic process (GO:0043066),0.3725567379518744,1.2424535915897599,0.055323590814196244,0.6681453373757889,1.0,81/444,12.90%,PRKCH;LEF1;TEK;TJP1;FOXO1;CD38;KDR;IL6ST;CAV1;TBX1;MEF2C;RNF144B;SOCS2;PIM3;ADAM10;FAS;PTK2B;NOTCH1;NFKBIA;FLT4;PAK2;BABAM2;CAT;DLL1;RPS6KA3;TMBIM6;FOXQ1;IKBKB;RPS6KA1;XBP1;GREM1;CX3CR1;MAPK8;ASAH2;SERPINB9;PLK2;XIAP;WNT5A;TOX3;DNAJA1;AVEN;HNRNPK;PTK2;RASA1;BCL3;BNIP2;NFKB1;ITGA5;MALT1;CITED1;PSEN1;AKT2;RHBDD1;BCL2L1;HIGD2A;EGR3;SEMA4D;GAS6;BNIP3;SFN;CBL;IL7;RB1;PIM1;LGMN;THOC6;RIPK1;TMBIM4;TMIGD1;BID;CARD16;RELA;TNFAIP8;RIPK2;PRDX2;PA2G4;GSTP1;RPL10;BIRC3;PHIP;PTMA
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.45823529269858876,-1.242119227572816,0.19708029197080293,0.6204531336370037,1.0,11/22,26.50%,TIMP3;TIMP2;ADRA2A;APOE;ADAM9;GPLD1;PTPN3;PACSIN3;SNX33;NRDC;TIMP1
prerank,nucleoside phosphate catabolic process (GO:1901292),0.5947560763630216,1.2418074546939764,0.25316455696202533,0.6691735673375995,1.0,1/13,0.26%,ENTPD1
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.5071972601986581,1.2417562378414437,0.2006220839813375,0.6684249137837244,1.0,7/33,11.86%,LEF1;CASP8;DCSTAMP;CTNNBIP1;CSF1;IL23A;RIPK1
prerank,cellular sodium ion homeostasis (GO:0006883),-0.4992091542311737,-1.241405456960341,0.1889400921658986,0.6207895581190315,1.0,4/15,3.39%,ATP1A2;SLC12A2;ATP1B1;SLC8A1
prerank,intestinal lipid absorption (GO:0098856),0.6065668648376797,1.2413836305111938,0.26258992805755393,0.6686737476876362,1.0,3/11,13.48%,UGCG;SOAT2;LIMA1
prerank,canonical Wnt signaling pathway (GO:0060070),0.4444189166636033,1.2409468406536408,0.1794871794871795,0.669059963199066,1.0,10/68,6.37%,LEF1;CAV1;DIXDC1;FZD6;FZD4;LRP5;TCF7L1;TCF7L2;WNT5A;WNT9B
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.5086980027503917,1.2402427616996592,0.1993911719939117,0.6702110378885123,1.0,6/29,16.62%,PLA2G4A;LPCAT3;PLA2G2D;PLAAT3;PNPLA8;TMEM86B
prerank,regulation of B cell apoptotic process (GO:0002902),0.598444575057785,1.240182593589998,0.23905109489051096,0.6695025212730621,1.0,2/12,2.31%,FOXP1;LYN
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.5741169896131705,1.2399722829605158,0.23076923076923078,0.6691778059633494,1.0,5/15,7.03%,KDR;PTK2B;SRMS;DYRK1A;BMX
prerank,clathrin-dependent endocytosis (GO:0072583),0.5319836624934255,1.239959347614059,0.20411392405063292,0.6683227256777382,1.0,8/26,11.71%,FNBP1L;ITSN2;FCHO2;DLL1;AP2B1;AP2A1;INPP5F;PICALM
prerank,cellular response to superoxide (GO:0071451),0.6203120087432216,1.2392264235770545,0.24912891986062718,0.6695809045623322,1.0,1/10,0.31%,NOS3
prerank,erythrocyte differentiation (GO:0030218),0.47051494612174555,1.2390841101869616,0.18432510885341075,0.6690899823030753,1.0,8/44,5.14%,LYN;TAL1;MFHAS1;ALAS1;RPS19;JAK3;RPS14;KMT2E
prerank,protein modification process (GO:0036211),0.4384716887376671,1.2389737793500974,0.16455696202531644,0.6685450888816351,1.0,15/76,11.60%,ST3GAL6;ST3GAL1;YES1;CPE;UBA7;PADI4;ST8SIA4;AKT2;FBXL2;FBXW2;ERO1A;UBE2D3;ICMT;ABL2;STK38
prerank,positive regulation of vascular permeability (GO:0043117),0.6141190509539067,1.2384925073220225,0.26,0.6690764283587508,1.0,7/12,9.62%,TJP1;OCLN;TJP2;PDE2A;TGFB1;TRPV4;TJP3
prerank,anterograde axonal transport (GO:0008089),-0.4174774338421638,-1.2383105359473383,0.16379310344827586,0.6278970065316621,1.0,17/37,28.45%,DLG2;KIF3A;KIF1A;KIF5C;RAB27B;AP3D1;DTNBP1;KIF1B;TRAK1;HSPB1;KIF5A;RAB21;SNAPIN;MAP1A;SPAST;BLOC1S4;AP3B2
prerank,cellular response to metal ion (GO:0071248),-0.3347007427428136,-1.2382476530146358,0.08292682926829269,0.6264166191693793,1.0,21/123,7.58%,BMP6;EGFR;PRKN;ADCY1;SLC41A1;ADGRV1;DLG2;SLC12A2;DLG4;SYT1;P2RX4;ADCY7;CDH1;ANK3;PRKAA2;RASGRP2;NLGN1;SYT9;SYT12;SYT11;LRRK2
prerank,regulation of axonogenesis (GO:0050770),-0.3822074603129386,-1.237947141855766,0.13738019169329074,0.6255343947553276,1.0,13/51,10.90%,ROBO1;PLXNA2;KIF13B;TIAM2;BRSK1;NTRK2;ROBO2;LRRC4C;NGF;MAP6;PLXNB1;SIPA1L1;SLIT2
prerank,positive regulation of chemokine production (GO:0032722),0.4782756340121219,1.2375509511915983,0.18787878787878787,0.670905746851013,1.0,8/44,13.42%,APP;IL6R;HIF1A;TIRAP;WNT5A;LPL;IL7;ADAM17
prerank,gene expression (GO:0010467),0.375470222229327,1.2374622196780054,0.07096069868995633,0.670262912650905,1.0,116/348,18.60%,RBPMS;ADARB1;HHEX;TSPAN5;DDX54;RPS15;IGF2BP3;RPS19;RPLP1;RPS14;RPSA;RPS16;EPC1;RPL38;EIF4E;TSPAN14;RPL34;RPS20;RPL39;DROSHA;HNRNPF;RPS7;PWP1;NXF2;RPS24;TAF1B;HNRNPK;RPL37A;BCL3;SRBD1;HNRNPD;RPL36;RPS18;WDR33;RSL24D1;RPL15;THOC2;RPS8;RPL14;RPL23;RPL17;MRPS18A;SMG7;RPL9;RNGTT;DHPS;RPL4;RPL13A;RPS11;RPL32;TNIP1;RBM3;YTHDC1;RPL22;RPS27;RPL31;RPS23;MMS19;ADAR;NUP214;RNPS1;MRPL13;RPL13;MRPS12;RPS12;THOC6;NUP98;MRPL35;HBS1L;RPL6;RPL10;FASTKD2;WARS1;PTMA;MRRF;UPF2;MRPL41;NUP133;NUP205;RPS29;RPS6;MEF2A;MRPL52;NUP54;RPL29;TOPORS;RPS25;RPL35A;RPS13;NUP43;NUP153;RPS21;MRPS16;RPL27;RPL18;XRN2;MRPL23;RPL27A;TSPAN33;MRPS5;RPS10;DDX20;HNRNPUL1;MRPL37;AGFG1;RPL11;ALYREF;CDC40;RPL8;THOC3;RPLP2;MRPL11;THOC1;PRPF4;RPL18A;CPSF1
prerank,negative regulation of complement activation (GO:0045916),-0.5709316140306258,-1.237050558292169,0.22784810126582278,0.6264082976968055,1.0,2/10,5.12%,SERPING1;CD55
prerank,positive regulation of heart rate (GO:0010460),0.55319064877565,1.2366551338657614,0.21269296740994853,0.6716021403824497,1.0,4/17,4.08%,EDN1;KCNQ1;PDE4D;ADRB1
prerank,negative regulation of developmental process (GO:0051093),0.45090687385608935,1.2364462550764688,0.17227456258411844,0.671327909834779,1.0,15/69,11.74%,NOS3;TBX1;CDK6;ARHGEF15;NOTCH1;KLF7;DLL1;GREM1;WNT9B;TGFB1;NFIB;GAS6;BNIP3;RC3H1;SINHCAF
prerank,negative regulation of gene expression (GO:0010629),0.3791312042229172,1.2361590601178938,0.09902067464635474,0.6712367010277481,1.0,56/302,11.79%,RPS6KA5;NANOS3;HDAC9;KDR;ENG;ESR1;APP;MEF2C;ERN1;ACVRL1;CLDN5;OCLN;DAPK1;PDGFB;FOXP1;GATA2;ADAM10;FBXW7;NOTCH1;HIF1A;CD34;IGF2BP3;TMBIM6;PTBP3;EPC1;DLL4;NANOS2;N4BP1;ATP2B4;H3-3A;MTF2;TNRC6C;AURKA;BTN2A2;TASOR;SRGN;PPM1D;TGFB1;GRB7;NFKB1;RNF139;PSEN1;NUDT16;DICER1;AEBP2;BTG2;RPL13A;CNOT1;SFRP2;APLNR;PPHLN1;DCP2;RB1;MRPL13;PICALM;LGMN
prerank,negative regulation of dephosphorylation (GO:0035305),0.5642755964060917,1.2360382888716468,0.22240802675585283,0.670711775122429,1.0,4/18,10.49%,PPP1R16B;MFHAS1;INPP5K;GPATCH2
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.6291882986946133,1.2358747753953951,0.24812030075187969,0.6694571095351495,1.0,2/10,6.95%,CNGB1;GNAT1
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.6291882986946133,1.2358747753953951,0.24812030075187969,0.6694571095351495,1.0,2/10,6.95%,CNGB1;GNAT1
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.5710217366565556,1.2355856852951776,0.24064171122994651,0.6694110724624978,1.0,4/15,4.00%,KDR;PRKD1;PRKD2;TMSB4X
prerank,positive regulation of T cell migration (GO:2000406),0.5372889452288808,1.2354059116529943,0.22682119205298013,0.6690601004676715,1.0,3/20,6.09%,APP;ADAM10;WNT5A
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.4197285232283628,1.2351178022959497,0.16666666666666666,0.6689915746190345,1.0,15/93,6.62%,APP;TNFRSF19;DAB2IP;MFHAS1;PTK2B;TPD52L1;TAOK2;PLCB1;TRAF1;FLT4;TIRAP;EDAR;SDCBP;DUSP22;SASH1
prerank,Golgi ribbon formation (GO:0090161),0.579928724022974,1.234930070142974,0.23529411764705882,0.668647484835742,1.0,5/13,8.41%,STX6;VAMP4;VTI1A;GCC2;TMED5
prerank,skeletal muscle organ development (GO:0060538),0.5266777355873598,1.234811310502109,0.22405271828665568,0.6680953701087688,1.0,3/26,4.96%,CAV1;MEF2C;FOXL2
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.46256736327154635,1.2346197194776383,0.1958762886597938,0.6677573865451893,1.0,4/46,2.31%,SEMA6A;CNKSR3;DAB2IP;LYN
prerank,muscle organ development (GO:0007517),-0.3770036153876966,-1.234409648086495,0.14968152866242038,0.6323092033113706,1.0,14/54,7.49%,LAMA2;IGF1;DMD;SGCD;COL6A3;FHL1;VAMP5;LARGE1;SGCE;ITGA11;SOX6;EVC;SPEG;MKX
prerank,regulation of MAPK cascade (GO:0043408),0.39784394149879293,1.2341206652650425,0.12454655380894801,0.6682591859940905,1.0,23/157,5.59%,TEK;FLT1;KDR;CAV1;TBX1;INSR;PDGFB;IQGAP1;DAB2IP;LYN;JCAD;FAS;PTPRJ;TAOK2;STK3;FLT4;PLCG2;CAV2;PAK2;STK4;CEACAM1;GREM1;RET
prerank,neuron development (GO:0048666),0.40035766970129893,1.2340392788469114,0.12682926829268293,0.6675948349017897,1.0,19/141,7.80%,FRY;FRYL;PBX1;APP;MEF2C;UGCG;STX3;PTPRM;RAB11A;LYN;PPP1R9B;BICDL1;XBP1;ULK1;OPHN1;RAPGEF2;RP1L1;B4GALT5;NEDD4
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.4577786637398475,1.2339154985834413,0.18714285714285714,0.6670685002369704,1.0,12/57,9.96%,IL6ST;IL15;IL6R;LYN;STAT3;GHR;CD40;STAP2;TNFRSF1A;NF2;IL23A;INPP5F
prerank,nitrogen compound transport (GO:0071705),0.40195021601887215,1.233777861431205,0.13708690330477355,0.6666189965052867,1.0,32/141,15.49%,CALCRL;ABCG2;CERT1;SLC6A2;MYH9;SEC14L1;EDN1;SLC7A7;SLC38A5;ATP11B;SLC3A2;SLC6A6;SCAMP1;RAMP2;SLC43A2;CHMP2B;SLC52A3;ARRDC1;SLC15A2;RAB38;SLC38A1;SCARB2;CD320;PICK1;RILP;RAB7A;TXNIP;TCN2;SLC22A5;SLC18A2;SLC7A5;CEP290
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.4125975798882929,1.2335898645058405,0.14303959131545338,0.6663079517361642,1.0,39/109,23.10%,NFATC1;PLCG1;LYN;PPP3CA;PLCG2;PAK2;IKBKB;MAPK8;PPP3CB;RAC1;PSMA2;NFKB1;MALT1;IKBKG;PSMA8;PSMA6;CUL1;RELA;TRAF6;PSME1;LAT;SOS1;TAB3;CALM1;MAP2K4;PSMA4;GRB2;PSMF1;PAK1;BCL10;PSMB7;MAP3K1;PSMB1;MAP2K7;PSMD2;PSMA5;PSMC3;JUN;FCER1G
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.5792464890246494,1.2332951929508966,0.2429078014184397,0.6662356673153126,1.0,7/13,28.67%,IRAK4;TRAF6;IRAK2;PIK3R4;TNIP2;PIK3AP1;IRAK1
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.45680469050081496,1.2330695208910931,0.18867924528301888,0.6659849861573808,1.0,7/52,5.48%,PRKCH;EPB41;STX3;SPTBN1;NKD2;SORBS1;ATP2B4
prerank,regulation of stem cell proliferation (GO:0072091),-0.49082045385077155,-1.2321420773284752,0.2127659574468085,0.6372230520760397,1.0,7/17,24.55%,FBLN1;GJA1;AGO3;HNRNPU;HMGB2;TERT;PTPRC
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.3584074631055881,1.231926291390021,0.004004004004004004,0.668320401034174,1.0,271/1667,12.43%,MECOM;DACH2;ERG;LEF1;MRTFB;ELK3;FLI1;RPS6KA5;FOXO1;LHX6;EPAS1;TEAD4;HDAC9;DACH1;ZHX3;PBX1;BMPR2;LDB2;ENG;CAV1;ITGA6;TBX1;ESR1;SMARCA2;APP;PPARD;TSHZ2;MEF2C;ZBTB16;TOX4;LMO2;ACVRL1;PRKD1;NR5A2;CRTC1;MAML2;AHR;ETV6;SMAD1;ZIC3;NFATC1;LRRFIP1;NLRC5;IRF2;FOXP1;GATA2;DAB2IP;SOX13;ELF2;MED13L;EDN1;HHEX;ARHGEF2;PDE2A;LRP5;TAL1;PRKD2;NEDD4L;STAT3;EFNA1;NR3C1;FNIP2;PPP3CA;NOTCH1;HIF1A;EBF1;KLF7;RREB1;KLF8;NFKBIA;CCNK;KDM3A;SOX17;TGIF1;PKNOX2;PITX1;NCK1;WWTR1;ARID3B;ZFP57;SOX18;BAZ2B;JMY;TCF12;TSHZ1;PPP1R12A;HMBOX1;FOSL2;MAFF;TOX;RIPPLY3;MRTFA;PKN1;ZBTB46;NCOA1;DLL1;RPS6KA3;KLF2;ZNF292;FOXF1;FOXQ1;SS18;ELK4;RPS14;IKBKB;MCPH1;SDCBP;RPS6KA1;SP6;FOXL2;XBP1;ZFP92;TET3;ID1;EPC1;TCF7L1;SMAD7;ACVR2A;GREM1;DLL4;FOXF2;SBNO2;ARID1B;ATP2B4;HOXA10;PHF20;MTF2;LPIN3;TCF7L2;TCF4;JMJD1C;LIN9;TEAD2;TNRC6C;PITX3;PPP3CB;ESRRG;DUSP22;CHP2;WNT5A;CNBP;SKAP1;RCOR1;TOX3;ATMIN;KLF10;ACVR1;NR1I3;FBP1;FOXA3;ELF5;FOSL1;IRF2BPL;CD40;HNF1B;ETS2;JUNB;TRIB3;ASCL4;KLF13;LYL1;CHD1;SPDEF;ARRB1;PPM1D;HNRNPK;RBM14;TNFRSF1A;TGFB1;HOXD8;HOXD1;TGFA;GMEB2;TCF3;AGRN;NFKB1;GATAD2A;MAMSTR;ARID1A;PKD2;KDM4C;NEUROD1;CTBP1;WWC2;BACH2;CITED1;NRL;ZNF2;CREM;KAT6B;PHF6;SMARCA5;EZH1;PSEN1;CREB1;TAF3;FOXK1;CRK;ZFPM1;SUB1;RPL23;BRD4;PCGF5;CHD2;IER2;TCF15;SOX4;RELB;IKBKG;DICER1;AEBP2;MAFB;BRIP1;BACH1;MED27;RNF4;YEATS2;NFIB;CREB3L4;NRIP1;MAMLD1;MAD2L2;SP2;SKIL;CNOT1;KLF12;SMAD5;SRCAP;SFRP2;UBE2D3;USF2;EGR3;TNIP1;SEMA4D;SMARCE1;ZBTB10;PHF20L1;GLYR1;TFAP4;POU2F1;GABPB1;CSRNP1;SPEN;CNOT2;MC1R;GLMP;ZMIZ1;ENY2;RB1;ATF6;EID1;CBFB;SP3;CEBPD;GRIN1;RIPK1;PRDM2;DCAF1;ACTR2;ZNF319;RPRD1B;MUC1;ASXL1;NOP53;MIER1;SIRT6;RELA;RIPK2;MAX;TET2;LCORL
prerank,microtubule anchoring at centrosome (GO:0034454),-0.5554294692911442,-1.2318748498511434,0.23191489361702128,0.6362612442988276,1.0,7/10,30.27%,NINL;KIF3A;PCM1;CCDC68;CEP19;DCTN1;NIN
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),0.580056154600361,1.2317920650486338,0.25457875457875456,0.667853415459474,1.0,1/14,1.32%,ERN1
prerank,negative regulation of TORC1 signaling (GO:1904262),-0.5117981124484257,-1.2316448363942347,0.22169811320754718,0.635213051434538,1.0,6/13,23.98%,RNF152;CASTOR2;SZT2;SESN2;ITFG2;ATM
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.4357130025819156,1.2312584497275134,0.20133333333333334,0.6684349528401176,1.0,20/76,17.21%,DCUN1D3;CAV1;FBXW7;RASD2;FKBP1A;SMAD7;XIAP;MYCBP2;MALT1;TNIP1;UBE3A;SAE1;RIPK2;PRICKLE1;BIRC3;TRAF6;NDFIP2;BIRC2;WDR48;CUL3
prerank,positive regulation of interleukin-2 production (GO:0032743),0.519968721827975,1.2311732219004583,0.220949263502455,0.6678354191993354,1.0,5/25,8.24%,SPTBN1;PRKD2;PDE4D;PLCG2;MALT1
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.5637997066083554,1.2306299503609581,0.23283082077051925,0.6684822132997429,1.0,4/16,5.27%,PPP1R16B;GATA2;JCAD;DLL4
prerank,response to UV-A (GO:0070141),-0.5146417953076615,-1.230323587485563,0.22494432071269488,0.6371830327337775,1.0,3/14,13.52%,EGFR;MMP2;CERS1
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.5066127593805511,1.2302237974153087,0.20556414219474498,0.6687742537009381,1.0,9/29,10.61%,IL15;SOCS2;STAT3;JAK3;GHR;IFNAR1;IFNAR2;PKD2;NMI
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.47735605634310413,-1.2295703308263624,0.19,0.6375576971623661,1.0,7/21,9.22%,IGF1;BMPR1A;IGFBP5;GJA1;FGF2;ADAMTS1;MMP2
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.41359841075373344,1.2292248333464781,0.1633416458852868,0.6707011320314114,1.0,22/112,7.46%,ENG;MEF2C;ACVRL1;CLDN5;F11R;SMAD1;SMURF1;PARD3;NRROS;PDE2A;NR3C1;PXN;FKBP1A;ID1;PTPRK;SMAD7;USP15;DUSP22;WNT5A;ACVR1;TGFB1;PTK2
prerank,regulation of response to cytokine stimulus (GO:0060759),0.5446628780821662,1.2291706235594893,0.24610051993067592,0.6700034090636162,1.0,8/19,20.12%,LIFR;WNT5A;CBFB;IFIH1;MAP2K5;IRAK2;PARP9;TAF9
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.5051798763355602,-1.228927867803506,0.2,0.6377584671935548,1.0,5/15,7.50%,GRM7;GRM5;GRM1;GRM3;DAGLA
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.4814601971096886,1.2286710893268527,0.21894409937888198,0.6705393299106495,1.0,9/39,13.89%,FNBP1L;MYO1D;ACTN4;PPFIA2;BICDL1;MYO1E;MYO1C;CCDC186;NDEL1
prerank,mitotic sister chromatid cohesion (GO:0007064),0.5631294818677661,1.2281153831077931,0.24263431542461006,0.6711547720113893,1.0,6/16,17.01%,RAD21L1;HASPIN;RB1;PDS5A;RAD21;PDS5B
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.42280738502367404,1.2280809068405507,0.17763157894736842,0.6704286592917466,1.0,16/83,12.40%,CDK17;CDK6;EIF4E;PLK2;ACVR1;CDKN1B;POLA1;CDT1;BRD4;CDK2;BACH1;CDK18;RB1;EIF4EBP1;CUL1;MAX
prerank,small GTPase mediated signal transduction (GO:0007264),0.4086234135510811,1.227749323247832,0.1671018276762402,0.6704528797739158,1.0,22/103,10.10%,ARHGAP31;RAPGEF5;NTN1;PRKD1;BCR;GNB1;RREB1;GRAP;RASGRP3;RALB;PLK2;CCDC88A;RAPGEF2;NRAS;KRAS;RAC1;SHOC2;RAB38;CDK2;G3BP1;MAPK11;RGL2
prerank,import into cell (GO:0098657),-0.40574010992102155,-1.2277123926286988,0.18840579710144928,0.6395968126819819,1.0,9/41,5.16%,ATP1A2;SLC6A13;SLC1A3;SLC47A1;GLUL;SLC22A4;SNAP25;SLC39A14;SLC5A3
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.34866377089083556,-1.2270504016975479,0.10276679841897234,0.6397650961375647,1.0,23/80,17.01%,PLPP3;ATP9A;KIF3C;KIF3A;COPZ2;COPB1;KDELR3;COPA;COPG1;ERGIC1;TMED9;GBF1;ERGIC2;ARFGAP1;ARCN1;HTT;BICD2;KIFAP3;KLC1;GOLPH3L;ARFGAP2;KIF5A;SCFD1
prerank,Rap protein signal transduction (GO:0032486),0.6188119460667628,1.2269409447036632,0.24903474903474904,0.6718968868051408,1.0,4/10,7.52%,RAP1B;PLK2;RAPGEF2;RAP1A
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.4603575828497482,1.2255321173887679,0.19490254872563717,0.6751141397996565,1.0,14/44,19.01%,NANOS3;NANOS2;TNRC6C;PRR5L;PUM1;BTG2;CNOT1;RC3H1;ZFP36;CNOT7;PNPT1;ZFP36L1;METTL14;DHX36
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.5888776128562857,1.2252550783762213,0.25444839857651247,0.6750546664937417,1.0,4/14,12.18%,USP15;PUM1;PUM2;OASL
prerank,microvillus assembly (GO:0030033),0.5724315744055414,1.2249092124110144,0.2495446265938069,0.6751900847681648,1.0,5/14,7.52%,RAP1B;RAPGEF2;STK26;TNIK;RAP1A
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.5554917735803179,1.2235194607742101,0.24664429530201343,0.6781927147308741,1.0,3/17,7.63%,RAB27A;KCNB1;STX1A
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.41748225235050446,1.223483378273524,0.18494055482166447,0.6774497231399572,1.0,24/93,12.95%,CAV1;APP;PRKD1;CNKSR3;PRKD2;FNIP2;DDIT4;PDE4D;PPM1F;NCK1;SH2D3C;STK4;SMAD7;ATP2B4;INPP5K;BCAR3;TGFB1;RPTOR;MAD2L2;SFRP2;GAS6;RIPK2;RACK1;HSP90AB1
prerank,negative regulation of multicellular organismal process (GO:0051241),0.3846181007580701,1.2228865727983573,0.142018779342723,0.678305269212264,1.0,28/199,7.32%,RPS6KA5;NOS3;PTPRG;HDAC9;BMPR2;NOVA2;MEF2C;IL15;DAB2IP;PAEP;EFNA1;NOTCH1;KLF7;RAB11FIP1;LAMA4;EVL;RPS19;ID1;SMAD7;RAB11FIP5;N4BP1;ATP2B4;PGAM5;BTN2A2;WNT9B;SOST;SRGN;TGFB1
prerank,cell junction maintenance (GO:0034331),-0.5161119519242375,-1.2224500183965532,0.2367816091954023,0.6510850271747484,1.0,7/14,32.37%,NLGN2;CLDN1;CHCHD10;MYADM;PRTN3;DCTN1;PARD6A
prerank,Notch signaling pathway (GO:0007219),0.4418440282797432,1.2224039839787715,0.19744318181818182,0.6788077988274814,1.0,9/59,5.27%,SORBS2;PBX1;MAML2;ADAM10;NOTCH1;PLXND1;DLL1;DTX3L;DLL4
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.5910682624947895,1.2221209257918766,0.25925925925925924,0.6787494058333846,1.0,4/12,11.56%,ELF2;LYN;RC3H1;CBFB
prerank,nucleotide-sugar biosynthetic process (GO:0009226),-0.46812043208022647,-1.2218622487983137,0.2073170731707317,0.6511966811721588,1.0,8/19,17.49%,RENBP;PGM3;NAGK;GFPT1;GFPT2;UGP2;GNPDA1;UGDH
prerank,cellular response to oxygen-containing compound (GO:1901701),0.3718510515036696,1.221256551935243,0.10694597574421169,0.6803419693517012,1.0,47/291,10.32%,FOXO1;TGM2;TBX1;ESR1;MEF2C;PRKD1;DAPK1;AHR;PDGFB;SH3BP4;DAB2IP;FZD4;PDE2A;LYN;KCNQ1;PTK2B;GNB1;TNFRSF1B;RAP1B;PXN;TIRAP;XBP1;PTPRK;CX3CR1;SBNO2;MAPK8;ATP2B4;RET;WNT5A;RAPGEF2;WNT9B;IL36G;INPP5K;PPBP;RAP1A;BRINP2;NFKB1;PKD2;LPL;CASP1;RPTOR;CREB1;DEFA6;CDK2;NRIP1;TWF2;LARS1
prerank,metal ion homeostasis (GO:0055065),0.47030981883802436,1.2206018827909613,0.21540880503144655,0.681330556486833,1.0,7/40,11.62%,TMTC2;CAV1;SLC12A7;TRPV6;SLC12A9;CYP27B1;GRIN1
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.533602675538005,-1.2205565009143453,0.23370786516853934,0.6532170119530002,1.0,4/11,10.12%,IGF1;IRS1;TSC2;EIF2AK3
prerank,cellular component assembly (GO:0022607),0.37623637924844283,1.2204894313762986,0.10146561443066517,0.6807950407430075,1.0,48/253,13.86%,PARVB;SLC2A1;LCP1;SPTBN1;OCLN;EPS8;LIMS2;CD2AP;MAGI1;NEDD9;PARD3;FAS;PTK2B;SHROOM2;TRAF1;SHROOM1;CARD10;RHOJ;PLS3;RAD21L1;NCKAP1;QSOX1;STX7;ABCA3;TEAD2;OPHN1;WNT5A;RP1L1;CD40;RAC1;TGFB1;TRIP13;LLGL1;SKAP2;NIFK;IKBKG;TFAP4;GAS6;FSCN1;ACD;CYFIP1;PICALM;HAS2;LIMA1;CAPZA1;CFAP46;PEX14;IL1RAP
prerank,protein neddylation (GO:0045116),0.580658710996317,1.2203147605127982,0.25862068965517243,0.6804846522231047,1.0,2/13,7.26%,DCUN1D3;RNF7
prerank,microvillus organization (GO:0032528),0.5825382593580967,1.220040948380678,0.24440298507462688,0.6804180495555932,1.0,5/13,7.52%,RAP1B;RAPGEF2;STK26;TNIK;RAP1A
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.5198462590005197,1.2197949440829738,0.22466216216216217,0.680227007194105,1.0,7/24,10.44%,PDE2A;RASD2;PDE4D;PRKAR2B;RAPGEF2;CGAS;APLNR
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.4265505633845757,1.219719768884535,0.20424403183023873,0.6796073409990709,1.0,18/76,13.36%,CBFA2T3;SMURF1;RNF144B;FBXW7;NKD2;SMAD7;RNF144A;TRIB3;PTK2;RNF139;RAD23A;SUMO2;HECTD1;COP1;NOP53;PRICKLE1;RACK1;TRIB1
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.5559162165207612,1.2196418485942784,0.243006993006993,0.6790034434673358,1.0,4/16,10.01%,CEACAM1;STX7;IL23A;CYRIB
prerank,cellular response to hexose stimulus (GO:0071331),0.5195293695016501,1.2193060443085135,0.25041736227045075,0.6791329659418301,1.0,8/23,13.47%,UNC13B;ERN1;KCNB1;XBP1;SOX4;GAS6;RACK1;IGF1R
prerank,alpha-amino acid metabolic process (GO:1901605),-0.3839037389681599,-1.219029074931799,0.12121212121212122,0.6559369392513932,1.0,13/45,13.84%,GLUL;ASPA;NOX4;NAALAD2;ASPG;SLC25A12;GPT2;GOT1;MTHFD1;RIMKLA;OAT;SLC25A13;CBS
prerank,regulation of intracellular protein transport (GO:0033157),0.49423279388905356,1.2188251209810066,0.2173228346456693,0.6796896837096655,1.0,10/32,15.49%,PTPN14;LCP1;PRR5L;PCNT;TGFB1;GCC2;PTPN1;UHMK1;NDEL1;CEP290
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.5097170248208174,1.2187054777368076,0.22169059011164274,0.6791962678192294,1.0,3/26,4.28%,CAV1;MFHAS1;TIRAP
prerank,chromatin remodeling (GO:0006338),0.4177707279969553,1.218324036940205,0.17792207792207793,0.6793701723645534,1.0,30/100,19.40%,ESR1;SMARCA2;BAZ2B;KDM6A;PADI4;ARID1B;CECR2;ARID1A;KDM4C;SMARCA5;EZH1;NPM3;SRCAP;SMARCE1;RB1;HNRNPC;TOP1;NPM1;KAT2B;ATRX;JARID2;PIH1D1;ACTR5;KDM5C;BAZ1A;KDM4A;CHRAC1;PAK1;BAHD1;CHD1L
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.37832044567749606,1.217768967490871,0.12729357798165136,0.6801008524875216,1.0,27/214,7.52%,SEMA6A;TEK;KDR;APP;PDE8A;ICAM1;SEMA7A;CNKSR3;PDGFB;HTR2A;DAB2IP;LYN;PRKD2;MFHAS1;PDGFD;PTK2B;FBXW7;NOTCH1;FLT4;TIRAP;ARHGAP8;CEACAM1;RAPGEF2;PDGFC;ARRB1;TGFB1;RAP1A
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.5066318804122981,1.217757101593903,0.222397476340694,0.6793169881892721,1.0,8/29,14.10%,NLRC5;SAMHD1;WNT5A;IFNAR2;PTPN1;HSP90AB1;CNOT7;UBE2K
prerank,positive regulation of insulin secretion (GO:0032024),0.48142326917874795,1.217659222980444,0.2115085536547434,0.678786642613126,1.0,4/36,5.97%,MYRIP;ACSL4;TCF7L2;PPP3CB
prerank,positive regulation of actin filament bundle assembly (GO:0032233),-0.3756870510700373,-1.2176337697253024,0.15501519756838905,0.6582301650438561,1.0,16/51,11.20%,LPAR1;ROCK2;PPM1E;ARHGEF10L;NRP1;CCN2;TGFBR1;ARHGEF10;TPM1;CARMIL1;SFRP1;FHOD1;RGCC;TGFB3;S100A10;PFN2
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.403698084331564,1.2176087223063479,0.16290726817042606,0.6781204025387942,1.0,29/121,10.81%,PECAM1;IL6ST;IL15;PDGFB;NEDD9;IL6R;ARHGEF2;LYN;STAT3;EFNA1;PTK2B;PTPRJ;PLCG2;PAK2;GHR;GREM1;ENPP2;ACVR1;CD40;STAP2;TNFRSF1A;TGFB1;ITGA5;PTPN1;IL23A;FCGR1A;SEMA4D;GAS6;EPHA4
prerank,positive regulation of stress fiber assembly (GO:0051496),-0.38771873578949856,-1.217519071443144,0.1771117166212534,0.6568862242591846,1.0,16/44,11.20%,LPAR1;ROCK2;PPM1E;ARHGEF10L;NRP1;CCN2;TGFBR1;ARHGEF10;TPM1;CARMIL1;SFRP1;FHOD1;RGCC;TGFB3;S100A10;PFN2
prerank,icosanoid metabolic process (GO:0006690),0.47210504567979034,1.2174618620285194,0.23088023088023088,0.6777234244645967,1.0,7/40,8.63%,PTGS2;PLA2G4A;PTGS1;EPHX1;ALOX5AP;PON2;LTC4S
prerank,superoxide anion generation (GO:0042554),-0.5152547849775362,-1.2164488354502108,0.2135306553911205,0.6583184168330711,1.0,6/13,24.48%,NOX4;ALOX12;CYBB;NOX1;NCF2;TAFA4
prerank,positive regulation of phosphorylation (GO:0042327),0.3771355095263602,1.216127853831172,0.12148481439820022,0.6804597114983685,1.0,40/240,8.76%,TEK;LIMCH1;PECAM1;FLT1;KDR;ENG;ITGA6;TBX1;TIE1;APP;PDE8A;EPHB4;INSR;VEGFC;LYN;FAS;EFNA1;HIF1A;PFKFB3;FLT4;FGF23;STK4;LMTK2;RALB;SDCBP;VEGFD;ACVR2A;RET;LIMK2;KRAS;CD40;RAC1;ARRB1;TNIK;TGFB1;PTK2;NIBAN1;PSEN1;AKT2;ANG
prerank,regulation of cardiac muscle contraction (GO:0055117),-0.40622611448720614,-1.2160895397977385,0.17133956386292834,0.6576303514621998,1.0,9/34,12.59%,ANK2;ATP1B1;SLC8A1;P2RX4;PRKACA;ATP2A2;RYR2;SLC9A1;ADRA1A
prerank,positive regulation of phagocytosis (GO:0050766),0.46632286294710257,1.2159984929388217,0.20710059171597633,0.6799842082708037,1.0,4/47,2.90%,RAB27A;IL15;GATA2;PTPRJ
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.3530348298225889,1.2156166771687626,0.004,0.6801809863266326,1.0,239/1645,11.61%,MECOM;DACH2;ERG;LEF1;ELK3;FLI1;RPS6KA5;FOXO1;LHX6;EPAS1;CDK17;CD38;TEAD4;HDAC9;ATP8B1;DACH1;ZHX3;PBX1;ENG;TBX1;SLC39A8;APBB2;ESR1;SMARCA2;PPARD;TSHZ2;MEF2C;CBFA2T3;ZBTB16;TOX4;SOX7;ACVRL1;NR5A2;INSR;AHR;ETV6;SMAD1;ZIC3;NFATC1;LRRFIP1;PDGFB;IRF2;FOXP1;GATA2;DAB2IP;SOX13;ELF2;MLLT3;MED13L;FZD4;HHEX;LRP5;TAL1;STAT3;NR3C1;NOTCH1;HIF1A;EBF1;PPM1F;KLF7;RREB1;AFAP1L2;KLF8;CCNK;KDM3A;SOX17;TGIF1;PKNOX2;PITX1;WWTR1;PLCB1;ARID3B;CHD7;ZFP57;SOX18;BAZ2B;JMY;TCF12;TSHZ1;HMBOX1;FOSL2;MAFF;TOX;PKN1;ZBTB46;NCOA1;RPS6KA3;KLF2;ZNF292;FOXF1;FOXQ1;ELK4;IKBKB;RPS6KA1;SP6;VGLL4;DTX3L;SCMH1;FOXL2;ZFP92;ID1;EPC1;TCF7L1;LIN54;KMT2E;PTPRK;SMAD7;SPIN1;FOXF2;SBNO2;ARID1B;ATP2B4;HOXA10;PHF20;RET;MTF2;TCF7L2;TCF4;JMJD1C;LIN9;TEAD2;PITX3;PPP3CB;ESRRG;WNT5A;CNBP;SKAP1;ATF7IP;RCOR1;TOX3;ATMIN;KLF10;ACVR1;FOXA3;ELF5;FOSL1;IRF2BPL;SOST;INPP5K;ASCC1;HNF1B;DYRK1A;CDKN1B;ETS2;JUNB;TRIB3;ASCL4;KLF13;LYL1;CHD1;SPDEF;ARRB1;HNRNPK;TGFB1;FOXN2;HOXD8;HOXD1;TGFA;BCL3;ZNF326;GMEB2;TCF3;HNRNPD;NFKB1;GATAD2A;MAMSTR;PCBD2;ARID1A;KDM4C;NEUROD1;CTBP1;POLA1;WWC2;BACH2;CITED1;NRL;CDT1;ZNF2;CREM;KAT6B;PHF6;SMARCA5;PSEN1;CREB1;FOXK1;PRDM8;CRK;MYBBP1A;SUB1;BRD4;PCGF5;CHD2;HINT1;TCF15;SOX4;RELB;MAP2K3;AEBP2;MAFB;BRIP1;BACH1;MED27;RNF4;YEATS2;EDRF1;NFIB;CREB3L4;MAMLD1;MAD2L2;SP2;KLF12;SMAD5;SRCAP;SFRP2;USF2;EGR3;FOXN3;SMARCE1;ZBTB10;CDK18;PHF20L1;TFAP4;GAS6;POU2F1;CSRNP1;SPEN;RBM15;BTG1;CNOT2;MMS19;ZMIZ1;ENY2;RB1;ZMYND11;ATF6;EID1;CBFB;SP3;CEBPD
prerank,acylglycerol catabolic process (GO:0046464),0.49930757822051214,1.2154130966534324,0.23575949367088608,0.6799554739947763,1.0,6/30,15.26%,ABHD2;LIPE;LPL;FABP12;PNPLA2;FAAH
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),-0.3457912207393162,-1.2151971255183913,0.12546125461254612,0.6586123498118259,1.0,18/72,17.22%,FGFR2;FGF1;HNRNPH1;SPRED1;FGF2;RBFOX2;FLRT2;FLRT1;TIA1;FGFBP1;FGFR4;SPRED2;FGF7;POLR2B;POLR2K;HNRNPA1;FGF10;GTF2F1
prerank,negative regulation of JNK cascade (GO:0046329),0.4858228147027394,1.2147749419297778,0.2049586776859504,0.6809498671160399,1.0,1/31,0.03%,MECOM
prerank,regulation of hemopoiesis (GO:1903706),-0.5532106345493175,-1.2142736583351397,0.2202247191011236,0.6595754720423019,1.0,4/10,14.20%,PTN;PRKCB;RUNX1;IL17D
prerank,negative regulation of interleukin-2 production (GO:0032703),0.5323694131847381,1.2140840760059493,0.25,0.6820511853841941,1.0,5/18,12.67%,HDAC7;CD34;HOMER2;HOMER3;ZFP36
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.4744352449490538,1.2138430953374222,0.22,0.6818839093677876,1.0,8/39,8.29%,ACER2;NEXMIF;FZD4;NOTCH1;ACTN4;ADAM15;RASA1;NF2
prerank,cellular calcium ion homeostasis (GO:0006874),-0.3236344329616573,-1.212967765507374,0.08791208791208792,0.6617276592340908,1.0,22/133,10.29%,SLC24A3;ANK2;ATP13A5;ATP13A3;BCL2;SLC8A3;ATP1B1;SLC8A1;MCU;DMPK;SLC35G1;TRPC3;STIM1;PRKACA;TRPC6;ANXA6;TRPC1;ATP2A2;RYR2;CXCL12;SLC24A2;TRPC4
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.6104359782473416,1.2129321225928436,0.2677595628415301,0.683729688830848,1.0,2/10,6.14%,ESR1;ATF7IP
prerank,central nervous system myelination (GO:0022010),-0.5320903266662091,-1.2129283285818897,0.23348017621145375,0.660164895839372,1.0,8/11,22.51%,PLP1;B4GALT6;CNTNAP1;MYRF;TENM4;PTEN;ABCA2;SOX10
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.47005628565940344,1.2126100709269938,0.22884012539184953,0.683798930132037,1.0,13/37,15.95%,CAV1;NCK1;BOK;RPS7;BCL2L11;LCK;BCL2L1;SIAH1;BID;RACK1;S100A9;DDIT3;BMF
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.5559645584570722,1.2122840514625977,0.24236983842010773,0.6838945731352007,1.0,7/16,22.35%,INSR;BNIP3;IGF1R;IRAK3;GLE1;TBC1D25;HDAC6
prerank,regulation of cytoplasmic translation (GO:2000765),-0.5029292872437503,-1.2122195386226278,0.2459396751740139,0.6605263126133059,1.0,4/14,7.10%,CPEB1;CPEB2;CPEB3;CPEB4
prerank,mesonephros development (GO:0001823),-0.5304112053502614,-1.2115719861328864,0.24311926605504589,0.6606337979097167,1.0,4/11,2.95%,FGF1;BMP7;OSR1;BMP4
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),-0.518416203698782,-1.2114767400942452,0.24611973392461198,0.6591906919270104,1.0,5/13,12.06%,IRS1;IGF2;PRKCZ;ECHDC3;SNX5
prerank,rRNA 3'-end processing (GO:0031125),-0.5436601249232077,-1.2112227339664274,0.232409381663113,0.6582154619899053,1.0,4/10,19.16%,ERI3;EXOSC7;EXOSC3;EXOSC9
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.5154164769063865,1.210878356850557,0.22240802675585283,0.6870303011566767,1.0,10/24,15.75%,OCLN;WASF2;NCKAP1;RAC1;TWF2;FSCN1;CYFIP1;ACTR2;ACTR3;ARPC2
prerank,carboxylic acid catabolic process (GO:0046395),-0.5212063352645386,-1.2107027543966469,0.24305555555555555,0.6580435545546789,1.0,4/12,12.63%,RENBP;NAGK;GNPDA1;PON3
prerank,lymphocyte migration (GO:0072676),0.4828254481900949,1.2104321083335334,0.2248062015503876,0.6874663945838918,1.0,4/32,10.40%,S1PR1;MSN;RET;CCL14
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.44664956022059854,1.210213055700194,0.2066957787481805,0.6872698773743227,1.0,8/52,7.36%,PRKCH;STX3;SPTBN1;NKD2;SORBS1;ATP2B4;ITGA3;ATP2C1
prerank,cGMP metabolic process (GO:0046068),0.5609545444718944,1.2101438794272055,0.2703180212014134,0.6866155189121367,1.0,2/12,2.54%,PDE2A;NPR1
prerank,cell junction organization (GO:0034330),0.42839738949834394,1.2097756337488572,0.18157543391188252,0.686889571699824,1.0,13/71,9.62%,TJP1;APBB2;APP;OCLN;PPFIBP1;LIMS2;TJP2;PPFIA2;OPHN1;TGFB1;AGRN;PSEN1;TJP3
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.4391158873371079,1.2095962259642026,0.20196353436185133,0.6865738633517324,1.0,24/59,23.27%,DAB2IP;NFKBIA;IKBKB;TNFRSF1A;BCL3;RELB;IKBKG;RIPK1;RELA;RIPK2;BIRC3;NKIRAS1;TRAF6;ERC1;TBKBP1;TAB3;BIRC2;IRAK2;TIFA;BCL10;REL;NLRC3;TANK;TRAF2
prerank,purine nucleotide catabolic process (GO:0006195),0.5644125363037386,1.2095602808746542,0.27007299270072993,0.6858373658217792,1.0,5/13,14.45%,GDA;NT5C2;HINT1;XDH;NUDT15
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.5013743400253945,1.2093574156257982,0.2255054432348367,0.6856088746974925,1.0,4/29,5.59%,TNFSF10;CAV1;PAK2;RET
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.489668231922068,1.2088446235455486,0.2389240506329114,0.6862795793687079,1.0,2/33,1.15%,PRKG1;MEF2C
prerank,regulation of smooth muscle cell proliferation (GO:0048660),-0.37965986594162593,-1.2086109650839336,0.1701492537313433,0.6625106487478234,1.0,10/46,4.51%,IGF1;PDGFRB;OGN;IGFBP5;IL18;BMP4;CDH13;THBS1;IGFBP3;APOD
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.49504385842558035,1.2085460716568686,0.23197492163009403,0.6862361229587847,1.0,5/29,5.73%,ELOVL7;ACSL4;FASN;ELOVL5;ACSL5
prerank,cardiac left ventricle morphogenesis (GO:0003214),0.5729802622610185,1.2081424701135703,0.2756756756756757,0.6864812035787883,1.0,5/13,12.94%,NOTCH1;CPE;FOXF1;SFRP2;TGFBR2
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.5625628760990821,1.2081113354299253,0.25945017182130586,0.6857429485281414,1.0,11/16,26.73%,CHMP4B;CHMP4A;VPS28;TMEM50B;STAM;VTA1;LEPROT;VPS36;VPS25;TMEM50A;CHMP4C
prerank,protein acetylation (GO:0006473),0.49273350131756144,1.2078775448760763,0.2384737678855326,0.6855844348729987,1.0,6/30,15.39%,FOXO1;HAT1;NAA11;KAT2B;KAT6A;NAA16
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.5119966635134976,1.2072122125249123,0.24615384615384617,0.6866804481771442,1.0,5/22,7.03%,PDGFB;PDGFD;TAOK2;GREM1;PDGFC
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.5944008050245928,1.2066340856810787,0.2809611829944547,0.6874495185531672,1.0,7/11,16.67%,ARHGEF2;CASP8;PELI1;YBX3;RIPK1;BIRC3;BIRC2
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.421206668235416,1.205647243459766,0.1889763779527559,0.6893624561987163,1.0,19/87,8.35%,ENG;ACVRL1;CLDN5;F11R;SMAD1;SMURF1;PARD3;NRROS;PXN;FKBP1A;ID1;PTPRK;SMAD7;USP15;DUSP22;ACVR1;TGFB1;PTK2;CITED1
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.503554378375338,1.2055252626058464,0.24414715719063546,0.6889264269248311,1.0,5/25,9.92%,TAL1;STAT3;HIF1A;ACVR2A;MAPK11
prerank,negative regulation of ossification (GO:0030279),0.5237403164094294,1.2054951973434582,0.2652027027027027,0.6881942241113791,1.0,7/23,7.02%,MEF2C;PTK2B;NOTCH1;FGF23;GREM1;SOST;SRGN
prerank,negative regulation of phosphorylation (GO:0042326),-0.343678646976925,-1.205297478838759,0.13765182186234817,0.6704527139829193,1.0,13/85,4.40%,PID1;PTPN13;NTRK3;PLPP3;PRKN;BMP7;FBLN1;NUPR1;HDAC4;PPARA;BMP4;IGFBP3;IMPACT
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.5208439849619516,1.2051373032956287,0.2354948805460751,0.6883679029552865,1.0,8/21,15.14%,MYH9;ADAM10;SPPL2A;ERAP1;PSEN1;APH1A;ADAM17;SPPL3
prerank,protein O-linked glycosylation via serine (GO:0018242),-0.5467462906267007,-1.2049317765181435,0.2565789473684211,0.6698024670951195,1.0,5/10,25.59%,GALNT13;POGLUT2;GALNT1;GALNT3;GALNT16
prerank,axon development (GO:0061564),-0.3480293407768453,-1.2049145965953725,0.12096774193548387,0.6682207088289858,1.0,20/78,11.40%,DOCK7;FGFR2;SEMA5A;GRM7;BRSK1;PLP1;S100A6;ANK3;SHTN1;RYK;NTNG1;S100B;CTNNA2;DCC;NRCAM;BAIAP2;NREP;RAB10;GAP43;CNTN4
prerank,histone acetylation (GO:0016573),0.4398096240975636,1.2048409024803879,0.20422535211267606,0.688381803677256,1.0,16/69,15.21%,LEF1;EPC1;PHF20;JADE2;JADE1;KAT6B;HAT1;JADE3;YEATS2;EP400;PHF20L1;KAT2B;MBIP;KAT6A;ZZZ3;TRIM16
prerank,regulation of myeloid cell differentiation (GO:0045637),0.4361077531363117,1.2047922191449507,0.2184873949579832,0.6877145170672815,1.0,13/62,11.56%,MEF2C;ZBTB16;CDK6;LYN;PTK2B;KMT2E;H3-3A;TNRC6C;ZFPM1;MAFB;EIF6;RBM15;CBFB
prerank,inositol phosphate-mediated signaling (GO:0048016),0.5278169261304381,1.2046264064116035,0.24787775891341257,0.6873482996358306,1.0,5/19,10.12%,NFATC1;EDN1;PPP3CA;PPP3CB;NMUR2
prerank,glycerophospholipid metabolic process (GO:0006650),0.4192182491591219,1.2046236967720434,0.20107962213225372,0.6865520597443536,1.0,16/75,14.62%,GPCPD1;PLA2G4A;PLCG1;SERINC5;PLCB1;DGKH;ENPP6;ABCA3;PLA2G2D;SYNJ1;GDPD1;PIGQ;PIGG;PDXP;PNPLA6;PIGF
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.5161415859280706,1.204179795188474,0.2592,0.6869147794462647,1.0,6/24,9.68%,HTR2A;PLCG2;LCK;ITPR3;PKD2;ERO1A
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.47596888695420064,1.2041481610054479,0.2248062015503876,0.6861921425377733,1.0,10/35,11.53%,ESR1;PLPP1;NR3C1;KDM3A;DDX54;NCOA4;NEDD4;ARID1A;ZMIZ1;UBE3A
prerank,inhibitory synapse assembly (GO:1904862),-0.5163183904691363,-1.203820913114982,0.25313807531380755,0.6696349807131404,1.0,5/11,12.88%,GABRG2;GABRA2;PLXNB1;LGI2;GABRB3
prerank,regulation of filopodium assembly (GO:0051489),-0.3997457796424707,-1.203753672405766,0.1729106628242075,0.6682138134487262,1.0,16/38,15.28%,DPYSL3;DOCK11;NRP1;RHOQ;PRKCD;ARAP1;TENM2;FXR2;NLGN1;RIPOR2;TGFB3;GAP43;PALM;PLPPR5;RALA;CAPZB
prerank,organophosphate ester transport (GO:0015748),0.5013689094775433,1.2036576770435445,0.24052718286655683,0.6867200505555832,1.0,5/24,9.85%,PLTP;SCARB1;PRELID2;ABCA3;PITPNC1
prerank,positive regulation of transferase activity (GO:0051347),0.39234346755183114,1.203042324217203,0.1569115815691158,0.6875873744027607,1.0,21/142,7.80%,TEK;FLT1;KDR;DCUN1D3;TIE1;EPHB4;CD200;INSR;NEK7;SERINC5;FBXW7;FLT4;HMBOX1;LMTK2;DTX3L;GREM1;RET;TRIB3;TGFB1;HNRNPD;WRAP53
prerank,regulation of neuron apoptotic process (GO:0043523),-0.337894258724086,-1.20291424916583,0.1322314049586777,0.6688632394424998,1.0,39/96,24.16%,EPHA7;PRKN;BCL2;NUPR1;SLC30A10;NRBP2;PPARGC1A;NDNF;NTRK2;NF1;NGF;SIX1;TRIM2;EGLN3;SNX6;CPEB4;SRPK2;RETREG1;APOE;TGFB3;NFATC4;TGFB2;GRID2;PRKCI;MT3;MDK;CLCF1;PPT1;TYRO3;BACE1;NTF3;CRLF1;AGAP2;FAIM2;CLN3;BAX;NSMF;AKT1S1;ERBB3
prerank,regulation of cardiac muscle cell contraction (GO:0086004),-0.4290157592785297,-1.2028073931512324,0.22371967654986524,0.6675512727468949,1.0,6/27,10.19%,ANK2;CACNA1C;DLG1;ATP2A2;RYR2;CTNNA3
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.4883747750256431,1.2027769820855394,0.23380726698262244,0.6874735426894091,1.0,4/29,5.65%,LEF1;TLE4;TCF7L1;TCF7L2
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.3533437590738122,1.2027016431844162,0.04641775983854692,0.6868673093849017,1.0,134/807,12.75%,MECOM;LEF1;ELK3;RPS6KA5;FOXO1;CD38;HDAC9;ATP8B1;DACH1;ZHX3;LDB2;CAV1;ESR1;SMARCA2;PPARD;MEF2C;CBFA2T3;ZBTB16;SOX7;AHR;ETV6;LRRFIP1;PDGFB;IRF2;FOXP1;DAB2IP;SOX13;EDN1;HHEX;PDE2A;NEDD4L;STAT3;EFNA1;NR3C1;FNIP2;NOTCH1;PPM1F;KLF7;RREB1;KLF8;TGIF1;PLCB1;ZFP57;SOX18;HMBOX1;RIPPLY3;KLF2;ELK4;RPS14;MCPH1;SDCBP;VGLL4;SCMH1;FOXL2;ID1;EPC1;PTPRK;SMAD7;DLL4;SBNO2;MTF2;TCF7L2;DUSP22;WNT5A;CNBP;ATF7IP;RCOR1;KLF10;NR1I3;FBP1;IRF2BPL;INPP5K;CDKN1B;ETS2;TRIB3;SPDEF;TGFB1;BCL3;TCF3;NFKB1;GATAD2A;CTBP1;WWC2;CITED1;CREM;KAT6B;PHF6;EZH1;PSEN1;CREB1;TAF3;FOXK1;MYBBP1A;ZFPM1;RPL23;DICER1;BACH1;YEATS2;NRIP1;MAD2L2;SP2;SKIL;CNOT1;KLF12;SFRP2;UBE2D3;FOXN3;SEMA4D;SMARCE1;TFAP4;GAS6;POU2F1;SPEN;RBM15;CNOT2;RB1;ZMYND11;EID1;CBFB;SP3;SAMD1;PRDM2;DCAF1;MUC1;NOP53;MIER1;SIRT6;RELA;MAX;PRICKLE1;PA2G4;ZFP36;RPL10;MIDEAS
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.4138577662691421,1.2026159112551535,0.19764397905759162,0.686269810751068,1.0,15/88,10.49%,EXOC6;CLINT1;APP;EXOC6B;SCAMP1;DOP1B;ARRB1;AP2A1;EXOC5;AP1S2;LLGL1;SNAP23;PUM1;EXOC4;VAMP8
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.51003086032437,1.2025111890409228,0.26986754966887416,0.6857541960273488,1.0,2/24,2.95%,ABCG2;ALAS1
prerank,positive regulation of Ras protein signal transduction (GO:0046579),-0.35424545006632946,-1.202384373553885,0.1513157894736842,0.6671556800540859,1.0,10/62,5.64%,ROBO1;NOTCH2;IGF1;LPAR1;COL3A1;AKAP13;RASGRF1;AUTS2;ALS2;NGF
prerank,response to interferon-beta (GO:0035456),0.519144442744886,1.202003644507333,0.24587458745874588,0.6863508178335017,1.0,11/22,19.11%,AIM2;IFNAR2;UBE2K;IFITM3;IRGM;PNPT1;CDC34;STAT1;PLSCR1;BST2;IFITM1
prerank,sodium ion export across plasma membrane (GO:0036376),-0.5010530631731518,-1.2019590905196493,0.2374429223744292,0.6667686707737064,1.0,4/13,11.27%,ATP1A2;ATP1B1;ATP1B2;SLC9A1
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.5918212797480695,1.2016507482435834,0.2912966252220249,0.6865225991716103,1.0,5/11,14.03%,ATF7IP;TASOR;PPHLN1;SIRT6;SETDB2
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.5002057365762467,1.2012314785806886,0.2247557003257329,0.6869054682527395,1.0,4/25,5.85%,ABI3;TBC1D30;EVL;LIMK2
prerank,fatty acid biosynthetic process (GO:0006633),0.4384303730466122,1.201180319178169,0.21636615811373092,0.6862482459072191,1.0,10/63,11.84%,ELOVL7;PTGS2;ABHD2;ELOVL5;XBP1;ASAH2;LPL;LTC4S;DEGS1;ABCD1
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.38987738808075245,1.2011683015173351,0.174390243902439,0.6854870411101375,1.0,17/138,8.70%,TEAD4;HDAC9;ESR1;PPARD;NR5A2;MAML2;NR3C1;HDAC7;NOTCH1;WWTR1;TEAD2;ESRRG;NR1I3;GTF2F2;GTF2E2;TAF3;TAF4B
prerank,negative regulation of receptor internalization (GO:0002091),0.5808066805225611,1.2007470575774015,0.27387387387387385,0.6858661462608491,1.0,3/12,4.84%,ANKRD13A;RIN3;SDCBP
prerank,negative regulation of defense response to virus (GO:0050687),-0.522758134628993,-1.2003177902855056,0.2650103519668737,0.6699149903498844,1.0,7/10,31.50%,PCBP2;ITCH;TRAF3IP1;PPM1B;C1QBP;RNF26;MUL1
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.5619550797034596,1.1996772050682214,0.2854609929078014,0.6879756542012934,1.0,5/14,11.40%,PPP3CA;PPM1F;NCK1;PPP2R2C;PPP2R2D
prerank,regulation of muscle cell differentiation (GO:0051147),0.48077636206607116,1.199603205843168,0.25117004680187205,0.6873987724180844,1.0,9/31,9.92%,HDAC9;MEF2C;CDH2;CTNNA1;TCF3;BNIP2;CDH15;SPAG9;MAPK11
prerank,heme biosynthetic process (GO:0006783),0.5175367769060215,1.1995850865673936,0.2635135135135135,0.6866590553962651,1.0,2/22,2.95%,ABCG2;ALAS1
prerank,positive regulation of keratinocyte migration (GO:0051549),-0.5405135284694321,-1.1989887297971098,0.28794642857142855,0.6721603790433026,1.0,6/10,32.73%,IQSEC1;ADAM9;FGF7;FGF10;MTOR;EPB41L4B
prerank,positive regulation of T cell differentiation (GO:0045582),0.4646968740141925,1.1986677837127888,0.21350078492935637,0.688408339833018,1.0,8/36,11.30%,LEF1;TESPA1;XBP1;IHH;SOX4;IL23A;IL7;ZMIZ1
prerank,negative regulation of response to wounding (GO:1903035),-0.46290911900455595,-1.1986280381948224,0.23918575063613232,0.6715856118076906,1.0,8/19,16.94%,PTPRS;FGF2;CD109;CASK;AJAP1;SERPINE1;CERS2;MDK
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.4757075581575445,1.1982479359151157,0.23053435114503817,0.6886988312378557,1.0,6/34,9.42%,PTPRB;PTPN12;PTPRJ;DUSP22;DUSP16;PTPN1
prerank,regulation of granulocyte chemotaxis (GO:0071622),-0.46071786507802137,-1.19797453320026,0.22982885085574573,0.6718181081466923,1.0,3/19,3.57%,CAMK1D;IL34;THBS1
prerank,regulation of cholesterol storage (GO:0010885),0.5442584217446464,1.1979337492062154,0.2773972602739726,0.6887817565691788,1.0,5/15,15.51%,PPARD;SCARB1;LPL;ABCG1;TTC39B
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.3758045826103135,1.1969406891687404,0.14301801801801803,0.6907136623702783,1.0,40/208,12.73%,NOD1;TNFSF10;ESR1;TNFRSF19;PRKD1;DAB2IP;TRIM14;CASP8;FKBP1A;TRAF1;PLCG2;PLEKHG5;TIRAP;EDAR;IKBKB;TRIM68;PELI1;PLK2;WNT5A;MID2;CD40;TNFRSF1A;ATP2C1;TRIM25;MAP3K3;MALT1;CASP1;NEK6;BRD4;IKBKG;TNIP1;ZMYND11;IRAK4;RIPK1;CARD16;MIER1;RELA;RIPK2;GSTP1;BIRC3
prerank,protein N-linked glycosylation (GO:0006487),0.4284999758739907,1.196607836286515,0.20260492040520983,0.690755692951662,1.0,5/66,1.62%,ST6GAL1;SLC39A8;ST3GAL1;MGAT4A;STT3B
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.4633485416990511,1.196496462606895,0.24492979719188768,0.6902689569458431,1.0,11/39,12.94%,KDR;ENG;TIE1;RASIP1;LRP5;DLL4;PKD2;CITED1;SFRP2;MET;TGFBR2
prerank,regulation of response to biotic stimulus (GO:0002831),0.49874096013793384,1.1962665388794809,0.2496,0.6901293882428186,1.0,11/28,16.96%,FOXP1;SAMHD1;CASP8;TIRAP;N4BP1;XIAP;ERAP1;BIRC3;ZMPSTE24;BIRC2;ELMOD2
prerank,membrane repolarization (GO:0086009),-0.4930979297979312,-1.1959583036410948,0.2543859649122807,0.6760907916006522,1.0,5/15,9.88%,ATP1A2;ATP1B1;KCND3;KCNJ2;ATP1B2
prerank,nuclear membrane disassembly (GO:0051081),-0.504414849424029,-1.195880385449765,0.23788546255506607,0.6746925985804552,1.0,5/14,13.49%,PRKCB;LPIN1;PRKCA;AKAP8L;CNEP1R1
prerank,exit from mitosis (GO:0010458),0.5835050484015705,1.1953795374389786,0.28214285714285714,0.691866774401373,1.0,6/12,23.45%,EPS8;CHMP4B;PPP2R2D;CTDP1;SIRT7;CLASP2
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.33579790222456773,-1.1951846275031694,0.1320754716981132,0.6750054673713467,1.0,24/86,13.53%,BMP6;ZEB2;SULF1;BMPR1A;FOXD1;BMP5;BMP7;TGFBR1;BMP4;THBS1;TWSG1;CCN1;RBPJ;TGFB1I1;DAB2;INHBA;HIPK2;SLC2A10;TGFB3;TGFB2;ACVR1B;NUP93;GDF11;GDF1
prerank,negative regulation of metabolic process (GO:0009892),-0.36857889100128866,-1.1951444859537532,0.18092105263157895,0.6734902675871728,1.0,10/54,7.08%,PLCL1;ALDH1A1;DOCK7;LGR4;NPR3;ADAMTS5;FOXC2;ACOT11;NOVA1;RBPJ
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.4474704047889023,1.1944319941009367,0.22028985507246376,0.6937244621109808,1.0,2/53,1.96%,CALCRL;HTR2A
prerank,triglyceride catabolic process (GO:0019433),0.5329450334894755,1.1938122455047864,0.2779605263157895,0.6947175222339679,1.0,3/19,13.65%,LPL;FABP12;PNPLA2
prerank,regulation of necroptotic process (GO:0060544),0.5017631123677149,1.1935405859042725,0.2533112582781457,0.6946820151291433,1.0,8/23,12.73%,ARHGEF2;CASP8;SDCBP;PELI1;MLKL;YBX3;RIPK1;BIRC3
prerank,dopamine metabolic process (GO:0042417),0.5347138643961216,1.1934170222038598,0.2691029900332226,0.6942715324411445,1.0,4/18,7.00%,MAOA;GCH1;MAOB;SNCAIP
prerank,positive regulation of interleukin-12 production (GO:0032735),0.48707630330495744,1.1932628303830497,0.26666666666666666,0.6939440406366835,1.0,7/31,12.40%,PLCB1;PLCG2;TIRAP;CD40;IL23A;MAPK11;RIPK2
prerank,positive regulation of cellular biosynthetic process (GO:0031328),-0.3072705446934231,-1.1932174421133346,0.13071895424836602,0.6773295069421106,1.0,30/166,10.71%,SAMD4A;IGF1;ZEB2;EGFR;PLD1;PDGFRB;GLI2;IRS1;SLC6A9;LPGAT1;THBS1;P2RX4;FGF2;SMOC2;CPEB3;PPARGC1A;HSP90AA1;FXR2;SMAD3;IGF2;LDLR;SREBF1;PRR16;GLI1;LARP6;RGCC;ARNT;CIRBP;SLC27A1;FGFR4
prerank,regulation of nervous system development (GO:0051960),-0.3843585432972468,-1.1931541826527783,0.20056497175141244,0.6759069882023979,1.0,12/37,18.36%,DOCK7;PTN;SIRT2;PER2;HEYL;LGI4;BHLHE41;HEY2;NPHP3;TENM4;HMGB2;HEY1
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.4012255501678616,1.1930966044044895,0.2139240506329114,0.6935959055882517,1.0,26/118,10.81%,SHANK3;ABI3;TBX1;LFNG;MEF2C;NEDD4L;ADGRA2;PLXND1;LZTS1;PPFIA2;FLT4;PAK2;CDH2;DLL1;TSPAN12;CEACAM1;FMNL2;EGLN1;TNIK;TGFB1;NEDD4;ZRANB1;CYRIB;SEMA4D;RC3H1;EPHA4
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.3829592980782884,1.1929186715442115,0.16484848484848486,0.693286528315496,1.0,22/166,8.70%,TEAD4;HDAC9;ESR1;PPARD;NR5A2;MAML2;NR3C1;HDAC7;NOTCH1;WWTR1;CAVIN1;TEAD2;ESRRG;NR1I3;GTF2F2;TAF1B;POLR1A;GTF2E2;RRN3;SMARCA5;TAF3;TAF4B
prerank,negative regulation of actin filament polymerization (GO:0030837),0.513952233848449,1.1926994037995813,0.2733224222585925,0.6930868948106179,1.0,7/22,11.96%,KANK3;HIP1R;SSH2;TMSB4X;CYRIB;TWF2;PFN4
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.5894389071884515,1.192664467283898,0.27355072463768115,0.6924046593888723,1.0,3/12,8.23%,FOXP1;TIRAP;LPL
prerank,Fc receptor signaling pathway (GO:0038093),0.3979934092854371,1.192621414643996,0.1856060606060606,0.6917369676038556,1.0,39/110,23.10%,NFATC1;PLCG1;LYN;PPP3CA;PLCG2;PAK2;IKBKB;MAPK8;PPP3CB;RAC1;PSMA2;NFKB1;MALT1;IKBKG;PSMA8;PSMA6;CUL1;RELA;TRAF6;PSME1;LAT;SOS1;TAB3;CALM1;MAP2K4;PSMA4;GRB2;PSMF1;PAK1;BCL10;PSMB7;MAP3K1;PSMB1;MAP2K7;PSMD2;PSMA5;PSMC3;JUN;FCER1G
prerank,negative regulation of nuclear division (GO:0051784),-0.5340093677845663,-1.1923715206353855,0.25943396226415094,0.6764215281855813,1.0,3/11,7.21%,BMP7;BMP4;TOM1L2
prerank,regulation of interleukin-1 production (GO:0032652),0.5559219759707816,1.1923424079749676,0.29246935201401053,0.6917133976268773,1.0,3/15,10.66%,FOXP1;CEACAM1;GAS6
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.416360770426963,1.1922604292218113,0.2162883845126836,0.6911612569112077,1.0,12/78,7.33%,PRKCH;ABI3;STX3;SPTBN1;PPP2R5A;NKD2;NUMB;SORBS1;STX7;ATP2B4;TGFB1;ITGA3
prerank,blood vessel diameter maintenance (GO:0097746),0.4725070958855843,1.1919317293885312,0.250386398763524,0.6913269677037436,1.0,5/34,5.56%,NOS3;EDN1;NPR1;KLF2;KCNMB4
prerank,regulation of cellular biosynthetic process (GO:0031326),0.4911350636377112,1.191834405324779,0.25,0.6908047520168739,1.0,8/28,12.61%,ADIPOR2;TNFRSF1B;CX3CR1;RAC1;SIRT5;NOS1AP;EIF6;ADIPOR1
prerank,cellular response to interleukin-7 (GO:0098761),0.5307094596899777,1.1915388878961561,0.26537785588752194,0.6900457471099067,1.0,7/17,11.13%,SOCS2;STAT3;JAK3;CISH;JAK1;IL7R;IL7
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.5307094596899777,1.1915388878961561,0.26537785588752194,0.6900457471099067,1.0,7/17,11.13%,SOCS2;STAT3;JAK3;CISH;JAK1;IL7R;IL7
prerank,nucleosome assembly (GO:0006334),0.4864615115260688,1.1911639097814,0.260655737704918,0.6903023132842404,1.0,10/31,16.50%,PADI4;H3-3A;KAT6B;SMARCA5;HAT1;NAP1L4;GRWD1;NPM1;ATRX;ANP32B
prerank,negative regulation of cilium assembly (GO:1902018),0.566239840996379,1.1911153249671544,0.28520499108734404,0.6896499525641353,1.0,2/12,5.85%,TBC1D30;LIMK2
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.46064405628704247,1.1910616682116204,0.24005681818181818,0.6890306554333674,1.0,8/43,7.32%,PPARD;PDGFB;GATA2;STAT3;NR3C1;HIF1A;FOSL1;TGFB1
prerank,cardiac ventricle development (GO:0003231),0.5236068761256134,1.1906659365028358,0.26916524701873934,0.6892793083272105,1.0,4/20,5.27%,ENG;PDE2A;NOTCH1;DLL4
prerank,negative regulation of protein autophosphorylation (GO:0031953),0.5911718110686817,1.1903228709486304,0.28893058161350843,0.6894713367938139,1.0,2/10,0.86%,ENG;CAV1
prerank,N-glycan processing (GO:0006491),0.5296163681449593,1.1900374629249206,0.25274725274725274,0.6894178968626723,1.0,5/18,15.07%,MGAT4A;MAN2A1;ST8SIA4;GNPTAB;MAN1A2
prerank,peptide catabolic process (GO:0043171),-0.43655877014785566,-1.1899287527437448,0.19896640826873385,0.6819518083303765,1.0,4/23,7.32%,CPQ;GGT5;NPEPPS;ENPEP
prerank,regulation of extracellular matrix organization (GO:1903053),-0.48594510427012505,-1.189787829958332,0.2441860465116279,0.6807156258439537,1.0,9/15,10.71%,LRP1;AEBP1;DDR1;FAP;EFEMP2;RUNX1;DDR2;SLC2A10;FGFR4
prerank,response to glucose (GO:0009749),0.45277915480806596,1.1897248945617505,0.24514200298953662,0.689467145908837,1.0,14/46,13.78%,UNC13B;ERN1;KCNB1;XBP1;TCF7L2;LPL;NEUROD1;EIF2B5;SOX4;GAS6;RACK1;PFKL;IGF1R;EIF2B2
prerank,epithelial cell differentiation (GO:0030855),-0.3372276017573591,-1.1896649766706815,0.14682539682539683,0.6794595044786633,1.0,18/88,13.11%,FSTL1;MAF;FGFR2;BMP4;ERBB4;SCUBE1;ANXA1;SIX1;JAG1;DAB2;BDH2;GLI1;VEGFA;TAGLN;ANXA4;RAB10;FZD7;VDAC1
prerank,regulation of dendrite morphogenesis (GO:0048814),-0.41279204331211583,-1.1893380771947437,0.1897018970189702,0.6787531737216733,1.0,9/32,5.84%,SDC2;HECW2;ADGRB3;OBSL1;CUX2;CAPRIN2;PTPRD;IL1RAPL1;CUX1
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.5786884246352013,1.1893095251068677,0.2808586762075134,0.6897689352691294,1.0,3/13,12.72%,PTGS2;NAXE;SLC5A8
prerank,protein targeting to lysosome (GO:0006622),0.519670213200968,1.1886197349432313,0.28061224489795916,0.6908294926841508,1.0,9/20,18.79%,NCOA4;GCC2;NEDD4;SCARB2;M6PR;GNPTAB;RAB7A;NAGPA;GGA3
prerank,regulation of cell growth (GO:0001558),0.3746791685480071,1.1884721792099704,0.14716106604866744,0.6904541562901895,1.0,36/204,11.67%,BMPR2;NET1;DCUN1D3;APBB2;SMARCA2;ACVRL1;SH3BP4;SOCS2;ADAM10;NPR1;PTPRJ;SOX17;KIF26A;TAOK2;RPS6KA3;PPP1R9B;SDCBP;RPS6KA1;VGLL4;CEACAM1;H3-3A;CISH;ADAM15;JADE1;FBP1;DCSTAMP;CDKN1B;TGFB1;RPTOR;SGK3;MAD2L2;CYP27B1;SFRP2;BTG1;RB1;IL17RB
prerank,regulation of synapse maturation (GO:0090128),0.5885384540720152,1.1883937719107172,0.2821969696969697,0.6899055843021474,1.0,2/10,2.14%,ARHGEF15;DAB2IP
prerank,negative regulation of cell migration (GO:0030336),0.3861465958740068,1.1883476872317444,0.18472906403940886,0.6892538986110855,1.0,23/137,6.76%,PTPRG;LIMCH1;MCTP1;DACH1;ENG;NEXMIF;ACVRL1;CLDN5;ADARB1;DAB2IP;SRGAP3;SRGAP2;PTPRJ;STK24;SRGAP1;ADGRG1;EVL;PTPRK;SMAD7;DUSP22;ADAM15;RAC1;STK26
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.5169073827753868,1.1870985001798386,0.27787307032590053,0.6919058983449192,1.0,4/22,4.28%,DAB2IP;LYN;MFHAS1;TIRAP
prerank,positive regulation of JUN kinase activity (GO:0043507),0.5040212620707374,1.1870973324034577,0.2809917355371901,0.6911481955331211,1.0,5/23,8.93%,DAB2IP;EDN1;TNFRSF11A;SASH1;MAP3K11
prerank,positive regulation of protein metabolic process (GO:0051247),0.39865302564181426,1.1870638256707935,0.20539152759948653,0.690479962846169,1.0,18/110,9.88%,FOXO1;APP;SMURF1;DAB2IP;NEDD4L;PAEP;NFKBIA;KLF2;MAPK8;PLK2;WNT5A;CDKN1B;TGFB1;NEDD4;PSEN1;CSF1;IL23A;VPS28
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.43672008652474154,1.1869148354744707,0.22608695652173913,0.6901144065104322,1.0,19/54,16.67%,CASP4;CASP8;TRAF1;SPPL2A;IKBKB;HIPK1;TNFRSF1A;CASP1;IKBKG;GAS6;RIPK1;CARD16;GSTP1;RACK1;BIRC3;ADAM17;UBE2K;OTULIN;BIRC2
prerank,endothelial cell migration (GO:0043542),0.4766868290326773,1.1861276431161747,0.26339969372128635,0.6915341758343996,1.0,8/37,5.01%,NOS3;MYH9;ADGRA2;PLXND1;PXN;SOX18;PLEKHG5;ID1
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.5679400035835638,1.1859475214129551,0.3026086956521739,0.691238508979021,1.0,5/12,13.03%,PTPN14;TGFB1;NEDD4;NUP214;UHMK1
prerank,leukotriene biosynthetic process (GO:0019370),0.5557226159592499,1.1859118563406126,0.28647686832740216,0.6905788532665428,1.0,3/14,8.63%,PLA2G4A;ALOX5AP;LTC4S
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.419814119674136,1.1856952279124027,0.2152777777777778,0.6903825429046353,1.0,13/72,8.09%,TEK;FLT1;KDR;INSR;PDGFB;LYN;PDGFD;SELP;PDGFC;PIK3CG;PTK2;NEDD4;GAB1
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),-0.370325952472985,-1.1855129425159538,0.17006802721088435,0.6879518903098633,1.0,11/57,8.32%,LPAR1;ADCY5;ADCY1;ADCY2;AKAP12;GRM7;ADCY7;ADCY6;PSAP;GNAI1;ADRA2A
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.5043910751775761,1.1854926242805222,0.26677577741407527,0.6901304209646955,1.0,6/26,12.61%,ADIPOR2;ELOVL5;CEACAM1;TRIB3;EIF6;ADIPOR1
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.5016854726459395,-1.1852479318718825,0.23703703703703705,0.6870734327904721,1.0,3/13,6.95%,ERRFI1;CBLB;SNX6
prerank,positive regulation of response to external stimulus (GO:0032103),0.3898404081245048,1.1850866113927794,0.19509043927648578,0.6904280260516764,1.0,24/128,12.18%,APP;IL15;STX3;PDGFB;PDE2A;GBP5;PPM1F;NFKBIZ;NFKBIA;SCARF1;USP15;WNT5A;SASH1;TNFRSF1A;TGFB1;LPL;PUM1;IL23A;TNIP1;NMI;P2RY12;PUM2;RIPK1;OASL
prerank,regulation of protein phosphorylation (GO:0001932),0.3672549106649614,1.1848100273520679,0.1590145576707727,0.6903871314492713,1.0,41/256,8.62%,TEK;LIMCH1;PECAM1;KDR;ENG;TBX1;APP;PDE8A;OCLN;INSR;VEGFC;PPP2R5A;DAB2IP;LYN;FAS;EFNA1;FNIP2;BST1;FYN;WWTR1;FLT4;FGF23;STK4;RALB;VEGFD;ACVR2A;LIMK2;CCDC88A;PRR5L;KRAS;CD40;INPP5K;RAC1;ARRB1;TNIK;TGFB1;PTK2;NIBAN1;PPP2R5E;PPP2R5B;AKT2
prerank,keratinocyte differentiation (GO:0030216),0.4901294434933216,1.1846059854524265,0.25873015873015875,0.6901747239721976,1.0,7/29,14.08%,UGCG;BCR;EXPH5;WNT5A;CLIC4;TXNIP;ASAH1
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.4984931175399908,1.1845968266928686,0.26644182124789206,0.6894473894346954,1.0,5/23,9.37%,ELOVL7;ACSL4;ELOVL5;ACSL5;FAR2
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.4680915550206398,1.1841348945118815,0.24233128834355827,0.689914531312918,1.0,7/36,8.29%,CAV1;NOTCH1;JAK3;GHR;BCL3;PIGU;NF2
prerank,regulation of brown fat cell differentiation (GO:0090335),0.5353928336117066,1.1840333302317625,0.2815884476534296,0.6894752695276747,1.0,3/16,3.01%,PTGS2;SOX13;RREB1
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),-0.5304002235661163,-1.1835849661148832,0.27061310782241016,0.69044749414961,1.0,6/10,21.13%,IRS1;IRS2;SLC45A3;SNCA;GPLD1;PTH1R
prerank,negative regulation of calcium ion transport (GO:0051926),-0.4879988712518852,-1.1832656683913598,0.2647058823529412,0.6898155217441538,1.0,1/15,0.03%,ATP1A2
prerank,axonogenesis (GO:0007409),0.3676678170356061,1.1829573043700834,0.17579908675799086,0.691657924383921,1.0,41/237,10.81%,NRP2;SHANK3;SEMA6A;RPS6KA5;APP;SEMA5B;EPHB4;SPTBN1;SEMA7A;PLCG1;PARD3;EFNA1;NOTCH1;KLF7;BSG;FYN;TAOK2;LAMA3;ROBO4;EVL;LMTK2;LAMA1;SEMA6B;RET;ULK1;OPHN1;PPP3CB;WNT5A;PTK2;B4GALT5;GRB7;GAB1;SEMA6D;FEZ2;LLGL1;DSCAM;SIAH1;SEMA4D;CXCR4;SPTAN1;EPHA4
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.4364459154533967,-1.1822070566033422,0.2454308093994778,0.6894936690872685,1.0,10/23,18.64%,ZEB2;THBS1;TGFB1I1;DAB2;HIPK2;SLC2A10;CITED2;CDKN1C;FLCN;MEN1
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.4364459154533967,-1.1822070566033422,0.2454308093994778,0.6894936690872685,1.0,10/23,18.64%,ZEB2;THBS1;TGFB1I1;DAB2;HIPK2;SLC2A10;CITED2;CDKN1C;FLCN;MEN1
prerank,regulation of myelination (GO:0031641),0.4957809731206899,1.1821119347294962,0.2576985413290113,0.6931110623025781,1.0,4/25,5.31%,JAM2;PARD3;TNFRSF1B;TMEM98
prerank,positive regulation of calcium ion transport (GO:0051928),-0.38862327856232093,-1.18202131172414,0.21448467966573817,0.6884385122428323,1.0,8/36,9.31%,ANK2;PDGFRB;CACNA1D;P2RX4;CACNB2;TRPC3;TRPC6;CXCL12
prerank,intracellular lipid transport (GO:0032365),0.5172105512009062,1.1816861184543215,0.28449744463373083,0.6935040278685947,1.0,6/21,11.84%,CERT1;ACACB;ABCD4;PLEKHA8;CPT1A;ABCD1
prerank,regulation of glycogen biosynthetic process (GO:0005979),-0.4220152099927017,-1.1813001716825506,0.228287841191067,0.6889477839746303,1.0,8/24,12.15%,IGF1;IRS1;ENPP1;SELENOS;IGF2;IRS2;PPP1R3C;PPP1R3F
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.5100421061993381,1.1809813139032077,0.2909090909090909,0.6946295901265649,1.0,6/23,8.14%,PIEZO1;MEF2C;EDN1;GREM1;TGFB1;ATP11A
prerank,sterol transport (GO:0015918),0.5184615066901682,1.1809538516669897,0.28397212543554007,0.6939517101920493,1.0,1/19,0.86%,CAV1
prerank,regulation of activated T cell proliferation (GO:0046006),-0.4175437013580118,-1.1808666647883983,0.21584699453551912,0.6885320301397878,1.0,4/30,5.19%,IGF1;IGFBP2;IL18;IGF2
prerank,cellular response to retinoic acid (GO:0071300),0.45340272289227856,1.1808236215326953,0.2620481927710843,0.6935358622389712,1.0,11/42,11.11%,TBX1;FZD4;LYN;PTK2B;RET;WNT5A;WNT9B;BRINP2;CREB1;TWF2;ABL2
prerank,melanosome transport (GO:0032402),0.532680232763582,1.1808073827263705,0.285958904109589,0.6920862150691235,1.0,2/18,2.16%,RAB27A;RAB11A
prerank,pigment granule transport (GO:0051904),0.532680232763582,1.1808073827263705,0.285958904109589,0.6920862150691235,1.0,2/18,2.16%,RAB27A;RAB11A
prerank,negative regulation of mononuclear cell migration (GO:0071676),-0.5254122706647535,-1.1804509680378572,0.27111111111111114,0.6880742472402879,1.0,5/12,11.08%,NBL1;BMP5;CCN3;SLIT2;MIA3
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),-0.4193438893161264,-1.180121528006003,0.24390243902439024,0.6874682657935327,1.0,10/26,17.19%,EGFR;ANXA1;CCND2;ADAMTS1;UBE2E2;TFDP1;RGCC;CDK10;HYAL1;FGF10
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.5569810357959896,1.1798789556798122,0.2874564459930314,0.6937876984902397,1.0,4/14,5.27%,MMRN2;NOTCH1;CARD10;DLL4
prerank,cellular response to BMP stimulus (GO:0071773),-0.3507395323582808,-1.179831419414745,0.18181818181818182,0.6866630347027587,1.0,13/66,6.29%,BMP6;ADAMTS12;BMPR1A;TGFBR3;DDX5;BMP5;RGMA;BMP7;BMP4;RUNX2;SMAD6;SMAD3;TMEM100
prerank,synaptic vesicle localization (GO:0097479),0.562357689576999,1.1790469664258254,0.27041742286751363,0.6952734562763127,1.0,1/13,0.41%,RAB27A
prerank,cellular macromolecule catabolic process (GO:0044265),0.43918462136564834,1.1783044432555863,0.257183908045977,0.6965013619245686,1.0,16/49,16.64%,STT3B;DAB2IP;ISG20;RNASEH2A;MTREX;UBE2G1;HNRNPD;RAB12;RNASEH2C;RIPK1;RNASEH2B;OGA;XRN2;RNF5;PNPT1;CHEK2
prerank,second-messenger-mediated signaling (GO:0019932),0.3991619256913579,1.1779062068007133,0.20810810810810812,0.6968159957126978,1.0,8/82,5.38%,NOS3;MCTP1;PLCG1;EDN1;SELE;PLCG2;PPP1R9B;CX3CR1
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.41564423501043324,1.1771013742463392,0.23439667128987518,0.6982870009261273,1.0,18/75,13.24%,HEG1;RASIP1;DAB2IP;HHEX;LRP5;LYN;PTPRJ;PRKAR2B;PKIG;INPP5K;CDKN1B;PTPN1;TFAP4;RB1;STK38;GSTP1;INCA1;DUSP7
prerank,fat-soluble vitamin metabolic process (GO:0006775),-0.43956804560412677,-1.1760261281893318,0.24607329842931938,0.6960556600064296,1.0,2/22,1.34%,ALDH1A2;RBP1
prerank,positive regulation of cellular protein catabolic process (GO:1903364),0.5204324784080591,1.17595861553438,0.2962328767123288,0.7006017817641212,1.0,3/18,4.89%,CTSC;MSN;VGLL4
prerank,lipoprotein biosynthetic process (GO:0042158),0.5808702193961429,1.1759207713839102,0.30978260869565216,0.6999472033847578,1.0,1/11,1.17%,UGCG
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.40587985223224454,1.1748000225132884,0.23076923076923078,0.7021588865182147,1.0,20/85,13.54%,CBFA2T3;ECSCR;RNF144B;DAB2IP;FBXW7;NKD2;SMAD7;RNF144A;TRIB3;ATXN3;KCNE2;RAD23A;SUMO2;HECTD1;COP1;NOP53;PRICKLE1;RACK1;TRIB1;FMR1
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.5725163541003961,1.1746467269068206,0.30700179533213645,0.7018153056358031,1.0,4/11,7.92%,TBX1;LRP5;WNT5A;CTNNBIP1
prerank,regulation of mitotic cell cycle (GO:0007346),0.37382292900424136,1.1746319690043199,0.1983663943990665,0.7011279717107602,1.0,37/171,14.52%,APP;NEK7;IQGAP1;TAL1;PIM3;SIK1;AFAP1L2;TTC28;CAV2;PKN2;SDCBP;BTG3;EIF4E;ASAH2;CDKN1B;TGFB1;BRINP2;PSMA2;NEK6;ANAPC7;ANAPC1;BTG2;PSMA8;ANGEL2;PSMA6;TFAP4;BTG1;CDC26;RB1;EIF4EBP1;CUL1;LGMN;ANAPC16;CDC25C;BUB3;PDXP;PSME1
prerank,positive regulation of cellular protein metabolic process (GO:0032270),-0.3212409940171943,-1.1746037602312678,0.15625,0.6985848305478598,1.0,18/101,10.71%,SAMD4A;PLD1;CYFIP2;OGT;THBS1;ASPH;CPEB3;HSP90AA1;DACT1;FXR2;AGTR1;PRR16;EZR;BTRC;LARP6;INHBA;CIRBP;FGFR4
prerank,tricarboxylic acid metabolic process (GO:0072350),-0.5047542700394163,-1.1745009094385406,0.2703962703962704,0.6973048043085722,1.0,5/12,23.78%,IDH2;IDH1;IDH3A;ACO2;IDH3G
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.5273172907970494,1.173779198875604,0.2748735244519393,0.7026308230869258,1.0,3/17,5.11%,DGKZ;PTPRJ;CEACAM1
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.5824679974810856,1.1718312776623026,0.30134357005758156,0.7071059532970616,1.0,3/10,11.86%,PDE8A;STK26;RIPK1
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.49146049335122033,1.1716527168276887,0.2815533980582524,0.7068522350281438,1.0,6/25,10.89%,HIP1;HIP1R;AFAP1L2;CCDC88A;BCAR3;CBL
prerank,regulation of cell communication by electrical coupling (GO:0010649),0.5535670838902341,1.1709402013029564,0.300556586270872,0.7079611284081971,1.0,2/13,2.87%,CAV1;PDE4D
prerank,gene silencing by miRNA (GO:0035195),0.4670198480373544,1.1704867161986316,0.27099841521394613,0.7083957025705212,1.0,10/32,13.14%,CNOT6;TNRC6C;DICER1;PUM1;CNOT1;EIF6;ADAR;PUM2;ZFP36;CNOT7
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.584006523097984,1.1701260538159706,0.2977941176470588,0.7086015289734453,1.0,2/12,6.76%,CEACAM1;TRIB3
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.5773469807648275,1.1700559610173074,0.2967032967032967,0.7080253487510793,1.0,3/10,5.22%,LYN;FAS;GREM1
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.49901956683606663,1.1700048328574615,0.30477759472817134,0.7074137865601676,1.0,3/26,2.59%,SHANK3;APP;PTK2B
prerank,I-kappaB phosphorylation (GO:0007252),0.5781200256449266,1.169573445651529,0.311284046692607,0.7078360272877854,1.0,2/10,14.40%,DAB2IP;ERC1
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.4061746759025462,1.1693052142640277,0.2416555407209613,0.7078290933272979,1.0,22/86,10.42%,PECAM1;APP;IL15;PDGFB;IL6R;ARHGEF2;EFNA1;PTK2B;PTPRJ;BST1;FYN;PLCG2;PAK2;GHR;ENPP2;ACVR1;TGFB1;ITGA5;SAMSN1;IL23A;SFRP2;SEMA4D
prerank,regulation of cytokinesis (GO:0032465),0.40804362345171186,1.1690232587379132,0.24197860962566844,0.7078066966993992,1.0,22/78,21.86%,PKP4;RAB11A;PKN2;PLK2;AURKA;SH3GLB1;AURKC;BCL2L1;KIF23;PDXP;GIPC1;E2F7;CALM1;RHOA;CUL3;PRPF40A;CETN2;PRKCE;GIT1;PLK1;RACGAP1;PIK3R4
prerank,cellular response to osmotic stress (GO:0071470),0.5052819326471709,1.1687996362127442,0.30033557046979864,0.7076672853247201,1.0,6/21,16.39%,ARHGEF2;TRPV4;PKD2;YBX3;MYLK;ZFP36L1
prerank,artery development (GO:0060840),0.5128574305788721,1.168619761354428,0.30327868852459017,0.7074046083736686,1.0,6/23,5.17%,BMPR2;ENG;TBX1;ACVRL1;PDE2A;SMAD7
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),-0.4414800305255626,-1.1683773389402108,0.2425,0.7133210758468694,1.0,6/22,11.44%,BMP7;CD44;MBP;GCNT2;WNK1;FLOT2
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.5326336291270936,-1.1681342059632802,0.27645788336933047,0.7124583380952302,1.0,6/10,29.91%,DLGAP4;NPTXR;DLGAP1;DLGAP2;NPTX2;BEGAIN
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.5202012292771296,1.1679936630275298,0.2864157119476268,0.7082952173882182,1.0,5/19,4.58%,SEMA6A;DAB2IP;JCAD;DLL1;TSPAN12
prerank,chromatin assembly (GO:0031497),0.4614542346727876,1.1678613490198126,0.27203647416413373,0.7079157389603579,1.0,14/38,22.14%,PADI4;LIN54;H3-3A;KAT6B;SMARCA5;EZH1;NAP1L4;GRWD1;NPM1;ATRX;ANP32B;BAHD1;SART3;PRDM9
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.5725450881952256,1.1677483890904863,0.32656826568265684,0.7074930649863842,1.0,5/10,17.60%,PDE2A;PDE4D;APLNR;PDE3A;CDC34
prerank,positive regulation of muscle cell differentiation (GO:0051149),0.48833915469917344,1.1676825198915397,0.2679738562091503,0.7069251623122774,1.0,8/24,9.92%,MEF2C;CDH2;CTNNA1;TCF3;BNIP2;CDH15;SPAG9;MAPK11
prerank,cellular senescence (GO:0090398),-0.414120894326179,-1.167241097072905,0.23577235772357724,0.7135019557207034,1.0,13/27,28.80%,PRKCD;ECRG4;TBX2;CDKN1A;TBX3;MAP2K1;ULK3;TERF2;SMC6;ID2;CALR;CDKN2B;SMC5
prerank,cell-cell junction assembly (GO:0007043),0.4251887774537548,1.1669374314337968,0.2421340629274966,0.7081494672395283,1.0,9/63,5.62%,TJP1;PKP4;CLDN5;PKN2;PAK2;CDH2;SMAD7;CTNNA1;RAMP2
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.5379044311694592,1.1668966235224174,0.30324909747292417,0.7075086126596556,1.0,5/16,10.24%,SMCHD1;SHLD1;CGAS;MAD2L2;HELB
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),-0.3135712600814236,-1.1666839166681016,0.12,0.7134913415613999,1.0,23/122,11.56%,SAMD4A;IGF1;EGFR;PLD1;PDGFRB;GLI2;IRS1;SLC6A9;THBS1;AR;FGF2;SMOC2;CPEB3;FXR2;IGF2;PRR16;GLI1;LARP6;RGCC;CIRBP;FGFR4;TGFB2;IRS2
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),-0.474374250028548,-1.1665003468051123,0.27315914489311166,0.7124335868625089,1.0,6/16,24.14%,SLC39A14;PRKCA;GPER1;MRAP2;ACP3;C3
prerank,positive regulation of smoothened signaling pathway (GO:0045880),-0.4432684816453566,-1.1662419979372016,0.24561403508771928,0.7117091197586812,1.0,9/21,20.13%,DCDC2;EVC;ARMC9;GLI1;SFRP1;SMO;KIF7;ULK3;GAS8
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.4176680790965307,1.1661988601210624,0.2517580872011252,0.7086979997359341,1.0,11/69,9.60%,APP;ARHGEF2;STAT3;PTPRJ;PLCG2;TIRAP;WNT5A;LPL;PSEN1;TNFRSF8;IL23A
prerank,modification-dependent protein catabolic process (GO:0019941),0.36624765058059155,1.1656651176867214,0.2,0.7093466566029362,1.0,51/193,18.42%,RNF125;KLHL3;SMURF1;RNF144B;NEDD4L;ZNRF3;DTX3L;XBP1;KCTD10;FBXL4;KCTD6;UBL7;AURKA;RNF144A;UBE3B;ATXN3;ARRB1;RNF7;UBE2G1;ARRDC1;RNF167;FBXL7;NEDD4;TRIM25;UBE2H;ANAPC7;RNF146;ANAPC1;SIAH1;RC3H1;CBL;CDC26;LONP1;MYLIP;ANAPC16;RNF215;KLHL8;UBE2K;BUB3;TOPORS;ELOC;ARIH2;RNF5;AREL1;NDFIP2;NEDD8;UBE2I;CUL3;CDC34;RNF40;PSMF1
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.580588458777688,1.165585120367169,0.3079777365491651,0.7088103793456817,1.0,2/10,5.38%,CEACAM1;CX3CR1
prerank,cellular protein metabolic process (GO:0044267),0.3497678614500025,1.1647961747037257,0.15122470713525027,0.7101934064139251,1.0,112/396,15.89%,ST3GAL6;APP;ST3GAL1;MGAT4A;MSRB3;DAB2IP;ADAM10;YES1;FUCA2;RPS15;FGF23;CPE;UBA7;CDH2;IGF2BP3;RPS19;RPLP1;RPS14;PADI4;RPSA;RPS16;RPL38;QSOX1;CSF2RB;SPARCL1;RPL34;ABCA3;RPS20;RPL39;VWA1;RPS7;RPS24;ST8SIA4;GOLM1;UBE2G1;RPL37A;SRBD1;RPL36;RPS18;RSL24D1;RPL15;PSEN1;AKT2;RPS8;RPL14;RPL23;RPL17;APLP2;FBXL2;FBXW2;CSF1;MRPS18A;ERO1A;RPL9;DHPS;RPL4;RAB12;RPL13A;UBE2D3;RPS11;RPL32;TNIP1;ICMT;GAS6;APH1A;RPL22;RPS27;RPL31;RPS23;ABL2;MRPL13;RPL13;MRPS12;RPS12;STK38;LGMN;RIPK1;MRPL35;HBS1L;RPL6;RPL10;WARS1;MRRF;OMA1;MRPL41;SPCS1;ADAM17;RPS29;RPS6;PNPLA2;MRPL52;PROC;RPL29;RPS25;RPL35A;RPS13;MSRB2;RPS21;MRPS16;RPL27;LAMB1;RPL18;MRPL23;SPPL3;EVA1A;RPL27A;MRPS5;TMEM132A;RNF5;RPS10;NAGPA;CP
prerank,nitric oxide mediated signal transduction (GO:0007263),0.531004921534933,1.1646150324037223,0.3057553956834532,0.7099147472152284,1.0,1/16,0.31%,NOS3
prerank,protein localization to cell surface (GO:0034394),-0.4103562501927457,-1.164369854161694,0.24867724867724866,0.7154633634277355,1.0,11/26,17.78%,ANK2;ANGPT1;FBLN5;GGA2;PRRT1;FGF7;JAM3;GGA1;WNT11;FGF10;UNC50
prerank,cholesterol homeostasis (GO:0042632),0.4180870144214664,1.1642828719191094,0.2578444747612551,0.7100081779718278,1.0,9/64,8.23%,HDAC9;CAV1;SCARB1;LRP5;MALL;XBP1;CNBP;SOAT2;LPL
prerank,nerve growth factor signaling pathway (GO:0038180),-0.5363221206368034,-1.1641906549673788,0.26824034334763946,0.714398125982799,1.0,3/10,6.71%,MAGI2;NGF;KIDINS220
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.4051414134982701,1.1639761025891506,0.24764468371467024,0.7100894434243675,1.0,16/78,13.36%,CAV1;CBFA2T3;RNF144B;NKD2;SMAD7;RNF144A;TRIB3;RAD23A;SUMO2;HECTD1;COP1;NOP53;SIRT6;PRICKLE1;RACK1;TRIB1
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),0.5475727826524509,1.1638950979452076,0.3230174081237911,0.7095736537643358,1.0,2/13,3.86%,ELOVL7;ELOVL5
prerank,positive regulation of microtubule polymerization (GO:0031116),0.4814592171520279,1.1637779512200894,0.28289473684210525,0.7091479902118938,1.0,9/28,20.86%,OCLN;RAC1;MET;PAK1;CDK5RAP2;CLIP1;NUMA1;RPS3;GIT1
prerank,osteoclast differentiation (GO:0030316),0.49914840891167966,1.163346264048461,0.29604130808950085,0.7095401966023319,1.0,5/22,9.45%,FOXP1;TNFRSF11A;SBNO2;DCSTAMP;CSF1
prerank,positive regulation of interleukin-13 production (GO:0032736),-0.5406777051272079,-1.1632998216558186,0.3163716814159292,0.7153099999639732,1.0,2/10,7.15%,IL18;PRKCZ
prerank,positive regulation of leukocyte degranulation (GO:0043302),-0.4888456857149106,-1.1632966890532845,0.3,0.7137300145918201,1.0,5/13,23.36%,GAB2;STX4;SYK;ITGB2;SPHK2
prerank,negative regulation of cellular metabolic process (GO:0031324),0.4587099012609983,1.1632310639782775,0.2785388127853881,0.7090970195212483,1.0,9/37,7.85%,ANKRD13A;RIN3;EDN1;PLIN5;SDCBP;PTX3;BTN2A2;SIRT5;NFKB1
prerank,positive regulation of macrophage migration (GO:1905523),-0.4501244880183193,-1.1629685461169734,0.2688679245283019,0.7131216909726006,1.0,3/19,3.65%,IL34;THBS1;P2RX4
prerank,plasma membrane organization (GO:0007009),0.42617268700395744,1.1629062265180699,0.2597402597402597,0.7092535144350232,1.0,14/61,11.84%,MYOF;FNBP1L;UGCG;SPTBN1;CAVIN2;MYH9;EHD2;CHMP4A;ARL8B;CXCR4;ANO6;A4GALT;DEGS1;ABCD1
prerank,response to cholesterol (GO:0070723),-0.46691501234017896,-1.162833093734541,0.25934579439252337,0.7119079204148973,1.0,8/17,20.94%,TGFBR1;GRAMD1B;GRAMD1C;LRP6;SMO;GPLD1;PTCH1;ABCA2
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.49832385720207084,1.1627603283309975,0.288,0.7089445850654312,1.0,3/22,9.06%,ESR1;HNF1B;SUB1
prerank,regulation of ATP biosynthetic process (GO:2001169),-0.47698964239096964,-1.1624359372884752,0.24829157175398633,0.7115011872106318,1.0,3/16,4.15%,PID1;PPARA;PPARGC1A
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.43704186024564756,1.1620510055339646,0.2578241430700447,0.7100777064547177,1.0,19/48,22.76%,ARID1B;TAF1B;POLR1A;ARID1A;SMARCA5;MYBBP1A;MYO1C;ZMIZ1;POLR1G;CDCA4;KAT2B;POLR1B;SERTAD2;TAF1A;ATAD2;DEK;POLR2L;ERCC6;PHF2
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.5756009547965906,1.1619734257717445,0.31608133086876156,0.7095656357521704,1.0,4/10,16.10%,DAB2IP;EFNA1;EPHA4;RIC1
prerank,pyruvate metabolic process (GO:0006090),-0.3646500240454387,-1.1615693112549326,0.2,0.7123552770044659,1.0,21/52,27.78%,ME1;ENO2;ME2;HK2;TPI1;LDHB;VDAC1;HOGA1;PDHA1;DLAT;ENO3;PFKFB1;PFKM;PCK2;NR4A3;HAGH;ALDOA;PKM;ENO1;ALDOC;LDHAL6B
prerank,histone H4 acetylation (GO:0043967),0.4363499088460695,1.1615288917798257,0.2558139534883721,0.7100542042797151,1.0,8/47,10.08%,LEF1;EPC1;PHF20;JADE2;JADE1;HAT1;JADE3;EP400
prerank,regulation of osteoblast differentiation (GO:0045667),0.4051348109264186,1.1613915486365123,0.23383768913342504,0.7096552358116186,1.0,18/82,8.35%,ZHX3;BMPR2;IL6ST;MEF2C;PRKD1;CDK6;IL6R;LRP5;HDAC7;NOTCH1;WWTR1;FGF23;ACVR2A;GREM1;ACVR1;PTK2;CTNNBIP1;CITED1
prerank,muscle filament sliding (GO:0030049),-0.3880183627337859,-1.161348203826321,0.2520775623268698,0.709872495256147,1.0,6/38,13.64%,DMD;ACTN2;TPM1;TPM2;DES;TPM4
prerank,actin-myosin filament sliding (GO:0033275),-0.3880183627337859,-1.161348203826321,0.2520775623268698,0.709872495256147,1.0,6/38,13.64%,DMD;ACTN2;TPM1;TPM2;DES;TPM4
prerank,sterol homeostasis (GO:0055092),0.4149374913360054,1.1611064825601942,0.2670299727520436,0.7096423270492023,1.0,13/65,13.76%,HDAC9;CAV1;SCARB1;LRP5;MALL;XBP1;CNBP;SOAT2;LPL;CYP39A1;ABCD1;LIMA1;ABCG1
prerank,negative regulation of mitochondrion organization (GO:0010823),-0.39811545931838477,-1.160498665454982,0.24507042253521127,0.7107842977002037,1.0,2/33,1.21%,IGF1;PRKN
prerank,regulation of small molecule metabolic process (GO:0062012),-0.4159789119022056,-1.1599438574520602,0.22427440633245382,0.7108216627045408,1.0,6/28,9.84%,PRKN;PDK1;PPARA;RORA;EPHX2;APOE
prerank,negative regulation of hormone secretion (GO:0046888),0.5715722458236575,1.159767400415061,0.344294003868472,0.7124545378960738,1.0,3/10,5.35%,RAB11FIP1;FGF23;RAB11FIP5
prerank,actin crosslink formation (GO:0051764),0.5653684587686806,1.1595095142531002,0.3151183970856102,0.7124012096789771,1.0,2/12,1.54%,LCP1;EPS8
prerank,negative regulation of smooth muscle cell migration (GO:0014912),0.552938372375674,1.1594195441859598,0.30297397769516726,0.7119102864488659,1.0,2/14,1.15%,PRKG1;MEF2C
prerank,regulation of ossification (GO:0030278),0.4623806800745583,1.159389911263471,0.28193832599118945,0.7112563924573018,1.0,10/36,10.25%,BMPR2;MEF2C;ZBTB16;S1PR1;NOTCH1;WNT5A;ACVR1;SOST;ANKH;CYP27B1
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),-0.5011341609467549,-1.1590500333642137,0.2938388625592417,0.7118365046592857,1.0,3/11,9.31%,AXL;SELENOS;CXCL12
prerank,response to interleukin-6 (GO:0070741),0.5740382639008543,1.1585961313173516,0.3333333333333333,0.7126016045487671,1.0,4/10,8.35%,ST3GAL6;SBNO2;NFKB1;CITED1
prerank,positive regulation of T cell proliferation (GO:0042102),0.4245384436300644,1.1582004894883526,0.25920679886685555,0.7128905931554096,1.0,9/55,9.60%,IL6ST;VCAM1;IL15;NCK1;JAK3;IL27RA;TNFRSF13C;ICOSLG;IL23A
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.4888867074153803,1.1575962045502777,0.30906148867313915,0.7137655693491847,1.0,7/26,11.79%,APP;TAL1;PKN2;EIF4E;PPP1R10;EIF4EBP1;LGMN
prerank,phosphatidylinositol metabolic process (GO:0046488),0.38688700048470126,1.1575858616074477,0.22411533420707733,0.7130740223464733,1.0,21/109,9.96%,INPP5D;PLA2G4A;PLCG1;PIP5K1B;PITPNM2;PGAP1;MTM1;PIK3C2A;PLCB1;PLCG2;PIK3R6;MTMR6;PLA2G2D;INPP5K;BMX;PIK3CG;PLAAT3;SYNJ1;PLEKHA8;INPP5F;OCRL
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.407928580553429,1.1575182820823755,0.25771812080536916,0.7125352891726082,1.0,18/79,10.31%,BMPR2;EPN2;SMAD1;SMURF1;MMRN2;DAB2IP;HHEX;NOTCH1;SMAD7;ACVR2A;GREM1;ATP2B4;SOST;NEDD4;PTPN1;SKIL;SMAD5;UBE2D3
prerank,RNA catabolic process (GO:0006401),0.43823334878944536,1.1568410687679356,0.27876106194690264,0.7136444391399583,1.0,13/46,16.24%,ERN1;ISG20;NANOS2;RNASEH2A;MTREX;HNRNPD;NUDT16;DCP2;RNASEH2C;RNASEH2B;ZFP36;XRN2;PNPT1
prerank,branched-chain amino acid metabolic process (GO:0009081),-0.44452564710780706,-1.1567983964466266,0.2695035460992908,0.7150969165862652,1.0,7/20,17.71%,ACADSB;MCCC2;IVD;BCKDHB;ACAT1;ACAD8;ALDH6A1
prerank,branched-chain amino acid catabolic process (GO:0009083),-0.44452564710780706,-1.1567983964466266,0.2695035460992908,0.7150969165862652,1.0,7/20,17.71%,ACADSB;MCCC2;IVD;BCKDHB;ACAT1;ACAD8;ALDH6A1
prerank,cardiac ventricle morphogenesis (GO:0003208),0.43842969588884234,1.1563773149013188,0.2791044776119403,0.7141565025307685,1.0,13/41,12.94%,ENG;MEF2C;NOTCH1;FKBP1A;CPE;FOXF1;SMAD7;DLL4;TGFB1;SOX4;SFRP2;MYH6;TGFBR2
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.45301876817728476,1.1560267761036576,0.2662440570522979,0.7143294833903807,1.0,9/38,10.81%,CAV1;APP;PDGFB;NEDD9;EFNA1;PTPN1;FCGR1A;GAS6;EPHA4
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.5228393838157983,1.1557004922539083,0.3316239316239316,0.7145074246294357,1.0,3/17,8.49%,PLA2G4A;PLA2G2D;PLAAT3
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),-0.496245318558145,-1.155498048841509,0.27740492170022374,0.7173076173540732,1.0,5/13,19.81%,BMP5;DKK3;APOE;PLEK;REST
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.40650728890952365,1.155473949378369,0.24161073825503357,0.7144229655572569,1.0,22/70,24.92%,LMO2;GATA2;TAL1;TCF12;PSMA2;TCF3;TCF15;PSMA8;PSMA6;CBFB;PSME1;PSMA4;PSMF1;EIF2AK2;PSMB7;PSMB1;PSMD2;PSMA5;PSMC3;PUS7;PSMD3;PSMA3
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),-0.46703285704621467,-1.1554112611842344,0.2713004484304933,0.7160094049872794,1.0,3/16,4.93%,PRKN;PDK1;RORA
prerank,regulation of keratinocyte differentiation (GO:0045616),0.48312835447348274,1.1552304371849127,0.3108108108108108,0.7143513946784514,1.0,1/24,0.04%,PRKCH
prerank,C4-dicarboxylate transport (GO:0015740),-0.4973313671398665,-1.1551852699210303,0.30385487528344673,0.7151522778072126,1.0,10/14,32.77%,SLC1A2;SLC25A12;SLC25A13;SLC1A1;SLC25A18;SLC25A14;SLC13A5;SLC25A10;LRRC8E;LRRC8D
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.441566919824805,1.154332942035791,0.29153605015673983,0.7160343312571964,1.0,7/37,3.99%,CADM1;VCAM1;ICAM1;PVR;SELE;SELP;AMIGO2
prerank,ribosomal subunit export from nucleus (GO:0000054),0.5497793850195203,1.1541378543581515,0.3302063789868668,0.7158438792984102,1.0,5/13,14.04%,RPS15;XPO1;RRS1;EIF6;NPM1
prerank,amino acid transport (GO:0006865),-0.36013141745442767,-1.1532716429781016,0.22865853658536586,0.7192904763971537,1.0,11/49,11.23%,SLC7A11;SLC7A2;PDPN;SLC1A5;SLC6A12;SLC38A11;SLC25A47;SLC6A15;SLC7A14;SLC7A6;SLC43A1
prerank,oligosaccharide metabolic process (GO:0009311),0.43621277738440745,1.1532194320348919,0.27232796486090777,0.7175409524567992,1.0,2/46,0.45%,ST3GAL6;ST6GALNAC3
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.4455515638734268,1.1527586162268089,0.27136431784107945,0.7180238793316321,1.0,7/38,12.62%,ESR1;DAB2IP;CASP8;TNIP1;ZMYND11;RIPK1;GSTP1
prerank,limb development (GO:0060173),-0.41178955532715555,-1.1525070646949422,0.21875,0.7199828811668048,1.0,5/28,5.42%,SMOC1;GLI3;PCSK5;RSPO2;SALL1
prerank,regulation of neutrophil migration (GO:1902622),0.5707949434916739,1.152061680191184,0.30714285714285716,0.7192091962877839,1.0,2/10,6.61%,BST1;RAC1
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.39906893583250813,-1.1520086566752001,0.22590361445783133,0.7199063136444924,1.0,10/33,9.52%,EGFR;ANXA1;CCND2;STXBP4;ADAMTS1;GLI1;PAF1;UBE2E2;TFDP1;RGCC
prerank,ventricular septum morphogenesis (GO:0060412),-0.40913609745037016,-1.1519683255326472,0.2608695652173913,0.7184880314031564,1.0,8/27,6.87%,ROBO1;BMPR1A;TGFBR3;TGFBR1;BMP4;ZFPM2;ROBO2;HEYL
prerank,regulation of neuroblast proliferation (GO:1902692),-0.46854910148574536,-1.1517845382526641,0.2727272727272727,0.7174717176061606,1.0,6/15,10.32%,PTN;NF1;LRRK2;SMARCD3;VEGFA;FZD3
prerank,neurotransmitter transport (GO:0006836),-0.33076871801852015,-1.1513176505360954,0.1925925925925926,0.7172111699566992,1.0,25/73,16.69%,ATP1A2;SLC1A3;GLUL;SYT1;APBA1;BRSK1;SNAP25;NAAA;NRXN1;SLC6A15;SLC1A2;LIN7A;GABRA2;SNPH;CASK;PTPRN2;SLC29A1;NRXN2;GAD2;SLC1A1;SLC22A2;RIMS1;DVL1;SYN1;PDZD11
prerank,monocarboxylic acid catabolic process (GO:0072329),0.4936630924490321,1.1512787144954726,0.3137931034482759,0.7205364611096245,1.0,4/21,6.56%,PPARD;CYP26A1;LPIN3;CYP26C1
prerank,negative regulation of developmental growth (GO:0048640),-0.398238539907483,-1.151010768657968,0.25742574257425743,0.7165323466788679,1.0,15/30,20.55%,PTPRS;MAP2;DCC;DUSP10;WWC1;CDKN1A;CDKL3;RTN4;SEMA3G;BBS2;ULK2;MT3;NKD1;PTEN;PTCH1
prerank,regulation of interleukin-8 production (GO:0032677),0.4119738599311775,1.150768753123958,0.2664796633941094,0.7211191268339061,1.0,8/69,7.51%,NOD1;PRKD2;STAT3;AFAP1L2;TMSB4X;TIRAP;ARRB1;BCL3
prerank,mammary gland epithelium development (GO:0061180),-0.47698119007779916,-1.1503464124667497,0.296551724137931,0.7169980888953441,1.0,2/14,3.30%,WNT4;ERBB4
prerank,positive regulation of cellular amide metabolic process (GO:0034250),-0.33166140826233415,-1.149530483200651,0.1968503937007874,0.7177678567723281,1.0,13/80,10.09%,SAMD4A;PLD1;ROCK2;SLC2A13;PRKCD;THBS1;CPEB3;LRRTM3;FXR2;PRR16;LARP6;SMPD3;CIRBP
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.5395337175775621,1.1495081467809214,0.33575317604355714,0.7237886033091109,1.0,3/14,9.42%,DAB2IP;BCL2L11;PTPN1
prerank,positive regulation of cell development (GO:0010720),0.46982366758779415,1.1494152350478541,0.2921875,0.7233008043388361,1.0,9/31,17.56%,TGM2;NUMB;CX3CR1;SPEN;PDE3A;SNW1;NIBAN2;RASSF10;RFX3
prerank,regulation of cilium assembly (GO:1902017),0.41328550718715096,1.1491931075868187,0.2556179775280899,0.7231686251729362,1.0,7/62,7.58%,TBC1D8;TBC1D30;TBC1D22A;TBC1D15;LIMK2;CCDC88A;TBC1D2
prerank,dendritic cell migration (GO:0036336),0.5299004586797369,1.1487727045026153,0.307032590051458,0.7235115454724675,1.0,3/16,10.51%,EPS8;PIK3CG;CXCR4
prerank,cellular response to chemokine (GO:1990869),0.4405350247317482,1.1487615584049837,0.28444444444444444,0.7228254726847715,1.0,3/46,6.84%,LRCH1;PTK2B;PPBP
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.5100158514109409,1.148551361915464,0.30615640599001664,0.7226565008423599,1.0,8/20,17.65%,ZBTB16;CDK6;PTK2B;MAFB;ZFP36;ZFP36L1;CDC73;CIB1
prerank,protein localization to lysosome (GO:0061462),0.47655182608428276,1.1482197653867907,0.30293159609120524,0.7228369206498828,1.0,13/28,22.89%,SH3BP4;NCOA4;GCC2;NEDD4;SCARB2;GLMP;M6PR;RAB7A;NAGPA;GGA3;KPTN;MFSD1;LMBRD1
prerank,positive regulation of immune response (GO:0050778),0.41019006971051725,1.1481547465563655,0.24830393487109906,0.7222934629611287,1.0,13/64,19.90%,IL6ST;IL15;GBP5;XBP1;SKAP1;IL23A;NMI;EIF2AK4;KARS1;POLR3B;PLSCR1;NLRP3;SLC15A4
prerank,long-chain fatty acid metabolic process (GO:0001676),0.4152585316524808,1.1479923680116502,0.27071823204419887,0.7220045333988012,1.0,13/64,15.26%,PTGS2;PLA2G4A;ACSL4;ELOVL5;EPHX1;ASAH2;ACSL5;LTC4S;CPT1A;ABCD1;GSTP1;PNPLA8;FAAH
prerank,positive regulation of secretion (GO:0051047),0.5629252669808593,1.1476928894168354,0.3278084714548803,0.7220829498917731,1.0,2/11,4.96%,NPR1;XBP1
prerank,regulation of vasoconstriction (GO:0019229),0.471342378260435,1.1475629995341168,0.3,0.7217323446104199,1.0,3/27,5.56%,BMPR2;CAV1;KCNMB4
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.537678284788862,1.1474603628350781,0.325497287522604,0.7213065195911809,1.0,4/15,7.32%,JAK3;SMAD7;CUEDC2;TGFB1
prerank,myotube cell development (GO:0014904),-0.5145902460574523,-1.147425341521999,0.31554524361948955,0.7222638372846852,1.0,2/10,5.77%,IGF1;SIX1
prerank,mRNA methylation (GO:0080009),0.532359314320842,1.1472779504971915,0.325044404973357,0.721060223638622,1.0,9/15,27.21%,CBLL1;WTAP;VIRMA;TRMT6;METTL14;TRMT10C;TRMT61B;METTL16;NSUN2
prerank,basement membrane organization (GO:0071711),-0.48853692925502795,-1.1469925463016117,0.3143507972665148,0.7218733103914151,1.0,5/14,7.93%,NID1;NID2;NTN4;NTNG1;FLRT2
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.39602270666594824,1.1467976899573784,0.27622841965471445,0.7216011083147091,1.0,11/86,8.58%,APP;OCLN;EDN1;PTK2B;NCK1;EVL;NCKAP1;RAC1;CDC42EP3;TRPV4;PSEN1
prerank,protein localization to chromosome (GO:0034502),0.45449812201055045,1.14662022505273,0.2921875,0.7213550076315601,1.0,12/34,20.94%,ESR1;RPA1;HASPIN;PINX1;ACD;RB1;MCM9;ATRX;RAD21;XRCC4;MSH2;PLK1
prerank,nucleoside salvage (GO:0043174),0.5766839544630737,1.1465831440386294,0.34307992202729043,0.7207396075920828,1.0,3/10,9.72%,UCK2;UPP1;HPRT1
prerank,positive regulation of vasoconstriction (GO:0045907),0.5412410737064529,1.1463748922097656,0.3362521891418564,0.7206045271198394,1.0,1/13,0.86%,CAV1
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.47789769202956306,1.146227356687125,0.30256410256410254,0.7202236742407633,1.0,6/26,11.84%,RAB27A;PLCG2;ABCB7;GRIN1;COA8;ABCD1
prerank,neutrophil migration (GO:1990266),0.4182238635606321,1.14609884057336,0.2722063037249284,0.7198962402486292,1.0,7/58,11.77%,PECAM1;EDN1;BSG;PPBP;PIK3CG;CCL14;IRAK4
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.4028786222124853,1.1453049756848832,0.2713903743315508,0.721226430309906,1.0,13/80,8.27%,NOD1;TNFSF10;SOX7;DAPK1;PPM1F;RPS6KA3;RPS6KA1;FOXL2;XIAP;CYCS;GRAMD4;MALT1;CASP1
prerank,negative regulation of chemotaxis (GO:0050922),0.4654118549107601,1.1452488963810912,0.3136645962732919,0.7206657096343443,1.0,5/31,5.54%,SEMA6A;SEMA5B;SEMA7A;NOTCH1;SEMA6B
prerank,multivesicular body assembly (GO:0036258),0.471443238677149,1.1449637636843828,0.31209150326797386,0.7207198024118262,1.0,15/30,26.73%,RAB11A;CHMP2B;CHMP4B;CHMP4A;VPS28;VPS37C;STAM;VTA1;TSG101;VPS36;STAM2;PDCD6IP;VPS25;CHMP3;CHMP4C
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.5671942638484196,1.144915322458201,0.3379174852652259,0.7201298132871884,1.0,3/10,12.39%,CAV1;KCNE2;KCNRG
prerank,protein localization to organelle (GO:0033365),-0.29925624034809634,-1.1446816497518535,0.12953367875647667,0.7269671770080742,1.0,38/133,18.16%,ANK2;COL1A1;BMP7;BICD1;BMP4;TULP3;WDR35;MICALL1;OBSL1;SIX1;LMNA;ARL3;LAMP2;LRRK2;IFT20;OPTN;TIA1;PAF1;MDM2;GBF1;GET4;EHD1;CNEP1R1;BICD2;MTCH2;BBS9;SYS1;BBS2;ARFRP1;DVL1;ABCA7;GET1;SCG3;IFT140;DDRGK1;FAM83H;TULP1;RAB35
prerank,negative regulation of protein modification process (GO:0031400),-0.33015158751450774,-1.1444872199847012,0.19217081850533807,0.725982576073981,1.0,12/79,6.16%,PID1;PTPN13;NTRK3;DMD;PLPP3;PRKN;SNTA1;FBLN1;IGFBP3;IMPACT;PRKAA2;LRP6
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),-0.3352237988990461,-1.1444257899202233,0.21212121212121213,0.7246554886605815,1.0,21/74,11.50%,PHLDB2;COL1A1;EPHA3;BMP5;PDPN;PHLDB1;TGFBR1;SPRED1;DAG1;SMAD3;AXIN2;TGFB1I1;DAB2;VASN;SFRP1;GCNT2;RGCC;TGFB3;SPRED2;TGFB2;SPRED3
prerank,cellular response to glucagon stimulus (GO:0071377),-0.4538062405483914,-1.1440281728086754,0.2711864406779661,0.7242328269163565,1.0,9/17,14.55%,ADCY5;ADCY1;ADCY2;ADCY7;ADCY6;PRKACA;PRKAR1B;PRKAR1A;ADCY3
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.4208119849531665,1.1438152210840273,0.2686131386861314,0.7223538202654047,1.0,14/49,16.68%,CAV1;SGMS1;BOK;BCL2L11;LCK;PTPMT1;BCL2L1;SIAH1;BID;RACK1;S100A9;DDIT3;BMF;BCL2L10
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.40674983951318827,1.1437828662566512,0.2801120448179272,0.7217264263081007,1.0,11/73,9.60%,APP;ARHGEF2;STAT3;PTPRJ;PLCG2;TIRAP;WNT5A;LPL;PSEN1;TNFRSF8;IL23A
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.517175308369066,1.14338878121839,0.3174061433447099,0.7219639000196764,1.0,2/17,8.23%,HDAC9;LPL
prerank,fatty acid elongation (GO:0030497),0.53773367676759,1.143337709088656,0.3333333333333333,0.721386270233342,1.0,2/13,3.86%,ELOVL7;ELOVL5
prerank,positive regulation of cardiocyte differentiation (GO:1905209),0.5570894373741297,1.1431849826339557,0.3374558303886926,0.7210708107150848,1.0,3/11,7.32%,MEF2C;GREM1;TGFB1
prerank,ephrin receptor signaling pathway (GO:0048013),0.39634794637298687,1.1426086031225338,0.253028263795424,0.7218666296747048,1.0,23/82,12.03%,EPHB4;ANKS1A;LYN;EFNA1;YES1;FYN;KALRN;ARPC3;SDCBP;AP2B1;ARPC1B;RAC1;PTK2;RASA1;AP2A1;PSEN1;ARHGEF7;CRK;APH1A;EPHA4;ANKS1B;GRIN1;ACTR2
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.5317600957198078,1.142571581290571,0.34137291280148424,0.721270344116003,1.0,7/14,24.26%,WRAP53;MMS19;ACTR2;WDR48;FUS;ERCC6;ARID2
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.5036243495914621,1.1425633877245065,0.3059210526315789,0.7205894754343336,1.0,6/20,12.35%,SMAD1;NOTCH1;HIF1A;XBP1;SMAD5;RELA
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.476467995242711,1.1420943288761682,0.3063209076175041,0.7210673275284026,1.0,12/25,27.39%,CHMP2B;CHMP4B;CHMP4A;RILP;TMEM50B;VTA1;LEPROT;CHMP3;TMEM50A;CHMP4C;LYST;SORT1
prerank,negative regulation of ATP metabolic process (GO:1903579),-0.45256653389824725,-1.1420445311750813,0.3103448275862069,0.7286327333335126,1.0,4/17,2.89%,PID1;NUPR1;HDAC4;PPARA
prerank,regulation of protein dephosphorylation (GO:0035304),0.44713667019099906,1.141242704264505,0.3028919330289193,0.7226363509280957,1.0,4/37,2.51%,PPP1R16B;PPP2R5A;PPP1R2;MFHAS1
prerank,regulation of response to oxidative stress (GO:1902882),0.5527375585291312,1.1412391072754464,0.3393177737881508,0.7219469773790221,1.0,1/11,0.56%,MCTP1
prerank,inorganic cation import across plasma membrane (GO:0098659),-0.3296279381039547,-1.140817225978944,0.20141342756183744,0.7306165484690538,1.0,15/75,9.88%,ATP1A2;SLC8A3;CACNA2D1;SLC12A2;SLC6A1;SLC9A9;ATP1B1;SLC8A1;ABCC9;SLC39A14;KCNJ2;KCNJ13;SLC39A10;SLC24A2;ATP1B2
prerank,lipoprotein catabolic process (GO:0042159),-0.5117465369653045,-1.1405234882111093,0.3165322580645161,0.7299556483013657,1.0,6/11,18.94%,NOTUM;APOE;CTSD;ABHD10;ABHD17C;PPT1
prerank,superoxide metabolic process (GO:0006801),0.4700937539505366,1.1400670220692344,0.31160572337042924,0.7241770873851169,1.0,3/29,4.89%,NOS3;NRROS;PREX1
prerank,regulation of phosphorylation (GO:0042325),0.38255254115622606,1.140029479194897,0.2490566037735849,0.723589136790624,1.0,30/120,14.80%,LDB2;ITGA6;APP;NLRC5;LYN;FNIP2;HIF1A;IKBKB;SDCBP;CCDC88A;CDKN1B;PTK2;DYNLL1;PSEN1;ANG;DSCAM;BTBD10;EIF6;NUP214;NUP98;CORO1C;NOP53;PHIP;SLC2A6;NUP133;NUP205;CDH5;NUP54;NUP43;NUP153
prerank,cellular response to ketone (GO:1901655),-0.382460589810262,-1.1399854609199473,0.2631578947368421,0.729949588357871,1.0,11/35,9.25%,ADCY5;ROCK2;ADCY1;ADCY2;AR;ADCY6;SPP1;GNAI1;SFRP1;SRC;PTGFR
prerank,regulation of protein autophosphorylation (GO:0031952),0.44578508805788286,1.1399819747885978,0.29133858267716534,0.7230155138200158,1.0,8/36,8.36%,ENG;PDGFB;PPP2R5A;PDGFD;TAOK2;PDGFC;PPP2R5E;PPP2R5B
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.36853787757043094,1.1396825878673367,0.24646226415094338,0.7230888104121472,1.0,32/158,12.73%,NOD1;TNFSF10;TNFRSF19;PRKD1;TRIM14;CASP8;FKBP1A;PLEKHG5;TIRAP;EDAR;IKBKB;TRIM68;PELI1;PLK2;MID2;CD40;TNFRSF1A;ATP2C1;TRIM25;MAP3K3;MALT1;CASP1;NEK6;BRD4;IKBKG;IRAK4;RIPK1;CARD16;MIER1;RELA;RIPK2;BIRC3
prerank,histone deubiquitination (GO:0016578),0.5144333982735021,1.1395158428464345,0.32730560578661844,0.7227963237373057,1.0,8/18,21.21%,USP3;USP15;BRCC3;ENY2;USP7;USP21;TRRAP;ATXN7
prerank,regulation of acrosome reaction (GO:0060046),0.5691291139354159,1.1386636609119498,0.34074074074074073,0.7242306741780958,1.0,1/10,3.54%,PLCB1
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.4139150223018082,1.1380857411607648,0.2814710042432815,0.7250890796973896,1.0,12/65,8.74%,HIP1;HIP1R;PTPN12;DAB2IP;MVB12B;PTPRJ;AFAP1L2;CEACAM1;CCDC88A;BCAR3;TGFA;ARHGEF7
prerank,positive regulation of catabolic process (GO:0009896),0.41444600606598747,1.1378275074534876,0.26961483594864477,0.7250671882781781,1.0,14/65,15.09%,FOXO1;SMURF1;DAB2IP;NEDD4L;PLK2;WNT5A;CDKN1B;NEDD4;VPS28;RILP;ASB11;RAB7A;APC;VSIR
prerank,cellular response to tumor necrosis factor (GO:0071356),0.3609826895386031,1.137638713014621,0.23404255319148937,0.724837490912035,1.0,43/175,17.82%,DAB2IP;ARHGEF2;AIM2;TNFRSF11A;PTK2B;TNFRSF1B;NFKBIA;ACTN4;TRAF1;TMSB4X;TNFRSF25;EDAR;IKBKB;TNFSF8;DCSTAMP;CD40;INPP5K;TNFRSF1A;PSMA2;TNFRSF13C;YBX3;TNFRSF8;PSMA8;TNFRSF9;CCL14;PSMA6;RIPK1;RELA;ZFP36;BIRC3;HAS2;ADAM17;GBP3;ASAH1;TRAF6;PSME1;BAG4;ZFP36L1;BIRC2;ERBIN;CIB1;STAT1;PSMA4
prerank,regulation of cell projection organization (GO:0031344),-0.4866983347826272,-1.1373733281969902,0.32207207207207206,0.7359979218839784,1.0,9/13,32.61%,NTNG1;MOV10;MFSD2A;MACF1;MYO9A;CCL19;TREM2;SPRY2;ERMN
prerank,negative regulation of viral entry into host cell (GO:0046597),0.5588370571159142,1.1371044189255732,0.3321554770318021,0.7254579808084933,1.0,4/12,7.55%,LY6E;PTX3;MID2;SNX3
prerank,cellular protein catabolic process (GO:0044257),0.41140608543735296,1.137016488633558,0.3041018387553041,0.7249826319276643,1.0,17/59,13.70%,CTSC;DAB2IP;CASP8;AP2B1;UBE2G1;AP2A1;CTSK;CTSO;MALT1;RAB12;PSMA6;BNIP3;LONP1;LGMN;RIPK1;MYLIP;RAB7A
prerank,regulation of JUN kinase activity (GO:0043506),0.4475709347805131,1.136806902432564,0.2751572327044025,0.7248412033449122,1.0,13/33,20.56%,DAB2IP;EDN1;TNFRSF11A;SASH1;DNAJA1;MAP3K11;AIDA;GSTP1;TRAF6;PAK1;HIPK3;DUSP19;RPS3
prerank,regulation of focal adhesion assembly (GO:0051893),0.41973454780976144,1.1366168624744426,0.29160739687055476,0.724640743553966,1.0,10/54,7.46%,TEK;LIMCH1;KDR;ACVRL1;PEAK1;PTPRJ;PPM1F;DUSP22;RAC1;PTK2
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.5664372767705926,1.1364770843254535,0.3333333333333333,0.7242980770565679,1.0,2/10,1.39%,ZBTB16;ACVRL1
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.5098797123878788,1.1359174590256031,0.3167808219178082,0.7250655972373055,1.0,1/17,0.19%,TEK
prerank,vascular process in circulatory system (GO:0003018),0.5402003812240386,1.1350144484215028,0.3390119250425894,0.7260565600661129,1.0,2/13,2.54%,NOS3;NPR1
prerank,regulation of tube diameter (GO:0035296),0.5402003812240386,1.1350144484215028,0.3390119250425894,0.7260565600661129,1.0,2/13,2.54%,NOS3;NPR1
prerank,lipid modification (GO:0030258),0.43946792595301126,1.134922431968896,0.2983257229832572,0.7256038142417807,1.0,6/37,8.05%,PLPP1;DGKZ;SGPP2;LPCAT3;DGKH;MBOAT1
prerank,cAMP metabolic process (GO:0046058),-0.47643296160937454,-1.1347564704642925,0.31235955056179776,0.742120843644898,1.0,5/13,5.09%,ADCY5;ADCY1;ADCY2;ADCY7;ADCY6
prerank,B cell homeostasis (GO:0001782),0.5704446476746471,1.1345636773695251,0.36363636363636365,0.7258265104671268,1.0,2/10,2.31%,MEF2C;LYN
prerank,regulation of neuron differentiation (GO:0045664),-0.33145198458845726,-1.1344619914602632,0.22014925373134328,0.7413574595935375,1.0,29/76,20.77%,ZFHX3;NBL1;BMP7;IMPACT;YWHAG;VWC2;NGF;SIX1;NLGN1;HEYL;LRRK2;DTX1;NRCAM;BIN1;ALK;NREP;CNTN4;BRINP3;GPRC5B;MMD2;DISP3;HEY1;CDK5RAP3;SOX2;REST;NTF3;ID2;TIAM1;KCTD11
prerank,positive regulation of secretion by cell (GO:1903532),0.4034207565263702,1.134431645987929,0.2835408022130014,0.725470692371858,1.0,10/70,8.76%,RAB27A;UNC13B;CADPS2;CD2AP;EDN1;KCNB1;EXPH5;TGFB1;STX1A;ANG
prerank,cellular response to zinc ion (GO:0071294),-0.4668611122518618,-1.134275804835834,0.3414043583535109,0.7403654158844368,1.0,2/15,16.20%,P2RX4;MT3
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.48298651147049043,-1.1341926551134305,0.31105990783410137,0.7390770941422536,1.0,8/13,35.41%,SEC16B;CD81;SEC16A;EDEM2;TMEM30B;TM9SF4;SAR1A;SORL1
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.4815296867082811,1.13387838359478,0.3138801261829653,0.7262826049978282,1.0,5/27,4.01%,SHANK3;TJP1;F11R;WASF2;PAK2
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.5001791700838616,1.1338244437876712,0.3345070422535211,0.7250364970068808,1.0,4/20,2.85%,APP;INSR;HIF1A;PFKFB3
prerank,positive regulation of glycolytic process (GO:0045821),0.5001791700838616,1.1338244437876712,0.3345070422535211,0.7250364970068808,1.0,4/20,2.85%,APP;INSR;HIF1A;PFKFB3
prerank,chromatin assembly or disassembly (GO:0006333),-0.5076603717232068,-1.1333941793758697,0.31235955056179776,0.7398176234225492,1.0,5/11,28.02%,HDAC8;MTA2;TP53;RBBP4;HIRIP3
prerank,regulation of protein export from nucleus (GO:0046825),0.48804124707436575,1.133054011981301,0.34076433121019106,0.72635179939068,1.0,6/23,16.75%,PTPN14;TCF7L2;GAS6;UHMK1;ANP32B;RAPGEF3
prerank,nucleotide-sugar metabolic process (GO:0009225),0.5554138872885607,1.132956777766253,0.32685512367491165,0.7259236316626265,1.0,1/12,0.47%,CSGALNACT1
prerank,base conversion or substitution editing (GO:0016553),0.556796555363233,1.1329026628577594,0.34990791896869244,0.725386074667243,1.0,3/11,11.21%,ADARB1;NUDT16;ADAR
prerank,glutamate receptor signaling pathway (GO:0007215),0.452372075243298,1.132844155474803,0.3020030816640986,0.7248386217207108,1.0,6/37,4.04%,GNAQ;APP;PTK2B;PLCB1;HOMER2;KCNB1
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.41058876532157795,1.1324117663589202,0.3012729844413013,0.7252821122538392,1.0,11/60,12.35%,LEF1;TCF7L2;TNRC6C;ATF7IP;HNF1B;PPM1D;NFKB1;SUB1;MED27;CBFB;RELA
prerank,muscle cell development (GO:0055001),-0.38409136862488485,-1.1319465415435257,0.3027027027027027,0.7423665294979187,1.0,9/30,9.35%,ANK2;IGF1;DMD;CXADR;SLC8A1;EFEMP2;SGCZ;VEGFA;BIN1
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),-0.3595196718399941,-1.1317139563299974,0.2515527950310559,0.741508430583043,1.0,12/48,14.82%,ANK2;DMD;CEMIP;JPH1;AKAP6;PRKACA;UBASH3B;TRPC1;GSTM2;GPER1;JPH2;SNCA
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.511350327315824,-1.1316477374501053,0.32608695652173914,0.7401856863141418,1.0,1/10,0.36%,ZEB2
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.5338276884483271,1.1315950995463928,0.3310104529616725,0.7266543488289172,1.0,4/14,10.57%,PLCG1;ECSCR;CD40;ANO6
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.5635554741560588,1.131135667477929,0.358695652173913,0.7272110142879393,1.0,3/10,13.42%,ADAM10;WNT5A;ADAM17
prerank,detection of calcium ion (GO:0005513),-0.47403705082038167,-1.1309699755427607,0.3258426966292135,0.7406262193236565,1.0,4/13,9.11%,SYT1;KCNMB2;STIM1;RYR2
prerank,regulation of protein processing (GO:0070613),-0.4212715225343412,-1.1306090130269244,0.2835820895522388,0.7401730444506527,1.0,5/21,8.79%,CCBE1;GAS1;SERPINE2;LRRK2;RUNX1
prerank,organelle assembly (GO:0070925),0.33863849884550395,1.1302387759165418,0.21367521367521367,0.7289385300971996,1.0,55/385,12.96%,PGM5;ABCC4;FLII;ABLIM1;FNBP1L;EXOC6;EHD4;NEK7;RAB11A;NOTCH1;STARD9;CNGB1;CD34;TMOD3;SSX2IP;DISC1;STX7;CEP41;EDC3;ULK1;ABCA3;CHMP2B;PCNT;BBIP1;CDS2;RBM14;GRB7;EHD2;DYNLL1;RAB38;EXOC5;NEK6;ATG101;CHMP4B;CHMP4A;TEKT5;G3BP1;VPS28;EXOC4;OCRL;CEP83;RC3H1;RPS23;ARL13B;LSM3;EMC6;EHD3;GABARAPL1;ACTR2;RAB43;RILP;MYH6;WDR11;DBNL;EXOC8
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.3627806135085302,1.1300954568053652,0.2622169249106079,0.7286292094491554,1.0,25/150,8.62%,TEK;ENG;ESR1;INSR;KITLG;PDGFB;HIP1;MFHAS1;RASD2;PTPRJ;FYN;FGF23;F7;CX3CR1;RET;TCF7L2;RAC1;TRIB3;LCK;TGFB1;PIK3CG;PTK2;TGFA;GAB1;AKT2
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.45536638010268504,1.129985784636633,0.3,0.7282474862947859,1.0,8/31,14.11%,PPP1R13B;HIP1R;CASP8;MAPK8;BOK;SFN;BID;YWHAQ
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.4092292317106603,1.129604601962898,0.3001345895020188,0.7285650778592732,1.0,15/63,12.78%,TNFSF10;CAV1;ITGA6;FAS;CASP8;TRAF1;PAK2;TCF7L2;ACVR1;ZMYND11;RIPK1;BID;RELA;GSTP1;PHIP
prerank,activation of protein kinase A activity (GO:0034199),-0.45817754506685493,-1.1294933732055317,0.2942583732057416,0.7417906967365862,1.0,9/16,14.55%,ADCY5;ADCY1;ADCY2;ADCY7;ADCY6;PRKACA;PRKAR1B;PRKAR1A;ADCY3
prerank,positive regulation of histone modification (GO:0031058),0.453850262987586,1.1289868916606975,0.303951367781155,0.7294313742056747,1.0,11/33,21.37%,RPS6KA5;ARRB1;CTBP1;APLNR;GLYR1;FMR1;RPS6KA4;KDM1A;SAP30BP;SART3;TADA2B
prerank,postreplication repair (GO:0006301),0.4267504913098231,1.1288401374197874,0.29239766081871343,0.7291247169191184,1.0,16/45,26.59%,POLK;RPA1;TRIM25;WDR33;PRIMPOL;RAD18;USP43;RFC3;NSMCE1;MSH2;UBE2V2;RFC5;ZBTB1;POLN;UBE2N;RPA3
prerank,regulation of monocyte differentiation (GO:0045655),0.5297391609249726,1.128567654859693,0.3194675540765391,0.729140915039928,1.0,5/14,9.45%,CDK6;FOXP1;DCSTAMP;CTNNBIP1;CSF1
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.5560323483291967,1.1284092622864001,0.362453531598513,0.7288920373305912,1.0,2/10,2.28%,TBX1;LRP5
prerank,cell chemotaxis (GO:0060326),-0.34462529581951423,-1.1283295526389376,0.22569444444444445,0.7436202532102524,1.0,11/60,6.12%,LPAR1;PDGFRB;PDGFRA;NRP1;KIT;CCR9;PRKCD;SEMA5A;PARVA;CCN3;AGTR1
prerank,digestive tract morphogenesis (GO:0048546),-0.4719765075808613,-1.127938952030595,0.3129251700680272,0.7432627093391453,1.0,5/14,11.95%,FGFR2;PDGFRA;RBPMS2;GLI1;STRA6
prerank,regulation of autophagy (GO:0010506),0.3580580782505417,1.1276722714434149,0.23777019340159272,0.7300715734988992,1.0,35/216,11.39%,FOXO1;ACER2;ERN1;PRKD1;DAPK1;RASIP1;SH3BP4;STAT3;TRIM14;FBXW7;PIK3C2A;EIF4E;TRIM68;MAPK8;PLK2;ULK1;BOK;DRAM2;MID2;SH3GLB1;TRIB3;ATP6V0A1;NEDD4;RPTOR;ATG101;FOXK1;FBXL2;ATP6V1G2;NPRL2;EXOC4;DEPP1;PRKAB1;BNIP3;ABL2;ATF6
prerank,positive regulation of BMP signaling pathway (GO:0030513),0.4765387072173118,1.1274310617896082,0.32784184514003295,0.7300290344790946,1.0,5/25,5.18%,BMPR2;ENG;ACVRL1;NOTCH1;ACVR2A
prerank,regulation of secretion by cell (GO:1903530),0.41723114432474223,1.1271540632378818,0.29827089337175794,0.7300991491254839,1.0,14/54,17.27%,MCTP1;MEF2C;KCNMB4;SNCAIP;LLGL1;RAB12;VAMP8;RAB26;RHBDF2;MCTP2;FMR1;RIC1;RAB8B;CPLX2
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.5156145854150288,1.1270543656625593,0.3157894736842105,0.729679156503486,1.0,9/17,25.08%,NUS1;DPAGT1;ALG6;ALG8;MPDU1;DOLK;ALG12;ALG14;DOLPP1
prerank,polyol metabolic process (GO:0019751),0.42237952729698014,1.126701840512073,0.31492537313432833,0.7299214336071419,1.0,9/46,10.61%,INPP5D;PLCB4;PLCG1;PLCB1;PLCG2;ITPKB;SYNJ1;OCRL;INPP1
prerank,pulmonary valve development (GO:0003177),0.505757829874993,1.1260060250340658,0.33687943262411346,0.7310525621445506,1.0,5/18,3.04%,NOS3;BMPR2;NFATC1;NOTCH1;TNFRSF1B
prerank,cellular response to organic substance (GO:0071310),0.3779352080191285,1.1255835726888312,0.2714468629961588,0.731480368705594,1.0,18/116,7.32%,LEF1;PTPN14;BMPR2;ACVRL1;PDGFB;PTPN12;SOCS2;STAT3;SIGIRR;NCOA1;GHR;ACVR2A;MAPK8;ASAH2;RAMP2;ACVR1;INPP5K;TGFB1
prerank,inflammatory response (GO:0006954),0.357757002487405,1.1254378657414499,0.2441860465116279,0.7311639364015745,1.0,31/195,12.40%,HDAC9;NOD1;F11R;NRROS;STAT3;MFHAS1;AFAP1L2;SELE;ADGRE5;ACKR1;IKBKB;PTX3;PLA2G2D;IL36G;CD40;RAC1;PPBP;HNRNPA0;TNFRSF1A;TGFB1;PIK3CG;LY75;NFKB1;PXK;RELB;IKBKG;CCL14;CXCR4;TACR1;RELA;RIPK2
prerank,mitotic nuclear membrane disassembly (GO:0007077),-0.48976993202113256,-1.1253129769001833,0.30042918454935624,0.7492737112544654,1.0,4/12,13.49%,PRKCB;LPIN1;PRKCA;CNEP1R1
prerank,negative regulation of hippo signaling (GO:0035331),0.5331733424297509,1.1244150501046724,0.3551236749116608,0.7330734422355457,1.0,4/12,9.50%,MARK3;VGLL4;WWC2;MAP2K3
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.4373900899796707,1.1239828853465292,0.3203732503888025,0.7334865212577768,1.0,16/42,22.55%,SMCHD1;SHLD1;WRAP53;CGAS;MAD2L2;HELB;MMS19;ACTR2;SIRT6;SPIDR;WDR48;KDM1A;FUS;RMI2;RIF1;ERCC6
prerank,regulation of innate immune response (GO:0045088),0.4113680799794816,1.1239502719243697,0.3029871977240398,0.732896072783985,1.0,18/57,18.51%,GBP5;SAMHD1;CASP8;TIRAP;N4BP1;XIAP;IFNAR2;ERAP1;PTPN1;NMI;BIRC3;HSP90AB1;IRAK3;BIRC2;POLR3B;PLSCR1;PARP9;CDC37
prerank,regulation of protein secretion (GO:0050708),-0.2980682545637489,-1.1238811724654738,0.24413145539906103,0.7520734457129887,1.0,23/119,11.82%,CACNA1C;BMP6;IGF1;RAPGEF4;SLC12A2;CACNA1D;DPP4;FRMD4A;SNAP25;KCNC2;PER2;KCNS3;PRKCA;ERP29;EZR;ADRA2A;RHBDF1;APOE;TGFB3;STXBP5L;MYOM1;TGFB2;ADAM9
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.4169288482414732,1.123519228150579,0.31601731601731603,0.7333328220723699,1.0,8/50,14.18%,NOD1;APP;ACTN4;SASH1;IL23A;NMI;RELA;TRAF6
prerank,regulation of cell-substrate adhesion (GO:0010810),0.4394818024021511,1.1233379164650832,0.30721966205837176,0.7331014896630197,1.0,9/42,8.34%,PDGFB;FZD4;NOTCH1;PPM1F;BST1;RAC1;ATXN3;PTK2;RSU1
prerank,regulation of intracellular pH (GO:0051453),-0.37797732329155337,-1.1232416579750226,0.2879581151832461,0.75247135021202,1.0,12/34,22.67%,SLC4A10;SLC9A9;LRRK2;SLC4A3;SLC4A2;SLC9A1;SLC26A6;CFTR;SLC4A8;SLC9A8;NOX1;CLN3
prerank,heart development (GO:0007507),0.36692311540423994,1.1231400085512455,0.25495049504950495,0.732934536606729,1.0,25/150,7.46%,TEK;HDAC9;BMPR2;TBX1;MEF2C;EPHB4;HEG1;ACVRL1;INSR;PDGFB;NOTCH1;SOX17;CHD7;CASP8;SOX18;FKBP1A;PDLIM1;KDM6A;FOXF1;RBM20;RAMP2;ACVR1;CDKN1B;TGFB1;PTK2
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.49109832904754325,-1.122879803316125,0.34444444444444444,0.7504732237190288,1.0,4/12,16.71%,IGF1;AKAP6;SLC9A1;CAMTA1
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),-0.49109832904754325,-1.122879803316125,0.34444444444444444,0.7504732237190288,1.0,4/12,16.71%,IGF1;AKAP6;SLC9A1;CAMTA1
prerank,nucleocytoplasmic transport (GO:0006913),0.43530165228952045,1.122818546694061,0.32872503840245776,0.733058318493498,1.0,10/40,15.88%,ANP32A;RSRC1;XPO1;MALT1;BACH2;CITED1;NUP98;NUP205;NPM1;DDX20
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.4950311387786771,-1.1226953292442075,0.3394495412844037,0.7494927767086963,1.0,5/11,22.56%,STX4;TICAM1;MAVS;ITGB2;CAMK4
prerank,inositol phosphate metabolic process (GO:0043647),0.4197290145346498,1.1226078915852,0.3164933135215453,0.7329139579571454,1.0,9/46,10.61%,INPP5D;PLCB4;PLCG1;PLCB1;PLCG2;ITPKB;SYNJ1;OCRL;INPP1
prerank,regulation of developmental growth (GO:0048638),0.46093685289063757,1.122524184180555,0.3217665615141956,0.7324519461361338,1.0,5/29,5.15%,APP;INSR;PLCB1;DLL1;GHR
prerank,negative regulation of fat cell differentiation (GO:0045599),0.44615808539096086,1.122446845632409,0.3003194888178914,0.7319946445203895,1.0,9/34,12.50%,FOXO1;GATA2;WWTR1;WNT5A;TRIB3;TGFB1;ZFPM1;ASXL1;TRIO
prerank,neuromuscular process controlling balance (GO:0050885),-0.4715361925747812,-1.1222555176489761,0.3553530751708428,0.7492550035632665,1.0,5/12,22.67%,NRXN1;PCDH15;SHANK1;TPP1;CLN3
prerank,negative regulation of cell communication (GO:0010648),0.4818185907741912,1.122181158084817,0.32405891980360063,0.7319731890640766,1.0,5/21,9.42%,KIF26A;SRMS;FGF23;ACVR1;PTPN1
prerank,aorta development (GO:0035904),-0.4678278448146593,-1.122101583165348,0.3349282296650718,0.7482051232613447,1.0,6/14,7.86%,ROBO1;LRP1;PDGFRB;ROBO2;JAG1;EFEMP2
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.3994105855665346,1.1220978034032345,0.2906815020862309,0.7315200555534872,1.0,20/76,19.71%,CD200;NLRC5;DAB2IP;AIM2;NFKBIA;TMSB4X;ARRB1;LRRC14;IRAK3;DDIT3;G3BP2;OTULIN;CHP1;MAP2K5;ERBIN;IRAK2;USP7;NLRP3;HAVCR2;TAX1BP1
prerank,endothelial tube morphogenesis (GO:0061154),0.5678885909748447,1.1219182148600912,0.3675675675675676,0.7313094078330716,1.0,7/10,19.67%,ACVRL1;PRKD2;CCM2;RHOB;RHOA;CTNNB1;STARD13
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.357422224984153,1.1216986792880168,0.25177304964539005,0.7312136106568348,1.0,23/182,5.98%,KDR;ENG;ESR1;APP;MEF2C;ACVRL1;CLDN5;OCLN;ANKRD13A;PDGFB;RIN3;FOXP1;GATA2;ADAM10;FBXW7;NOTCH1;HIF1A;CD34;SDCBP;DLL4;ATP2B4;TNRC6C;AURKA
prerank,hyaluronan catabolic process (GO:0030214),-0.43912135161440147,-1.121537267113573,0.34405940594059403,0.7482820910110337,1.0,6/18,16.40%,CEMIP;FGF2;CD44;SLC9A1;HEXA;HYAL1
prerank,positive regulation of DNA binding (GO:0043388),-0.38713544660583954,-1.121445421515264,0.2568306010928962,0.7470640795401798,1.0,4/31,5.64%,IGF1;PRKN;SIRT2;NGF
prerank,protein localization to cell periphery (GO:1990778),0.36622541809103776,1.1213092703061989,0.2704714640198511,0.7315023935388727,1.0,24/133,7.64%,CAV1;EHD4;SPTBN1;F11R;SMURF1;RAB11A;TSPAN5;DENND4C;BSG;PACS1;NKD2;FCHO2;KCNB1;IKBKB;TSPAN14;RAMP2;RAPGEF2;TMEM88;INPP5K;ATP1B3;TNIK;TNFRSF1A;RAP1A;EHD2
prerank,MAPK cascade (GO:0000165),0.3424053460454072,1.1212534687104914,0.21878453038674034,0.7309783750251615,1.0,50/295,12.08%,SHANK3;TEK;RASAL2;KDR;MEF2C;SPTBN1;KITLG;RASGRF2;PDGFB;DAB2IP;FYN;TAOK2;RASGRP3;FGF23;MARK3;JAK3;IKBKB;CSF2RB;MAPK8;RET;RAPGEF2;NRAS;KRAS;TNIK;JAK1;TGFB1;PTK2;TGFA;SYNGAP1;RASA1;PSMA2;NFKB1;MAP3K3;RASA4;SHOC2;IKBKG;ZDHHC9;BCL2L1;MAPK11;PSMA8;RGL2;PSMA6;RASA2;SPTAN1;ICMT;CCM2;CUL1;GRIN1;ABHD17B;PEBP1
prerank,regulation of interleukin-17 production (GO:0032660),0.4614964769395161,1.1209773871815365,0.3328025477707006,0.7310279901599055,1.0,8/31,18.15%,IL15;TGFB1;RFTN1;IL23A;VSIR;SLC7A5;DDIT3;CARD9
prerank,long-chain fatty acid import into cell (GO:0044539),0.561090918567913,1.1208099929737032,0.3570057581573896,0.7307871244243307,1.0,1/10,0.52%,SLC2A1
prerank,anterior/posterior pattern specification (GO:0009952),-0.344259300281894,-1.1201352074001558,0.2733333333333333,0.749449470224928,1.0,12/53,6.87%,WLS;HOXC4;HOXC6;TGFBR1;HOXA3;HOXA5;PCSK5;HOXA7;HOXC5;HOXB4;HOXB3;HEYL
prerank,regulation of lipid storage (GO:0010883),0.49011679741566994,1.1199176133305067,0.3327974276527331,0.732424377201511,1.0,6/22,11.76%,FBXW7;NFKBIA;PLIN5;NFKB1;LPL;ITGB3
prerank,engulfment of apoptotic cell (GO:0043652),-0.45345417643470554,-1.1196145194952574,0.3316953316953317,0.7494573661810322,1.0,3/15,3.82%,RHOBTB2;THBS1;XKR4
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.4526195585041945,1.119478661914185,0.33384853168469864,0.732867633518216,1.0,7/30,7.05%,NET1;F11R;ARHGEF3;PRAG1;ADGRG1;RAC1;ARRB1
prerank,monocarboxylic acid metabolic process (GO:0032787),-0.3028958380649968,-1.1192464317976674,0.20754716981132076,0.7490939251656428,1.0,37/117,19.56%,IGF1;ALDH1A2;ABAT;ACADSB;PPARA;ME1;CYP26B1;ACOT11;GGT5;ALDH4A1;CPT1C;NAAA;MCCC2;CKB;PER2;ME2;PCCB;ACSL3;ECHDC3;MECR;AASDH;SLC5A6;LDHB;VDAC1;GPAM;SCPEP1;HOGA1;SCP2;PDHA1;ALOX12;DLAT;PDZD11;ACSF2;ANGPTL3;AOAH;SLC27A4;CYP2S1
prerank,positive regulation of dendritic spine development (GO:0060999),0.49177776592309924,1.1187427758648074,0.35135135135135137,0.7340833021925833,1.0,1/20,0.09%,SHANK3
prerank,protein K48-linked ubiquitination (GO:0070936),0.41444974048709654,1.1187256117025515,0.3032544378698225,0.7334671696893161,1.0,17/54,17.60%,KLHL3;NEDD4L;ZNRF1;DTX3L;PELI1;UBE2G1;UBE2H;RNF146;RNF4;UBE2D3;UBE3A;UBE2K;TOPORS;ARIH2;RNF5;CUL3;CDC34
prerank,epithelial cell migration (GO:0010631),0.43708674205386494,1.118389036198101,0.32116788321167883,0.733613475978118,1.0,8/37,4.31%,NOS3;ADGRA2;PLXND1;PXN;PKN3;PKN2;PLEKHG5;PKN1
prerank,regulation of microglial cell activation (GO:1903978),-0.4562708811835853,-1.1182075655274164,0.332579185520362,0.7506293491124792,1.0,12/15,47.17%,LDLR;SYT11;SPHK1;TTBK1;PTPRC;TREM2;GRN;STAP1;CST7;TAFA3;CCL3;NR1D1
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),0.5061865025883547,1.1177864353860811,0.34146341463414637,0.7344743951341434,1.0,2/18,2.59%,SHANK3;PTK2B
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.31963889937528916,-1.1176779906166374,0.22180451127819548,0.7506775749130811,1.0,17/84,12.29%,CELF2;SON;DDX5;RBFOX1;CELF4;FXR2;DAZAP1;DDX17;RBFOX2;NOVA1;SRPK2;TIA1;U2AF2;CIRBP;RBM4;CELF1;SF1
prerank,protein localization to cell junction (GO:1902414),0.4770530481444741,1.1171663361685036,0.34348561759729274,0.7354175577134984,1.0,6/22,9.62%,TJP1;HEG1;TJP2;PAK2;JAK1;TJP3
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.413513039468594,1.1170348456503922,0.32753623188405795,0.7350945419060293,1.0,11/56,7.32%,BMPR2;ENG;RBPMS;ACVRL1;SDCBP;SMAD7;ACVR2A;GREM1;ACVR1;SNX25;TGFB1
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.4554581974310325,1.1169625958119789,0.3333333333333333,0.7346000542530912,1.0,4/27,5.48%,UTRN;NEDD4L;FXYD6;ATP2B4
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),-0.3258792060892003,-1.1167832436684801,0.24714828897338403,0.7518241562676845,1.0,20/75,11.40%,DOCK7;SDC2;FGFR2;DCDC2;MAP2;BRSK1;FARP1;S100A6;ANK3;SHTN1;RYK;NTNG1;MAP6;S100B;CTNNA2;DCC;NRCAM;BAIAP2;RAB10;CNTN4
prerank,negative regulation of blood coagulation (GO:0030195),0.4363579164009484,1.1166982615726788,0.3282208588957055,0.7345832227943745,1.0,5/38,4.50%,NOS3;PDGFB;EDN1;CD34;F7
prerank,peptide metabolic process (GO:0006518),-0.31943369913688047,-1.115965385102348,0.24691358024691357,0.7526935107970101,1.0,12/75,10.56%,AEBP1;DMD;CPQ;MGAT3;PCSK5;GSTT1;NPEPPS;ENPEP;CPXM2;CPXM1;GSTM1;SPCS3
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.35628253658308773,1.1159581482245045,0.28150765606595995,0.7357876168422575,1.0,40/190,12.70%,CAV1;ESR1;CD2AP;SH3BP4;DAB2IP;PDE2A;LYN;DDIT4;HDAC7;PDE4D;PTPRJ;ADGRG3;CASP8;TMSB4X;MARK3;PIK3IP1;TNFAIP8L1;VGLL4;ATP2B4;INPP5K;TRIB3;WWC2;PPP2R5B;UBR1;MAP2K3;BCL2L1;NPRL2;CYRIB;TNIP1;APLNR;NMI;ZMYND11;RIPK1;PEBP1;NOP53;RELA;XDH;ADIPOR1;GSTP1;RACK1
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.4625594627673586,-1.11571731709093,0.3127962085308057,0.7519171838958781,1.0,4/15,8.93%,PRKN;BCL2;CD44;MDM2
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.41827365107381287,1.115609171885006,0.33086053412462907,0.7359906321478816,1.0,8/45,7.32%,BMPR2;ENG;RBPMS;ACVRL1;SDCBP;ACVR2A;ACVR1;TGFB1
prerank,regulation of lamellipodium organization (GO:1902743),-0.46228533539742295,-1.1155960545101655,0.32532751091703055,0.7508386175744659,1.0,3/14,7.60%,PDPN;CARMIL1;CD44
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.4009468819007306,-1.115533690612639,0.3118556701030928,0.7495617003706826,1.0,3/26,8.32%,ATP1A2;GNB5;ADRA2A
prerank,homocysteine metabolic process (GO:0050667),-0.48863974004622307,-1.115145805407423,0.33636363636363636,0.7492335398516898,1.0,6/11,24.83%,NOX4;CBS;BLMH;CTH;MMUT;MTRR
prerank,regulation of actin filament depolymerization (GO:0030834),-0.48937915562556633,-1.1139673287349892,0.35294117647058826,0.7511204783918072,1.0,2/12,2.80%,PLEKHH2;SEMA5A
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.5324948213573809,1.113597771358221,0.352622061482821,0.7404157204321122,1.0,6/13,19.48%,BCL2L11;BNIP3;BMF;RHOT1;BNIP3L;RHOT2
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.39586479873015823,1.1134210080678935,0.31805555555555554,0.7401912051753098,1.0,20/72,16.64%,ACER2;CNOT6;CNOT6L;PLK2;AURKA;CDKN1B;BCL3;CRADD;SOX4;BTG2;CNOT1;TFAP4;SFN;CNOT2;MUC1;CNOT7;CDC25C;ATRX;E2F7;CHEK2
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.5133294955438169,1.1132275973289212,0.3562386980108499,0.7400276029300341,1.0,4/14,6.11%,PRKAR2B;PKIG;ATP2B4;RAPGEF2
prerank,neuron migration (GO:0001764),0.41322328394108854,1.1132158193250994,0.34416543574593794,0.7394004926838615,1.0,8/48,6.61%,MEF2C;CELSR1;NAV1;DDIT4;CEP85L;DISC1;RAPGEF2;RAC1
prerank,neuron maturation (GO:0042551),0.4990313791272285,1.112549953600384,0.3494809688581315,0.7403892798772326,1.0,4/18,7.50%,APP;ANKS1A;SCARF1;B4GALT5
prerank,positive regulation of ruffle assembly (GO:1900029),0.5221686512486523,1.1123119959422996,0.3621908127208481,0.7403240030752554,1.0,3/13,13.89%,EPS8;P2RY12;NDEL1
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.42379527158676494,1.1122365718392278,0.33234859675036926,0.7398358548915598,1.0,10/45,8.09%,RPS6KA5;PLCG1;IQGAP1;PTK2B;PIK3C2A;TGFB1;PTK2;TGFA;GRB7;GAB1
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.46369052140967054,1.1121522633652037,0.3463949843260188,0.7393947007298598,1.0,9/27,14.40%,TAOK2;IKBKB;MAPK8;NFKB1;IKBKG;MAPK11;CCM2;CUL1;MAP3K20
prerank,protein autoubiquitination (GO:0051865),-0.33622395485962275,-1.111928266645428,0.264026402640264,0.7553988541853666,1.0,13/61,13.27%,RNF220;PRKN;SH3RF1;SH3RF3;RNF13;SH3RF2;AMFR;RNF181;MDM2;LRSAM1;ITCH;DDB2;UBE2B
prerank,regulation of peptidase activity (GO:0052547),0.49043332710191967,1.1118875350213309,0.3546218487394958,0.7394395730481683,1.0,1/19,0.86%,CAV1
prerank,positive regulation of heart contraction (GO:0045823),-0.43423275971643727,-1.1116961869368251,0.3491271820448878,0.7546157828853316,1.0,5/19,12.59%,ATP1A2;ATP2A2;RYR2;TGFB2;ADRA1A
prerank,epithelial to mesenchymal transition (GO:0001837),0.42256573632235495,1.1114907341716733,0.32503660322108346,0.7398188421099349,1.0,8/47,7.32%,LEF1;ENG;NOTCH1;HIF1A;FOXF2;WNT5A;TASOR;TGFB1
prerank,negative regulation of immune response (GO:0050777),0.35844718326970726,1.1106684313381787,0.26674641148325356,0.7411933978960409,1.0,22/154,11.14%,CALCRL;CYSLTR1;ADCY4;PLCG1;MYH9;LYN;YES1;GNB1;FYN;PRKAR2B;PLCG2;ADRB1;RAMP2;PLK2;SAMSN1;CREB1;INSL3;FCGR1A;NMI;MC4R;RC3H1;MC1R
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),-0.3946498370800711,-1.109807139263832,0.3113456464379947,0.7585292579750477,1.0,10/27,9.77%,DCN;BGN;CSPG4;CHST15;PXYLP1;CHSY3;VCAN;CHSY1;CHST3;XYLT1
prerank,amino acid transmembrane transport (GO:0003333),-0.3588114386396399,-1.1097930280456052,0.2781065088757396,0.7571147589746724,1.0,6/45,3.68%,SLC7A11;SLC6A13;SLC47A1;SFXN2;SLC22A4;SLC38A11
prerank,atrioventricular valve development (GO:0003171),0.5098979332838803,1.1097338112032247,0.35058430717863104,0.7429265796105372,1.0,6/14,12.94%,BMPR2;NOTCH1;ACVR1;ZFPM1;APLNR;TGFBR2
prerank,protein targeting to membrane (GO:0006612),0.389042657784991,1.1097090662240912,0.30278884462151395,0.742326278677953,1.0,26/83,19.74%,PARD3;AQP11;TAOK2;SDCBP;SEC63;TRAM1;ZDHHC18;PEX26;CHMP4B;CHMP4A;ZDHHC9;MYO1C;ICMT;ABCD1;PEX14;ALDH3A2;VPS37C;ARL6IP1;RAB8B;ZDHHC24;SEC62;SIL1;ZDHHC1;NACA;SSR1;ZDHHC6
prerank,response to growth factor (GO:0070848),0.43136783307763243,1.1095708405112765,0.33078101071975496,0.7419873091785818,1.0,13/41,17.65%,BMPR2;ACVRL1;PDGFB;ACVR2A;ACVR1;TWF2;RACK1;TGFBR2;ERBB2;ACVR2B;CTNNB1;MAP2K5;CIB1
prerank,gland development (GO:0048732),-0.3398838874260141,-1.1095109208260692,0.2745762711864407,0.7564614706044323,1.0,23/59,17.34%,FGFR2;GLI2;TGFBR3;WNT4;DKK3;TGFBR1;IGSF3;COBL;ANXA1;SALL1;NF1;SIX1;EZR;TGFB3;STRA6;CITED2;WNT11;TBX3;PAX8;MDK;FGF10;ARHGAP35;EPHB3
prerank,regulation of histone modification (GO:0031056),-0.4610129889024304,-1.1094498884544837,0.3190045248868778,0.7552036896722194,1.0,6/13,20.83%,IGF2;AKAP8L;CDK9;MYOCD;FLCN;NNMT
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.5494654007310262,1.109446730367828,0.36507936507936506,0.7409635324525987,1.0,3/10,12.64%,AP2B1;AP2A1;MYLIP
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.5494654007310262,1.109446730367828,0.36507936507936506,0.7409635324525987,1.0,3/10,12.64%,AP2B1;AP2A1;MYLIP
prerank,response to ATP (GO:0033198),-0.4438547971752436,-1.1085392736392299,0.3246445497630332,0.7563601338384681,1.0,4/18,8.19%,P2RX4;ABCC9;TRPC3;TAF1
prerank,cellular response to topologically incorrect protein (GO:0035967),0.444523752321466,1.1072934961758798,0.32172470978441126,0.7456798668442642,1.0,6/31,9.42%,ERN1;DAB2IP;TMBIM6;ATXN3;RHBDD1;PTPN1
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.5408289540747699,1.1071583006161176,0.3737957610789981,0.7453773725323329,1.0,4/10,7.32%,NOTCH1;TNFRSF1B;TNFRSF1A;TGFB1
prerank,response to ethanol (GO:0045471),-0.45688122914440177,-1.107005179536877,0.3177570093457944,0.7592916767241534,1.0,3/14,10.69%,GRIN3A;ADCY7;GRIN2A
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.5329106409273798,1.1068910520143456,0.36209813874788493,0.745416543259342,1.0,7/12,15.21%,CYP26A1;KLF2;CYP26C1;CNOT1;ASXL1;SNW1;TRIM16
prerank,positive regulation of innate immune response (GO:0045089),0.44832659927788066,1.10632749872289,0.33610648918469216,0.7461400913570942,1.0,10/30,19.90%,NLRC5;GBP5;RPS19;WNT5A;NMI;UBE2K;POLR3B;PLSCR1;TRIM62;SLC15A4
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.5414713378150673,1.106152098571539,0.3715953307392996,0.7459254500725363,1.0,4/11,20.71%,WRAP53;TERF1;CCT7;CCT2
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),-0.4822462803186341,-1.105915958550044,0.36283185840707965,0.7609309190933753,1.0,4/12,12.06%,IRS1;IGF2;PRKCZ;SNX5
prerank,positive regulation of chemotaxis (GO:0050921),0.4296371533416067,1.1058666817149425,0.3211009174311927,0.7459463704089907,1.0,9/43,4.50%,KDR;STX3;PRKD1;PDGFB;IL6R;PRKD2;PPM1F;TMSB4X;F7
prerank,regulation of tumor necrosis factor production (GO:0032680),0.3680579575021726,1.1055424482332612,0.30361757105943155,0.7461000653461848,1.0,24/112,15.63%,APP;FOXP1;ARHGEF2;STAT3;PTPRJ;CD34;PLCG2;TIRAP;CX3CR1;WNT5A;LPL;PSEN1;DICER1;TNFRSF8;IL23A;GAS6;MC1R;RIPK1;GSTP1;ZFP36;IFIH1;ILRUN;VSIR;IRAK3
prerank,cardiac muscle cell development (GO:0055013),-0.4295484570587683,-1.1054849774414035,0.3148148148148148,0.7606965493037545,1.0,7/20,10.83%,PDGFRB;PDGFRA;CXADR;SLC8A1;OBSL1;VEGFA;FHOD3
prerank,neuron projection extension (GO:1990138),0.4453413888481203,1.105442526219055,0.32829046898638425,0.7456846663812341,1.0,5/32,5.97%,NRP2;SEMA5B;IQGAP1;ULK1;PPP3CB
prerank,positive regulation of cell killing (GO:0031343),0.5257654460036112,1.105360589783173,0.363302752293578,0.7452375510462284,1.0,3/13,6.61%,MAPK8;WNT5A;RAC1
prerank,cyclic purine nucleotide metabolic process (GO:0052652),-0.4173790115343605,-1.1051056270337132,0.3333333333333333,0.7603067343669611,1.0,6/21,7.01%,ADCY5;ADCY1;ADCY2;ADCY7;ADCY6;GUCY1A1
prerank,atrioventricular valve morphogenesis (GO:0003181),0.48841864229698895,1.105088527255008,0.3424657534246575,0.7452404777863922,1.0,6/19,9.32%,BMPR2;EFNA1;NOTCH1;ACVR1;ZFPM1;SOX4
prerank,mitochondrion morphogenesis (GO:0070584),-0.49408293840503914,-1.1049245734640385,0.34810126582278483,0.7594108455838285,1.0,1/11,0.15%,PID1
prerank,response to alcohol (GO:0097305),-0.3910203595924321,-1.1048691052272153,0.3237822349570201,0.758181164242527,1.0,5/27,10.90%,TGFBR3;TGFBR1;GRIN3A;GRIN2A;SLIT2
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.3643755503624508,1.1044448962939153,0.2998776009791922,0.7462225592567349,1.0,15/124,8.08%,FRY;FRYL;APP;STX3;PTPRM;RAB11A;LYN;PPP1R9B;BICDL1;ULK1;OPHN1;RAPGEF2;RAC1;NEDD4;PKD2
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.5498346741827951,1.1043911857763813,0.37781954887218044,0.7450450550960529,1.0,3/11,7.26%,PTK2B;JAK3;JAK1
prerank,cellular response to interleukin-2 (GO:0071352),0.5498346741827951,1.1043911857763813,0.37781954887218044,0.7450450550960529,1.0,3/11,7.26%,PTK2B;JAK3;JAK1
prerank,fatty acid metabolic process (GO:0006631),0.3675957946364864,1.1038784415035356,0.31592039800995025,0.745677656784344,1.0,14/115,8.63%,ADIPOR2;PTGS2;PPARD;ACSL4;FASN;CRAT;XBP1;ALOX5AP;LPIN3;ACSL5;CYP4B1;PON2;LPL;LTC4S
prerank,epithelium development (GO:0060429),-0.299725910709368,-1.1038779660466724,0.24675324675324675,0.7595560265398641,1.0,22/107,12.08%,ALDH1A2;FGFR2;WNT4;ERRFI1;OSR1;MEOX2;DAG1;PKD1;LOXL3;DACT1;KANK2;SALL1;SIX1;RCN3;AHI1;BDH2;VEGFA;SMO;TAGLN;ANXA4;MTHFD1;TBX2
prerank,ventricular cardiac muscle tissue development (GO:0003229),-0.4097921868211115,-1.1037459671801093,0.3448275862068966,0.7584960601307128,1.0,3/23,4.25%,FGFR2;TGFBR3;TPM1
prerank,hyaluronan metabolic process (GO:0030212),-0.4038405179098812,-1.1031709978510982,0.3383458646616541,0.7587334653707264,1.0,7/23,16.40%,CEMIP;FGF2;CD44;SLC9A1;HEXA;ABCC5;HYAL1
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.45927415216535095,-1.1031265977362954,0.33043478260869563,0.757444558600931,1.0,5/14,17.06%,IL18;CD55;PTPN22;CD81;SYK
prerank,camera-type eye morphogenesis (GO:0048593),-0.49658325483140164,-1.1030784599645191,0.34782608695652173,0.7561723120668721,1.0,5/10,12.08%,TENM3;NF1;LRP6;VEGFA;TBX2
prerank,positive regulation of cytokinesis (GO:0032467),0.44573194720146975,1.1029974707670556,0.36927621861152143,0.7472267720978598,1.0,7/32,17.21%,PKP4;PKN2;AURKC;KIF23;GIPC1;RHOA;CUL3
prerank,negative regulation of Wnt signaling pathway (GO:0030178),-0.28104082824089843,-1.1029156639548299,0.1949685534591195,0.7552466493905929,1.0,34/186,11.07%,BICC1;RBMS3;TRABD2B;LRP1;GLI3;IGFBP2;PRKN;DKK3;RNF43;GRB10;WWOX;IGFBP6;DACT1;INVS;LZTS2;SFRP4;PSME4;TMEM64;LRP6;CXXC4;SIAH2;AXIN2;NOTUM;AMFR;DAB2;GLI1;TLE2;SFRP1;MCC;TSC2;APOE;APCDD1;FUZ;DKK2
prerank,cellular response to decreased oxygen levels (GO:0036294),-0.3371590610677356,-1.1029122875205366,0.2779783393501805,0.7538548015142472,1.0,19/65,9.52%,CPEB1;BMP7;SLC8A3;CPEB2;SIRT2;NDNF;KCND2;RORA;EGLN3;LMNA;P4HB;NPEPPS;CPEB4;MDM4;SFRP1;MDM2;VEGFA;HIPK2;RGCC
prerank,positive regulation of protein catabolic process (GO:0045732),0.3872408175937142,1.1028781594140757,0.3237704918032787,0.7468971479839666,1.0,11/84,7.80%,FOXO1;SMURF1;DAB2IP;NEDD4L;MSN;TNFRSF1B;VGLL4;PLK2;WNT5A;CDKN1B;NEDD4
prerank,activation of GTPase activity (GO:0090630),0.3810727217671594,1.1028768371284798,0.3198433420365535,0.7462477255578576,1.0,14/89,7.58%,TBC1D8;RALGAPA2;TBC1D30;ARHGEF15;TBC1D4;CCDC125;BCR;RALGAPA1;SGSM1;TBC1D22A;TBC1D15;SIPA1L3;TBC1D12;TBC1D2
prerank,response to metal ion (GO:0010038),0.39490887289400184,1.1028258733845466,0.33152173913043476,0.7457236143773958,1.0,9/67,7.80%,CAV1;NEDD4L;PPP3CA;HIF1A;GPHN;PAM;TRPV6;ITPR3;NEDD4
prerank,protein-containing complex assembly (GO:0065003),0.3404023927970556,1.102608207181726,0.27547592385218367,0.7456378682491605,1.0,41/259,14.29%,LEF1;CTSC;SLC2A1;OCLN;CD2AP;MAGI1;PARD3;ADAM10;FAS;AIM2;PTK2B;TLE4;CASP8;TRAF1;CARD10;TCF7L1;TCF7L2;BOK;TEAD2;CD40;TNFRSF1A;TGFA;FBXL7;LLGL1;SKAP2;NIFK;IKBKG;ANO6;TFAP4;CUL1;PICALM;RIPK1;TRAPPC3;PREB;DBNL;CAPZA1;PEX14;IL1RAP;ASH2L;BCL9L;APC
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.47314131887098515,1.1024395160814695,0.3583916083916084,0.7453768942823381,1.0,8/23,18.51%,NLRC5;JAK1;HSP90AB1;IRGM;STAT1;IFNGR1;PARP9;CDC37
prerank,innate immune response in mucosa (GO:0002227),0.5510888724916365,1.1024026039329622,0.38011695906432746,0.7448264754170059,1.0,2/10,9.15%,RPL39;DEFA6
prerank,regulation of biomineral tissue development (GO:0070167),0.47216973375847227,1.1023269829075133,0.34846029173419774,0.7443668437270299,1.0,7/26,10.66%,NOS3;S1PR1;NOTCH1;TGFB1;ANKH;CYP27B1;GAS6
prerank,positive regulation of nuclear division (GO:0051785),0.4672724113103098,1.1021162654711993,0.337152209492635,0.7442285455554382,1.0,6/25,7.47%,INSR;PDGFB;EDN1;LRP5;AURKA;TGFA
prerank,postsynaptic membrane organization (GO:0001941),0.4947968894771594,1.1019055036872514,0.34385964912280703,0.7441051282854296,1.0,2/17,4.29%,SHANK3;GPHN
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.4713092090183275,1.1018220953029232,0.34609250398724084,0.7436628645513241,1.0,3/22,5.11%,DGKZ;PTPRJ;CEACAM1
prerank,regulation of T cell mediated immunity (GO:0002709),0.5461512760678483,1.1016914060772907,0.3683206106870229,0.7433501616523461,1.0,1/10,3.04%,TNFRSF1B
prerank,circulatory system development (GO:0072359),0.37030205222459506,1.1014903297939072,0.3096446700507614,0.7432022746830799,1.0,24/118,9.32%,TEK;HDAC9;TBX1;MEF2C;HEG1;ACVRL1;PDGFB;FBXW7;NOTCH1;SOX17;CASP8;SOX18;FLT4;PDLIM1;KDM6A;FOXF1;RBM20;RAMP2;ACVR1;CDKN1B;TGFB1;PKD2;ZFPM1;SOX4
prerank,aromatic amino acid family catabolic process (GO:0009074),-0.450640518259876,-1.101118868203071,0.31497797356828194,0.7575720297797813,1.0,12/15,51.94%,FAH;GSTZ1;KYAT1;HGD;HAAO;KYNU;AADAT;TDO2;KMO;QDPR;IDO1;ACMSD
prerank,regulation of cell-cell adhesion (GO:0022407),0.42547228324823955,1.1010755543375488,0.34055727554179566,0.7435816857308317,1.0,8/39,8.29%,PTPRG;PODXL;MAGI1;CEACAM1;SMAD7;TGFB1;PTK2;NF2
prerank,glycogen metabolic process (GO:0005977),-0.3968812291645553,-1.100933752516879,0.29280397022332505,0.7567397914919305,1.0,12/27,20.80%,PYGB;PHKB;PYGM;PER2;PRKAG2;GAA;PPP1R3C;UGP2;AGL;GYS1;PHKA2;PHKG1
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.42433136026582885,1.1006532113260024,0.32798833819241985,0.7439813932862048,1.0,6/42,11.80%,POLK;RPA1;TRIM25;PRIMPOL;POLA1;USP43
prerank,RNA polyadenylation (GO:0043631),0.45740566386305415,1.100199952441195,0.3469721767594108,0.7438347037924307,1.0,12/26,27.56%,APP;WDR33;MTPAP;PNPT1;CDC73;CPSF1;TENT4B;CPSF2;PCF11;CPSF3;TUT1;PAPOLA
prerank,mRNA polyadenylation (GO:0006378),0.45740566386305415,1.100199952441195,0.3469721767594108,0.7438347037924307,1.0,12/26,27.56%,APP;WDR33;MTPAP;PNPT1;CDC73;CPSF1;TENT4B;CPSF2;PCF11;CPSF3;TUT1;PAPOLA
prerank,cellular response to amyloid-beta (GO:1904646),0.436633748350797,1.1000392728216353,0.3285939968404423,0.7435752689869205,1.0,11/35,11.79%,APP;VCAM1;ICAM1;CASP4;FYN;ATP1A3;CACNA1A;PSEN1;EPHA4;GRIN1;LGMN
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.5198777026020331,1.0999783116765196,0.34615384615384615,0.7430829521165756,1.0,4/13,12.35%,PPARD;PDGFB;NFIB;RELA
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.5015710976012362,-1.0999293823040093,0.3686534216335541,0.7581986758014488,1.0,2/10,8.79%,SH3RF1;RUNX1
prerank,regulation of histone acetylation (GO:0035065),0.445806928534893,1.0997191125397814,0.35202492211838005,0.7430513926257004,1.0,4/33,10.54%,RPS6KA5;ARRB1;CTBP1;GLYR1
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.49989072440035304,-1.0993308833475466,0.3762993762993763,0.7585220087833383,1.0,4/10,17.31%,CACNA2D1;CACNB2;PDE4B;CACNB3
prerank,positive regulation of macrophage chemotaxis (GO:0010759),-0.45788084150951175,-1.0990447101172343,0.34675615212527966,0.7579637576156646,1.0,2/14,3.57%,IL34;THBS1
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.42964628909102187,1.098787540183252,0.36492890995260663,0.744718357517861,1.0,16/37,20.12%,SDCBP;N4BP1;EIF3H;UCHL5;RPS7;RPL23;NOP53;HSP90AB1;UBXN1;GIPC1;RYBP;RPL11;USP7;CSNK2A2;CSNK2A1;TAF9
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.505329966121545,1.0986348659448932,0.3710247349823322,0.744453622109987,1.0,5/16,16.71%,SELE;SELP;RELA;TRAF6;RHOA
prerank,regulation of actin filament-based process (GO:0032970),-0.3202597604102907,-1.098523437732974,0.2490974729241877,0.7580641341502526,1.0,14/70,8.24%,LRP1;EPHA3;PDGFRB;ROCK2;EFNA5;RHOQ;PRKCD;GPM6B;RHOBTB2;RND3;ARHGAP18;EZR;CNN2;RHOBTB3
prerank,metal ion transport (GO:0030001),0.37886088905664317,1.0978356924028831,0.32483221476510066,0.7457726969856253,1.0,16/86,10.25%,CALCRL;CAV1;SLC39A8;SLC3A2;CACNA1E;FYN;RAMP2;CACNA1A;TRPV6;ATP2C1;TRPV4;PKD2;PSEN1;CDH23;NMUR2;CYP27B1
prerank,cellular response to unfolded protein (GO:0034620),0.45241003596528145,1.0978177414705328,0.34582623509369675,0.7451811676769898,1.0,5/26,9.42%,ERN1;DAB2IP;TMBIM6;RHBDD1;PTPN1
prerank,acute-phase response (GO:0006953),0.5290846072172558,1.0974593092245228,0.35701598579040855,0.7454794227090257,1.0,5/12,17.96%,IL6R;SIGIRR;ITIH4;IL22;PLSCR1
prerank,regulation of TORC1 signaling (GO:1903432),-0.3699417225871856,-1.0972234361671682,0.29411764705882354,0.760353754903706,1.0,14/33,26.16%,RNF152;KLHL22;CASTOR2;SZT2;SMCR8;GPR137B;SESN2;DGKQ;FLCN;GPR137C;ITFG2;PIP4P1;ATM;RRAGD
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",-0.4352077600775396,-1.0969808879447591,0.32786885245901637,0.7596270929773554,1.0,3/16,5.96%,DDX5;CELF4;DDX17
prerank,carbohydrate catabolic process (GO:0016052),-0.36411956184054317,-1.09697200829416,0.29754601226993865,0.7582683605413575,1.0,20/38,38.83%,ENO2;HK2;TPI1;ENO3;PFKFB1;NEU1;PFKM;ALDOA;NAGA;PKM;ENO1;MAN2C1;ALDOC;NEU2;HKDC1;GAPDH;NEU3;ALDOB;ENO4;HK3
prerank,cytoskeleton organization (GO:0007010),0.36773716771067977,1.0957211475751265,0.32418952618453867,0.749193819393086,1.0,18/114,9.23%,SEMA6A;FGD5;ARAP3;NEDD9;FGD6;NECTIN2;DST;FMNL3;SIPA1L3;CDC42BPB;MAST2;CECR2;RAC1;FMNL2;TNIK;RHOBTB1;ZRANB1;ANK1
prerank,nervous system development (GO:0007399),0.32669790826016704,1.095346639569184,0.2489406779661017,0.7494953348179246,1.0,40/429,7.32%,ADGRG6;SHANK3;SEMA6A;MPZ;DNM3;SLC2A1;RAPGEF5;LDB2;MEF2C;ZBTB16;ZIC3;CELSR1;NAV1;STAT3;GDA;ADGRA2;SNTG2;PLXND1;HAPLN3;BTBD1;WWTR1;CHD7;PCDHB4;CDH2;EVL;MAL;IGF2BP3;RPS6KA3;KALRN;MBNL1;NCKAP1;SEMA6B;OPHN1;CYP26C1;IRF2BPL;DYRK1A;ATXN3;ST8SIA4;PDGFC;TGFB1
prerank,negative regulation of cell population proliferation (GO:0008285),0.3313940362783972,1.0950021238868668,0.271259418729817,0.7496963338756609,1.0,52/351,10.61%,NOS3;PTPN14;BMPR2;SMARCA2;APP;CBFA2T3;SOX7;ACVRL1;CD200;B2M;CDK6;PLPP1;SH3BP4;GATA2;ADARB1;DAB2IP;LYN;PTK2B;NOTCH1;PTPRJ;AQP11;MTSS1;ADGRG1;SLC16A2;TES;DLL1;VGLL4;BTG3;PTPRK;GREM1;DLL4;WNT5A;RAPGEF2;KLF10;CDKN1B;PPM1D;TGFB1;CTNNBIP1;PKD2;RNF139;NF2;CTBP1;ANG;PINX1;SOX4;SST;TNFRSF8;BTG2;CYP27B1;SFRP2;TFAP4;NMI
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.4445803565291149,1.0946137485350516,0.3387358184764992,0.7499798003729921,1.0,8/32,9.31%,PPP1R13B;DDIT4;JMY;HIPK1;BOK;BCL3;MYBBP1A;HINT1
prerank,cellular response to lipopolysaccharide (GO:0071222),0.3752052422169418,1.0945790976724459,0.33423180592991913,0.74941918572136,1.0,19/101,12.67%,MEF2C;DAB2IP;LYN;TNFRSF1B;XBP1;CX3CR1;SBNO2;MAPK8;WNT5A;IL36G;PPBP;TGFB1;NFKB1;CASP1;DEFA6;CARD16;RELA;GSTP1;ZFP36
prerank,DNA replication initiation (GO:0006270),0.4259907492315629,1.0945756831340887,0.35384615384615387,0.748784946615884,1.0,16/37,26.59%,MCM10;RPA1;POLA1;CDT1;CDK2;PRIM2;ORC5;ORC3;CDC34;PURA;DBF4;ORC6;GMNN;PRIM1;MCM6;RPA3
prerank,positive regulation of histone methylation (GO:0031062),-0.40603087247629377,-1.0943887680142321,0.34285714285714286,0.7640496239946472,1.0,5/24,8.64%,OGT;AUTS2;TET1;CTR9;PAF1
prerank,regulation of type I interferon production (GO:0032479),0.38095517372871357,1.0943470303655236,0.3469387755102041,0.7487012567264569,1.0,23/84,20.68%,RNF125;LRRFIP1;NLRC5;UBA7;TIRAP;TRIM25;NFKB1;POLA1;G3BP1;CGAS;RELA;IFIH1;ILRUN;NFKB2;GPATCH3;STAT6;CTNNB1;POLR3B;DHX36;TAX1BP1;NLRP4;POLR3A;POLR2L
prerank,positive regulation of neuron apoptotic process (GO:0043525),-0.40359456655849735,-1.0939384805824053,0.314214463840399,0.7639393805038852,1.0,5/24,11.47%,EPHA7;NUPR1;NF1;SRPK2;TGFB2
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.34717469691417774,-1.0938487241017982,0.31746031746031744,0.7628016599904796,1.0,8/52,6.61%,CELF2;DDX5;RBFOX1;CELF4;FXR2;DDX17;RBFOX2;NOVA1
prerank,embryonic heart tube development (GO:0035050),0.5194506527891745,1.093300967698043,0.36363636363636365,0.7507356545202322,1.0,3/14,6.27%,SOX17;SOX18;ACVR1
prerank,positive regulation of multicellular organismal process (GO:0051240),0.33641731456488316,1.093079030824164,0.2738225629791895,0.7506343111076605,1.0,51/308,13.47%,PRKCH;LEF1;EPAS1;ADIPOR2;BMPR2;CAV1;CADM1;ZBTB16;IL15;PDGFB;NPR1;RREB1;KDM3A;WWTR1;PLCB1;ADRB1;RPS19;LCN2;SDCBP;XBP1;GHR;SHLD1;GATM;ESRRG;WNT5A;ACVR1;INPP5K;PDGFC;TGFB1;PIK3CG;B4GALT5;AGPAT1;IL23A;UCN;MAD2L2;CYP27B1;VAMP8;CXCR4;PRKAB1;GAS6;IL4R;MAP3K13;UCP2;PEMT;SIRT6;ADIPOR1;TGFBR2;HADH;OMA1;ESRRB;IGF1R
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.5402527070540044,1.0930184260726,0.36538461538461536,0.7501337357646323,1.0,3/10,16.94%,SIGIRR;IRAK3;MAP2K5
prerank,endosome organization (GO:0007032),0.42281565584470626,1.0928989480952926,0.32526475037821484,0.749770911327248,1.0,9/41,12.96%,RAB27A;ALS2CL;CLCN3;CHMP2B;EEA1;SNX3;CORO1C;RILP;EXOC8
prerank,blood vessel endothelial cell migration (GO:0043534),0.4775663585539853,1.0927584395921401,0.37458745874587457,0.7494891642040559,1.0,6/22,5.22%,KDR;EPHB4;MYH9;SOX18;ID1;GREM1
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.5039565737401084,1.092078904568781,0.3670886075949367,0.7505432947079913,1.0,1/16,1.41%,CLDN5
prerank,mitochondrion localization (GO:0051646),0.48565964858710337,1.0919392378034467,0.3711864406779661,0.7502497679529742,1.0,7/19,18.92%,NECTIN2;MTM1;MEF2A;MFN1;MSTO1;TRAK2;ZBED3
prerank,regulation of interferon-gamma production (GO:0032649),0.3844828848373317,1.0917692582627738,0.3392857142857143,0.7500307525582711,1.0,6/71,10.66%,IL1R1;PDE4D;ZFPM1;IL23A;CYRIB;GAS6
prerank,atrial septum development (GO:0003283),-0.4565478870805276,-1.091733284745847,0.3532110091743119,0.7672633148622164,1.0,2/13,0.29%,ANK2;NOTCH2
prerank,regulation of B cell activation (GO:0050864),0.45593069495405303,1.0916061729710678,0.37185929648241206,0.7498005257344443,1.0,2/25,8.07%,AHR;SAMSN1
prerank,negative regulation of B cell proliferation (GO:0030889),0.5313900126422261,1.0911878307774974,0.3867403314917127,0.7501626837738905,1.0,2/11,10.78%,LYN;RC3H1
prerank,mitochondrion transport along microtubule (GO:0047497),0.5191026130749121,1.091161080832661,0.3712784588441331,0.7495902909137984,1.0,6/13,24.25%,HIF1A;RHOT1;RHOT2;UXT;OPA1;NEFL
prerank,positive regulation of dephosphorylation (GO:0035306),0.4484628176213396,1.0910926382108224,0.3603174603174603,0.7491255113102915,1.0,8/27,16.25%,PPP1R16B;PPP2R5A;CHP2;TGFB1;CDH5;PPP1R7;SPPL3;CALM1
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),-0.4722051933997466,-1.091030856693064,0.36644591611479027,0.7664674370628524,1.0,2/12,1.76%,EFNA5;FBLN1
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),-0.4722051933997466,-1.091030856693064,0.36644591611479027,0.7664674370628524,1.0,2/12,1.76%,EFNA5;FBLN1
prerank,leukotriene metabolic process (GO:0006691),0.48208687696824337,1.0909707633709802,0.3470790378006873,0.7487858315425083,1.0,3/19,8.63%,PLA2G4A;ALOX5AP;LTC4S
prerank,positive regulation of RNA splicing (GO:0033120),0.43986926474028604,1.0909095839968554,0.35294117647058826,0.7483092070499515,1.0,8/29,14.92%,ERN1;RBM20;SF3B4;DYRK1A;HNRNPLL;RBM3;NUP98;SNW1
prerank,tyrosine metabolic process (GO:0006570),-0.47227508899820575,-1.0902873227106895,0.36017897091722595,0.7672004095964143,1.0,6/11,45.22%,FAH;GSTZ1;HGD;THAP4;DCT;IYD
prerank,Golgi to plasma membrane transport (GO:0006893),0.40704162153783796,1.0900215085925213,0.347949080622348,0.7498554129419134,1.0,11/47,13.42%,EXOC6;SPTBN1;EXOC6B;VAMP4;GCC2;EXOC5;LLGL1;EXOC4;RAB26;EXOC8;RAB31
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.43231374890499663,1.0899830644267476,0.3769230769230769,0.7493388331260862,1.0,7/34,8.98%,LIMS2;NEDD9;DOCK1;RREB1;RAC1;ARHGEF7;CRK
prerank,regulation of chemotaxis (GO:0050920),0.44614382814481773,1.0898893606528661,0.3574660633484163,0.7489372844413307,1.0,10/30,11.15%,STX3;PDGFB;ADGRA2;PPM1F;ZSWIM6;MYCBP2;TGFB1;CYRIB;CXCR4;P2RY12
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.38414926446330294,1.0888348626233493,0.35724137931034483,0.7509477018268907,1.0,13/72,14.29%,SHANK3;KANK3;HIP1R;ARHGEF2;SSH2;DYRK1A;CAMSAP2;CYRIB;TWF2;PFDN1;LIMA1;CDH5;APC
prerank,potassium ion homeostasis (GO:0055075),-0.3985653423431825,-1.0886161512166643,0.32390745501285345,0.7706231294877524,1.0,6/23,9.88%,ATP1A2;SLC12A2;ATP1B1;KCNMA1;KCNJ2;ATP1B2
prerank,post-translational protein modification (GO:0043687),0.33017564460434123,1.088526571122393,0.28047464940668826,0.7510897029508286,1.0,60/332,15.53%,EPAS1;DCUN1D3;KLHL3;APP;KLHL5;ZBTB16;MGAT4A;STT3B;RAB11A;SOCS2;KLHL2;ADAM10;NEURL2;FBXW7;HIF1A;BTBD1;FUCA2;FGF23;PTP4A2;CDH2;QSOX1;SPARCL1;FBXL4;KCTD6;VWA1;CISH;GOLM1;RNF7;PSMA2;FBXL7;RAB2A;RAB38;RHBDD1;APLP2;FBXW2;CSF1;COPS2;PSMA8;ASB10;PSMA6;ICMT;GAS6;COPS4;FBXO30;CUL1;COP1;RAB11B;ASB11;ASB4;RAB5A;PNPLA2;FBXL3;PROC;PSME1;ELOC;SOCS6;LAMB1;EVA1A;DCAF17;TMEM132A
prerank,protein localization to plasma membrane (GO:0072659),0.35341853957661196,1.08805928909661,0.30893300248138955,0.7516048661058684,1.0,24/129,7.64%,EHD4;SPTBN1;F11R;SMURF1;RAB11A;TSPAN5;DENND4C;BSG;PACS1;NKD2;FCHO2;KCNB1;IKBKB;TSPAN14;RAMP2;CCDC88A;RAPGEF2;TMEM88;INPP5K;ATP1B3;TNIK;TNFRSF1A;RAP1A;EHD2
prerank,positive regulation of natural killer cell activation (GO:0032816),-0.45457573289499786,-1.0874211080469829,0.32494279176201374,0.7725524841982694,1.0,2/13,2.50%,AXL;IL18
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.4470303745953646,1.0873054080795423,0.3394648829431438,0.752837997268117,1.0,14/30,20.12%,SDCBP;N4BP1;EIF3H;UCHL5;NOP53;HSP90AB1;UBXN1;GIPC1;RYBP;SVIP;STYX;RPL11;USP7;TAF9
prerank,T cell mediated immunity (GO:0002456),0.5126084915976263,1.0872615677254402,0.36594202898550726,0.752332971862788,1.0,1/13,0.90%,CADM1
prerank,negative regulation of viral life cycle (GO:1903901),0.5223553619538086,1.0872398698944152,0.3634782608695652,0.7517477840481195,1.0,4/15,7.55%,LY6E;PTX3;MID2;SNX3
prerank,carbohydrate biosynthetic process (GO:0016051),0.47492287037101855,1.0871485791310767,0.3560732113144759,0.7513430525181567,1.0,1/21,0.14%,ST3GAL6
prerank,central nervous system neuron development (GO:0021954),0.49778709263279436,1.0868064467031082,0.3769363166953528,0.7515666416898152,1.0,3/15,7.50%,LHX6;RAPGEF2;B4GALT5
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.3772170037206091,1.0867667678567743,0.3478854024556617,0.7510301116109132,1.0,19/95,12.67%,MEF2C;DAB2IP;TNFRSF1B;TIRAP;XBP1;CX3CR1;SBNO2;MAPK8;WNT5A;IL36G;PPBP;NFKB1;CASP1;DEFA6;CYRIB;CARD16;RELA;GSTP1;ZFP36
prerank,Rac protein signal transduction (GO:0016601),0.4962884809049786,1.0867003745350843,0.39078498293515357,0.7505646840846303,1.0,6/18,12.83%,EPS8;ELMO1;NCKAP1;RAC1;CYFIP1;DBNL
prerank,sensory perception of light stimulus (GO:0050953),-0.3106603341679367,-1.0860216856790335,0.3,0.7752060007351405,1.0,11/87,6.10%,COL1A1;SLC4A10;ADGRV1;EYA4;COL11A1;EFEMP1;EML2;COL18A1;DHRS3;PCDH15;WHRN
prerank,negative chemotaxis (GO:0050919),0.4387545470965938,1.086004504005982,0.3626543209876543,0.7516485563859157,1.0,3/33,1.68%,SEMA6A;NTN1;SEMA7A
prerank,positive regulation of MAP kinase activity (GO:0043406),0.38497660146243035,1.0859763656427528,0.34153005464480873,0.7510905201747049,1.0,13/66,7.41%,FLT1;PDGFB;DAB2IP;EDN1;PDGFD;TNFRSF11A;TPD52L1;PIK3R6;CD40;SASH1;PDGFC;TGFB1;PIK3CG
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.5062201300637359,1.0854864424322492,0.3834862385321101,0.7516355335401463,1.0,4/14,14.18%,CARD10;TIRAP;MALT1;TRAF6
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.4080265812704652,1.085085070745897,0.35703703703703704,0.7519889630653599,1.0,5/47,5.22%,FOXO1;DAB2IP;FAS;TAOK2;GREM1
prerank,organelle organization (GO:0006996),0.327788391105893,1.0849771200352065,0.28969957081545067,0.7516400327565993,1.0,63/388,13.90%,SEMA6A;FGD5;NOS3;FNBP1L;ATP8B1;CAV1;PRKD1;ARAP3;NEDD9;FGD6;NECTIN2;DST;ALAS1;VPS13D;FMNL3;CAV2;PLIN5;SIPA1L3;STX7;CDC42BPB;MAST2;DOP1B;ABCA3;CYCS;CHMP2B;CECR2;CYP26C1;FMNL2;SYNE1;TNIK;TMEM135;SIRT5;TMED7;PKD2;RAB2A;TMED5;RAB38;PLAAT3;ABCD4;ARHGEF7;ZRANB1;CHMP4B;CHMP4A;ANK1;MREG;HPS3;GABPB1;TFB2M;RNF112;LONP1;ABCD1;RAB43;SNX11;PHIP;BRWD3;CSPG5;PLD2;RAB31;RAB7A;ATL1;PITPNB;PEX14;RANBP10
prerank,ketone body metabolic process (GO:1902224),-0.4907707158300559,-1.0844458993551458,0.3932135728542914,0.7782621589225306,1.0,6/10,14.64%,OXCT1;HMGCLL1;BDH2;ACAT1;BDH1;AACS
prerank,odontogenesis of dentin-containing tooth (GO:0042475),-0.43784953411300365,-1.084120700035043,0.35990888382687924,0.7777691951321718,1.0,4/15,6.16%,GLI2;EDA;WNT6;LRP6
prerank,methylguanosine-cap decapping (GO:0110156),0.5387610534355886,1.0836378861719387,0.4188679245283019,0.7543016444758892,1.0,7/10,28.00%,EDC3;DCP2;PNRC2;LSM1;DCP1B;PATL2;DCPS
prerank,Notch signaling involved in heart development (GO:0061314),-0.47748062646771117,-1.083551774035677,0.375,0.7780262485757388,1.0,7/11,18.36%,NOTCH2;JAG1;HEYL;RBPJ;SNAI1;HEY2;HEY1
prerank,positive regulation of protein localization to membrane (GO:1905477),0.37216972556149003,1.0833667592251945,0.33025099075297226,0.7543326511174411,1.0,11/98,5.48%,PRKCH;STX3;SPTBN1;PPP1R13B;FYN;CASP8;NKD2;KCNB1;SORBS1;MAPK8;ATP2B4
prerank,monocarboxylic acid biosynthetic process (GO:0072330),-0.32244176249626133,-1.0831866124866192,0.3026315789473684,0.77761808760779,1.0,10/59,15.07%,ALDH1A2;CYP7B1;CYP27A1;ABCD3;PER2;ACACA;OSBPL3;OSBPL6;HOGA1;SCP2
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.4791014643450445,-1.082990757040233,0.3790849673202614,0.7767827698598411,1.0,2/11,7.60%,BCL2;CD44
prerank,regulation of exosomal secretion (GO:1903541),-0.4288029452634361,-1.082529477524656,0.35083532219570407,0.7766624085943027,1.0,7/19,17.68%,PRKN;ATP9A;SDC4;SMPD3;SDC1;SNF8;VPS4A
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.43231461715977915,1.0825270271078005,0.3700787401574803,0.7557558135648775,1.0,6/32,14.35%,RPS19;RPL39;PPBP;ANG;DEFA6;S100A9
prerank,microglial cell activation (GO:0001774),0.4763133042739702,1.0815962656268465,0.3618881118881119,0.7574257357907119,1.0,2/21,5.38%,APP;CX3CR1
prerank,response to insulin (GO:0032868),0.38393127954681666,1.0812218795126256,0.3401639344262295,0.7577369335064758,1.0,15/80,10.82%,FOXO1;HDAC9;INSR;TBC1D4;DENND4C;SORBS1;XBP1;CEACAM1;LPIN3;INPP5K;TRIB3;CITED1;AKT2;RAB12;EIF6
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.36469370759993297,1.0809513027740743,0.33682830930537355,0.7577493433158357,1.0,26/100,15.34%,CBFA2T3;RNF144B;NKD2;SDCBP;SMAD7;N4BP1;FOXF2;EIF3H;UCHL5;RNF144A;TRIB3;XPO1;GNA12;RAD23A;SUMO2;HECTD1;COP1;NOP53;PRICKLE1;RACK1;HSP90AB1;TRIB1;UBXN1;GIPC1;RYBP;ARIH2
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.5458992933453737,1.0804530296273436,0.4011090573012939,0.7583265060492921,1.0,2/10,3.44%,TBX1;ACTN4
prerank,tRNA aminoacylation (GO:0043039),0.4239383786014883,1.080292244948671,0.36276083467094705,0.7581005313830942,1.0,10/37,17.58%,GARS1;FARS2;IARS1;LARS1;WARS1;RARS1;QRSL1;AIMP1;KARS1;WARS2
prerank,translesion synthesis (GO:0019985),0.4144665067292407,1.0800694284277452,0.36176470588235293,0.7580154562548828,1.0,6/42,11.80%,POLK;RPA1;TRIM25;PRIMPOL;MAD2L2;USP43
prerank,regulation of neutrophil chemotaxis (GO:0090022),-0.39848243033141256,-1.079833533729868,0.36724565756823824,0.7829907206245884,1.0,10/23,21.05%,CAMK1D;DPP4;MCU;RIPOR2;DAPK2;SLIT2;JAM3;MDK;CCL19;CD74
prerank,apoptotic DNA fragmentation (GO:0006309),0.490035202132172,1.0797776932189511,0.38271604938271603,0.7580795995237845,1.0,6/16,22.75%,FOXL2;CECR2;DICER1;ENDOG;KPNB1;HMGB1
prerank,positive regulation of interleukin-17 production (GO:0032740),0.467136433692308,1.0797516837898453,0.3805601317957166,0.7575114430050477,1.0,4/22,9.60%,IL15;TGFB1;RFTN1;IL23A
prerank,connective tissue development (GO:0061448),-0.3605983138681236,-1.0793879587318869,0.3490304709141274,0.7828936202966631,1.0,9/35,7.60%,SOX5;SULF1;SULF2;PKD1;SOX6;SH3PXD2B;ITGB8;SLC39A13;CD44
prerank,regulation of T cell chemotaxis (GO:0010819),0.5376961910245656,1.0788878231125367,0.4072727272727273,0.7590607615753806,1.0,3/11,13.42%,ADAM10;WNT5A;ADAM17
prerank,sensory perception of pain (GO:0019233),-0.3997548569103903,-1.0783555262031168,0.3722627737226277,0.7844767213727984,1.0,11/21,31.70%,P2RX4;PTGES;RETREG1;TRPA1;CCR2;CCL2;KCNA2;SCN9A;CHRNB2;ALOXE3;P2RX7
prerank,cell proliferation in forebrain (GO:0021846),-0.49045960333920535,-1.078332181821506,0.39101123595505616,0.7831637572942515,1.0,3/10,15.22%,DOCK7;PCM1;NUMBL
prerank,ether lipid biosynthetic process (GO:0008611),0.5390056236740451,1.0781491725067849,0.40304182509505704,0.7602504542051736,1.0,1/10,1.67%,PLA2G4A
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),0.5188489921846519,1.0780383358763719,0.389413988657845,0.7599013411319128,1.0,4/12,8.54%,PODXL;IQGAP1;PROM1;MYO1E
prerank,ganglioside metabolic process (GO:0001573),0.4754536665730575,1.0779575497213572,0.3875432525951557,0.759459578386245,1.0,4/20,12.36%,ST6GALNAC3;ST8SIA4;ST6GALNAC4;CLN6
prerank,pyrimidine nucleobase metabolic process (GO:0006206),-0.467537447056411,-1.0779419536896837,0.386411889596603,0.7828172099732094,1.0,2/12,2.41%,DPYSL3;DPYD
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.3801771946364624,1.077704198041942,0.36187845303867405,0.7594920349091933,1.0,16/73,12.95%,CAV1;APP;PRKD1;PRKD2;FNIP2;SH2D3C;STK4;ATP2B4;BCAR3;TGFB1;RPTOR;MAD2L2;SFRP2;GAS6;RIPK2;HSP90AB1
prerank,negative regulation of protein ubiquitination (GO:0031397),0.4019967222530106,1.0776228308655995,0.37755102040816324,0.759081493469498,1.0,14/50,16.45%,CAV1;DTX3L;SMAD7;N4BP1;DNAJA1;ARRB1;PINX1;SOX4;SPOPL;VPS28;NXN;UBXN1;PRKCG;CHP1
prerank,regulation of kinase activity (GO:0043549),0.3721874452712138,1.0770672028796593,0.3469119579500657,0.759757414148528,1.0,11/89,5.59%,TEK;FLT1;LDB2;KDR;TIE1;EPHB4;INSR;NLRC5;FLT4;LMTK2;RET
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.3825669378727966,1.077040775075857,0.33568406205923834,0.7592113921874147,1.0,11/66,5.16%,CAV1;B2M;CDK6;PTPRM;DAB2IP;FBXW7;AQP11;MTSS1;CAV2;CEACAM1;PTPRK
prerank,regulation of protein metabolic process (GO:0051246),0.4083118514619439,1.076925296099892,0.3551673944687045,0.7588699993310779,1.0,13/44,17.17%,APP;NEDD4L;FKBP1A;KLF2;MAPK8;PM20D2;SPOPL;HSP90AB1;MTPN;ACE;CHEK2;MAP2K5;NEDD8
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.4341326146921854,1.0768370891168904,0.3576158940397351,0.7584690382252051,1.0,8/31,10.42%,CDK6;LRP5;HDAC7;NOTCH1;FGF23;GREM1;CITED1;SEMA4D
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",0.40723207949222673,1.0763761499167335,0.34782608695652173,0.7590042164404156,1.0,6/46,5.93%,SHANK3;MEF2C;DGKZ;PTK2B;CDH2;OPHN1
prerank,ciliary basal body-plasma membrane docking (GO:0097711),-0.30092244333198387,-1.0761069914903494,0.27380952380952384,0.7865695832033407,1.0,33/95,23.26%,NINL;HSP90AA1;YWHAG;ALMS1;CC2D2A;AHI1;IQCB1;PRKACA;KIF24;SDCCAG8;NPHP1;CEP63;RPGRIP1L;CEP89;CEP192;ODF2;MKS1;RAB3IP;CEP152;PCM1;CEP43;TTBK2;TCTN1;DCTN3;DYNC1H1;TCTN2;C2CD3;TMEM67;CKAP5;HAUS6;B9D2;HAUS2;SFI1
prerank,membrane lipid metabolic process (GO:0006643),0.4571311583399138,1.0758557613190616,0.3537190082644628,0.7596577200572459,1.0,4/22,10.19%,ST3GAL6;B4GALT4;CERKL;ST6GALNAC4
prerank,negative regulation of cell development (GO:0010721),-0.3859666045808443,-1.0757370088120892,0.3587570621468927,0.7861927772880286,1.0,3/25,1.35%,IGF1;FBN1;APPL2
prerank,visual perception (GO:0007601),-0.3099474554861862,-1.075454533699892,0.3671875,0.7855975946609839,1.0,9/84,4.63%,COL1A1;SLC4A10;ADGRV1;EYA4;COL11A1;EFEMP1;EML2;COL18A1;DHRS3
prerank,oligosaccharide biosynthetic process (GO:0009312),0.4763785854872363,1.0751596485306982,0.3902027027027027,0.7606768876605674,1.0,1/20,0.14%,ST3GAL6
prerank,positive regulation of cellular component organization (GO:0051130),0.3596898795639687,1.074815949847044,0.341688654353562,0.760914446238184,1.0,15/107,7.32%,SHANK3;INSR;DAB2IP;TAL1;NEDD4L;ATP10A;FNIP2;BIK;ABCB7;TIRAP;DLL1;CBLL1;SH3GLB1;BCL2L11;TGFB1
prerank,regulation of signal transduction (GO:0009966),0.34098230481322656,1.074482384816408,0.338302752293578,0.7611268101909945,1.0,33/190,10.21%,RGS3;LIFR;ESR1;LFNG;APP;UGCG;PRKD1;SOCS2;PRAG1;GIT2;MFNG;BST1;FYN;KIF26A;NCK1;WWTR1;PLCB1;PXN;SRMS;DLL1;TSPAN12;TCF7L1;ACVR1;VWA2;TGFB1;ITGA3;SNX3;LLGL1;CRK;PTPN1;ZFAND2B;CDC42SE2;RGS12
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),-0.38422717235548287,-1.0739155618532001,0.3525,0.7885738221580925,1.0,2/26,1.35%,LGR4;APPL2
prerank,cell projection assembly (GO:0030031),0.47275282630559456,1.0738000762780413,0.3780687397708674,0.7621491356697992,1.0,4/22,6.61%,PARVB;RHOJ;NCKAP1;RAC1
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.4716311436140722,1.073688251182906,0.40034071550255534,0.761783661310709,1.0,6/20,13.14%,CNOT6;TNRC6C;HELZ;CNOT1;EIF6;CNOT7
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.37106719317267584,1.0735769072496149,0.33557951482479786,0.7614418211484552,1.0,19/87,11.11%,ABI3;ESAM;F11R;EPS8;HIP1R;CELSR1;IQGAP1;PTK2B;BST1;TAOK2;ARHGAP17;CCDC88A;RAC1;RHOBTB1;CRK;RICTOR;TWF2;FSCN1;ABL2
prerank,dicarboxylic acid metabolic process (GO:0043648),-0.33270282651013394,-1.0735502030433692,0.3344262295081967,0.788209774451754,1.0,19/52,24.83%,ME1;ADHFE1;IDH2;ME2;ALDH1L1;GCLC;FPGS;GPT2;IDH1;GOT1;MTHFD1;SLC19A1;HOGA1;MTHFD2L;MDH1;ALDH18A1;GGT1;GOT2;MTRR
prerank,response to glucagon (GO:0033762),-0.4143502301778551,-1.0733795593370394,0.3444976076555024,0.7873006215827062,1.0,9/19,14.55%,ADCY5;ADCY1;ADCY2;ADCY7;ADCY6;PRKACA;PRKAR1B;PRKAR1A;ADCY3
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.397719996686496,1.0726726164497469,0.3653566229985444,0.7630787399633672,1.0,4/52,5.12%,PDIA5;ERN1;XBP1;EXTL3
prerank,calcium ion homeostasis (GO:0055074),-0.3004092268018117,-1.072559934285771,0.2711864406779661,0.7882237609080012,1.0,14/95,9.51%,SLC24A3;ANK2;ATP13A5;ATP13A3;SLC8A3;ATP1B1;SLC8A1;DMPK;FAM20A;STIM1;ATP2A2;RYR2;CXCL12;SLC24A2
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.44826495897098534,1.0725577085668714,0.3996627318718381,0.7627338483904582,1.0,5/25,8.78%,CSGALNACT1;B3GNT3;B3GNT4;B4GAT1;B3GNT6
prerank,defense response to tumor cell (GO:0002357),0.5455702832029253,1.0723728000549204,0.40943396226415096,0.762573394742587,1.0,2/10,1.66%,ABI3;DAPK1
prerank,cellular amino acid catabolic process (GO:0009063),-0.31081382530224944,-1.0722316666797636,0.33203125,0.7877375306413389,1.0,24/87,17.71%,DDO;GLUL;ABAT;ACADSB;ASPA;ALDH4A1;MCCC2;IVD;PRODH;HMGCLL1;ALDH7A1;FAH;BCKDHB;HNMT;PHYKPL;ACAT1;GOT1;CBS;HOGA1;ACAD8;CARNS1;BLMH;GSTZ1;ALDH6A1
prerank,phagosome-lysosome fusion (GO:0090385),0.5329507386319523,1.0721774109364894,0.40409683426443205,0.7624089477046903,1.0,4/10,15.28%,ARL8B;RAB7A;RAB7B;SYT7
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),0.47956196186451594,1.071859182114826,0.37777777777777777,0.7625668851344835,1.0,5/18,13.29%,HHEX;NXF2;THOC2;ENY2;NUP133
prerank,cholesterol transport (GO:0030301),0.4055959201142535,1.071266098862174,0.3541666666666667,0.7633844195853188,1.0,11/45,19.36%,CAV1;SCARB1;STARD5;SOAT2;LIMA1;ABCG1;STAR;STX12;CEL;OSBPL2;ABCA1
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.3811967275587713,1.0712374075933835,0.35443037974683544,0.7628489019020236,1.0,13/70,11.99%,IL6R;DAB2IP;FAS;TNFRSF1B;CASP8;HIPK1;BOK;TNFRSF1A;TGFB1;CRADD;BCL2L1;RIPK1;BID
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.43783493505941673,1.069891935684443,0.38263665594855306,0.7654869433164742,1.0,2/30,1.62%,ST6GAL1;STT3B
prerank,covalent chromatin modification (GO:0016569),0.512220279620108,1.0696413880778495,0.4157509157509158,0.7654800804942371,1.0,6/14,22.75%,CHD1;AURKC;PARP2;SETD5;SIRT7;HLCS
prerank,organelle fission (GO:0048285),0.4589985563349736,1.0695278757690923,0.3838383838383838,0.765132937512014,1.0,1/24,0.27%,DNM3
prerank,cardiolipin metabolic process (GO:0032048),0.5091610309674595,1.0693792117407641,0.3950617283950617,0.7648633222096404,1.0,3/13,7.70%,PLA2G4A;HADHA;PTPMT1
prerank,cardiac cell development (GO:0055006),-0.4681826647314189,-1.069319178757815,0.36129032258064514,0.7946372232858016,1.0,4/11,9.30%,CXADR;SLC8A1;JAG1;VEGFA
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.4791594326774753,-1.068972143512992,0.405982905982906,0.7928893725976708,1.0,3/10,18.25%,MBP;WNK1;MYADM
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.4791594326774753,-1.068972143512992,0.405982905982906,0.7928893725976708,1.0,3/10,18.25%,MBP;WNK1;MYADM
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.3251859787634732,-1.0689012826974014,0.31448763250883394,0.7917542858078812,1.0,22/57,16.30%,DLG2;NLGN2;ACTN2;DLG4;GRIA2;DLG1;GRIA3;GRIA1;NLGN1;DLGAP4;DLG3;GRIA4;SHANK1;GRIN2A;PRRT1;CAMK2B;CACNG4;SHISA7;NPTXR;NETO1;DLGAP1;LRRC7
prerank,regulation of protein localization to nucleus (GO:1900180),0.4132732064341948,1.0682528125376138,0.3855421686746988,0.7669537562453841,1.0,7/43,7.32%,MFHAS1;WWTR1;CARD10;DTX3L;CTNNA1;LIMK2;TGFB1
prerank,positive regulation of leukocyte migration (GO:0002687),0.44333581264803773,1.068017726709208,0.384,0.7668976033286654,1.0,4/27,9.45%,ICAM1;IL6R;F7;CSF1
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.4144173806952596,1.067734154396894,0.3847328244274809,0.7669546068062345,1.0,8/42,12.58%,SMARCA2;ARID1B;CECR2;ARID1A;SMARCA5;SRCAP;SMARCE1;HNRNPC
prerank,cellular response to heat (GO:0034605),-0.35788707039550294,-1.0673355798339246,0.3404255319148936,0.7949165306510084,1.0,6/35,8.91%,FGF1;THBS1;ANO1;HSP90AA1;PRKACA;RBBP7
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),-0.42825884275123216,-1.0671670852626194,0.37264150943396224,0.794030215544506,1.0,8/17,23.68%,CAMK1D;MCU;RIPOR2;DAPK2;MDK;CCL19;CD74;DNM1L
prerank,regulation of organelle organization (GO:0033043),0.3677755824622639,1.0669336073769284,0.3546666666666667,0.7682399176309849,1.0,19/80,17.31%,TJP1;F11R;PDE2A;MSN;MTM1;PAK2;PTK2;CAMSAP2;CDT1;SCARB2;PJVK;EHD3;PREB;CLIC4;S100A9;RDX;ARL6IP1;RHOT1;ARMH3
prerank,protein deacetylation (GO:0006476),0.4126663373512124,1.0669102995377195,0.3869565217391304,0.7676757287513793,1.0,8/41,12.75%,HDAC9;HDAC7;RCOR1;RBM14;SIRT5;MIER1;SIRT6;MIDEAS
prerank,positive regulation of lipid catabolic process (GO:0050996),-0.40415016850614316,-1.066655333903655,0.3725,0.7941620443796824,1.0,3/19,2.89%,IRS1;PRKCD;PPARA
prerank,regulation of chromosome segregation (GO:0051983),0.47658762796639614,1.0665414131765143,0.3862876254180602,0.7679727132069835,1.0,7/16,20.61%,PUM1;RAD18;PUM2;CSNK2A2;CSNK2A1;NUMA1;RMI2
prerank,calcium ion import across plasma membrane (GO:0098703),-0.4403407295776406,-1.0663034161457052,0.3738738738738739,0.7937454812010524,1.0,4/14,9.51%,SLC8A3;CACNA2D1;SLC8A1;SLC24A2
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),-0.41649182411757635,-1.0661535306412118,0.3746958637469586,0.7928874468123407,1.0,8/19,23.68%,CAMK1D;MCU;RIPOR2;DAPK2;MDK;CCL19;CD74;DNM1L
prerank,positive regulation of macroautophagy (GO:0016239),0.40051015048427246,1.066149591386764,0.38450074515648286,0.768356694597254,1.0,13/48,17.15%,KDR;SPTLC2;VPS13D;RALB;SH3GLB1;IKBKG;BNIP3;GNAI3;FYCO1;IRGM;RAB3GAP2;EPM2A;HSPB8
prerank,cellular response to insulin stimulus (GO:0032869),0.3592358600996551,1.066109060548699,0.3598014888337469,0.7678408280583269,1.0,22/124,10.11%,FOXO1;HDAC9;INSR;TBC1D4;DENND4C;PIK3C2A;CAV2;SH2B2;SORBS1;GRB14;XBP1;CEACAM1;LPIN3;INPP5K;TRIB3;BCAR3;GRB7;ATP6V0A1;GAB1;AKT2;ATP6V1G2;RAB12
prerank,detection of mechanical stimulus (GO:0050982),0.47217476022523436,1.0659631762532034,0.3843537414965986,0.7675810648460947,1.0,5/19,8.28%,PIEZO1;CDH2;PTK2;PKD2;PKDREJ
prerank,axon extension (GO:0048675),0.45836340946980725,1.0659612098535562,0.3977635782747604,0.7669760217993392,1.0,4/23,5.97%,NRP2;SEMA5B;ULK1;PPP3CB
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.5080471592244468,1.0655248736596399,0.3977055449330784,0.7674492814555672,1.0,3/13,12.87%,PDE8A;RACK1;MET
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),-0.39230234151236854,-1.0652163584082177,0.36553524804177545,0.7941964765918688,1.0,9/23,25.42%,ZWINT;PLK5;CHFR;ZFYVE19;VPS4A;SETMAR;CDK5RAP3;CHEK1;BUB1B
prerank,fatty acid transmembrane transport (GO:1902001),0.4796065965609142,1.0641388761843542,0.4048865619546248,0.7701962159095972,1.0,5/19,11.84%,SLC2A1;ACACB;ABCD4;CPT1A;ABCD1
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.37543161699954525,-1.0638321049507875,0.34663341645885287,0.7967369440201779,1.0,6/26,6.09%,IGF1;IRS1;RHOQ;C2CD5;CLIP3;OSBPL8
prerank,epidermal cell differentiation (GO:0009913),0.412713855493145,1.0635884574682222,0.3774436090225564,0.7708595189997074,1.0,7/41,14.08%,UGCG;BCR;WNT5A;USH2A;CLIC4;TXNIP;ASAH1
prerank,negative regulation of mitotic cell cycle (GO:0045930),-0.33219406085553643,-1.0635666325120654,0.3344947735191638,0.7960977484520834,1.0,12/45,12.53%,BMP7;BMP4;GAS1;ZWINT;SMAD3;TOM1L2;BCL6;TRIM35;RGCC;FZD3;BRINP3;CHFR
prerank,motor neuron axon guidance (GO:0008045),0.49545122770647715,1.0633302263277367,0.4151260504201681,0.7708643608962206,1.0,3/15,10.81%,NTN1;RAC1;EPHA4
prerank,regulation of cytoskeleton organization (GO:0051493),-0.28876644295994264,-1.0630636632455075,0.28078817733990147,0.7961583707480377,1.0,19/108,8.67%,PHLDB2;LRP1;EPHA3;PDGFRB;ROCK2;EFNA5;RHOQ;PHLDB1;BICD1;PRKCD;GPM6B;RHOBTB2;RND3;ARHGAP18;PRKAA2;MAP6;EZR;RHOBTB3;PLXNB1
prerank,ventricular septum development (GO:0003281),-0.34898063033472543,-1.0629508027784023,0.37222222222222223,0.7951062752193814,1.0,12/37,11.95%,ROBO1;BMPR1A;TGFBR3;TGFBR1;ZFPM2;ROBO2;SALL1;HEYL;MDM4;SLIT2;TGFB2;STRA6
prerank,negative regulation of double-strand break repair (GO:2000780),0.44058627007050183,1.0629301364224801,0.4003189792663477,0.7712285586987846,1.0,7/30,12.11%,RNF169;SMCHD1;SHLD1;CGAS;MAD2L2;HELB;CYREN
prerank,peptidyl-asparagine modification (GO:0018196),0.432328197894993,1.062652165152836,0.391025641025641,0.7712848738438004,1.0,2/31,1.62%,ST6GAL1;STT3B
prerank,positive regulation of protein secretion (GO:0050714),0.3804333296329567,1.062629938169586,0.3775933609958506,0.770724475962462,1.0,9/69,9.32%,MYRIP;UNC13B;CD2AP;ACSL4;EXPH5;TCF7L2;TGFB1;ANG;SOX4
prerank,response to calcium ion (GO:0051592),0.35711611150447675,1.0625422601841081,0.3555276381909548,0.7703142065454525,1.0,16/102,8.08%,CAV1;MEF2C;CPNE8;IQGAP1;PPP3CA;PLCG2;ALOX5AP;KCNMB4;CHP2;WNT5A;ITPKB;TRPV6;ITPR3;NEDD4;RASA4;PKD2
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.36566098207225745,1.0625276673474495,0.3828947368421053,0.7697488012816043,1.0,25/86,22.48%,EPAS1;HIF1A;KLF2;EGLN1;PSMA2;BACH1;PSMA8;PSMA6;MUC1;HIGD1A;PSME1;ELOC;DDIT3;PSMA4;PSMF1;CUL2;DNAJB1;PSMB7;PSMB1;EGLN2;PSMD2;ANKRD2;GCN1;PSMA5;PSMC3
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.36272785529847246,-1.0620260477166177,0.337468982630273,0.7963189971970954,1.0,8/31,9.11%,BMPR1A;FGFR2;TGFBR3;TGFBR1;ZFPM2;TPM1;RBPJ;RYR2
prerank,cellular response to DNA damage stimulus (GO:0006974),0.32128806575091295,1.061937500812218,0.3544575725026853,0.770595244614835,1.0,95/336,22.93%,FOXO1;ACER2;POLK;FOXP1;LYN;SAMHD1;FNIP2;TNFRSF1B;CCNK;TAOK2;USP3;BABAM2;UBA7;RNF169;DTX3L;HERC2;XIAP;BOK;BCL2L11;MCM10;RPA1;TIGAR;MTREX;BCL3;POLA1;PSEN1;RAD51D;IKBKG;CGAS;BCL2L1;BACH1;BTG2;PARP2;RECQL;RAD18;HELB;FAN1;HUS1;XRCC2;SFN;MMS19;UNG;MCM9;BID;NOP53;WDR76;ERCC4;NSMCE4A;FMR1;NPM1;ASH2L;APC;SUSD6;TOPORS;YY1;OARD1;ENDOV;DDIT3;GTF2H4;CHEK2;BCL2L10;PDS5A;SPIDR;WDR48;PDS5B;RFC3;CIB1;GRB2;KMT5B;PAK1;MGMT;BAK1;NUDT1;CHD1L;RBBP5;GTF2H1;TAF9;MSH2;HIC1;RAD17;RPS3;RMI2;TRRAP;SETX;RIF1;MAP2K6;SIRT7;CASP2;MBD4;RFC5;TAOK1;SUV39H1;PHF1;NIPBL;MAPK14
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.35020640192010694,1.0616704983618055,0.35301668806161746,0.7706044275860924,1.0,28/119,14.79%,INPP5D;PIP5K1B;SOCS2;PITPNM2;MTM1;PIK3C2A;PLCG2;PIK3R6;MTMR6;CISH;ITPKB;INPP5K;BMX;PIK3CG;PIGU;SYNJ1;PLEKHA8;INPP5F;OCRL;MTMR12;PIGQ;RAB5A;SLA2;PGAP4;PIGG;PIGF;SOCS6;SOCS4
prerank,regulation of ceramide biosynthetic process (GO:2000303),-0.4297251900506274,-1.0606242145558389,0.40979955456570155,0.7989143627607299,1.0,8/15,23.36%,PRKCD;SMPD3;SPHK1;NSMAF;ORMDL2;PLA2G6;SMPD2;SPHK2
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.42387103222234934,-1.0595437062331043,0.3969298245614035,0.8006547289937083,1.0,3/17,7.36%,BMP6;CD55;PRKCA
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),0.5192069489173702,1.0592460186849795,0.41712204007285975,0.7758586979402103,1.0,3/11,7.32%,MEF2C;GREM1;TGFB1
prerank,metal ion export (GO:0070839),-0.36012310951878884,-1.0588784920551917,0.3490304709141274,0.801222987170173,1.0,4/31,4.91%,ATP1A2;KCNK5;ATP1B1;KCND3
prerank,erythrocyte development (GO:0048821),0.5272522188696326,1.058371059652834,0.421875,0.7774349169308948,1.0,1/10,2.95%,ALAS1
prerank,amyloid precursor protein catabolic process (GO:0042987),0.4916523397073812,1.058329877430618,0.4149305555555556,0.77692586788964,1.0,6/14,13.76%,ADAM10;DYRK1A;PSEN1;APH1A;ADAM17;ABCG1
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.5082514459340302,1.0577446168108857,0.4318181818181818,0.777701957124832,1.0,7/13,23.51%,UBA7;SAE1;DESI2;DESI1;ATG7;UBA3;SENP6
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.45455092140141307,1.0576014166641827,0.4166666666666667,0.7774097345205134,1.0,3/20,8.58%,TGM2;RAP1GDS1;PSEN1
prerank,positive regulation of cell cycle process (GO:0090068),0.36356770553641005,1.0575826117812481,0.3575063613231552,0.7768514099939443,1.0,24/91,19.30%,PKP4;INSR;PDGFB;EDN1;LRP5;PKN2;AURKA;TGFA;DYNC1LI1;AURKC;NUDT16;KIF23;PHIP;MAP3K20;GIPC1;ATRX;E2F7;CEP295;RHOA;RAD21;CUL3;PLSCR1;NUMA1;BTC
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.47352748227591074,-1.0573896494866082,0.3882863340563991,0.8041210262849314,1.0,2/11,4.18%,NRP1;SIRT2
prerank,positive regulation of protein kinase activity (GO:0045860),0.34460726226137617,1.0571344195853445,0.3549190535491905,0.7773337309616654,1.0,38/148,16.71%,INSR;PDGFB;NEDD9;IQGAP1;IL6R;DAB2IP;EFNA1;PTK2B;TAOK2;STK3;PAK2;STK4;RALB;CCDC88A;RAPGEF2;TNIK;PTK2;RAP1A;RPTOR;PTPN1;CSF1;MAP2K3;IL23A;FCGR1A;GAS6;EPHA4;ITGB3;TGFBR2;HSP90AB1;TRAF6;PAK4;ACE;MMD;LAT;IRGM;CALM1;PIH1D1;RHOA
prerank,glycosphingolipid biosynthetic process (GO:0006688),0.4830846346299869,1.0568951585338342,0.4028268551236749,0.7772904463573674,1.0,4/16,10.65%,ST6GALNAC3;ST8SIA4;ST6GALNAC4;A4GALT
prerank,calcium ion import into cytosol (GO:1902656),-0.42878238763109827,-1.0567907283399982,0.3761467889908257,0.8044695545611644,1.0,4/15,9.51%,SLC8A3;CACNA2D1;SLC8A1;SLC24A2
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.35843464568377414,1.0565299735321547,0.3629242819843342,0.777558587178614,1.0,27/94,17.24%,ERN1;PPP1R13B;DAB2IP;FNIP2;CASP4;PPM1F;TNFRSF1B;STK24;JMY;BOK;TRIB3;BCL2L11;MYBBP1A;HINT1;BCL2L1;ERO1A;BNIP3;SFN;CUL1;GSKIP;TOPORS;APAF1;DDIT3;CHEK2;BCL2L10;CUL3;ARL6IP5
prerank,regulation of mitochondrial membrane potential (GO:0051881),-0.34397967855738826,-1.056117747898773,0.37846153846153846,0.8050057549985451,1.0,2/40,1.56%,PID1;BCL2
prerank,response to amyloid-beta (GO:1904645),0.4039443234330342,1.0560450937636543,0.3867069486404834,0.7781415462520073,1.0,11/44,11.79%,APP;VCAM1;ICAM1;CASP4;FYN;ATP1A3;CACNA1A;PSEN1;EPHA4;GRIN1;LGMN
prerank,cellular response to cadmium ion (GO:0071276),-0.39304594556415795,-1.0558886439263362,0.39267015706806285,0.8042934960784808,1.0,1/24,0.38%,EGFR
prerank,nucleotide biosynthetic process (GO:0009165),-0.42040791248307563,-1.055526389316815,0.3900709219858156,0.8040328768155981,1.0,8/18,21.54%,NMNAT2;ME1;PRPS2;MTHFD1;NMNAT1;PRPSAP2;NMNAT3;PRPSAP1
prerank,negative regulation of myoblast differentiation (GO:0045662),0.50820619137761,1.0554101814895396,0.4295900178253119,0.7791507265592251,1.0,4/13,12.48%,NOTCH1;DLL1;TGFB1;PRICKLE1
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),-0.3103332463817717,-1.0550178393382694,0.3204225352112676,0.804073148995634,1.0,17/65,11.50%,FBN1;LTBP1;TGFBR1;HTRA3;SPRED1;PPARA;SMAD6;FBN2;SMAD3;CD109;SNX6;ASPN;TGFB1I1;VASN;SLC2A10;SPRED2;SPRED3
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.4503372931900369,1.0549355817471002,0.3905511811023622,0.7796771441037951,1.0,5/24,7.32%,IL6ST;PTGS2;HIF1A;FLT4;TGFB1
prerank,positive regulation of neutrophil migration (GO:1902624),-0.4161873050173581,-1.0547871042631847,0.37889688249400477,0.8033826207094233,1.0,8/18,23.68%,CAMK1D;MCU;RIPOR2;DAPK2;MDK;CCL19;CD74;DNM1L
prerank,lipid phosphorylation (GO:0046834),0.5210862535383513,1.054424835329389,0.418426103646833,0.7802941229126322,1.0,3/10,11.25%,DGKZ;DGKH;DGKE
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",-0.4356905213716816,-1.0543668649641753,0.3825503355704698,0.8031716221475796,1.0,8/15,25.09%,NLGN2;NLGN1;CNTNAP4;ADRA1A;CLN3;BAIAP3;ZDHHC12;ZDHHC3
prerank,phosphatidylcholine metabolic process (GO:0046470),0.3767735465127456,1.0537606809975986,0.37986577181208053,0.7813091217269704,1.0,15/70,18.25%,PLA2G4A;LPCAT3;CEPT1;ENPP2;LPIN3;ABCA3;PLA2G2D;MBOAT1;PLAAT3;PEMT;CHKA;PNPLA8;TMEM86B;CSNK2A2;CSNK2A1
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.5198772031629932,1.0536513415021436,0.425,0.7809719751960467,1.0,4/12,4.38%,LFNG;PTK2B;MFNG;DLL1
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.4730486692932069,1.0532055123202078,0.4007029876977153,0.7814000464705065,1.0,5/18,18.99%,LYN;SH2B2;SLA2;FPR3;BCAR1
prerank,negative regulation of protein polymerization (GO:0032272),0.43415170938980086,1.0529565999149186,0.40826446280991735,0.7813284491997381,1.0,6/27,10.18%,KANK3;HIP1R;SSH2;DYRK1A;CYRIB;TWF2
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),-0.33008217050470917,-1.0526463919212699,0.3404255319148936,0.8067397852283554,1.0,7/55,6.12%,PID1;PDGFRB;PRKN;THBS1;SIRT2;CYP1B1;AGTR1
prerank,in utero embryonic development (GO:0001701),-0.38331782787325686,-1.05232320486964,0.3691588785046729,0.8062996565930808,1.0,7/25,10.18%,FGFR2;ARNT2;TGFBR1;PKD1;IGF2;VEGFA;TGFB3
prerank,glycosphingolipid metabolic process (GO:0006687),0.40871238818889255,1.051530523016054,0.39123867069486407,0.7841912235785218,1.0,4/42,4.86%,ST6GALNAC3;UGCG;ESYT2;GLTP
prerank,glutamine family amino acid metabolic process (GO:0009064),0.417531315356324,1.051441038000812,0.38625954198473283,0.7837856873293169,1.0,4/33,3.41%,SLC39A8;DGLUCY;GLS2;GLS
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.5096237409600926,1.0513394569241745,0.4249084249084249,0.7834184478529151,1.0,5/11,16.06%,ARID1B;ARID1A;ZMIZ1;CDCA4;SERTAD2
prerank,protein localization to mitochondrion (GO:0070585),-0.4621271992284857,-1.0507526015375177,0.4040632054176072,0.809371516783123,1.0,6/11,21.89%,LRRK2;HK2;MTCH2;RALA;COX18;MAIP1
prerank,cellular response to reactive oxygen species (GO:0034614),-0.3205893066389132,-1.050606555025202,0.35789473684210527,0.808464906276232,1.0,8/59,5.16%,EGFR;PDGFRA;MAP3K5;PRKCD;TPM1;IMPACT;CYP1B1;ANXA1
prerank,regulation of gene expression (GO:0010468),0.3074704024493412,1.0501971975819302,0.3420787083753784,0.7855807410765466,1.0,122/903,10.78%,LEF1;RPS6KA5;NOS3;RAB27A;NOVA2;KDR;ENG;SLC39A8;APBB2;ESR1;SMARCA2;APP;MEF2C;SOX7;ACVRL1;CLDN5;OCLN;NR5A2;CDK6;INSR;AHR;SMAD1;PDGFB;IRF2;FOXP1;GATA2;SOX13;PDE2A;LYN;ADAM10;STAT3;NR3C1;TRIM14;FBXW7;NOTCH1;HIF1A;MSN;PPM1F;NFKBIZ;RREB1;SOX17;WWTR1;CHD7;CASP8;SOX18;CD34;PLCG2;FGF23;KDM6A;IGF2BP3;RBM20;MBNL1;PTBP3;MBNL2;TCF7L1;LIN54;SPIN1;DLL4;TRIM68;SBNO2;MAPK8;ATP2B4;SERPINB9;MTF2;RAMP2;JMJD1C;TEAD2;TNRC6C;PITX3;AURKA;ESRRG;HNRNPF;WNT5A;CNBP;RPS7;UBAP2;BTN2A2;IL36G;KRAS;ASCC1;AFF1;MBNL3;LYL1;HNRNPK;TGFB1;FOXN2;ZNF326;TCF3;HNRNPD;NFKB1;NOS1AP;MARF1;WWC2;CITED1;ZNF2;CREM;KAT6B;PSEN1;PRDM8;MYBBP1A;IHH;YBX3;RPL23;CDK2;HINT1;SOX4;CSF1;DICER1;ICOSLG;PUM1;MAFB;BACH1;HNRNPLL;MAPK11;ATXN7L3B;SFRP2;FOXN3;APLNR;PRKAB1;GAS6;YTHDC1;RC3H1
prerank,glycerolipid metabolic process (GO:0046486),0.5071928455933126,1.0500143064967185,0.409683426443203,0.7854268705451394,1.0,1/11,2.23%,DGKZ
prerank,protein localization to membrane (GO:0072657),0.3315775012618096,1.0499341204455372,0.3707995365005794,0.7850003952623051,1.0,39/187,12.21%,SHANK3;CAV1;EHD4;SPTBN1;F11R;SMURF1;RAB11A;TSPAN5;DENND4C;BSG;PACS1;NKD2;FCHO2;KCNB1;CPE;IKBKB;TSPAN14;RAMP2;RAPGEF2;TMEM88;INPP5K;SH3GLB1;ATP1B3;TNIK;TNFRSF1A;RAP1A;EHD2;AGRN;RAB38;ARL5A;ANK1;RFTN1;RAB12;TM9SF1;GAS6;PICK1;EHD3;BID;RAB11B
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.3614072703026939,1.0498161571276365,0.3852040816326531,0.7846725338361369,1.0,16/102,8.62%,FOXO1;HDAC9;CAV1;ADCY4;INSR;TBC1D4;DENND4C;PRKAR2B;SORBS1;XBP1;CEACAM1;LPIN3;INPP5K;TRIB3;NFKB1;AKT2
prerank,regulation of lysosomal lumen pH (GO:0035751),-0.4518482946988617,-1.0497944772540748,0.3870246085011186,0.8094216199563585,1.0,9/12,33.01%,LRRK2;ATP6AP2;PPT1;CLN3;TMEM199;TMEM165;TMEM9;CCDC115;GRN
prerank,pyrimidine nucleoside catabolic process (GO:0046135),-0.4793175396429589,-1.0497354103666858,0.40700218818380746,0.8082591941769321,1.0,4/10,15.60%,DPYD;UPB1;NT5E;NT5C1A
prerank,neuropeptide signaling pathway (GO:0007218),0.38388291147349407,1.0495629765909995,0.385049365303244,0.7846575675264953,1.0,13/58,19.79%,CYSLTR1;NXPH2;CPE;RAPGEF2;HCRTR1;MCHR1;NMUR2;LTB4R;AGRP;HCRTR2;OPRL1;GLRA3;PPY
prerank,positive regulation of ATP metabolic process (GO:1903580),-0.3636245396717456,-1.0491924709496159,0.3770491803278688,0.8084920128455242,1.0,9/32,9.79%,PID1;IGF1;NUPR1;ZBTB20;PPARA;PPARGC1A;PRKAA2;PFKFB4;ARNT
prerank,negative regulation of kinase activity (GO:0033673),0.38243934212217506,1.0484611513770368,0.40350877192982454,0.7866385546240025,1.0,16/62,13.61%,GNAQ;PPP2R5A;PPM1F;WWTR1;PAK2;CEACAM1;INPP5K;CDKN1B;TRIB3;NPRL2;SFN;RB1;GSTP1;WARS1;TRIB1;GSKIP
prerank,response to cadmium ion (GO:0046686),-0.38052971444148137,-1.0482971421461718,0.40970350404312667,0.8096750232637882,1.0,1/26,0.38%,EGFR
prerank,cell cycle G1/S phase transition (GO:0044843),0.3836209705358495,1.0477807273302955,0.3881856540084388,0.7877157831778331,1.0,23/61,24.16%,CDK6;EIF4E;PLK2;ACVR1;CDKN1B;MAP3K11;CDK2;RB1;EIF4EBP1;CUL1;MAX;CUL3;CDC34;CUL2;E2F3;TRIM71;DBF4;CCNH;CRLF3;LATS1;CCNA2;CUL4B;PLK3
prerank,regulation of neuroinflammatory response (GO:0150077),0.46344677924771116,1.0470663998759904,0.4084033613445378,0.7888507469549282,1.0,3/19,3.04%,PTGS2;CD200;TNFRSF1B
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.4447100319784644,1.046663445429425,0.42333333333333334,0.789196054406133,1.0,10/25,24.48%,SF3B4;SCAF11;PRPF4;SRSF10;LSM1;PRPF3;TRA2B;DBR1;SRSF4;SLU7
prerank,response to interferon-alpha (GO:0035455),0.4805905058433792,1.0461180519513402,0.4357638888888889,0.7899161933239954,1.0,9/16,19.34%,IFNAR1;IFNAR2;GAS6;RO60;ADAR;IFITM3;BST2;IFITM1;EIF2AK2
prerank,negative regulation of cellular component organization (GO:0051129),-0.30135950546779733,-1.046009881508531,0.3591549295774648,0.8148675521039918,1.0,20/74,16.86%,BMP6;EPHA3;TMEFF2;AR;FAP;IMPACT;CARMIL1;SYT11;PRKCZ;RTEL1;SRC;VEGFA;SCAMP5;LRSAM1;RUBCN;TRAF3IP1;XRCC5;LCMT1;ABCA7;NR1H4
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.31556187862986423,1.0457349553785469,0.3789359391965255,0.7902268588387642,1.0,90/341,21.22%,RNF125;KLHL3;SMURF1;RNF144B;NEDD4L;MVB12B;FBXW7;ZNRF1;ZNRF3;DTX3L;XBP1;KCTD10;PELI1;FBXL4;KCTD6;UBL7;AURKA;RNF144A;UBE3B;ATXN3;ARRB1;RNF7;UBE2G1;ARRDC1;PSMA2;RNF167;FBXL7;NEDD4;TRIM25;ARMC8;UBE2H;ANAPC7;RNF146;ZRANB1;SPOPL;RNF4;ANAPC1;ZFAND2B;VPS28;PSMA8;RAD23A;SIAH1;UBE2D3;PSMA6;RC3H1;CBL;CDC26;COP1;MYLIP;ANAPC16;RNF215;KLHL8;UBE2K;BUB3;TOPORS;UBXN1;PSME1;ELOC;ARIH2;RNF5;DDIT3;VPS37C;UBE3D;AREL1;CRBN;NDFIP2;BIRC2;NHLRC1;CTNNB1;MAEA;NEDD8;UBE2I;CUL3;CDC34;PSMA4;RNF40;PSMF1;ZFAND2A;TSG101;FBXO8;APPBP2;PSMB7;TRIM71;PSMB1;UBE2L3;HACE1;PLK1;KCTD2;ARIH1;PSMD2
prerank,insulin receptor signaling pathway (GO:0008286),0.37869341488420133,1.0456636399264605,0.3953488372093023,0.7897744935231934,1.0,13/69,9.30%,FOXO1;INSR;PIK3C2A;CAV2;SH2B2;SORBS1;GRB14;BCAR3;GRB7;ATP6V0A1;GAB1;AKT2;ATP6V1G2
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.42263731447940156,1.0454566278165778,0.42105263157894735,0.7896867849125053,1.0,9/35,11.71%,B2M;HIP1;HIP1R;RAC1;SMAP1;HNRNPK;CBL;MKLN1;PICALM
prerank,amyloid fibril formation (GO:1990000),0.3954633912220892,1.0452606755703164,0.38108882521489973,0.7895319835259472,1.0,11/51,11.86%,APP;B2M;ADAM10;TSPAN5;FKBP1A;TSPAN14;H3-3A;SNCAIP;SIAH1;APH1A;RIPK1
prerank,positive regulation of phospholipase C activity (GO:0010863),0.4028610884266366,1.044839252884933,0.4017991004497751,0.7899115924051963,1.0,6/40,3.22%,GNAQ;FLT1;ESR1;PLCG1;HTR2A;SELE
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.42132902705949044,1.0445539173427243,0.42105263157894735,0.789929115485666,1.0,9/34,12.78%,INSR;PDGFB;EDN1;LRP5;AURKA;TGFA;ANAPC7;RB1;PHIP
prerank,negative regulation of organelle assembly (GO:1902116),0.41890813645329505,1.044373499749149,0.39596273291925466,0.7897308470045787,1.0,8/35,10.44%,TBC1D30;MTM1;LIMK2;RBM14;FEZ2;CHMP4B;CHMP4A;NBDY
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.44757778411867105,1.044311588498033,0.4295415959252971,0.7892688349851871,1.0,4/24,6.96%,PLA2G4A;ABCA3;PLA2G2D;CDS2
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),0.488811982315536,1.043796146524788,0.42805755395683454,0.789862913924642,1.0,3/14,10.14%,NECTIN2;SHLD1;MAD2L2
prerank,T cell differentiation in thymus (GO:0033077),-0.43017295929050936,-1.0437765290786585,0.4158878504672897,0.8198574588956593,1.0,1/14,0.67%,GLI3
prerank,mitotic metaphase plate congression (GO:0007080),0.38705320201142324,1.043740918867066,0.41354466858789624,0.7893958654978916,1.0,9/51,12.45%,RAB11A;CHMP2B;CDT1;KIF22;RRS1;PINX1;CHMP4B;CHMP4A;MAD1L1
prerank,response to prostaglandin E (GO:0034695),-0.4794008088449016,-1.0436050217989168,0.4344086021505376,0.8189856482336182,1.0,5/10,18.90%,TGFBR3;ADCY6;SFRP1;GNG2;CCL19
prerank,reverse cholesterol transport (GO:0043691),0.4938216159941527,1.043569841356021,0.43112701252236135,0.7892106978106853,1.0,4/13,23.47%,SCARB1;ABCG1;ABCA1;CLU
prerank,response to unfolded protein (GO:0006986),0.39130348513369523,1.0433655655122998,0.40307692307692305,0.789123220306992,1.0,15/48,19.08%,ERN1;STT3B;DAB2IP;TMBIM6;DNAJA1;RHBDD1;DNAJB5;PTPN1;HSP90AB1;ERP44;DDIT3;HSPB8;HSPE1;BAK1;DNAJB1
prerank,mitochondrial translation (GO:0032543),0.3525416850387195,1.043002030217804,0.39169909208819714,0.7893857895561526,1.0,46/104,26.44%,MRPS18A;NDUFA7;MRPL13;MRPS12;MRPL35;FASTKD2;MRRF;MRPL41;MRPL52;MRPL4;QRSL1;MTIF3;MRPS16;MRPL23;MRPS5;MTRF1L;MRPL37;PTCD3;MRPL11;MRPL54;MRPS9;GADD45GIP1;MRPL43;MRPS26;MRPL12;MRPL44;MRPS30;NOA1;AURKAIP1;MRPL1;MRPL50;RARS2;MRPL17;MRPL39;MRPL14;MRPL32;MRPS11;MRPL9;MRPL46;MTIF2;DAP3;MRPL19;MRPL15;MRPL42;GFM1;MRPL24
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.36397994057196426,1.0427291953519067,0.40745672436750996,0.7894590684423384,1.0,20/74,22.48%,EPAS1;NOTCH1;HIF1A;EGLN1;PSMA2;BACH1;PSMA8;PSMA6;HIGD1A;PSME1;ELOC;PSMA4;PSMF1;CUL2;PSMB7;PSMB1;EGLN2;PSMD2;PSMA5;PSMC3
prerank,negative regulation of protein localization to membrane (GO:1905476),0.44994845807013323,1.0425274856481965,0.40553745928338764,0.7893161830595069,1.0,7/24,11.71%,ABI3;PPP2R5A;NUMB;INPP5K;TGFB1;BCL2L1;PICALM
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.3635283734813529,1.0424864903292763,0.41496598639455784,0.7888059454842343,1.0,7/76,6.67%,TEK;EDN1;PTK2B;NCK1;EVL;NCKAP1;CDC42EP3
prerank,DNA double-strand break processing (GO:0000729),-0.40606616737602236,-1.0422316813740549,0.38954869358669836,0.8215211252607091,1.0,12/18,38.38%,RAD50;SETMAR;KAT5;DNA2;SLX4;BARD1;RAD52;ATM;BLM;EXD2;RNF138;NBN
prerank,cellular transition metal ion homeostasis (GO:0046916),0.3612573120069405,1.0420407609257047,0.41130091984231276,0.7892058898388625,1.0,6/91,4.59%,ABCG2;SLC39A8;APP;SLC31A1;ABCB7;LCN2
prerank,positive regulation of lipid storage (GO:0010884),0.46582758201193486,1.0420157507115495,0.4482758620689655,0.7886588515296851,1.0,4/21,8.23%,SCARB1;PLIN5;NFKB1;LPL
prerank,sulfur amino acid metabolic process (GO:0000096),-0.38002519822417635,-1.0420087789164316,0.3910761154855643,0.8207869393405949,1.0,10/24,27.99%,NOX4;SMS;GCLC;MTHFD1;CBS;CTH;MMUT;ADI1;MTRR;CDO1
prerank,protein prenylation (GO:0018342),0.5210321970576026,1.041946862219991,0.42429906542056073,0.7882263489538324,1.0,6/10,27.17%,PGGT1B;PTAR1;FNTA;FNTB;RABGGTB;CHML
prerank,positive regulation of metabolic process (GO:0009893),0.35580179883715257,1.0418707758671366,0.40628930817610065,0.7878257090542493,1.0,23/103,13.47%,EPAS1;ADIPOR2;CAV1;INSR;FASN;ACACB;KDM3A;ADRB1;LCN2;GATM;ESRRG;PDGFC;AGPAT1;CXCR4;PRKAB1;IL4R;UCP2;PEMT;SIRT6;ADIPOR1;HADH;OMA1;IGF1R
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.3469971108427246,1.0416385891512117,0.4144486692015209,0.7877039058090977,1.0,20/128,7.46%,BMPR2;ENG;ACVRL1;CLDN5;F11R;SMAD1;SMURF1;PARD3;NRROS;PXN;FKBP1A;ID1;PTPRK;SMAD7;ACVR2A;USP15;DUSP22;ACVR1;TGFB1;PTK2
prerank,thyroid hormone generation (GO:0006590),-0.47170115645443367,-1.0414453636269594,0.42342342342342343,0.8210750801343122,1.0,2/10,7.88%,CPQ;SLC5A5
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.3692014447287444,1.0410512322226975,0.40054495912806537,0.7885050128514711,1.0,9/74,6.27%,NOS3;TNFSF10;ITGA6;ICAM1;ARHGEF2;FAS;CASP8;TCF7L2;ACVR1
prerank,regulation of macrophage chemotaxis (GO:0010758),0.45554582540875266,1.0409955849062902,0.44276094276094274,0.7880460005469996,1.0,4/21,9.45%,MTUS1;PTK2B;PTK2;CSF1
prerank,regulation of actin filament bundle assembly (GO:0032231),0.4437391313386234,1.0408784677489094,0.4262295081967213,0.787720100310214,1.0,1/26,0.09%,SHANK3
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.5180584158492549,1.0407603196784785,0.42962962962962964,0.7873954913152382,1.0,4/11,16.37%,LPCAT3;ATL1;MOSPD3;ARL6IP1
prerank,chloride transport (GO:0006821),-0.2984082879247807,-1.0407516660286165,0.33935018050541516,0.8216997593751922,1.0,18/74,15.12%,SLC4A10;SLC1A3;SLC26A7;SLC12A2;SLC6A1;GLRB;ANO1;CLCN2;GABRG2;ANO4;GABRA2;GABRB1;ANO3;GABRB3;GABRG3;SLC26A6;FXYD1;SLC1A1
prerank,positive regulation of mitochondrion organization (GO:0010822),0.38209811011974226,1.0406228480586988,0.4113372093023256,0.7871175697228783,1.0,7/57,6.83%,TNFSF10;KDR;HIP1R;BIK;BOK;AURKA;BCL2L11
prerank,macrophage activation involved in immune response (GO:0002281),0.49605531643914497,1.0404788802566884,0.44402985074626866,0.786874291419349,1.0,4/13,10.61%,PLCG2;CX3CR1;SBNO2;NMI
prerank,phospholipid dephosphorylation (GO:0046839),0.407488722618784,1.040377348811325,0.4193061840120664,0.786514476412342,1.0,15/37,20.45%,PLPP1;SGPP2;MTM1;MTMR6;INPP5K;SYNJ1;INPP5F;OCRL;MTMR12;PLPP6;PLPP5;MTMR9;MTMR2;SACM1L;PLPPR2
prerank,regulation of viral life cycle (GO:1903900),0.4517923310130273,1.0402300571386176,0.4144736842105263,0.7862489763198376,1.0,4/21,7.85%,TRIM14;NECTIN2;TRIM68;TRIM25
prerank,positive regulation of telomerase activity (GO:0051973),0.413598140909622,1.0400279195158677,0.41430948419301167,0.7861236334444944,1.0,6/33,12.95%,NEK7;HMBOX1;GREM1;WRAP53;ACD;HSP90AB1
prerank,atrial septum morphogenesis (GO:0060413),0.515357070371277,1.039426084099643,0.42018348623853213,0.7869276328915809,1.0,4/10,9.32%,BMPR2;ACVR1;ZFPM1;SOX4
prerank,positive regulation of viral life cycle (GO:1903902),-0.3871560810067776,-1.03906701146366,0.38860103626943004,0.8253032545814202,1.0,8/22,21.05%,AXL;P4HB;LGALS1;DDB1;KPNA2;VPS4A;TYRO3;CD74
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.40397949115832904,1.0389600844988929,0.402457757296467,0.7874529146805834,1.0,8/39,10.14%,NEXMIF;PODXL;NOTCH1;PPM1F;TGFB1;PTK2;NF2;MAD2L2
prerank,regulation of receptor internalization (GO:0002090),0.41681813318399474,1.0386385468457877,0.4405487804878049,0.7877215003147113,1.0,11/35,11.51%,ANKRD13A;INSR;RIN3;SELE;SDCBP;GREM1;ARRB1;SCYL2;MKLN1;TBC1D5;PICK1
prerank,regulation of sodium ion transport (GO:0002028),-0.35232798495943474,-1.0382676356331724,0.3654390934844193,0.8261747053202056,1.0,8/34,5.31%,SNTA1;P2RX4;WNK4;NKAIN4;ANK3;DLG1;SLMAP;NKAIN2
prerank,formation of extrachromosomal circular DNA (GO:0001325),-0.4816060089236026,-1.038024883524023,0.43737166324435317,0.822895631969977,1.0,8/10,32.54%,SMARCAL1;DNA2;SLX4;XRCC3;EXO1;ERCC1;BLM;WRN
prerank,t-circle formation (GO:0090656),-0.4816060089236026,-1.038024883524023,0.43737166324435317,0.822895631969977,1.0,8/10,32.54%,SMARCAL1;DNA2;SLX4;XRCC3;EXO1;ERCC1;BLM;WRN
prerank,telomere maintenance via telomere trimming (GO:0090737),-0.4816060089236026,-1.038024883524023,0.43737166324435317,0.822895631969977,1.0,8/10,32.54%,SMARCAL1;DNA2;SLX4;XRCC3;EXO1;ERCC1;BLM;WRN
prerank,nucleoside catabolic process (GO:0009164),-0.47397854484070545,-1.0379085325311155,0.45227272727272727,0.8219073906135728,1.0,4/11,15.60%,DPYD;UPB1;NT5E;NT5C1A
prerank,long-chain fatty acid transport (GO:0015909),-0.36541641105844463,-1.037669182698088,0.36910994764397903,0.8212224870928744,1.0,19/30,31.70%,ACSL1;ABCD3;PRKAA2;PRKAG2;ACACA;ACSL3;APOE;SLC27A1;MFSD2A;PRKAB2;SLC27A4;CPT2;PPARG;RPS6KB1;ABCD2;SLC27A6;CD36;CPT1B;FABP5
prerank,DNA dealkylation (GO:0035510),0.5104419123528041,1.0375260393643913,0.4275491949910555,0.7891379328502368,1.0,4/10,18.55%,ASCC1;ASCC3;MPG;MGMT
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.5104419123528041,1.0375260393643913,0.4275491949910555,0.7891379328502368,1.0,4/10,18.55%,ASCC1;ASCC3;MPG;MGMT
prerank,neural tube development (GO:0021915),-0.43883679108185636,-1.0373370012615708,0.413716814159292,0.8208409248935817,1.0,3/15,4.70%,ALDH1A2;PKD1;DACT1
prerank,ERBB signaling pathway (GO:0038127),0.3723263931389602,1.0372329031511678,0.41418439716312055,0.7892339005675617,1.0,11/64,8.09%,RPS6KA5;PLCG1;PTPN12;IQGAP1;PTK2B;PIK3C2A;TGFB1;PTK2;TGFA;GRB7;GAB1
prerank,axonal transport of mitochondrion (GO:0019896),0.5068167082499708,1.0372078956910282,0.45293072824156305,0.7886899108175912,1.0,6/11,27.15%,HIF1A;ACTR10;TRAK2;OPA1;NEFL;HAP1
prerank,regulation of mRNA polyadenylation (GO:1900363),-0.42062436698736844,-1.0371089156525732,0.4250614250614251,0.82018895171298,1.0,4/17,13.09%,CPEB1;CPEB3;CTR9;CDK9
prerank,response to purine-containing compound (GO:0014074),-0.40641440110772087,-1.0370308700724982,0.423963133640553,0.8190880278878961,1.0,4/17,9.11%,P2RX4;ABCC9;TRPC3;RYR2
prerank,regulation of protein ubiquitination (GO:0031396),0.3471993517522454,1.0369257513599086,0.421455938697318,0.7887734419936413,1.0,29/108,17.21%,CAV1;FBXW7;FKBP1A;SMAD7;N4BP1;FOXF2;XIAP;MYCBP2;SASH1;DNAJA1;ARRB1;MALT1;PINX1;SOX4;SPOPL;VPS28;UBE3A;RIPK2;PRICKLE1;NXN;BIRC3;HSP90AB1;TRAF6;UBXN1;PRKCG;CHP1;NDFIP2;BIRC2;CUL3
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.41833283730778525,1.0368777091268089,0.42130365659777425,0.788297654024107,1.0,2/29,1.06%,MCTP1;APP
prerank,negative regulation of signal transduction (GO:0009968),0.32009529062115766,1.0367858434473742,0.40176600441501104,0.7879242464144086,1.0,40/249,8.35%,SEMA6A;EGFL7;NTN1;EPN2;NFATC1;MMRN2;GATA2;PTPN12;DAB2IP;HHEX;LYN;DDIT4;FBXW7;PTPRJ;KIF26A;NCK1;SRMS;SIGIRR;NKD2;CYP26A1;PLIN5;DLL1;TMBIM6;GRB14;VGLL4;DLL4;CX3CR1;ASAH2;KCTD6;ACVR1;CYP26C1;SOST;INPP5K;ARRB1;ARRDC1;GRB7;NEDD4;CTNNBIP1;MOSMO;CITED1
prerank,cortical actin cytoskeleton organization (GO:0030866),0.46009500816011767,1.036428378103315,0.42736486486486486,0.7882026823820912,1.0,6/20,8.81%,LCP1;FMNL3;IKBKB;NCKAP1;FMNL2;LLGL1
prerank,establishment of mitotic spindle localization (GO:0040001),-0.35868723104134803,-1.0362664673282753,0.40161725067385445,0.8200539064136487,1.0,16/28,33.67%,GJA1;GPSM2;HTT;UBXN2B;NUSAP1;NDC80;MISP;SPDL1;CENPA;FBXW11;CLASP1;DCTN1;INSC;ZW10;ESPL1;PKHD1
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.449340946820063,1.0360276215983046,0.42158516020236086,0.7885475911516544,1.0,3/20,2.77%,ENG;ACVRL1;NOTCH1
prerank,regulation of viral transcription (GO:0046782),0.39903242469098105,1.0359913483099656,0.4077961019490255,0.7880340781477485,1.0,13/39,22.29%,TRIM14;MID2;GTF2F2;NELFE;ZFP36;NELFCD;IFITM3;CTDP1;TRIM62;NELFB;POLR2L;NELFA;POLR2J
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),0.4857603256056647,1.0355053148007645,0.44021739130434784,0.7886127539829306,1.0,5/14,15.90%,NFKBIA;TMSB4X;PKD2;NFKBIE;G3BP2
prerank,mesenchymal cell differentiation (GO:0048762),0.38849133258096014,1.0354778435345284,0.4240231548480463,0.788085826198333,1.0,8/51,7.32%,LEF1;ENG;MEF2C;NOTCH1;HIF1A;FOXF2;WNT5A;TGFB1
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.4541373931935302,-1.035128333202842,0.43317972350230416,0.821930368199051,1.0,5/12,10.19%,CACNA1C;DLG1;RYR2;BIN1;CTNNA3
prerank,mitochondrial protein processing (GO:0034982),0.5047402222008177,1.0349830254494714,0.45387453874538747,0.7886071094082817,1.0,2/11,13.21%,IMMP2L;OMA1
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.3838372376486981,1.0347211026480991,0.4090909090909091,0.7886509415889177,1.0,17/48,20.20%,FNIP2;DDIT4;TNFRSF1B;HIPK1;BOK;BCL2L11;BCL3;BCL2L1;SFN;TOPORS;SNW1;TMEM109;CHEK2;BCL2L10;BAK1;MSH2;HIC1
prerank,response to hydrogen peroxide (GO:0042542),0.39412644773941846,1.0346501115026323,0.39741750358680056,0.7882230905777441,1.0,9/45,12.46%,NET1;FYN;STK24;CAT;STK26;RIPK1;RHOB;RELA;GLRX2
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),-0.2933173770419551,-1.0346211777983583,0.388,0.8220688683187412,1.0,10/77,6.94%,IGF1;PRKN;BCL2;TGFBR1;SH3RF1;BMP4;THBS1;AR;ITGAV;SIAH2
prerank,negative regulation of receptor binding (GO:1900121),0.5199551736171859,1.034067654874568,0.44656488549618323,0.7890124023929607,1.0,2/10,6.17%,B2M;ADAM15
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.28118860738234813,-1.0340293257486879,0.41409691629955947,0.8225095561135709,1.0,22/95,11.50%,ZEB2;TGFBR3;DKK3;TGFBR1;HTRA3;SPRED1;PPARA;THBS1;SMAD6;SMAD3;CD109;SNX6;ASPN;TGFB1I1;DAB2;BCL9;VASN;HIPK2;SLC2A10;SPRED2;NREP;SPRED3
prerank,Wnt signaling pathway (GO:0016055),0.3567390741812443,1.0340192143101083,0.41245136186770426,0.7885372017131376,1.0,12/92,7.55%,LEF1;DIXDC1;FZD6;FZD4;LRP5;PLCG2;CPE;TCF7L1;TCF7L2;WNT5A;WNT9B;SNX3
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.43661547813297563,1.0328174481779206,0.41352201257861637,0.7907500924944696,1.0,7/24,10.83%,EPC1;H3-3A;MTF2;TASOR;PPM1D;AEBP2;PPHLN1
prerank,regulation of cell cycle process (GO:0010564),0.34805669810540213,1.0328014350095274,0.3919270833333333,0.7902047898726825,1.0,28/104,21.86%,DCUN1D3;RAB11A;CAV2;PLK2;AURKA;SH3GLB1;AURKC;NUDT16;BCL2L1;RPRD1B;MAD1L1;CDC25C;APC;PDXP;CALM1;CTNNB1;PRPF40A;CSNK2A2;CSNK2A1;CETN2;NUMA1;RMI2;DBF4;GIT1;PLK1;RACGAP1;TIPIN;PIK3R4
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.5131832518991823,1.0324766177043443,0.4631782945736434,0.7903892935949881,1.0,3/10,2.97%,NEXMIF;NOTCH1;PPM1F
prerank,microtubule anchoring (GO:0034453),-0.4373297418509235,-1.0322864528278153,0.43790849673202614,0.8260422731867721,1.0,4/12,13.81%,BICD1;DAG1;PCM1;BICD2
prerank,iron ion transmembrane transport (GO:0034755),0.5198920552828075,1.0315775434964987,0.44727272727272727,0.791944642904066,1.0,2/10,4.22%,SLC39A8;ABCB7
prerank,carbohydrate homeostasis (GO:0033500),0.3699734214722051,1.031386205254752,0.41483516483516486,0.7917846679393322,1.0,13/67,14.54%,ADIPOR2;INSR;STAT3;KLF7;KCNB1;TCF7L2;INPP5K;NEUROD1;SOX4;ADIPOR1;IGF1R;RPS6;MBD5
prerank,pinocytosis (GO:0006907),-0.47175731246134295,-1.0313311423923335,0.4355179704016913,0.8274938182092986,1.0,7/10,29.28%,CARMIL1;SNX5;PPT1;PYCARD;DOCK2;SNX33;AHSG
prerank,positive regulation of neurogenesis (GO:0050769),0.37000710600995795,1.0312238036342822,0.4223776223776224,0.7915478311598229,1.0,7/68,5.38%,SHANK3;PLXNA4;TGM2;PLXND1;NUMB;DISC1;CX3CR1
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.4326026535167521,1.031209035119864,0.4153605015673981,0.7910016216039298,1.0,5/26,7.32%,IL6ST;PTGS2;HIF1A;FLT4;TGFB1
prerank,positive regulation of telomere capping (GO:1904355),0.46888850674777016,1.0311949248602226,0.4537205081669691,0.7904445556922746,1.0,2/17,7.79%,NEK7;HNRNPD
prerank,positive regulation of DNA recombination (GO:0045911),0.4303858346803958,1.0310182750660555,0.4370860927152318,0.7902916017322601,1.0,12/27,24.26%,SHLD1;WRAP53;MAD2L2;MMS19;ACTR2;WDR48;KMT5B;FUS;RIF1;PRDM9;ERCC6;ARID2
prerank,cellular response to chemical stress (GO:0062197),0.3532639545276058,1.0308268912485068,0.4087301587301587,0.7901528502555863,1.0,14/96,12.62%,FOXO1;CAV1;PRKD1;FAS;CAT;GSR;CYCS;PRR5L;TRPV4;PKD2;ERO1A;LONP1;PRDX2;GSTP1
prerank,heart process (GO:0003015),-0.43282978655043625,-1.030668125144746,0.42424242424242425,0.827975531400669,1.0,3/14,7.90%,SGCD;NOX4;SGCZ
prerank,fatty acid oxidation (GO:0019395),0.37373379096455706,1.0306310379366515,0.4163027656477438,0.7900375806439738,1.0,9/57,14.26%,ADIPOR2;PPARD;HADHA;ECI1;ABCD4;ABCD1;ADIPOR1;HADH;ALDH3A2
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),-0.43173625554002004,-1.0301113410220142,0.41774891774891776,0.8283225539528045,1.0,6/12,20.94%,ROCK2;APOE;FLOT2;ABCA7;CHRNA7;ABCA2
prerank,negative regulation of innate immune response (GO:0045824),0.4095749222181504,1.0297812450540509,0.42771084337349397,0.7914289472272245,1.0,7/34,15.63%,NLRC5;SAMHD1;RPS19;USP15;NMI;CNOT7;IRAK3
prerank,regulation of epithelial cell proliferation (GO:0050678),0.358385503544725,1.0295372890622274,0.3994708994708995,0.791415950022559,1.0,10/85,3.30%,TBX1;TIE1;ACVRL1;PRKD1;B2M;CDK6;DAB2IP;SGPP2;AQP11;MTSS1
prerank,protein acylation (GO:0043543),0.408230122263975,1.0293574898032658,0.4362519201228879,0.7912132958689995,1.0,10/38,20.91%,FOXO1;ZDHHC18;ZDHHC9;HHAT;KAT2B;KAT6A;ZDHHC1;ZDHHC6;SELENOK;ZDHHC8
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.4483228622985305,-1.02929455715464,0.4349775784753363,0.8292089451450355,1.0,2/12,7.60%,BCL2;CD44
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),-0.47028668356583514,-1.0291046166224926,0.4442105263157895,0.8284351863076168,1.0,5/10,30.41%,MIA3;TICAM1;TREM2;CD36;TLR6
prerank,myelin assembly (GO:0032288),-0.47525630974479516,-1.0288897801247296,0.4732142857142857,0.8277436628826499,1.0,6/10,23.46%,EPB41L3;CNTNAP1;GPC1;TENM4;ABCA2;NCMAP
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.3273604692317462,1.0288775769471725,0.41041162227602906,0.7918456742630589,1.0,17/159,5.11%,MPZ;PECAM1;CADM1;VCAM1;ICAM1;CLDN5;PTPRM;NECTIN2;PVR;SELE;BSG;PCDHB4;SELP;ROBO4;AMIGO2;CDH2;CEACAM1
prerank,regulation of cartilage development (GO:0061035),0.4587148890394981,1.0288774230040554,0.43103448275862066,0.7912634347966889,1.0,2/18,1.19%,BMPR2;ZBTB16
prerank,renal filtration (GO:0097205),-0.4676248658034905,-1.0287933157267348,0.4272930648769575,0.8267042175899328,1.0,2/10,2.03%,SULF1;SULF2
prerank,toll-like receptor signaling pathway (GO:0002224),0.35458294657886585,1.0287603526100908,0.43010752688172044,0.7909392873123972,1.0,23/84,17.54%,CASP8;PLCG2;TIRAP;RPS6KA3;IKBKB;CTSK;IKBKG;RFTN1;MAPKAPK3;UBE2D3;TNIP1;NMI;IRAK4;LGMN;RIPK1;RIPK2;BIRC3;TRAF6;S100A9;IRAK3;TAB3;BIRC2;IRAK2
prerank,cyclooxygenase pathway (GO:0019371),0.521806458790328,1.0279816490903253,0.44815465729349735,0.7921833740525164,1.0,3/10,7.16%,PTGS2;PTGS1;CBR1
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.46397738485504414,1.02780660394773,0.4353982300884956,0.7920325805940871,1.0,2/17,6.32%,PLA2G4A;PLA2G2D
prerank,necroptotic process (GO:0070266),0.4656762770125191,1.0276212385004146,0.453448275862069,0.791910527196828,1.0,5/16,17.87%,PGAM5;MLKL;RIPK1;TRPM7;IPMK
prerank,peptide cross-linking (GO:0018149),-0.37016367261761923,-1.0272292390688669,0.4024390243902439,0.8296890747528535,1.0,4/25,5.16%,COL3A1;THBS1;NDNF;ANXA1
prerank,histone H4 deacetylation (GO:0070933),0.5233104038405397,1.0270625660245318,0.4435946462715105,0.7926081645091652,1.0,2/10,6.17%,HDAC9;RCOR1
prerank,defense response to Gram-negative bacterium (GO:0050829),0.3848120039298217,1.0267622513466157,0.41158059467918623,0.7927159950192677,1.0,6/42,9.60%,IL6R;SELP;RPS19;DROSHA;DEFA6;IL23A
prerank,calcium-mediated signaling (GO:0019722),0.3484022620490971,1.0266557710742397,0.4068965517241379,0.7924137422342745,1.0,13/93,5.97%,MCTP1;KDR;VCAM1;PLCG1;EDN1;PPP3CA;PTPRJ;SELE;PLCG2;SELP;PPP1R9B;CX3CR1;PPP3CB
prerank,antibacterial humoral response (GO:0019731),0.4621020085841861,1.0266520074578729,0.4391080617495712,0.7918437147689587,1.0,3/16,9.15%,RPL39;ANG;DEFA6
prerank,epithelial cell morphogenesis (GO:0003382),-0.41947411396218026,-1.0265126715813186,0.419953596287703,0.8303564862641759,1.0,4/17,13.05%,COL22A1;COL18A1;COL15A1;DACT2
prerank,NIK/NF-kappaB signaling (GO:0038061),0.3618113477493066,1.0263751284818368,0.42993197278911566,0.7918896620159905,1.0,27/72,24.92%,CARD10;TIRAP;PSMA2;MALT1;RELB;DICER1;PSMA8;PSMA6;CUL1;RELA;BIRC3;TRAF6;PSME1;NFKB2;BIRC2;PSMA4;PSMF1;PSMB7;PSMB1;REL;PSMD2;PSMA5;PSMC3;TRAF2;COPS8;PSMD3;PSMA3
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.345252192631125,1.0263038960827051,0.4434447300771208,0.7914758654446862,1.0,19/101,9.04%,FLT1;PDGFB;DAB2IP;EDN1;PDGFD;TPD52L1;PIK3R6;RALB;ATP2B4;WNT5A;RAPGEF2;CD40;PDGFC;TGFB1;PIK3CG;CCNYL1;PKD2;RPTOR;CCNY
prerank,negative regulation of ATPase activity (GO:0032780),-0.41254737483587267,-1.0262639767974415,0.4219114219114219,0.8297385139957812,1.0,8/16,27.62%,IFIT1;TSC1;VCPKMT;ATP5IF1;TP53;PPIF;PAM16;PLN
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.4227531747254276,1.0259984434347846,0.4297253634894992,0.7915419519981669,1.0,14/29,26.27%,CNOT6;EDC3;EXOSC1;DCP2;LSM3;HBS1L;CNOT7;LSM7;LSM1;DCP1B;LSM2;DDX6;DIS3;EXOSC4
prerank,cellular response to catecholamine stimulus (GO:0071870),0.4394575147026695,1.0254345874372734,0.4242928452579035,0.7922861073132664,1.0,4/23,5.48%,TGM2;KCNQ1;GNB1;ATP2B4
prerank,synapse assembly (GO:0007416),0.36542232835388,1.0250176314258854,0.42492917847025496,0.7926547366085759,1.0,6/67,6.09%,SHANK3;DNM3;PLXND1;PCDHB4;CDH2;WNT5A
prerank,regulation of phospholipase C activity (GO:1900274),0.4637205744385469,1.024631735758502,0.42408376963350786,0.7929906920665651,1.0,3/15,1.87%,FLT1;ESR1;PLCG1
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.43561444644689923,1.0246141636809682,0.4361525704809287,0.7924491439150847,1.0,4/21,14.04%,RAB11A;BRD4;CDC25C;NPM1
prerank,L-amino acid transport (GO:0015807),-0.3608500625049032,-1.0246015766593741,0.3931203931203931,0.8330300640447912,1.0,9/28,18.51%,SLC7A2;SLC1A3;SLC1A2;SLC25A12;SLC25A13;SLC1A1;SLC25A18;SLC36A1;PRAF2
prerank,phosphate ion homeostasis (GO:0055062),-0.4554132016748112,-1.024461422210331,0.45,0.8321316879926284,1.0,3/10,10.71%,ENPP1;SFRP4;FGFR4
prerank,monocyte differentiation (GO:0030224),0.5162328112749314,1.0244176687259392,0.4655493482309125,0.7923194475347134,1.0,2/10,2.11%,PIR;MYH9
prerank,regulation of cellular protein localization (GO:1903827),-0.32720665757143674,-1.0242216800293513,0.3887240356083086,0.8314940989213019,1.0,9/45,11.11%,GPC6;GPC3;MAP2;HSP90AA1;PRKAA2;GPC5;GBF1;GPC4;CCDC66
prerank,Ras protein signal transduction (GO:0007265),0.33383653128503965,1.0241381485519259,0.4093789607097592,0.7923853970119868,1.0,33/137,12.83%,NTN1;PRKD1;EPS8;ARHGEF3;ELMO1;CELSR1;GNB1;RREB1;GRAP;RAP1B;RASGRP3;ADGRG1;PLEKHG5;RALB;NCKAP1;PLK2;RAPGEF2;NRAS;KRAS;RAC1;CDC42EP3;RAP1A;GNA12;SHOC2;CDK2;G3BP1;MAPK11;RGL2;RB1;CYFIP1;RHOB;GNA13;DBNL
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.4216268613697917,1.0239749035357346,0.4292845257903494,0.7921933730894073,1.0,10/25,24.31%,CCNK;ZNF326;EAF1;ZMYND11;ALYREF;THOC1;THOC5;SETD5;ERCC6;TCEA2
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.42500078505586397,1.0234388913157646,0.433489827856025,0.7927800364897347,1.0,6/25,15.19%,B2M;PLCG2;WNT5A;MALT1;TRAF6;SLC7A5
prerank,cellular response to alkaloid (GO:0071312),0.4613385211559612,1.023345742414574,0.4380305602716469,0.7924051618531893,1.0,2/17,7.68%,TGM2;CASP7
prerank,long-term synaptic potentiation (GO:0060291),-0.39526681970306704,-1.0233279972645581,0.44554455445544555,0.8327321458093405,1.0,8/21,13.74%,SLC8A3;TSHZ3;PRKCZ;SLC24A2;STX4;GRIN2A;NFATC4;GRIN2D
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.36926585757976504,1.0230708478558235,0.443342776203966,0.7924655291837994,1.0,10/59,5.11%,PECAM1;CADM1;PTPRM;NECTIN2;PVR;BSG;ROBO4;AMIGO2;CDH2;CEACAM1
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.4330458199547381,1.0228637213613105,0.4413223140495868,0.7923554026151872,1.0,7/25,9.86%,ITGA6;APP;SDCBP;PSEN1;ANG;DSCAM;BTBD10
prerank,cell part morphogenesis (GO:0032990),-0.4358087223653438,-1.022605344020339,0.44190871369294604,0.8334758420670658,1.0,1/13,0.15%,PID1
prerank,regulation of histone methylation (GO:0031060),-0.4370179741382826,-1.022592292793625,0.43842364532019706,0.8322342696518673,1.0,5/13,22.21%,TET1;CTR9;PAF1;NNMT;AASS
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),-0.4167888445358784,-1.0219120786085685,0.4416475972540046,0.8328223109005846,1.0,4/15,17.06%,GLI3;CD55;HSPH1;SYK
prerank,response to iron ion (GO:0010039),-0.4478554478518894,-1.0216359424673374,0.45633187772925765,0.8323396525330513,1.0,2/12,1.56%,BMP6;BCL2
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.4400608972479614,1.0212904305411628,0.4526813880126183,0.7954648543570677,1.0,4/23,12.62%,PTGS2;ASAH2;LTC4S;GSTP1
prerank,actin filament bundle assembly (GO:0051017),0.40999395873467176,1.0208525406619764,0.4265625,0.7958411709628952,1.0,6/33,4.51%,LCP1;EPS8;NEDD9;SHROOM2;SHROOM1;PLS3
prerank,regulation of cell division (GO:0051302),0.35936244346697427,1.0204901267251747,0.4441340782122905,0.7961417936820165,1.0,19/72,18.52%,RAB11A;MLLT3;TAL1;DLL1;PLK2;AURKA;SH3GLB1;AURKC;BCL2L1;SFRP2;SFN;RACK1;ESRRB;TXNIP;PDXP;CALM1;PRPF40A;CIB1;CETN2
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.43678829206252795,1.0204247986893291,0.446843853820598,0.7957183278476331,1.0,2/24,7.12%,POLK;RPA1
prerank,morphogenesis of an epithelial sheet (GO:0002011),-0.47112162619265907,-1.0202941813921054,0.46382978723404256,0.8348311517090259,1.0,3/10,6.16%,BMP5;BMP7;LRP6
prerank,oxoacid metabolic process (GO:0043436),-0.361949245720125,-1.0201166942627877,0.42317380352644834,0.8340651481880543,1.0,4/27,7.99%,DDO;ENPP1;TPST1;ABHD14B
prerank,peptidyl-lysine modification (GO:0018205),-0.28258446905653745,-1.0198196756348572,0.42857142857142855,0.8336217977761883,1.0,18/99,12.16%,EYA1;LOXL1;HDAC4;PLOD2;LOXL3;SIRT2;NNAT;P3H3;SENP3;LOX;SENP7;RAE1;POM121;PIAS1;PIAS3;NDC1;SENP5;NUP93
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.4352837884787425,-1.0197208698657245,0.43123543123543123,0.8326305328515816,1.0,4/13,10.04%,IGF1;RAMP1;SOAT1;SLC2A10
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.492867765356704,1.0196368595398555,0.45794392523364486,0.7968887908675873,1.0,4/12,14.44%,STX3;STX1A;SNAP23;STX11
prerank,neuron projection development (GO:0031175),0.32842214715983437,1.019377109411139,0.44014510278113667,0.7969304743726943,1.0,20/168,8.12%,SHANK3;FRY;FRYL;APP;STX3;PTPRM;DAB2IP;RAB11A;LYN;SRGAP2;TAOK2;PPP1R9B;BICDL1;NCKAP1;ULK1;OPHN1;RAPGEF2;TNIK;NEDD4;CAMSAP2
prerank,C21-steroid hormone biosynthetic process (GO:0006700),-0.4344433015968602,-1.0189199075381212,0.4298245614035088,0.833566650576333,1.0,7/12,31.35%,AKR1B1;FDX1;FDXR;TSPO;TSPOAP1;CACNA1H;FDX2
prerank,plasma membrane invagination (GO:0099024),0.4249364670887088,1.0187489088974617,0.45307443365695793,0.7978175659129987,1.0,3/29,2.11%,DOCK1;ELMO1;MYH9
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.42799694130143184,1.018234123796906,0.4584664536741214,0.7984144495986574,1.0,10/23,20.07%,MTM1;MTMR6;INPP5K;SYNJ1;INPP5F;OCRL;MTMR12;MTMR9;MTMR2;SACM1L
prerank,dorsal/ventral pattern formation (GO:0009953),-0.4006891274364207,-1.0175419991788759,0.44339622641509435,0.8360151715173857,1.0,3/20,1.10%,BMPR1A;GLI2;NBL1
prerank,negative regulation of coagulation (GO:0050819),-0.4188408080373413,-1.0171377133718873,0.44724770642201833,0.8358746966264449,1.0,6/14,10.34%,VTN;TFPI;SERPINE2;APOE;SERPINE1;HS3ST5
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.3716405420119533,1.0168616122894285,0.4244604316546763,0.8010300296767111,1.0,12/56,17.78%,NOD1;PLCG2;RPS6KA3;CTSK;MAPKAPK3;IRAK4;LGMN;TRAF6;S100A9;TAB3;IRAK2;TIFA
prerank,centromere complex assembly (GO:0034508),-0.3387846482925789,-1.0168454046646556,0.44668587896253603,0.8354043207945813,1.0,23/36,41.07%,RBBP7;CENPP;ITGB3BP;CENPT;MIS18BP1;CENPU;CENPK;RBBP4;CENPH;HELLS;KNL1;CENPF;CENPX;CENPQ;CENPA;NASP;DLGAP5;CENPC;CENPW;MIS12;CENPM;CENPL;CENPS
prerank,ventricular cardiac muscle cell action potential (GO:0086005),-0.4081839576922084,-1.0165385810502565,0.4428904428904429,0.8349933293974898,1.0,2/17,1.71%,ANK2;SNTA1
prerank,defense response to fungus (GO:0050832),0.4550708441939859,1.0163455347376837,0.45309734513274336,0.8016373429768726,1.0,5/17,19.52%,PLCG2;CX3CR1;S100A9;CARD9;BCL10
prerank,artery morphogenesis (GO:0048844),0.4247989414065254,1.015835142398469,0.45085803432137284,0.8022777474541393,1.0,6/30,5.17%,BMPR2;ENG;TBX1;NOTCH1;FOXF1;SMAD7
prerank,cellular response to organic cyclic compound (GO:0071407),0.3281070952146976,1.0158080334543553,0.44430844553243576,0.8017655777556599,1.0,21/141,8.08%,TGM2;ESR1;MEF2C;AHR;PDGFB;PDE2A;KCNQ1;NR3C1;MSN;GNB1;RAP1B;CTNNA1;ATP1A3;ATP1A1;RAPGEF2;INPP5K;NCOA4;TGFB1;RAP1A;CASP7;PKD2
prerank,establishment of protein localization to membrane (GO:0090150),0.3680207644405438,1.0151456051484866,0.4325452016689847,0.8027727553679335,1.0,14/66,12.21%,PARD3;RAB11A;REEP1;AQP11;TAOK2;SDCBP;SEC63;ZDHHC18;ZDHHC9;RFTN1;MYO1C;ICMT;BID;RAB11B
prerank,renal water homeostasis (GO:0003091),-0.3731698367288053,-1.0151328558654276,0.4307692307692308,0.8376426157250793,1.0,9/23,14.55%,ADCY5;ADCY1;ADCY2;ADCY7;ADCY6;PRKACA;PRKAR1B;PRKAR1A;ADCY3
prerank,mitotic recombination (GO:0006312),-0.4236009539972799,-1.0149540284697183,0.4457013574660634,0.8368456215458371,1.0,10/15,30.89%,TEP1;RAD50;DMC1;SMC6;TPRKB;RAD52;GEN1;XRCC3;SMC5;ERCC1
prerank,regulation of translation (GO:0006417),0.32707760666330077,1.0145694999654904,0.4334916864608076,0.8034990846507706,1.0,44/173,18.21%,NANOS3;APP;DAPK1;IGF2BP3;RPS6KA3;RPS6KA1;NANOS2;EIF4E;EIF3H;BCL3;GRB7;NIBAN1;HNRNPD;EIF1;RNF139;SOX4;BTG2;RPL13A;CNOT1;RBM3;EIF6;MRPL13;CYFIP1;EIF5B;RPL10;RACK1;EIF2AK4;MTPN;CNOT7;FMR1;EIF2B2;PAIP1;NPM1;ERBB2;LARP4B;LSM14A;YBX1;PAIP2B;EIF5;CTIF;CSDE1;EEF2;METTL14;LARP4
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.3590469890980442,1.0142711181693747,0.44686648501362397,0.8036320974552895,1.0,13/76,12.61%,NOD1;APP;HDAC7;ADGRG3;NFKBIA;ACTN4;TMSB4X;SASH1;BCL3;IL23A;NMI;RELA;ADIPOR1
prerank,cellular response to starvation (GO:0009267),0.32928759737516455,1.014021255608203,0.43364928909952605,0.8036633949990565,1.0,24/147,13.27%,FOXO1;BMPR2;PRKD1;FAS;SIK1;STK24;RALB;XBP1;MAPK8;KLF10;SH3GLB1;STK26;RPTOR;MYBBP1A;ATP6V1G2;NPRL2;LARS1;NUAK1;PICK1;SIK2;GABARAPL1;XPR1;EIF2AK4;AOC1
prerank,histone H3 deacetylation (GO:0070932),0.46744806458724886,1.013863731598896,0.47285464098073554,0.8034316230568957,1.0,2/15,4.62%,HDAC9;ELK4
prerank,positive regulation of protein localization to cell surface (GO:2000010),0.47983262220183,1.013498644100913,0.44299065420560746,0.8037138405545624,1.0,1/13,1.30%,STX3
prerank,neuron apoptotic process (GO:0051402),0.4464538131245909,1.0134356724069582,0.45969125214408235,0.8032880030183205,1.0,5/19,11.99%,APP;FAS;SIAH1;BNIP3;BID
prerank,regulation of BMP signaling pathway (GO:0030510),0.36037328076366865,1.0133611192607221,0.44214876033057854,0.8028890191458765,1.0,15/73,10.31%,BMPR2;ENG;ACVRL1;SMAD1;SMURF1;NOTCH1;SMAD7;ACVR2A;GREM1;XIAP;SOST;ITGA3;SKIL;SMAD5;UBE2D3
prerank,aorta morphogenesis (GO:0035909),0.4697050445042291,1.0133560780926405,0.46113074204946997,0.8023257455539566,1.0,4/17,5.27%,ENG;TBX1;ACVRL1;DLL4
prerank,protein homotetramerization (GO:0051289),0.3778504845354637,1.0127872618851774,0.4455587392550143,0.8030175528490001,1.0,5/49,3.41%,B2M;GBP5;SAMHD1;ACACB;GLS
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),-0.28573418163171055,-1.01252737387159,0.43776824034334766,0.8421699052533742,1.0,23/87,17.22%,FGFR2;FGF1;HNRNPH1;SPRED1;FGF2;NDNF;RBFOX2;CD44;FLRT2;FLRT1;TIA1;SFRP1;FGFBP1;FGFR4;SPRED2;FGF7;NR4A1;POLR2B;POLR2K;HNRNPA1;HYAL1;FGF10;GTF2F1
prerank,response to ketone (GO:1901654),0.4283819865025891,1.0120529425549012,0.45718901453957994,0.804118438294142,1.0,5/24,11.53%,CAV1;ABHD2;TGFB1;CATSPERD;UBE3A
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.4753257854926882,1.0117948579575224,0.45753899480069327,0.8041619237368138,1.0,5/13,16.06%,ARID1B;ARID1A;ZMIZ1;CDCA4;SERTAD2
prerank,negative regulation of protein binding (GO:0032091),0.3601741800380376,1.0114293840501978,0.4484181568088033,0.8044362403084312,1.0,11/71,9.03%,CAV1;B2M;PDGFB;TMBIM6;RALB;DISC1;MAPK8;AURKA;ADAM15;CTNNBIP1;ZFPM1
prerank,intracellular protein transport (GO:0006886),0.311116179916088,1.011117656094916,0.43729189789123196,0.8045630681830154,1.0,80/304,19.28%,TBC1D8;RASSF9;STX3;TBC1D30;SMURF1;TBC1D4;ARHGEF2;STAT3;IPO11;SGSM1;TBC1D22A;TBC1D15;STX6;HERC2;STX7;PPP1R10;TBC1D12;ARL4A;TGFB1;AP2A1;TBC1D2;STX1A;TMED7;XPO1;TMED5;RAB38;AKT2;ARL5A;VPS28;AP3B1;IPO8;MYO1C;HOMER3;ACD;NUP214;TBC1D5;PICK1;STX8;RAB43;PRICKLE1;WDR11;STXBP3;PREB;EVI5;TBC1D8B;NUP133;RAB31;RAB5A;RAB7A;RABGAP1L;RAB5B;NPM1;SNX13;RAB18;STX11;GIPC1;TNPO3;RAB32;NUP153;AP1S3;RAB6A;STX12;RIC1;RAB3GAP2;CHP1;RPL11;TLK1;DESI1;SNX1;RAB1A;TRAK2;SIL1;CDC37;STAM;COG7;GGA3;VPS26B;PTTG1IP;ARL5B;MYO6
prerank,positive regulation of axon extension (GO:0045773),0.43721498621473837,1.0110054329177391,0.453781512605042,0.8042285856286623,1.0,6/22,12.83%,NTN1;SEMA7A;DSCAM;TWF2;MAP3K13;DBNL
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.3926720621395593,-1.010952148696002,0.44987775061124696,0.8452107098900362,1.0,7/18,12.92%,UNC13C;GRIA2;GRIK4;GRIK2;GRIK5;GRID2;GRIK1
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.4174716795089087,1.010880404144844,0.43478260869565216,0.8039370787984924,1.0,12/28,22.55%,SMCHD1;DTX3L;SHLD1;WRAP53;MAD2L2;ACTR2;CYREN;KMT5B;PARP9;RIF1;SIRT7;ERCC6
prerank,extracellular transport (GO:0006858),0.4864832421545965,1.0107183110320919,0.47923875432525953,0.8037324176951732,1.0,4/13,19.55%,ARRDC1;SPA17;CABYR;TSG101
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.44892493604195877,1.0106966881247126,0.4592720970537262,0.8032004311200881,1.0,7/17,19.34%,LYN;TAOK2;KLHDC10;MID1;ARL6IP5;CARD9;EIF2AK2
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.3530154812175556,1.0106270081807553,0.4656290531776913,0.802788990133385,1.0,20/88,16.10%,NANOS3;DAPK1;DAB2IP;EDN1;IGF2BP3;NANOS2;GRB7;NFKB1;RNF139;BTG2;RPL13A;CNOT1;MRPL13;RACK1;CNOT7;FMR1;LSM14A;YBX1;PAIP2B;RIC1
prerank,response to tumor necrosis factor (GO:0034612),0.3447355586924475,1.0105523204207196,0.43386243386243384,0.8023959757530026,1.0,20/91,14.08%,GCH1;DAB2IP;ARHGEF2;ADAM10;TNFRSF11A;MAP4K3;SELE;CASP8;IKBKB;DCSTAMP;CD40;INPP5K;YBX3;CCL14;RIPK1;RELA;ZFP36;HAS2;GBP3;ASAH1
prerank,positive regulation of developmental process (GO:0051094),0.32432216570803263,1.0103089328756671,0.45443499392466585,0.8023616437125409,1.0,23/164,8.74%,SHANK3;BMPR2;KDR;ZBTB16;INSR;PDGFB;DAB2IP;FZD4;RREB1;PLCB1;RPS6KA3;SLC6A6;RPS6KA1;XBP1;ENPP2;SHLD1;AURKA;WNT5A;ACVR1;B4GALT5;NEUROD1;PSEN1;ARHGEF7
prerank,mammary gland development (GO:0030879),-0.37971616426699295,-1.0101514772815778,0.43734643734643736,0.8461111792158624,1.0,8/21,17.20%,GLI2;WNT4;ERBB4;VEGFA;TGFB3;PRLR;TBX3;ARHGAP35
prerank,regulation of cellular metabolic process (GO:0031323),-0.3226917699845223,-1.0098929647987778,0.4482758620689655,0.8455606444591777,1.0,6/45,6.99%,PID1;PRKN;PPARA;TBC1D16;CYP1B1;ACACA
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.4437376752449691,1.0096423222602076,0.4411764705882353,0.8032977776409675,1.0,6/20,11.71%,ABI3;PPP2R5A;NUMB;TGFB1;BCL2L1;PICALM
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.3883470501061211,-1.0095267057931623,0.4292929292929293,0.8452630224166414,1.0,5/19,7.99%,ENPP1;SLC26A2;TPST1;PAPSS2;ABHD14B
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.4751481470725245,1.0093740090975023,0.45901639344262296,0.8033941833316299,1.0,7/15,24.34%,REEP1;ATL1;RAB18;ZFYVE27;ARL6IP1;REEP3;LNPK
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.44109659531371415,1.0092626592036724,0.4427860696517413,0.8030782180726111,1.0,6/20,11.71%,ABI3;PPP2R5A;NUMB;TGFB1;BCL2L1;PICALM
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),-0.36943668072818503,-1.009255790659952,0.45103092783505155,0.8447685788242473,1.0,7/23,16.50%,MAP6;KIF1A;KIF5C;DYNC1I1;KIF1B;HOOK2;KIF5A
prerank,regulation of dephosphorylation (GO:0035303),0.4810407744821656,1.0092161277133016,0.47278911564625853,0.8026026621696474,1.0,3/15,9.82%,PPP1R16B;INPP5K;SMG7
prerank,establishment of mitotic spindle orientation (GO:0000132),-0.3713044395267626,-1.0091269422701359,0.45153061224489793,0.8438671638510992,1.0,13/23,33.67%,GJA1;GPSM2;HTT;UBXN2B;NDC80;MISP;SPDL1;CENPA;FBXW11;DCTN1;INSC;ZW10;PKHD1
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.37525851341772654,1.0090711253737248,0.44113263785394935,0.8023580359681375,1.0,15/53,14.85%,ECSCR;DAB2IP;FBXW7;FOXF2;UCHL5;OPHN1;KCNE2;XPO1;GNA12;RAD23A;HSP90AB1;FMR1;NUDT15;PSME1;PRKCG
prerank,transcription by RNA polymerase II (GO:0006366),0.3049351819336421,1.0089519797313127,0.43373493975903615,0.8020619635521715,1.0,50/305,14.92%,TEAD4;HDAC9;ESR1;PPARD;NR5A2;PIR;MAML2;MLLT3;NR3C1;HDAC7;NOTCH1;RREB1;CCNK;WWTR1;GTF2I;XBP1;TEAD2;ESRRG;NR1I3;GTF2F2;KLF13;GTF2E2;GMEB2;NFKB1;WDR33;TRIP13;NELFE;TAF3;TRIM24;TAF4B;MED27;COPS2;RNGTT;EAF1;POU2F1;INTS11;CBFB;CEBPD;SNAPC3;RPRD1B;RNMT;GTF2A2;BTF3;INTS12;ESRRB;RPRD2;NRBP1;KAT2B;ELOC;SNW1
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.3772618244780195,-1.0088569680760555,0.4567901234567901,0.8433545228832873,1.0,4/21,4.18%,PRKN;SLC30A10;PPARA;SIRT2
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.441136412380209,1.0087068600582834,0.4546979865771812,0.802086443598131,1.0,5/21,10.01%,CD2AP;DAB2IP;FBP1;SYNGAP1;CYRIB
prerank,cellular response to organonitrogen compound (GO:0071417),0.3401426472516332,1.0083481170124606,0.4581673306772908,0.8023753884616737,1.0,22/99,16.75%,MEF2C;AHR;SH3BP4;PDE2A;KCNQ1;RAP1B;XBP1;CTNNA1;RAPGEF2;INPP5K;RAP1A;PKD2;RPTOR;LARS1;P2RY12;RELA;AOC1;PDE3A;PDXP;ZFP36L1;CTNNB1;RAPGEF3
prerank,central nervous system development (GO:0007417),0.3117669467634764,1.0079877703662492,0.4491620111731844,0.8026462081643377,1.0,35/250,10.51%,SLC2A1;PBX1;ADGRL2;SHROOM4;ZBTB16;LSR;ZIC3;CELSR1;STAT3;DDIT4;ADGRA2;SNTG2;HAPLN3;CHD7;SHROOM2;ADGRG1;AMIGO2;CDH2;MAL;DLL1;RPS6KA3;NCKAP1;CX3CR1;SEMA6B;CYP26C1;PDGFC;DNAJC30;PKD2;EIF2B5;SYNJ1;SOX4;NFIB;NMUR2;SCYL2;CXCR4
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),-0.39720474637850833,-1.007972547091511,0.44987775061124696,0.844551065956355,1.0,5/18,11.08%,PPARA;WNK1;PAG1;PTPN22;MIA3
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.4079065277570874,1.0079575285444857,0.46899841017488075,0.8021404951080351,1.0,3/31,6.76%,DCUN1D3;FBXW7;TRIB3
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.29899506027973205,1.007636388646221,0.47173689619732784,0.8022688065298876,1.0,92/572,12.67%,HDAC9;DACH1;LDB2;CAV1;ESR1;SMARCA2;PPARD;MEF2C;ZBTB16;ETV6;LRRFIP1;PDGFB;IRF2;FOXP1;DAB2IP;SOX13;EDN1;HHEX;PDE2A;NEDD4L;STAT3;EFNA1;NR3C1;FNIP2;NOTCH1;KLF7;RREB1;KLF8;TGIF1;ZFP57;SOX18;HMBOX1;RIPPLY3;KLF2;ELK4;RPS14;MCPH1;SDCBP;ID1;EPC1;SMAD7;DLL4;MTF2;TCF7L2;DUSP22;CNBP;KLF10;NR1I3;FBP1;IRF2BPL;ETS2;TRIB3;SPDEF;TCF3;NEDD4;NFKB1;GATAD2A;CTBP1;WWC2;CREM;PHF6;EZH1;PSEN1;TAF3;ZFPM1;RPL23;DICER1;BACH1;YEATS2;NFIB;NRIP1;MAD2L2;SP2;SKIL;CNOT1;KLF12;UBE2D3;SEMA4D;SPEN;CNOT2;RB1;EID1;CBFB;PRDM2;DCAF1;NOP53;MIER1;SIRT6;RELA;MAX;ZFP36;RPL10
prerank,proton transmembrane transport (GO:1902600),-0.34294128893079356,-1.0075985962866205,0.4289772727272727,0.844244956391303,1.0,5/36,11.94%,ATP1A2;ATP6V0A4;SLC9A1;SLC25A27;ATP6V0D1
prerank,regulation of spindle organization (GO:0090224),-0.40281090353237176,-1.0074276543008756,0.441588785046729,0.8434146316797155,1.0,9/18,30.06%,PARP3;GNAI1;GPSM2;RAE1;DYNC1H1;TPX2;FSD1;DCTN1;MAP9
prerank,negative regulation of signaling (GO:0023057),0.41799515156638495,1.007384546859801,0.44861337683523655,0.8022503241394976,1.0,5/25,9.42%,KIF26A;SRMS;FGF23;ACVR1;PTPN1
prerank,protein homotrimerization (GO:0070207),-0.4186463723473002,-1.0073789672364286,0.475,0.8410502145844703,1.0,4/14,12.21%,SLC1A5;SCARA5;SLC1A2;CLYBL
prerank,protein trimerization (GO:0070206),-0.4186463723473002,-1.0073789672364286,0.475,0.8410502145844703,1.0,4/14,12.21%,SLC1A5;SCARA5;SLC1A2;CLYBL
prerank,muscle tissue morphogenesis (GO:0060415),0.456201464001736,1.0072982398102224,0.4444444444444444,0.8018725836242564,1.0,2/16,2.77%,TBX1;NOTCH1
prerank,positive regulation of gene silencing by miRNA (GO:2000637),-0.35670879758953905,-1.0072421034350387,0.4370179948586118,0.840143401211673,1.0,3/27,2.95%,EGFR;DDX5;BMP4
prerank,negative regulation of cell differentiation (GO:0045596),0.3177693695028106,1.0070762825553112,0.458133971291866,0.801844104259099,1.0,35/181,12.82%,FOXO1;CAV1;TBX1;ZBTB16;CDK6;GATA2;DAB2IP;LRP5;EFNA1;PTK2B;HDAC7;NOTCH1;NFKBIA;WWTR1;FGF23;DLL1;SMAD7;GREM1;WNT5A;TRIB3;TGFB1;CITED1;ZFPM1;USH2A;MAD2L2;SFRP2;SEMA4D;RB1;SINHCAF;ITGB3;ASXL1;TRIO;XDH;ADIPOR1;EIF2AK4
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.3812422369275561,1.0070141551967744,0.4663677130044843,0.8014237988487349,1.0,10/42,17.58%,GARS1;FARS2;IARS1;TARS3;LARS1;WARS1;RARS1;AIMP1;KARS1;WARS2
prerank,negative regulation of catabolic process (GO:0009895),-0.31558359597514624,-1.006317208158528,0.42727272727272725,0.8413986720387222,1.0,9/47,11.31%,EGFR;NUPR1;HDAC4;PPARA;SIRT2;MDM4;ADRA2A;ALK;CST3
prerank,chromatin remodeling at centromere (GO:0031055),-0.3462843883822536,-1.0063159701750686,0.453551912568306,0.8401635290712468,1.0,14/31,26.48%,RBBP7;CENPP;ITGB3BP;CENPT;MIS18BP1;CENPU;CENPK;RBBP4;CENPH;HELLS;KNL1;CENPX;CENPQ;CENPA
prerank,cellular glucan metabolic process (GO:0006073),-0.44492454395623415,-1.0061427669385814,0.4602510460251046,0.8393840939901545,1.0,5/11,12.04%,PHKB;PYGM;PRKAG2;PPP1R3C;UGP2
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),-0.4265978472439853,-1.0059949060421751,0.4646924829157175,0.8385667630190964,1.0,3/13,7.99%,ENPP1;TPST1;ABHD14B
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),-0.4056318965612704,-1.0059398816197762,0.45754716981132076,0.8374856593981698,1.0,5/17,9.52%,EGFR;PKD1;CCND2;SPDYA;RGCC
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.4008561473383226,1.0059208000473767,0.46645367412140576,0.8033940412665451,1.0,11/32,20.98%,CAVIN1;TAF1B;POLR1A;RRN3;POLR1G;POLR1B;GTF2H4;TAF1A;GTF2H1;POLR2L;CCNH
prerank,protein insertion into ER membrane (GO:0045048),0.3969616660177889,1.0058806827221758,0.4496951219512195,0.8029189111081186,1.0,7/37,14.26%,APP;STX1A;TRAM1;TRAM1L1;EMC6;EMC3;ALDH3A2
prerank,actin filament bundle organization (GO:0061572),0.40592104056766165,1.0057190420611026,0.45741324921135645,0.8027254392488319,1.0,6/33,4.51%,LCP1;EPS8;NEDD9;SHROOM2;SHROOM1;PLS3
prerank,regulation of vasculature development (GO:1901342),0.4187880926873233,1.005572520580745,0.4790697674418605,0.8024941130486082,1.0,8/26,16.74%,ADGRA2;PLXND1;TSPAN12;EGLN1;WARS1;ERBB2;PROK2;CTNNB1
prerank,myotube differentiation (GO:0014902),0.46590236591141365,1.005571927342002,0.47594501718213056,0.801936348994182,1.0,2/17,1.15%,JAM2;MEF2C
prerank,mononuclear cell differentiation (GO:1903131),0.4267819284953799,1.0050083390995985,0.45718901453957994,0.8026898854311725,1.0,3/24,2.31%,PIR;MYH9;LYN
prerank,"phagocytosis, engulfment (GO:0006911)",0.4049149329472394,1.0047829835142437,0.46248085758039814,0.8026236829010645,1.0,6/36,10.39%,DOCK1;ELMO1;MYH9;RAC1;RHOBTB1;FCGR1A
prerank,vasoconstriction (GO:0042310),0.4913108762621659,1.004715715979424,0.4700374531835206,0.8022146781734517,1.0,2/11,3.43%,EDN1;PIK3C2A
prerank,positive regulation of cyclase activity (GO:0031281),0.4812045403104185,1.0046445900303713,0.46785714285714286,0.8018055112929424,1.0,3/14,5.46%,NOS3;ORAI1;MAPK8
prerank,type I interferon signaling pathway (GO:0060337),0.3904158029165579,1.0046283251898485,0.4528023598820059,0.800725497145629,1.0,12/41,19.11%,IRF2;SAMHD1;ISG20;IFNAR1;IFNAR2;JAK1;ADAR;OASL;IFITM3;STAT1;BST2;IFITM1
prerank,cellular response to type I interferon (GO:0071357),0.3904158029165579,1.0046283251898485,0.4528023598820059,0.800725497145629,1.0,12/41,19.11%,IRF2;SAMHD1;ISG20;IFNAR1;IFNAR2;JAK1;ADAR;OASL;IFITM3;STAT1;BST2;IFITM1
prerank,negative regulation of hemostasis (GO:1900047),-0.4308436969346434,-1.0045503978812766,0.4503311258278146,0.8400071013448062,1.0,5/12,10.33%,VTN;TFPI;SERPINE2;APOE;SERPINE1
prerank,actin filament network formation (GO:0051639),0.48700176910754284,1.0043416630282809,0.4618181818181818,0.8008380552514411,1.0,3/11,4.51%,LCP1;ACTN1;PLS3
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.35218714324919725,1.0039793127103855,0.4501347708894879,0.8011034601023835,1.0,16/71,14.79%,CTSC;CASP8;ATXN3;CTSK;CTSO;MALT1;ZRANB1;RHBDD1;CHMP4B;PSMA8;PSMA6;LONP1;LGMN;OMA1;DDI1;SOCS6
prerank,negative regulation of transferase activity (GO:0051348),0.4149490077963041,1.003107410284257,0.4542635658914729,0.802574197783253,1.0,8/28,12.92%,DTX3L;SMAD7;INPP5K;CDKN1B;PINX1;NPRL2;ZFP36;ERCC4
prerank,regulation of neurogenesis (GO:0050767),0.371065367182581,1.0024499733972272,0.46253602305475505,0.8034499253144585,1.0,6/55,5.38%,TGM2;B2M;NOTCH1;NUMB;DLL1;CX3CR1
prerank,positive regulation of endocytosis (GO:0045807),-0.3277626547424075,-1.0022384248648168,0.46439628482972134,0.8451070682279046,1.0,11/45,10.33%,LRP1;GPC3;VTN;APPL2;AXL;BICD1;NLGN1;CLIP3;DAB2;APOE;SERPINE1
prerank,arachidonic acid metabolic process (GO:0019369),0.4049986024467957,1.0021692723490454,0.46656760772659733,0.803514482347364,1.0,5/35,7.16%,PTGS2;PLA2G4A;PTGS1;EPHX1;CBR1
prerank,regulation of T cell activation (GO:0050863),0.38575027308116,1.0021312749000377,0.456752655538695,0.8030427411428755,1.0,6/42,10.01%,TNFRSF1B;JAK3;TNFSF8;TIGIT;LCK;CYRIB
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),-0.4314297725617533,-1.0020751002116584,0.44565217391304346,0.8443261056084893,1.0,5/12,16.94%,PPARA;WNK1;MIA3;FUT9;MDK
prerank,regulation of NMDA receptor activity (GO:2000310),0.4061018358037421,1.0015847868886543,0.471875,0.8037290050179234,1.0,4/32,2.59%,APP;MEF2C;DAPK1;PTK2B
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.39200884704849415,-1.001561761995858,0.4567307692307692,0.8445367435892457,1.0,3/18,2.95%,EGFR;DDX5;BMP4
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.3741524705415183,1.0015524103439548,0.4538904899135447,0.8032555901883954,1.0,13/49,17.65%,MEF2C;KMT2E;H3-3A;TNRC6C;ZFPM1;EIF6;RBM15;CBFB;RAB7B;ASH2L;KAT2B;ITGA2B;CIB1
prerank,activation of protein kinase B activity (GO:0032148),-0.3483668533139047,-1.0012460135765668,0.46,0.8441625360765715,1.0,6/29,8.32%,IGF1;NTRK3;FGF1;IL18;OSBPL8;ADRA2A
prerank,protein transport (GO:0015031),0.30569455144249524,1.00110134794774,0.4874041621029573,0.8037406421465593,1.0,87/332,20.12%,TBC1D8;CALCRL;STX3;SPTBN1;TBC1D30;TBC1D4;MYH9;ARHGEF2;SGSM1;TBC1D22A;TBC1D15;LMTK2;STX6;HERC2;STX7;SCAMP1;SLC10A7;RAMP2;VAMP4;CHMP2B;TBC1D12;ARL4A;ARRDC1;AP2A1;TBC1D2;GCC2;ATP6V0A1;STX1A;TMED7;TMED5;RAB38;ARL5A;NEURL1B;ATP6V1G2;AFM;RAB12;AP3B1;ACD;TBC1D5;PICK1;STX8;RAB26;RAB11B;RAB43;RILP;WDR11;STXBP3;PREB;EVI5;TBC1D8B;RAB31;RAB5A;RAB7A;RABGAP1L;ABCG1;TXNIP;RAB5B;NPM1;SNX13;RAB18;STX11;RAB32;RAB6A;CEP290;STX12;COPG2;RIC1;RAB3GAP2;RAB8B;TLK1;ARL6IP5;SNX4;SNX1;RAB1A;SIL1;COG7;GGA3;VPS26B;ARL5B;MYO6;ABCA1;ATP6V1F;PPY;PDCD6;MIA2;VPS35;TVP23B
prerank,negative regulation of transport (GO:0051051),0.37389570919177245,1.0010304574754987,0.45348837209302323,0.8033439514226468,1.0,4/51,2.97%,MCTP1;PRKD1;CTTNBP2NL;PPM1F
prerank,regulation of exocytosis (GO:0017157),0.381218326406756,1.00084262628726,0.44635193133047213,0.8032540880835406,1.0,10/46,17.27%,RAB27A;CADPS2;EXPH5;RAB12;RAB26;RAB5A;STXBP6;RAB8B;SYTL4;CPLX2
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.43721394082184756,-1.0006049264436947,0.4688888888888889,0.844729458702081,1.0,3/12,8.87%,BMP7;CD44;GCNT2
prerank,regulation of amyloid fibril formation (GO:1905906),0.4596483494530126,1.0003102906720707,0.4539130434782609,0.8039421863829003,1.0,7/15,23.47%,APP;PSEN1;PFDN1;PFDN5;PFDN2;IAPP;CLU
prerank,regulation of tissue remodeling (GO:0034103),0.4538901614652608,0.9997025765102271,0.45718901453957994,0.8048093832546827,1.0,5/18,9.60%,IL15;FLT4;CEACAM1;TGFB1;IL23A
prerank,negative regulation of nervous system development (GO:0051961),0.45717686263321283,0.9995752275881065,0.4734133790737564,0.804542389588876,1.0,2/17,2.77%,B2M;NOTCH1
prerank,regulation of macromolecule metabolic process (GO:0060255),0.3214323405085684,0.9995533440288217,0.47664670658682634,0.804034588183497,1.0,26/170,11.19%,NOVA2;APP;CDK6;AHR;FOXP1;TRIM14;HIF1A;NFKBIZ;KDM6A;IGF2BP3;TRIM68;UBAP2;AFF1;HNRNPK;RASA1;HNRNPD;MARF1;PSEN1;IHH;YBX3;CDK2;ATXN7L3B;APLNR;SCARB2;RO60;MKLN1
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.3103176407614938,-0.9994492583111895,0.45454545454545453,0.8466544285987389,1.0,12/48,10.52%,DOCK5;NRP1;OBSL1;CARMIL1;CUX2;CAPRIN2;PTPRD;IL1RAPL1;CUX1;P4HB;FBXW8;S100A10
prerank,proteoglycan biosynthetic process (GO:0030166),0.4104554990004161,0.9994228286705422,0.4952076677316294,0.8037619985363188,1.0,3/31,5.12%,CSGALNACT1;BMPR2;EXTL3
prerank,cellular response to calcium ion (GO:0071277),0.3560093649119421,0.9993503631992562,0.4604904632152589,0.8033448439626115,1.0,14/67,13.74%,MEF2C;CPNE8;IQGAP1;PLCG2;ALOX5AP;CHP2;WNT5A;ITPKB;RASA4;PKD2;SYT15;LGMN;CLIC4;MEF2A
prerank,regulation of neuron death (GO:1901214),0.3460576461295388,0.9993337387035142,0.45698924731182794,0.8028295397694921,1.0,12/82,9.86%,MEF2C;CD200;DDIT4;TNFRSF1B;FYN;CD34;WNT5A;CHMP4B;CHMP4A;IKBKG;CSF1;BTBD10
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.43433692815785213,-0.9992674101466805,0.45434298440979953,0.8459218315157282,1.0,4/11,7.82%,PRKN;PTPN23;DAB2;EZR
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.47176939974829657,0.9989280912429156,0.47285464098073554,0.8031754621785777,1.0,2/12,3.59%,CELSR1;LAMA3
prerank,chondroitin sulfate biosynthetic process (GO:0030206),-0.38008066213228303,-0.9988781326501537,0.4631043256997455,0.8456824373812056,1.0,8/21,9.50%,DCN;BGN;CSPG4;CHST15;CHSY3;VCAN;CHSY1;CHST3
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.4272651550700064,0.9988661449958077,0.45315161839863716,0.8027703597692656,1.0,9/22,23.49%,CCNK;BTBD18;BRD4;CDC73;ALYREF;THOC1;THOC5;ERCC6;EAPP
prerank,regulation of hormone secretion (GO:0046883),0.4616009412968165,0.9987224587739851,0.45390070921985815,0.8025197023422708,1.0,2/15,4.06%,EDN1;FGF23
prerank,regulation of trans-synaptic signaling (GO:0099177),-0.34151454091980504,-0.9986339112958355,0.4401114206128134,0.8451286837343683,1.0,12/33,12.92%,NLGN2;LRRC4C;NGF;NLGN1;NRG3;GRIK4;NLGN3;IQSEC2;GRIK2;GRIK5;GRID2;GRIK1
prerank,positive regulation of cell growth (GO:0030307),0.33981611039862686,0.9985395164078277,0.4669312169312169,0.802390116473992,1.0,21/96,14.35%,NTN1;SEMA7A;SMURF1;EDN1;NEDD4L;ADAM10;ITSN2;RPS6KA3;SDCBP;RPS6KA1;H3-3A;RPTOR;TWF2;SFRP2;SEMA4D;MAP3K13;DBNL;MTPN;ADAM17;ERBB2;S100A9
prerank,regulation of MAP kinase activity (GO:0043405),0.34364029335584473,0.9984822229002654,0.4649006622516556,0.8019612459576854,1.0,15/92,7.41%,FLT1;PDGFB;DAB2IP;EDN1;LYN;PDGFD;PTPRJ;TPD52L1;PIK3R6;CD40;INPP5K;TRIB3;PDGFC;TGFB1;PIK3CG
prerank,pentose-phosphate shunt (GO:0006098),-0.44821008994135403,-0.9978731063939693,0.4819277108433735,0.8460073512488929,1.0,3/11,9.97%,H6PD;PGD;TKT
prerank,regulation of receptor recycling (GO:0001919),-0.40026021683234114,-0.9978331409202947,0.47345132743362833,0.8448855866635654,1.0,5/16,14.82%,TBC1D16;ANXA2;OPTN;RAB29;SNCA
prerank,pyrimidine nucleoside metabolic process (GO:0006213),-0.41198437194882176,-0.9977481079534265,0.4880174291938998,0.8439061769379688,1.0,4/14,15.60%,DPYD;UPB1;NT5E;NT5C1A
prerank,renal absorption (GO:0070293),0.5087777916047674,0.9975818875604309,0.4934086629001883,0.8034433274656044,1.0,3/10,8.48%,KLHL3;KCNQ1;SLC15A2
prerank,BMP signaling pathway (GO:0030509),0.36767887862431503,0.9973576231107513,0.45988538681948427,0.8033793548988561,1.0,10/62,7.32%,BMPR2;ENG;ACVRL1;SMAD1;SMURF1;SMAD7;ACVR2A;USP15;ACVR1;TGFB1
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.3524784493046872,0.9973103525649265,0.4628099173553719,0.8029420871115489,1.0,28/70,25.41%,B2M;IKBKB;MFSD6;TAP2;PSMA2;IKBKG;SNAP23;PSMA8;FCGR1A;PSMA6;VAMP8;PSME1;PSMA4;PSMF1;SEC22B;PSMB7;PSMB1;PSMD2;LNPEP;PSMA5;PSMC3;TAP1;CYBA;FCER1G;PSMD3;PSMA3;VAMP3;TAPBP
prerank,bone morphogenesis (GO:0060349),0.47001710830206855,0.9972932980115717,0.4714038128249567,0.8024316488513561,1.0,2/14,2.28%,BMPR2;LRP5
prerank,regulation of epidermal cell differentiation (GO:0045604),-0.3675075774041223,-0.9972263430044853,0.48104265402843605,0.8440934217638507,1.0,6/21,9.32%,ROCK2;ERRFI1;BMP4;SFRP4;RUNX1;MAFG
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.46617819930184906,0.9971596505668157,0.4910394265232975,0.8021881419299397,1.0,2/14,4.38%,CAV1;DLL1
prerank,positive regulation of kinase activity (GO:0033674),0.3356995471032573,0.9970516089320471,0.49417852522639066,0.8018541356103656,1.0,15/107,7.52%,TEK;FLT1;KDR;TIE1;EPHB4;INSR;IQGAP1;PTK2B;FLT4;LMTK2;RET;RAPGEF2;TIGAR;PTK2;RAP1A
prerank,sensory organ development (GO:0007423),0.3683345288633073,0.9966956953132106,0.48364153627311524,0.8021023623676566,1.0,7/51,5.02%,PBX1;CHD7;SHROOM2;FREM2;SMCHD1;HIPK1;SIPA1L3
prerank,regulation of viral genome replication (GO:0045069),0.3714261602842752,0.9966822022712889,0.4581560283687943,0.8015895962494094,1.0,16/56,19.34%,NR5A2;ADARB1;PKN2;ISG20;N4BP1;RAD23A;TNIP1;ADAR;OASL;CNOT7;IFIH1;IFITM3;PLSCR1;BST2;IFITM1;EIF2AK2
prerank,presynaptic endocytosis (GO:0140238),-0.35771430886608957,-0.9966621745147478,0.46116504854368934,0.8444384881023654,1.0,8/24,14.82%,NLGN2;SYT1;SYNJ2;NLGN1;STON2;NLGN3;AMPH;SNCA
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.4005051217435903,0.9965906463507538,0.44861337683523655,0.8012566765317628,1.0,4/33,5.18%,TAL1;STAT3;HIF1A;ACVR2A
prerank,glycolipid biosynthetic process (GO:0009247),-0.32848378077795226,-0.9963895245081325,0.46418338108882523,0.8439317898157429,1.0,13/38,21.01%,LARGE1;ST6GALNAC5;PIGN;GBGT1;ST3GAL5;B4GALT6;PIGA;ST8SIA1;PIGH;PGAP3;SCCPDH;PIGW;ST3GAL4
prerank,membrane assembly (GO:0071709),-0.33995302400331345,-0.9959417490526489,0.4453125,0.8439276635295555,1.0,17/34,17.68%,NLGN2;ANK3;PTPRD;IL1RAPL1;TLCD2;NRXN1;NLGN1;ANXA2;STX4;S100A10;NLGN3;FLOT2;STX2;NRXN2;UBXN2B;TLCD1;VPS4A
prerank,striated muscle cell differentiation (GO:0051146),0.4626378823946765,0.9957264642857508,0.4735042735042735,0.8026367494350861,1.0,2/16,3.06%,MEF2C;SIK1
prerank,regulation of blood coagulation (GO:0030193),0.41805474393861763,0.9952996905013602,0.4659270998415214,0.8030170619257266,1.0,4/27,4.56%,CAV1;EDN1;CD34;ENPP4
prerank,RNA transport (GO:0050658),-0.29417457490342463,-0.9950110877600769,0.46886446886446886,0.8453231229898965,1.0,13/71,11.21%,RBFOX1;SRSF5;SIDT1;HNRNPA2B1;DDX39B;SIDT2;KIF5C;SRSF2;ATXN2;SRSF11;U2AF2;RAE1;POM121
prerank,regulation of catecholamine secretion (GO:0050433),-0.3491203100190508,-0.9949576604880136,0.4595959595959596,0.8442851066607876,1.0,8/29,17.03%,PRKN;SYT1;SYT9;SYT12;SYT11;DTNBP1;SNCA;SYT3
prerank,cellular protein localization (GO:0034613),0.3050346922781308,0.9949071106556224,0.4729878721058434,0.8033676549913032,1.0,55/285,14.72%,TBC1D8;ESAM;STX3;OCLN;TBC1D30;SMURF1;TBC1D4;CELSR1;HHEX;ARHGEF2;REEP1;SGSM1;TBC1D22A;CPE;TBC1D15;STX6;ID1;MESD;PTPRK;HERC2;STX7;WNT5A;TBC1D12;ARL4A;AP2A1;TBC1D2;STX1A;TMED7;PIGU;TMED5;RAB38;ARL5A;AP3B1;TM9SF1;ACD;PIGK;TBC1D5;PICK1;STX8;RAB43;CEP68;WDR11;STXBP3;EVI5;TBC1D8B;RAB31;RAB5A;RABGAP1L;AMOT;RAB5B;NPM1;SNX13;RAB18;STX11;RAB32
prerank,glycolytic process (GO:0006096),-0.3524810822276774,-0.9946476666408348,0.4835164835164835,0.8439192534922997,1.0,15/28,38.83%,ENO2;HK2;TPI1;ENO3;PFKFB1;PFKM;ALDOA;PKM;ENO1;ALDOC;HKDC1;GAPDH;ALDOB;ENO4;HK3
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.3441779834839719,0.9943712636300438,0.4612352168199737,0.8040138874359215,1.0,21/87,18.42%,DCUN1D3;CDK6;AURKA;JADE1;AVEN;PSMA2;FBXL7;PKD2;PINX1;PSMA8;PSMA6;RB1;CUL1;APC;PSME1;E2F7;ZFP36L1;CDC73;PSMA4;RBL1;PSMF1
prerank,protein secretion (GO:0009306),-0.3071521779120276,-0.9942932034560403,0.46808510638297873,0.8436037492141298,1.0,9/56,11.37%,WLS;PCSK5;ANXA1;TANGO2;RCN3;COPG1;STEAP3;MIA3;RAB10
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),0.4909998970308117,0.9938988914637249,0.4688715953307393,0.804517690508337,1.0,3/10,20.71%,WRAP53;CCT7;CCT2
prerank,RNA destabilization (GO:0050779),-0.39418101316886234,-0.9934813480635352,0.45146726862302483,0.8445771041053869,1.0,3/18,14.56%,ROCK2;CELF1;FTO
prerank,potassium ion import across plasma membrane (GO:1990573),-0.32171696517357595,-0.9929681259673959,0.4511494252873563,0.8447985299831662,1.0,7/41,9.88%,ATP1A2;SLC12A2;ATP1B1;ABCC9;KCNJ2;KCNJ13;ATP1B2
prerank,fructose 6-phosphate metabolic process (GO:0006002),-0.45231100824098824,-0.9929593667443748,0.5172413793103449,0.8436238966314854,1.0,5/10,18.15%,PFKP;HK2;GFPT1;GFPT2;PFKM
prerank,positive regulation of transport (GO:0051050),0.34483065894591935,0.9927580414005215,0.48622589531680444,0.8065022241613,1.0,9/85,6.60%,RAB27A;IL15;HIP1R;GATA2;NEDD4L;DLL1;BOK;CBLL1;INPP5K
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.4749150819285946,0.9926698780622419,0.4859154929577465,0.8061405656640038,1.0,2/13,4.00%,NOS3;TMSB4X
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.4082900347056526,0.9925495312002112,0.47029702970297027,0.8058468351390085,1.0,5/28,9.68%,ERN1;DAB2IP;CASP4;TRIB3;ERO1A
prerank,neuromuscular junction development (GO:0007528),-0.3650410824399276,-0.9921575771515764,0.45792079207920794,0.8445995440023942,1.0,7/24,8.65%,PDZRN3;UNC13C;PPFIBP2;ANK3;CACNB2;LRRK2;CACNB1
prerank,positive regulation of lyase activity (GO:0051349),0.46851972679418796,0.9921237661930902,0.47927927927927927,0.8062380828683839,1.0,2/14,3.49%,NOS3;ORAI1
prerank,macrophage differentiation (GO:0030225),0.4687939576351088,0.9920027954642266,0.46714031971580816,0.8059461005826283,1.0,3/13,9.45%,IL15;CASP8;CSF1
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.42744213412226323,0.990960922084667,0.47619047619047616,0.8077515391096303,1.0,7/20,19.92%,ACSL4;FASN;FAR2;SLC25A1;DGAT1;CBR4;PPT2
prerank,regulation of gluconeogenesis (GO:0006111),-0.3579222251550075,-0.9908477956974578,0.49872773536895676,0.8467796817781665,1.0,10/27,20.83%,OGT;PPARGC1A;SELENOS;C1QTNF3;PTPN2;DDB1;DGKQ;CRY1;PDK2;NNMT
prerank,ear morphogenesis (GO:0042471),-0.38098781428216355,-0.9908022161893326,0.4797979797979798,0.8457024327386033,1.0,4/20,5.77%,ZIC1;FGFR2;OSR1;SIX1
prerank,glucose 6-phosphate metabolic process (GO:0051156),-0.37462513719448853,-0.990300680026427,0.46859903381642515,0.8458693228140436,1.0,5/21,15.21%,HK2;H6PD;PGD;TKT;G6PC3
prerank,regulation of insulin secretion (GO:0050796),0.33543799906736205,0.9898165696576161,0.47354497354497355,0.8097534879147464,1.0,13/101,8.26%,MYRIP;SLC2A1;ACSL4;LRP5;CACNA1E;KCNB1;TCF7L2;CACNA1A;PPP3CB;RAP1A;STX1A;ITPR3;NEUROD1
prerank,anion transmembrane transport (GO:0098656),0.35101987882235075,0.9898006512758477,0.48739495798319327,0.809251723922801,1.0,6/67,3.02%,LRRC8C;SLC6A5;SLC39A8;LRRC8B;SLC38A5;SLC3A2
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),-0.2978473589323821,-0.9896676537228353,0.479020979020979,0.8463744502546937,1.0,25/56,27.26%,SON;ROCK2;SPIRE1;SNX18;ANK3;CIT;ARL3;JTB;RTKN;DCTN3;VPS4A;STAMBP;RAB35;NUSAP1;EFHC1;CKAP2;CUL7;ALKBH4;RHOC;SEPTIN9;SNX33;IST1;CENPA;CEP55;SPAST
prerank,retina homeostasis (GO:0001895),0.4304514594981991,0.9893344958745831,0.5041186161449753,0.8097326937362862,1.0,2/23,3.14%,B2M;CNGB1
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.44729106134155266,0.989317536083472,0.47643979057591623,0.8092160740170189,1.0,6/16,9.42%,PDGFB;PDGFD;PTPRJ;PIK3C2A;PDGFC;PTPN1
prerank,regulation of neuron projection arborization (GO:0150011),-0.40826821038104333,-0.9888809237254509,0.46731234866828086,0.847229201687399,1.0,8/15,16.13%,GRIP1;DLG4;NTNG1;MOV10;MFSD2A;MACF1;DVL1;MYO9A
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.40342668466351034,0.9888161915130779,0.49029126213592233,0.8096992460468728,1.0,14/31,26.27%,CNOT6;EDC3;EXOSC1;DCP2;LSM3;HBS1L;CNOT7;LSM7;LSM1;DCP1B;LSM2;DDX6;DIS3;EXOSC4
prerank,purine ribonucleotide biosynthetic process (GO:0009152),-0.3122687140786807,-0.9884930435483539,0.461038961038961,0.8470772409882337,1.0,11/48,10.40%,ADCY5;AMPD3;ADCY1;ADCY2;SLC26A2;ADCY7;ADCY6;PAPSS2;GUCY1A1;DCAKD;ACAT1
prerank,phospholipid homeostasis (GO:0055091),-0.4393272050999352,-0.9880901919312706,0.4769585253456221,0.846942314615302,1.0,4/11,18.10%,TLCD2;RCN3;TLCD1;ANGPTL3
prerank,actin nucleation (GO:0045010),0.43337449746239326,0.9880425256051723,0.4966996699669967,0.8108640869779449,1.0,7/21,17.85%,JMY;ARPC3;ARPC1B;ACTR2;ACTR3;ARPC2;WHAMM
prerank,T cell migration (GO:0072678),0.4701681547564532,0.9879154883972221,0.47491039426523296,0.8106079405542094,1.0,3/13,7.41%,S1PR1;MSN;PIK3CG
prerank,macrophage chemotaxis (GO:0048246),-0.44779290800077703,-0.9878670399277047,0.5011086474501109,0.8463191331655256,1.0,4/10,34.14%,TAFA4;CCL2;CXCL17;CCL5
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.39927884368513095,0.9875682211043594,0.4953560371517028,0.8108813345094592,1.0,6/33,8.10%,ESR1;PKN1;TRIM68;H3-3A;KCTD6;KDM4C
prerank,positive regulation of isotype switching (GO:0045830),0.45890324584888514,0.9874143550488435,0.47058823529411764,0.8106621372578187,1.0,4/15,10.14%,SHLD1;CD40;TGFB1;MAD2L2
prerank,protein kinase A signaling (GO:0010737),0.47617289669962154,0.9873294812460128,0.4721254355400697,0.8103137502199527,1.0,1/12,1.24%,LCP1
prerank,regulation of glycolytic process (GO:0006110),0.3551377478404246,0.9872283193182845,0.4978843441466855,0.8099700487064457,1.0,17/68,14.80%,APP;CBFA2T3;INSR;HIF1A;PFKFB3;FBP1;TIGAR;PSEN1;EIF6;NUP214;NUP98;SLC2A6;NUP133;NUP205;NUP54;NUP43;NUP153
prerank,response to laminar fluid shear stress (GO:0034616),0.4941239937172369,0.9867320809420014,0.4843462246777164,0.8105017582942323,1.0,4/10,19.36%,KLF2;SMAD7;MAP2K5;ABCA1
prerank,negative regulation of cellular protein localization (GO:1903828),0.3947147412681927,0.9865790738905814,0.48540706605222733,0.8103367753199517,1.0,6/34,8.40%,ANKRD13A;NEDD4L;MFHAS1;CTNNA1;DNAJA1;CDT1
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.44366141318840613,0.9863483228612998,0.4963768115942029,0.8103193977765013,1.0,3/18,11.99%,HIP1R;BOK;BID
prerank,regulation of DNA binding (GO:0051101),0.37898431582009257,0.9862641518223367,0.4804630969609262,0.8099829219372832,1.0,7/44,10.60%,LEF1;NFKBIA;MAPK8;TGFB1;BCL3;CDT1;TFAP4
prerank,inorganic anion transmembrane transport (GO:0098661),-0.2930929507914382,-0.9860109327225335,0.5,0.8502319332097406,1.0,26/63,22.92%,SLC1A3;SLC12A2;SLC6A1;SLC26A2;GLRB;ANO1;GABRG2;ANO4;SLC5A5;GABRA2;SLC20A1;GABRB1;ANO3;SLC5A6;GABRB3;GABRG3;SLC1A1;CFTR;SLC4A8;SLC25A3;SLC25A14;CLCN1;GABRA1;SLC12A8;GABRA5;GABRA3
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.41643950416601355,0.9856535142113586,0.4718543046357616,0.8108089841398931,1.0,4/22,5.27%,GATA2;SLC16A2;TOX;DLL4
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.44617162900690027,0.9853564650089923,0.4772727272727273,0.8109153030831983,1.0,7/16,18.10%,SMCHD1;DTX3L;SHLD1;WRAP53;MAD2L2;KMT5B;PARP9
prerank,regulation of oligodendrocyte differentiation (GO:0048713),-0.38297734025648333,-0.9851036773648649,0.49744897959183676,0.851485006610469,1.0,4/18,5.63%,IL34;PTN;DAAM2;NF1
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.4065094717710814,0.9850911383353669,0.4782608695652174,0.8109941818205426,1.0,4/29,11.79%,JAM2;ANO6;GAS6;LGMN
prerank,regulation of cell size (GO:0008361),0.4127559543334689,0.9848681974270167,0.4788273615635179,0.8109526417136308,1.0,8/23,16.71%,EDN1;MSN;RAC1;RPTOR;LARS1;MTPN;RDX;RHOA
prerank,iron-sulfur cluster assembly (GO:0016226),0.4116889562715319,0.9842496253608145,0.4706896551724138,0.811751395983954,1.0,11/24,24.30%,ABCB7;GLRX3;MMS19;NUBP2;NUBP1;HSCB;LYRM4;NUBPL;FXN;CIAPIN1;CIAO2B
prerank,vitamin transport (GO:0051180),0.4023991482527506,0.9842482141655756,0.47896440129449835,0.811214820564625,1.0,6/29,13.94%,ABCG2;SLC52A3;AFM;CD320;SLC2A6;TCN2
prerank,stem cell development (GO:0048864),0.4475960770461884,0.9831310432341709,0.506872852233677,0.8130958003272994,1.0,7/16,25.55%,CDH2;CYP26C1;KBTBD8;PDCD6;PEF1;TCOF1;NOLC1
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.4801409738113453,0.9824937245588223,0.5099457504520796,0.8140024675550626,1.0,3/11,10.78%,JAK3;SMAD7;RC3H1
prerank,"synaptic transmission, cholinergic (GO:0007271)",-0.3861118946445796,-0.9824244130565583,0.4876237623762376,0.8574289843420723,1.0,14/19,46.13%,APOE;CHRFAM7A;CHRNA7;SLC5A7;CHRNB2;ACHE;COLQ;RAPSN;CHRNA5;CHRNA3;RIC3;CHRNE;CHRNB4;CHRNB3
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.4031564653017512,-0.9821121570763155,0.48394004282655245,0.8571321603345342,1.0,3/13,5.19%,IGF1;IRS1;IGF2
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.39413953255992534,-0.9816350987762519,0.49047619047619045,0.8572301801461008,1.0,4/17,12.59%,AKAP13;ADRA1B;ADRA2A;ADRA1A
prerank,negative regulation of lipid storage (GO:0010888),0.43697731325053757,0.9814890052128391,0.4974958263772955,0.815679013410966,1.0,6/19,15.51%,PPARD;NFKBIA;ITGB3;PNPLA2;ABCG1;TTC39B
prerank,organophosphate catabolic process (GO:0046434),0.4889549598959239,0.9810990126615026,0.4934579439252336,0.815969655241632,1.0,3/11,14.45%,ENPP2;PDXP;NUDT15
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.45666188355945325,0.9810262240562759,0.49409780775716694,0.8155977720849071,1.0,3/14,6.09%,SEMA7A;PLCG2;WNT5A
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.3995263500862103,0.980735636291275,0.5015527950310559,0.8157197003941157,1.0,9/31,17.99%,DCUN1D3;CDK6;JADE1;PKD2;RB1;APC;E2F7;CDC73;RBL1
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.3808838065691,0.9805228676991937,0.48466257668711654,0.8156314760620439,1.0,10/41,10.81%,PDGFB;NEDD9;EFNA1;FBXW7;FYN;TGFA;PTPN1;FCGR1A;GAS6;EPHA4
prerank,synapse organization (GO:0050808),0.32299009281188873,0.9804046970159783,0.5044472681067345,0.8153759032220744,1.0,11/125,4.29%,SHANK3;DNM3;UNC13B;APBB2;APP;PPFIBP1;PLXND1;PPFIA2;PCDHB4;CDH2;GPHN
prerank,negative regulation of bone mineralization (GO:0030502),0.4655505640685579,0.9802960977020235,0.5142857142857142,0.8150915024770803,1.0,5/13,11.76%,PTK2B;FGF23;GREM1;SRGN;RFLNB
prerank,regulation of endocytosis (GO:0030100),0.3554933243347498,0.9798179262795753,0.48776978417266187,0.8155437673894288,1.0,8/61,6.19%,MCTP1;PRKD1;HIP1;HIP1R;NEDD4L;DLL1;OPHN1;CBLL1
prerank,brain development (GO:0007420),0.3208763937703871,0.9794849316304272,0.48819875776397514,0.8156805862049477,1.0,18/136,11.62%,SHANK3;PBX1;ADGRL2;SHROOM4;DDIT4;SHROOM2;ADGRG1;AMIGO2;CDH2;CX3CR1;RAPGEF2;DNAJC30;SYNJ1;NFIB;SCYL2;CXCR4;UBE3A;GRIN1
prerank,mesenchyme development (GO:0060485),-0.3983033565558526,-0.9793051976767617,0.47921225382932164,0.862306434613116,1.0,4/15,2.95%,FGFR2;BMP7;TGFBR1;BMP4
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.38198950159377626,0.979221167486657,0.495253164556962,0.8157402967757797,1.0,6/40,7.32%,LEF1;NOTCH1;WWTR1;SDCBP;TCF7L2;TGFB1
prerank,negative regulation of interleukin-1 beta production (GO:0032691),-0.37594467851455526,-0.978963306581622,0.5025252525252525,0.8621076900281688,1.0,1/19,0.34%,IGF1
prerank,positive regulation of transmembrane transport (GO:0034764),-0.4108752708384393,-0.9787254721348252,0.5171673819742489,0.8615309893946465,1.0,5/13,14.47%,ACSL1;C2CD5;CLIP3;AZIN1;SLC26A6
prerank,early endosome to late endosome transport (GO:0045022),0.43593409354679635,0.978484852814426,0.4852686308492201,0.8167924062322406,1.0,7/20,13.70%,LMTK2;EEA1;STX8;RILP;KIF16B;RAB5A;RAB7A
prerank,embryonic appendage morphogenesis (GO:0035113),-0.4320886305156528,-0.9783921690925947,0.5034324942791762,0.8611776318999046,1.0,5/12,20.55%,CYP26B1;LRP6;TGFB2;SKI;PTCH1
prerank,regulation of autophagosome maturation (GO:1901096),-0.4065113283814412,-0.9781912863046018,0.49882903981264637,0.8605572513972505,1.0,6/13,25.43%,TMEM39A;RUBCN;SMCR8;ADRB2;CLN3;PHF23
prerank,nucleoside phosphate biosynthetic process (GO:1901293),-0.4165300432424455,-0.9779886429390205,0.504424778761062,0.8598456009661857,1.0,2/14,3.16%,NMNAT2;ME1
prerank,endocytic recycling (GO:0032456),0.370992221822851,0.9773559869642916,0.5028169014084507,0.818695836207753,1.0,9/50,13.70%,EHD4;DENND1B;LMTK2;STX6;SNX3;EHD2;EHD3;RAB11B;RAB7A
prerank,negative regulation of cell aging (GO:0090344),0.450451961278402,0.9772119061858147,0.48440065681444994,0.8184857666115063,1.0,5/16,17.99%,CDK6;MAP3K3;AKT3;YBX1;RBL1
prerank,placenta development (GO:0001890),0.4626341915635894,0.9768822533081337,0.4890909090909091,0.8186153628592314,1.0,5/12,15.97%,PTK2;CITED1;ANG;PLAC1;E2F7
prerank,glucose catabolic process to pyruvate (GO:0061718),-0.35389053334699183,-0.9765051309685554,0.506426735218509,0.8614441860850888,1.0,10/24,27.29%,PFKP;ENO2;HK2;TPI1;ENO3;PFKM;ALDOA;PKM;ENO1;ALDOC
prerank,canonical glycolysis (GO:0061621),-0.35389053334699183,-0.9765051309685554,0.506426735218509,0.8614441860850888,1.0,10/24,27.29%,PFKP;ENO2;HK2;TPI1;ENO3;PFKM;ALDOA;PKM;ENO1;ALDOC
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.41496009339689754,0.9764166632655961,0.5066445182724253,0.8185206042818526,1.0,6/23,14.11%,PPP1R13B;CASP8;MAPK8;SFN;BID;YWHAQ
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.41496009339689754,0.9764166632655961,0.5066445182724253,0.8185206042818526,1.0,6/23,14.11%,PPP1R13B;CASP8;MAPK8;SFN;BID;YWHAQ
prerank,cellular protein-containing complex assembly (GO:0034622),0.31382594134289055,0.9764030732527843,0.5136094674556213,0.8180097319719517,1.0,30/160,15.22%,SMAD1;HIP1;HIP1R;IMMP2L;PIK3C2A;NCK1;PXN;FKBP1A;FCHO2;TESPA1;RPL38;TCF4;VAMP4;TGFB1;CHMP4B;CHMP4A;TBCA;HIGD2A;VAMP8;POMP;PICALM;LONP1;NUP98;HSP90AB1;OMA1;NUP205;RAB5IF;HIGD1A;NUP153;STXBP6
prerank,actin cytoskeleton reorganization (GO:0031532),0.3573188155372996,0.9763393150228341,0.48246844319775595,0.8176222443144463,1.0,13/63,9.48%,PARVB;THSD7A;NEDD9;MYH9;S1PR1;CDC42BPB;TNIK;ATP2C1;PLEK2;TRPV4;GAB1;PTPN1;RICTOR
prerank,secondary alcohol biosynthetic process (GO:1902653),-0.3416052198104385,-0.9759119168033367,0.4945652173913043,0.8618954557179772,1.0,12/30,22.49%,INSIG2;HMGCS1;NSDHL;ACAT2;INSIG1;FDFT1;MVK;FDPS;LSS;DHCR24;CYP51A1;DHCR7
prerank,positive regulation of fatty acid oxidation (GO:0046321),-0.42006374448622386,-0.9759111604259517,0.5089285714285714,0.8607172761869689,1.0,3/12,4.15%,IRS1;PPARA;PPARGC1A
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.4791738535577732,0.9758524407700095,0.5070422535211268,0.8181639777379327,1.0,1/10,0.47%,CSGALNACT1
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.3488357410364389,-0.9758374687431536,0.4858757062146893,0.8597544594412224,1.0,7/30,7.58%,FSTL1;TGFBR3;DKK3;TWSG1;SMAD3;SFRP4;BCL9
prerank,regulation of protein-containing complex assembly (GO:0043254),0.33071470849515316,0.975364838911357,0.4948453608247423,0.8186788384234752,1.0,28/110,17.01%,DAB2IP;TAL1;FNIP2;BIK;SELP;TIRAP;RALB;ULK1;ATF7IP;SOST;SH3GLB1;BCL2L11;TGFB1;CDT1;AIDA;RB1;BID;NOP53;RACK1;PREB;WARS1;CDH5;SVIP;BMF;IRGM;PIH1D1;SPIDR;TMC8
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.44639185286896843,-0.9751385879654269,0.5071868583162218,0.8604915617218244,1.0,2/10,11.16%,CD55;CD81
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.33863525875468214,-0.9749741550304369,0.485,0.8597195954578547,1.0,9/30,12.19%,NOTCH2;IGF1;RASGRF1;ITGAV;NGF;SHC1;SRC;IRS2;MMD2
prerank,protein catabolic process (GO:0030163),0.35308117172617876,0.9748957328960104,0.5092724679029957,0.8191882088251922,1.0,17/59,16.64%,STT3B;DAB2IP;CEACAM1;UBE2G1;CTRL;TRIM24;PSMA8;RAB12;SIAH1;RIPK1;CLN6;OGA;DDI1;SOCS6;RNF5;DDI2;CHEK2
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.4870786166410124,0.9748897553906319,0.49714285714285716,0.8186661936130566,1.0,4/10,19.30%,FBXW7;TGFA;ADAM17;BTC
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),-0.3368176370339128,-0.9743123792824232,0.49444444444444446,0.8602633489743061,1.0,14/33,20.66%,APPL2;PKD1;MN1;STXBP4;TAF1;GLI1;PAF1;PLK5;CDKN1A;TCIM;E2F1;DDRGK1;PTEN;ID2
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.31182085675557736,0.9739622947470451,0.5224242424242425,0.8201314264900152,1.0,30/172,13.57%,INPP5D;PLA2G4A;PIP5K1B;DGKZ;PITPNM2;MTM1;LPCAT3;PIK3C2A;PLCG2;PIK3R6;DGKH;CEPT1;LPIN3;MTMR6;PLA2G2D;INPP5K;CDS2;BMX;PIK3CG;AGPAT1;SYNJ1;PLEKHA8;INPP5F;OCRL;DGKE;MTMR12;PEMT;PLD2;RAB5A;CHKA
prerank,positive regulation of positive chemotaxis (GO:0050927),0.4415110611943099,0.9738774259482287,0.4791666666666667,0.8197845872533872,1.0,4/15,5.07%,KDR;VEGFC;F7;VEGFD
prerank,negative regulation of macrophage activation (GO:0043031),-0.3857944031564986,-0.9737517954953543,0.5216346153846154,0.8605760217701975,1.0,4/16,6.74%,IL31RA;LRFN5;LDLR;SYT11
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.35352585010709636,0.9735965361432793,0.4921090387374462,0.8198677984063705,1.0,9/59,12.35%,LEF1;TCF7L2;TNRC6C;FOSL1;PPM1D;NFKB1;MED27;CBFB;RELA
prerank,receptor signaling pathway via STAT (GO:0097696),0.4176055023151641,0.973585338765646,0.5024311183144247,0.819354931688005,1.0,10/25,17.69%,SOCS2;STAT3;GHR;IFNAR1;IFNAR2;PKD2;NMI;SOCS6;STAT6;STAT1
prerank,positive regulation of lipid localization (GO:1905954),-0.4259083445894236,-0.9733847658635567,0.5087719298245614,0.8603995209686265,1.0,2/11,4.67%,LRP1;IKBKE
prerank,mitotic cytokinesis (GO:0000281),-0.30333301054864215,-0.97256250631198,0.5084745762711864,0.8613943814891136,1.0,21/47,27.26%,SON;ROCK2;SNX18;ANK3;CIT;ARL3;JTB;RTKN;KLHDC8B;CNTROB;STAMBP;RAB35;NUSAP1;EFHC1;CKAP2;CUL7;RHOC;SNX33;CENPA;CEP55;SPAST
prerank,positive regulation of behavior (GO:0048520),0.490998265123286,0.9725445885021687,0.5210727969348659,0.8210331550991987,1.0,1/10,1.15%,MEF2C
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.41466874853751157,0.9725339424020493,0.4950980392156863,0.8205181426702948,1.0,6/24,12.16%,NOTCH1;HIF1A;KLF2;MBTPS2;ATF6;MUC1
prerank,cilium organization (GO:0044782),0.3033421892195277,0.9722488101846357,0.5168408826945412,0.8206109266175968,1.0,28/210,12.96%,ABCC4;ABLIM1;FNBP1L;EXOC6;EHD4;RAB11A;NOTCH1;CNGB1;SSX2IP;DISC1;CEP41;PCNT;BBIP1;EHD2;DYNLL1;PKD2;EXOC5;TEKT5;EXOC4;OCRL;CEP83;ARL13B;EHD3;RTTN;ACTR2;RILP;WDR11;EXOC8
prerank,embryonic organ development (GO:0048568),0.3523742783323506,0.9721502869178053,0.508695652173913,0.8202911223447197,1.0,11/61,9.03%,TEAD4;PBX1;KDR;KITLG;TAL1;SOX17;SOX18;TEAD2;TGFB1;NEUROD1;ZFPM1
prerank,positive regulation of protein polymerization (GO:0032273),0.35430426306813445,0.9717766481140532,0.5288184438040345,0.820576703067027,1.0,7/65,6.67%,OCLN;PTK2B;NCK1;EVL;NCKAP1;RAC1;CDC42EP3
prerank,negative regulation of cellular senescence (GO:2000773),0.4606853366208716,0.9713413687805484,0.4939759036144578,0.8209964906059913,1.0,5/13,17.99%,CDK6;MAP3K3;AKT3;YBX1;RBL1
prerank,negative regulation of immune system process (GO:0002683),0.4437592587662411,0.9713393196039065,0.48722316865417375,0.8204688375470187,1.0,2/16,2.31%,CD200;LYN
prerank,nucleoside triphosphate metabolic process (GO:0009141),-0.41062731119664464,-0.9712231868065178,0.4878587196467991,0.8638376592901609,1.0,2/14,8.64%,ENPP1;ENPP3
prerank,cellular lipid catabolic process (GO:0044242),0.40632257393795135,0.9712224692981134,0.4934640522875817,0.8201949841108795,1.0,3/27,5.64%,PPARD;ENPP2;LPIN3
prerank,neuron differentiation (GO:0030182),0.3095045946062217,0.9711357537722327,0.5206611570247934,0.8198614867896589,1.0,17/165,9.32%,LHX6;PBX1;MEF2C;UGCG;ACSL4;FZD4;DDIT4;XBP1;PITX3;OPHN1;WNT5A;WNT9B;NEUROD1;THOC2;USH2A;IER2;SOX4
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.42728644515140873,0.9707844657306418,0.49746192893401014,0.8200694262076486,1.0,4/18,15.40%,EDN1;ABL2;PDP1;RFK
prerank,response to UV (GO:0009411),0.3345085355482181,0.9704607240243657,0.5316129032258065,0.8202471355947639,1.0,18/95,14.61%,DCUN1D3;POLK;MAP4K3;CAT;PTPRK;N4BP1;MAPK8;BCL3;NEDD4;PRIMPOL;RHBDD1;MC1R;RELA;EIF2AK4;ERCC4;FMR1;NPM1;YY1
prerank,mitotic sister chromatid segregation (GO:0000070),0.33536539116411823,0.9698324879033727,0.5163826998689384,0.821060186808077,1.0,22/98,18.25%,TENT4A;RAB11A;RAD21L1;MCPH1;CHMP2B;KIF22;HASPIN;RRS1;PINX1;CHMP4B;CHMP4A;NCAPH;KIF23;RB1;PDS5A;RAD21;PDS5B;CUL3;WRAP73;SMC4;CSNK2A2;CSNK2A1
prerank,somite development (GO:0061053),-0.43217778001113216,-0.9696596122394587,0.4890829694323144,0.8668186816398737,1.0,4/11,11.32%,MEOX2;LOXL3;SMO;MTHFD1
prerank,carboxylic acid transmembrane transport (GO:1905039),-0.3155742462958111,-0.9695403692746516,0.5071633237822349,0.8659825998256886,1.0,8/40,14.25%,SLC7A11;SLC13A3;SLC38A11;SLC27A1;SLC7A6;SLC5A6;ABCC5;SLC19A1
prerank,negative regulation of type I interferon production (GO:0032480),0.3751855868839393,0.9692361437431906,0.524812030075188,0.8218137024553176,1.0,9/40,14.75%,RNF125;NLRC5;UBA7;TRIM25;RELB;IFIH1;ILRUN;YY1;GPATCH3
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.4262116365818142,0.9687648654185025,0.518581081081081,0.8223175088545973,1.0,3/18,13.39%,RAB11A;BRD4;CDC25C
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.41101857555312377,0.9686318374916741,0.5091514143094842,0.8220545661822317,1.0,4/23,12.08%,SLC12A7;CLCN3;SLC12A9;SLC9A7
prerank,female gamete generation (GO:0007292),0.393929636309477,0.9683682585641727,0.4946401225114854,0.822069562181271,1.0,4/29,8.15%,NANOS3;NANOS2;TRIP13;MARF1
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.44004838388663386,0.9683590310974105,0.5061511423550088,0.8215581868051917,1.0,4/17,6.60%,PARD3;DDIT4;SMAD7;INPP5K
prerank,DNA methylation (GO:0006306),0.4222222615001201,0.968171520026703,0.496,0.8214304568664298,1.0,10/23,18.39%,ZFP57;KMT2E;ATF7IP;PPM1D;GATAD2A;PICK1;SPOCD1;ATRX;TEX15;EHMT1
prerank,neuromuscular process (GO:0050905),0.44306886160786024,0.9678398199980436,0.5008210180623974,0.821636179515838,1.0,2/16,5.88%,GCH1;MYCBP2
prerank,retinoic acid metabolic process (GO:0042573),-0.398780579610156,-0.967686758163367,0.5172413793103449,0.8697393147556207,1.0,2/14,3.70%,ALDH1A2;CYP26B1
prerank,negative regulation of viral process (GO:0048525),0.36215234816353087,0.9673856905158592,0.5098870056497176,0.8220955041338642,1.0,16/57,19.38%,TRIM14;ISG20;N4BP1;PTX3;MID2;TNIP1;OASL;ZFP36;IFIH1;IFITM3;STAT1;PLSCR1;BST2;IFITM1;EIF2AK2;TRIM62
prerank,positive regulation of immune system process (GO:0002684),0.44038477695707107,0.9671836118263242,0.5244755244755245,0.822001502152736,1.0,1/16,1.27%,IL15
prerank,synaptic vesicle endocytosis (GO:0048488),0.38683684265986523,0.9663118612531792,0.5023696682464455,0.823389649152878,1.0,6/33,8.97%,DNM3;ITSN2;FCHO2;OPHN1;STX1A;SYNJ1
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),-0.3709576663180477,-0.9661125406089415,0.5012722646310432,0.8727089363920886,1.0,8/20,22.60%,SLC8A3;MCU;MICU1;YME1L1;SLC25A23;SLC8B1;MAIP1;SMDT1
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.40436593172306823,0.9661092119544421,0.5022900763358779,0.823309801094218,1.0,7/29,12.73%,CASP8;IKBKB;CD40;IKBKG;UBE2D3;RIPK1;BIRC3
prerank,catecholamine metabolic process (GO:0006584),-0.40874628336365193,-0.966080598110512,0.5192307692307693,0.8716374906088437,1.0,1/14,1.21%,PRKN
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),-0.3245988516085081,-0.9660532256951466,0.49700598802395207,0.8705345949847648,1.0,11/35,18.33%,MAGI2;PDGFRB;ITGA1;PPP4R4;PPP6R2;CRY2;HTT;PTPA;BOD1L1;TSC1;CSNK2B
prerank,response to estradiol (GO:0032355),0.3851381513497468,0.9658019309868678,0.5046153846153846,0.8234555855032948,1.0,5/31,9.89%,ESR1;SOCS2;STAT3;TGFB1;NRIP1
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),-0.4088783805596344,-0.9657912963739341,0.5182648401826484,0.8700248345673889,1.0,4/13,17.09%,RHOQ;LRRK2;RAB23;ENTPD7
prerank,negative regulation of cellular catabolic process (GO:0031330),-0.28843228664620724,-0.9654575939456013,0.528169014084507,0.8697255373629352,1.0,13/63,12.38%,TIMP3;LEPR;BCL2;TIMP2;NUPR1;SIRT2;KLHL22;DAPL1;EIF4G3;PTPN22;CST3;RGP1;RUBCN
prerank,negative regulation of protein phosphorylation (GO:0001933),0.3166474978860573,0.9653939596522971,0.5310596833130329,0.8238252183028618,1.0,24/150,8.07%,GNAQ;ENG;CAV1;OCLN;CNKSR3;PARD3;DAB2IP;LYN;DDIT4;PDE4D;PPM1F;NCK1;WWTR1;PAK2;CEACAM1;SMAD7;GREM1;PRR5L;INPP5K;TRIB3;SNX25;TGFB1;NIBAN1;SAMSN1
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.40734341984183636,-0.9652904654575727,0.48504273504273504,0.868994754393966,1.0,3/12,5.19%,IGF1;IRS1;IGF2
prerank,extracellular matrix assembly (GO:0085029),-0.3626283421845062,-0.965170234992481,0.531328320802005,0.8681659249605299,1.0,6/23,7.86%,TNXB;GPM6B;FBLN5;NTN4;NTNG1;EFEMP2
prerank,negative regulation of axonogenesis (GO:0050771),-0.33590890606415336,-0.9645778061051622,0.5226130653266332,0.8685730304901986,1.0,12/27,22.85%,PTPRS;MAP2;DCC;CDKL3;RTN4;SEMA3G;ULK2;MT3;PTEN;THY1;GDI1;RNF6
prerank,cellular response to lipid (GO:0071396),0.30549706436192536,0.9641221244969433,0.5442739079102715,0.8260118120873452,1.0,32/191,10.18%,TBX1;ESR1;MEF2C;AHR;DAB2IP;FZD4;LYN;NR3C1;PTK2B;MSN;TNFRSF1B;XBP1;CX3CR1;SBNO2;MAPK8;RET;ATP1A3;ATP1A1;WNT5A;ADAM15;WNT9B;IL36G;NCOA4;PPBP;BRINP2;NFKB1;LPL;CASP1;CREB1;DEFA6;NRIP1;TWF2
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.42285665769925074,0.9639396587227314,0.5129533678756477,0.8258988126812786,1.0,8/20,21.33%,DROSHA;DICER1;PUM1;PUM2;HENMT1;TRIM71;MRPL44;PRKRA
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.49097698149392943,0.9637459898002056,0.5173745173745173,0.825802122268278,1.0,2/10,6.59%,LYN;CD40
prerank,termination of RNA polymerase I transcription (GO:0006363),0.39234238775878716,0.9636451730203798,0.5089141004862237,0.825486805384047,1.0,10/30,20.98%,CAVIN1;TAF1B;POLR1A;POLR1G;POLR1B;GTF2H4;TAF1A;GTF2H1;POLR2L;CCNH
prerank,regulation of gene silencing by miRNA (GO:0060964),0.34902450832511234,0.9635335922906976,0.5042372881355932,0.8252115781573369,1.0,15/62,14.80%,STAT3;H3-3A;TGFB1;PUM1;IPO8;NUP214;PUM2;NUP98;ZFP36;NUP133;NUP205;FMR1;NUP54;NUP43;NUP153
prerank,negative regulation of autophagy (GO:0010507),-0.29898005192864047,-0.9633454884145853,0.5052631578947369,0.8706124948211449,1.0,15/54,16.20%,LEPR;SNRNP70;BCL2;NUPR1;NRBP2;SIRT2;KLHL22;LRRK2;DAPL1;EIF4G3;PTPN22;RUBCN;SMCR8;SNCA;MT3
prerank,regulation of protein kinase B signaling (GO:0051896),0.30186504212460263,0.9627911242414484,0.5232558139534884,0.8263376032255296,1.0,27/193,8.62%,TEK;ENG;ESR1;INSR;KITLG;PDGFB;HIP1;MFHAS1;RASD2;PTPRJ;FYN;FGF23;F7;CX3CR1;RET;TCF7L2;INPP5K;RAC1;TRIB3;LCK;TGFB1;PIK3CG;PTK2;TGFA;GAB1;PPP2R5B;AKT2
prerank,thymus development (GO:0048538),0.4639563825176914,0.9624809972742495,0.5125,0.8264686155375286,1.0,1/13,0.88%,TBX1
prerank,protein polyubiquitination (GO:0000209),0.2934288888109127,0.9624657462890274,0.565121412803532,0.8259710689352106,1.0,89/297,24.92%,RNF125;KLHL3;SMURF1;RNF144B;NEDD4L;TRIM14;FBXW7;ZNRF1;TRAF1;DTX3L;TRIM68;PELI1;FBXL4;RNF144A;UBE3B;SASH1;UBE2G1;PSMA2;RNF167;FBXL7;NEDD4;UBE2H;ANAPC7;RNF146;FBXW2;RNF4;ANAPC1;PSMA8;SIAH1;UBE2D3;PSMA6;RC3H1;FBXO30;CDC26;UBE3A;CUL1;CBFB;HECTD1;MYLIP;FBXL3;UBE2K;TRAF6;TOPORS;PSME1;ARIH2;RNF5;DCAF15;TPP2;UBE3D;AREL1;BIRC2;NHLRC1;CTNNB1;CUL3;HERC6;CDC34;PSMA4;FBXW10;UBE2Q1;PSMF1;PELI2;TRIM62;FBXO17;PSMB7;TRIM71;PSMB1;UBE2L3;HACE1;ARIH1;THOP1;PSMD2;UBE2V2;KLHL42;LNPEP;PSMA5;PSMC3;FBXO7;FBXO11;TRAF2;UBE2J2;UBE2D1;RFFL;TNKS;UBE2R2;PSMD3;LONRF1;UBE2E1;FZR1;PSMA3
prerank,positive regulation of transporter activity (GO:0032411),-0.4143970080461481,-0.9620061520298376,0.5175644028103045,0.8729635503918117,1.0,9/13,37.66%,TRPC6;WNK3;NR1H3;SGK2;SGK1;KCTD7;PDZK1;STK39;RXRA
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.4790272828086058,0.9617742424561512,0.5166666666666667,0.8269334303405939,1.0,7/10,29.84%,NF2;INPP5F;PPP2R1A;PIBF1;PPP2CA;PARP14;SOCS3
prerank,regulation of synapse organization (GO:0050807),0.3915103772747104,0.961548841423366,0.5233644859813084,0.8269089259877779,1.0,9/26,20.64%,MEF2C;WNT5A;NEDD4;EPHA4;ABHD17B;KLK8;PDLIM5;ABHD17A;SETD5
prerank,divalent inorganic cation homeostasis (GO:0072507),0.41029262904393865,0.9615051462556363,0.5281090289608177,0.8264656560758593,1.0,6/25,13.74%,TMTC2;CAV1;TRPV6;CYP27B1;GRIN1;TRPM7
prerank,acute inflammatory response (GO:0002526),0.41597624600731925,0.961393023914557,0.514003294892916,0.8261662555264587,1.0,7/23,17.96%,IL6R;SIGIRR;CTNNBIP1;ANO6;ITIH4;IL22;PLSCR1
prerank,regulation of lipid biosynthetic process (GO:0046890),0.3857760325515408,0.9613002770196807,0.5023622047244094,0.8258371211545189,1.0,8/32,15.82%,ADIPOR2;SORBS1;CEACAM1;CREB1;EIF6;ADIPOR1;ASAH1;STAR
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.42697789524631136,-0.9612998681876008,0.5357142857142857,0.8737896387943526,1.0,5/11,20.99%,NECAB1;SOAT1;ABCA7;ABCA2;NECAB3
prerank,androgen receptor signaling pathway (GO:0030521),0.47293098339249773,0.9612909118019904,0.5146520146520146,0.825329836969169,1.0,5/11,14.07%,PLPP1;KDM3A;ARID1A;ZMIZ1;PMEPA1
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.456771327273047,0.9608594906348066,0.5321100917431193,0.8256880697571695,1.0,5/13,13.14%,TNRC6C;BTG2;CNOT1;ZFP36;CNOT7
prerank,sister chromatid segregation (GO:0000819),-0.3311299450473162,-0.9608283324511125,0.523936170212766,0.8739266580959201,1.0,16/31,33.41%,TOP2B;ZWINT;KLHL22;NUSAP1;CENPK;KNSTRN;KIF18B;KIFC1;NDC80;TOP2A;CDCA8;SGO1;INO80;DSN1;ZW10;ESPL1
prerank,tryptophan catabolic process (GO:0006569),-0.4235010269958204,-0.9606616725592663,0.50418410041841,0.8731849896755451,1.0,9/11,51.94%,KYAT1;HAAO;KYNU;AADAT;AFMID;TDO2;KMO;IDO1;ACMSD
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.4605928150358908,0.9596671670411658,0.5271739130434783,0.8277524501495013,1.0,1/12,1.29%,LMO2
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.4432843894368378,-0.9595016363193328,0.5100671140939598,0.8751468449537677,1.0,4/11,21.28%,PARP3;PARP11;PARP8;TIPARP
prerank,integrin-mediated signaling pathway (GO:0007229),0.34146207061350536,0.9594637232462379,0.5398936170212766,0.8276501021165169,1.0,13/73,7.98%,PRKD1;SEMA7A;NEDD9;DOCK1;MYH9;ADAM10;PTK2B;DST;LAMA3;CEACAM1;ADAM15;PTK2;ITGA5
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.37086192711414867,0.9594596064862203,0.533532041728763,0.8271362840993425,1.0,10/41,11.62%,HTR2A;PLCG2;ATP2B4;TRPV6;LCK;ITPR3;TRPV4;PKD2;ERO1A;GRIN1
prerank,regulation of cellular component movement (GO:0051270),0.3589421641593224,0.9591785039112576,0.5109489051094891,0.827230459223825,1.0,10/49,5.88%,CDK6;LYN;PRAG1;ACTN4;ZSWIM6;PKN2;ACTN1;PKN1;RPS19;MYCBP2
prerank,nucleosome organization (GO:0034728),0.3581508823814815,0.9591415360738333,0.5347432024169184,0.8267801861632005,1.0,20/55,24.68%,PADI4;LIN54;H3-3A;ARID1A;KAT6B;SMARCA5;NAP1L4;SRCAP;SMARCE1;GRWD1;NPM1;ATRX;ANP32B;VPS72;SART3;PRDM9;SMARCC1;ARID2;SMARCD1;SET
prerank,regulation of actin nucleation (GO:0051125),-0.41303211432239606,-0.9589767460605231,0.5277777777777778,0.8753454757435722,1.0,4/12,24.30%,GSN;ARFIP2;ARPIN;CORO1B
prerank,positive regulation of wound healing (GO:0090303),-0.3209282244693652,-0.9588081507343496,0.546242774566474,0.8746663282461863,1.0,9/36,11.47%,PLPP3;VTN;THBS1;FOXC2;SMOC2;ANXA1;ADRA2A;SERPINE1;CLDN1
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.31975100410927626,-0.9583680760915902,0.5233918128654971,0.874683351120347,1.0,13/39,15.46%,DMD;OSR1;HECW2;FGF14;WNK4;ANK3;SLMAP;WNK1;GPD1L;SCN2B;FXYD1;WNK3;NETO1
prerank,mRNA modification (GO:0016556),0.41354518596824613,0.9578456165703032,0.5233333333333333,0.8289631800160288,1.0,12/22,27.21%,CBLL1;WTAP;VIRMA;TRMT6;METTL14;TRUB1;RPUSD2;PUS7;TRMT10C;TRMT61B;METTL16;NSUN2
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.41251028832589276,0.9575567546949497,0.5087719298245614,0.8290746515379595,1.0,4/21,8.74%,TGM2;RAP1GDS1;MICU2;MCUB
prerank,response to thyroid hormone (GO:0097066),0.45083416805872234,0.9570475324587965,0.5415929203539823,0.8296308596296104,1.0,1/13,1.29%,LMO2
prerank,regulation of hippo signaling (GO:0035330),0.4370319288553085,0.9569799741100292,0.532871972318339,0.8292559685562272,1.0,5/17,9.50%,MARK3;VGLL4;NF2;WWC2;MAP2K3
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),-0.4166780945831404,-0.9565505262202214,0.5167785234899329,0.8782926386686835,1.0,2/13,8.79%,GLI3;RUNX1
prerank,cGMP-mediated signaling (GO:0019934),-0.41428887669506076,-0.9559259967861228,0.5292841648590022,0.8787705469003757,1.0,4/13,13.73%,IRAG1;KCNC2;APOE;GUCY1B1
prerank,cell projection organization (GO:0030030),0.39722876886704905,0.9552130309229656,0.519872813990461,0.8324161507842438,1.0,7/30,12.99%,PARVB;RHOJ;NCKAP1;RAC1;P2RY12;CYFIP1;CSPG5
prerank,regulation of regulatory T cell differentiation (GO:0045589),-0.35731976310278085,-0.9551942900739628,0.5111111111111111,0.8794929294907209,1.0,7/22,23.32%,NFATC2;BCL6;RUNX1;DUSP10;MDK;LAG3;FANCA
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),-0.39059519940364373,-0.9550655558628177,0.5,0.8786703392083807,1.0,4/15,5.77%,FGFR2;PDGFRA;TGFBR1;SIX1
prerank,transcription by RNA polymerase I (GO:0006360),0.3780361002816889,0.9550528543799441,0.5181674565560821,0.8322570142025444,1.0,12/34,22.00%,CAVIN1;TAF1B;POLR1A;RRN3;POLR1G;POLR1B;GTF2H4;TAF1A;GTF2H1;POLR2L;CCNH;TCOF1
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.3405012394911123,0.9546097557639291,0.5329744279946165,0.832640003273219,1.0,26/73,23.34%,ZFP57;EPC1;H3-3A;MTF2;TASOR;TAF1B;POLR1A;PPM1D;SMARCA5;MYBBP1A;AEBP2;MYO1C;PPHLN1;POLR1G;KAT2B;POLR1B;JARID2;PHF19;TAF1A;DEK;POLR2L;HDAC6;ERCC6;PHF2;PHF1;BMI1
prerank,positive regulation of phospholipase activity (GO:0010518),0.40816717452824786,0.9545073167660734,0.523972602739726,0.8323443703744535,1.0,3/22,1.87%,FLT1;ESR1;PLCG1
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.3976225945239757,0.9544780463947395,0.5242424242424243,0.8318834913493002,1.0,7/30,12.73%,CASP8;IKBKB;CD40;IKBKG;UBE2D3;RIPK1;BIRC3
prerank,negative regulation of microtubule polymerization (GO:0031115),-0.4258782017954257,-0.9543128153085969,0.525987525987526,0.8794818208414842,1.0,3/12,6.04%,EML2;MAP2;CLIP3
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.35484078318455625,0.9540848639690527,0.5302806499261448,0.8321719799252671,1.0,16/54,16.64%,CNOT6;CNOT6L;PLK2;AURKA;CDKN1B;CRADD;SOX4;BTG2;CNOT1;SFN;CNOT2;MUC1;CNOT7;CDC25C;E2F7;CHEK2
prerank,translational elongation (GO:0006414),0.3219938023433802,0.9538241369663187,0.5298701298701298,0.8321636902474393,1.0,42/101,26.44%,MRPS18A;MRPL13;MRPS12;EEF2K;MRPL35;RACK1;MRPL41;MRPL52;MRPL4;MRPS16;MRPL23;MRPS5;MRPL37;EEFSEC;EEF2;PTCD3;MRPL11;MRPL54;MRPS9;GADD45GIP1;MRPL43;MRPS26;MRPL12;MRPL44;MRPS30;AURKAIP1;MRPL1;MRPL50;MRPL17;MRPL39;EEF1G;MRPL14;MRPL32;MRPS11;MRPL9;MRPL46;DAP3;MRPL19;MRPL15;MRPL42;GFM1;MRPL24
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.39567307775842353,0.9538105134171648,0.5322834645669291,0.831662798501434,1.0,7/32,8.29%,ACER2;NEXMIF;ACVRL1;DUSP22;ADAM15;RASA1;NF2
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.4451148684377829,0.9537659431496418,0.5166666666666667,0.8312319213803246,1.0,4/15,4.00%,PRKD1;PRKD2;NOTCH1;TMSB4X
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.40743096544650576,0.9535694366361482,0.5268456375838926,0.8311159331735548,1.0,3/22,2.77%,IL6ST;EDN1;NOTCH1
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.34499749404085334,0.9534979472483047,0.5417256011315418,0.8307393986544064,1.0,15/63,13.39%,CNOT6;CNOT6L;PLK2;AURKA;CDKN1B;CRADD;CDK2;SOX4;BTG2;CNOT1;SFN;CNOT2;MUC1;CNOT7;CDC25C
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.4228308263543403,-0.9532083675609089,0.5424836601307189,0.8813681461548039,1.0,5/11,17.96%,EGLN3;P4HB;P4HA1;P4HTM;P4HA2
prerank,regulation of telomerase activity (GO:0051972),0.3611472620713955,0.9529653151967648,0.5255023183925811,0.8313540040187184,1.0,10/45,16.74%,NEK7;HMBOX1;GREM1;WRAP53;PINX1;ACD;ERCC4;HSP90AB1;TERF1;CTNNB1
prerank,mesenchymal cell development (GO:0014031),0.4329860405343609,0.9529445470350698,0.5362068965517242,0.8308881477075931,1.0,3/18,6.56%,NOTCH1;CDH2;CYP26C1
prerank,cellular component disassembly (GO:0022411),0.3584848478843928,0.9529053462915793,0.5221745350500715,0.8304492247370457,1.0,4/53,3.25%,TLL1;LCP1;ADAM10;BSG
prerank,epidermis development (GO:0008544),-0.294724532906942,-0.9524883105107442,0.5670731707317073,0.8820630849368976,1.0,11/56,14.14%,FGFR2;SVEP1;CCN2;ATP2A2;CRABP2;GLI1;FLOT2;SCEL;FGF7;EDA2R;LAMC2
prerank,extracellular matrix disassembly (GO:0022617),0.35892635818575047,0.9524558677669044,0.5351506456241033,0.8308489011276173,1.0,4/53,3.25%,TLL1;LCP1;ADAM10;BSG
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.3335603381995585,-0.9524520876192678,0.5344352617079889,0.879861763360009,1.0,13/29,26.48%,RBBP7;CENPP;ITGB3BP;CENPT;MIS18BP1;CENPU;CENPK;RBBP4;CENPH;KNL1;CENPX;CENPQ;CENPA
prerank,CENP-A containing chromatin organization (GO:0061641),-0.3335603381995585,-0.9524520876192678,0.5344352617079889,0.879861763360009,1.0,13/29,26.48%,RBBP7;CENPP;ITGB3BP;CENPT;MIS18BP1;CENPU;CENPK;RBBP4;CENPH;KNL1;CENPX;CENPQ;CENPA
prerank,zinc ion homeostasis (GO:0055069),-0.3338039026388738,-0.9524108866410601,0.5429362880886427,0.878818257310742,1.0,5/28,8.73%,PRKN;SLC30A10;SLC39A14;SLC39A13;SLC39A10
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.44160931105613943,0.9522075189387054,0.5146299483648882,0.8308599077045805,1.0,5/17,11.69%,WASF2;NCKAP1;GMFG;PICK1;CYFIP1
prerank,negative regulation of cell cycle (GO:0045786),0.33696915591948495,0.9520888122371237,0.5394021739130435,0.8305980367239101,1.0,18/73,14.94%,PPP1R13B;CDK6;HHEX;BTG3;PTPRK;CDKN1B;TGFB1;BRINP2;RNF167;BTG2;ANGEL2;TFAP4;BTG1;RB1;RHOB;INCA1;APC;GMNC
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.4711955625294886,0.9520808013744456,0.5275735294117647,0.8300933689787181,1.0,4/10,21.98%,ATRX;JARID2;KDM1A;RIF1
prerank,anterograde trans-synaptic signaling (GO:0098916),0.2969459535641217,0.9517260748574426,0.571103526734926,0.8302926378229136,1.0,18/224,6.78%,MPZ;UNC13B;SLC6A5;SLC6A2;SLC12A7;HTR2A;PDE7B;CACNA1E;PRKAR2B;PCDHB4;SYPL1;RPS6KA3;SDCBP;RPS6KA1;KCNMB4;CACNA1A;HCRTR1;ATXN3
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.41856310369868566,0.9513989214377552,0.5428082191780822,0.8304509690384917,1.0,4/20,6.76%,FBXW7;SIK1;CEACAM1;TRIB3
prerank,response to histamine (GO:0034776),-0.43956721549516886,-0.9510341538042077,0.549792531120332,0.8812139289386891,1.0,3/10,12.88%,GABRG2;GABRB1;GABRB3
prerank,positive regulation of ATPase activity (GO:0032781),-0.304585480609861,-0.9504400716441767,0.5527777777777778,0.8816486658122852,1.0,11/41,20.44%,ATP1B1;TPM1;RYR2;ATP1B2;DNAJB11;PFN2;HNRNPU;FGF10;MSH6;SETMAR;DNAJB2
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.41487407175171354,-0.9501594608745545,0.5388026607538803,0.881226866524577,1.0,7/12,23.89%,ANO1;STX4;GPLD1;CFTR;PLA2G6;ADCY8;BAIAP3
prerank,regulation of response to interferon-gamma (GO:0060330),0.45134156727048746,0.9499647689273222,0.5215827338129496,0.8329315115711212,1.0,8/14,25.48%,JAK1;HSP90AB1;STAT1;IFNGR1;PARP9;CDC37;JAK2;SUMO1
prerank,peptide hormone secretion (GO:0030072),0.4037878425813787,0.9496109446946018,0.5263157894736842,0.8331247055811736,1.0,3/26,8.26%,EDN1;SNX19;NEUROD1
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.33261685120728324,0.9495116891736575,0.5294117647058824,0.8328204795785111,1.0,7/75,4.52%,RGS3;EDN1;NMT2;GIT2;CNGB1;PLCB1;PPP1R9B
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),-0.3677905541341754,-0.9494024598412925,0.5270935960591133,0.8820303027355947,1.0,5/20,9.52%,EGFR;PKD1;CCND2;SPDYA;RGCC
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.45946572284517256,0.9493272897871555,0.5361010830324909,0.832690765954402,1.0,4/12,17.74%,SEC63;CHMP4B;CHMP4A;SEC62
prerank,autophagosome assembly (GO:0000045),0.3520987698622907,0.9489494267900871,0.5416666666666666,0.832951789025332,1.0,17/52,24.22%,SMURF1;ULK1;ATG101;EMC6;GABARAPL1;RAB43;RAB7A;ATG2A;ATG2B;STX12;IRGM;RAB1A;ATG7;UBXN2A;RAB1B;VMP1;RB1CC1
prerank,positive regulation of receptor internalization (GO:0002092),-0.354031644108303,-0.9489018858021278,0.5135869565217391,0.8821495760512691,1.0,7/22,9.99%,MAGI2;ANGPT1;SFRP4;ATAD1;AHI1;VEGFA;CD63
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.3330042084893219,0.9488437829993385,0.530961791831357,0.8326704681275593,1.0,18/80,14.29%,FNBP1L;OCLN;EPS8;WASF2;NCKAP1;CCDC88A;RAC1;CDC42EP3;AGRN;TWF2;FSCN1;P2RY12;CYFIP1;ACTR2;FMR1;NDEL1;ACTR3;APC
prerank,zymogen activation (GO:0031638),-0.3085509167168392,-0.9487798390699763,0.5673076923076923,0.8813292354363472,1.0,6/39,10.69%,CYFIP2;ASPH;MMP14;KLK2;PLAT;GRIN2A
prerank,cholesterol biosynthetic process (GO:0006695),-0.3324858244087939,-0.9487304001791843,0.5506849315068493,0.880303854369838,1.0,12/31,22.49%,INSIG2;HMGCS1;NSDHL;ACAT2;INSIG1;FDFT1;MVK;FDPS;LSS;DHCR24;CYP51A1;DHCR7
prerank,mitotic spindle assembly (GO:0090307),0.3711139909390271,0.9485956643831734,0.540381791483113,0.8326756934294071,1.0,17/42,21.61%,RAB11A;AURKC;STAG2;KIF23;STAG1;LSM14A;CHEK2;RHOA;ABRAXAS2;WRAP73;MZT1;BCCIP;PIBF1;KIF4A;RACGAP1;KPNB1;KIF2A
prerank,pharyngeal system development (GO:0060037),0.44509972786635893,0.948556806885906,0.5381944444444444,0.8322440479794687,1.0,2/15,0.88%,BMPR2;TBX1
prerank,histone H3-K36 demethylation (GO:0070544),-0.4385093442189537,-0.9484593640997063,0.5199115044247787,0.8798806282943414,1.0,3/10,12.48%,KDM7A;KDM2A;KDM8
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.45162373111667536,0.9484556098728967,0.5063063063063064,0.8314143215330043,1.0,4/11,10.61%,INPP5K;SYNJ1;OCRL;INPP1
prerank,inositol phosphate dephosphorylation (GO:0046855),0.45162373111667536,0.9484556098728967,0.5063063063063064,0.8314143215330043,1.0,4/11,10.61%,INPP5K;SYNJ1;OCRL;INPP1
prerank,protein insertion into membrane (GO:0051205),0.3894514925549876,0.9483428324033277,0.5403225806451613,0.8311374330356505,1.0,5/32,10.00%,APP;REEP1;STX1A;TRAM1;TRAM1L1
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),-0.34176761703256975,-0.9482942717981939,0.531578947368421,0.8791602952635625,1.0,10/25,27.29%,PFKP;ENO2;HK2;TPI1;ENO3;PFKM;ALDOA;PKM;ENO1;ALDOC
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.3928679315368748,0.948061065177979,0.5390749601275917,0.83122566743926,1.0,8/27,20.48%,TIRAP;TNIP1;IRAK4;TRAF6;IRAK3;TAB3;IRAK2;MAP3K1
prerank,protein K63-linked deubiquitination (GO:0070536),0.3815218254790339,0.9478294298381243,0.5284810126582279,0.8311901046361992,1.0,10/31,19.16%,BABAM2;ATXN3;BRCC3;ZRANB1;OTUD4;ABRAXAS2;YOD1;USP8;USP7;USP25
prerank,activation of phospholipase C activity (GO:0007202),0.3886826107592568,0.9477058369589593,0.5493421052631579,0.8309093148084458,1.0,4/29,3.22%,GNAQ;PLCG1;HTR2A;SELE
prerank,nucleotide metabolic process (GO:0009117),-0.35664100249830794,-0.9463197276527218,0.5465393794749404,0.8829254246989995,1.0,8/23,21.94%,NMNAT2;FHIT;ME1;ENPP3;NMNAT1;NMNAT3;GUK1;CTPS2
prerank,regulation of mitochondrion organization (GO:0010821),-0.2999485943065462,-0.9461562268950742,0.5110410094637224,0.8822030324508351,1.0,6/47,8.42%,PID1;PRKN;PPARGC1A;SREBF1;LRRK2;SQSTM1
prerank,negative regulation of transmembrane transport (GO:0034763),0.47047600262483047,0.945928037162395,0.5379061371841155,0.8341060561296938,1.0,3/10,8.62%,CTTNBP2NL;INPP5K;AKT2
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.330256497503233,0.9458321665315472,0.52734375,0.8337854740443541,1.0,20/90,14.29%,EPAS1;ADIPOR2;CAV1;KDM3A;ADRB1;LCN2;GATM;ESRRG;PDGFC;CXCR4;PRKAB1;IL4R;UCP2;PEMT;SIRT6;ADIPOR1;HADH;OMA1;IGF1R;APC
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.4406517375546808,0.9456470244236297,0.5491949910554562,0.8336730898315845,1.0,4/14,20.55%,CSF1;IL23A;TRAF6;CCR1
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),-0.28103318773896724,-0.9451662602880897,0.555956678700361,0.8835922451442083,1.0,20/66,17.64%,EGFR;APPL2;FHL1;PKD1;DACT1;DLG1;KANK2;ANXA1;CCND2;ADAMTS1;UBE2E2;TFDP1;RGCC;PLK5;CDKN1A;RBL2;E2F1;HYAL1;FGF10;CDK2AP2
prerank,positive regulation of calcium-mediated signaling (GO:0050850),-0.4127694804699975,-0.9449365038054542,0.5603448275862069,0.8830098396437089,1.0,2/11,3.65%,CDH13;P2RX4
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.403361605202372,-0.9448723953683129,0.551948051948052,0.8820404808572239,1.0,4/12,8.00%,CBLB;F3;APOD;IFT20
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.37808381607875674,0.9444825052502275,0.5562700964630225,0.8355434780262031,1.0,8/34,15.63%,DAB2IP;LYN;MFHAS1;GRAMD4;OTUD4;LRRC14;RAB7B;IRAK3
prerank,positive regulation of cellular metabolic process (GO:0031325),0.3238318475528138,0.9443203507929847,0.5624195624195624,0.8353970703978228,1.0,22/98,13.54%,PPARD;INSR;PDGFB;FASN;ACACB;NFKBIA;SELE;GREM1;IFNAR1;ARRB1;CBR1;TGFB1;AGPAT1;CSF1;INPP5F;SCYL2;TBC1D5;PICK1;RIPK1;XDH;TGFBR2;FMR1
prerank,vesicle transport along microtubule (GO:0047496),-0.34605071522963016,-0.9429468217399567,0.5527777777777778,0.8857697338864567,1.0,8/23,17.24%,KIF3A;KIF1A;DYNC1I1;HTT;TRAK1;KIFAP3;KIF5A;DYNC1H1
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.38682399937293743,0.9429400584901004,0.5192926045016077,0.8378001340570711,1.0,6/29,14.82%,ESR1;KCTD6;CNOT1;CNOT2;CBFB;STRN3
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),-0.4277006549856605,-0.942936471891903,0.5613305613305614,0.883537398487842,1.0,6/10,23.36%,PRKCD;SMPD3;NSMAF;PLA2G6;SMPD2;SPHK2
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.4277006549856605,-0.942936471891903,0.5613305613305614,0.883537398487842,1.0,6/10,23.36%,PRKCD;SMPD3;NSMAF;PLA2G6;SMPD2;SPHK2
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),-0.33987981864203304,-0.9427345895857001,0.5343511450381679,0.8829181480862294,1.0,5/26,11.27%,IGF1;FHL2;AKAP6;EFHB;SLC9A1
prerank,regulation of transport (GO:0051049),0.3767568215341204,0.941837977380744,0.5385779122541604,0.839559581709782,1.0,3/36,2.16%,EPB41;ICA1;RAB11A
prerank,protein ubiquitination (GO:0016567),0.2806255167492512,0.9418192407235587,0.6515463917525773,0.8390859860810965,1.0,147/471,24.92%,EPAS1;RNF125;KLHL3;SMURF1;RNF144B;RNF141;NEDD4L;KLHL2;TRIM14;FBXW7;HIF1A;KLHL7;RNF38;ZNRF1;ZNRF3;DTX3L;UHRF2;KCTD10;HERC2;TRIM68;PELI1;FBXL4;MYCBP2;RNF144A;UBE3B;CBLL1;SASH1;ARRB1;RNF7;TRIM47;UBE2G1;ARRDC1;PSMA2;RNF167;FBXL7;NEDD4;TRIM25;RNF139;KLHL24;UBR1;TRIM24;UBE2H;ANAPC7;RNF146;FBXL2;FBXW2;RNF4;PSMA8;RAD18;SIAH1;UBE2D3;PSMA6;RC3H1;CBL;FBXO30;UBE3A;CUL1;CBFB;RNF112;MYLIP;RACK1;RNF25;ASB11;ANAPC16;ASB4;PEX14;FBXL3;KLHL8;UBE2K;TRAF6;TOPORS;PSME1;ELOC;MSL2;ARIH2;DCAF15;OTULIN;TPP2;UBE3D;AREL1;CRBN;BIRC2;NHLRC1;CTNNB1;CDC73;NEDD8;CUL3;HERC6;CDC34;PSMA4;KLHL18;FBXW10;USP7;RNF40;UBE2Q1;PSMF1;ABCB11;CUL2;KBTBD8;PELI2;OBI1;TRIM62;BCL10;FBXO17;PHC1;PSMB7;TRAF7;TRIM71;PSMB1;UBE2L3;HACE1;PLK1;ARIH1;THOP1;PSMD2;UBE2V2;VPS18;FBXO25;RNF111;RTF1;KLHL42;RNF103;LNPEP;PSMA5;PSMC3;FBXO7;UCHL3;FBXO11;TRAF2;PCNP;UBE2J2;CUL4B;DET1;UBE2D1;PEX10;TNKS;RNF11;MKRN2;UBE2R2;PSMD3;TSPAN17;SDE2;LONRF1;UBE2E1;TRIM33;VHL;PSMA3
prerank,protein modification by small protein conjugation (GO:0032446),0.28552554064784474,0.9417872614240393,0.625,0.8386369117125813,1.0,78/361,18.82%,EPAS1;DCUN1D3;KLHL3;SMURF1;NEDD4L;KLHL2;TRIM14;FBXW7;HIF1A;KLHL7;RNF38;ZNRF3;UBA7;DTX3L;UHRF2;KCTD10;HERC2;TRIM68;MYCBP2;RNF144A;CBLL1;ARRB1;RNF7;TRIM47;UBE2G1;ARRDC1;STX1A;FBXL7;NEDD4;RNF139;KLHL24;UBR1;TRIM24;UBE2H;ANAPC7;FBXL2;RAD18;UBE2D3;SUMO2;CBL;NUP214;CUL1;NUP98;SAE1;MYLIP;RACK1;RNF25;ASB11;ANAPC16;NUP133;IFIH1;NUP205;PEX14;FBXL3;KLHL8;UBE2K;NUP54;TOPORS;ELOC;NUP43;NUP153;MSL2;ARIH2;DCAF15;OTULIN;AREL1;CRBN;CDC73;NEDD8;UBE2I;CUL3;CDC34;KLHL18;USP7;RNF40;ABCB11;ATG7;CUL2
prerank,organic hydroxy compound biosynthetic process (GO:1901617),-0.30154057827148517,-0.9417645064603162,0.5747800586510264,0.8843427772411421,1.0,10/44,15.17%,CYP7B1;CYP27A1;INSIG2;PER2;PRKAG2;OSBPL3;OSBPL6;INSIG1;SCP2;ALOX12
prerank,response to reactive oxygen species (GO:0000302),0.349215142321939,0.9414856070516777,0.5420974889217134,0.8387457461207539,1.0,14/54,13.79%,HIF1A;FYN;STK24;PXN;CAT;PTPRK;MAPK8;STK26;PKD2;PJVK;COA8;GLRX2;GSTP1;SOD2
prerank,protein K48-linked deubiquitination (GO:0071108),0.40971407347299843,0.9413010231631216,0.5486111111111112,0.8385804631364371,1.0,7/23,19.16%,MINDY1;MINDY2;ATXN3;OTUD4;YOD1;USP8;USP25
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),-0.3577358823364396,-0.9410234687448847,0.5467625899280576,0.8850796413052922,1.0,4/20,8.32%,OSR1;ACTN2;HECW2;ADRA2A
prerank,translational termination (GO:0006415),0.32337126146766165,0.9410050578771082,0.5727391874180865,0.8386924274691351,1.0,41/95,26.44%,MRPS18A;MRPL13;MRPS12;MRPL35;APEH;MRRF;MRPL41;MRPL52;MRPL4;MRPS16;MRPL23;MRPS5;MTRF1L;MRPL37;PTCD3;MRPL11;MRPL54;MRPS9;GADD45GIP1;MRPL43;MRPS26;MRPL12;MRPL44;MRPS30;AURKAIP1;MRPL1;N6AMT1;MRPL50;MRPL17;MRPL39;MRPL14;MRPL32;MRPS11;MRPL9;MRPL46;DAP3;MRPL19;MRPL15;MRPL42;GSPT2;MRPL24
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.28556727920662434,0.9407937572998969,0.6193058568329718,0.8385906287923833,1.0,49/348,10.83%,LEF1;NOS3;RAB27A;APP;MEF2C;CLDN5;OCLN;INSR;SMAD1;PDGFB;GATA2;PDE2A;STAT3;NOTCH1;HIF1A;MSN;PPM1F;SELE;CD34;PLCG2;FGF23;KLF2;DTX3L;GREM1;DLL4;MAPK8;SERPINB9;RAMP2;TNRC6C;WNT5A;RPS7;ATF7IP;IL36G;KRAS;TASOR;ARRB1;TGFB1;NOS1AP;CITED1;PSEN1;RPL23;PTPN1;CSF1;MAPK11;INPP5F;SCYL2;PRKAB1;GAS6;PPHLN1
prerank,histone H3-K9 demethylation (GO:0033169),0.45742268478323833,0.9407426771136216,0.5369369369369369,0.8381761307737331,1.0,5/11,18.64%,KDM3A;JMJD1C;KDM4C;KDM4A;KDM1A
prerank,regulation of establishment of cell polarity (GO:2000114),-0.3752443577884179,-0.9406567443660552,0.5379464285714286,0.8849012823396687,1.0,4/16,8.32%,GSN;ROCK2;SHTN1;RIPOR2
prerank,ion homeostasis (GO:0050801),-0.3283157724875693,-0.9403613925143167,0.5714285714285714,0.8845305429665641,1.0,8/30,10.51%,SLC4A10;FHL1;WNK4;WNK1;UNC80;SLC4A3;AP3D1;SLC4A2
prerank,negative regulation of neuron apoptotic process (GO:0043524),-0.2766422428873919,-0.940290284649384,0.583941605839416,0.8836083473837546,1.0,24/69,20.15%,PRKN;BCL2;SLC30A10;NRBP2;PPARGC1A;NDNF;NTRK2;NGF;SIX1;SNX6;CPEB4;RETREG1;APOE;TGFB3;NFATC4;PRKCI;NONO;MT3;MDK;CLCF1;PPT1;TYRO3;NTF3;CRLF1
prerank,neurotrophin signaling pathway (GO:0038179),-0.3548371852519331,-0.9399526653118428,0.5145631067961165,0.883380692223655,1.0,4/21,6.71%,MAGI2;NTRK2;NGF;KIDINS220
prerank,selective autophagy (GO:0061912),0.3452935391962896,0.9398499479348816,0.577259475218659,0.8395625171753918,1.0,11/56,15.30%,KLHL3;WDFY3;ULK1;PCNT;DYNLL1;DYNC1LI1;PJVK;ARL13B;RAB7A;ATG2A;ATG2B
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",-0.4105430285824419,-0.9397626724072472,0.5377969762419006,0.8827360472255346,1.0,2/11,8.79%,TWSG1;RUNX1
prerank,RNA processing (GO:0006396),-0.23964651978718465,-0.939569001882317,0.673202614379085,0.8820815373654326,1.0,34/176,16.05%,CELF2;SON;HNRNPH1;ATXN1;BICD1;SRSF5;PPARGC1A;HNRNPA2B1;DDX39B;LUC7L3;DUSP11;DDX17;RBMS1;NOVA1;APOBEC1;PRKACA;SRSF2;ADARB2;SRPK2;AKAP8L;WBP4;SRSF11;U2AF2;ZCRB1;RBM4;RNASEL;CELF1;LSM6;HNRNPR;HNRNPU;ELAVL4;RNPC3;SNRNP48;NONO
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.35560293967889633,0.9394254471291077,0.5513595166163142,0.8398958571006068,1.0,9/47,8.98%,LIMS2;NEDD9;DOCK1;RREB1;ACTN4;RAC1;PTK2;ARHGEF7;CRK
prerank,positive regulation of actin filament polymerization (GO:0030838),-0.29543373989730143,-0.9394201100536468,0.5525525525525525,0.8813529443393134,1.0,11/44,14.47%,GSN;SPIRE1;CARMIL1;NCK2;BIN1;BAIAP2;PFN2;CDC42EP4;CDC42EP5;LMOD1;CTTN
prerank,mitochondrion organization (GO:0007005),0.30135229667375063,0.9393401341455861,0.5857142857142857,0.8395650170349895,1.0,24/165,13.95%,DNM3;NOS3;IMMP2L;ALAS1;BIK;VPS13D;MTM1;CAV2;CYCS;SIRT5;RAB38;BCL2L1;HIGD2A;BNIP3;GABPB1;AKT3;TFB2M;PITRM1;LONP1;BID;OMA1;RAB5IF;MEF2A;HIGD1A
prerank,protein-DNA complex assembly (GO:0065004),0.31113124255982344,0.9391933792678016,0.5719745222929936,0.8393896460154218,1.0,39/116,26.59%,PADI4;H3-3A;TCF4;RPA1;PSMA2;CDT1;KAT6B;SMARCA5;NAP1L4;PSMA8;PSMA6;GRWD1;NPM1;PSME1;ORC5;ATRX;ORC3;GTF2H4;ANP32B;PSMA4;PSMF1;CETN2;CHD1L;GTF2H1;PSMB7;PSMB1;SART3;CCNH;PSMD2;PSMA5;PSMC3;CUL4B;PSMD3;PSMA3;GTF2H5;ORC6;GMNN;MCM6;RPA3
prerank,positive regulation of phosphatase activity (GO:0010922),-0.3554655111029974,-0.939019741165203,0.5429292929292929,0.8812919955705479,1.0,3/21,4.64%,MAGI2;PDGFRB;ITGA1
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.3867574436312462,-0.9388652517635838,0.5602836879432624,0.8805822450970269,1.0,3/16,8.47%,AUTS2;BCOR;CTR9
prerank,regulation of leukocyte migration (GO:0002685),-0.384507219747032,-0.9387762748378911,0.5445783132530121,0.8796822315433865,1.0,5/16,11.16%,HOXA7;ANXA1;VEGFA;MIA3;CD81
prerank,negative regulation of MAP kinase activity (GO:0043407),0.3515971029558029,0.938537606820192,0.5343283582089552,0.8401899599251135,1.0,10/44,13.24%,DAB2IP;LYN;PTPRJ;INPP5K;DNAJA1;PTPN1;AIDA;STK38;GSTP1;DUSP7
prerank,positive regulation of neuron differentiation (GO:0045666),0.3639942486363437,0.9382049149522707,0.5239567233384853,0.8403710825772703,1.0,6/40,8.26%,MEF2C;ARHGEF2;TCF4;BRINP2;TCF3;NEUROD1
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.35759250788581964,0.9381966529230293,0.5461309523809523,0.8398744203608584,1.0,10/47,12.94%,RAB27A;PDGFB;PLCG2;CBR1;TGFB1;GRIN1;RIPK1;XDH;GSTP1;TGFBR2
prerank,regulation of cellular catabolic process (GO:0031329),0.34842113046649215,0.9381924485659838,0.5585331452750353,0.8393700205420519,1.0,11/62,11.84%,ACER2;DAPK1;BOK;DRAM2;TRIB3;RPTOR;FBXL2;DEPP1;SCARB2;ABL2;ABCD1
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.40586860661276225,0.9374935926500295,0.5506993006993007,0.8402979674959665,1.0,4/23,7.13%,CBFA2T3;SIK1;FBP1;TIGAR
prerank,regulation of protein modification process (GO:0031399),0.35947091278083365,0.9370539435973333,0.5375552282768777,0.840684364563254,1.0,12/50,14.67%,PPP1R16B;LYN;FNIP2;CCDC88A;PTK2;PARG;CORO1C;NOP53;PHIP;WARS1;CDH5;KAT2B
prerank,modulation of chemical synaptic transmission (GO:0050804),0.3149673442122968,0.9369601011994264,0.5492957746478874,0.8403700330609677,1.0,14/107,7.09%,MCTP1;APP;MEF2C;DGKZ;BCR;BTBD9;CDH2;SYN3;CX3CR1;KCNMB4;CACNA1A;OPHN1;SNCAIP;CLSTN1
prerank,nuclear membrane organization (GO:0071763),-0.36161436831654103,-0.9367650210486704,0.5518072289156627,0.8836400184257112,1.0,12/19,30.57%,AKAP8L;GPER1;UBXN2B;VPS4A;TMEM43;TARDBP;TOR1B;TOR1A;SPAST;TOR1AIP1;DCTN1;CHMP2A
prerank,peptidyl-lysine monomethylation (GO:0018026),-0.4171703346585499,-0.9361843205517283,0.548936170212766,0.8840451578154778,1.0,4/10,30.36%,KMT5A;SETD4;SETD7;METTL18
prerank,regulation of keratinocyte proliferation (GO:0010837),-0.3510747918905644,-0.9361727343665783,0.5672371638141809,0.8829710904212825,1.0,7/22,17.19%,NOTCH2;FGFR2;STXBP4;CASK;FGF7;MDK;FGF10
prerank,negative regulation of lymphocyte activation (GO:0051250),0.3974987754958438,0.9360541854023505,0.5439739413680782,0.8417400331776282,1.0,4/21,10.90%,JAK3;TIGIT;SAMSN1;LST1
prerank,regulation of macroautophagy (GO:0016241),0.32090865573866556,0.9356399129280777,0.5613810741687979,0.8421050102640504,1.0,16/105,10.76%,KDR;ERN1;LZTS1;QSOX1;MAPK8;ULK1;SH3GLB1;ATP6V0A1;NEDD4;RPTOR;ATG101;ATP6V1G2;IKBKG;EXOC4;PRKAB1;BNIP3
prerank,histone monoubiquitination (GO:0010390),-0.3401460078712507,-0.9352969732909185,0.5396419437340153,0.8842029472075671,1.0,8/24,16.21%,BCOR;CTR9;PAF1;LEO1;DDB2;RING1;ATXN7L3;DDB1
prerank,cellular response to radiation (GO:0071478),0.3589872718449356,0.9347860864937476,0.5533834586466165,0.8433718859702632,1.0,5/40,12.26%,NET1;OPN4;HUS1;OPN5;RHOB
prerank,positive regulation of defense response to virus by host (GO:0002230),0.39647958075652995,0.9347293811533347,0.535472972972973,0.8429646521995381,1.0,8/24,18.36%,AIM2;DTX3L;CGAS;IL23A;EIF2AK4;STAT1;PARP9;ZDHHC1
prerank,mitotic chromosome condensation (GO:0007076),0.39341502033184433,0.9346899695160135,0.5472868217054263,0.842540028840893,1.0,7/26,18.25%,TENT4A;MCPH1;NCAPH;RB1;SMC4;CSNK2A2;CSNK2A1
prerank,mitochondrial translational termination (GO:0070126),0.32425702440108933,0.9346091179145773,0.5727636849132176,0.8421963520689985,1.0,38/88,26.44%,MRPS18A;MRPL13;MRPS12;MRPL35;MRRF;MRPL41;MRPL52;MRPL4;MRPS16;MRPL23;MRPS5;MTRF1L;MRPL37;PTCD3;MRPL11;MRPL54;MRPS9;GADD45GIP1;MRPL43;MRPS26;MRPL12;MRPL44;MRPS30;AURKAIP1;MRPL1;MRPL50;MRPL17;MRPL39;MRPL14;MRPL32;MRPS11;MRPL9;MRPL46;DAP3;MRPL19;MRPL15;MRPL42;MRPL24
prerank,regulation of protein localization (GO:0032880),0.33938422832836607,0.934123271389037,0.572987721691678,0.84270986401704,1.0,16/58,17.30%,TRIM14;FBXW7;PPM1F;FKBP1A;STX6;TRIM68;MAPK8;TRIM25;PICALM;ITGB3;RACK1;HSP90AB1;RABGAP1L;CEP290;MMD;USP8
prerank,positive regulation of neuron death (GO:1901216),-0.3005564957727985,-0.9336813273505022,0.5833333333333334,0.8871811586756888,1.0,9/46,14.82%,EPHA7;NUPR1;MAP3K5;EFNB2;NF1;SRPK2;TGFB2;C1QA;SNCA
prerank,genitalia development (GO:0048806),0.4472598994049968,0.9336211821350159,0.5418894830659536,0.8432348669160218,1.0,3/12,6.09%,CHD7;FOXF2;WNT5A
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.38438506758508717,0.9332394606073185,0.5564516129032258,0.8434967151696218,1.0,8/29,22.18%,RAD21L1;TRIP13;MEIOB;TERB1;TERB2;RAD21;PRDM9;SIRT7
prerank,response to steroid hormone (GO:0048545),0.3813036730630582,0.9331125778152017,0.5422427035330261,0.8432615466298616,1.0,8/31,11.53%,CAV1;NR3C1;ABHD2;ATP1A3;ATP1A1;TGFB1;CATSPERD;UBE3A
prerank,regulation of neuron projection development (GO:0010975),0.29819985994371395,0.9329909987952747,0.6133333333333333,0.8430031156691329,1.0,24/163,8.58%,SHANK3;ABI3;ITGA6;PRKD1;DAB2IP;LYN;PRAG1;PTK2B;PPFIA2;PAK2;TOX;CDH2;DISC1;SCARF1;RET;CCDC88A;WNT5A;RAPGEF2;RAP1A;SNX3;TRPV4;MBOAT1;CAMSAP2;PSEN1
prerank,cell-matrix adhesion (GO:0007160),0.3198165624123937,0.9324998313205831,0.5585585585585585,0.8434560720872881,1.0,15/95,7.33%,THSD1;VCAM1;PEAK1;BCR;TAOK2;PPFIA2;CD34;SORBS1;ACTN1;PTPRK;BCAM;ADAM15;RAC1;VWA2;ITGA3
prerank,wound healing (GO:0042060),0.3403983649983751,0.932273345816422,0.5944444444444444,0.8433732724682464,1.0,6/62,2.90%,MYOF;PRCP;MYH9;SCARB1;PPP3CA;DST
prerank,lymphocyte chemotaxis (GO:0048247),-0.3128689820914817,-0.9320598967206758,0.5847457627118644,0.8901712494482384,1.0,3/34,3.99%,CYP7B1;SLC12A2;CXCL16
prerank,response to fatty acid (GO:0070542),0.4184958154815703,0.9317702825198386,0.554006968641115,0.8439131230747445,1.0,1/17,0.30%,FOXO1
prerank,regulation of gene expression by genetic imprinting (GO:0006349),-0.41274622784406056,-0.9311780874707538,0.5824175824175825,0.8912977846796112,1.0,2/10,5.19%,DNMT3A;IGF2
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.30036215452312653,0.9309403124444198,0.5958986731001207,0.8451068743720431,1.0,25/161,10.43%,CAV1;DAB2IP;SOX13;MLLT3;FZD6;FZD4;TLE4;SOX17;WWTR1;STK3;NKD2;ZNRF3;STK4;GREM1;TCF7L2;WNT5A;JADE1;TMEM88;SOST;PSMA2;PSMA8;MAD2L2;SFRP2;SCYL2;PSMA6
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.35094429588925147,-0.9303551456958528,0.5425790754257908,0.8922891085483837,1.0,1/20,0.34%,IGF1
prerank,metallo-sulfur cluster assembly (GO:0031163),0.39562412644296474,0.9303105440685304,0.5463917525773195,0.8459013605103322,1.0,10/22,24.30%,ABCB7;MMS19;NUBP2;NUBP1;HSCB;LYRM4;NUBPL;FXN;CIAPIN1;CIAO2B
prerank,cellular defense response (GO:0006968),-0.30265864304489476,-0.9299742184674189,0.5855855855855856,0.8921125763341652,1.0,7/40,13.07%,DCDC2;CCR9;LBP;LSP1;ADORA2A;RAB23;IL1RL2
prerank,heterochromatin assembly (GO:0031507),0.41791903972711447,0.9299695440990008,0.5619694397283531,0.8460842443631823,1.0,4/20,8.56%,SMCHD1;H3-3A;ZNFX1;EZH1
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.4139615322864624,0.929961787067913,0.5119047619047619,0.845590724646454,1.0,3/18,5.94%,CAV1;NEDD4L;SLC43A2
prerank,regulation of complement activation (GO:0030449),0.36224783470956284,0.92981814553979,0.5509259259259259,0.8453669698186842,1.0,4/40,7.48%,CFH;PROS1;CFB;CR1L
prerank,regulation of execution phase of apoptosis (GO:1900117),-0.4141418077835123,-0.9297753797033053,0.5536842105263158,0.8914758657235535,1.0,6/11,21.30%,FAP;SIRT2;FZD3;PTGIS;DFFA;TP53
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.4120640721642781,0.9295128984898622,0.5621890547263682,0.8454542680427772,1.0,1/21,0.86%,CAV1
prerank,positive regulation of mitochondrial fission (GO:0090141),-0.3734778375280436,-0.9290387679736725,0.5552941176470588,0.8921408101382263,1.0,4/18,4.03%,DCN;PRKN;SPIRE1;MCU
prerank,regulation of cellular protein catabolic process (GO:1903362),0.4084886184066929,0.928696547533464,0.5680272108843537,0.8466294983113785,1.0,3/18,4.89%,DAB2IP;MSN;VGLL4
prerank,mRNA metabolic process (GO:0016071),-0.25915148227779555,-0.9283299611587784,0.6260162601626016,0.8927996080282162,1.0,16/90,13.74%,SON;DDX5;SRSF5;PPARGC1A;HNRNPA2B1;PRKACA;PCBP2;SRSF2;AKAP8L;AGO3;SRSF11;U2AF2;CNOT10;CELF1;LSM6;HNRNPR
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),-0.35926944885656376,-0.9279997677091796,0.5294117647058824,0.8924962165510483,1.0,5/18,11.92%,HDAC4;SOX6;CCN3;BHLHE41;FZD7
prerank,cognition (GO:0050890),0.35403542301168106,0.9279259941369113,0.5412293853073463,0.8476534839547502,1.0,5/42,5.98%,APP;SHROOM4;CHD7;DOP1B;CHMP2B
prerank,purine ribonucleotide catabolic process (GO:0009154),0.4030683698012269,0.9275228531661911,0.5676625659050967,0.847957860193881,1.0,7/21,12.53%,PDE2A;PDE4D;NT5C2;NUDT16;HINT1;HPRT1;XDH
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.37363434738547285,-0.9274365929164551,0.583732057416268,0.8928125645498982,1.0,5/15,7.53%,AAK1;SNAP91;DGKD;BMP2K;DAB2
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.37501921094824264,0.9273027054467866,0.5636363636363636,0.8478886898208094,1.0,9/33,17.99%,DCUN1D3;CDK6;JADE1;PKD2;RB1;APC;E2F7;CDC73;RBL1
prerank,regulation of RNA metabolic process (GO:0051252),0.33434902938968514,0.927293667292951,0.5632022471910112,0.8473993159203639,1.0,14/59,12.18%,NOVA2;TNFRSF1B;IGF2BP3;RBM20;MBNL1;PTBP3;MBNL2;HNRNPF;MBNL3;RASA1;ZNF326;HNRNPLL;RC3H1;OASL
prerank,TOR signaling (GO:0031929),0.3828088722324902,0.9268632662719061,0.5472972972972973,0.84777897874386,1.0,8/26,18.72%,CCDC88A;PRR5L;RPTOR;RICTOR;EIF4EBP1;RPS6;TIPRL;SYAP1
prerank,generation of neurons (GO:0048699),0.2920206382861598,0.9265639983111151,0.6051703877790834,0.8478896767296117,1.0,17/190,6.61%,LHX6;MEF2C;CDK6;ACSL4;CELSR1;FZD4;NAV1;DDIT4;CEP85L;DLL1;DISC1;CX3CR1;OPHN1;WNT5A;RAPGEF2;WNT9B;RAC1
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.4072553253375404,0.9256239760970763,0.5504424778761062,0.849243717145991,1.0,6/21,9.64%,NCK1;TMBIM6;XBP1;BOK;BCL2L11;BCL2L1
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.4458353836165936,0.9255940752923094,0.5658627087198516,0.8487962542644244,1.0,2/12,9.45%,UCK2;UPP1
prerank,lipid biosynthetic process (GO:0008610),-0.26200265964867275,-0.9255176038850645,0.592,0.89640217713121,1.0,20/77,21.40%,ACSL1;ABCD3;AGPAT4;PRKAA2;SREBF1;ACACA;PCYT2;GPAM;SCD;PRLR;FDFT1;ACSS2;SCP2;MVK;LPCAT1;AGPAT3;FDXR;LSS;SCD5;CYP51A1
prerank,primary miRNA processing (GO:0031053),0.46622549073235353,0.925001892282417,0.5420560747663551,0.8494818376892991,1.0,2/10,5.95%,SMAD1;DROSHA
prerank,tRNA metabolic process (GO:0006399),0.4246510667914034,0.9248399113181727,0.5669565217391305,0.8493070364472333,1.0,5/17,15.49%,FARS2;DTD1;RPP30;ADAT1;KARS1
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.42214009366906946,0.9247261456943989,0.5484429065743944,0.8490155579621388,1.0,2/15,3.86%,PPARD;ELOVL5
prerank,DNA conformation change (GO:0071103),0.41637094133571007,0.9242900309573102,0.5470383275261324,0.8493788506982853,1.0,4/17,15.11%,HHEX;HAT1;TOP1;KAT6A
prerank,protein localization to vacuole (GO:0072665),0.43279516272495927,0.9242809297158779,0.5441696113074205,0.8488899612809917,1.0,3/13,11.29%,SH3BP4;SH3GLB1;GLMP
prerank,diacylglycerol metabolic process (GO:0046339),0.3872506752311671,0.9242661892294584,0.5568760611205433,0.8484179649503005,1.0,9/23,15.78%,DGKZ;LIPE;DGKH;ANG;DGKE;MOGAT1;PNPLA2;DGAT1;MOGAT2
prerank,C21-steroid hormone metabolic process (GO:0008207),-0.3493540960409069,-0.9238871189620529,0.5770171149144254,0.8994136861032178,1.0,5/20,22.74%,AKR1B1;FDX1;FDXR;TSPO;TSPOAP1
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.3596863751078444,0.9236753825720428,0.559748427672956,0.8490768711165576,1.0,7/37,8.46%,APP;PARD3;DDIT4;SMAD7;INPP5K;TGFB1;RPTOR
prerank,programmed necrotic cell death (GO:0097300),0.41280456508572394,0.923605647047802,0.5567010309278351,0.8487011878050985,1.0,5/18,17.87%,PGAM5;MLKL;RIPK1;TRPM7;IPMK
prerank,negative regulation of catalytic activity (GO:0043086),0.39437172206749294,0.9234795474850073,0.5764705882352941,0.8484405419887397,1.0,3/24,7.31%,NOTCH1;PPP1R12A;NOSIP
prerank,peptidyl-lysine methylation (GO:0018022),-0.331601163379173,-0.9231910825732905,0.5942408376963351,0.8999990783323155,1.0,11/26,30.36%,KMT5A;EHMT2;SETD4;VCPKMT;EEF1AKMT1;METTL21A;ANTKMT;EEF2KMT;SETD7;EEF1AKMT3;METTL18
prerank,macrophage migration (GO:1905517),-0.3883208085174527,-0.9228003288508881,0.5586206896551724,0.8998765286761818,1.0,6/13,34.14%,P2RX4;TAFA4;CCR2;CCL2;CXCL17;CCL5
prerank,inositol phosphate catabolic process (GO:0071545),0.43625089439676856,0.9225951093576524,0.5607985480943739,0.849762859893878,1.0,4/12,10.61%,INPP5K;SYNJ1;OCRL;INPP1
prerank,carbohydrate transport (GO:0008643),0.4444077801835469,0.9224236517021971,0.5754189944134078,0.8496194734139629,1.0,1/11,3.29%,AQP11
prerank,regulation of immune effector process (GO:0002697),0.3553363789323576,0.9222258367919032,0.5927051671732523,0.8495425135720686,1.0,4/41,7.48%,CFH;PROS1;CFB;CR1L
prerank,inner ear morphogenesis (GO:0042472),-0.3519788689122387,-0.9221702394441228,0.5525606469002695,0.9003147734115747,1.0,5/22,9.50%,ZIC1;FGFR2;SIX1;TBX18;TTC39C
prerank,negative regulation of gluconeogenesis (GO:0045721),0.4519290000568313,0.9216553938699308,0.5711382113821138,0.850197153142624,1.0,1/11,3.06%,SIK1
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.38783652174773364,0.9213940462797798,0.5520661157024793,0.8502179592112372,1.0,7/24,14.50%,AQP11;LPCAT3;TMBIM6;XBP1;BCL2L1;RACK1;UBXN1
prerank,protein complex oligomerization (GO:0051259),0.3217476426474043,0.9209650411683729,0.608,0.8505688075358412,1.0,25/85,23.71%,LRRC8C;EHD4;AQP11;MAT2A;BOK;PKD2;RNF112;EHD3;ATL1;G3BP2;LRRC8A;PNPT1;TIFA;CARD9;GLRA3;FUS;BCL10;HOMER1;ELAVL1;CPSF6;JMJD6;OPA1;PDCD6IP;ZBTB1;STOML2
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.4552901992815847,0.9205274639358365,0.5472061657032755,0.8509310875955266,1.0,2/10,5.93%,MSN;OPHN1
prerank,regulation of protein localization to cell periphery (GO:1904375),0.40717906906421936,0.9204167899606207,0.5746140651801029,0.850617383528719,1.0,4/18,11.52%,SPTBN1;STX7;VAMP8;STX8
prerank,positive regulation of protein deacetylation (GO:0090312),0.4326911533360626,0.9202818458477445,0.5660377358490566,0.8503831513441794,1.0,6/14,22.92%,DYRK1A;CTBP1;APLNR;FNTA;SAP30BP;NIPBL
prerank,protein destabilization (GO:0031648),-0.3165664261567496,-0.9201978444508311,0.5806451612903226,0.9041119169500974,1.0,7/32,14.82%,GSN;PRKN;BTRC;MDM2;KDM8;HTT;SNCA
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.36994837317502466,0.919714271024564,0.5646879756468798,0.8510100689643879,1.0,6/31,16.20%,GCH1;GPHN;MOCOS;SRD5A2;STAR;SRD5A1
prerank,transport along microtubule (GO:0010970),-0.3945384329932586,-0.9196364549392296,0.5762331838565022,0.9043590299168152,1.0,6/13,11.02%,ARHGAP21;APBA1;CLIP3;COPG1;DYNC1I1;SPG11
prerank,megakaryocyte differentiation (GO:0030219),0.44391501713301884,0.9194319699985439,0.5574712643678161,0.8510794659786658,1.0,2/11,9.03%,TAL1;ZFPM1
prerank,maintenance of gastrointestinal epithelium (GO:0030277),-0.39166424227023255,-0.9192598971197646,0.5460526315789473,0.9041928257248354,1.0,1/12,3.26%,RBP4
prerank,intermediate filament organization (GO:0045109),0.4171719871591679,0.918950280092418,0.5511669658886894,0.8515354977265265,1.0,5/17,24.25%,MTM1;KLHL24;BFSP2;DNAJB6;NEFL
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.3965992310844082,0.918937390881199,0.5694682675814752,0.8510570807059671,1.0,4/21,5.38%,TOX;DISC1;DLL4;CX3CR1
prerank,midbody abscission (GO:0061952),0.4040613405034601,0.9187023207162717,0.5506993006993007,0.851054912355663,1.0,3/17,9.19%,CHMP2B;CHMP4B;CHMP4A
prerank,nuclear body organization (GO:0030575),-0.4071371039815898,-0.9186419613130423,0.5547445255474452,0.9046347887481936,1.0,8/12,31.22%,AFF2;SRPK2;HIPK2;USP50;HABP4;USPL1;ETS1;ZPR1
prerank,glycerol metabolic process (GO:0006071),-0.4180470402234131,-0.9183308681688227,0.5653153153153153,0.9043166202994501,1.0,4/10,18.10%,GK;GOT1;TPI1;ANGPTL3
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.36229718558425617,0.9181057898373364,0.5602605863192183,0.8517428872918013,1.0,7/32,20.90%,NEK7;HMBOX1;ACD;CTNNB1;CCT7;CCT2;MAP2K7
prerank,cardiocyte differentiation (GO:0035051),-0.4215959919994913,-0.9178973991813919,0.5661914460285132,0.9042685620619489,1.0,6/10,22.53%,AKAP13;TGFB2;MYOCD;KDM6B;EEF1AKMT4-ECE2;CBY1
prerank,positive regulation of gene expression (GO:0010628),0.27528320537863576,0.9178358654533664,0.6868365180467091,0.8517700895661833,1.0,57/442,10.82%,LEF1;NOS3;RAB27A;CADM1;APP;TENT4A;MEF2C;IL15;ERN1;CLDN5;OCLN;SMAD1;PDGFB;GATA2;PDE2A;STAT3;NOTCH1;HIF1A;MSN;PPM1F;CD34;PLCG2;FGF23;RBM20;DLL4;MAPK8;SERPINB9;RAMP2;TNRC6C;WNT5A;RPS7;IL36G;KRAS;DYRK1A;TAF1B;POLR1A;TGFB1;PIK3CG;BCL3;AGPAT1;NIBAN1;HNRNPD;NOS1AP;CITED1;SMARCA5;PSEN1;MYBBP1A;RPL23;SOX4;CSF1;HNRNPLL;MAPK11;RBM3;PRKAB1;MYO1C;GAS6;EIF6
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.4480640421668798,0.9176311967124349,0.54510556621881,0.8507072814551,1.0,4/11,19.84%,SLC25A16;PANK2;PANK3;PPCDC
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.4480640421668798,0.9176311967124349,0.54510556621881,0.8507072814551,1.0,4/11,19.84%,SLC25A16;PANK2;PANK3;PPCDC
prerank,coenzyme A biosynthetic process (GO:0015937),0.4480640421668798,0.9176311967124349,0.54510556621881,0.8507072814551,1.0,4/11,19.84%,SLC25A16;PANK2;PANK3;PPCDC
prerank,positive regulation of protein maturation (GO:1903319),0.4432342669561169,0.9171012940036465,0.5660714285714286,0.8512684380078201,1.0,3/11,9.32%,NKD2;RHBDD1;SOX4
prerank,regulation of protein kinase C signaling (GO:0090036),-0.3816114461105317,-0.9170854919020651,0.5744186046511628,0.9051937065835303,1.0,8/14,18.25%,ADGRV1;DGKD;ULK4;VEGFA;ADRA1A;GPD1L;WNT11;MYADM
prerank,regulation of humoral immune response (GO:0002920),0.35360012590885365,0.9169866739007763,0.5852187028657617,0.8509971329929147,1.0,4/44,7.48%,CFH;PROS1;CFB;CR1L
prerank,positive regulation of cation channel activity (GO:2001259),0.3592407214564178,0.9167971771809507,0.56752655538695,0.8508664502510924,1.0,2/40,4.00%,SHANK3;TMSB4X
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.4417425350300515,0.9162852169916693,0.5698324022346368,0.8513690768663922,1.0,6/13,23.44%,DPAGT1;ALG6;ALG8;MPDU1;ALG12;ALG14
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.3813000334229235,0.9162531662242278,0.5826377295492488,0.8509234805662169,1.0,10/25,23.49%,BTBD18;NELFE;BRD4;EAF1;ZMYND11;NELFCD;CDC73;NELFB;NELFA;EAPP
prerank,regulation of cellular pH (GO:0030641),-0.3281972205836535,-0.9158082182435285,0.581151832460733,0.9073992154669026,1.0,9/29,19.95%,SLC4A10;SLC9A9;SLC4A3;SLC4A2;SLC9A1;LACC1;SLC26A6;SLC4A8;SLC9A8
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.3894094225936083,0.9155025015661715,0.5857142857142857,0.8519098193195165,1.0,4/24,7.95%,B2M;MFSD6;TAP2;ERAP1
prerank,histone H2A monoubiquitination (GO:0035518),-0.3622695439350369,-0.9153248355268381,0.5990338164251208,0.9075408623283289,1.0,7/17,21.33%,BCOR;PCGF2;DDB2;RING1;DDB1;PCGF6;PCGF1
prerank,regulation of programmed necrotic cell death (GO:0062098),0.39922866869760665,0.9153006059599327,0.5327586206896552,0.8518128222995026,1.0,9/20,18.51%,CASP8;SDCBP;PELI1;MLKL;RIPK1;BIRC3;ASAH1;BIRC2;CDC37
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.35946631385264133,0.915232266483372,0.5829383886255924,0.8514552590501505,1.0,10/39,18.35%,SOCS2;PIK3C2A;CISH;ITPKB;PIK3CG;SLA2;SOCS6;SOCS4;EFR3B;PIK3C2B
prerank,positive regulation of viral genome replication (GO:0045070),0.3763273448955065,0.9150871966800033,0.5764331210191083,0.8512533224497857,1.0,6/29,13.14%,NR5A2;ADARB1;PKN2;RAD23A;ADAR;CNOT7
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.4393219227475988,0.9148622401102966,0.5862708719851577,0.8511956593751818,1.0,4/11,12.73%,DCTD;TPK1;NT5C3A;SLC19A3
prerank,positive regulation of growth (GO:0045927),0.3275247084280507,0.9147039068223798,0.5815899581589958,0.8510199486769601,1.0,15/64,14.35%,INSR;ADAM10;PPM1F;PLCB1;RPS6KA3;SDCBP;RPS6KA1;H3-3A;RPTOR;RFTN1;SFRP2;MTPN;ADAM17;ERBB2;S100A9
prerank,membrane repolarization during action potential (GO:0086011),0.4449637001312816,0.9146382629310813,0.5834970530451866,0.8506452408091373,1.0,3/13,7.06%,KCNQ1;ATP1A1;KCNE2
prerank,cellular biogenic amine metabolic process (GO:0006576),0.44690582433487375,0.9143408409861283,0.5709090909090909,0.8507625419387055,1.0,1/12,1.02%,MAOA
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.34123428794234445,0.9143251589377261,0.6046176046176046,0.8502950782335591,1.0,11/51,10.31%,BMPR2;SMAD1;SMURF1;NOTCH1;SMAD7;ACVR2A;GREM1;SOST;SKIL;SMAD5;UBE2D3
prerank,maintenance of protein location in nucleus (GO:0051457),0.39393836075114036,0.9141632282624967,0.5693069306930693,0.8501160073436386,1.0,4/20,14.49%,SYNE1;BCL3;TAF3;TOPORS
prerank,indolalkylamine catabolic process (GO:0046218),-0.41722982075288073,-0.9136572197906294,0.5746887966804979,0.9105522293963704,1.0,8/10,51.94%,KYAT1;HAAO;KYNU;AADAT;TDO2;KMO;IDO1;ACMSD
prerank,embryonic axis specification (GO:0000578),-0.37420621582134306,-0.9136066195910156,0.5688073394495413,0.9095704094301712,1.0,8/15,28.81%,COBL;SMAD6;CXXC4;TBX3;PTCH1;FZD5;STIL;RIPPLY2
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.3260773017625687,0.9133281109508904,0.5938803894297635,0.8513442580674808,1.0,25/67,25.41%,B2M;IKBKB;TAP2;PSMA2;IKBKG;SNAP23;PSMA8;FCGR1A;PSMA6;VAMP8;PSME1;PSMA4;PSMF1;SEC22B;PSMB7;PSMB1;PSMD2;PSMA5;PSMC3;TAP1;CYBA;PSMD3;PSMA3;VAMP3;TAPBP
prerank,protein autoprocessing (GO:0016540),0.41407794949356175,0.9124294866535746,0.5671378091872792,0.8526569007125141,1.0,3/17,13.21%,CASP4;CASP1;OMA1
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),-0.2891961928775962,-0.9123159201966496,0.6020066889632107,0.9117148822471264,1.0,13/46,21.71%,ZIC1;PRKCD;CDH1;SMAD3;CAMK1;MAVS;PIK3R2;TRIM28;UBR5;HDAC3;JUP;TP53;BAG3
prerank,positive regulation of lipid metabolic process (GO:0045834),0.3929994327309372,0.9121881729402015,0.5739130434782609,0.8526440263554936,1.0,3/22,8.58%,PPARD;SORBS1;CREB1
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.39527822256376627,0.9116678844403118,0.5761589403973509,0.8532024583126782,1.0,5/20,14.29%,HHEX;CDKN1B;TFAP4;INCA1;APC
prerank,signal transduction in response to DNA damage (GO:0042770),0.34211457335172335,0.9115810004433691,0.5954887218045113,0.8528777936920384,1.0,14/49,20.50%,ACER2;BCL3;BRIP1;MAD2L2;HUS1;BID;MAP3K20;ATRX;E2F7;CHEK2;TIPRL;GRB2;MYO6;RAD17
prerank,phosphate ion transmembrane transport (GO:0035435),0.4352055127268967,0.9115802794984117,0.5494505494505495,0.8523840924681882,1.0,4/12,12.60%,SLC37A3;SLC25A30;SLC37A1;XPR1
prerank,xenobiotic transport (GO:0042908),0.42642982867124885,0.9115483360214928,0.5872727272727273,0.8519478114289217,1.0,3/17,8.48%,ABCG2;ABCA3;SLC15A2
prerank,protein polyglutamylation (GO:0018095),0.45125980525117715,0.911424390148078,0.5776173285198556,0.8516965271933014,1.0,5/11,20.81%,CEP41;TTLL7;TTLL5;TPGS1;TTLL9
prerank,regulation of protein catabolic process (GO:0042176),0.3123160134703371,0.9112000649235517,0.6033376123234917,0.8516781500168423,1.0,20/99,16.64%,FOXO1;SMURF1;DAB2IP;NEDD4L;PLK2;WNT5A;CDKN1B;SNX3;NEDD4;VPS28;MAD2L2;RAB26;RILP;ASB11;RAB7A;APC;PRKCG;IRAK3;AREL1;CHEK2
prerank,nucleus organization (GO:0006997),0.340414520466376,0.9110520494108553,0.5895522388059702,0.8514602639201961,1.0,11/47,14.27%,RPS19;CHMP2B;SYNE1;CHMP4B;CHMP4A;NUP98;NUP133;NUP205;SPAG4;PITPNB;NUP54
prerank,positive regulation of double-strand break repair (GO:2000781),0.3540666167856842,0.9110257166341107,0.6021671826625387,0.8510218720154213,1.0,17/39,25.04%,SMCHD1;DTX3L;SHLD1;WRAP53;MAD2L2;MMS19;ACTR2;SPIDR;WDR48;KMT5B;PARP9;MGMT;FUS;RIF1;ERCC6;ARID2;FMN2
prerank,lysine catabolic process (GO:0006554),-0.4022014819162626,-0.910767428639633,0.5936794582392777,0.91337139785629,1.0,7/12,36.35%,ALDH7A1;PHYKPL;AASS;GCDH;SLC25A21;HYKK;CRYM
prerank,lysine metabolic process (GO:0006553),-0.4022014819162626,-0.910767428639633,0.5936794582392777,0.91337139785629,1.0,7/12,36.35%,ALDH7A1;PHYKPL;AASS;GCDH;SLC25A21;HYKK;CRYM
prerank,negative regulation of ion transport (GO:0043271),-0.33197329111117224,-0.9097803162385824,0.5890052356020943,0.9147393837280163,1.0,8/24,14.95%,ACTN2;GPM6B;WNK4;SYT11;ADRA2A;WNK1;SNCA;WNK3
prerank,response to nutrient levels (GO:0031667),0.4103275065007223,0.9090040906795385,0.5557491289198606,0.8544974388997221,1.0,3/17,8.46%,KCNB1;ULK1;RPTOR
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.3085759515347769,0.908904696061651,0.6208226221079691,0.854215558353271,1.0,22/104,14.33%,BMPR2;CAV1;SMAD1;SMURF1;NOTCH1;FKBP1A;SMAD7;ACVR2A;GREM1;ACVR1;SOST;SNX25;TGFB1;SKIL;SMAD5;UBE2D3;TGFBR2;ADAM17;PMEPA1;FAM89B;BCL9L;ACVR2B
prerank,protein deubiquitination (GO:0016579),0.2826929613546307,0.9083200110965084,0.6528089887640449,0.8549579570259982,1.0,73/242,23.27%,ESR1;SMAD1;HIF1A;NFKBIA;MINDY1;USP3;BABAM2;MINDY2;SMAD7;USP15;UCHL5;ATXN3;SNX3;PSMA2;BRCC3;FOXK1;ZRANB1;IKBKG;PSMA8;RAD23A;TNIP1;PSMA6;OTUD4;ENY2;RIPK1;ASXL1;BIRC3;IFIH1;TRAF6;APC;PSME1;MBD5;YY1;KAT2B;USP12;OTULIN;ACTR5;BIRC2;RHOA;ABRAXAS2;WDR48;RHOT1;NEDD8;YOD1;USP8;WDR20;DESI2;NFRKB;PSMA4;USP7;PSMF1;STAM;NLRP3;USP25;USP21;SMAD2;PSMB7;PSMB1;TRRAP;ATXN7;PSMD2;TADA2B;TNIP2;BABAM1;PSMA5;CCNA2;PSMC3;EIF3F;JOSD1;STAM2;UCHL3;ADRM1;TRAF2
prerank,excitatory postsynaptic potential (GO:0060079),0.4080364486678076,0.9082364038633572,0.6016949152542372,0.8546122522655707,1.0,1/19,1.15%,MEF2C
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.36988761024786887,0.9080956048157116,0.5889070146818923,0.8543830881511582,1.0,2/32,1.87%,CAV1;PLCG1
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.32664058766714255,0.9080660134664797,0.5814606741573034,0.8539469580481704,1.0,9/59,6.68%,PRKD1;PRKD2;LMTK2;HIPK1;CDC42BPB;MAPK8;ULK1;ACVR1;DYRK1A
prerank,chloride transmembrane transport (GO:1902476),-0.2849918117816316,-0.9079752518010165,0.6507462686567164,0.9180467515048215,1.0,20/48,22.92%,SLC1A3;SLC12A2;SLC6A1;GLRB;ANO1;GABRG2;ANO4;GABRA2;GABRB1;ANO3;GABRB3;GABRG3;SLC1A1;CFTR;SLC4A8;CLCN1;GABRA1;SLC12A8;GABRA5;GABRA3
prerank,lytic vacuole organization (GO:0080171),-0.31453365818738643,-0.9076567864484782,0.6194444444444445,0.9177848928872149,1.0,13/32,25.87%,ARSB;LRRK2;GAA;CLVS2;HPS4;HPS1;HOOK2;TPP1;CLN3;ACP3;SNAPIN;LAMTOR1;MTOR
prerank,negative regulation of defense response (GO:0031348),0.32385682770093427,0.9076452494035742,0.6005434782608695,0.8543015127073028,1.0,4/77,3.34%,TEK;PPARD;MFHAS1;LPCAT3
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.3406982095134734,0.9075540852619743,0.6055312954876274,0.8539946201909389,1.0,11/52,15.34%,PPP1R13B;FBXW7;CASP8;MAPK8;SH3GLB1;UBE2D3;SFN;BID;SAE1;YWHAQ;ARIH2
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.29067060988347326,-0.907551855660776,0.6189111747851003,0.9169534005185318,1.0,9/43,18.44%,IGF1;LBP;SELENOS;SYT11;PTPN22;SIRPA;NR1H4;CACTIN;CHRNA7
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.3464727700425924,-0.9073276645679659,0.5985915492957746,0.9163792258057376,1.0,10/22,23.98%,DDX5;PLA2R1;SPRED1;SPRED2;SPRED3;CHD5;CDK5RAP3;ATR;MSX1;ATM
prerank,protein homooligomerization (GO:0051260),0.3015861477048306,0.907269676642081,0.6121437422552665,0.8540636064230624,1.0,27/114,19.75%,EHD4;B2M;GBP5;SAMHD1;ACACB;AQP11;GLS;ALOX5AP;MLKL;PKD2;HPRT1;RNF112;EHD3;SIGMAR1;SOD2;ATL1;G3BP2;PNPT1;APIP;TIFA;CBR4;CARD9;GLRA3;FUS;OSBPL2;BCL10;ALDH1A3
prerank,regulation of establishment of planar polarity (GO:0090175),0.31395175115207147,0.9072224005958184,0.6089743589743589,0.8536626201843518,1.0,13/88,12.59%,SMURF1;CELSR1;FZD6;FZD4;AP2B1;WNT5A;RAC1;AP2A1;PSMA2;PSMA8;PSMA6;PRICKLE1;VANGL2
prerank,heterotypic cell-cell adhesion (GO:0034113),0.38668805920572136,0.9068002157292392,0.5617597292724196,0.853984405219929,1.0,5/25,11.76%,VCAM1;CD200;ITGA5;IZUMO1;ITGB3
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.335443249448683,0.9066074526071015,0.5912518853695324,0.8538873396366929,1.0,15/51,24.36%,NEK7;HMBOX1;PINX1;ACD;DCP2;HNRNPC;TERF1;CTNNB1;CCT7;CCT2;TEN1;MAP2K7;SMG6;TENT4B;TNKS
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),-0.32572703078948595,-0.906110204124587,0.5810473815461347,0.9182117077630008,1.0,10/27,15.93%,SLC7A2;SLC1A3;SLC47A1;SLC6A9;SLC1A2;SLC25A12;SLC25A13;SLC1A1;SLC22A2;SLC25A18
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.4425882060989489,0.9058172228452739,0.5920303605313093,0.8544357779428818,1.0,3/11,16.25%,FKBP1A;PKD2;CALM1
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.4425882060989489,0.9058172228452739,0.5920303605313093,0.8544357779428818,1.0,3/11,16.25%,FKBP1A;PKD2;CALM1
prerank,regulation of organelle assembly (GO:1902115),0.3194086058051262,0.9057868600409181,0.5978260869565217,0.853999456403,1.0,13/73,14.04%,TBC1D8;MSN;TBC1D22A;TBC1D15;PLK2;TBC1D12;TBC1D2;RNF4;NPRL2;TBC1D5;EVI5;RAB5A;NPM1
prerank,membrane raft organization (GO:0031579),-0.365245789579499,-0.9056874086758017,0.5673076923076923,0.9181620795656324,1.0,7/15,22.67%,ANXA2;S100A10;FLOT2;ABCA7;MYADM;PPT1;CLN3
prerank,acyl-CoA metabolic process (GO:0006637),0.36167392808590904,0.9055506102265795,0.5862573099415205,0.8539714866951253,1.0,3/35,4.12%,HMGCS2;ACACB;GLYAT
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.43626014737730895,0.9054258757219236,0.562962962962963,0.8537358159008245,1.0,6/13,19.85%,JAK3;PIGU;IL7R;MGAT5;CRLF2;HES1
prerank,negative regulation of tumor necrosis factor production (GO:0032720),-0.29382299607827106,-0.9049167558823241,0.6309859154929578,0.9189443125395798,1.0,9/41,18.44%,IGF1;LBP;SELENOS;SYT11;PTPN22;SIRPA;NR1H4;CACTIN;CHRNA7
prerank,regulation of defense response to virus (GO:0050688),-0.37431770492425587,-0.9048674655823576,0.6017505470459519,0.9179578403878133,1.0,8/14,28.89%,PCBP2;ITCH;TRAF3IP1;PPM1B;C1QBP;RNF26;IFNLR1;DHX9
prerank,cytoplasmic translational initiation (GO:0002183),-0.3618782698548293,-0.9048561846587243,0.5689655172413793,0.9168967033280739,1.0,9/17,31.24%,EIF4A1;EIF2S2;RBM4;EIF3A;EIF2D;EIF4G1;EIF2B3;EIF4A2;EIF4B
prerank,positive regulation of amyloid-beta formation (GO:1902004),-0.3562719703333497,-0.9043688164446203,0.6060606060606061,0.9170222121423196,1.0,3/18,4.59%,ROCK2;SLC2A13;LRRTM3
prerank,SNARE complex assembly (GO:0035493),0.44826943876296566,0.9035395232110692,0.5785582255083179,0.8568632791271508,1.0,3/10,15.22%,VAMP4;VAMP8;STXBP6
prerank,Rho protein signal transduction (GO:0007266),0.3362959276807574,0.9033686374211156,0.5845697329376854,0.8567004111374379,1.0,7/53,4.39%,NTN1;EPS8;ARHGEF3;CELSR1;ADGRG1;PLEKHG5;RHOJ
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.3725334059000194,0.9022593641278269,0.5912052117263844,0.8583806021858386,1.0,6/29,11.72%,SMAD1;DROSHA;DICER1;PUM1;ADAR;PUM2
prerank,RNA modification (GO:0009451),0.3334259801135261,0.9022081721730147,0.5930735930735931,0.8579748497998928,1.0,16/54,25.63%,ADARB1;CDKAL1;RBM15;ADAR;NSUN4;HENMT1;DTWD2;TRMT6;PUS7L;JMJD6;THUMPD1;TRUB1;NSUN6;PUS7;AARS2;LCMT2
prerank,phagolysosome assembly (GO:0001845),0.4367708315286776,0.9022034329956887,0.580110497237569,0.8574954981960383,1.0,4/12,15.28%,ARL8B;RAB7A;RAB7B;SYT7
prerank,potassium ion export across plasma membrane (GO:0097623),0.4307764270412383,0.9021758401829757,0.5743494423791822,0.8570582196768316,1.0,2/13,7.06%,KCNQ1;KCNE2
prerank,regulation of endocytic recycling (GO:2001135),-0.3996547818814835,-0.9019826810143847,0.6090712742980562,0.9217527839467471,1.0,4/11,13.77%,ACTN2;ATP9A;EHD1;ARHGAP1
prerank,nucleic acid metabolic process (GO:0090304),-0.2712437005012567,-0.9018240811748603,0.6690140845070423,0.9210259717333583,1.0,24/69,23.57%,ENPP1;HNRNPH1;HNRNPA2B1;DUSP11;RECQL5;RBFOX2;PCBP2;ATXN2;NT5E;RAD50;POLR2B;HNRNPR;HNRNPU;POLR2K;HNRNPA1;KPNA2;GTF2F1;SETMAR;DNA2;PDE12;POLR2I;POLG;DNASE2;DNASE1L2
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.4117555447864172,0.9018107589192936,0.5789473684210527,0.8572848489495636,1.0,2/15,2.21%,IL6ST;EDN1
prerank,negative regulation of RNA splicing (GO:0033119),0.38583787286731946,0.9016856148090024,0.5790378006872853,0.8570423505562716,1.0,8/19,27.18%,TMBIM6;PTBP3;RNPS1;RPS13;SRSF10;SRSF4;RBMX;RPS26
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.43104323811657735,0.901651286832872,0.582089552238806,0.8566253052384072,1.0,4/12,8.78%,B3GNT3;B3GNT4;B4GAT1;B3GNT6
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.44173256025410934,0.9011083439121556,0.5706106870229007,0.8572006414835688,1.0,3/11,15.33%,H3-3A;HAT1;ATRX
prerank,membrane depolarization (GO:0051899),0.36190035297005063,0.9007883923566163,0.5847589424572317,0.857329458410636,1.0,3/32,5.86%,CAV1;CACNA1E;CACNA1A
prerank,regulation of cholesterol esterification (GO:0010872),-0.4124904959554492,-0.9002795058026053,0.6049107142857143,0.9235847963330412,1.0,4/10,25.15%,AGTR1;APOE;ABCA2;LAMTOR1
prerank,photoperiodism (GO:0009648),0.36818068957541206,0.9002600310911609,0.5967741935483871,0.8578539579952367,1.0,5/28,13.99%,CRTC1;SIK1;OPN5;PDE6B;FBXL3
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.41320105300130927,-0.9001607052733747,0.6255506607929515,0.9227755898937978,1.0,1/10,1.35%,APPL2
prerank,cellular response to hypoxia (GO:0071456),-0.24109238112141668,-0.8998462857426177,0.7112299465240641,0.9224960126670122,1.0,20/126,9.79%,CPEB1;BMP7;SLC8A3;CPEB2;SIRT2;NDNF;KCND2;RORA;PSME4;EGLN3;LMNA;P4HB;NPEPPS;MDM4;SFRP1;MDM2;VEGFA;HIPK2;RGCC;ARNT
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.33275051275698037,0.8990894606105205,0.5957120980091883,0.8596629729641108,1.0,8/54,7.93%,CAV1;NEDD4L;KCNQ1;GNB1;KCNMB4;KCNE2;NEDD4;NOS1AP
prerank,positive regulation of nervous system development (GO:0051962),-0.2943581259563639,-0.8990861459957831,0.6519174041297935,0.9231970633656676,1.0,12/42,13.07%,NLGN2;CLSTN2;CUX2;PTPRD;IL1RAPL1;NRXN1;NLGN1;SERPINF1;NLGN3;SRPX2;GRID2;GPER1
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.35569282912838057,-0.8990228729714624,0.5825471698113207,0.9222536447651066,1.0,6/16,21.37%,AMPD3;LHPP;PAICS;ATIC;PFAS;ADSS1
prerank,regulation of mononuclear cell migration (GO:0071675),0.38554284601334576,0.8989069017565204,0.567062818336163,0.859525382845281,1.0,5/23,9.45%,LYN;STK10;MSN;PTK2;CSF1
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.28418212312337215,-0.8987373224766063,0.6456456456456456,0.9218747898523897,1.0,11/44,16.20%,SH3RF1;THBS1;NGF;FNIP1;SIAH2;CD44;SRC;VEGFA;SNCA;USP47;MT3
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.43111643814405415,0.8985092791099428,0.576171875,0.8598298027581606,1.0,2/11,7.93%,ALG10B;NOS1AP
prerank,response to organophosphorus (GO:0046683),-0.3640964806908865,-0.8983647244146082,0.6069868995633187,0.9216200954561669,1.0,3/16,5.70%,P2RX4;ABCC9;TRPC3
prerank,eye photoreceptor cell differentiation (GO:0001754),0.4433552747698257,0.8983290054059417,0.5618374558303887,0.8596731262598725,1.0,3/12,9.24%,STAT3;PROM1;DSCAM
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.40408184683595055,-0.8977163152995176,0.5822510822510822,0.9220555014955951,1.0,3/10,2.54%,VTN;PRKCB;GRB10
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.3928632127678848,0.8976126061540997,0.597972972972973,0.8605661813707937,1.0,5/18,16.45%,MFHAS1;CTNNA1;POLR1A;ILRUN;CHP1
prerank,autonomic nervous system development (GO:0048483),-0.35667339566442235,-0.8973955934199532,0.5785714285714286,0.9217573469780003,1.0,3/17,8.07%,NRP1;NF1;SEMA3A
prerank,positive regulation of axonogenesis (GO:0050772),0.34295245821067377,0.8972148666209301,0.5852187028657617,0.8608402032822713,1.0,4/43,2.82%,PLXNA4;NTN1;SEMA7A;PLXND1
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.40162698751177783,-0.8964959569679952,0.5982142857142857,0.9227940085156768,1.0,4/11,8.61%,RSPO3;PLEKHA4;DAB2;SFRP1
prerank,negative regulation of viral genome replication (GO:0045071),0.3504397413256636,0.8962681537807093,0.61863173216885,0.8622005053133366,1.0,12/40,19.34%,ISG20;N4BP1;INPP5K;TASOR;TNIP1;OASL;IFIH1;IFITM3;PLSCR1;BST2;IFITM1;EIF2AK2
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.3275074731916665,-0.8957976325883931,0.6091370558375635,0.9233524079535332,1.0,6/24,13.36%,DMD;JPH1;AKAP6;PRKACA;GSTM2;JPH2
prerank,release of cytochrome c from mitochondria (GO:0001836),0.40079056428870696,0.8956460136831257,0.5676156583629893,0.8629353793410686,1.0,6/17,13.79%,BOK;BCL2L1;GGCT;SFN;BID;SOD2
prerank,proteasomal protein catabolic process (GO:0010498),0.28114921862601244,0.8955961523098629,0.6713286713286714,0.862547663698973,1.0,59/201,22.48%,SMURF1;NEDD4L;FBXW7;ZNRF1;KCTD10;PELI1;ATXN3;ARRB1;UBE2G1;PSMA2;NEDD4;ARMC8;RNF139;RHBDD1;SPOPL;RNF4;ZFAND2B;PSMA8;RAD23A;SIAH1;UBE2D3;PSMA6;COP1;DDI1;UBE2K;TOPORS;UBXN1;PSME1;SOCS6;RNF5;DDIT3;DDI2;UBE3D;AREL1;CRBN;BIRC2;NHLRC1;CTNNB1;MAEA;CUL3;CDC34;PSMA4;DNAJB12;PSMF1;ZFAND2A;APPBP2;CCDC47;PSMB7;TRIM71;PSMB1;HACE1;KCTD2;SEL1L;PSMD2;KCTD5;KLHL42;UBXN2A;PSMA5;PSMC3
prerank,mucosal immune response (GO:0002385),0.4175579780701504,0.8955829755389304,0.5948905109489051,0.862084056369229,1.0,2/15,9.15%,RPL39;DEFA6
prerank,glycine metabolic process (GO:0006544),0.4322406129032419,0.8951128476004244,0.585635359116022,0.8625316656801699,1.0,1/12,4.12%,GLYAT
prerank,transepithelial transport (GO:0070633),0.4129636383926374,0.8943724978296903,0.603202846975089,0.863508313339734,1.0,2/15,4.74%,ABCG2;BEST1
prerank,organelle transport along microtubule (GO:0072384),-0.3072266821424441,-0.8939774518974924,0.6100278551532033,0.9264564135935314,1.0,8/31,16.41%,BICD1;ARHGAP21;COPG1;DYNC1I1;HTT;BICD2;TRAK1;MAP1S
prerank,smooth muscle tissue development (GO:0048745),0.4423922005353835,0.8937525720879801,0.5917602996254682,0.864255844703902,1.0,1/10,0.85%,ENG
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.3687989865449487,0.893565958971363,0.6,0.8641427692984398,1.0,5/27,13.99%,CRTC1;SIK1;OPN5;PDE6B;FBXL3
prerank,hexose metabolic process (GO:0019318),0.3530904908572527,0.8932834114963513,0.6063348416289592,0.8641606455869714,1.0,7/39,14.01%,PPARD;FUCA2;FBP1;SORD;PMM2;OMA1;GALM
prerank,anterior/posterior axis specification (GO:0009948),-0.3706845238579379,-0.8931058497265458,0.6279620853080569,0.92745735281236,1.0,1/15,0.48%,WLS
prerank,regulation of peptide hormone secretion (GO:0090276),0.3185521947725458,0.8930785635818546,0.6331444759206799,0.8640602325030872,1.0,10/67,8.26%,SLC2A1;CACNA1E;CHD7;KCNB1;CACNA1A;PPP3CB;RAP1A;STX1A;ITPR3;NEUROD1
prerank,positive regulation of proteolysis (GO:0045862),0.3281996201274777,0.8929982369915891,0.6244604316546762,0.8637389717163924,1.0,4/55,3.89%,CTSC;TNFRSF1B;CASP8;NKD2
prerank,negative regulation of JUN kinase activity (GO:0043508),0.429427104339948,0.892878144953281,0.6170634920634921,0.8634703145995124,1.0,6/10,23.82%,DNAJA1;AIDA;GSTP1;HIPK3;DUSP19;PDCD4
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.32994879954562234,0.8923454719872272,0.5786516853932584,0.864011830516245,1.0,13/52,13.14%,CNOT6;PAN3;CNOT6L;EDC3;CNOT1;RC3H1;EXOSC1;CNOT2;DCP2;LSM3;HBS1L;ZFP36;CNOT7
prerank,regulation of receptor binding (GO:1900120),0.43670630381484804,0.8923109295911232,0.5783582089552238,0.8635849978099734,1.0,2/10,6.17%,B2M;ADAM15
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.4410534244162081,0.8920535886299766,0.5865209471766849,0.8636013501251887,1.0,6/11,30.15%,CYCS;UQCRQ;UQCRC1;UQCC3;UQCRC2;UQCR11
prerank,response to peptide hormone (GO:0043434),-0.2908374776952783,-0.8919808731718,0.6454545454545455,0.9290098699121976,1.0,9/43,10.14%,ROCK2;TGFBR3;IRS1;IGFBP5;OGT;ANXA1;GNAI1;SRC;SLC27A1
prerank,pulmonary valve morphogenesis (GO:0003184),0.4026942560879375,0.8916634129422447,0.5969125214408233,0.8638368381364967,1.0,3/17,2.77%,NOS3;NFATC1;NOTCH1
prerank,negative regulation of stress fiber assembly (GO:0051497),0.38834854253197176,0.8916571102995167,0.5961227786752827,0.8633676107933633,1.0,5/24,6.60%,TJP1;F11R;WASF2;PAK2;INPP5K
prerank,establishment of spindle orientation (GO:0051294),-0.3132940933436711,-0.8916497044314379,0.6180371352785146,0.9286834015166385,1.0,15/28,33.67%,GJA1;GPSM2;HTT;UBXN2B;LLGL2;NDC80;MISP;SPDL1;CENPA;FBXW11;CLASP1;DCTN1;INSC;ZW10;PKHD1
prerank,negative regulation of biosynthetic process (GO:0009890),0.39813776590468725,0.8916331648934782,0.5971731448763251,0.8629255354429107,1.0,6/16,15.16%,ABCB7;CEACAM1;COA8;ABCD1;GSTP1;SLC18A2
prerank,spindle assembly (GO:0051225),0.31946184600538996,0.8909876688128578,0.6193820224719101,0.8637322107489598,1.0,19/67,21.96%,NEK7;RAB11A;STARD9;NEK6;STAG2;STAG1;LSM14A;CHEK2;RHOA;ABRAXAS2;WRAP73;MZT1;NUMA1;BCCIP;RPS3;PIBF1;KPNB1;KIF2A;SAC3D1
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.42203515943544745,0.8904618014519697,0.6021314387211367,0.8642342171668744,1.0,3/13,12.70%,NCK1;PTPN1;RACK1
prerank,positive regulation of sodium ion transport (GO:0010765),0.4306394267535184,0.890227031246547,0.6068840579710145,0.8642217986888445,1.0,1/12,1.76%,CNKSR3
prerank,lymphocyte mediated immunity (GO:0002449),-0.38433899368223734,-0.8900328694461707,0.6153846153846154,0.9314368944614464,1.0,3/12,14.89%,CD55;JAG1;GNL1
prerank,regulation of microtubule polymerization (GO:0031113),0.3465793024454593,0.8899007595515188,0.6144200626959248,0.8643587433482386,1.0,12/40,20.56%,OCLN;RAC1;DYRK1A;CAMSAP2;PRUNE1;MET;CDH5;PAK1;CDK5RAP2;CLIP1;NUMA1;RPS3
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),-0.3155606864468951,-0.8897098205688324,0.6236842105263158,0.9310945925289643,1.0,7/29,12.79%,GOLGA5;COPZ2;COPB1;COPA;COPG1;TRAPPC10;COG8
prerank,response to gamma radiation (GO:0010332),0.3695711432713858,0.8895126286885049,0.5838815789473685,0.8645887514259795,1.0,1/24,0.84%,DCUN1D3
prerank,"transcription, DNA-templated (GO:0006351)",0.2769413409963987,0.8887427450497966,0.7041763341067285,0.8655862269150169,1.0,62/207,22.55%,PIR;MLLT3;RREB1;CCNK;XBP1;EPC1;PWP1;GTF2F2;KLF13;TAF1B;GTF2E2;BCL3;GMEB2;NFKB1;TRIP13;NELFE;SMARCA5;TAF3;TRIM24;TAF4B;COPS2;RNGTT;EAF1;TFB2M;RO60;MMS19;RNPS1;CBFB;CEBPD;SNAPC3;RNMT;GTF2A2;PTMA;BTF3;MEF2A;TOPORS;ELOC;NELFCD;CTDP1;MNT;GTF2H4;GTF3C1;CDC73;TAF1A;HIPK3;NR4A2;GTF2H1;TAF9;NELFB;POLR3A;MRPL12;DEK;POLR2L;CCNH;SETX;TAF15;TAF7;NELFA;RTF1;NOCT;POLR2J;ERCC6
prerank,positive regulation of mRNA processing (GO:0050685),-0.337506501029467,-0.8885627379049569,0.6211031175059952,0.9327383346854814,1.0,5/21,10.09%,CELF4;DAZAP1;PAF1;LEO1;CIRBP
prerank,dendrite morphogenesis (GO:0048813),0.3559665506383895,0.8878760908897491,0.6325581395348837,0.8667505404528041,1.0,3/35,3.42%,SHANK3;KLF7;TAOK2
prerank,iron ion homeostasis (GO:0055072),0.3270887785055229,0.8877184588163384,0.622286541244573,0.8665665288931287,1.0,12/58,17.46%,ABCG2;B2M;ABCB7;LCN2;GLRX3;CUL1;PICALM;HMOX2;CP;FRRS1;NEDD8;NUBP1
prerank,endoplasmic reticulum organization (GO:0007029),0.31970315733663385,0.8874335031902842,0.635752688172043,0.866645265931606,1.0,12/72,14.32%,APP;REEP1;LPCAT3;CAV2;DOP1B;STX1A;TRAM1;TRAM1L1;RNF112;ATL1;ALDH3A2;RAB18
prerank,protein tetramerization (GO:0051262),0.31167482349659453,0.8863476009273306,0.6304347826086957,0.8681847406883956,1.0,5/67,3.41%,B2M;GBP5;SAMHD1;ACACB;GLS
prerank,hepaticobiliary system development (GO:0061008),-0.3408878310677633,-0.8862402785058315,0.6226415094339622,0.9370768122617823,1.0,4/20,5.63%,TGFBR3;WNT4;COBL;NF1
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.31743690781475514,0.8861641490469828,0.6304654442877292,0.8680284598407848,1.0,22/64,25.60%,MLLT3;CCNK;GTF2F2;NELFE;EAF1;ELOC;NELFCD;CTDP1;GTF2H4;CDC73;GTF2H1;NELFB;POLR2L;CCNH;NELFA;RTF1;POLR2J;ADRM1;IWS1;TCEA2;GTF2H5;PCID2
prerank,glucose metabolic process (GO:0006006),-0.2664901391247168,-0.8851896372837492,0.6825938566552902,0.9384596043294627,1.0,18/58,18.71%,RBP4;PPARGC1A;APOD;SLC39A14;PER2;ENO2;GAA;SLC25A12;GOT1;TPI1;IRS2;SLC25A13;G6PC3;ENO3;PFKFB1;MDH1;CRY1;PCK2
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.42796830896738536,0.8849786370968582,0.6145251396648045,0.8698445851881221,1.0,5/11,15.16%,FYN;ABCB7;COA8;ABCD1;SLC18A2
prerank,photoreceptor cell development (GO:0042461),-0.3627265325673605,-0.8847231010051892,0.5977011494252874,0.93851255596053,1.0,5/14,18.05%,AHI1;ARL3;VEGFA;MFSD2A;TULP1
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.4214485585240465,0.8843764829802411,0.5960502692998204,0.8704875155003453,1.0,6/12,29.26%,CDT1;WDR18;TIPIN;GMNN;TICRR;KAT7
prerank,homotypic cell-cell adhesion (GO:0034109),-0.2884864213311599,-0.8840759973889194,0.6579804560260586,0.9388518958547385,1.0,6/39,8.63%,PLPP3;PDGFRA;MEGF11;GNAS;UBASH3B;MYL9
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.4129426227743118,0.8833705781883879,0.615819209039548,0.8719674011358856,1.0,3/15,7.06%,KCNQ1;ATP1A1;KCNE2
prerank,positive regulation of cell division (GO:0051781),0.3479798456119639,0.883049560050034,0.625,0.8720991828523663,1.0,3/38,4.00%,PKP4;TAL1;PKN2
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.4174255792406838,0.8828729718103636,0.6049149338374291,0.8719476046172945,1.0,5/14,22.83%,TSEN34;RTCB;CPSF1;TSEN2;RTRAF
prerank,regulation of lipid metabolic process (GO:0019216),0.30190726534086554,0.8828693408754592,0.6627296587926509,0.8714656714108826,1.0,7/88,5.80%,CAV1;PPARD;PLPP1;FASN;ACACB;NCOA1;TGS1
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.4152355946512205,0.8824774962719303,0.6092592592592593,0.8717392539480667,1.0,4/13,8.78%,B3GNT3;B3GNT4;B4GAT1;B3GNT6
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.4364837365764023,0.8821437696598053,0.6245283018867924,0.8718907722093253,1.0,5/10,23.71%,CDT1;ATRX;E2F7;DBF4;STOML2
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.3949650223245391,-0.881948798134532,0.6283783783783784,0.9427876946200827,1.0,1/11,1.79%,GRK3
prerank,vacuolar acidification (GO:0007035),-0.3320374624974451,-0.881463672062989,0.6243386243386243,0.942841782482788,1.0,13/21,35.59%,ATP6V0A4;ATP6V0D1;ATP6AP2;PPT1;SLC11A1;CLN3;TMEM199;TMEM9;CCDC115;ATP6V0D2;GRN;DMXL2;TCIRG1
prerank,double-strand break repair (GO:0006302),0.2814782241960901,0.8811724706134884,0.6935096153846154,0.8732303726531975,1.0,37/158,18.10%,TENT4A;SAMHD1;BABAM2;DTX3L;HERC2;MAPK8;MMS22L;RPA1;TRIP13;POLA1;SMARCA5;BRCC3;RAD51D;BRIP1;SEM1;PARP2;RECQL;MEIOB;MAD2L2;FAN1;HUS1;XRCC2;MCM9;RMI1;CYREN;ERCC4;UBXN1;YY1;ACTR5;CHEK2;SPIDR;KDM4A;RAD21;NSMCE1;CIB1;DCLRE1C;PARP9
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.3582021038405333,-0.8811211290249392,0.6408450704225352,0.9425430428961378,1.0,4/16,8.32%,RANBP3L;IGFBP3;BOC;RIPOR2
prerank,pre-miRNA processing (GO:0031054),0.41509399477859726,0.8808670799563645,0.5948905109489051,0.8733113099886639,1.0,5/14,21.33%,DROSHA;DICER1;ADAR;MRPL44;PRKRA
prerank,neuromuscular synaptic transmission (GO:0007274),-0.34647090818426385,-0.880477993093429,0.6475,0.942898208460861,1.0,8/18,30.69%,DTNA;KIF1B;FCHSD2;STAC3;TBC1D24;TSPOAP1;SLC5A7;CHRNB2
prerank,negative regulation of phosphate metabolic process (GO:0045936),-0.32964682865106315,-0.8804528316561714,0.6128205128205129,0.9418805943759919,1.0,6/22,15.91%,BMP7;BMP4;INHBA;CDKN1A;CDKN1C;PLEK
prerank,proteoglycan metabolic process (GO:0006029),0.3751108222079742,0.8801173553635775,0.6110183639398998,0.8742301964082485,1.0,2/26,0.68%,CSGALNACT1;BMPR2
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.3416936232955978,0.8800346887818862,0.6348733233979136,0.873899294677176,1.0,11/41,14.80%,HIF1A;SCARB2;EIF6;NUP214;NUP98;SLC2A6;NUP133;NUP205;NUP54;NUP43;NUP153
prerank,ERBB2 signaling pathway (GO:0038128),-0.3103763828277737,-0.8799208944768968,0.6259541984732825,0.9420223006666711,1.0,6/31,9.03%,EGFR;ERBB4;HSP90AA1;SHC1;PRKCA;SRC
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.3160489316945948,0.879900436461111,0.6114369501466276,0.8736855119345333,1.0,6/60,7.80%,NEK7;PDGFB;PRKD2;HMBOX1;GREM1;WRAP53
prerank,"wound healing, spreading of cells (GO:0044319)",0.377160794121083,0.8794727383318023,0.6127450980392157,0.8740093088747869,1.0,5/24,7.98%,LCP1;ACVRL1;MRTFA;CEACAM1;ITGA5
prerank,regulation of smooth muscle contraction (GO:0006940),-0.3240221363519712,-0.8793955788206735,0.6290322580645161,0.9421657721182907,1.0,10/20,22.57%,PLCE1;KCNB2;SPHK1;CTTN;MYOCD;ZDHHC21;CHRM3;ADRB2;CHRM2;DAPK3
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.3979035694293828,0.8791524701289614,0.5931623931623932,0.8741374047626259,1.0,7/15,22.85%,KHNYN;NUDT16;DICER1;RPP30;ZC3H12C;RNASEH1;LACTB2
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),-0.3732133640145783,-0.8791363124625696,0.6513157894736842,0.9416816479560384,1.0,3/13,10.69%,CYFIP2;ASPH;GRIN2A
prerank,negative regulation of neuron death (GO:1901215),0.297469277959136,0.8789184999458148,0.6560424966799469,0.8740712906169557,1.0,14/93,9.86%,MEF2C;CD200;PTK2B;TNFRSF1B;CD34;FOXQ1;TOX3;RASA1;CITED1;CHMP4B;CHMP4A;IKBKG;CSF1;BTBD10
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.36026457224871844,0.8784385121480592,0.6310517529215359,0.8745178180252863,1.0,6/30,10.42%,CAV1;SAMSN1;NF2;INPP5F;SFRP2;SEMA4D
prerank,regulation of mitochondrial fission (GO:0090140),-0.3253775316096582,-0.8782789446351658,0.6349614395886889,0.9426258309199653,1.0,5/24,7.58%,DCN;PRKN;SPIRE1;MCU;LRRK2
prerank,action potential (GO:0001508),0.3423815913739748,0.8780600597256085,0.6234756097560976,0.8747699978347838,1.0,5/44,7.06%,GNAQ;KCNQ1;KCNB1;KCNMB4;KCNE2
prerank,positive regulation of protein processing (GO:0010954),0.3821519066528528,0.8776988552349422,0.608,0.8749805893597006,1.0,4/19,9.08%,MYH9;LPCAT3;NKD2;RHBDD1
prerank,mRNA catabolic process (GO:0006402),0.3307452339785343,0.8776522212710927,0.6270430906389302,0.874578631065676,1.0,18/44,27.43%,ERN1;NANOS2;NUDT16;NBDY;RC3H1;DCP2;ZFP36;XRN2;PNPT1;DHX34;RNH1;RIDA;NBAS;LSM2;EXOSC4;HSPA1B;METTL16;TUT7
prerank,regulation of myoblast differentiation (GO:0045661),0.3589030942027976,0.8773888729733155,0.6188976377952756,0.874588589813015,1.0,5/32,7.32%,MEF2C;NOTCH1;PLCB1;DLL1;TGFB1
prerank,fibrinolysis (GO:0042730),-0.3741105868688595,-0.8772030826238228,0.6425233644859814,0.9438885857317119,1.0,4/13,27.27%,PLAT;SERPINE1;PLAU;HRG
prerank,ubiquinone metabolic process (GO:0006743),-0.3520006023690304,-0.8771862678455411,0.6053215077605322,0.9428518411226183,1.0,7/15,31.37%,COQ8B;COQ5;FDXR;AIFM2;COQ10A;COQ10B;COQ6
prerank,myoblast differentiation (GO:0045445),0.4062302840516624,0.8765674514928327,0.613126079447323,0.8756417530603054,1.0,3/14,5.65%,EPAS1;MBNL1;TCF7L2
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.34999396999485555,0.8762848024149603,0.6291079812206573,0.8757062645246478,1.0,4/31,10.90%,LYN;PLA2G2D;RC3H1;LST1
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.34267238582162063,0.8750104982103555,0.6349693251533742,0.8775838730263852,1.0,14/39,20.49%,PTPN12;DAB2IP;PTPRJ;TGFA;ARHGEF7;CBL;LGMN;ERBB2;SH3GL2;GRB2;STAM;BTC;TSG101;EPS15
prerank,regulation of protein kinase activity (GO:0045859),0.2989720260607202,0.8749699315830564,0.6768447837150128,0.8771711492901547,1.0,21/106,13.61%,GNAQ;IQGAP1;PTK2B;PPM1F;WWTR1;PAK2;CEACAM1;RAPGEF2;INPP5K;TRIB3;PTK2;RAP1A;CSF1;MAP2K3;GAS6;SFN;RB1;GSTP1;WARS1;TRIB1;GSKIP
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.4196077803699636,0.8745248650958527,0.6044776119402985,0.8775337712096808,1.0,3/12,9.45%,LYN;PTK2;CSF1
prerank,melanocyte differentiation (GO:0030318),-0.3879863514469118,-0.874489694169568,0.6059322033898306,0.9478901271327334,1.0,4/11,8.53%,ENPP1;MITF;KIT;USP13
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.31464660281964835,0.8743968170306965,0.6609929078014184,0.877314421720263,1.0,21/62,25.60%,MLLT3;CCNK;GTF2F2;NELFE;EAF1;ELOC;NELFCD;CTDP1;GTF2H4;CDC73;GTF2H1;NELFB;POLR2L;CCNH;NELFA;RTF1;POLR2J;ADRM1;IWS1;GTF2H5;PCID2
prerank,cGMP biosynthetic process (GO:0006182),0.4196224101824283,0.8742796860135973,0.6114081996434938,0.8770246836334947,1.0,1/10,2.54%,NPR1
prerank,regulation of primary metabolic process (GO:0080090),-0.233638485192974,-0.8737833267536511,0.8287292817679558,0.948405767178002,1.0,35/126,20.66%,CHD9;ROCK2;PPARA;PSAP;LDLR;PSME4;SREBF1;HMGCS1;ACACA;C1QTNF2;OAZ2;SMARCD3;APOE;TNFAIP8L3;FGFR4;ODC1;IRS2;PSMD12;GPAM;SCD;AZIN1;CERS2;FDFT1;MVK;FDPS;ABCA7;CARM1;PRKAB2;PSMC4;PSMB6;LSS;NCOR1;ZFP69;HDAC3;ID2
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.3711702694090565,0.8736110690294188,0.6288998357963875,0.8778004987524983,1.0,2/26,3.34%,PDE8A;FYN
prerank,sulfur compound biosynthetic process (GO:0044272),0.29343116773109024,0.8731615261716186,0.6733921815889029,0.8781226523192531,1.0,23/104,13.97%,ST3GAL6;CSGALNACT1;ST3GAL1;B3GNT3;MAT2A;B4GALT4;SLC35B3;SLC10A7;B3GNT4;SLC26A1;B4GALT5;GSTO2;GSTA4;B4GAT1;TPK1;SLC35D2;GGCT;GCLM;MPST;GSTP1;CSPG5;NCAN;OPLAH
prerank,regulation of defense response to virus by host (GO:0050691),0.3519610272033778,0.872881728009055,0.6298076923076923,0.878160085015147,1.0,8/30,18.36%,AIM2;DTX3L;CGAS;IL23A;EIF2AK4;STAT1;PARP9;ZDHHC1
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.336937690727419,0.8727779554832334,0.6332842415316642,0.8778416358928718,1.0,9/41,15.26%,PLA2G4A;ELOVL5;PTGS1;EPHX1;DEGS1;ABCD1;GSTP1;PNPLA8;FAAH
prerank,positive regulation of glucose import (GO:0046326),0.3801530267554298,0.8727722662178082,0.5964601769911504,0.8773699624269904,1.0,3/21,4.21%,OCLN;INSR;SORBS1
prerank,negative regulation of protein-containing complex assembly (GO:0031333),-0.26829149659743395,-0.872575089617635,0.6885245901639344,0.9499941423668506,1.0,12/49,15.83%,SMAD6;IMPACT;DACT1;PRKCZ;SRC;THRA;JAM3;TRAF3IP1;ANKRD27;PYDC1;PPM1A;LCMT1
prerank,body fluid secretion (GO:0007589),-0.3456511596964297,-0.872105171338256,0.639344262295082,0.9499595254439529,1.0,5/15,15.13%,ERBB4;SLC22A4;VEGFA;PRLR;SLC22A2
prerank,positive regulation of cellular protein localization (GO:1903829),0.311173545457705,0.8717092959408564,0.6613832853025937,0.8788433956200706,1.0,10/69,9.88%,STX3;FYN;WWTR1;CARD10;DTX3L;LIMK2;CCDC88A;TGFB1;CDT1;VPS28
prerank,positive regulation of catalytic activity (GO:0043085),0.34165521606833066,0.8715784378727188,0.6536144578313253,0.8786058355175715,1.0,20/37,29.64%,CAV1;MAPK8;PSEN1;APH1A;ABL2;CIB1;XRCC4;MSH2;ATP7A;PHACTR4;MAPK14;FXN;B3GAT3;SOD1;NOD2;MSH3;MID1IP1;PSEN2;BCAS3;MAPK3
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.3463163307970441,0.8710050882209119,0.647244094488189,0.879169727228872,1.0,7/35,10.48%,FASN;HMGCS2;ALOX5AP;PAM;LTC4S;FAR2;SLC25A1
prerank,regulation of lipid kinase activity (GO:0043550),0.43774546803947684,0.870372180367978,0.6178571428571429,0.8798989122491838,1.0,3/11,17.99%,PPP2R5A;RB1;RBL1
prerank,T cell differentiation (GO:0030217),0.33993927752140696,0.8703454654714659,0.6356821589205397,0.8794613738281599,1.0,7/40,10.70%,LFNG;SOX13;CHD7;DLL4;LCK;SOX4;JAG2
prerank,cellular zinc ion homeostasis (GO:0006882),0.368622133353111,0.8701771915186386,0.65,0.8792918987087339,1.0,2/26,7.19%,SLC39A8;LCK
prerank,ether lipid metabolic process (GO:0046485),-0.35298703661377306,-0.8699302590479603,0.6339285714285714,0.953718576679909,1.0,1/14,0.33%,AGMO
prerank,acetyl-CoA metabolic process (GO:0006084),0.4084740372355614,0.8696380583007683,0.6521739130434783,0.8797995433521905,1.0,2/15,3.00%,HMGCS2;ACACB
prerank,positive regulation of bone resorption (GO:0045780),0.4269103849940169,0.8693302448730449,0.614100185528757,0.8798801157623914,1.0,3/11,10.75%,TNFRSF11A;DCSTAMP;MC4R
prerank,male gonad development (GO:0008584),0.3512219852445362,0.8692069494795475,0.6289808917197452,0.8796503664346085,1.0,7/34,13.32%,KITLG;BIK;WNT5A;NCOA4;MAMLD1;ADAM21;SRD5A2
prerank,regulation of ERAD pathway (GO:1904292),0.4264905995414881,0.8689055700505152,0.6043956043956044,0.8797257645710989,1.0,4/11,19.16%,AQP11;ATXN3;UBXN1;USP25
prerank,mitochondrial transport (GO:0006839),-0.2663691993015499,-0.8685554801982238,0.7443365695792881,0.9556612446495432,1.0,18/53,25.19%,BCL2;HSP90AA1;TOMM40;TIMM22;SLC25A13;FLVCR1;MTX2;COX18;SLC25A4;TIMM17B;MAIP1;TSPO;TIMM8B;TMEM14A;TIMM9;PPIF;GDAP1;TIMM10
prerank,cholesterol efflux (GO:0033344),0.37374126125285145,0.8684926533120768,0.6339434276206323,0.8799898867919279,1.0,5/20,19.36%,SCARB1;SOAT2;ABCG1;STX12;ABCA1
prerank,polyamine metabolic process (GO:0006595),-0.3707195199387143,-0.8684103398987091,0.6377118644067796,0.9549072919926841,1.0,4/13,12.96%,OAZ2;SMS;ODC1;SAT1
prerank,mitochondrial translational elongation (GO:0070125),0.3009594286212156,0.8681871917292233,0.6864064602960969,0.8800805037310118,1.0,37/88,26.44%,MRPS18A;MRPL13;MRPS12;MRPL35;MRPL41;MRPL52;MRPL4;MRPS16;MRPL23;MRPS5;MRPL37;PTCD3;MRPL11;MRPL54;MRPS9;GADD45GIP1;MRPL43;MRPS26;MRPL12;MRPL44;MRPS30;AURKAIP1;MRPL1;MRPL50;MRPL17;MRPL39;MRPL14;MRPL32;MRPS11;MRPL9;MRPL46;DAP3;MRPL19;MRPL15;MRPL42;GFM1;MRPL24
prerank,synaptic vesicle membrane organization (GO:0048499),0.39026964048403634,0.8679572036813059,0.6230366492146597,0.8800500652988925,1.0,3/17,9.47%,STX3;STX1A;SNAP23
prerank,nuclear export (GO:0051168),-0.2529806006017159,-0.8675328190734243,0.7815126050420168,0.955735157454599,1.0,11/80,11.21%,RANBP3L;ATXN1;SRSF5;PKD1;DDX39B;SRSF2;STRADA;SRSF11;U2AF2;RAE1;POM121
prerank,lysosome organization (GO:0007040),-0.2932500627725711,-0.8675081320158312,0.6945244956772334,0.954716164663314,1.0,14/36,25.87%,ARSB;LRRK2;GAA;CLVS2;HPS4;HPS1;HOOK2;TPP1;CLN3;ACP3;SNAPIN;LAMTOR1;TMEM165;MTOR
prerank,development of primary male sexual characteristics (GO:0046546),0.3493970957008355,0.8672351826347048,0.6363636363636364,0.8808956874465261,1.0,7/34,13.32%,KITLG;BIK;WNT5A;NCOA4;MAMLD1;ADAM21;SRD5A2
prerank,regulation of ERBB signaling pathway (GO:1901184),0.4039778327718404,0.8669334818315629,0.6472663139329806,0.8809919618860113,1.0,6/15,14.30%,PTPN12;MVB12B;CEACAM1;LGMN;RHBDF2;ERBB2
prerank,copper ion transport (GO:0006825),0.4281912725680359,0.8660560608902311,0.6038394415357766,0.8821555038754144,1.0,2/11,10.24%,SLC31A1;ATP7B
prerank,high-density lipoprotein particle assembly (GO:0034380),-0.3888988198673126,-0.8656157291216191,0.6328293736501079,0.9578367600652523,1.0,3/10,16.70%,PRKACA;APOE;ABCA7
prerank,establishment of protein localization to mitochondrion (GO:0072655),-0.2757430560304639,-0.8654322967599367,0.6863354037267081,0.9571720972875993,1.0,15/46,27.50%,HK2;TOMM40;AIFM1;TIMM22;RALA;TIMM17B;GRPEL2;TSPO;TIMM8B;TIMM21;TIMM9;GDAP1;DNAJC15;TIMM10;PAM16
prerank,phosphate ion transport (GO:0006817),0.3935857857690347,0.8652179098918813,0.6267857142857143,0.883194226420718,1.0,4/16,12.60%,SLC37A3;SLC25A30;SLC37A1;XPR1
prerank,regulation of proteolysis (GO:0030162),-0.26930977337167783,-0.8649491154101956,0.7012578616352201,0.957214883627764,1.0,11/48,14.40%,CYFIP2;OGT;ASPH;SERPINE2;CAMK2N1;PLAT;BTRC;FGFR4;CST3;ITCH;LTBP4
prerank,DNA repair (GO:0006281),0.26312560177397887,0.8646131036922159,0.7612761276127613,0.8838470684359746,1.0,73/284,22.55%,TENT4A;POLK;USP3;BABAM2;DTX3L;HERC2;MAPK8;ASCC1;RNASEH2A;ATXN3;RPA1;ASCC3;WDR33;TRIP13;PRIMPOL;POLA1;SMARCA5;BRCC3;RAD51D;BRIP1;BACH1;BTG2;PARP2;RECQL;RAD18;RAD23A;MAD2L2;FAN1;HUS1;XRCC2;MC1R;MMS19;UNG;NOP53;ERCC4;NSMCE4A;NPM1;MPG;UBXN1;ENDOV;GTF2H4;ACTR5;CHEK2;PDS5A;WDR48;KDM4A;RAD21;PDS5B;RFC3;NSMCE1;CIB1;KMT5B;DCLRE1C;PARP9;CETN2;MGMT;NUDT1;CHD1L;PMS1;GTF2H1;XRCC4;FAAP100;MSH2;RAD17;RMI2;TRRAP;SETX;UBE2V2;BABAM1;MBD4;RFC5;NSD2;ERCC6
prerank,primary neural tube formation (GO:0014020),-0.29883713757338093,-0.8640113354199467,0.6569148936170213,0.9582415188518019,1.0,7/30,11.47%,LMO4;COBL;LRP6;TSC2;FUZ;MTHFD1;TGFB2
prerank,negative regulation of synaptic transmission (GO:0050805),-0.3213462207042709,-0.8637741621349598,0.683698296836983,0.9577240182440294,1.0,5/23,10.85%,ATAD1;SYT11;LRRK2;SLC24A2;PRRT1
prerank,regulation of axon guidance (GO:1902667),-0.38888296539124123,-0.8636442826992651,0.6299559471365639,0.956942812983348,1.0,3/10,9.30%,NRP1;ZSWIM8;VEGFA
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.37543393025165595,0.8636216473900478,0.6432160804020101,0.8851431511678642,1.0,4/23,7.33%,ENG;SMAD7;TGFB1;ITGA3
prerank,negative regulation of glycolytic process (GO:0045820),0.42967840381379085,0.8635527392053375,0.623400365630713,0.884306510259551,1.0,3/10,7.13%,CBFA2T3;FBP1;TIGAR
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.42967840381379085,0.8635527392053375,0.623400365630713,0.884306510259551,1.0,3/10,7.13%,CBFA2T3;FBP1;TIGAR
prerank,regulation of ion transport (GO:0043269),-0.254035507795241,-0.8634545512865751,0.7328519855595668,0.9563002382736305,1.0,26/76,22.98%,PRKN;SYT1;P2RX4;NKAIN4;ANK3;NKAIN2;SYT9;SYT12;SYT11;SNX6;KCNJ2;KCNJ13;WNK1;DTNBP1;KCNJ10;SNCA;KCNJ8;KCNJ15;SYT3;KCNJ6;NKAIN3;CLDN10;SYT2;SPTBN4;VAMP2;SYT6
prerank,epithelial cell development (GO:0002064),0.3756449053411199,0.8634496768272898,0.6483704974271012,0.8840166525267328,1.0,3/20,9.67%,EXPH5;SIPA1L3;SLC4A7
prerank,regulation of autophagy of mitochondrion (GO:1903146),-0.3331030135599733,-0.8631749012278377,0.6416464891041163,0.9558427653276643,1.0,8/19,23.68%,PRKN;SREBF1;VDAC1;HTT;HAX1;HTRA2;FZD5;DNM1L
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),-0.3884883754960273,-0.8630663484628633,0.6451612903225806,0.9550041083655298,1.0,2/10,2.47%,OSR1;HECW2
prerank,histone deacetylation (GO:0016575),0.32935652338583454,0.8626974554854335,0.6566523605150214,0.8849449390015406,1.0,7/43,12.75%,HDAC9;ELK4;RCOR1;RBM14;MIER1;SIRT6;MIDEAS
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.39068998899792173,0.8625899944813098,0.6380789022298456,0.8846721445266785,1.0,2/19,5.12%,CSGALNACT1;EXTL3
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.39793530614126915,0.8617658163606015,0.6274165202108963,0.8858075171934426,1.0,1/15,2.43%,GBP5
prerank,positive regulation of blood coagulation (GO:0030194),-0.3422298679081942,-0.8612952773086238,0.6563245823389021,0.9578446257894376,1.0,3/17,10.33%,F3;THBS1;SERPINE1
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.4206528562460764,0.8612602181094657,0.6457960644007156,0.8862176138820661,1.0,11/11,57.96%,PKD1L3;RTP3;RTP4;RTP2;TAS1R3;PIGR;GNAT2;GNAT3;TAS1R2;LPO;PKD2L1
prerank,peptidyl-lysine dimethylation (GO:0018027),-0.33140118815535174,-0.8611431523867983,0.6605504587155964,0.95709408116847,1.0,6/18,29.31%,EHMT2;KMT2D;SETMAR;SETD4;SETD7;SETD1A
prerank,cardiac muscle cell membrane repolarization (GO:0099622),0.4232750725321363,0.8609791792903692,0.6340996168582376,0.8863052631337965,1.0,2/11,5.71%,KCNQ1;ATP1A1
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.400791326223507,0.860674635547981,0.6171328671328671,0.8863871315454844,1.0,6/15,19.25%,DDIT4;ZFYVE27;SOS1;GRB2;BCAR1;FRS2
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.36594069050896144,0.860293100768248,0.6502463054187192,0.8866172366889349,1.0,2/22,6.09%,TNFRSF1B;WNT5A
prerank,aminoglycan metabolic process (GO:0006022),-0.39427069458949987,-0.8602116628945183,0.6545842217484008,0.9580141870080249,1.0,6/10,29.57%,XYLT1;B4GALT7;B3GAT2;CHST9;B3GALT6;GAL3ST3
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.39861939117017736,0.8600779366053617,0.6468468468468469,0.8865307233812632,1.0,2/14,3.04%,CD200;TNFRSF1B
prerank,proteolysis (GO:0006508),-0.20962869768244802,-0.8599966357734257,0.9134615384615384,0.9574477662529051,1.0,28/252,9.22%,TRABD2B;ADAMTS12;AEBP1;CPQ;ADGRV1;F3;DPP4;HTRA3;OGT;PCSK5;FAP;GGT5;MMP14;HTRA1;MMP16;NAALAD2;ADAM19;TASP1;CLPX;NPEPPS;ENPEP;CPXM2;ADAM33;PLAT;APH1B;MDM2;CPXM1;MMP2
prerank,regulation of macrophage differentiation (GO:0045649),-0.34404366103862566,-0.8599789850730847,0.639344262295082,0.9564285317990712,1.0,4/15,14.35%,IL34;PRKCA;INHBA;PTPN2
prerank,ribosomal large subunit biogenesis (GO:0042273),0.31466340842615276,0.8593961280417722,0.6598240469208211,0.8873270493543195,1.0,18/54,22.88%,RPF1;RSL24D1;RRS1;RPL14;EIF6;NOP53;RPL6;RPL10;NOP16;NPM1;RPL35A;MAK16;RPL11;RPL3;TRAF7;RPL7;RPL26;MRPL1
prerank,positive regulation of immune effector process (GO:0002699),0.35124316698157665,0.8592075721749906,0.6572379367720466,0.887201664803125,1.0,4/27,9.60%,PTPRJ;RPS19;XBP1;IL23A
prerank,regulation of protein localization to cell surface (GO:2000008),0.3493013366835403,0.8591805672978529,0.6373626373626373,0.8867815391963113,1.0,6/33,12.95%,STX3;NEDD4L;RAB11FIP5;PICALM;RAB11B;HSP90AB1
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),-0.3596502675383553,-0.8587827115487241,0.6617647058823529,0.9580246405124307,1.0,5/14,16.58%,PRKN;SELENOS;LRRK2;CREB3;CREB3L1
prerank,positive regulation of cell cycle (GO:0045787),0.31054943058255147,0.8585673401445199,0.6497890295358649,0.8873809084728224,1.0,13/62,11.79%,APP;PDGFB;TAL1;PKN2;EIF4E;CDKN1B;CCNYL1;PKD2;CCNY;NUDT16;RAD23A;EIF4EBP1;LGMN
prerank,cellular amide metabolic process (GO:0043603),0.29018047275891345,0.8583529272891515,0.7208121827411168,0.88727325779351,1.0,8/102,5.80%,ST6GAL1;ST3GAL1;PLPP1;CPD;CPE;GLYAT;ASAH2;MTHFD1L
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),-0.3708154182576351,-0.8583195131962412,0.6659619450317125,0.9579849604568924,1.0,7/12,35.73%,CDC14B;BTRC;PTEN;GORASP1;GOLGA2;UBE2C;UBE2S
prerank,activation of protein kinase activity (GO:0032147),0.28883589506323154,0.85781540958805,0.7001287001287001,0.8877794336961218,1.0,18/106,9.48%,ADCY4;INSR;PDGFB;PTK2B;TAOK2;STK3;PRKAR2B;PAK2;CARD10;TIRAP;STK4;GHR;CCDC88A;WNT5A;TNIK;MALT1;ANG;RICTOR
prerank,NLS-bearing protein import into nucleus (GO:0006607),-0.3619186883321302,-0.8577530859186812,0.6471861471861472,0.9581504362877626,1.0,3/13,16.48%,CBLB;RGPD1;KPNA2
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.4280056506941897,0.8576989971623088,0.6290322580645161,0.8875121149805384,1.0,3/10,10.66%,LYN;RAPGEF2;GAS6
prerank,regulation of protein targeting to membrane (GO:0090313),0.35534195737490387,0.8576373514180042,0.6287051482059283,0.88715629335161,1.0,9/28,17.65%,FYN;KCNB1;INPP5K;AKT2;MYO1C;TCAF2;ERBB2;CHP1;CIB1
prerank,cellular response to oxidative stress (GO:0034599),0.2863182878403553,0.8575980831897663,0.7192546583850932,0.8867533741181031,1.0,11/118,6.02%,FOXO1;PRKD1;DAPK1;HIF1A;PXN;CAT;PTPRK;MAPK8;GSR;CYCS;PRR5L
prerank,positive regulation of cellular respiration (GO:1901857),-0.3719416865375773,-0.8571941903182269,0.6258205689277899,0.9583236185795467,1.0,1/11,1.98%,NUPR1
prerank,sterol biosynthetic process (GO:0016126),-0.2944261811184895,-0.8571295275032708,0.6878453038674033,0.9573886758872364,1.0,13/33,22.49%,INSIG2;PRKAG2;HMGCS1;NSDHL;ACAT2;INSIG1;FDFT1;MVK;FDPS;LSS;DHCR24;CYP51A1;DHCR7
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.36904011633003764,0.8570708339916504,0.6688417618270799,0.8872717349599708,1.0,3/24,5.15%,PTK2B;NOTCH1;GHR
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.3636728702376202,-0.8567548122385852,0.6666666666666666,0.9570991692573568,1.0,6/13,23.44%,CDH13;LDLR;CD81;SYK;ITGB2;PPARG
prerank,intracellular sterol transport (GO:0032366),0.3964312775140441,0.8563020310376389,0.6506024096385542,0.8882372933446968,1.0,9/13,30.69%,ABCG1;STAR;OSBPL2;ABCA1;STARD4;NPC1;RELCH;NPC2;OSBP
prerank,protein stabilization (GO:0050821),0.2722139809004258,0.8562390343403746,0.7523474178403756,0.887888054072376,1.0,50/168,22.13%,GNAQ;TSPAN1;HIP1;HIP1R;EFNA1;FBXW7;SOX17;STK3;STK4;SMAD7;RPS7;ATF7IP;TMEM88;ATP1B3;CREB1;RPL23;SOX4;AFM;EPHA4;GLMP;FKBPL;COA8;NOP53;HSP90AB1;NAA16;STX12;BAG4;IRGM;CHP1;CHEK2;RPL11;BAG1;USP7;CDC37;COG7;MTMR9;ZBED3;SWSAP1;NLK;CCT7;TAF9;PPIB;CCT2;BAG2;CCNH;SEL1L;PRKRA;CDC37L1;MFSD1;TNIP2
prerank,insulin secretion (GO:0030073),0.3762637728186231,0.8562071451855757,0.6536412078152753,0.8874754543998618,1.0,4/19,12.21%,RAB11FIP5;SNX19;NEUROD1;RAB11B
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),0.41628441985273057,0.8562014817448583,0.628731343283582,0.8870086158503583,1.0,2/11,4.20%,SCARB1;PLIN5
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.3789834915583085,0.8561886225499553,0.642512077294686,0.8865535461253827,1.0,7/21,13.14%,CNOT6;PAN3;CNOT6L;CNOT1;CNOT2;ZFP36;CNOT7
prerank,amyloid precursor protein metabolic process (GO:0042982),0.3831944608167067,0.8557736088870789,0.6356073211314476,0.8868738188015782,1.0,5/18,13.76%,ADAM10;PSEN1;APH1A;ADAM17;ABCG1
prerank,sarcomere organization (GO:0045214),-0.3069315136048227,-0.8557619031392698,0.6925064599483204,0.9581941884197914,1.0,10/27,34.53%,ACTN2;TPM1;FHOD3;MYOM2;KRT19;TNNT3;MYPN;MYLK3;TCAP;OBSCN
prerank,activin receptor signaling pathway (GO:0032924),-0.34345927221045336,-0.8557153386039071,0.6599099099099099,0.9572433894240211,1.0,4/15,12.06%,TGFBR1;SMAD3;INHBA;ACVR1B
prerank,purine-containing compound catabolic process (GO:0072523),0.4021582886366205,0.8554215899073281,0.6328413284132841,0.887019274420955,1.0,4/13,14.45%,GDA;NT5C2;XDH;NUDT15
prerank,cellular response to gamma radiation (GO:0071480),-0.3429978031071297,-0.8552429927996199,0.665158371040724,0.9571958427239374,1.0,8/17,23.98%,MDM2;XRCC5;XRCC6;ATR;TSPYL5;TP53;CRYAB;ATM
prerank,cell differentiation in spinal cord (GO:0021515),0.4200024729821408,0.8550561180716212,0.6431159420289855,0.887198888031046,1.0,2/10,9.32%,SOX13;SOX4
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.42649402113634216,0.8549180106172531,0.6410748560460653,0.8869886925361338,1.0,2/10,2.90%,PTPN12;PTPRJ
prerank,regulation of axon extension (GO:0030516),0.3327249697690514,0.8548778829811242,0.6828528072837633,0.8865904793968427,1.0,3/37,4.06%,NTN1;SEMA7A;DIP2B
prerank,negative regulation of interferon-beta production (GO:0032688),-0.3874167327212209,-0.8546731308792939,0.6457399103139013,0.9573488838278028,1.0,5/10,20.98%,PTPRS;SIRPA;PPM1B;CACTIN;PYCARD
prerank,negative regulation of stem cell differentiation (GO:2000737),0.40941230881331336,0.8544939721941328,0.6333938294010889,0.8868486606353971,1.0,5/12,20.18%,NOTCH1;TCF15;ESRRB;HES1;NELFB
prerank,transition metal ion transport (GO:0000041),0.33339897131907364,0.8542937657868364,0.6610942249240122,0.8867372193432308,1.0,4/35,10.24%,SLC39A8;SLC31A1;ATP2C1;ATP7B
prerank,establishment of protein localization to plasma membrane (GO:0061951),-0.2939337449002509,-0.8540818445290075,0.6913946587537092,0.9576097310943645,1.0,13/36,16.51%,VAMP5;ANK3;AFDN;OPTN;GGA2;RAB10;GGA1;SYS1;BBS2;ARFRP1;MACF1;GOLPH3L;GOLGA4
prerank,nucleotide-excision repair (GO:0006289),0.2903167355362698,0.8536586371040427,0.7242268041237113,0.8873922473847815,1.0,29/101,24.50%,POLK;ATXN3;RPA1;POLA1;BRIP1;COPS2;RAD23A;FAN1;HUS1;COPS4;MMS19;ERCC4;AQR;GTF2H4;RFC3;USP7;CETN2;CHD1L;GTF2H1;POLR2L;CCNH;RNF111;POLR2J;RFC5;ERCC6;CUL4B;COPS8;LIG4;POLL
prerank,negative regulation of lyase activity (GO:0051350),-0.3454823615696707,-0.8535054912377598,0.6715328467153284,0.9577299757729127,1.0,6/16,24.83%,ADGRV1;GRM3;PALM;GABBR2;CCR2;MTRR
prerank,regulation of T cell differentiation in thymus (GO:0033081),-0.363712374800581,-0.8529946710381985,0.6595238095238095,0.9577250667061401,1.0,2/13,2.95%,GLI2;BMP4
prerank,catecholamine biosynthetic process (GO:0042423),0.4158966232335797,0.8529808830457959,0.64349376114082,0.8881570383043037,1.0,1/11,1.55%,GCH1
prerank,regulation of calcium ion import (GO:0090279),0.3788507853333853,0.8524693243017154,0.6581632653061225,0.8886099809137876,1.0,3/21,8.08%,PDGFB;FYN;PKD2
prerank,regulation of mitotic nuclear division (GO:0007088),0.3188641094830371,0.8516000513062547,0.6739130434782609,0.8897429881450529,1.0,7/55,7.47%,INSR;PDGFB;EDN1;LRP5;CAV2;AURKA;TGFA
prerank,manganese ion transport (GO:0006828),-0.35679835336646204,-0.851444972964352,0.6682926829268293,0.9600765162322061,1.0,7/14,13.02%,SLC30A10;SLC39A14;TRPC3;TRPC6;TRPC1;TRPC4;TRPC5
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.4115099265067752,0.8512589890525423,0.6132075471698113,0.8898620690749208,1.0,2/10,10.78%,BTN2A2;RC3H1
prerank,tube closure (GO:0060606),-0.2953233204967867,-0.8508035781514925,0.6914600550964187,0.9603870768613271,1.0,7/31,11.47%,LMO4;COBL;LRP6;TSC2;FUZ;MTHFD1;TGFB2
prerank,positive regulation of embryonic development (GO:0040019),-0.3333079234359473,-0.8502753433003575,0.6691729323308271,0.9604768764540813,1.0,2/19,2.02%,WNT4;OSR1
prerank,regulation of ion transmembrane transport (GO:0034765),0.34145469564594466,0.8502559067092972,0.660655737704918,0.8911996687037903,1.0,5/33,10.57%,NEDD4L;KCNQ1;KCNE2;NEDD4;ANO6
prerank,GTP metabolic process (GO:0046039),-0.35285341271802906,-0.8500972388365308,0.6699029126213593,0.9597816110059328,1.0,4/15,17.09%,RHOQ;LRRK2;RAB23;ENTPD7
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),-0.3846614290294445,-0.8489427110701022,0.6601307189542484,0.9611169566389925,1.0,4/10,19.63%,OGT;SELENOS;DGKQ;PDK2
prerank,pore complex assembly (GO:0046931),0.36742629771153607,0.8485834697653452,0.64,0.8937722970904532,1.0,6/19,15.34%,ADAM10;ANO6;NUP98;NUP205;NUP153;TSPAN33
prerank,liver development (GO:0001889),0.3322661568747049,0.8484370577709939,0.646774193548387,0.8935486575721038,1.0,5/32,8.08%,LSR;ZIC3;XBP1;AURKA;PKD2
prerank,skin development (GO:0043588),0.3049692085194895,0.8483729554809639,0.7012278308321964,0.8931855974430537,1.0,8/65,7.33%,ITGA6;UGCG;LSR;BCR;DLL1;WNT5A;ASCL4;ITGA3
prerank,monosaccharide transmembrane transport (GO:0015749),-0.3381193146488793,-0.8479906900468663,0.6674259681093394,0.9620702231372155,1.0,4/16,14.18%,SLC5A3;SLC2A12;SLC2A10;SLC45A3
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.3540687736686265,0.8477311808329308,0.6764705882352942,0.8939066539185296,1.0,5/28,11.99%,DAB2IP;CASP8;TNFRSF1A;CRADD;BID
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.36962830633465515,0.8468800156063829,0.6426174496644296,0.8950041800219968,1.0,4/21,8.95%,LIMCH1;PEAK1;PTK2;SLK
prerank,modulation by host of viral genome replication (GO:0044827),-0.3569152070560131,-0.8466185786928657,0.6578366445916115,0.9639375824407167,1.0,4/13,13.22%,PRKN;IFI27;NUCKS1;TBC1D20
prerank,ubiquinone biosynthetic process (GO:0006744),-0.3411299815772374,-0.8461656192907645,0.6337719298245614,0.9638536735214749,1.0,7/15,31.37%,COQ8B;COQ5;FDXR;COQ10A;NDUFA9;COQ10B;COQ6
prerank,negative regulation of macroautophagy (GO:0016242),0.3530528584641809,0.8455077300292092,0.6808510638297872,0.8969260027878371,1.0,6/26,9.19%,LZTS1;MTM1;QSOX1;FEZ2;CHMP4B;CHMP4A
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),0.38857641612985466,0.8454815818191354,0.6415410385259631,0.8964939132333012,1.0,4/16,8.04%,ESR1;DDX54;NCOA4;ARID1A
prerank,synaptic vesicle cycle (GO:0099504),-0.2948978350140191,-0.8453874553223044,0.7381546134663342,0.9644684417614094,1.0,4/30,6.02%,BRSK1;SNAP25;PCLO;NLGN1
prerank,negative regulation of interleukin-17 production (GO:0032700),0.4293467661203921,0.8451784246528161,0.6596958174904943,0.8965720765231542,1.0,2/10,15.66%,VSIR;DDIT3
prerank,cellular response to acid chemical (GO:0071229),0.35083646981220473,0.8449587294007654,0.6447574334898278,0.8965076014232847,1.0,5/27,10.32%,SH3BP4;KLF2;XBP1;RPTOR;LARS1
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.40412649429498515,0.8449550859764154,0.6355311355311355,0.8960391298620276,1.0,2/11,7.26%,LYN;JAK1
prerank,alcohol catabolic process (GO:0046164),-0.3820867411406401,-0.844914666620442,0.6591928251121076,0.9643801863225079,1.0,3/10,16.20%,CYP27A1;APOE;MT3
prerank,regulation of histone H3-K9 acetylation (GO:2000615),-0.37302851833989437,-0.8448428905555879,0.6413502109704642,0.9634717351128648,1.0,4/10,23.36%,CAMK1;SMARCB1;CHEK1;SPHK2
prerank,cortical cytoskeleton organization (GO:0030865),0.32840355186799103,0.8447874970851664,0.6744186046511628,0.895869313956283,1.0,9/41,8.81%,LCP1;FMNL3;IKBKB;NCKAP1;RAC1;FMNL2;TRPV4;RHOBTB1;LLGL1
prerank,protein targeting (GO:0006605),0.2826440942377496,0.8447866774778153,0.7546468401486989,0.8953955596918958,1.0,25/118,18.98%,RASSF9;PARD3;AQP11;TAOK2;SDCBP;SEC63;ZDHHC18;ZDHHC9;ZFAND2B;MYO1C;ICMT;HOMER3;PITRM1;SPCS1;GIPC1;AP1S3;VPS37C;RPL11;ZDHHC24;TRAK2;ZDHHC1;CDC37;TOMM22;NACA;ZFAND2A
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.3173183635406109,0.8446854127183535,0.7031700288184438,0.8951073478256081,1.0,12/48,16.24%,HIF1A;TIGAR;EIF6;NUP214;NUP98;SLC2A6;NUP133;NUP205;NUP54;NUP43;NUP153;PNPT1
prerank,positive regulation of macrophage activation (GO:0043032),-0.3303040986556801,-0.8446202637350011,0.6847058823529412,0.9628827920044221,1.0,2/17,3.57%,LBP;THBS1
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.255434928494374,-0.844498740880454,0.7285714285714285,0.962083325237674,1.0,9/56,9.52%,EGFR;ANXA1;CCND2;ANAPC5;RAD51B;ADAMTS1;UBE2E2;TFDP1;RGCC
prerank,monoacylglycerol metabolic process (GO:0046462),0.3917762514491283,0.8444855985541032,0.6442477876106195,0.8949904996389666,1.0,4/13,15.78%,PLA2G4A;DGAT1;FAAH;MOGAT2
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.3164651852250165,0.8440587877616558,0.7051094890510949,0.895266781181793,1.0,11/51,14.62%,VEGFC;IL6R;F7;VEGFD;PTK2;CSF1;ANO6;GAS6;LGMN;ADAM17;PGF
prerank,bile acid biosynthetic process (GO:0006699),-0.30946681459650316,-0.8438747428424906,0.6852300242130751,0.9623867167884822,1.0,5/24,15.07%,CYP7B1;CYP27A1;OSBPL3;OSBPL6;SCP2
prerank,cellular response to amino acid stimulus (GO:0071230),0.340120092440187,0.843754109016376,0.6788432267884322,0.8953386044484538,1.0,6/33,10.32%,SH3BP4;FYN;XBP1;RPTOR;UBR1;LARS1
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.4039029149320549,0.8434936069478769,0.6511194029850746,0.8953349388422615,1.0,6/13,24.87%,DDX20;AAR2;SRSF10;SART3;PRPF3;LSM2
prerank,Golgi to plasma membrane protein transport (GO:0043001),-0.3010102784417924,-0.8434734713948471,0.6896551724137931,0.9621714276521236,1.0,13/30,18.28%,VAMP5;ANK3;OPTN;GGA2;RAB10;GGA1;SYS1;BBS2;ARFRP1;MACF1;GOLPH3L;GOLGA4;SEC16A
prerank,regulation of phosphate metabolic process (GO:0019220),0.3853596888825955,0.8433901827052069,0.6437389770723104,0.8950458559363115,1.0,4/16,9.82%,IKBKB;TIGAR;PSEN1;SMG7
prerank,phospholipid metabolic process (GO:0006644),0.2988406917594342,0.8433699810177739,0.7040540540540541,0.8946091799799859,1.0,8/71,8.49%,PLA2G4A;PLPP1;ENPP2;PLA2G2D;AGPAT1;MBOAT1;LPL;PLAAT3
prerank,mRNA destabilization (GO:0061157),-0.2762496681074728,-0.8433638403361644,0.7478753541076487,0.9613782540627441,1.0,12/38,26.49%,ROCK2;CPEB3;MOV10;CELF1;FTO;RC3H2;TUT4;PDE12;RBM24;TARDBP;ZFP36L2;POLR2D
prerank,receptor recycling (GO:0001881),0.42241976467969206,0.8432860065141852,0.6438356164383562,0.8943058356432249,1.0,3/10,12.21%,LMTK2;EHD3;RAB11B
prerank,regulation of DNA replication (GO:0006275),-0.26466168016133773,-0.8430765855570801,0.7897897897897898,0.9609340103740966,1.0,6/49,8.83%,EGFR;GLI2;EHMT2;NUCKS1;GLI1;ZBTB38
prerank,negative regulation of intracellular protein transport (GO:0090317),-0.3083724455647941,-0.8428025258516635,0.691747572815534,0.9604838623826465,1.0,5/22,13.56%,APOD;LRRK2;SUFU;RAB23;INSIG1
prerank,neutral amino acid transport (GO:0015804),0.342554075593273,0.8424140826378483,0.6729857819905213,0.8953551754716786,1.0,7/28,15.19%,SLC38A5;SLC3A2;SLC6A6;SLC43A2;SLC38A1;SLC36A4;SLC7A5
prerank,regulation of Golgi organization (GO:1903358),-0.3341568012619312,-0.8419555574479979,0.6651884700665188,0.9611083738803835,1.0,7/17,24.72%,MYO5A;MAP2K2;RBSN;MAP2K1;PDE4DIP;RAB33B;CAMSAP3
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.32874804397397944,0.841612725233325,0.6661631419939577,0.8963304087529684,1.0,8/39,20.05%,POLK;RPA1;FAN1;ERCC4;GTF2H4;RFC3;CHD1L;GTF2H1
prerank,regulation of axon regeneration (GO:0048679),-0.3603793641244213,-0.8414463316959387,0.6689814814814815,0.9611097260929653,1.0,2/12,2.38%,PTN;PTPRS
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),-0.3569960159628413,-0.8412290621553595,0.672289156626506,0.9605270336257581,1.0,3/13,13.01%,APOD;SUFU;RAB23
prerank,synaptic vesicle recycling (GO:0036465),-0.28961725493718027,-0.8411982799983314,0.7066326530612245,0.9595602200502653,1.0,12/31,23.15%,NLGN2;SYT1;SYNJ2;NLGN1;STON2;NLGN3;AMPH;SNCA;TBC1D24;SYT2;VAMP2;CANX
prerank,peptidyl-proline modification (GO:0018208),-0.3006979141822131,-0.841168197497627,0.7026315789473684,0.9585935231724959,1.0,5/25,14.45%,FKBP5;NKTR;FKBP10;PPIC;PPIH
prerank,apoptotic cell clearance (GO:0043277),0.3471850865973402,0.8408067141296736,0.6682242990654206,0.8973112496594523,1.0,6/30,11.76%,TGM2;SCARB1;RAC1;RHOBTB1;GAS6;ITGB3
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.27062892624145696,-0.8406579179691742,0.7574850299401198,0.9586199447765396,1.0,6/43,9.46%,EGFR;ERRFI1;CBLB;ITGA1;SNX6;MVP
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.33419095647185587,0.8405085760554518,0.6734104046242775,0.8973734096225326,1.0,11/40,11.51%,B2M;INSR;HIP1;SELE;GREM1;ARRB1;HNRNPK;SCYL2;CBL;TBC1D5;PICK1
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.2937312149817038,0.8400501704603623,0.7435233160621761,0.89772318918318,1.0,13/85,12.59%,SMURF1;CELSR1;FZD6;FZD4;AP2B1;WNT5A;RAC1;AP2A1;PSMA2;PSMA8;PSMA6;PRICKLE1;VANGL2
prerank,regulation of RNA splicing (GO:0043484),0.2952110046503221,0.8399523964470906,0.7076271186440678,0.8974324109336532,1.0,13/69,10.70%,ERN1;TMBIM6;RBM20;MBNL1;PTBP3;MBNL2;HNRNPF;DYRK1A;MBNL3;HNRNPK;ZNF326;HNRNPLL;YTHDC1
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),-0.2954709584149812,-0.8398460159259411,0.7275132275132276,0.9591899339932611,1.0,13/31,22.98%,SYT1;CACNA1G;SYT9;SYT12;SYT11;ADRA2A;SCAMP5;SYT3;CBARP;REST;SYT2;RAB3GAP1;SYT6
prerank,glutamate metabolic process (GO:0006536),0.36999815757362325,0.8395763026046422,0.6621621621621622,0.8976218288323133,1.0,3/19,3.41%,DGLUCY;GLS2;GLS
prerank,signal peptide processing (GO:0006465),-0.3689600710519946,-0.8395175738961501,0.6521739130434783,0.9588290238908795,1.0,3/11,14.13%,PCSK5;SPCS3;SPCS2
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.2802137980427274,-0.8383917838191457,0.7356020942408377,0.9600467919383018,1.0,8/32,14.82%,CEMIP;AKAP6;TRPC1;GSTM2;GPER1;HTT;JPH2;SNCA
prerank,regulation of urine volume (GO:0035809),0.4214883199636483,0.8382026476477012,0.6436567164179104,0.8996265107028871,1.0,3/10,13.31%,NPR1;INPP5K;HAS2
prerank,P-body assembly (GO:0033962),0.4053493137984333,0.8379979834801005,0.6678765880217786,0.8995104166828163,1.0,7/12,27.51%,EDC3;RC3H1;LSM3;LSM14A;EIF4ENIF1;DDX6;PATL2
prerank,positive regulation of biosynthetic process (GO:0009891),0.326196550902655,0.837830963817871,0.6820276497695853,0.8993245013211559,1.0,7/40,13.02%,RAB27A;PLCG2;SORBS1;TGFB1;CREB1;GRIN1;MTPN
prerank,negative regulation of response to external stimulus (GO:0032102),0.285431983196649,0.837665939220605,0.7445721583652618,0.8991426337411909,1.0,17/105,14.28%,TEK;PPARD;MFHAS1;LPCAT3;SIGIRR;TNFRSF1A;CRK;INPP5F;NMI;EPHA4;RB1;CARD16;TRIB1;CDH5;KLK8;ILRUN;PROC
prerank,membrane lipid catabolic process (GO:0046466),-0.39095341914892273,-0.8374088048622741,0.6681318681318681,0.9610622767354225,1.0,6/10,27.31%,CYP1B1;PDXDC1;PPT1;SMPD2;NAGA;SGPL1
prerank,non-motile cilium assembly (GO:1905515),-0.29133393524232787,-0.8364651655130833,0.7008547008547008,0.9619032366929611,1.0,9/30,19.62%,IFT88;RPGRIP1L;TTC8;CEP89;FUZ;PCM1;C2CD3;TMEM17;IFT57
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.32617928189190265,0.8364349889355658,0.6869158878504673,0.9008655954068657,1.0,6/40,11.99%,TNFSF10;BIK;BCL2L11;BCL2L1;BNIP3;BID
prerank,protein maturation (GO:0051604),-0.2307349332204564,-0.8363265625921552,0.8385826771653543,0.9611772613713924,1.0,28/95,22.67%,AEBP1;F3;OGT;PCSK5;MMP14;NNAT;MMP16;ADAM19;NAA40;TASP1;CPXM2;APH1B;CPXM1;DNAJB11;CCS;TSPAN15;PCSK6;NCSTN;LMF1;CPM;CIAO1;NFU1;BACE1;PTCH1;CTSS;NAA60;EEF1AKMT4-ECE2;CLN3
prerank,regulation of establishment of protein localization (GO:0070201),0.3942663291298404,0.8358654911212842,0.655536028119508,0.9013874928659319,1.0,5/14,16.91%,DNAJA1;GAPVD1;CEP290;CEP295;SPIDR
prerank,establishment of apical/basal cell polarity (GO:0035089),0.38755535070400177,0.8358378608420344,0.6598513011152416,0.900964115833694,1.0,3/14,10.67%,MSN;OPHN1;FSCN1
prerank,regulation of Ras protein signal transduction (GO:0046578),0.2867579177879635,0.8353923821212649,0.726552179656539,0.9012898680388882,1.0,12/86,8.48%,EPS8;DAB2IP;ARHGEF2;LYN;BCR;NOTCH1;DENND4C;ARHGAP17;OPHN1;FBP1;SYNGAP1;SHOC2
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.401366777400493,0.8351377660802873,0.6629834254143646,0.901266111890267,1.0,4/12,14.99%,LPCAT3;SOAT2;APOC4;DGAT1
prerank,positive regulation of protein dephosphorylation (GO:0035307),-0.287330889908814,-0.83454772218189,0.7361111111111112,0.9638136591590645,1.0,4/32,4.64%,MAGI2;PDGFRB;PRKCD;ITGA1
prerank,regulation of multicellular organismal development (GO:2000026),0.35619424835083946,0.8335933351747542,0.6633663366336634,0.9035157273987486,1.0,2/25,3.28%,INSR;SOX17
prerank,histone modification (GO:0016570),0.2798737184420248,0.8332304141392343,0.7525380710659898,0.9036981428713693,1.0,16/109,12.99%,RPS6KA5;HDAC9;USP3;PADI4;PHF20;RCOR1;RBM14;KAT6B;AURKC;CDK2;PARP2;PHF20L1;ENY2;MIER1;MIDEAS;PADI1
prerank,negative regulation of insulin secretion (GO:0046676),0.3746159503550133,0.8331136837956105,0.6455696202531646,0.9034451387793891,1.0,3/17,4.04%,PIM3;KLF7;KCNB1
prerank,negative regulation of adenylate cyclase activity (GO:0007194),-0.357443276676907,-0.8328249447816908,0.6905311778290993,0.9663749763895673,1.0,3/13,13.84%,ADGRV1;GRM3;PALM
prerank,ERAD pathway (GO:0036503),-0.23601580831765978,-0.8327914853918996,0.8188405797101449,0.9654276871187055,1.0,19/83,20.59%,PRKN;UGGT2;SELENOS;RCN3;AMFR;USP13;UBXN4;JKAMP;UBE4B;NPLOC4;GET4;UBE2G2;UBE4A;RNF121;USP19;DNAJC18;FAM8A1;DNAJB2;TMEM67
prerank,epiboly involved in wound healing (GO:0090505),0.3785621548219985,0.8327633083921896,0.6530612244897959,0.9035901462944672,1.0,3/16,5.11%,LCP1;MRTFA;CEACAM1
prerank,purine ribonucleotide metabolic process (GO:0009150),-0.24259843184301,-0.8321836343352813,0.8192307692307692,0.9656440796028035,1.0,7/68,7.99%,AMPD3;RHOQ;ENPP1;ACOT11;TPST1;LRRK2;ABHD14B
prerank,negative regulation of cyclase activity (GO:0031280),-0.3508909759832599,-0.832160431475163,0.6919431279620853,0.9646745417035276,1.0,3/14,13.84%,ADGRV1;GRM3;PALM
prerank,negative regulation of lipid metabolic process (GO:0045833),0.3484279229944738,0.8319767954245025,0.6655518394648829,0.9045010627160021,1.0,2/22,5.11%,PPP2R5A;CEACAM1
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.33801498654413853,-0.8318562256301437,0.6577017114914425,0.964239563703613,1.0,7/15,25.89%,RYR2;SPCS3;RAB10;SPCS2;RAB3GAP1;SEC61A1;SRPRB
prerank,regulation of autophagosome assembly (GO:2000785),0.3316108084888212,0.8317335188105727,0.6872037914691943,0.9044483445520448,1.0,8/33,9.75%,MTM1;RALB;TBC1D12;SH3GLB1;FEZ2;CHMP4B;CHMP4A;NPRL2
prerank,RNA 3'-end processing (GO:0031123),0.29349134055442033,0.8315453359787576,0.7219917012448133,0.9043092541380954,1.0,26/69,27.56%,TENT4A;WDR33;THOC2;RNPS1;THOC6;RPRD1B;MTPAP;RPRD2;PNPT1;ALYREF;CDC40;THOC3;THOC1;CPSF1;RPRD1A;THOC5;THOC7;SRSF4;TENT4B;SLU7;CPSF2;PCF11;CPSF3;TUT1;TUT7;PAPOLA
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.2850210612595182,0.8308405869629867,0.7447368421052631,0.9050811481607969,1.0,18/88,16.91%,DAB2IP;TAL1;FNIP2;BIK;TIRAP;SDCBP;SH3GLB1;BCL2L11;TGFB1;CDT1;BID;RACK1;WARS1;RAB7A;CDH5;BMF;PIH1D1;SPIDR
prerank,chemical synaptic transmission (GO:0007268),0.25459489427898696,0.8308375177114794,0.8272827282728272,0.9046140103939985,1.0,19/284,6.78%,MPZ;UNC13B;SLC6A5;SLC6A2;SLC12A7;HTR2A;PDE7B;CACNA1E;PRKAR2B;PCDHB4;SYPL1;RPS6KA3;SDCBP;RPS6KA1;SYN3;KCNMB4;CACNA1A;HCRTR1;ATXN3
prerank,regulation of multicellular organism growth (GO:0040014),0.39090284913016243,0.8308127127868622,0.6948853615520282,0.9041915964822066,1.0,2/15,5.15%,APP;GHR
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.39917949164427063,0.8307594076237481,0.6702898550724637,0.9038072863105471,1.0,4/13,13.42%,PLCG1;AKT3;SIRT6;ADAM17
prerank,synaptonemal complex assembly (GO:0007130),0.3852544875300011,0.8304162206225215,0.6467391304347826,0.9034297548181529,1.0,3/15,16.98%,RAD21L1;TRIP13;RAD21
prerank,synaptonemal complex organization (GO:0070193),0.3852544875300011,0.8304162206225215,0.6467391304347826,0.9034297548181529,1.0,3/15,16.98%,RAD21L1;TRIP13;RAD21
prerank,regulation of cell death (GO:0010941),0.2815410884762913,0.8301687822655773,0.7433155080213903,0.903389801142338,1.0,6/94,3.44%,ACER2;PDE8A;PRKD1;SRGAP2;TNFRSF1B;NCK1
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.3957738621043435,0.8301447859705658,0.6519524617996605,0.902963668476181,1.0,3/13,10.66%,AQP11;LPCAT3;MBTPS2
prerank,positive regulation of tissue remodeling (GO:0034105),0.4135071232847785,0.8298973587522347,0.6654611211573237,0.9028962302185666,1.0,2/10,9.60%,IL15;IL23A
prerank,zinc ion transport (GO:0006829),0.3621699586106257,0.8296197508214994,0.6617886178861788,0.902926269225068,1.0,1/21,0.92%,SLC39A8
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.40139823086380316,0.8295458256117577,0.6654343807763401,0.902593499725187,1.0,1/12,0.70%,UNC13B
prerank,nuclear pore organization (GO:0006999),0.38425239776567366,0.8292016621944561,0.6754850088183422,0.9027226017578813,1.0,5/14,14.80%,NUP98;NUP133;NUP205;NUP54;NUP153
prerank,mitotic cell cycle phase transition (GO:0044772),0.26212451396589587,0.8291845856351363,0.8,0.9022843317149172,1.0,47/204,20.98%,EPS8;CDK6;TPD52L1;PLCB1;PRKAR2B;PPP1R12A;EIF4E;CEP41;PLK2;AURKA;PCNT;ACVR1;CDKN1B;FBXL7;DYNLL1;ANAPC7;CCNY;CHMP4B;CDK2;CNTRL;CEP57;ANAPC1;RB1;PPP2R2D;EIF4EBP1;CUL1;MAX;CDC25C;FBXL3;CEP290;CCNJ;CTDP1;CHEK2;CUL3;CEP131;CDC34;CEP72;PPP2R2A;CETN2;CDK5RAP2;CUL2;PPP2R1A;E2F3;TRIM71;DBF4;PLK1;CCNH
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),-0.29850199192033033,-0.829061448229649,0.7338501291989664,0.9687332966871065,1.0,5/25,18.36%,IGF1;PER2;DOT1L;HEY2;HEY1
prerank,organic cation transport (GO:0015695),-0.3188159653793491,-0.8284476447399478,0.7156177156177156,0.9689117310787349,1.0,5/20,15.25%,SLC47A1;SLC22A4;SLC25A42;SLC22A2;SLC22A18
prerank,regulation of cholesterol transport (GO:0032374),-0.31766653751208684,-0.8284324673840436,0.7102137767220903,0.9679246288079705,1.0,1/20,0.50%,LRP1
prerank,RNA stabilization (GO:0043489),-0.2811719027125655,-0.8272476129860505,0.7402234636871509,0.9692100452462438,1.0,9/33,23.08%,TENT5A;AXIN2;CIRBP;HNRNPU;TENT5C;E2F1;PHAX;SLC11A1;RBM24
prerank,motile cilium assembly (GO:0044458),-0.3623497882135484,-0.8271356242088268,0.6851851851851852,0.9684226296545715,1.0,4/12,15.42%,BBOF1;BBS5;CCDC39;RSPH9
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.37788666256569714,0.826438750019914,0.6746575342465754,0.9066183069145838,1.0,4/15,16.39%,NR3C1;BCL2L11;ZFP36;ZFP36L1
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.3769249476538349,0.826289567827023,0.6765217391304348,0.9064118697309557,1.0,3/17,5.22%,KDR;EPHB4;GREM1
prerank,regulation of protein localization to centrosome (GO:1904779),-0.3731588417461165,-0.8261908702190722,0.7077922077922078,0.969135544038249,1.0,1/10,2.25%,BICD1
prerank,regulation of stem cell differentiation (GO:2000736),0.27994619860459985,0.825962560443654,0.7438867438867439,0.906526800234985,1.0,11/89,11.56%,LMO2;GATA2;TAL1;NOTCH1;TCF12;PSMA2;TCF3;TCF15;PSMA8;PSMA6;CBFB
prerank,response to organonitrogen compound (GO:0010243),-0.2723268657195294,-0.8249835471581425,0.7210031347962382,0.970492948926076,1.0,3/38,5.80%,PRKN;GLRB;RCN3
prerank,polyol biosynthetic process (GO:0046173),-0.32954169571624226,-0.8241377707418426,0.7146282973621103,0.971136440235704,1.0,3/16,8.40%,CYP27A1;FGF2;ISYNA1
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.2942038321876724,0.8238129460078312,0.7343532684283728,0.9096790792101542,1.0,13/72,17.52%,POLK;ISG20;EDC3;RNASE1;RPA1;RNASE4;DICER1;FAN1;PNRC2;ERCC4;XRN2;GTF2H4;RFC3
prerank,positive regulation of glial cell differentiation (GO:0045687),-0.3302336330149539,-0.8238009888582893,0.7089201877934272,0.9707749787563992,1.0,4/17,9.35%,IL34;PTN;SERPINE2;BIN1
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.3368100639036683,0.8237995607675528,0.7060653188180405,0.909238894847724,1.0,5/30,8.10%,FOXP1;PKN1;TRIM68;H3-3A;KDM4C
prerank,positive regulation of hormone secretion (GO:0046887),0.370729274982021,0.8236943566453556,0.6882661996497373,0.908949743440656,1.0,2/17,10.49%,EDN1;VAMP8
prerank,cellular response to glucose starvation (GO:0042149),-0.2646571607763145,-0.8234443812266296,0.7891566265060241,0.9704837085731832,1.0,12/41,16.47%,BRSK1;IMPACT;PRKAA2;PRKAG2;CPEB4;EIF2AK3;PRKAG3;SZT2;NUAK2;HNRNPA1;SESN2;PRKAG1
prerank,negative regulation of small molecule metabolic process (GO:0062014),-0.323924555576075,-0.8230161520584713,0.7200956937799043,0.9703336758883313,1.0,4/20,19.06%,WNT4;C1QTNF3;CRY1;NCOR1
prerank,positive regulation of cell death (GO:0010942),0.2970578685167712,0.8222426645744534,0.7342657342657343,0.9109590206266996,1.0,10/59,12.40%,ACER2;DDIT4;FYN;SLC6A6;WNT5A;CDKN1B;BNIP3;PICALM;RIPK1;RIPK2
prerank,microtubule bundle formation (GO:0001578),0.3105937482759097,0.8220707278727604,0.7280832095096582,0.9107937333966467,1.0,12/42,23.57%,NAV1;RP1L1;CFAP46;SPAG16;CHP1;CDK5RAP2;CLIP1;NUMA1;PLK1;GAS2L1;CFAP206;RSPH4A
prerank,response to X-ray (GO:0010165),-0.3439476953303327,-0.821992451579024,0.695364238410596,0.971192974780916,1.0,6/14,23.98%,ANXA1;NUCKS1;IKBIP;XRCC5;XRCC6;ATM
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.3683581859028141,0.8219700644636179,0.7041522491349481,0.9105004426806064,1.0,5/19,16.38%,DDIT4;HIPK1;BCL3;SNW1;TMEM109
prerank,GPI anchor metabolic process (GO:0006505),0.3424432342112515,0.8208741480010778,0.6859903381642513,0.9119242039734448,1.0,8/26,18.19%,PGAP1;PIGU;PIGQ;PGAP4;PIGG;PIGF;PIGL;PIGC
prerank,positive regulation of synaptic transmission (GO:0050806),0.29321385466019934,0.8207162793238023,0.7482614742698191,0.9117365248790185,1.0,3/72,2.59%,SHANK3;APP;PTK2B
prerank,positive regulation of protein export from nucleus (GO:0046827),0.37747189585706376,0.8202564045944053,0.7060869565217391,0.9121046813821376,1.0,7/15,27.11%,TCF7L2;GAS6;ANP32B;RAPGEF3;YWHAE;GSK3B;EMD
prerank,steroid biosynthetic process (GO:0006694),-0.24617137278174162,-0.8201937137739042,0.8193548387096774,0.9736672224958105,1.0,15/56,22.71%,CYP7B1;CYP27A1;INSIG2;PRKAG2;OSBPL3;OSBPL6;INSIG1;PRLR;FDFT1;SCP2;FDXR;LSS;CYP51A1;DHCR7;DHRS11
prerank,DNA geometric change (GO:0032392),-0.30194820489903207,-0.8193837441051902,0.7421052631578947,0.9741982638418094,1.0,5/24,11.10%,HNRNPA2B1;ANXA1;RECQL5;RTEL1;RAD50
prerank,mitochondrial membrane organization (GO:0007006),-0.2829571846701935,-0.8182566162302123,0.773841961852861,0.9752770368901614,1.0,14/32,32.03%,BCL2;MICOS10;CHCHD3;CHCHD6;MTX2;SLC25A4;MAIP1;PPIF;SAMM50;APOO;PMAIP1;DNAJC11;TMEM11;IMMT
prerank,negative regulation of translation (GO:0017148),0.28531265814871326,0.8180216115854487,0.7754569190600522,0.915460272844339,1.0,19/87,15.90%,NANOS3;DAPK1;IGF2BP3;NANOS2;GRB7;RNF139;PUM1;BTG2;RPL13A;CNOT1;MRPL13;EIF4EBP1;RACK1;EIF2AK4;CNOT7;FMR1;LSM14A;YBX1;PAIP2B
prerank,water transport (GO:0006833),-0.3592001351746061,-0.8178969748391908,0.7056451612903226,0.9749290311811739,1.0,1/12,1.60%,PDPN
prerank,positive regulation of translation (GO:0045727),-0.2276381189125436,-0.8176270014353423,0.8674698795180723,0.9744249912802793,1.0,9/94,10.09%,SAMD4A;PLD1;THBS1;CPEB3;FXR2;PRR16;RMND1;LARP6;CIRBP
prerank,peptidyl-threonine modification (GO:0018210),0.29153688727052385,0.8172049911402164,0.7601115760111576,0.9163785164443758,1.0,9/66,6.68%,PRKD1;PRKD2;LMTK2;HIPK1;CDC42BPB;MAPK8;ULK1;ACVR1;DYRK1A
prerank,DNA methylation or demethylation (GO:0044728),0.3659178129458368,0.8170669010450101,0.7110016420361248,0.9156665285412126,1.0,8/19,18.39%,KMT2E;ATF7IP;PPM1D;GATAD2A;SPOCD1;ATRX;TEX15;EHMT1
prerank,DNA alkylation (GO:0006305),0.3659178129458368,0.8170669010450101,0.7110016420361248,0.9156665285412126,1.0,8/19,18.39%,KMT2E;ATF7IP;PPM1D;GATAD2A;SPOCD1;ATRX;TEX15;EHMT1
prerank,protein modification by small protein removal (GO:0070646),0.25305203452129726,0.8165643942469247,0.843400447427293,0.9160328058992339,1.0,76/252,24.09%,ESR1;SMAD1;HIF1A;NFKBIA;USP3;BABAM2;SMAD7;USP15;UCHL5;ATXN3;SNX3;PSMA2;BRCC3;FOXK1;ZRANB1;IKBKG;COPS2;PSMA8;RAD23A;TNIP1;PSMA6;OTUD4;COPS4;RIPK1;ASXL1;BIRC3;IFIH1;TRAF6;APC;PSME1;MBD5;YY1;KAT2B;USP12;ACTR5;BIRC2;RHOA;ABRAXAS2;WDR48;RHOT1;NEDD8;YOD1;USP8;WDR20;DESI2;DESI1;NFRKB;PSMA4;USP7;PSMF1;STAM;NLRP3;USP25;USP21;SMAD2;PSMB7;PSMB1;TRRAP;ATXN7;PSMD2;TADA2B;TNIP2;BABAM1;PSMA5;CCNA2;PSMC3;EIF3F;JOSD1;STAM2;UCHL3;ADRM1;TRAF2;SENP6;COPS8;UBE2D1;SUDS3
prerank,regulation of fatty acid beta-oxidation (GO:0031998),-0.33926814541705286,-0.816552814301328,0.7155756207674944,0.975421886803312,1.0,4/14,14.18%,IRS1;PPARA;IRS2;MFSD2A
prerank,response to amino acid (GO:0043200),0.3290212745213597,0.8162071239594669,0.7151898734177216,0.9161855317189952,1.0,6/31,11.62%,SH3BP4;TMBIM6;XBP1;RPTOR;LARS1;GRIN1
prerank,regulation of TOR signaling (GO:0032006),0.2943785293756336,0.8160779095115539,0.7489539748953975,0.9159410211584684,1.0,10/67,10.66%,SH3BP4;DDIT4;TNFAIP8L1;GNA12;RPTOR;UBR1;RICTOR;NPRL2;LARS1;GAS6
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.36772126730976296,0.8158590410870484,0.6827094474153298,0.9158645461134676,1.0,2/16,2.21%,IL6ST;EDN1
prerank,female gonad development (GO:0008585),-0.3144725813820224,-0.8154409877685308,0.7348837209302326,0.9764402814843799,1.0,7/19,19.47%,KIT;VEGFA;INHBA;NR2F2;CEBPB;INHBB;NUP107
prerank,regulation of centrosome cycle (GO:0046605),0.3475135864118949,0.8154116652534354,0.6789473684210526,0.9161799858221844,1.0,5/21,17.56%,CHMP2B;AURKA;CHMP4B;NPM1;CEP131
prerank,spliceosomal snRNP assembly (GO:0000387),0.31906401891267,0.8153081016123437,0.719047619047619,0.915878369946335,1.0,19/38,31.38%,TGS1;WDR77;DDX20;AAR2;STRAP;SRSF10;SART1;SART3;PRPF3;SNRPD3;LSM2;SNUPN;PRMT5;SNRPD2;SNRPD1;COIL;SNRPB;CLNS1A;GEMIN8
prerank,coenzyme A metabolic process (GO:0015936),0.3779082184545216,0.8148823792546496,0.6601423487544484,0.9161231399807522,1.0,5/14,21.04%,SLC25A16;PANK2;PANK3;PPCDC;CROT
prerank,cilium assembly (GO:0060271),0.24670773480229963,0.814658008209181,0.8574561403508771,0.9160381413123626,1.0,33/297,12.96%,ABCC4;ABLIM1;FNBP1L;EXOC6;EHD4;RAB11A;NOTCH1;CNGB1;PRKAR2B;SSX2IP;DISC1;CEP41;SPATA6;PCNT;RP1L1;BBIP1;EHD2;DYNLL1;EXOC5;CNTRL;TEKT5;CEP57;EXOC4;OCRL;CEP83;DYNLRB1;ARL13B;EHD3;ACTR2;RILP;VANGL2;WDR11;EXOC8
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.353594901713256,0.8143997951399937,0.7080536912751678,0.9160057967509833,1.0,7/22,22.27%,MVB12B;NEDD4;VPS28;VPS37C;STAM;TSG101;VPS36
prerank,kinetochore organization (GO:0051383),-0.34886916877884644,-0.8143728093829693,0.7064439140811456,0.9774010326847676,1.0,9/13,37.46%,CENPT;CENPH;NDC80;CENPF;CENPA;DLGAP5;CENPC;CENPW;MIS12
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.329219241310262,0.8137560666101307,0.7138157894736842,0.9166163029340453,1.0,4/30,11.84%,ELOVL7;ELOVL5;ABCD4;ABCD1
prerank,regulation of fibroblast migration (GO:0010762),0.35266040060781256,0.8130464112686119,0.6698872785829307,0.917317282133483,1.0,7/20,12.01%,PRR5L;RAC1;TGFB1;PTK2;GNA12;ARHGEF7;CORO1C
prerank,mRNA transport (GO:0051028),0.2762929656289746,0.8130058267409166,0.7796833773087071,0.9169281733454023,1.0,28/101,19.96%,HHEX;EIF4E;NXF2;WDR33;THOC2;SMG7;YTHDC1;NUP214;RNPS1;THOC6;NUP98;ZFP36;UPF2;NUP133;NUP205;FMR1;NUP54;NUP43;NUP153;AGFG1;ZFP36L1;ALYREF;CDC40;THOC3;THOC1;CPSF1;GLE1;THOC5
prerank,secretion (GO:0046903),0.3838803321572429,0.8128679826484375,0.6851211072664359,0.9167054066827602,1.0,3/14,8.39%,NPR1;TPD52;GUCA1B
prerank,positive regulation of establishment of protein localization (GO:1904951),0.3630112964795909,0.8124947773363123,0.6866197183098591,0.9168852144900403,1.0,7/19,25.98%,WRAP53;CHP1;CEP295;CCT7;CCT2;CEP120;CENPJ
prerank,alanine transport (GO:0032328),0.3993555291157127,0.8120209795011757,0.6666666666666666,0.9172161778005689,1.0,2/10,13.56%,SLC6A6;SLC36A4
prerank,negative regulation of interleukin-6 production (GO:0032715),0.3406918468838025,0.8118051475510717,0.7,0.9171202792857417,1.0,5/27,17.37%,CD200;ARRB1;GAS6;IRAK3;CD200R1
prerank,synaptic vesicle exocytosis (GO:0016079),0.3106641732168799,0.8113987562122249,0.7055214723926381,0.9173514216503924,1.0,2/40,1.30%,UNC13B;STX3
prerank,negative regulation of neuron differentiation (GO:0045665),0.349623335568814,0.8109397538034039,0.6902800658978583,0.9176469371788641,1.0,2/22,4.38%,B2M;DLL1
prerank,mitochondrion distribution (GO:0048311),0.3860276239183256,0.8104427117446459,0.6594202898550725,0.9180029920885149,1.0,4/12,18.22%,MTM1;MEF2A;MSTO1;TRAK2
prerank,fatty acid transport (GO:0015908),0.3655395110244434,0.810022477075819,0.7005347593582888,0.9182792078894029,1.0,1/17,1.07%,PPARD
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.3160478926811448,0.8093935528794649,0.7234678624813154,0.9188872883172633,1.0,7/35,13.91%,PCDHB4;SELP;ATP2C1;CDH23;PCDHB5;PCDHB11;CDH5
prerank,telomere maintenance (GO:0000723),-0.2568898375576738,-0.808328840590549,0.7993630573248408,0.9875833577938097,1.0,22/50,31.08%,PARP3;RTEL1;TEP1;RAD50;XRCC5;TERF2;XRCC6;SMC6;ATR;DNA2;TPRKB;TERT;PRKDC;ATM;POLD1;LTO1;XRCC3;POLD2;SMC5;DCLRE1B;RPA2;BLM
prerank,zinc ion transmembrane transport (GO:0071577),0.3507564798252426,0.8083256082062807,0.6870860927152318,0.9202359709624488,1.0,1/22,0.92%,SLC39A8
prerank,myoblast fusion (GO:0007520),0.39800278756668506,0.8080524603779871,0.686456400742115,0.9202304895002479,1.0,2/12,7.96%,JAM2;PTGFRN
prerank,steroid catabolic process (GO:0006706),0.4001418655101175,0.8080428849475836,0.6684397163120568,0.9197783905355951,1.0,2/10,10.25%,FGF23;CYP27B1
prerank,negative regulation of myotube differentiation (GO:0010832),0.3852327123682212,0.8077614530092069,0.6830188679245283,0.919789107943615,1.0,2/12,4.96%,NOTCH1;XBP1
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.3442451430834381,0.8074887955185142,0.7133655394524959,0.919791305880521,1.0,1/25,1.15%,MEF2C
prerank,apoptotic mitochondrial changes (GO:0008637),0.32868109460678446,0.8069476087295826,0.6988543371522095,0.9202245646895884,1.0,9/32,14.19%,BIK;BOK;BCL2L1;GGCT;BNIP3;SFN;BID;SOD2;THEM4
prerank,negative regulation of protein localization to cell surface (GO:2000009),-0.35208605042059676,-0.8067041715718182,0.6980306345733042,0.9894090333243654,1.0,2/11,3.04%,ACTN2;GPM6B
prerank,negative regulation of interleukin-1 production (GO:0032692),-0.2961542733655395,-0.8062220802861799,0.75,0.989328660699469,1.0,1/23,0.34%,IGF1
prerank,polarized epithelial cell differentiation (GO:0030859),0.38255228822843756,0.8061815585543143,0.6915887850467289,0.921030855715054,1.0,2/13,5.93%,MSN;OPHN1
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),-0.32636339435669154,-0.8055115421730223,0.740139211136891,0.9896187704655609,1.0,5/15,32.64%,SELENOS;NPLOC4;DERL2;HSP90B1;VCP
prerank,inner mitochondrial membrane organization (GO:0007007),-0.2562159568943516,-0.8053450764966095,0.8149253731343283,0.9889249077341715,1.0,19/47,32.03%,MICOS10;CHCHD3;CHCHD6;TIMM22;MTX2;ATP5PO;MAIP1;TIMM8B;TIMM9;TIMM10;ATP5PF;ATP5ME;SAMM50;ATP5MG;DMAC2L;APOO;DNAJC11;TMEM11;IMMT
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.38357908515974243,0.8052908407264858,0.6935483870967742,0.9221113817956825,1.0,1/12,1.99%,FOXP1
prerank,positive regulation of triglyceride metabolic process (GO:0090208),0.36753548658216695,0.8052108826296976,0.6913793103448276,0.9217945044159674,1.0,2/16,4.20%,SCARB1;PLIN5
prerank,regulation of protein polymerization (GO:0032271),0.31665648054827467,0.8051762565962696,0.7276923076923076,0.9213787530590652,1.0,6/35,12.83%,ESAM;RASA1;CAMSAP2;ARHGAP28;PRUNE1;DBNL
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.40069360515879693,0.8048599833952147,0.7101449275362319,0.9214034706410026,1.0,5/11,12.94%,SMAD7;USP15;ACVR1;TGFB1;TGFBR2
prerank,regulation of macrophage activation (GO:0043030),0.3264828858235568,0.8047549580385026,0.7202472952086554,0.921128762437813,1.0,3/30,6.09%,CD200;MFHAS1;WNT5A
prerank,positive regulation of coagulation (GO:0050820),-0.3642515518954123,-0.8035935253162458,0.7313769751693002,0.9900350411009889,1.0,4/10,22.91%,THBS1;SERPINE1;ST3GAL4;HPSE
prerank,positive regulation of hemostasis (GO:1900048),-0.3642515518954123,-0.8035935253162458,0.7313769751693002,0.9900350411009889,1.0,4/10,22.91%,THBS1;SERPINE1;ST3GAL4;HPSE
prerank,central nervous system neuron differentiation (GO:0021953),-0.26634708218292946,-0.8017916463051952,0.7848837209302325,0.9922064596144325,1.0,16/33,28.79%,MAP2;NTRK2;RYK;LRP6;MDGA1;GRID2;CHD5;FAIM2;MDGA2;SPOCK1;NPY;LHX1;KNDC1;CEND1;LMX1A;WNT2
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.34093051332232677,0.801364046520939,0.7272727272727273,0.9263171007122504,1.0,6/22,14.90%,PPM1F;PPM1D;DUSP16;DUSP7;DUSP2;PDP1
prerank,DNA recombination (GO:0006310),-0.26094759950693247,-0.8010682377051219,0.8052325581395349,0.9926189934314711,1.0,19/37,32.54%,RECQL5;RAD51B;RTEL1;RAD50;RHNO1;DMC1;IGHMBP2;RAD51C;FBH1;RAD52;GEN1;XRCC3;RAD54L;RPAIN;EXO1;SUPV3L1;ERCC1;BLM;WRN
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),0.3968914758046301,0.8006076062862725,0.6927374301675978,0.9271529505028336,1.0,2/11,5.22%,RIN3;GREM1
prerank,regulation of stem cell population maintenance (GO:2000036),-0.31785079189028026,-0.8005912767094354,0.7259615384615384,0.9925014413211319,1.0,4/18,14.39%,PTN;CNOT3;TAF6L;WDR43
prerank,visual system development (GO:0150063),0.311978477608901,0.8004515516210646,0.7149253731343284,0.9269651836019943,1.0,4/37,5.02%,PBX1;FREM2;HIPK1;SIPA1L3
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.34547363427976957,0.8002687020848193,0.7248764415156508,0.9268098652573344,1.0,8/22,24.92%,PSMA2;PSMA8;PSMA6;PSMA4;PSMB7;PSMB1;PSMA5;PSMA3
prerank,V(D)J recombination (GO:0033151),0.40227948143256453,0.8001980801243008,0.6954954954954955,0.9264733998303611,1.0,5/11,24.15%,TCF3;DCAF1;XRCC4;HMGB1;LIG4
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.24268065605911066,0.799596326701027,0.8971553610503282,0.927024842285968,1.0,76/314,22.48%,STT3B;SMURF1;NEDD4L;FBXW7;ZNRF1;KCTD10;PELI1;FBXL4;AURKA;ATXN3;ARRB1;UBE2G1;PSMA2;FBXL7;NEDD4;TRIM25;ARMC8;UBR1;ANAPC7;FBXL2;CDK2;SPOPL;RNF4;ANAPC1;ZFAND2B;PSMA8;RAD23A;SIAH1;UBE2D3;PSMA6;CDC26;RB1;CUL1;COP1;ANAPC16;FBXL3;UBE2K;BUB3;TOPORS;UBXN1;PSME1;RNF5;DDIT3;UBE3D;AREL1;CRBN;BIRC2;NHLRC1;CTNNB1;MAEA;CUL3;YOD1;CDC34;PSMA4;DNAJB12;PSMF1;CUL2;ZFAND2A;DNAJC10;APPBP2;FBXO17;PSMB7;TRIM71;PSMB1;HACE1;PLK1;KCTD2;SEL1L;DNAJB9;PSMD2;KCTD5;KLHL42;RNF103;UBXN2A;PSMA5;PSMC3
prerank,regulation of mitochondrial depolarization (GO:0051900),-0.36011103225951785,-0.7995141963004925,0.6757894736842105,0.993367070120467,1.0,4/10,9.03%,DCN;BCL2;LRRK2;SRC
prerank,positive regulation of response to wounding (GO:1903036),-0.29444753243678334,-0.7993993434123565,0.7825,0.9925729821536032,1.0,6/24,13.72%,PTN;VTN;ANXA1;ADRA2A;CLDN1;HBEGF
prerank,cardiac muscle cell differentiation (GO:0055007),0.3499550077340362,0.7993635200378885,0.7416520210896309,0.926905107355208,1.0,3/21,6.27%,MEF2C;SIK1;ACVR1
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.2946805850115904,-0.7988481746575422,0.7669902912621359,0.9925505858169783,1.0,6/22,22.31%,ERI3;FTSJ3;EXOSC7;EXOSC3;EXOSC9;KRI1
prerank,response to leucine (GO:0043201),0.406213791140052,0.7986920752758264,0.689908256880734,0.9270832663251598,1.0,3/10,10.32%,RPTOR;UBR1;LARS1
prerank,cellular response to leucine (GO:0071233),0.406213791140052,0.7986920752758264,0.689908256880734,0.9270832663251598,1.0,3/10,10.32%,RPTOR;UBR1;LARS1
prerank,regulation of response to DNA damage stimulus (GO:2001020),-0.2647038651612999,-0.7984307854581965,0.7867867867867868,0.9922823217761999,1.0,4/40,5.86%,PRKCD;KMT5A;FXR2;NEK4
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.2547935388816447,0.7982891082487034,0.8414043583535109,0.9273164161689859,1.0,45/148,24.73%,PPP1R13B;JMY;RPS15;HIPK1;PHF20;RPS20;AURKA;RPA1;TAF3;RRS1;TAF4B;RPL23;CDK2;RICTOR;BRIP1;MAPK11;NUAK1;PRKAB1;HUS1;RMI1;NOP53;KAT6A;CHEK2;RPL11;RFC3;PRKAA1;USP7;CSNK2A2;CSNK2A1;EHMT1;TTC5;TAF9;RAD17;RMI2;TAF15;TAF7;MAP2K6;RFC5;MAPK14;MAPKAP1;PDPK1;RFFL;PLK3;PIP4K2B;MBD3
prerank,regulation of B cell differentiation (GO:0045577),-0.31437146175310393,-0.7981503258666818,0.753393665158371,0.991748544933922,1.0,5/17,20.66%,MMP14;SFRP1;INHBA;SYK;ID2
prerank,triglyceride metabolic process (GO:0006641),0.2988786341027699,0.7980661993963731,0.757754800590842,0.9271830733843556,1.0,10/48,15.78%,CAV1;LPIN3;LPL;PLAAT3;FABP12;GK5;MOGAT1;PNPLA2;DGAT1;MOGAT2
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.33606009006587256,0.7980064701216231,0.7132987910189983,0.9268117835193382,1.0,7/23,16.25%,APP;TGFB1;RPTOR;RIPK2;UBE2K;IRGM;CALM1
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.34183370805939917,0.798003318355784,0.7118110236220473,0.9263539990356942,1.0,8/24,17.65%,FYN;KCNB1;AKT2;MYO1C;TCAF2;ERBB2;CHP1;CIB1
prerank,histone lysine demethylation (GO:0070076),0.33718032759440364,0.7976993152236964,0.7277227722772277,0.9263797243366549,1.0,4/25,8.10%,KDM3A;KDM6A;JMJD1C;KDM4C
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",-0.22575155679820225,-0.7971731899388367,0.8523985239852399,0.992455886943967,1.0,15/80,15.16%,DENND2A;SGSM2;SNX32;SNX6;STX16;RHOBTB3;RAB29;TMED9;GBF1;SNX5;RGP1;TRAPPC10;GGA1;ARFRP1;RBSN
prerank,response to endoplasmic reticulum stress (GO:0034976),0.2710008531154887,0.7971158123019829,0.7862694300518135,0.9269129528198697,1.0,14/107,11.39%,ERN1;RASGRF2;DAB2IP;CASP4;NCK1;TRIB3;BCL2L11;NIBAN1;RNF139;EIF2B5;RHBDD1;ERO1A;MBTPS2;ATF6
prerank,histone mRNA catabolic process (GO:0071044),0.3642389214611146,0.7970936953713159,0.6867256637168142,0.9264836651363485,1.0,7/15,27.43%,DCP2;MTPAP;LSM1;TENT4B;EXOSC4;TUT1;TUT7
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.2769868042907691,0.7970187651542175,0.7906040268456376,0.926161464965315,1.0,27/84,24.92%,AURKA;PSMA2;ANAPC7;CDK2;ANAPC1;PSMA8;PSMA6;CDC26;RB1;ANAPC16;BUB3;PSME1;CUL3;PSMA4;PSMF1;PSMB7;PSMB1;PLK1;PSMD2;PSMA5;PSMC3;UBE2D1;PSMD3;UBE2E1;FBXO5;FZR1;PSMA3
prerank,negative regulation of T cell activation (GO:0050868),0.3138074975154078,0.7970011569563794,0.7363494539781591,0.9257251042803548,1.0,4/35,6.40%,JAK3;CEACAM1;PLA2G2D;TIGIT
prerank,UV protection (GO:0009650),-0.36168627414318855,-0.7969042077033223,0.7382978723404255,0.9919248670860691,1.0,3/10,12.97%,SCARA3;MFAP4;ERCC5
prerank,positive regulation of telomere maintenance (GO:0032206),0.318394950926413,0.7962680663082556,0.7283333333333334,0.9264712234913971,1.0,5/31,15.33%,NEK7;PPP1R10;HNRNPD;SIRT6;ATRX
prerank,negative regulation of protein kinase B signaling (GO:0051898),-0.2628274778115358,-0.7962234055718631,0.804945054945055,0.9921324458851181,1.0,10/38,19.80%,MAGI2;PPARA;DAG1;TSC2;PHLPP2;GPER1;PHLDA3;OTUD3;FLCN;PTEN
prerank,negative regulation by host of viral process (GO:0044793),0.3998165626232049,0.7960613069957126,0.7,0.9263661817778054,1.0,3/10,12.82%,CCNK;PTX3;EIF2AK4
prerank,histone H4-K8 acetylation (GO:0043982),0.37147933615461937,0.7960309664017979,0.7009009009009008,0.9254881832068377,1.0,4/15,9.14%,PHF20;JADE2;JADE1;JADE3
prerank,histone H4-K5 acetylation (GO:0043981),0.37147933615461937,0.7960309664017979,0.7009009009009008,0.9254881832068377,1.0,4/15,9.14%,PHF20;JADE2;JADE1;JADE3
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.34816685098580713,0.795851459888975,0.7388429752066116,0.9253183082751284,1.0,7/21,23.45%,ARHGEF2;CAMSAP2;APC;CIB1;ATXN7;TAOK1;CLASP2
prerank,regulation of telomere capping (GO:1904353),0.3385062075872938,0.7955324349046714,0.71160409556314,0.9253842132801414,1.0,2/23,7.79%,NEK7;HNRNPD
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.2835807978957641,-0.7954445343067755,0.800531914893617,0.9924873290252162,1.0,6/26,10.24%,KANK2;HEYL;DAB2;SFRP1;CRY2;SMARCA4
prerank,GPI anchor biosynthetic process (GO:0006506),0.32424339247583756,0.7945500024152591,0.7527733755942948,0.9265087266121238,1.0,9/30,18.19%,PGAP1;PIGU;PIGK;PIGQ;PGAP4;PIGG;PIGF;PIGL;PIGC
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.36619421052987244,0.7935533436462,0.725177304964539,0.9276582739475941,1.0,2/14,11.84%,CRAT;ABCD1
prerank,neural tube closure (GO:0001843),-0.2705233780078644,-0.7930893193612959,0.7806267806267806,0.9955919268001785,1.0,7/34,11.47%,LMO4;COBL;LRP6;TSC2;FUZ;MTHFD1;TGFB2
prerank,negative regulation of bone remodeling (GO:0046851),-0.3627449227079038,-0.7926878390746586,0.7031963470319634,0.9953261731669419,1.0,4/11,18.69%,UBASH3B;SFRP1;GPR137B;TMEM119
prerank,negative regulation of leukocyte migration (GO:0002686),0.39760066319568177,0.7925401282006955,0.714548802946593,0.9288244531674146,1.0,1/10,1.49%,CD200
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.3087811069877784,0.7924738955730262,0.7345132743362832,0.9284652283421854,1.0,4/37,6.04%,STAT3;GBP5;HIF1A;CUEDC2
prerank,regulation of mRNA stability (GO:0043488),-0.20855141599588511,-0.7924713999488089,0.9822485207100592,0.9946587046258991,1.0,30/145,20.97%,SAMD4A;ROCK2;PRKCD;FXR2;TENT5A;PSME4;AXIN2;PRKCA;CIRBP;EXOSC7;CELF1;IGF2BP2;PSMD12;CSDC2;EXOSC3;HNRNPU;FTO;RC3H2;TENT5C;PCBP4;E2F1;HSPB1;SAMD4B;TBRG4;PSMC4;PSMB6;EXOSC9;FASTKD3;PDE12;EIF4G1
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.32854830415589864,0.7924130682560447,0.7306397306397306,0.9281016599115853,1.0,4/26,5.97%,LRP5;PIM3;KLF7;PPP3CB
prerank,protein peptidyl-prolyl isomerization (GO:0000413),-0.2928187671917748,-0.7922861849832048,0.7560975609756098,0.9939521213462269,1.0,4/20,14.45%,FKBP5;NKTR;PPIC;PPIH
prerank,regulation of microtubule depolymerization (GO:0031114),0.33615148360423625,0.791667682715901,0.752442996742671,0.9287866678780311,1.0,8/25,23.45%,ARHGEF2;TRPV4;CAMSAP2;APC;CIB1;ATXN7;TAOK1;CLASP2
prerank,dendritic cell differentiation (GO:0097028),0.3426322939561723,0.7914422893387247,0.7207792207792207,0.9286747893628418,1.0,4/22,12.94%,LYN;DCSTAMP;GAS6;TGFBR2
prerank,microtubule polymerization or depolymerization (GO:0031109),-0.2938521695676336,-0.7902697261836267,0.7814207650273224,0.9963840807568451,1.0,10/25,32.01%,KIF24;MAP7D3;NCKAP5L;TPPP3;CKAP5;KIF18B;STMN4;FGF13;TPPP;STMN2
prerank,positive regulation of reproductive process (GO:2000243),-0.2820723200970992,-0.7900692545671604,0.7936507936507936,0.9957671184997516,1.0,11/31,28.19%,SIRT2;VEGFA;INHBA;SYDE1;ACVR1B;INHBB;CFAP69;SMURF2;CACNA1H;C1QBP;HYAL3
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.3898020465780244,0.789910622423774,0.7177121771217713,0.930693356376561,1.0,3/11,12.16%,MAD2L2;TFAP4;MUC1
prerank,regulation of intracellular transport (GO:0032386),0.31339059107851064,0.789722470923997,0.7484662576687117,0.9305530175998132,1.0,8/38,13.89%,LCP1;DNAJC30;RNF139;PTPN1;INPP5F;NUP214;RAB11B;NDEL1
prerank,bile acid metabolic process (GO:0008206),-0.2855913594552779,-0.788821290931237,0.8041237113402062,0.9968951175496246,1.0,5/27,15.07%,CYP7B1;CYP27A1;OSBPL3;OSBPL6;SCP2
prerank,positive regulation of type 2 immune response (GO:0002830),-0.32064689870306945,-0.7888126618900059,0.7420091324200914,0.995910704362062,1.0,3/14,11.16%,IL18;PRKCZ;CD81
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.3823456147455372,0.7887434632556766,0.7241379310344828,0.931174655973392,1.0,5/12,16.45%,HOMER2;ATP2B4;HOMER3;RCAN1;CHP1
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.3823456147455372,0.7887434632556766,0.7241379310344828,0.931174655973392,1.0,5/12,16.45%,HOMER2;ATP2B4;HOMER3;RCAN1;CHP1
prerank,regulation of osteoclast differentiation (GO:0045670),-0.2720678930787944,-0.7879970509447624,0.8119891008174387,0.9963116610604733,1.0,6/33,18.15%,FBN1;UBASH3B;PRXL2A;GPR137B;CEBPB;FSTL3
prerank,peptidyl-lysine trimethylation (GO:0018023),-0.2840550507284818,-0.7879456093125802,0.7989556135770235,0.9953956152214217,1.0,7/26,19.12%,OGT;KMT5C;CTR9;KMT2D;SETD4;VCPKMT;BEND3
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.3110578155404247,0.787300493166147,0.7430769230769231,0.9330094673841032,1.0,11/37,26.59%,POLK;RPA1;ERCC4;GTF2H4;RFC3;CHD1L;GTF2H1;RFC5;CUL4B;GTF2H5;RPA3
prerank,regulation of wound healing (GO:0061041),0.30868022186867583,0.7871129038293861,0.7469325153374233,0.9328677401346319,1.0,5/42,10.38%,CAV1;OCLN;PTK2;CRK;INSL3
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.2994755611203762,0.7868718972061045,0.756797583081571,0.9328020663894288,1.0,5/46,7.54%,PLA2G4A;DGKZ;DGKH;PLA2G2D;AGPAT1
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.33011485446937205,0.7860344833184846,0.7204472843450479,0.9336563216484698,1.0,4/28,12.83%,ESAM;RASA1;ARHGAP28;DBNL
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),-0.3545786566897192,-0.7856991820565624,0.7133757961783439,0.9982379467059064,1.0,5/10,18.49%,PRKAA2;KLF15;MYOCD;DIP2A;FLCN
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.3201904544187798,0.7856645916173711,0.7414075286415712,0.9337929049589196,1.0,6/29,12.61%,DAB2IP;EFNA1;SMAD7;MAD2L2;SFRP2;ADIPOR1
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.2930816368637178,0.7852402616203754,0.7633928571428571,0.9339989240199017,1.0,8/48,13.14%,NLRC5;SAMHD1;SIGIRR;OTUD4;GAS6;CARD16;GSTP1;CNOT7
prerank,regulation of translational initiation (GO:0006446),0.281966480570083,0.785204311449533,0.8053221288515406,0.9335949996852845,1.0,16/63,17.26%,NCK1;EIF3H;EIF1;EIF2B5;EIF4EBP1;EIF5B;EIF2AK4;UHMK1;FMR1;EIF2B2;PAIP1;NPM1;PAIP2B;EIF5;CTIF;CSDE1
prerank,mitochondrial fusion (GO:0008053),-0.30823620337966895,-0.7848413134659491,0.7414187643020596,0.9986937540305003,1.0,5/18,25.12%,MIGA2;CHCHD3;MIEF2;BAX;GDAP1
prerank,response to ionizing radiation (GO:0010212),0.28018304178427017,0.7844623569438838,0.8042553191489362,0.9343252901635635,1.0,7/70,12.26%,NET1;DCUN1D3;BABAM2;BRCC3;HUS1;COP1;RHOB
prerank,double-strand break repair via homologous recombination (GO:0000724),0.26852775304817933,0.7843851202932094,0.8207171314741036,0.9339972919698023,1.0,20/95,19.10%,SAMHD1;RAD21L1;MMS22L;RPA1;RAD51D;SEM1;RECQL;MEIOB;FAN1;HUS1;XRCC2;MCM9;RMI1;ERCC4;YY1;SPIDR;RAD21;NSMCE1;SWSAP1;GINS2
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.3505785591924225,0.783776523834213,0.7202680067001676,0.9345214728015819,1.0,4/18,16.39%,NR3C1;BCL2L11;ZFP36;ZFP36L1
prerank,protein auto-ADP-ribosylation (GO:0070213),-0.3431855816231669,-0.7835431496627603,0.7388392857142857,0.9998457857823569,1.0,4/12,21.28%,PARP3;PARP11;PARP8;TIPARP
prerank,cellular response to UV-A (GO:0071492),-0.3480537839614512,-0.7835233251641281,0.7521551724137931,0.9988879923412594,1.0,6/11,35.49%,MMP2;CERS1;PPID;TIMP1;MMP3;MME
prerank,negative regulation of osteoclast differentiation (GO:0045671),-0.3129099696338783,-0.7834331577290967,0.7442396313364056,0.9980294221147834,1.0,1/18,0.53%,FBN1
prerank,histone exchange (GO:0043486),-0.260303654778659,-0.7829878746766693,0.7988980716253443,0.9977731235083588,1.0,14/37,26.48%,RBBP7;CENPP;ITGB3BP;CENPT;MIS18BP1;CENPU;ZNHIT1;CENPK;RBBP4;CENPH;KNL1;CENPX;CENPQ;CENPA
prerank,cellular response to hydrogen peroxide (GO:0070301),0.31222796292002136,0.7823685439108921,0.7492307692307693,0.9362850021505519,1.0,6/33,12.97%,NET1;RNF112;RIPK1;RHOB;RELA;SIGMAR1
prerank,cellular response to UV (GO:0034644),0.2777345924697484,0.7823510097605196,0.8168044077134986,0.9358566170637375,1.0,18/76,19.01%,POLK;PTPRK;N4BP1;NEDD4;RHBDD1;MC1R;CARD16;OPN5;EIF2AK4;ERCC4;FMR1;NPM1;YY1;BMF;ACTR5;KDM1A;BAK1;DHX36
prerank,regulation of sister chromatid cohesion (GO:0007063),-0.33159688712980007,-0.7822451628248688,0.74364896073903,0.9980029334433567,1.0,2/12,6.97%,HDAC8;AXIN2
prerank,organophosphate biosynthetic process (GO:0090407),-0.25852709786279837,-0.7817416715882662,0.8269794721407625,0.9978804642056264,1.0,15/37,25.92%,FGF2;AGPAT4;GK;PCYT2;TKT;TPI1;GPAM;LPCAT1;AGPAT3;PPIP5K2;IP6K1;PNPO;NFS1;FADS1;MOCS1
prerank,stress granule assembly (GO:0034063),-0.29131223397218214,-0.7813548592529981,0.774818401937046,0.9974774222129563,1.0,6/20,19.49%,BICD1;ATXN2;CIRBP;UBAP2L;DYNC1H1;ATXN2L
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.3019240959292553,0.7812898395470229,0.7865671641791044,0.9371210540025103,1.0,10/41,14.80%,HIF1A;EIF6;NUP214;NUP98;SLC2A6;NUP133;NUP205;NUP54;NUP43;NUP153
prerank,fluid transport (GO:0042044),-0.3436867240945139,-0.780666682352781,0.7409766454352441,0.997608200973376,1.0,1/12,1.60%,PDPN
prerank,regulation of feeding behavior (GO:0060259),0.3821731247683197,0.780596823229417,0.7185185185185186,0.9377455780029407,1.0,4/11,16.41%,STAT3;UCN;EIF2AK4;AGRP
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.3780562230420213,0.7804717904824031,0.720508166969147,0.9374902637042436,1.0,4/12,12.62%,EDN1;TGFB1;AP2A1;GSTP1
prerank,protein targeting to peroxisome (GO:0006625),-0.2766541368952272,-0.7794455260943147,0.8016085790884718,0.9986093326762432,1.0,11/29,27.00%,ABCD3;ATAD1;PEX1;PXMP2;PEX7;PEX11B;ZFAND6;PEX5;GDAP1;ABCD2;PEX16
prerank,macroautophagy (GO:0016236),0.26049915725072054,0.7792634122509854,0.8370646766169154,0.9389633365934855,1.0,37/118,24.43%,KLHL3;ULK1;CHMP2B;PGAM5;TECPR1;DYNLL1;ATG101;CHMP4B;CHMP4A;VPS28;ARL8B;VAMP8;PRKAB1;TBC1D5;GABARAPL1;ILRUN;VPS37C;MFN1;YOD1;PRKAA1;MTERF3;CSNK2A2;CSNK2A1;STAM;TOMM22;ATG7;VTA1;TSG101;PLEKHM1;VTI1B;PIK3R4;VPS36;STAM2;MTMR14;RB1CC1;ZFYVE1;PIP4K2B
prerank,central nervous system projection neuron axonogenesis (GO:0021952),-0.33201697949129233,-0.7791672229992521,0.7533632286995515,0.9980721942483293,1.0,5/12,23.18%,GLI2;SZT2;TSKU;SPTBN4;EPHB2
prerank,regulation of regulated secretory pathway (GO:1903305),0.31045700377191693,0.7788054617523117,0.767515923566879,0.9392431599175916,1.0,6/34,15.85%,RAB27A;TRPV6;SYT15;RAB5A;SYT7;RIMS4
prerank,negative regulation of centrosome duplication (GO:0010826),0.3804219902365907,0.7786762154606693,0.7186932849364791,0.938973551057872,1.0,4/11,18.62%,RBM14;NPM1;KAT2B;CDK5RAP2
prerank,sulfur compound transport (GO:0072348),0.31971322535901237,0.7784824343808323,0.7837837837837838,0.9388213097615496,1.0,4/27,9.77%,ABCG2;SLC6A6;SLC26A1;SLC25A30
prerank,regulation of oxidative stress-induced cell death (GO:1903201),-0.3476694886862589,-0.7780806933007152,0.7346491228070176,0.9988281748149941,1.0,2/11,6.81%,PRKN;P4HB
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.3756517675280756,0.7778515483758143,0.7243947858472998,0.9393312727999832,1.0,4/13,15.66%,TMSB4X;PSEN1;MAD2L2;DDIT3
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.3856046820326573,0.7778249935060468,0.7295825771324864,0.9389079226751263,1.0,4/11,12.01%,RREB1;ENPP2;ARHGEF7;CORO1C
prerank,negative regulation of interleukin-12 production (GO:0032695),0.36369873206124176,0.7778086817799587,0.705574912891986,0.9384721095485117,1.0,4/14,20.66%,JAK3;TIGIT;IRAK3;PIBF1
prerank,NAD biosynthetic process (GO:0009435),0.3478982150761196,0.7774170697587487,0.7482876712328768,0.9386458045939853,1.0,3/20,12.72%,PTGS2;NAXE;SLC5A8
prerank,regulation of fibroblast proliferation (GO:0048145),0.2937264896396916,0.7771698794371277,0.7951807228915663,0.9385692293202164,1.0,5/45,7.03%,CDK6;PDGFB;DAB2IP;WNT5A;PDGFC
prerank,fatty acid beta-oxidation (GO:0006635),0.2894441711110053,0.7771276357192985,0.7672672672672672,0.93817845631858,1.0,12/51,19.59%,PPARD;CRAT;HADHA;ECI1;ABCD4;ABCD1;HADH;AUH;ETFDH;ETFA;ETFB;ACAD10
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.3796413611846024,0.7765674449183564,0.724561403508772,0.9385602532197312,1.0,1/11,4.96%,XBP1
prerank,aggrephagy (GO:0035973),-0.2762144852805868,-0.7765233637220753,0.7879581151832461,1.0,1.0,4/27,8.90%,PRKN;IFT88;SQSTM1;DYNC1I1
prerank,purine nucleotide metabolic process (GO:0006163),0.3264487842005672,0.7759188706444454,0.7516666666666667,0.9391251231679195,1.0,8/24,19.80%,GDA;NT5C2;ADSL;HPRT1;XDH;NUDT15;GART;PNP
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.3003571885599186,0.7756803510082274,0.7767145135566188,0.9390330552504361,1.0,8/35,20.90%,NEK7;HMBOX1;ACD;CTNNB1;DHX36;CCT7;CCT2;MAP2K7
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.34214816708223345,0.7754332155243604,0.7376,0.9389533977212333,1.0,4/20,10.57%,PLCG1;ECSCR;CD40;ANO6
prerank,negative regulation of interleukin-8 production (GO:0032717),0.34893037582613856,0.7753109888732356,0.7517123287671232,0.9386978237116245,1.0,3/17,7.51%,TMSB4X;ARRB1;BCL3
prerank,protein exit from endoplasmic reticulum (GO:0032527),-0.285168071065817,-0.7752962031135966,0.7754569190600522,1.0,1.0,11/23,39.55%,SELENOS;TMED9;NPLOC4;SEC16A;SEC13;DERL2;HSP90B1;VCP;TECPR2;DERL1;LMAN1
prerank,positive regulation of interferon-beta production (GO:0032728),-0.2598884439933285,-0.7750338105084124,0.8418079096045198,1.0,1.0,17/33,39.50%,HSP90AA1;OAS2;MAVS;RNF135;POLR3D;IRF3;PTPN11;DHX9;IRF7;TLR2;TLR8;TRIM56;TOMM70;POLR3C;IRF1;OAS3;IRF5
prerank,neutrophil chemotaxis (GO:0030593),0.28485226202022457,0.7748250603144878,0.7908961593172119,0.9389753527132282,1.0,5/53,10.40%,EDN1;BSG;PPBP;PIK3CG;CCL14
prerank,cellular response to estrogen stimulus (GO:0071391),0.3614376755772808,0.7742112427290039,0.7267657992565055,0.9395212147319512,1.0,4/14,14.57%,SERPINB9;NCOA4;TRIM24;PELP1
prerank,regulation of ATP metabolic process (GO:1903578),0.2845894019233186,0.7741871263142807,0.8253521126760563,0.9391012724796641,1.0,12/54,14.80%,HIF1A;AK4;EIF6;NUP214;ABCD1;NUP98;SLC2A6;NUP133;NUP205;NUP54;NUP43;NUP153
prerank,mRNA export from nucleus (GO:0006406),0.26337510082614246,0.7740442942080458,0.8394736842105263,0.9388804352951914,1.0,36/102,25.70%,HHEX;EIF4E;NXF2;WDR33;THOC2;SMG7;YTHDC1;NUP214;ENY2;RNPS1;THOC6;NUP98;UPF2;NUP133;NUP205;NUP54;NUP43;NUP153;AGFG1;ALYREF;CDC40;THOC3;THOC1;CPSF1;GLE1;THOC5;THOC7;SRSF4;IWS1;SMG6;NUP42;SLU7;CPSF2;NUP85;PCID2;CPSF3
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.330042011062297,0.7739458254550713,0.7203252032520325,0.9385912247479727,1.0,5/22,14.29%,HHEX;CDKN1B;TFAP4;INCA1;APC
prerank,regulation of lymphocyte activation (GO:0051249),0.3762120093742246,0.7736685557889389,0.7065420560747664,0.9385580979758609,1.0,3/12,16.14%,LCK;DCAF15;LAT
prerank,protein lipidation (GO:0006497),0.2871825448373051,0.7734863811751009,0.8104196816208393,0.9383843805900973,1.0,16/59,20.91%,UGCG;PIGU;ZDHHC18;ZDHHC9;HHAT;PIGQ;PGAP4;PIGG;PIGF;PIGL;PIGC;ZDHHC1;ATG7;ZDHHC6;SELENOK;ZDHHC8
prerank,response to sterol (GO:0036314),-0.34753105856002414,-0.7732166157311621,0.7354260089686099,1.0,1.0,3/11,13.56%,TGFBR1;RORA;INSIG1
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.3641298233508825,0.7728112801381855,0.7513513513513513,0.9389371154136751,1.0,5/13,13.33%,WNT5A;AGPAT1;GAS6;IL7;IFIH1
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.36279921886139516,0.7727724213974088,0.7461406518010292,0.9385478002550817,1.0,4/15,6.27%,FKBP1A;SMAD7;ACVR2A;ACVR1
prerank,mRNA stabilization (GO:0048255),0.29658633232890386,0.7725281155265034,0.7736434108527132,0.9384728888490479,1.0,15/40,22.93%,TIRAP;HNRNPA0;YBX3;ANGEL2;HNRNPC;ZFP36;PAIP1;YBX1;FUS;DAZL;ELAVL1;TAF15;NOCT;EIF4ENIF1;MAPK14
prerank,histone H4-K16 acetylation (GO:0043984),0.3422125875799068,0.7723851909705688,0.7452339688041595,0.9382235060774192,1.0,6/19,18.42%,PHF20;JADE2;JADE1;JADE3;MSL2;KANSL1
prerank,acylglycerol homeostasis (GO:0055090),0.34281682607656844,0.7722220828784427,0.7504105090311987,0.9380269071754238,1.0,6/20,17.92%,SCARB1;LPL;APOC4;PNPLA8;ANGPTL4;MLXIPL
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.26477967666248303,0.7719759038366178,0.8472775564409031,0.9379192159641135,1.0,25/96,19.96%,HHEX;EIF4E;NXF2;WDR33;THOC2;SMG7;YTHDC1;NUP214;RNPS1;THOC6;NUP98;UPF2;NUP133;NUP205;NUP54;NUP43;NUP153;AGFG1;ALYREF;CDC40;THOC3;THOC1;CPSF1;GLE1;THOC5
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.3417626375584254,0.7719536728715221,0.762684124386252,0.9374915873650497,1.0,6/22,13.76%,LYN;EFNA1;EPHA4;PICALM;RELA;ABCG1
prerank,arachidonic acid secretion (GO:0050482),-0.3459381277379766,-0.771877782279007,0.74,1.0,1.0,2/10,8.12%,ANXA1;BDKRB2
prerank,arachidonate transport (GO:1903963),-0.3459381277379766,-0.771877782279007,0.74,1.0,1.0,2/10,8.12%,ANXA1;BDKRB2
prerank,negative regulation of protein secretion (GO:0050709),0.2981273256194429,0.7717932947218397,0.7754172989377845,0.9372742351304627,1.0,4/38,5.35%,CD200;RAB11FIP1;KCNB1;RAB11FIP5
prerank,entry into host (GO:0044409),0.36640614691207646,0.7707091334459221,0.7267950963222417,0.9385035235141246,1.0,6/13,17.90%,CBLL1;CXCR4;CBL;MET;CTNNB1;GRB2
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.2693953888943538,0.7705879035718447,0.8346774193548387,0.9382360215776584,1.0,3/76,1.96%,TGM2;ESR1;HTR2A
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.38263129160005543,0.7699696775713977,0.7206703910614525,0.9387571619187915,1.0,5/10,22.43%,DISC1;CX3CR1;CTNNB1;KDM1A;CX3CL1
prerank,regulation of cilium movement (GO:0003352),-0.3502718592698252,-0.7690191100873278,0.7692307692307693,1.0,1.0,4/10,25.28%,CCDC39;DNAH11;CFAP43;DRC1
prerank,protein O-linked mannosylation (GO:0035269),0.33795638158172675,0.7685040566696936,0.7189097103918228,0.9405467360187133,1.0,3/18,8.87%,TMTC2;B4GAT1;RXYLT1
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.3277191774835777,0.7683015573639561,0.7491525423728813,0.9403955072635954,1.0,3/23,9.46%,FOXL2;CECR2;DICER1
prerank,mRNA 3'-end processing (GO:0031124),0.2662137202586046,0.7679011107216261,0.8531468531468531,0.9405623683519179,1.0,25/78,26.03%,APP;WDR33;THOC2;RNPS1;THOC6;RPRD1B;MTPAP;RPRD2;CDC73;ALYREF;CDC40;THOC3;THOC1;CPSF1;RPRD1A;THOC5;CPSF6;THOC7;SRSF4;TENT4B;SLU7;CPSF2;PCF11;CPSF3;LSM11
prerank,phosphatidic acid metabolic process (GO:0046473),0.2905153739582502,0.766989349745278,0.8003048780487805,0.9414768398247354,1.0,5/48,7.54%,PLA2G4A;DGKZ;DGKH;PLA2G2D;AGPAT1
prerank,regulation of viral release from host cell (GO:1902186),0.3322692330755529,0.7668762206538506,0.7615894039735099,0.9411853367837937,1.0,3/21,7.85%,CHMP2B;MID2;TRIM25
prerank,positive regulation of organelle organization (GO:0010638),-0.26008657703477145,-0.766744826189391,0.8616187989556136,1.0,1.0,14/32,32.05%,C2CD5;PPARGC1A;ANXA1;ANXA2;TMED9;SMCR8;HTRA2;ADRB2;RAB3GAP1;TREM2;ATL3;PLA2G5;P2RX7;KATNBL1
prerank,cobalamin metabolic process (GO:0009235),0.34914564269047443,0.7666887889973589,0.7596774193548387,0.941029020155796,1.0,6/17,22.89%,ABCD4;CD320;TCN2;MTR;MMAA;LMBRD1
prerank,regulation of monocyte chemotaxis (GO:0090025),-0.2852068042362912,-0.765998647919364,0.8170731707317073,1.0,1.0,6/24,13.20%,NBL1;CCN3;CXCL12;SERPINE1;SLIT2;CREB3
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.319162033265062,0.7659430378067881,0.7865168539325843,0.941711803191202,1.0,4/27,7.03%,CDK6;PDGFB;WNT5A;PDGFC
prerank,regulation of cell aging (GO:0090342),-0.3461466535906631,-0.7657048029863918,0.7690582959641256,1.0,1.0,2/11,6.51%,NEK4;LMNA
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.28957578032013587,-0.765668096718956,0.8274231678486997,1.0,1.0,4/20,11.96%,IL18;LBP;PTPN22;TICAM1
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.32973602868506785,0.7653938246679701,0.750814332247557,0.9421041108912281,1.0,6/23,12.61%,HDAC7;ADGRG3;TMSB4X;NMI;RELA;ADIPOR1
prerank,dendritic cell chemotaxis (GO:0002407),0.35684280805443047,0.7649630512284408,0.7491103202846975,0.9423284125078593,1.0,5/14,23.47%,PIK3CG;CXCR4;CCR1;HMGB1;TRPM2
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),-0.27256902865436883,-0.7645319701154568,0.8206521739130435,1.0,1.0,5/27,8.04%,BRSK1;IL1RAPL1;NTNG1;CTNNA2;ULK4
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.2950356384118021,0.7645209674263853,0.7856049004594181,0.9425443991688766,1.0,14/38,23.15%,GBP5;USP15;SASH1;PUM1;NMI;PUM2;OASL;POLR3B;PLSCR1;CD180;SLC15A4;ZCCHC3;CYBA;RIOK3
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.2852644454499397,-0.7641945911382901,0.8260869565217391,1.0,1.0,5/22,17.29%,ROCK2;PPP4R4;CRY2;PTPA;BOD1L1
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.2873859025568865,0.7635074913014586,0.8066860465116279,0.9432038192396283,1.0,12/50,14.80%,H3-3A;PUM1;IPO8;NUP214;PUM2;NUP98;NUP133;NUP205;FMR1;NUP54;NUP43;NUP153
prerank,regulation of gene silencing by RNA (GO:0060966),0.2873859025568865,0.7635074913014586,0.8066860465116279,0.9432038192396283,1.0,12/50,14.80%,H3-3A;PUM1;IPO8;NUP214;PUM2;NUP98;NUP133;NUP205;FMR1;NUP54;NUP43;NUP153
prerank,mitotic nuclear division (GO:0140014),0.2715939268486406,0.7628226108568801,0.8308724832214766,0.9438234379256868,1.0,20/71,21.61%,EPS8;RAB11A;CHMP4B;STAG2;PPP2R2D;NDEL1;STAG1;LSM14A;CTDP1;CHEK2;RHOA;ABRAXAS2;WRAP73;SMC4;MZT1;BCCIP;PIBF1;PLK1;KPNB1;KIF2A
prerank,autophagy of peroxisome (GO:0030242),-0.32867877030299397,-0.7620589054788058,0.7644444444444445,1.0,1.0,4/12,25.00%,SQSTM1;NBR1;ATM;PEX5
prerank,DNA metabolic process (GO:0006259),0.23327189215868807,0.7620552143699773,0.94,0.9445202638551604,1.0,66/270,22.45%,POLK;SAMHD1;USP3;UHRF2;TCF7L2;CNBP;RNASEH2A;MCM10;RPA1;PRIMPOL;POLA1;CDT1;RAD51D;CDK2;BACH1;BTG2;PARP2;RECQL;RAD18;HELB;FAN1;HUS1;XRCC2;ACD;MMS19;UNG;PARG;LONP1;NOP53;GLRX2;ERCC4;TOP1;NSMCE4A;NPM1;MPG;NUDT15;PRIM2;ENDOV;ORC5;ORC3;GTF2H4;TERF1;PDS5A;RAD21;PDS5B;RFC3;CDC34;KMT5B;USP7;MGMT;NUDT1;CHD1L;GTF2H1;MSH2;ENDOG;RAD17;RMI2;PURA;TRRAP;DBF4;UBE2V2;RNASEH1;RIF1;SIRT7;MBD4;RFC5
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.37317684276053464,0.7618370454422119,0.7504424778761062,0.944406953544538,1.0,4/12,14.03%,ATF7IP;TASOR;PPHLN1;SETDB2
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.31886398373775016,0.7617582223516648,0.7779552715654952,0.9440651104519305,1.0,6/26,14.79%,APP;FBXW7;TGFA;CBL;ADAM17;SOCS4
prerank,recombinational repair (GO:0000725),0.26862171504837595,0.761126501723803,0.8292011019283747,0.9445509514009384,1.0,14/77,14.61%,SAMHD1;MMS22L;RPA1;RAD51D;SEM1;RECQL;MEIOB;FAN1;HUS1;XRCC2;MCM9;RMI1;ERCC4;YY1
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.26537830013553576,0.7609473397319002,0.8387533875338753,0.9443676995769201,1.0,17/69,22.29%,CCNK;GTF2F2;GTF2E2;POU2F1;INTS11;SNAPC3;RPRD1B;GTF2A2;INTS12;RPRD2;POU2F2;RPRD1A;SP1;TAF9;POLR2L;INTS8;POLR2J
prerank,endomembrane system organization (GO:0010256),0.2440401283053569,0.760476552063061,0.8786407766990292,0.9446200808884494,1.0,14/178,8.74%,MYOF;ATP8B1;SPTBN1;PRKD1;CAV2;ALS2CL;DOP1B;CHMP2B;SYNE1;SRGN;TMED7;RAB2A;TMED5;ARHGEF7
prerank,glucan biosynthetic process (GO:0009250),0.3761002960039622,0.760282058881446,0.744954128440367,0.9440093274223321,1.0,5/12,23.25%,GBE1;PGM2;NHLRC1;PGM1;PGM2L1
prerank,glycogen biosynthetic process (GO:0005978),0.3761002960039622,0.760282058881446,0.744954128440367,0.9440093274223321,1.0,5/12,23.25%,GBE1;PGM2;NHLRC1;PGM1;PGM2L1
prerank,protein localization to nucleus (GO:0034504),-0.21339624255392495,-0.7599999715854066,0.9406392694063926,1.0,1.0,25/102,19.90%,COL1A1;APPL2;BMP7;BMP4;SIX1;LMNA;PAF1;MDM2;TSC2;FAM53C;IPO13;POM121;NUP93;INTS13;CNEP1R1;HNRNPU;TNPO2;DVL1;ABCA7;SYK;CHCHD10;RANBP17;NUP107;NOL8;SEC13
prerank,chromosome condensation (GO:0030261),0.3021966054031342,0.7599101014759198,0.7955555555555556,0.9440909066442029,1.0,7/36,18.25%,TENT4A;MCPH1;NCAPH;RB1;SMC4;CSNK2A2;CSNK2A1
prerank,positive regulation of stem cell proliferation (GO:2000648),-0.3051828787687837,-0.7596240560336627,0.7906403940886699,1.0,1.0,5/17,24.55%,GJA1;HNRNPU;LTBP3;TERT;PTPRC
prerank,neuron fate commitment (GO:0048663),0.35355000555207516,0.7594150055243806,0.7637931034482759,0.9443786529979835,1.0,2/14,5.27%,DLL1;DLL4
prerank,establishment of protein localization to extracellular region (GO:0035592),-0.24651085083010393,-0.7590738356359162,0.8456973293768546,1.0,1.0,13/39,24.90%,TANGO2;RCN3;COPG1;STEAP3;MIA3;RAB10;SCG2;LTBP2;NECAB3;RAB8A;OLFM2;CANX;RAB3C
prerank,triglyceride homeostasis (GO:0070328),0.31744745054906565,0.7587097490131369,0.7639553429027113,0.9449838915136697,1.0,7/26,17.92%,SCARB1;XBP1;LPL;APOC4;PNPLA8;ANGPTL4;MLXIPL
prerank,quinone biosynthetic process (GO:1901663),-0.3120583744531914,-0.7585179566256888,0.7510917030567685,1.0,1.0,6/14,31.37%,COQ8B;COQ5;FDXR;COQ10A;COQ10B;COQ6
prerank,transition metal ion homeostasis (GO:0055076),0.31480234130552154,0.7581628584794589,0.7756714060031595,0.9453277247636875,1.0,7/28,17.01%,B2M;ABCB7;XIAP;PICALM;HMOX2;CP;TMC8
prerank,positive regulation of protein transport (GO:0051222),0.2713296457248458,0.7581156277794917,0.8377997179125529,0.9449448804632126,1.0,9/67,9.88%,UNC13B;CD2AP;EXPH5;PRR5L;PCNT;TGFB1;ATP2C1;ANG;VPS28
prerank,lipid droplet organization (GO:0034389),0.32915682220301795,0.7578225357536669,0.773109243697479,0.9449108426742993,1.0,8/22,28.40%,PLIN5;CDS2;RAB18;HILPDA;PPIA;ZFYVE1;AUP1;FAF2
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.2754766843786332,0.7577230175094026,0.8288920056100981,0.9446098603601716,1.0,16/55,22.48%,AURKA;AVEN;PSMA2;FBXL7;PINX1;PSMA8;PSMA6;CUL1;PSME1;PSMA4;PSMF1;PSMB7;PSMB1;PSMD2;PSMA5;PSMC3
prerank,cellular iron ion homeostasis (GO:0006879),0.2801254007578929,0.7577085749997868,0.814388489208633,0.944180756391183,1.0,10/55,17.46%,ABCG2;ABCB7;LCN2;GLRX3;CUL1;HMOX2;CP;FRRS1;NEDD8;NUBP1
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.3646882163696338,0.7574911303648418,0.7535714285714286,0.9440603967732395,1.0,2/12,9.60%,PAEP;IL23A
prerank,protein monoubiquitination (GO:0006513),-0.25190811718078426,-0.7573688812357914,0.8475935828877005,1.0,1.0,7/36,14.32%,PRKN;KLHL22;CTR9;PAF1;LEO1;UBE2B;ATXN7L3
prerank,eosinophil chemotaxis (GO:0048245),-0.31116283319247595,-0.7569154270377834,0.7830188679245284,1.0,1.0,9/14,45.93%,SCG2;CCL2;CCL5;CCL11;CCL4;CCL7;CCL8;CCL1;CCL3
prerank,eosinophil migration (GO:0072677),-0.31116283319247595,-0.7569154270377834,0.7830188679245284,1.0,1.0,9/14,45.93%,SCG2;CCL2;CCL5;CCL11;CCL4;CCL7;CCL8;CCL1;CCL3
prerank,gastrulation (GO:0007369),0.3496516446105151,0.7550395262329984,0.768313458262351,0.9471939169763984,1.0,2/15,6.89%,LRP5;TASOR
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.3205047144235176,0.7540983849435532,0.7678855325914149,0.9481160707902915,1.0,4/26,9.63%,CDK6;CEACAM1;ZFPM1;MAFB
prerank,regulation of mast cell degranulation (GO:0043304),0.35645226625171944,0.7536131333848518,0.7473118279569892,0.948364984621071,1.0,1/14,2.31%,LYN
prerank,regulation of mitotic spindle organization (GO:0060236),-0.25721977437326926,-0.7535778762583907,0.8732782369146006,1.0,1.0,13/35,30.57%,PARP3;GNAI1;GPSM2;RAE1;HNRNPU;DYNC1H1;TPX2;FSD1;CHMP1A;EML3;DCTN1;MAP9;CHMP2A
prerank,cytosolic transport (GO:0016482),0.2529379960017877,0.752718491101364,0.8664021164021164,0.9492411673257714,1.0,21/108,16.10%,MYO1D;LMTK2;STX6;DOP1B;EEA1;VTI1A;AP2A1;GCC2;SPAG9;ANKFY1;TBC1D5;STX8;EHD3;RILP;KIF16B;EVI5;RAB5A;RAB7A;ERC1;RAB6A;RIC1
prerank,hematopoietic stem cell differentiation (GO:0060218),0.37342064195749025,0.7526719053614216,0.743879472693032,0.948861101446316,1.0,1/10,2.17%,MLLT3
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.3183193701724401,-0.7526375624871153,0.7829099307159353,1.0,1.0,8/13,35.41%,SEC16B;CD81;INSIG1;SEC16A;TMEM30B;TM9SF4;SAR1A;SORL1
prerank,regulation of microtubule nucleation (GO:0010968),-0.3443725156625468,-0.7525575649106827,0.7638297872340426,1.0,1.0,1/10,2.14%,EML2
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.2961634233308543,-0.752498750871167,0.7862232779097387,1.0,1.0,6/17,30.49%,P4HB;HSPB1;HTRA2;NME5;TREM2;VNN1
prerank,positive regulation of lymphocyte differentiation (GO:0045621),-0.28294239029405877,-0.7522353863999528,0.8357487922705314,1.0,1.0,7/19,23.46%,AXL;MMP14;MDK;SYK;XRCC6;RHOH;PRKDC
prerank,phagosome maturation (GO:0090382),0.30156027458318296,0.7520610931070096,0.7913561847988078,0.9492967787247482,1.0,8/35,14.72%,ATP6V0A1;RAB38;ATP6V1G2;MREG;RAB43;RAB31;RAB7A;RAB32
prerank,estrogen metabolic process (GO:0008210),-0.3106775219191252,-0.7516534176900717,0.7965686274509803,1.0,1.0,9/15,49.14%,CYP1B1;HSD17B14;HSD17B1;HSD17B2;HSD17B8;CYP1A1;SULT1A1;CYP19A1;HSD17B10
prerank,negative regulation of secretion by cell (GO:1903531),0.2881685851531998,0.7499335169464675,0.8094512195121951,0.951869215408886,1.0,8/38,15.22%,NOTCH1;TNFRSF1B;FGF23;TNFRSF1A;VAMP8;PNKD;RHBDF2;STXBP6
prerank,low-density lipoprotein particle remodeling (GO:0034374),-0.3282464485480824,-0.7494686299223428,0.7849462365591398,1.0,1.0,1/11,6.12%,AGTR1
prerank,RNA export from nucleus (GO:0006405),0.25408129285620606,0.7489819158831671,0.8651102464332037,0.9528219808376498,1.0,25/100,19.96%,HHEX;EIF4E;NXF2;WDR33;THOC2;SMG7;YTHDC1;NUP214;RNPS1;THOC6;NUP98;UPF2;NUP133;NUP205;NUP54;NUP43;NUP153;AGFG1;ALYREF;CDC40;THOC3;THOC1;CPSF1;GLE1;THOC5
prerank,negative regulation of mRNA catabolic process (GO:1902373),-0.25783073838578996,-0.7488502797430531,0.8379052369077307,1.0,1.0,8/29,23.08%,TENT5A;AXIN2;CIRBP;HNRNPU;TENT5C;E2F1;SLC11A1;RBM24
prerank,response to organic cyclic compound (GO:0014070),0.2798828642876764,0.7485478518440498,0.84375,0.9529785914439332,1.0,3/52,2.42%,ESR1;SOCS2;STAT3
prerank,negative regulation of leukocyte activation (GO:0002695),0.3472040724439844,0.7484819652287253,0.7529610829103215,0.9526171138211202,1.0,1/15,1.49%,CD200
prerank,positive regulation of chromosome organization (GO:2001252),0.34154972083843566,0.7484347148739348,0.7563636363636363,0.9522355307470891,1.0,5/15,19.01%,PPP1R10;SIRT6;ATRX;RAD21;DHX36
prerank,regulation of telomere maintenance (GO:0032204),0.30755523093247505,0.7480855678721925,0.8067092651757188,0.9522860150406253,1.0,8/26,19.01%,PPP1R10;HNRNPD;SIRT6;ERCC4;YLPM1;ATRX;USP7;DHX36
prerank,cytoplasmic microtubule organization (GO:0031122),0.2791168121299429,0.7479757585414234,0.836676217765043,0.9519971303303507,1.0,7/54,8.95%,RAB11A;DST;LIMK2;CCDC88A;TRPV4;CAMSAP2;SLK
prerank,regulation of cell cycle phase transition (GO:1901987),0.2560142433389892,0.7474794105352937,0.8743455497382199,0.9522209951793619,1.0,29/91,24.92%,FBXW7;ATP2B4;CDKN1B;PSMA2;ANAPC7;ANAPC1;PSMA8;PSMA6;TFAP4;CDC26;CUL1;ANAPC16;BUB3;PSME1;PSMA4;PSMF1;PSMB7;PSMB1;DBF4;PLK1;PSMD2;PSMA5;PSMC3;UBE2D1;PSMD3;UBE2E1;FBXO5;FZR1;PSMA3
prerank,DNA damage checkpoint signaling (GO:0000077),-0.26761158729412843,-0.7472611522603592,0.8248730964467005,1.0,1.0,11/28,23.98%,CEP63;CLSPN;DOT1L;RHNO1;E2F1;DONSON;USP28;ATR;INTS7;CHEK1;ATM
prerank,positive regulation of viral process (GO:0048524),0.27205939071270446,0.746781563384189,0.8469241773962805,0.9527582602076378,1.0,11/60,16.04%,NR5A2;ADARB1;PKN2;GTF2F2;NELFE;RAD23A;ADAR;CNOT7;RAB7A;NELFCD;CTDP1
prerank,inorganic ion transmembrane transport (GO:0098660),-0.32075614963266896,-0.7465029310227339,0.7846481876332623,1.0,1.0,8/12,42.05%,ABCC9;KCNJ8;CACNA1H;P2RX3;TRPM4;KCNJ11;RHAG;PKD2L1
prerank,regulation of centriole replication (GO:0046599),0.3360310301887174,0.7464299534371049,0.7619047619047619,0.9528407430431252,1.0,6/18,18.62%,PLK2;RBM14;NPM1;KAT2B;CEP295;CDK5RAP2
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),-0.31616467590524605,-0.7461157951863158,0.7915690866510539,1.0,1.0,4/14,10.14%,LPIN1;ETNK2;PCYT2;SLC27A1
prerank,chemical homeostasis (GO:0048878),0.27146923264598655,0.7460331504444531,0.8481012658227848,0.9528888323396614,1.0,7/61,10.33%,KLHL3;NEDD4L;FBXW7;AQP11;TLCD3A;SLC4A7;USF2
prerank,gonad development (GO:0008406),0.2906644121140791,0.7455016018499178,0.8095975232198143,0.9531844274816871,1.0,9/41,17.26%,KITLG;BIK;WNT5A;NCOA4;MAMLD1;ADAM21;SRD5A2;IRX5;CSDE1
prerank,intracellular cholesterol transport (GO:0032367),-0.3055610807085068,-0.7453223033843164,0.8009592326139089,1.0,1.0,4/15,17.68%,LDLR;LRP6;SERAC1;VPS4A
prerank,carbohydrate derivative biosynthetic process (GO:1901137),-0.2672881609635574,-0.7448714751846581,0.8457446808510638,1.0,1.0,8/26,21.01%,LARGE1;GK;GBGT1;TKT;TPI1;GAL3ST2;SCCPDH;ST3GAL4
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.2573933692248304,0.7448639591705186,0.864,0.953650164869992,1.0,13/78,15.61%,PDGFB;HHEX;CCNK;CDKN1B;CCNYL1;PKD2;CCNY;TFAP4;INCA1;CDC25C;ADAM17;APC;CCNJ
prerank,lipid catabolic process (GO:0016042),0.3435085848568414,0.7446282302310078,0.7744755244755245,0.9535170334910107,1.0,3/18,8.49%,LIPE;LPL;PLAAT3
prerank,water-soluble vitamin metabolic process (GO:0006767),0.2668807373648588,0.7445458245178456,0.8484438430311232,0.953179516419714,1.0,12/68,16.09%,SLC2A1;MTHFD1L;SLC52A3;GSTO2;ABCD4;PANK2;TPK1;CD320;SLC19A3;TCN2;RFK;MTR
prerank,cellular response to estradiol stimulus (GO:0071392),0.33836207995379375,0.7439877816805333,0.7785714285714286,0.953527008573322,1.0,1/18,0.95%,ESR1
prerank,cellular response to ATP (GO:0071318),-0.31530004313491244,-0.7438275131486417,0.8034934497816594,1.0,1.0,2/14,8.19%,P2RX4;TAF1
prerank,iron ion transport (GO:0006826),-0.23254212822637021,-0.7434558128266476,0.890282131661442,1.0,1.0,8/47,13.77%,SCARA5;ATP6V0A4;SLC39A14;ATP6V1B2;STEAP3;ATP6V0D1;ATP6V0B;ARHGAP1
prerank,purine-containing compound salvage (GO:0043101),0.35325158723778366,0.7431490853162748,0.7637051039697542,0.9542352016591946,1.0,4/12,19.80%,GMPR;HPRT1;ADA;PNP
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.3665643842581876,0.7429704878563946,0.738404452690167,0.9540167877357932,1.0,3/11,11.86%,CASP8;RFTN1;RIPK1
prerank,positive regulation of protein depolymerization (GO:1901881),-0.3328542063010858,-0.7429597576146529,0.7769953051643192,1.0,1.0,3/11,15.91%,SEMA5A;NES;PLEK
prerank,ERK1 and ERK2 cascade (GO:0070371),0.3204177872377052,0.742361011590113,0.7966942148760331,0.9544273072580649,1.0,1/21,0.83%,KDR
prerank,tRNA processing (GO:0008033),0.26659207887309977,0.7423123479446895,0.8452722063037249,0.954050538897889,1.0,20/61,27.84%,CDKAL1;FARS2;RPP30;TSEN34;RTCB;ADAT1;DTWD2;KARS1;TRMT6;CPSF1;TSEN2;THUMPD1;TRUB1;RTRAF;NSUN6;AARS2;LCMT2;TRMT10C;NSUN2;TSEN15
prerank,regulation of transposition (GO:0010528),0.3536018553655728,0.7423087569576367,0.7538994800693241,0.9536053224387976,1.0,5/13,25.07%,BTBD18;SPOCD1;TEX15;SIRT7;SMYD5
prerank,carnitine shuttle (GO:0006853),-0.32788095078517615,-0.7421775662987894,0.7834821428571429,1.0,1.0,3/11,6.99%,PRKAA2;PRKAG2;ACACA
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.3084013969600712,0.7406487568489555,0.7973856209150327,0.955515543347603,1.0,7/27,16.71%,SKAP1;LCK;CYRIB;RELA;HAS2;TRAF6;RHOA
prerank,snRNA transcription (GO:0009301),0.25833569005830476,0.7402296631038318,0.8656716417910447,0.9556718862975984,1.0,17/70,22.29%,CCNK;GTF2F2;GTF2E2;POU2F1;INTS11;SNAPC3;RPRD1B;GTF2A2;INTS12;RPRD2;POU2F2;RPRD1A;SP1;TAF9;POLR2L;INTS8;POLR2J
prerank,fat cell differentiation (GO:0045444),0.2728882559915496,0.7399803639568767,0.8561046511627907,0.9555903304132479,1.0,6/57,9.63%,FOXO1;TCF7L2;ERAP1;CTBP1;AKT2;MAFB
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.267328214187567,0.7398981650263255,0.844062947067239,0.9552568835045946,1.0,9/62,10.31%,ARHGEF2;ARMC10;TMBIM6;XBP1;DNAJA1;YBX3;BCL2L1;DDIAS;SFRP2
prerank,positive regulation of T-helper cell differentiation (GO:0045624),-0.31113950840185367,-0.7396688810190881,0.812206572769953,1.0,1.0,3/14,7.15%,IL18;ANXA1;PRKCZ
prerank,bicarbonate transport (GO:0015701),-0.2749901732811788,-0.7394144789720974,0.8644501278772379,1.0,1.0,8/25,18.09%,SLC4A10;SLC26A7;CA4;SLC4A3;SLC4A2;SLC26A6;CFTR;SLC4A8
prerank,response to acidic pH (GO:0010447),0.35426571753318153,0.7388881062757335,0.7495590828924162,0.9562471933469033,1.0,4/13,16.45%,RAB11FIP5;LGMN;RAB11B;CHP1
prerank,negative regulation of autophagosome assembly (GO:1902902),0.3506292123363089,0.7388820429306421,0.7544802867383512,0.9558051612676932,1.0,4/13,9.19%,MTM1;FEZ2;CHMP4B;CHMP4A
prerank,telomere maintenance via telomerase (GO:0007004),0.306360285206005,0.7384299763274216,0.7928348909657321,0.9559614948393702,1.0,7/28,16.50%,RPA1;WRAP53;PINX1;CDK2;ACD;HSP90AB1;TERF1
prerank,DNA integrity checkpoint signaling (GO:0031570),-0.2554209105481984,-0.73803175123301,0.8837209302325582,1.0,1.0,14/36,23.98%,CEP63;CLSPN;DOT1L;RAD9B;RHNO1;E2F1;SETMAR;DONSON;USP28;ATR;INTS7;DNA2;CHEK1;ATM
prerank,protein localization to Golgi apparatus (GO:0034067),0.3055617348893364,0.737816960661704,0.8071895424836601,0.9564022162276825,1.0,4/27,8.80%,GBP5;VPS13D;GCC2;ARL5A
prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.282878966665991,-0.7377123542783464,0.8373983739837398,1.0,1.0,4/20,10.14%,PLOD2;GCLC;FPGS;SLC27A1
prerank,response to peptide (GO:1901652),0.29409020573575695,0.7374473107320632,0.8018867924528302,0.9564620085525541,1.0,8/33,17.69%,STAT3;FYN;CACNA1A;EIF2B5;EIF2B2;STAT6;ERBIN;STAT1
prerank,RNA biosynthetic process (GO:0032774),0.3042659079331223,0.7373726130361725,0.8025682182985554,0.9561177593999561,1.0,13/31,30.05%,POLA1;SMARCA5;HELB;PRIM2;SETX;TAF7;TCEA2;BRF1;TTF2;PRIM1;PRMT5;POLA2;RSF1
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.30194327760388073,-0.737196040537034,0.8207547169811321,1.0,1.0,5/15,14.15%,RIPOR2;CAMK1;ADAM9;EHD1;CD53
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.20992431349520363,-0.7371957973010691,0.9461538461538461,1.0,1.0,26/78,23.24%,SEC24D;KIF3C;KIF3A;SEC31A;DYNC1I1;SEC23A;ACTR1B;AP2S1;CTSD;KIFAP3;DCTN5;CAPZB;KLC1;DCTN4;KIF5A;DCTN3;DYNC1H1;CTSL;SEC13;CTSS;KLC2;CD74;LAG3;AP1S1;CANX;DYNC1LI2
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.20992431349520363,-0.7371957973010691,0.9461538461538461,1.0,1.0,26/78,23.24%,SEC24D;KIF3C;KIF3A;SEC31A;DYNC1I1;SEC23A;ACTR1B;AP2S1;CTSD;KIFAP3;DCTN5;CAPZB;KLC1;DCTN4;KIF5A;DCTN3;DYNC1H1;CTSL;SEC13;CTSS;KLC2;CD74;LAG3;AP1S1;CANX;DYNC1LI2
prerank,sensory perception of chemical stimulus (GO:0007606),-0.3012542207577261,-0.7368206794529004,0.8140589569160998,1.0,1.0,8/15,44.34%,GNAS;ADCY3;GNAL;CD36;UBR3;C5AR1;BBS4;SYT10
prerank,fatty acid catabolic process (GO:0009062),0.2627044470966843,0.7361860736357351,0.8620199146514936,0.9572929928956271,1.0,11/67,16.76%,PPARD;ABHD2;LPIN3;HADHA;ECI1;ABCD4;ABCD1;HADH;ALDH3A2;FAAH;AUH
prerank,histone ubiquitination (GO:0016574),-0.28045015479174706,-0.7355977471543097,0.8374384236453202,1.0,1.0,5/21,14.32%,CTR9;PAF1;LEO1;UBE2B;ATXN7L3
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.3342781593175753,0.7353146381799579,0.7688172043010753,0.9580595811782596,1.0,1/15,1.07%,PPARD
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.3115440425494835,0.7352708445133571,0.797979797979798,0.9576639024690815,1.0,9/24,24.36%,PINX1;ACD;DCP2;HNRNPC;ERCC4;TERF1;TEN1;TENT4B;TNKS
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.32027970085675683,0.7342845880960016,0.8075040783034257,0.9585254901301957,1.0,8/21,22.94%,FOSL1;HNF1B;SUB1;DHX36;SETX;MED12;MED17;JUN
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),-0.21155798945635626,-0.7338167809563014,0.924812030075188,1.0,1.0,23/83,24.85%,NINL;HSP90AA1;YWHAG;ALMS1;ATF5;PRKACA;SDCCAG8;CEP63;CEP192;ODF2;CEP152;PCM1;CEP43;DCTN3;DYNC1H1;CKAP5;TP53;HAUS6;TPX2;HAUS2;SFI1;CENPF;CSNK1E
prerank,regulation of mRNA catabolic process (GO:0061013),0.24051797652946116,0.7336653850607494,0.9088699878493317,0.9589158937298504,1.0,32/121,22.48%,ANP32A;IGF2BP3;PRR5L;PSMA2;HNRNPD;XPO1;PUM1;SERBP1;PSMA8;CNOT1;PSMA6;RC3H1;EXOSC1;NUP214;DCP2;PUM2;ZFP36;CNOT7;FMR1;PSME1;PNPT1;ZFP36L1;PSMA4;PSMF1;DHX36;PSMB7;PSMB1;ELAVL1;PSMD2;ZC3H14;PSMA5;PSMC3
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",-0.29993058538617867,-0.7328806424960121,0.808252427184466,1.0,1.0,3/16,17.75%,WBP4;PSIP1;CACTIN
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.3407874001462654,0.7327913455310271,0.7630662020905923,0.9596616219854001,1.0,2/14,9.60%,PAEP;IL23A
prerank,negative regulation of B cell activation (GO:0050869),0.3115752045190914,0.7322827516443302,0.7983333333333333,0.9598915375570575,1.0,3/21,10.78%,LYN;SAMSN1;RC3H1
prerank,apoptotic nuclear changes (GO:0030262),0.3113703322674805,0.7317367356643756,0.7845394736842105,0.9602076236815593,1.0,3/24,9.46%,FOXL2;CECR2;DICER1
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.2713395276396595,0.7315040238293247,0.8539156626506024,0.9596198582739078,1.0,21/51,27.11%,LBR;CHMP2B;CHMP4B;CHMP4A;NUP98;NUP133;NUP205;NUP43;UBE2I;PPP2R2A;VRK1;PPP2R1A;KPNB1;REEP3;NUP85;PPP2CA;SUMO1;CHMP3;ANKLE2;CHMP4C;EMD
prerank,mitotic nuclear membrane organization (GO:0101024),0.2713395276396595,0.7315040238293247,0.8539156626506024,0.9596198582739078,1.0,21/51,27.11%,LBR;CHMP2B;CHMP4B;CHMP4A;NUP98;NUP133;NUP205;NUP43;UBE2I;PPP2R2A;VRK1;PPP2R1A;KPNB1;REEP3;NUP85;PPP2CA;SUMO1;CHMP3;ANKLE2;CHMP4C;EMD
prerank,histone H2A ubiquitination (GO:0033522),-0.290824418261602,-0.7311521552950836,0.803030303030303,1.0,1.0,6/17,21.33%,BCOR;DDB2;UBE2B;RING1;DDB1;PCGF1
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.32361764858420256,0.730928628364225,0.7954939341421143,0.9599420007797921,1.0,6/19,20.76%,PINX1;ACD;DCP2;HNRNPC;TERF1;TEN1
prerank,protein transmembrane import into intracellular organelle (GO:0044743),-0.252655590930302,-0.7303613872547148,0.8828337874659401,1.0,1.0,11/31,27.50%,PEX1;TOMM40;AIFM1;PEX7;TIMM17B;GRPEL2;TIMM21;PEX5;DNAJC15;PEX16;PAM16
prerank,regulation of protein targeting to mitochondrion (GO:1903214),-0.239256024310107,-0.7302793240743731,0.8885542168674698,1.0,1.0,12/38,23.52%,PRKN;SREBF1;NPEPPS;LRRK2;ABLIM3;HPS4;RHOU;HAX1;HTRA2;ATP5IF1;VPS11;FZD5
prerank,regulation of myoblast fusion (GO:1901739),-0.3307594879396999,-0.730145535754057,0.8292134831460675,1.0,1.0,3/11,14.15%,RIPOR2;EHD1;CD53
prerank,Golgi organization (GO:0007030),0.24381629014653555,0.7300961560040937,0.9142857142857143,0.9606577309295171,1.0,11/112,8.74%,ATP8B1;PRKD1;STX6;VAMP4;SYNE1;VTI1A;GCC2;TMED7;RAB2A;TMED5;ARHGEF7
prerank,regulation of early endosome to late endosome transport (GO:2000641),-0.28440071376831716,-0.7298456351600497,0.8111380145278451,1.0,1.0,8/18,22.08%,PTPN23;DAB2;EZR;SRC;MAP2K2;MAP2K1;RAB21;VPS11
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.3035657795710084,0.7295862488249842,0.832,0.9608796844764875,1.0,4/29,4.21%,SCARB1;ELOVL5;PLIN5;SORBS1
prerank,response to hexose (GO:0009746),0.3075861252356753,0.7292062864453422,0.8088962108731467,0.9609139704306066,1.0,6/25,13.78%,TCF7L2;LPL;NEUROD1;EIF2B5;PFKL;EIF2B2
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),-0.29887724681415323,-0.7289027740535915,0.8684807256235828,1.0,1.0,3/17,8.00%,ANK3;AKAP6;KCNAB1
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.3344415856575802,-0.7276725832109964,0.7972350230414746,1.0,1.0,3/10,14.82%,KLF15;THAP7;SNCA
prerank,substantia nigra development (GO:0021762),-0.2434292099520042,-0.72574470506019,0.8693333333333333,1.0,1.0,10/37,18.91%,NDRG2;SIRT2;PLP1;CKB;MBP;COX6B1;S100A1;TTBK1;SEC16A;PADI2
prerank,positive regulation of RNA metabolic process (GO:0051254),0.27859924548677556,0.7256914361994322,0.8516320474777448,0.9651418729370463,1.0,11/45,17.33%,ERN1;RBM20;DYRK1A;TGFB1;NFKB1;HNRNPLL;RIPK1;RELA;RIOK1;PNPT1;HEATR1
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.31135860505930846,-0.7254542376910994,0.8054919908466819,1.0,1.0,6/13,26.38%,CD44;MDM2;SNAI1;CD74;TWIST1;SNAI2
prerank,positive regulation of intracellular protein transport (GO:0090316),0.23828683306119572,0.7254435299542049,0.9171668667466987,0.9650328239236257,1.0,30/144,17.65%,PPP1R13B;FBXW7;FYN;CASP8;KCNB1;MAPK8;TCF7L2;PRR5L;CHP2;PCNT;SH3GLB1;TGFB1;PSEN1;AKT2;UBE2D3;MYO1C;GAS6;SFN;BID;TCAF2;SAE1;YWHAQ;ERBB2;ARIH2;CEP290;CHP1;ANP32B;RAPGEF3;CEP131;CIB1
prerank,snRNA processing (GO:0016180),0.3352802149904632,0.7248577425402899,0.7728813559322034,0.9653515513571319,1.0,6/16,26.79%,INTS11;INTS12;INTS8;TOE1;INTS6L;TUT1
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.2890223536819999,-0.7246998902914512,0.821917808219178,1.0,1.0,4/17,13.41%,PRKN;CD44;MDM2;SNAI1
prerank,regulation of vacuole organization (GO:0044088),0.31587980124464504,0.7245710506889255,0.8291873963515755,0.9652688876518785,1.0,5/20,13.43%,MTM1;TBC1D12;NPRL2;SCARB2;RAB5A
prerank,positive regulation of vacuole organization (GO:0044090),0.36180438811081794,0.7245468005276775,0.7657992565055762,0.9648552215036975,1.0,2/10,6.64%,RALB;SH3GLB1
prerank,histone H2B ubiquitination (GO:0033523),-0.331722428277746,-0.7238894908784091,0.7822410147991543,1.0,1.0,3/10,9.55%,CTR9;PAF1;LEO1
prerank,positive regulation of calcium ion import (GO:0090280),0.3534900385374354,0.7238206629041247,0.7963963963963964,0.9653859069553525,1.0,1/12,1.89%,PDGFB
prerank,autophagosome organization (GO:1905037),0.2712468614425166,0.7233281440742468,0.8575624082232012,0.965554592477185,1.0,16/50,24.22%,ULK1;ATG101;EMC6;GABARAPL1;RAB43;RAB7A;ATG2A;ATG2B;STX12;IRGM;RAB1A;ATG7;UBXN2A;RAB1B;VMP1;RB1CC1
prerank,RNA metabolic process (GO:0016070),0.2394878715832516,0.7231805072145067,0.9223057644110275,0.9652964382910599,1.0,32/127,18.44%,RBPMS;ADARB1;DDX54;ISG20;DROSHA;HNRNPF;RNASE1;GTF2F2;RNASEH2A;HNRNPA0;MTREX;HNRNPK;HNRNPD;RNASE4;LSM8;DICER1;RNGTT;RBM3;ADAR;RNASEH2C;RNASEH2B;HNRNPC;FASTKD2;WTAP;XRN2;DDX20;HNRNPUL1;PNPT1;METTL14;THOC1;PRPF4;HNRNPM
prerank,regulation of mRNA processing (GO:0050684),-0.24112049163259536,-0.7229498168441695,0.885558583106267,1.0,1.0,8/32,18.83%,SON;SRPK2;TIA1;SF1;KHDRBS3;PABPN1;SRSF3;SAFB2
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),-0.3260903591748189,-0.72280770390574,0.8179916317991632,1.0,1.0,4/10,22.65%,LBP;PTPN22;NR1H3;IFI35
prerank,glycoprotein catabolic process (GO:0006516),0.32601560899933846,0.7224200339234657,0.8013937282229965,0.9658447027556265,1.0,1/17,1.62%,STT3B
prerank,regulation of pH (GO:0006885),0.35082750292483034,0.7219456046980052,0.7574626865671642,0.9660411979628609,1.0,3/11,12.08%,CLCN3;ATP1A4;SLC9A7
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.2814751488837981,0.7218890110931274,0.8348484848484848,0.965661437009111,1.0,3/39,2.87%,UTRN;NEDD4L;FXYD6
prerank,regulation of phosphatase activity (GO:0010921),0.311346108256756,0.7217293998173613,0.8386075949367089,0.965422207349007,1.0,6/24,18.88%,PPP1R2;CHP2;GPATCH2;CHP1;TIPRL;MTMR9
prerank,regulation of mitotic spindle assembly (GO:1901673),0.3206273899909121,0.7216531993966048,0.8235294117647058,0.9650761669601433,1.0,7/19,26.73%,CHMP2B;CHMP4B;PLK1;PDCD6IP;CHMP3;HSPA1B;CHMP4C
prerank,negative regulation of DNA recombination (GO:0045910),0.2766724598121003,0.7211766073516432,0.8413897280966768,0.9652391004556733,1.0,13/43,22.29%,SMCHD1;SHLD1;CGAS;MAD2L2;HELB;ACD;ATRX;TERF1;MSH2;RMI2;POLR2L;RIF1;POLR2J
prerank,negative regulation by host of viral transcription (GO:0043922),0.3545300566186587,0.7204902954535637,0.8,0.9656803955949039,1.0,4/12,22.94%,INPP5K;TFAP4;PSMC3;JUN
prerank,platelet aggregation (GO:0070527),0.2895701848110557,0.7199927455355257,0.84,0.9659109162210552,1.0,6/33,12.81%,MYH9;ACTN1;PIK3CG;P2RY12;ITGB3;STXBP3
prerank,meiosis I (GO:0007127),0.315975832062765,0.7194245083754868,0.8268251273344652,0.9661557922203946,1.0,4/23,13.63%,BTBD18;BCL2L11;MEIOB;ZSCAN21
prerank,stem cell differentiation (GO:0048863),0.2849361733645273,0.7194059671168825,0.8445839874411303,0.9657374039534367,1.0,3/39,5.60%,MEF2C;MLLT3;MTF2
prerank,DNA catabolic process (GO:0006308),0.3507017523666627,0.7192539526182075,0.7829181494661922,0.9654678616040722,1.0,2/11,15.01%,ISG20;XRN2
prerank,regulation of cholesterol biosynthetic process (GO:0045540),-0.28566563064801964,-0.7183510889745077,0.8181818181818182,1.0,1.0,3/17,9.84%,FGF1;SREBF1;APOE
prerank,retrograde axonal transport (GO:0008090),-0.28312781086498423,-0.7180462557676249,0.8494117647058823,1.0,1.0,7/16,27.29%,DLG2;KIF1A;KIF5A;DYNC1H1;TMEM108;MAP1A;FBXW11
prerank,sterol metabolic process (GO:0016125),0.2590938861373231,0.7179681893100557,0.8959459459459459,0.9666824808569263,1.0,10/60,14.73%,PPARD;LBR;CH25H;CYP26A1;CYP26C1;SOAT2;CYP39A1;CLN6;ABCG1;PMVK
prerank,nuclear pore complex assembly (GO:0051292),-0.3251365871610463,-0.7177944669104747,0.8218884120171673,1.0,1.0,4/10,19.47%,NDC1;NUP93;RTN4;NUP107
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.2954329160018243,0.7169818346150033,0.816358024691358,0.9674791249757482,1.0,7/29,16.50%,RPA1;WRAP53;PINX1;CDK2;ACD;HSP90AB1;TERF1
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.3309088509541025,0.7165603903815035,0.8085470085470086,0.9675415140885252,1.0,2/16,6.76%,CEACAM1;TRIB3
prerank,negative regulation of TOR signaling (GO:0032007),0.2805819324026218,0.7153278987151598,0.8453453453453453,0.9686455078246433,1.0,5/36,9.75%,SH3BP4;DDIT4;TNFAIP8L1;UBR1;NPRL2
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.28832512404568755,-0.7147449950076528,0.8408071748878924,1.0,1.0,3/16,10.09%,CELF4;DAZAP1;CIRBP
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.3052662742269351,-0.7144586459609941,0.8382022471910112,1.0,1.0,3/13,10.33%,SYT1;CACNA1G;SCAMP5
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.28553795727088904,0.7144368308953039,0.8333333333333334,0.9693191363690179,1.0,4/33,7.41%,HTR2A;EDN1;PIK3C2A;PIK3CG
prerank,regulation of mRNA 3'-end processing (GO:0031440),-0.31270084821825805,-0.7143545076428695,0.8162790697674419,1.0,1.0,4/11,23.87%,PAF1;LEO1;BARD1;ZC3H3
prerank,ribonucleoprotein complex assembly (GO:0022618),0.2328594479292225,0.7139563494346419,0.9107142857142857,0.9694894527725477,1.0,37/132,21.84%,RPS15;RPS19;RPS14;RPSA;RPL38;SRPK3;TGS1;RSL24D1;RRS1;DICER1;YTHDC1;EIF6;RPS27;MCTS1;NOP53;RPL6;RPL10;HSP90AB1;SCAF11;WDR77;DDX20;EIF5;LUC7L2;RPL11;CDC73;STRAP;SRSF10;SART1;RPL3;TRAF7;SART3;RPS28;SETX;DENR;SF3A2;CPSF6;LUC7L
prerank,regulation of mitochondrial translation (GO:0070129),-0.2673126877777059,-0.7137092446097516,0.888095238095238,1.0,1.0,9/21,28.61%,RMND1;UQCC2;FASTKD3;MPV17L2;TRUB2;MRPS27;MTG1;C1QBP;TSFM
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.25161484386244787,0.7135019846486237,0.9094488188976378,0.9696189900497755,1.0,16/84,15.90%,NANOS3;DAPK1;IGF2BP3;NANOS2;GRB7;RNF139;BTG2;RPL13A;CNOT1;MRPL13;RACK1;CNOT7;FMR1;LSM14A;YBX1;PAIP2B
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),-0.23472679672115548,-0.7134561854083925,0.9325513196480938,1.0,1.0,18/40,32.54%,NUCKS1;RTEL1;CDK9;SMARCAL1;BOD1L1;SETMAR;DONSON;ATR;FBH1;POLE;GEN1;POLD1;CENPX;BLM;ZRANB3;EXD2;EME2;WRN
prerank,peptidyl-glutamic acid modification (GO:0018200),0.3108431115597303,0.7129079031400584,0.8023064250411862,0.9699142069172818,1.0,7/24,20.81%,CEP41;TTLL7;TTLL10;NAA11;TTLL5;TPGS1;TTLL9
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.2927825751588756,-0.7126390033747526,0.8405466970387244,1.0,1.0,7/15,25.80%,ADRA2A;APOE;ADAM9;GPLD1;PACSIN3;SNX33;NRDC
prerank,regulation of chromatin organization (GO:1902275),0.333814926200794,0.7124873360453595,0.7963963963963964,0.970010092170442,1.0,4/14,20.64%,MLLT3;PARG;TLK1;SETD5
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.28536421422315367,0.7124205547789524,0.8529862174578867,0.9696611070544703,1.0,7/33,16.50%,RPA1;WRAP53;PINX1;CDK2;ACD;HSP90AB1;TERF1
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.33789590099294603,0.7120132383673811,0.7919847328244275,0.9697222651778161,1.0,3/12,20.71%,WRAP53;CCT7;CCT2
prerank,protein deneddylation (GO:0000338),0.3571664303765685,0.7118433884540123,0.8091603053435115,0.9694581683615633,1.0,2/10,10.85%,COPS2;COPS4
prerank,histone H3-K4 trimethylation (GO:0080182),-0.3158735659256548,-0.7117804255521718,0.8231441048034934,1.0,1.0,4/11,19.12%,OGT;CTR9;KMT2D;BEND3
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.29206577423311997,0.7116577556524176,0.8374613003095975,0.9692314485861783,1.0,8/30,20.91%,FBXW7;SH3GLB1;UBE2D3;SAE1;ARIH2;CSNK2A2;UBE2L3;LEPROT
prerank,negative regulation of cell cycle process (GO:0010948),-0.2132284040899867,-0.7111711656419255,0.9601449275362319,1.0,1.0,18/61,22.61%,BMP7;BMP4;TOM1L2;EHMT2;RBBP7;TFDP1;PCGF2;CBX5;GPER1;RING1;ZFYVE19;E2F1;PCGF6;VPS4A;TERF2;TFDP2;CHEK1;RBBP4
prerank,tetrapyrrole metabolic process (GO:0033013),0.3212824368315015,0.7110573536765952,0.8149920255183413,0.969526513040907,1.0,6/18,22.89%,ABCD4;CD320;TCN2;MTR;MMAA;LMBRD1
prerank,B cell mediated immunity (GO:0019724),0.35660579455175306,0.7108204997309342,0.7696526508226691,0.9693558617356399,1.0,4/10,23.10%,SLA2;CARD9;MSH2;FCER1G
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.2923437352857222,0.7108001137987338,0.8416,0.9689358944942013,1.0,5/31,12.24%,PARD3;MSN;OPHN1;ANK1;PARD3B
prerank,Golgi inheritance (GO:0048313),-0.3198357255846619,-0.7105858420939872,0.8295964125560538,1.0,1.0,2/11,12.24%,GBF1;PLK5
prerank,phospholipid biosynthetic process (GO:0008654),0.28186575376795625,0.710531470860784,0.8460291734197731,0.9688243990098702,1.0,7/36,19.33%,SGMS1;MBOAT1;NUS1;DPAGT1;DOLK;CPNE3;GNPAT
prerank,amyloid-beta metabolic process (GO:0050435),-0.28306286807901787,-0.7103567600928683,0.8525798525798526,1.0,1.0,5/16,19.87%,MGAT3;APH1B;NCSTN;ABCA7;BACE1
prerank,homologous chromosome segregation (GO:0045143),0.31701125082093673,0.7101618824707316,0.8325123152709359,0.9688395522104359,1.0,6/20,25.04%,MEIOB;TERB1;TERB2;PRDM9;SIRT7;FMN2
prerank,oligodendrocyte differentiation (GO:0048709),0.3165504769245124,0.7100709282389406,0.8067796610169492,0.9685112962607361,1.0,4/19,13.78%,SOX13;EIF2B5;PRDM8;EIF2B2
prerank,aromatic amino acid family metabolic process (GO:0009072),-0.33022000059110845,-0.7096480086831622,0.8144329896907216,1.0,1.0,7/10,47.17%,ASRGL1;KYAT1;PCBD1;KYNU;THAP4;IYD;QDPR
prerank,negative regulation of cholesterol transport (GO:0032375),0.3506985378642127,0.7094229546884162,0.7929759704251387,0.9688871231702515,1.0,1/10,7.85%,NFKB1
prerank,calcium import into the mitochondrion (GO:0036444),-0.3201176849570673,-0.7090958397736695,0.8329571106094809,1.0,1.0,5/10,22.60%,MCU;MICU1;SLC25A23;MAIP1;SMDT1
prerank,adrenergic receptor signaling pathway (GO:0071875),0.31459755972992726,0.7090920396030685,0.7982758620689655,0.9688628254217362,1.0,3/20,6.11%,PDE4D;ADRB1;RAPGEF2
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.31175195956024104,-0.7089483122454571,0.8230088495575221,1.0,1.0,1/11,0.87%,GSN
prerank,cellular response to nitrogen compound (GO:1901699),0.31045481895053734,0.7088989770843193,0.8242320819112628,0.9686305857542951,1.0,7/20,16.91%,ATP2B4;AOC1;FMR1;DDI1;ATRX;DDI2;SPIDR
prerank,integrated stress response signaling (GO:0140467),-0.298243047654541,-0.7085682208668719,0.8123515439429929,1.0,1.0,5/14,26.52%,IMPACT;EIF2AK3;EIF2AK1;HSPA5;CCL2
prerank,dendrite self-avoidance (GO:0070593),0.3259162070175345,0.7082965841571291,0.8235294117647058,0.9689146305678348,1.0,3/16,9.24%,BSG;ROBO4;DSCAM
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),-0.1814515487954789,-0.7080022523172883,1.0,1.0,1.0,46/185,25.61%,APPL2;NINL;HECW2;PKD1;SIRT2;HSP90AA1;CDC14B;YWHAG;ALMS1;PSME4;ANAPC5;PRKACA;BTRC;SDCCAG8;RGCC;CEP63;ANAPC15;CEP192;ODF2;PLK5;PSMD12;CEP152;PCM1;CEP43;DDB1;E2F1;XPC;DCTN3;DYNC1H1;PSMC4;NEK11;PSMB6;CDC16;ID2;CKAP5;HAUS6;TPX2;HAUS2;SFI1;PSMD4;UBC;CENPF;PSMC5;CSNK1E;BUB1B;ZFP36L2
prerank,alpha-linolenic acid metabolic process (GO:0036109),-0.3122691618632731,-0.7075757029368978,0.8244111349036403,1.0,1.0,7/12,31.16%,ACSL1;FADS2;SCP2;ELOVL1;FADS1;ACOT8;ELOVL2
prerank,negative regulation of neurogenesis (GO:0050768),0.28039398712182206,0.7074000154761878,0.8384146341463414,0.9695391083419211,1.0,3/34,6.11%,B2M;NOTCH1;RAPGEF2
prerank,positive regulation of leukocyte activation (GO:0002696),0.3162318215759008,0.7072999627130799,0.8347978910369068,0.9692157484263582,1.0,4/18,15.49%,NECTIN2;WNT5A;CRLF2;KARS1
prerank,nuclear membrane reassembly (GO:0031468),0.26105601468740525,0.7068154723866226,0.8695652173913043,0.9693927086816537,1.0,22/54,27.11%,LBR;CHMP2B;CHMP4B;CHMP4A;NUP98;NUP133;NUP205;NUP43;UBE2I;PPP2R2A;VRK1;PPP2R1A;KPNB1;REEP3;UBXN2A;NUP85;PPP2CA;SUMO1;CHMP3;ANKLE2;CHMP4C;EMD
prerank,protein heterooligomerization (GO:0051291),0.31121320227196286,0.7067079622611973,0.8108581436077058,0.9690893571370592,1.0,6/17,21.60%,MAT2A;PKD2;GRIN1;CBR4;KRT10;CPSF6
prerank,modification-dependent macromolecule catabolic process (GO:0043632),-0.32021212174982716,-0.7066913517469031,0.8293838862559242,1.0,1.0,3/10,24.47%,CHFR;TUT4;UBC
prerank,folic acid-containing compound metabolic process (GO:0006760),-0.2723975551186229,-0.7058838154088437,0.8716707021791767,1.0,1.0,5/19,17.40%,ALDH1L1;FPGS;MTHFD1;SLC19A1;MTHFD2L
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.25134250350352183,0.7056049750391706,0.8973277074542897,0.9700023964527413,1.0,20/72,26.59%,POLK;RPA1;COPS2;COPS4;ERCC4;AQR;GTF2H4;RFC3;USP7;GTF2H1;POLR2L;CCNH;POLR2J;RFC5;ERCC6;CUL4B;COPS8;GTF2H5;ISY1;RPA3
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.2424313908956604,0.705492209983963,0.9072847682119205,0.9697038311058032,1.0,25/88,27.08%,FBXW7;FBXL4;PSMA2;FBXL7;FBXL2;PSMA8;PSMA6;CUL1;FBXL3;PSME1;PSMA4;PSMF1;CUL2;FBXO17;PSMB7;PSMB1;PSMD2;PSMA5;PSMC3;CUL4B;PSMD3;PSMA3;FBXW4;FBXL8;FBXL15
prerank,protein kinase B signaling (GO:0043491),0.3067957357166982,0.7052921510226335,0.8341625207296849,0.9694993309548139,1.0,5/23,16.39%,KDR;TGFB1;GAS6;THEM4;ZFP36L1
prerank,regulation of lipase activity (GO:0060191),-0.29914056716100973,-0.7050168805733914,0.843400447427293,1.0,1.0,5/13,18.10%,PCSK5;PCSK6;SNCA;LMF1;ANGPTL3
prerank,positive regulation of mitochondrial translation (GO:0070131),-0.29832289444889015,-0.7047184193910192,0.8302752293577982,1.0,1.0,7/14,27.68%,RMND1;UQCC2;FASTKD3;MPV17L2;TRUB2;MRPS27;C1QBP
prerank,protein import into mitochondrial matrix (GO:0030150),-0.2799153456522015,-0.7046626497338772,0.8734793187347932,1.0,1.0,9/18,37.15%,TOMM40;TIMM17B;GRPEL2;TIMM21;DNAJC15;PAM16;TIMM23;TOMM70;DNAJC19
prerank,DNA strand elongation (GO:0022616),-0.2695755550884989,-0.7043163291144793,0.8602620087336245,1.0,1.0,9/18,32.57%,RAD50;GINS3;GINS1;TERT;POLD2;GINS4;DCLRE1B;MCMDC2;MCM3
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),-0.3180227913755543,-0.7035722239400232,0.82,1.0,1.0,3/10,10.76%,RYK;LRP6;FZD1
prerank,RNA interference (GO:0016246),0.31915535634922404,0.7029254519568775,0.8303249097472925,0.9718712486803376,1.0,5/17,21.33%,DROSHA;DICER1;HENMT1;MRPL44;PRKRA
prerank,C-terminal protein amino acid modification (GO:0018410),-0.30534075409649647,-0.7023922251167353,0.8424657534246576,1.0,1.0,4/11,18.89%,AGBL4;LCMT1;GPLD1;AGBL1
prerank,snRNA metabolic process (GO:0016073),0.3217584935778026,0.7022162541396532,0.8157894736842105,0.9722611865408243,1.0,5/17,22.96%,MTREX;INTS11;INTS12;INTS8;RBM7
prerank,COPII vesicle coating (GO:0048208),0.25381925086711643,0.7021613919227273,0.9165526675786594,0.9709996035739212,1.0,1/61,0.35%,CTSC
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.25381925086711643,0.7021613919227273,0.9165526675786594,0.9709996035739212,1.0,1/61,0.35%,CTSC
prerank,vesicle coating (GO:0006901),0.25381925086711643,0.7021613919227273,0.9165526675786594,0.9709996035739212,1.0,1/61,0.35%,CTSC
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.23797182041062254,0.7018140580532897,0.9358638743455497,0.9709640131978104,1.0,22/104,20.05%,DAB2IP;LRP5;CCNK;RALB;CDKN1B;TRIB3;RPTOR;RB1;TRIB1;CDC25C;CCNJ;IRGM;CALM1;PIH1D1;RHOA;CIB1;CDC37;SYAP1;TSG101;BCCIP;DUSP19;GTF2H1
prerank,positive regulation of intracellular transport (GO:0032388),0.2723990578464969,0.7017377883915816,0.8771121351766513,0.970609330136119,1.0,15/38,25.80%,PGAP1;PRR5L;PCNT;EHD2;NEDD4;CEP290;CEP131;NUMA1;MLC1;TENM1;RIPOR1;STX18;PLK3;RUFY3;B3GAT3
prerank,regulation of cellular response to stress (GO:0080135),-0.19157931841327244,-0.7011759057160696,0.9877551020408163,1.0,1.0,28/115,23.98%,ROCK2;PRKN;NUPR1;HSP90AA1;NEK4;DNAJC7;AMFR;RAE1;POM121;NDC1;NUP93;HSPH1;CAMK2B;CEBPB;NPAS2;USP19;AIFM2;NUP107;SEC13;ATR;EIF4G1;MLST8;BAG3;ADCY8;CLN3;CRYAB;AKT1S1;ATM
prerank,myeloid cell activation involved in immune response (GO:0002275),0.31512660333895054,0.7011402457687713,0.837248322147651,0.9708562155688528,1.0,4/18,15.49%,PLCG2;SBNO2;NMI;KARS1
prerank,mitochondrial gene expression (GO:0140053),0.2703229182179242,0.7010987770897705,0.8631732168850073,0.9704652058563421,1.0,13/42,24.80%,MRPS18A;NDUFA7;TFB2M;MRPS12;FASTKD2;QRSL1;MRPS16;MRPL23;PTCD3;MRPL12;NOA1;RARS2;MRPS11
prerank,"DNA-templated transcription, termination (GO:0006353)",0.2478180464416681,0.701055367802594,0.9062937062937063,0.9700740741102799,1.0,28/68,31.05%,CAVIN1;TAF1B;POLR1A;WDR33;POLR1G;POLR1B;GTF2H4;TAF1A;CPSF1;GTF2H1;POLR2L;CCNH;SETX;SNRPD3;CPSF2;PCF11;TTF2;GTF2H5;CPSF3;LSM11;PAPOLA;PRMT5;POLR1F;CSTF3;GTF2H2;CSTF2T;POLR1H;SNRPB
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),-0.31690762363103153,-0.7009231926088471,0.8305084745762712,1.0,1.0,2/10,4.40%,SIRT2;IMPACT
prerank,regulation of astrocyte differentiation (GO:0048710),0.3330903228666072,0.700606740121146,0.7789855072463768,0.9701746873171818,1.0,2/12,10.81%,NOTCH1;EPHA4
prerank,early endosome to Golgi transport (GO:0034498),-0.31616244328585075,-0.7002351659980193,0.8208955223880597,1.0,1.0,4/11,18.21%,TMED9;TRAPPC10;RBSN;SNX2
prerank,protein export from nucleus (GO:0006611),0.2945469517252723,0.7001621705705647,0.8536977491961415,0.9702566478405705,1.0,8/27,17.35%,SMURF1;TGFB1;DUSP16;XPO1;NUP214;STYX;CHP1;DESI1
prerank,granulocyte chemotaxis (GO:0071621),0.25661991757530284,0.6999607571380974,0.8987161198288159,0.9700307415149089,1.0,5/55,10.40%,EDN1;BSG;PPBP;PIK3CG;CCL14
prerank,regulation of lymphocyte differentiation (GO:0045619),-0.27293174343861093,-0.6995258264299752,0.8663484486873508,1.0,1.0,5/18,25.61%,XRCC6;PRDM1;PRKDC;CCR2;ZFP36L2
prerank,nucleic acid-templated transcription (GO:0097659),0.2705147439091336,0.6992733753615042,0.8825301204819277,0.9703975221022424,1.0,9/42,14.49%,EPC1;PWP1;TAF1B;BCL3;MMS19;RNPS1;PTMA;MEF2A;TOPORS
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.3155608750872475,0.6989931066528899,0.8319604612850082,0.9702782219124096,1.0,4/19,17.56%,CFAP53;SPA17;CABYR;RFX3
prerank,steroid metabolic process (GO:0008202),-0.2009134061099123,-0.6987827937825574,0.9767441860465116,1.0,1.0,15/72,22.71%,CYP7B1;CYP27A1;CYP26B1;CYP1B1;FDX1;PRLR;FDFT1;SCP2;FDXR;CUBN;LSS;DHCR24;CYP51A1;TSPO;DHRS11
prerank,regulation of spindle assembly (GO:0090169),0.29267541753099907,0.6985649112221431,0.8235294117647058,0.9703637881308276,1.0,10/25,26.73%,CHMP2B;CHMP4B;RNF4;NUMA1;PLK1;PDCD6IP;SENP6;CHMP3;HSPA1B;CHMP4C
prerank,telomere maintenance via recombination (GO:0000722),-0.30963718147398867,-0.6984403990902109,0.853448275862069,1.0,1.0,7/11,30.89%,TEP1;RAD50;SMC6;TPRKB;XRCC3;SMC5;ERCC1
prerank,protein-DNA complex disassembly (GO:0032986),0.3201959587671686,0.69817244553956,0.8191304347826087,0.9703842207736778,1.0,8/16,24.68%,ARID1A;RPL23;SMARCE1;GRWD1;SMARCC1;ARID2;SMARCD1;SET
prerank,cranial nerve development (GO:0021545),0.34401007358019464,0.6971940459949769,0.7779816513761468,0.9710829083485127,1.0,1/11,3.59%,CHD7
prerank,DNA-dependent DNA replication (GO:0006261),0.22674475507313915,0.6965746893970001,0.955719557195572,0.9713349966452611,1.0,31/128,22.48%,MCM10;RPA1;PSMA2;PRIMPOL;POLA1;CDT1;CDK2;RECQL;PSMA8;HELB;PSMA6;PSME1;PRIM2;ORC5;ORC3;BAZ1A;RFC3;CDC34;PSMA4;PSMF1;GINS2;MCMBP;PSMB7;PSMB1;PURA;DBF4;PSMD2;SIRT7;PSMA5;RFC5;PSMC3
prerank,regulation of rRNA processing (GO:2000232),0.3256207190182978,0.6961688660437596,0.8074866310160428,0.9713791488256421,1.0,6/16,22.18%,NUDT16;RIOK1;KAT2B;HEATR1;RIOK2;SIRT7
prerank,negative regulation of response to biotic stimulus (GO:0002832),-0.2447140126706912,-0.6957526766855884,0.9263657957244655,1.0,1.0,8/26,18.98%,SIRT2;PCBP2;TRAFD1;ITCH;TRAF3IP1;PPM1B;CACTIN;TYRO3
prerank,outer dynein arm assembly (GO:0036158),-0.28277118838601933,-0.6951157058360043,0.8602941176470589,1.0,1.0,7/15,35.20%,DNAL1;DNAH8;ODAD4;DNAAF5;ODAD1;DNAAF4;CCDC63
prerank,establishment of protein localization to organelle (GO:0072594),0.248709773752623,0.6949803328114017,0.9145527369826435,0.9723129722879886,1.0,19/72,22.68%,RAB11A;STAT3;IPO11;PPP1R10;NEURL1B;IPO8;NUP214;PRICKLE1;NUP133;TNPO3;NUP153;PTTG1IP;E2F3;CSE1L;KPNB1;CD68;HIKESHI;EIF4ENIF1;APPL1
prerank,positive regulation of macrophage differentiation (GO:0045651),0.3470597515558168,0.6947298637144719,0.8118081180811808,0.9721694955670463,1.0,4/11,11.86%,CASP8;TGFB1;CSF1;RIPK1
prerank,endodermal cell fate commitment (GO:0001711),-0.3218008106622792,-0.6941286715507511,0.8407643312101911,1.0,1.0,3/10,9.55%,CTR9;PAF1;LEO1
prerank,mitotic cytokinetic process (GO:1902410),0.29693030352837724,0.6937111263410379,0.8224137931034483,0.9729174255571715,1.0,3/20,9.19%,CHMP2B;CHMP4B;CHMP4A
prerank,cholesterol metabolic process (GO:0008203),0.2483192235316857,0.6936146251100289,0.9113233287858117,0.9725901395973524,1.0,10/68,14.90%,PPARD;LBR;CH25H;SCARF1;SOAT2;CLN6;ABCG1;PMVK;GGPS1;PLPP6
prerank,myelin maintenance (GO:0043217),-0.3111405334142392,-0.6935919506618077,0.8488120950323974,1.0,1.0,1/10,1.47%,EPB41L3
prerank,organonitrogen compound catabolic process (GO:1901565),0.2537880525412606,0.6934855404037087,0.9134078212290503,0.9723033662870236,1.0,13/57,17.26%,PLA2G4A;ENPP2;CTRL;ERAP1;TRIM24;SIAH1;GNPDA2;MPST;CLN6;PNPLA8;ACE;ADO;GGACT
prerank,regulation of isotype switching (GO:0045191),-0.28741338002414063,-0.6927311715519591,0.8764568764568764,1.0,1.0,2/14,5.28%,PARP3;KMT5C
prerank,negative regulation of histone methylation (GO:0031061),0.34270806467325116,0.6916000600491985,0.8014311270125224,0.9740084048334338,1.0,4/10,22.77%,MTF2;JARID2;KDM1A;PHF1
prerank,AMP metabolic process (GO:0046033),-0.2977504157348019,-0.6911129035046162,0.8317972350230415,1.0,1.0,2/13,8.26%,AMPD3;NT5E
prerank,response to amino acid starvation (GO:1990928),0.2497655519127071,0.6910833286470259,0.9379217273954116,0.9741585252705744,1.0,18/72,22.14%,PRKD1;FAS;MAPK8;SH3GLB1;RPTOR;ATP6V1G2;NPRL2;LARS1;EIF2AK4;CASTOR1;RHEB;EIF2AK2;ATP6V1F;KPTN;WDR59;ATP6V1D;TFEB;GCN1
prerank,serine family amino acid metabolic process (GO:0009069),-0.27344241126585256,-0.6909262877109441,0.8665105386416861,1.0,1.0,9/16,34.62%,GCLC;MTHFD1;SARS1;CBS;CTH;SEPSECS;CDO1;THNSL2;PSPH
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.24837784738963303,0.6902720030992596,0.9226519337016574,0.9746137559221003,1.0,6/61,10.43%,CAV1;SIRT5;PSMA2;PANK2;PSMA8;PSMA6
prerank,regulation of cellular response to heat (GO:1900034),0.24002113304097766,0.6900317579549021,0.9125,0.9744451370110371,1.0,29/77,26.71%,CD34;RPA1;RPTOR;NUP214;NUP98;HSP90AB1;NUP133;NUP205;NUP54;NUP43;NUP153;BAG4;CHORDC1;HSPB8;BAG1;DNAJB1;IER5;DNAJB6;BAG2;HIKESHI;YWHAE;FKBP4;DNAJC2;NUP42;NUP85;GSK3B;CREBBP;RPA3;HSPA1B
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.3153779494052631,0.6893867333659931,0.8321678321678322,0.9747412074361868,1.0,4/17,13.83%,STAT3;BACH2;BTN3A3;SLA2
prerank,cellular response to amino acid starvation (GO:0034198),0.2501198783783095,0.6891222906590403,0.938858695652174,0.9745929735016355,1.0,18/71,22.14%,PRKD1;FAS;MAPK8;SH3GLB1;RPTOR;ATP6V1G2;NPRL2;LARS1;EIF2AK4;CASTOR1;RHEB;EIF2AK2;ATP6V1F;KPTN;WDR59;ATP6V1D;TFEB;GCN1
prerank,pre-replicative complex assembly (GO:0036388),0.2465775963945768,0.6890300848689349,0.9330484330484331,0.974254318790312,1.0,19/64,26.30%,PSMA2;CDT1;PSMA8;PSMA6;PSME1;ORC5;ORC3;PSMA4;PSMF1;PSMB7;PSMB1;PSMD2;PSMA5;PSMC3;PSMD3;PSMA3;ORC6;GMNN;MCM6
prerank,ruffle organization (GO:0031529),-0.2837897586238113,-0.6887607708259572,0.8743961352657005,1.0,1.0,5/16,15.91%,TPM1;CARMIL1;AIF1L;ARFIP2;PLEK
prerank,respiratory electron transport chain (GO:0022904),0.32049480238423295,0.6884714781276571,0.8317757009345794,0.9744369269792758,1.0,1/14,2.31%,GPD2
prerank,PERK-mediated unfolded protein response (GO:0036499),-0.314059162267194,-0.6883838616176539,0.8381374722838137,1.0,1.0,3/10,26.52%,EIF2AK3;HSPA5;CCL2
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",-0.283859245834021,-0.6882445738277025,0.8565217391304348,1.0,1.0,6/14,22.27%,BRCA2;XRCC5;TPP1;TERF2;ATR;TERT
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.299678162376104,0.6876264552150643,0.8566493955094991,0.9749431167450734,1.0,9/21,24.90%,RPS7;RPL23;MAD2L2;RPL11;RAB1A;BAG2;PLK1;FBXO5;FZR1
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.2949237687129312,0.6870821690341788,0.8532423208191127,0.975135615449308,1.0,3/20,9.64%,FAS;BOK;BCL2L1
prerank,negative regulation of DNA replication (GO:0008156),0.3255527337016399,0.6863386769315774,0.8208409506398537,0.9755129751296631,1.0,6/13,26.41%,GMNC;TERF1;PDS5A;RAD17;GMNN;GTPBP4
prerank,cell cycle checkpoint signaling (GO:0000075),-0.29867986223315024,-0.6863044094386003,0.8693586698337292,1.0,1.0,2/12,12.53%,ZWINT;CHFR
prerank,cellular response to ionizing radiation (GO:0071479),0.2546984487505306,0.6861088885776525,0.9080118694362018,0.9753327922281089,1.0,13/47,24.15%,NET1;HUS1;RHOB;MAP3K20;TMEM109;SPIDR;GRB2;KDM1A;RPL26;NIPBL;MAPK14;TANK;LIG4
prerank,regulation of transcription by RNA polymerase III (GO:0006359),-0.2679226223057131,-0.6857451357873965,0.877030162412993,1.0,1.0,8/19,29.68%,AR;ICE2;CEBPA;BRF2;MAF1;MTOR;NAB2;ZC3H8
prerank,mRNA processing (GO:0006397),0.2077045361113268,0.6839329026927973,0.9922822491730982,0.9773048576742358,1.0,87/287,25.96%,NOVA2;ERN1;RSRC1;HNRNPF;SF3B4;GTF2F2;CTNNBL1;HNRNPA0;MTREX;HNRNPK;RBM14;HNRNPD;WDR33;THOC2;LSM8;RNGTT;YTHDC1;SPEN;RBM15;RNPS1;LSM3;THOC6;RPRD1B;HNRNPC;RNMT;ZMAT2;SMU1;SF3B6;DHX15;RPRD2;SNRNP25;SCAF11;CWC27;SNW1;YBX1;AQR;HNRNPUL1;CWC22;GTF2H4;ALYREF;CDC40;LSM7;PRPF40A;THOC3;PHF5A;METTL14;RALY;CWF19L2;THOC1;PRPF4;HNRNPM;CPSF1;RPRD1A;SRSF10;FUS;THOC5;GTF2H1;SART1;SART3;POLR2L;ELAVL1;CCNH;SF3A2;CPSF6;POLR2J;PRPF3;AURKAIP1;THOC7;TRA2B;DBR1;SNRPD3;SRSF4;PSPC1;SLU7;CPSF2;SYF2;LSM2;HNRNPA3;PCF11;GTF2H5;RBMX;SNRNP200;CPSF3;PUF60;PRPF40B;ISY1;GCFC2
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.2510929177137297,-0.6835733319709159,0.8816120906801007,1.0,1.0,4/24,13.41%,BCL2;CD44;CXCL12;SNAI1
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.22107267701227798,0.6833639889466762,0.9645909645909646,0.9774823202369329,1.0,31/146,21.22%,RAB11A;PRKAR2B;CEP41;AURKA;PCNT;AVEN;PSMA2;FBXL7;DYNLL1;PINX1;BRD4;CDK2;CNTRL;CEP57;PSMA8;PSMA6;CUL1;CDC25C;PSME1;CEP290;CEP131;CEP72;PSMA4;PSMF1;CETN2;CDK5RAP2;PPP2R1A;PSMB7;PSMB1;PLK1;PSMD2
prerank,glutathione metabolic process (GO:0006749),0.2669862002059974,0.6833326149095189,0.8724340175953079,0.9770787276354047,1.0,8/38,13.97%,GSR;GSTA4;GGCT;GCLM;ETHE1;GLRX2;GSTP1;OPLAH
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.25212247139682437,0.6828072687756106,0.9226441631504922,0.9772255975346238,1.0,8/66,8.82%,WWTR1;CARD10;DTX3L;LIMK2;CHP2;TGFB1;PSEN1;PINX1
prerank,regulation of alcohol biosynthetic process (GO:1902930),-0.29624864781650484,-0.6821182613955882,0.8539823008849557,1.0,1.0,3/12,8.37%,CLCN2;SREBF1;H6PD
prerank,regulation of embryonic development (GO:0045995),0.276045676139892,0.682103857490745,0.8785046728971962,0.977535743530752,1.0,14/34,23.45%,INSR;SOX17;PLCB1;B4GALT5;NR2C2;NIBAN2;CFL1;EHMT1;ZBED3;DHX36;RACGAP1;CRB2;NIPBL;CLASP2
prerank,chemokine-mediated signaling pathway (GO:0070098),0.2625529545429307,0.6813754792794071,0.8951255539143279,0.9778526528840722,1.0,4/42,10.94%,PTK2B;PPBP;CCL14;RBM15
prerank,positive regulation of actin nucleation (GO:0051127),0.33484493328885556,0.6808306154551834,0.8104347826086956,0.9780285367752073,1.0,2/11,5.06%,WASF2;NCKAP1
prerank,protein mannosylation (GO:0035268),0.2938242049176205,0.6807337234602394,0.8618307426597582,0.9776907822848683,1.0,3/22,8.87%,TMTC2;B4GAT1;RXYLT1
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.2918610626057846,0.680113957190813,0.8794567062818336,0.9778993921795532,1.0,5/23,15.26%,NOTCH1;GHR;IL7R;MGAT5;CRLF2
prerank,protein deacylation (GO:0035601),-0.24828435583063183,-0.6799638864782845,0.9310344827586207,1.0,1.0,7/23,20.23%,HDAC4;SIRT2;NOTUM;ABHD10;ABHD17C;PPT1;HDAC3
prerank,positive regulation of protein sumoylation (GO:0033235),-0.3070026831315291,-0.6791977232248355,0.8683035714285714,1.0,1.0,3/10,11.82%,HDAC4;PIAS1;PIAS3
prerank,protein heterotetramerization (GO:0051290),0.3149674332305861,0.6780432435066519,0.8308550185873605,0.9796506357687332,1.0,7/13,27.54%,PKD2;GRIN1;CBR4;KRT10;CPSF6;FARSB;GRIN2B
prerank,protein alkylation (GO:0008213),-0.2558638518384785,-0.6777049398523204,0.9045092838196287,1.0,1.0,7/22,26.15%,LCMT1;VCPKMT;EEF1AKMT1;PRMT8;METTL21A;EEF2KMT;PRMT2
prerank,lipid homeostasis (GO:0055088),-0.2067688650430301,-0.6770327480302442,0.9832214765100671,1.0,1.0,16/57,24.29%,RBP1;ZBTB20;TLCD2;PRKAA2;RCN3;APOE;IRS2;TLCD1;ORMDL2;ANGPTL3;ABCA2;DGAT2;NR1H3;PPARG;CEBPA;POLD1
prerank,nuclear envelope organization (GO:0006998),-0.25618153806261384,-0.6770299353969901,0.8914141414141414,1.0,1.0,7/20,28.34%,DMPK;NUP93;VPS4A;TMEM43;TOR1B;TOR1A;TOR1AIP1
prerank,regulation of p38MAPK cascade (GO:1900744),0.26985313145999945,0.676133070263491,0.8798076923076923,0.981210186902938,1.0,3/35,6.62%,DAB2IP;MFHAS1;SASH1
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.2732941621911813,0.6759537247720184,0.8531684698608965,0.9809657049905184,1.0,7/32,18.25%,LPCAT3;CEPT1;LPIN3;PEMT;CHKA;CSNK2A2;CSNK2A1
prerank,regulation of vesicle-mediated transport (GO:0060627),0.2341124751678462,0.6752545894453776,0.9322709163346613,0.9812436052517756,1.0,21/91,18.65%,HIP1;HIP1R;RAB11A;SCARB1;OPHN1;RNF139;PTPN1;INPP5F;RAB12;ABL2;PICALM;RAB26;RAB11B;RAB5A;RAB5B;SYT7;PACSIN2;RAB8B;CPLX2;USP7;STXBP5
prerank,response to UV-B (GO:0010224),-0.29082363324965277,-0.6751683423462775,0.8914549653579676,1.0,1.0,7/12,37.48%,MFAP4;CDKN1A;HYAL1;CRIP1;HYAL3;MME;IL12A
prerank,peroxisomal membrane transport (GO:0015919),-0.23792810125289204,-0.6747844493316025,0.9060913705583756,1.0,1.0,10/27,27.00%,ABCD3;ATAD1;PEX1;PXMP2;PEX7;PEX11B;PEX5;GDAP1;ABCD2;PEX16
prerank,cellular response to oxygen levels (GO:0071453),-0.29204219100134715,-0.674475420004264,0.8481561822125814,1.0,1.0,6/10,35.27%,CPEB4;ATP6V0D1;TMEM199;CCDC115;ATP6V1G1;ATP6AP1
prerank,negative regulation of translational initiation (GO:0045947),0.3137219352849119,0.6725105355822923,0.813953488372093,0.9836141319113384,1.0,4/13,15.90%,EIF4EBP1;EIF2AK4;FMR1;PAIP2B
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),-0.2961864676411393,-0.6701432970898857,0.8458049886621315,1.0,1.0,3/11,10.76%,RYK;LRP6;FZD1
prerank,tRNA transport (GO:0051031),0.26551336234849743,0.6695648354102025,0.8989441930618401,0.98609240672695,1.0,9/35,17.14%,NUP214;NUP98;NUP133;NUP205;NUP54;NUP43;NUP153;YBX1;XPOT
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.29443609559140727,0.6688670587406329,0.8715277777777778,0.986359714406176,1.0,4/21,12.73%,AIM2;FYN;GRIN1;BIRC3
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.30002474089019243,-0.6686457653083615,0.869098712446352,1.0,1.0,1/10,4.18%,SIRT2
prerank,neurogenesis (GO:0022008),0.2540085000030875,0.668011968791143,0.9034175334323923,0.9867477525964096,1.0,11/43,18.62%,CDK6;BTBD1;BTBD3;NEUROD1;THOC2;CXCR4;NDUFS2;METTL14;TRAK2;BTBD6;CDK5RAP2
prerank,endoplasmic reticulum mannose trimming (GO:1904380),-0.2591168105164887,-0.667844938671954,0.8953771289537713,1.0,1.0,2/18,7.20%,UGGT2;AMFR
prerank,protein K63-linked ubiquitination (GO:0070534),0.25704935249565525,0.6663614243059325,0.918622848200313,0.9879664401767189,1.0,9/41,15.54%,TRAF1;PELI1;UBE2G1;NEDD4;RNF4;HECTD1;TRAF6;ARIH2;RNF5
prerank,COPII-coated vesicle budding (GO:0090114),0.23696734221176874,0.6662121505943718,0.9460916442048517,0.9876711881723638,1.0,1/68,0.35%,CTSC
prerank,regulation of pseudopodium assembly (GO:0031272),0.3312876488872736,0.6649068293368154,0.827708703374778,0.9881220939520697,1.0,2/10,14.29%,CDC42EP3;APC
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.3312876488872736,0.6649068293368154,0.827708703374778,0.9881220939520697,1.0,2/10,14.29%,CDC42EP3;APC
prerank,peptidyl-arginine modification (GO:0018195),0.3048293500175893,0.6648271653226109,0.859375,0.9877614563574992,1.0,4/15,21.15%,PADI4;PADI1;ART4;KRTCAP2
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.28701752248619944,0.6644750936086858,0.8818770226537217,0.9876731750764925,1.0,2/23,6.07%,CAV1;DUSP22
prerank,negative regulation of cation channel activity (GO:2001258),-0.2375628084387973,-0.6639456700540556,0.9470899470899471,1.0,1.0,9/26,26.51%,SLC6A9;GNB5;KCNAB1;GSTM2;CASQ2;CBARP;EPHB2;GPR35;EPO
prerank,positive regulation of viral transcription (GO:0050434),0.2751645485291883,0.6630682898508944,0.8887096774193548,0.9885539064858828,1.0,8/25,22.29%,GTF2F2;NELFE;NELFCD;CTDP1;NELFB;POLR2L;NELFA;POLR2J
prerank,chromosome organization (GO:0051276),0.2249682040711521,0.663024051053973,0.9573643410852714,0.9881577205711664,1.0,25/99,24.15%,HHEX;PADI4;TCF7L1;H3-3A;MTF2;TCF7L2;CDT1;EZH1;COPS2;COPS4;PADI1;NUP133;HMG20A;PHF19;EHMT1;CETN2;BAHD1;MSH2;GATAD1;LATS1;SUV39H1;PHF1;CUL4B;COPS8;LIG4
prerank,base-excision repair (GO:0006284),-0.20526928545808165,-0.6627866759204519,0.9817073170731707,1.0,1.0,21/48,32.70%,ERCC5;RFC1;USP47;APEX2;NEIL3;DNA2;POLE;MUTYH;POLG;TDG;NTHL1;POLD1;POLB;POLD2;NEIL1;LIG1;ADPRS;RPA2;FEN1;WRN;PRMT6
prerank,import into nucleus (GO:0051170),0.23601051685482619,0.6611733462456243,0.9495912806539509,0.989504982158678,1.0,21/73,25.16%,STAT3;IPO11;PPP1R10;BACH2;IPO8;NUP214;PRICKLE1;NUP133;TNPO3;NUP153;DDX20;PTTG1IP;E2F3;CSE1L;KPNB1;HIKESHI;EIF4ENIF1;APPL1;SNRPD3;NUP85;SNUPN
prerank,regulation of DNA metabolic process (GO:0051052),0.24925232603965058,0.6607973295348781,0.914616497829233,0.989451425339108,1.0,16/44,27.03%,HNRNPD;CDT1;IL7R;SUB1;HELB;PARG;YLPM1;ALYREF;WDR18;THOC1;UBE2V2;SIRT7;SMG6;UBE2N;SMARCAD1;TICRR
prerank,cellular response to virus (GO:0098586),0.2689261127534482,0.6607236178937861,0.890625,0.9890804665695996,1.0,12/30,25.22%,HIF1A;MAPK11;IFIH1;FMR1;RRP1B;IRGM;POU2F2;POU2AF1;MAPK14;RIOK3;EIF5A;CXCL10
prerank,negative regulation of interferon-gamma production (GO:0032689),-0.24489711073472317,-0.6604523521132786,0.9259259259259259,1.0,1.0,2/23,9.38%,AXL;INHBA
prerank,regulation of microtubule-based movement (GO:0060632),-0.30618616526711595,-0.660376116296873,0.8747203579418344,1.0,1.0,5/11,33.04%,MAP2;TTC21B;DRC1;NEFH;LAMP1
prerank,regulation of membrane depolarization (GO:0003254),0.3013966666821506,0.6599547305359474,0.8783333333333333,0.9894043846849437,1.0,2/18,5.17%,NEDD4L;SMAD7
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.3170159120235575,0.6595540333357877,0.8455743879472694,0.9893504788903115,1.0,7/12,28.93%,NELFE;NELFCD;NELFB;NELFA;EAPP;RNF168;RNF8
prerank,calcium-ion regulated exocytosis (GO:0017156),-0.2331067472066487,-0.6588710741757013,0.9398496240601504,1.0,1.0,4/27,6.74%,SYT1;SYT9;SYT12;SYT11
prerank,regulation of protein sumoylation (GO:0033233),0.29692651659641006,0.658199319444632,0.8491803278688524,0.9902156794131717,1.0,4/17,16.74%,RASD2;ZMIZ1;SAE1;CTNNB1
prerank,positive regulation of exosomal secretion (GO:1903543),-0.27669233002179194,-0.6579918241842561,0.9011494252873563,1.0,1.0,5/15,17.68%,SDC4;SMPD3;SDC1;SNF8;VPS4A
prerank,cytoplasmic sequestering of protein (GO:0051220),0.3143995912630226,0.6571589378610208,0.8434163701067615,0.9907247181682705,1.0,3/13,11.62%,NFKBIA;PKD2;NFKBIE
prerank,'de novo' posttranslational protein folding (GO:0051084),0.26545015707272224,0.6571208259394272,0.9080645161290323,0.9903155236955056,1.0,12/30,28.05%,DNAJB5;ERO1A;UGGT1;BAG1;HSPE1;DNAJB12;DNAJB1;CCT2;GAK;HSPA1B;HSPA13;HSPA14
prerank,histone mRNA metabolic process (GO:0008334),0.27290842979436736,0.6565548949491512,0.896551724137931,0.990406404604301,1.0,13/27,31.05%,DCP2;MTPAP;LSM1;SNRPD3;TENT4B;CPSF2;CPSF3;LSM11;EXOSC4;TUT1;TUT7;ERI1;SNRPB
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.31156063700389447,0.6559856076439198,0.8485981308411215,0.9904939619370133,1.0,7/13,28.93%,NELFE;NELFCD;NELFB;NELFA;EAPP;RNF168;RNF8
prerank,regulation of store-operated calcium entry (GO:2001256),0.3218833258557539,0.6550066442464667,0.8357400722021661,0.9909737290474304,1.0,4/10,21.77%,HOMER2;HOMER3;HOMER1;CASQ1
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.2859405200070718,0.6547066163752098,0.8967851099830795,0.9907956921302863,1.0,4/19,13.07%,PARD3;FSCN1;PARD3B;CLIC4
prerank,protein-containing complex disassembly (GO:0032984),0.24411628903612592,0.6546344281393661,0.9336158192090396,0.9904192960616031,1.0,6/54,14.29%,CAV1;TECPR1;RPL23;VAMP8;GABARAPL1;APC
prerank,negative regulation of mRNA processing (GO:0050686),-0.26708432622821887,-0.6539510040506005,0.8988235294117647,1.0,1.0,6/15,31.78%,U2AF2;PCBP4;BARD1;SRSF6;C1QBP;SRSF9
prerank,regulation of mitochondrial membrane permeability (GO:0046902),-0.2504169467804556,-0.6539490788315161,0.9050925925925926,1.0,1.0,1/18,1.56%,BCL2
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.2923561788987927,-0.6537592041495595,0.87248322147651,1.0,1.0,4/11,20.04%,PRKN;NONO;REST;NR4A3
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.28414784043090396,-0.6535283277522976,0.8656716417910447,1.0,1.0,4/11,25.19%,TIMM22;TIMM8B;TIMM9;TIMM10
prerank,miRNA mediated inhibition of translation (GO:0035278),0.31575276306064265,0.6534316258918942,0.8458646616541353,0.9906508814319526,1.0,3/11,12.67%,TNRC6C;EIF6;ZFP36
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",0.31575276306064265,0.6534316258918942,0.8458646616541353,0.9906508814319526,1.0,3/11,12.67%,TNRC6C;EIF6;ZFP36
prerank,secondary alcohol metabolic process (GO:1902652),0.25053145466110116,0.6534061710773287,0.9233038348082596,0.9902334535946051,1.0,5/42,13.76%,PPARD;CH25H;SOAT2;CLN6;ABCG1
prerank,maturation of 5.8S rRNA (GO:0000460),-0.2561474340244981,-0.6526771178740715,0.9137529137529138,1.0,1.0,3/17,14.86%,NSA2;FTSJ3;RRP15
prerank,protein insertion into mitochondrial membrane (GO:0051204),-0.23973375344591896,-0.6518901476128381,0.9287469287469288,1.0,1.0,10/23,29.99%,HSP90AA1;TIMM22;COX18;MAIP1;TIMM8B;BAX;TIMM9;TIMM10;SAMM50;PMAIP1
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.32185814895552384,0.6518817891745852,0.8486486486486486,0.991179541244944,1.0,4/11,22.18%,PWP1;NOP53;PIH1D1;SIRT7
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-0.2595609952416789,-0.6507700138477331,0.9112709832134293,1.0,1.0,5/18,21.76%,PRKN;NONO;HSPB1;HTRA2;NME5
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.2881376062592713,0.6507404749765899,0.8824593128390597,0.991766499420212,1.0,1/18,2.14%,DAB2IP
prerank,regulation of lipid catabolic process (GO:0050994),-0.25272357958155395,-0.6501577187934577,0.9159090909090909,1.0,1.0,4/19,18.10%,ADRA2A;ALK;RARRES2;ANGPTL3
prerank,regulation of sequestering of triglyceride (GO:0010889),0.302268808809489,0.647683894343628,0.8540540540540541,0.9940527283718412,1.0,4/15,14.42%,PLIN5;LPL;PNPLA2;APOC4
prerank,regulation of superoxide anion generation (GO:0032928),-0.2679148793664004,-0.6475453758194146,0.9009216589861752,1.0,1.0,4/14,22.18%,PRKCD;SYK;ITGB2;AATF
prerank,toxin transport (GO:1901998),0.3266809135340235,0.6475331677375811,0.8600746268656716,0.9937383374129259,1.0,1/10,2.40%,ADAM10
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.28196068998707724,0.6473429082777423,0.8737541528239202,0.993466645028344,1.0,3/22,12.53%,MFHAS1;SASH1;XDH
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.20637733762303687,0.6471270821010512,0.9891956782713085,0.9932292985875621,1.0,23/173,14.53%,CTSC;SPTBN1;PGAP1;F7;PROS1;VAMP4;COG5;VTI1A;TGFA;TMED7;DYNLL1;RAB2A;DYNC1LI1;TMED5;ANK1;SPTAN1;GAS6;TRAPPC3;PREB;ACTR10;CAPZA1;PROC;NRBP1
prerank,protein import into nucleus (GO:0006606),0.2328929447959406,0.6466134501852209,0.9589603283173734,0.9932556881010854,1.0,19/66,22.68%,STAT3;IPO11;PPP1R10;RPL23;IPO8;NUP214;PRICKLE1;NUP133;NUP54;TNPO3;NUP153;PTTG1IP;E2F3;CSE1L;KPNB1;KPNA4;HIKESHI;EIF4ENIF1;APPL1
prerank,regulation of inclusion body assembly (GO:0090083),0.31939345948370446,0.6465444942825123,0.8568807339449541,0.9928860147121831,1.0,3/11,20.03%,SNCAIP;DNAJB1;DNAJB6
prerank,dopaminergic neuron differentiation (GO:0071542),-0.2532242438819374,-0.6461708558897139,0.910761154855643,1.0,1.0,3/19,9.30%,RYK;LRP6;VEGFA
prerank,reticulophagy (GO:0061709),0.3132277560729664,0.6460251816510847,0.8405017921146953,0.9928885953098683,1.0,5/12,25.09%,ULK1;ATG2A;ATG2B;RB1CC1;UFM1
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.26706100081659007,0.6455550167936528,0.9032258064516129,0.9928759900748092,1.0,6/27,15.02%,CEPT1;LPIN3;PLA2G2D;PLAAT3;CHKA;PNPLA8
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.23136807596175016,0.6452850255418385,0.9539106145251397,0.9926863316609104,1.0,16/65,22.48%,AURKA;AVEN;PSMA2;FBXL7;PINX1;PSMA8;PSMA6;CUL1;PSME1;PSMA4;PSMF1;PSMB7;PSMB1;PSMD2;PSMA5;PSMC3
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.28719958223690617,0.6450966465097191,0.8948306595365418,0.9924053576237504,1.0,11/18,35.21%,DCP2;CCT7;CCT2;RUVBL1;RUVBL2;PARN;CCT8;NOP10;CCT6A;DKC1;EXOSC10
prerank,positive regulation of peptidase activity (GO:0010952),-0.24416109212258302,-0.644068247992823,0.9072164948453608,1.0,1.0,4/20,17.51%,RCN3;APH1B;NCSTN;DDRGK1
prerank,intracellular protein transmembrane transport (GO:0065002),-0.2110783968092012,-0.6437741293387499,0.9674556213017751,1.0,1.0,15/42,27.50%,C2CD5;PEX1;TOMM40;AIFM1;SEC61A2;PEX7;TIMM17B;GRPEL2;TIMM21;SEC61A1;PEX5;DNAJC15;HSPA5;PEX16;PAM16
prerank,RNA methylation (GO:0001510),0.2379494085292554,0.643606991277715,0.9534555712270804,0.9932678776696947,1.0,19/60,27.21%,TGS1;CBLL1;RBM15;TFB2M;NSUN4;FBLL1;HENMT1;WTAP;VIRMA;TRMT6;METTL14;NSUN6;ALKBH8;LCMT2;TRMT10C;TRMT61B;TRMT12;METTL16;NSUN2
prerank,regulation of chromosome organization (GO:0033044),0.2751008675914645,0.6435993742343795,0.884430176565008,0.992841754921499,1.0,7/22,24.15%,HNRNPD;CDT1;RB1;YLPM1;RMI2;SMG6;LIG4
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.23986126113888115,0.6427597962672053,0.9421128798842258,0.993150570253258,1.0,17/50,24.06%,PAK2;RPS6KA3;RPS6KA1;XIAP;GAS6;SFN;CARD16;PIH1D1;ARL6IP1;MAP2K5;CAAP1;CSNK2A1;DNAJB6;IGBP1;PLAUR;YWHAE;RFFL
prerank,ncRNA metabolic process (GO:0034660),0.25564936628750246,0.6423698364563915,0.9355322338830585,0.9930355482438106,1.0,5/37,13.10%,DTD1;DROSHA;NIFK;DICER1;HENMT1
prerank,histone H2A acetylation (GO:0043968),-0.24928310676912452,-0.6417150217708385,0.8955555555555555,1.0,1.0,6/16,23.36%,NAA40;MORF4L2;BRD8;ACTL6A;MEAF6;SPHK2
prerank,microtubule depolymerization (GO:0007019),-0.255294232759915,-0.641675359525584,0.9376558603491272,1.0,1.0,6/17,32.01%,KIF24;NCKAP5L;CKAP5;KIF18B;STMN4;STMN2
prerank,axonemal dynein complex assembly (GO:0070286),-0.22309050500647032,-0.6415040527625874,0.9397260273972603,1.0,1.0,12/28,35.20%,DNAI4;DNAL1;DNAH8;CCDC39;SPAG1;DRC1;TTC12;ODAD4;DNAAF5;ODAD1;DNAAF4;CCDC63
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.3106265953427111,0.6401081030739374,0.8534322820037106,0.9945196655609956,1.0,3/12,13.76%,NFKBIA;ITGB3;ABCG1
prerank,rRNA pseudouridine synthesis (GO:0031118),0.32270416169731975,0.6400804933236367,0.8809073724007561,0.9941093293445051,1.0,10/10,67.75%,RPUSD2;RPUSD4;RPUSD1;TSR3;NOP10;DKC1;NAF1;GAR1;RPUSD3;NHP2
prerank,negative regulation of amyloid fibril formation (GO:1905907),-0.2768783413848013,-0.6390701090165094,0.9,1.0,1.0,2/12,9.84%,LDLR;APOE
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.2349276972494284,-0.6386310925032246,0.9396984924623115,1.0,1.0,7/23,24.47%,DDB2;COPS7B;DDB1;XPC;COPS6;CUL4A;UBC
prerank,regulation of interferon-alpha production (GO:0032647),-0.23478234891083566,-0.6381357376538762,0.9360613810741688,1.0,1.0,3/23,13.78%,PTPRS;CHUK;MAVS
prerank,negative regulation of protein metabolic process (GO:0051248),0.2423885416831157,0.6378380867923319,0.9226277372262773,0.9955458543499702,1.0,11/48,15.63%,EDN1;PTX3;SNX3;NFKB1;MAD2L2;ITGB3;RILP;HSP90AB1;PFDN1;PRKCG;IRAK3
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.2209486025178417,0.6377675258387657,0.963758389261745,0.9951775741035042,1.0,31/79,27.02%,KIF26A;AP2B1;MFSD6;AP2A1;DYNLL1;DYNC1LI1;KIF22;AP1S2;KIF23;LGMN;RILP;ACTR10;CAPZA1;RAB7A;AP1S3;SH3GL2;OSBPL1A;KIF4A;RACGAP1;AP1G1;KIF2A;DCTN6;FCER1G;KIF18A;SAR1B;AP2M1;CAPZA2;CLTA;DNM2;CTSE;SPTBN2
prerank,protein import into peroxisome membrane (GO:0045046),-0.24068513625243437,-0.6373556438237822,0.9346733668341709,1.0,1.0,8/22,27.00%,ABCD3;ATAD1;PXMP2;PEX11B;PEX5;GDAP1;ABCD2;PEX16
prerank,autophagosome maturation (GO:0097352),-0.2155247058073522,-0.6369365434817706,0.947075208913649,1.0,1.0,11/32,29.09%,LAMP2;ATP2A2;LIX1;LIX1L;VPS16;VIPAS39;STX17;CLN3;GABARAP;WIPI2;EPG5
prerank,regulation of protein localization to Cajal body (GO:1904869),0.3109855618330196,0.6367547576076757,0.8528301886792453,0.9951743029614993,1.0,11/11,68.92%,CCT7;CCT2;CCT8;CCT6A;DKC1;LARP7;CCT4;CCT3;CCT5;TCP1;MEPCE
prerank,positive regulation of protein localization to Cajal body (GO:1904871),0.3109855618330196,0.6367547576076757,0.8528301886792453,0.9951743029614993,1.0,11/11,68.92%,CCT7;CCT2;CCT8;CCT6A;DKC1;LARP7;CCT4;CCT3;CCT5;TCP1;MEPCE
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.2785585450783348,0.6363990832009595,0.8877721943048577,0.9950441105004443,1.0,7/20,19.37%,NT5C2;AK4;ADSL;HPRT1;IMPDH1;ADSS2;GART
prerank,glutathione biosynthetic process (GO:0006750),0.3125488731203385,0.635509146128048,0.8578947368421053,0.9953352105178652,1.0,3/11,13.97%,GGCT;GCLM;OPLAH
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.2894687849771994,0.6353123790520767,0.8809946714031972,0.995063815060312,1.0,6/16,23.47%,BCL2L1;DDIAS;SFRP2;TPT1;RPS3;CLU
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.28180811988217963,0.6347880527472687,0.896551724137931,0.9950594903178565,1.0,5/18,15.85%,RAP1B;RAP1A;RAB5A;FMR1;RIMS4
prerank,proteasome assembly (GO:0043248),0.3033987021510492,0.6341111307225534,0.8513761467889909,0.9951857885236658,1.0,5/11,30.91%,POMP;PSMG2;ADRM1;OTUD6B;PSMG1
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.2966571248016991,0.6338163067533525,0.8763636363636363,0.9949814622539103,1.0,4/13,24.96%,DUT;UNG;MBD4;NEIL2
prerank,Golgi to lysosome transport (GO:0090160),0.3085814513257467,0.6337081483641196,0.8587570621468926,0.9946372249503763,1.0,5/11,27.39%,ANKFY1;EHD3;AP1G1;GAK;SORT1
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.2524248532294489,0.633539924158667,0.9240121580547113,0.9943539497677027,1.0,1/34,1.15%,MEF2C
prerank,regulation of mitotic sister chromatid separation (GO:0010965),0.3015460109940602,0.6328071721750114,0.8894645941278065,0.9944812466910637,1.0,3/15,9.73%,NEK6;ANAPC7;ANAPC1
prerank,protein K11-linked ubiquitination (GO:0070979),0.26506527372810723,0.6325008000516356,0.9022801302931596,0.9942953531904362,1.0,6/27,11.24%,UBE2H;ANAPC7;RNF4;ANAPC1;UBE2D3;CDC26
prerank,regulation of immunoglobulin production (GO:0002637),-0.23262107262354914,-0.6323791672541427,0.9447236180904522,1.0,1.0,6/23,26.98%,RBP4;STX4;CLCF1;EPHB2;PTPRC;FCGR2B
prerank,gas transport (GO:0015669),0.31423011738120654,0.632232530558282,0.8728971962616823,0.9940740899688676,1.0,10/10,68.60%,CA2;IPCEF1;AQP5;MB;AQP6;CYGB;RHAG;NGB;AQP1;MYC
prerank,ovarian follicle development (GO:0001541),0.3006068835298311,0.63142601172018,0.850187265917603,0.9942751054975708,1.0,4/13,13.78%,FOXL2;EIF2B5;ANG;EIF2B2
prerank,protein processing (GO:0016485),0.2129364688496794,0.6311627869703765,0.9831606217616581,0.9940604144139957,1.0,19/102,16.29%,ADAM10;CASP4;CPD;CPE;F7;SRGN;CASP1;PSEN1;APH1A;PITRM1;LGMN;OMA1;SPCS1;ADAM17;PCSK7;VSIR;SPPL3;ZMPSTE24;DDI2
prerank,protein localization to centrosome (GO:0071539),-0.2518365941983156,-0.6308179369120914,0.9311163895486936,1.0,1.0,4/17,18.88%,GOLGB1;CEP192;PCM1;C2CD3
prerank,ER-associated misfolded protein catabolic process (GO:0071712),-0.2802513454843952,-0.6307150245828832,0.8911111111111111,1.0,1.0,1/11,3.76%,UGGT2
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),-0.21951873811983919,-0.6304604550503452,0.9518716577540107,1.0,1.0,11/28,32.63%,MAP2;MAP1S;MAP1A;CAMSAP3;STMN4;CLASP1;SKA3;MAPRE1;GBA2;STMN2;ARL2
prerank,myeloid dendritic cell activation (GO:0001773),0.3056222225348383,0.6301704945794546,0.8705035971223022,0.9944113894021336,1.0,2/12,12.94%,DCSTAMP;TGFBR2
prerank,regulation of response to stress (GO:0080134),-0.27794772003749746,-0.6298959133318643,0.888402625820569,1.0,1.0,5/10,35.34%,EIF4G1;ADCY8;SLC38A2;CORO2B;DYRK3
prerank,cilium-dependent cell motility (GO:0060285),-0.23591694675361083,-0.6294516153070204,0.9358024691358025,1.0,1.0,8/22,25.28%,CFAP44;DNAH8;CCDC39;RSPH9;EFHC1;GAS8;DNAH2;DRC1
prerank,lysosome localization (GO:0032418),0.2463762612347501,0.6292701831375599,0.9431643625192012,0.9946724779706104,1.0,11/37,24.16%,MYH9;PIK3CG;SPAG9;ARL8B;NDEL1;SYTL4;PLEKHM1;TFEB;HDAC6;RAB3A;BORCS5
prerank,cellular respiration (GO:0045333),-0.20545653179315695,-0.6276273513514953,0.9724517906336089,1.0,1.0,15/41,29.84%,PPARGC1A;SLC25A13;SDHAF4;NR4A3;SLC25A14;MTFR1L;COQ10A;SDHC;UQCRB;NDUFS7;MDH2;COQ10B;UQCR10;COX4I2;MTLN
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.20534915859866046,0.6274017051440981,0.986335403726708,0.9956806020208414,1.0,24/129,18.62%,TPD52L1;PLCB1;PRKAR2B;PPP1R12A;CEP41;AURKA;PCNT;FBXL7;DYNLL1;CCNY;CDK2;CNTRL;CEP57;BACH1;CUL1;CDC25C;FBXL3;CEP290;CHEK2;CEP131;CEP72;PPP2R2A;CETN2;CDK5RAP2
prerank,microtubule polymerization (GO:0046785),-0.224185950044496,-0.6273718658276738,0.946236559139785,1.0,1.0,10/29,31.47%,TUBGCP5;MAP7D3;TPPP3;CKAP5;CCDC57;TPX2;CLASP1;FGF13;GOLGA2;TPPP
prerank,oligodendrocyte development (GO:0014003),0.29222781998653274,0.6265239178294789,0.8818493150684932,0.9959218340708901,1.0,4/15,13.78%,B4GALT5;EIF2B5;PRDM8;EIF2B2
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.21712150508733402,-0.6253641049523708,0.9596774193548387,1.0,1.0,7/32,15.88%,EML2;MAP2;CLIP3;NAV3;TTBK2;SNCA;APC2
prerank,establishment of spindle localization (GO:0051293),0.2959276115696357,0.6251783820157387,0.9076376554174067,0.9965102792324411,1.0,6/14,23.86%,LLGL1;CFL1;ZBED3;KPNB1;CLASP2;MAP4
prerank,regulation of secretion (GO:0051046),0.3056488203769713,0.6250390058956591,0.8954954954954955,0.9961816918208831,1.0,1/13,2.39%,KCNQ1
prerank,miRNA metabolic process (GO:0010586),0.27357202620224874,0.6246682006669684,0.9110378912685337,0.9960371583159244,1.0,10/20,31.94%,DROSHA;DICER1;TRIM71;PRKRA;SND1;TENT4B;TUT7;PARN;DIS3L2;XPO5
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.23717283911341752,-0.6246620776249451,0.9471264367816092,1.0,1.0,9/17,37.30%,GET4;EMC8;GET1;EMC4;EMC1;BAG6;GET3;CAMLG;EMC10
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.3084530478310279,0.6222156186813416,0.875,0.99745979245029,1.0,5/10,27.72%,PIH1D1;TAF9;RUVBL1;NUFIP1;RUVBL2
prerank,regulation of tau-protein kinase activity (GO:1902947),-0.28236559620626445,-0.6220126653193152,0.9044444444444445,1.0,1.0,1/10,4.29%,HSP90AA1
prerank,folic acid metabolic process (GO:0046655),-0.24656121785180476,-0.6217819485959954,0.9433497536945813,1.0,1.0,5/18,17.40%,ALDH1L1;FPGS;MTHFD1;SLC19A1;MTHFD2L
prerank,telomere organization (GO:0032200),-0.20168289672414447,-0.6197701613121404,0.975975975975976,1.0,1.0,19/43,32.54%,PARP3;RTEL1;RAD50;DOT1L;XRCC5;TERF2;XRCC6;ATR;DNA2;TERT;PRKDC;ATM;POLD1;LTO1;POLD2;DCLRE1B;RPA2;BLM;WRN
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.29280037997270497,0.6190858953923045,0.895910780669145,0.9992973863571457,1.0,3/13,17.55%,RRS1;RPS21;NOP14
prerank,DNA strand elongation involved in DNA replication (GO:0006271),-0.24292825202834561,-0.6188340271318891,0.9328859060402684,1.0,1.0,9/18,32.57%,GINS3;GINS1;POLE;POLD2;GINS4;LIG1;POLE3;MCMDC2;MCM3
prerank,regulation of oxidative phosphorylation (GO:0002082),-0.2523299356705503,-0.6186006938791339,0.9455782312925171,1.0,1.0,5/16,24.04%,NUPR1;UQCC2;SLC25A33;PDE12;PPIF
prerank,response to glucocorticoid (GO:0051384),0.25902282702686424,0.6182236515533877,0.9154228855721394,0.999492931539051,1.0,6/26,21.58%,NR3C1;BCL2L11;ZFP36;ZFP36L1;UBE2L3;SLIT3
prerank,negative regulation of viral release from host cell (GO:1902187),-0.2646937742516255,-0.6181078964866245,0.902676399026764,1.0,1.0,4/13,26.57%,TRIM35;TRIM28;TRIM8;TRIM5
prerank,protein localization to kinetochore (GO:0034501),-0.2584995930787617,-0.6178392029422228,0.9216101694915254,1.0,1.0,9/14,43.58%,IK;CENPT;KNL1;SPDL1;CDK1;ZW10;MIS12;TTK;ZWILCH
prerank,response to light stimulus (GO:0009416),0.22880032962078528,0.6177348230925808,0.9516616314199395,0.9994192429899684,1.0,7/55,12.92%,MAP4K3;MAPK8;OPN4;GNAT1;PRIMPOL;OPN5;ERCC4
prerank,protein palmitoylation (GO:0018345),-0.2155476966160626,-0.6171927401983283,0.9567567567567568,1.0,1.0,3/30,8.44%,GLUL;CLIP3;ZDHHC20
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),-0.18153708876955835,-0.6170377758652407,1.0,1.0,1.0,14/69,20.59%,SELENOS;AMFR;UBXN4;JKAMP;UBE4B;NPLOC4;UBE2G2;UBE4A;RNF121;USP19;DNAJC18;FAM8A1;DNAJB2;TMEM67
prerank,regulation of interferon-beta production (GO:0032648),-0.1914646167366036,-0.6164232847084605,0.9873817034700315,1.0,1.0,10/46,20.98%,PTPRS;HSP90AA1;OAS2;MAVS;RNF135;SIRPA;PPM1B;CACTIN;POLR3D;PYCARD
prerank,positive regulation of protein acetylation (GO:1901985),0.2990569430320345,0.6158031229067438,0.8799283154121864,1.0,1.0,4/12,17.53%,DIP2B;CEP295;RAPGEF3;PRKAA1
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.26156705835761684,0.6157740965677854,0.9165302782324058,0.999988945758062,1.0,5/27,15.11%,PHF20;KAT6B;PHF20L1;KAT2B;KAT6A
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.2793797618090678,0.615568743763551,0.9116117850953206,0.999712017121125,1.0,7/16,26.55%,NAA11;KAT2B;NAA16;NAA30;NAA35;NAA50;CREBBP
prerank,negative regulation of lipid catabolic process (GO:0050995),-0.24851707280368499,-0.6155506212789386,0.930952380952381,1.0,1.0,4/17,16.78%,ADRA2A;ALK;MFSD2A;GPLD1
prerank,ESCRT complex disassembly (GO:1904896),0.3072930771261776,0.6152847298996817,0.8837209302325582,0.9990508466596567,1.0,1/10,5.98%,CHMP2B
prerank,ESCRT III complex disassembly (GO:1904903),0.3072930771261776,0.6152847298996817,0.8837209302325582,0.9990508466596567,1.0,1/10,5.98%,CHMP2B
prerank,protein import into peroxisome matrix (GO:0016558),-0.2644533143155613,-0.6149496217232846,0.926605504587156,1.0,1.0,5/12,27.00%,PEX1;PEX7;PEX5L;PEX5;PEX16
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.2825446566709281,0.6146883472458825,0.8839590443686007,0.999027236511201,1.0,5/15,17.95%,PLCG2;NPM1;CDC73;CUL3;KLHL18
prerank,axonal transport (GO:0098930),0.24519224135802686,0.6142294229430607,0.9329359165424739,0.9989029376744747,1.0,2/36,2.90%,HIF1A;DST
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.23840800761480427,0.6141798043076286,0.9560761346998536,0.9985078960784414,1.0,10/36,23.34%,DAB2IP;EPC1;MAX;RYBP;APAF1;PHC3;EHMT1;PHC1;UXT;BMI1
prerank,protein sumoylation (GO:0016925),0.23180222643398965,0.6140670146629428,0.9653179190751445,0.9981492913412371,1.0,12/49,14.80%,STX1A;SUMO2;NUP214;NUP98;SAE1;NUP133;IFIH1;NUP205;NUP54;TOPORS;NUP43;NUP153
prerank,transferrin transport (GO:0033572),-0.20970080446699568,-0.6125050824212178,0.9731343283582089,1.0,1.0,6/33,13.77%,ATP6V0A4;ATP6V1B2;STEAP3;ATP6V0D1;ATP6V0B;ARHGAP1
prerank,mitotic spindle checkpoint signaling (GO:0071174),-0.23346142535441616,-0.6113493483595582,0.9516129032258065,1.0,1.0,8/20,26.22%,ZWINT;KLHL22;TEX14;IK;ATM;CENPF;BUB1B;KNTC1
prerank,spindle assembly checkpoint signaling (GO:0071173),-0.23346142535441616,-0.6113493483595582,0.9516129032258065,1.0,1.0,8/20,26.22%,ZWINT;KLHL22;TEX14;IK;ATM;CENPF;BUB1B;KNTC1
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),-0.23346142535441616,-0.6113493483595582,0.9516129032258065,1.0,1.0,8/20,26.22%,ZWINT;KLHL22;TEX14;IK;ATM;CENPF;BUB1B;KNTC1
prerank,tRNA export from nucleus (GO:0006409),0.24776126152164812,0.6110174803489122,0.9444444444444444,0.9994008997700242,1.0,8/32,17.14%,NUP214;NUP98;NUP133;NUP205;NUP54;NUP43;NUP153;XPOT
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.24776126152164812,0.6110174803489122,0.9444444444444444,0.9994008997700242,1.0,8/32,17.14%,NUP214;NUP98;NUP133;NUP205;NUP54;NUP43;NUP153;XPOT
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",-0.23874409989801493,-0.6103602294757027,0.9418886198547215,1.0,1.0,2/17,11.89%,SELENOS;NPLOC4
prerank,positive regulation of type I interferon production (GO:0032481),0.21670764618436417,0.6088803928481827,0.9820936639118457,1.0,1.0,15/73,20.68%,LRRFIP1;NFKB1;G3BP1;CGAS;RELA;RIPK2;IFIH1;NFKB2;STAT6;CTNNB1;STAT1;POLR3B;DHX36;POLR3A;POLR2L
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.25623964638193797,-0.6083388856591986,0.9284064665127021,1.0,1.0,2/14,8.47%,AUTS2;CTR9
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.18668639846769253,0.607304951815406,0.998868778280543,1.0,1.0,75/264,25.96%,NOVA2;RSRC1;SRPK3;TGS1;HNRNPF;SF3B4;GTF2F2;CTNNBL1;HNRNPA0;MTREX;HNRNPK;RBM14;HNRNPD;WDR33;LSM8;YTHDC1;SPEN;RBM15;RNPS1;LSM3;HNRNPC;ZMAT2;SMU1;SF3B6;DHX15;SNRNP25;SCAF11;WDR77;CWC27;SNW1;YBX1;AQR;DDX20;HNRNPUL1;CWC22;ALYREF;CDC40;LSM7;PRPF40A;PHF5A;METTL14;RALY;CWF19L2;PRPF4;HNRNPM;CPSF1;STRAP;SRSF10;FUS;SART1;SART3;POLR2L;ELAVL1;SF3A2;POLR2J;PRPF3;TRA2B;DBR1;SNRPD3;SRSF4;PSPC1;SLU7;CPSF2;SYF2;LSM2;HNRNPA3;PCF11;SNUPN;RBMX;SNRNP200;CPSF3;PUF60;PRPF40B;ISY1;GCFC2
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),-0.2596182797373475,-0.6072338632097563,0.9406392694063926,1.0,1.0,5/12,21.37%,LHPP;PAICS;ATIC;PFAS;ADSS1
prerank,cellular response to leucine starvation (GO:1990253),-0.27943847487785506,-0.6070128845384835,0.9218390804597701,1.0,1.0,4/10,26.16%,IMPACT;SESN2;MTOR;RRAGD
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),-0.2765570981685704,-0.6051731565330883,0.9139784946236559,1.0,1.0,6/11,37.54%,SMARCAL1;DONSON;FBH1;BLM;ZRANB3;LIG3
prerank,carnitine metabolic process (GO:0009437),0.29121096812277253,0.6044009618991921,0.8978494623655914,1.0,1.0,4/12,22.24%,CRAT;CPT1A;CROT;ALDH9A1
prerank,negative regulation of phosphatase activity (GO:0010923),-0.22528149472864817,-0.6028290877697497,0.9596541786743515,1.0,1.0,7/25,19.74%,PPP4R4;SH3RF2;CRY2;TGFB2;PTPA;BOD1L1;SH2D4A
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.23033924394768365,0.6018213117641844,0.9596273291925466,1.0,1.0,6/43,12.25%,TAOK2;BABAM2;BRCC3;FOXN3;HUS1;NOP53
prerank,mitotic spindle organization (GO:0007052),0.19595258670101434,0.6010642515796208,0.9939831528279182,1.0,1.0,42/153,24.75%,RAB11A;PLK2;AURKA;PCNT;DYNLL1;XPO1;DYNC1LI1;NEK6;AURKC;STAG2;KIF23;RPS27;NUP98;MAD1L1;NUP133;NDEL1;STAG1;BUB3;NUP43;LSM14A;CHEK2;RHOA;ABRAXAS2;WRAP73;MZT1;PPP1CC;CLIP1;BCCIP;PIBF1;SBDS;PLK1;KIF4A;KPNB1;KIF2A;TAOK1;DCTN6;CLASP2;KIF18A;MAP4;CENPN;TNKS;NUP85
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.2662951789256425,0.6003524508785585,0.9379432624113475,1.0,1.0,7/19,25.59%,GMPR;HPRT1;ADA;PNP;TYMS;POLL;ADK
prerank,skeletal muscle contraction (GO:0003009),-0.23199699828962106,-0.6002499508708394,0.9357798165137615,1.0,1.0,7/19,39.23%,STAC3;TNNI1;TNNT3;TNNC1;TCAP;STAC2;TNNI2
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.29766746319126686,0.6000083984832327,0.8950381679389313,1.0,1.0,3/10,17.92%,ELOVL5;ABCD1;MLXIPL
prerank,regulation of calcium-mediated signaling (GO:0050848),0.24990126704642904,0.5992370176682811,0.9356913183279743,1.0,1.0,4/25,13.83%,BST1;PLCG2;TMBIM4;SLA2
prerank,chromatin disassembly (GO:0031498),0.2847741011959099,0.5990730333849446,0.9296028880866426,1.0,1.0,7/14,24.68%,ARID1A;SMARCE1;GRWD1;SMARCC1;ARID2;SMARCD1;SET
prerank,nucleosome disassembly (GO:0006337),0.2847741011959099,0.5990730333849446,0.9296028880866426,1.0,1.0,7/14,24.68%,ARID1A;SMARCE1;GRWD1;SMARCC1;ARID2;SMARCD1;SET
prerank,positive regulation of superoxide anion generation (GO:0032930),-0.25392504341943845,-0.5987804774060486,0.9272727272727272,1.0,1.0,1/13,2.78%,PRKCD
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.23638514542791428,-0.598720555122053,0.9471153846153846,1.0,1.0,3/17,17.06%,PRKCZ;CEBPB;SYK
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.2406403818582091,0.5986727261641123,0.9429530201342282,1.0,1.0,5/32,12.25%,TAOK2;BABAM2;BRCC3;FOXN3;NOP53
prerank,protein ADP-ribosylation (GO:0006471),-0.21209816268569837,-0.5985708871307339,0.9521276595744681,1.0,1.0,3/28,7.76%,SIRT2;PARP3;PARP11
prerank,regulation of phospholipid metabolic process (GO:1903725),0.3031557188210421,0.5974038683670212,0.911070780399274,1.0,1.0,3/10,19.93%,ABCA3;MTMR9;MTMR2
prerank,cristae formation (GO:0042407),-0.21494739596854331,-0.5973785629024038,0.9639175257731959,1.0,1.0,11/27,32.03%,CHCHD3;CHCHD6;ATP5PO;ATP5PF;ATP5ME;SAMM50;ATP5MG;DMAC2L;APOO;DNAJC11;IMMT
prerank,DNA replication-independent nucleosome assembly (GO:0006336),-0.19482887990249745,-0.5967043392408448,0.9747899159663865,1.0,1.0,14/38,26.48%,RBBP7;CENPP;ITGB3BP;CENPT;MIS18BP1;CENPU;CENPK;RBBP4;HIRA;CENPH;KNL1;CENPX;CENPQ;CENPA
prerank,Golgi to endosome transport (GO:0006895),0.2742424798918417,0.5948824273761202,0.9114583333333334,1.0,1.0,5/16,20.49%,DOP1B;AP2A1;KIF16B;AP1AR;EPS15
prerank,ncRNA export from nucleus (GO:0097064),0.2384644774527726,0.5946899178103429,0.9511450381679389,1.0,1.0,9/36,17.14%,NUP214;NUP98;NUP133;NUP205;NPM1;NUP54;NUP43;NUP153;XPOT
prerank,linoleic acid metabolic process (GO:0043651),0.2725483391858661,0.5944787381693063,0.8972125435540069,1.0,1.0,4/17,15.02%,ELOVL5;ABCD1;GSTP1;PNPLA8
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.265923625583945,0.5940098718641671,0.9187279151943463,1.0,1.0,3/17,14.21%,HASPIN;RB1;BUB3
prerank,sensory perception of taste (GO:0050909),0.30148766555771783,0.5937933231509714,0.9037328094302554,1.0,1.0,10/10,69.87%,PKD1L3;ASIC1;ASIC2;TAS1R3;GNAT3;TAS1R2;PKD2L1;TAS1R1;ASIC3;CD36
prerank,nonribosomal peptide biosynthetic process (GO:0019184),-0.2585066641695597,-0.593413345438904,0.9166666666666666,1.0,1.0,5/12,24.45%,BDH2;GCLC;HAGH;GGT1;CNDP2
prerank,transcription by RNA polymerase III (GO:0006383),-0.20682976734348676,-0.593054630862196,0.9571788413098237,1.0,1.0,10/27,32.93%,ICE2;POLR2K;POLR3H;GTF3A;GTF3C4;POLR3K;CRCP;ZC3H8;TBP;SNAPC4
prerank,rRNA catabolic process (GO:0016075),-0.23576741207516638,-0.592158014848467,0.954653937947494,1.0,1.0,3/16,19.16%,EXOSC7;EXOSC3;EXOSC9
prerank,histone lysine methylation (GO:0034968),0.24110533567999876,0.5920223507458952,0.9494470774091627,1.0,1.0,13/33,29.23%,KDM6A;SMYD3;SETDB2;ASH2L;CXXC1;RBBP5;PRDM9;SUV39H1;N6AMT1;DYDC2;EZH2;SMYD2;SMYD1
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.18241970844760094,0.5913477693942111,0.9988584474885844,1.0,1.0,68/241,25.96%,NOVA2;RSRC1;HNRNPF;SF3B4;GTF2F2;CTNNBL1;HNRNPA0;MTREX;HNRNPK;RBM14;HNRNPD;WDR33;LSM8;YTHDC1;SPEN;RBM15;RNPS1;LSM3;HNRNPC;ZMAT2;SMU1;SF3B6;DHX15;SNRNP25;CWC27;SNW1;YBX1;AQR;HNRNPUL1;CWC22;ALYREF;CDC40;LSM7;PRPF40A;PHF5A;METTL14;RALY;CWF19L2;PRPF4;HNRNPM;CPSF1;SRSF10;FUS;SART1;SART3;POLR2L;ELAVL1;SF3A2;POLR2J;PRPF3;TRA2B;DBR1;SNRPD3;SRSF4;PSPC1;SLU7;CPSF2;SYF2;LSM2;HNRNPA3;PCF11;RBMX;SNRNP200;CPSF3;PUF60;PRPF40B;ISY1;GCFC2
prerank,lipid droplet formation (GO:0140042),0.3024448460735122,0.5911453738032255,0.9092627599243857,1.0,1.0,1/10,6.96%,CDS2
prerank,intracellular pH reduction (GO:0051452),0.24313175277336513,0.5909548366463142,0.9535232383808095,1.0,1.0,5/33,13.70%,CLCN3;ATP6V0A1;RAB38;ATP6V1G2;RAB7A
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.294529703670136,0.5909431827473876,0.8938547486033519,1.0,1.0,3/10,20.73%,ATP5PD;VPS9D1;ATP5MC2
prerank,secretory granule organization (GO:0033363),0.289238679276692,0.5904925840646897,0.9190647482014388,1.0,1.0,2/10,19.36%,SRGN;ABCA1
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),-0.19625248155006192,-0.5903242169082218,0.9827586206896551,1.0,1.0,8/34,24.55%,RBP4;STX4;PTPN22;LACC1;CLCF1;EPHB2;SPHK2;PTPRC
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),-0.26886242289474316,-0.5898064033903806,0.9245283018867925,1.0,1.0,3/10,23.39%,IVD;GCDH;ACADS
prerank,immunoglobulin mediated immune response (GO:0016064),-0.26751301726680243,-0.5885669554767282,0.9395248380129589,1.0,1.0,4/10,34.71%,CD81;CD74;FCGR2B;TLR8
prerank,histone H3-K4 methylation (GO:0051568),0.2444536494289023,0.5881809799218203,0.9464285714285714,1.0,1.0,7/26,22.14%,KDM6A;TET3;TET2;ASH2L;CXXC1;RBBP5;PRDM9
prerank,transcription preinitiation complex assembly (GO:0070897),0.2867014767924465,0.5879834879644898,0.926873857404022,1.0,1.0,2/12,12.88%,TAF1B;GTF2A2
prerank,negative regulation of chemokine production (GO:0032682),0.27549240459252117,0.5875155847025133,0.9134438305709024,1.0,1.0,3/14,16.94%,SIGIRR;GSTP1;MAP2K5
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.227311158779083,0.5874399487264829,0.9716840536512668,1.0,1.0,10/38,24.69%,NDUFA8;NDUFA7;NDUFA10;NDUFS2;NDUFS4;NDUFS6;NDUFB9;NDUFC1;NDUFS8;NDUFB7
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",-0.21736048956687332,-0.5870284667523566,0.9595959595959596,1.0,1.0,2/22,7.20%,UGGT2;AMFR
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.22138086318051392,-0.5858792145650955,0.966824644549763,1.0,1.0,8/21,26.22%,ZWINT;KLHL22;TEX14;IK;ATM;CENPF;BUB1B;KNTC1
prerank,protein localization to condensed chromosome (GO:1903083),-0.2538992258084052,-0.5848908964922557,0.9285714285714286,1.0,1.0,8/12,43.58%,IK;KNL1;SPDL1;CDK1;ZW10;MIS12;TTK;ZWILCH
prerank,DNA replication (GO:0006260),0.19409344743858953,0.5840711378223045,0.9937106918238994,1.0,1.0,37/105,29.55%,RNASEH2A;MCM10;RPA1;POLA1;DUT;CDK2;BRIP1;HELB;HUS1;MCM9;RMI1;TOP1;GRWD1;ORC5;ORC3;BAZ1A;RFC3;MCMBP;RAD17;RMI2;DBF4;TIPIN;RFC5;TBRG1;POLL;SET;ORC6;MCM6;RPA3;TICRR;RBBP8;TIMELESS;RFC2;TOP1MT;KAT7;POLG2;POLA2
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.27959836847840674,0.5839345079873063,0.9308510638297872,1.0,1.0,3/12,20.74%,CDT1;MAD1L1;CHAMP1
prerank,cell cycle G2/M phase transition (GO:0044839),0.19104828527253195,0.583783683344769,0.9950433705080545,1.0,1.0,13/130,9.40%,TPD52L1;PLCB1;PRKAR2B;PPP1R12A;CEP41;AURKA;PCNT;FBXL7;DYNLL1;CCNY;CDK2;CNTRL;CEP57
prerank,central nervous system neuron axonogenesis (GO:0021955),0.28430557912972576,0.5827287171589095,0.9281867145421903,1.0,1.0,3/12,12.95%,MYCBP2;B4GALT5;HSP90AB1
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.29061478760267,0.5821562224297685,0.9117647058823529,1.0,1.0,3/10,19.82%,EMC6;EMC3;EMC7
prerank,peroxisome organization (GO:0007031),0.2434089590040512,0.5818080066092176,0.9383333333333334,1.0,1.0,5/25,13.86%,TMEM135;PLAAT3;ABCD4;ABCD1;PEX14
prerank,negative regulation of protein depolymerization (GO:1901880),0.24562493853297074,0.5818043092435552,0.9483037156704361,1.0,1.0,8/24,23.45%,ARHGEF2;CAMSAP2;LIMA1;APC;CIB1;ATXN7;TAOK1;CLASP2
prerank,7-methylguanosine RNA capping (GO:0009452),0.23610191480024575,0.5815021410446383,0.9620853080568721,1.0,1.0,8/31,22.29%,GTF2F2;RNGTT;RNMT;GTF2H4;GTF2H1;POLR2L;CCNH;POLR2J
prerank,7-methylguanosine mRNA capping (GO:0006370),0.23610191480024575,0.5815021410446383,0.9620853080568721,1.0,1.0,8/31,22.29%,GTF2F2;RNGTT;RNMT;GTF2H4;GTF2H1;POLR2L;CCNH;POLR2J
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.26852475826111544,0.5801118314548005,0.9081455805892548,1.0,1.0,5/14,19.37%,ADSL;IMPDH1;RFK;ADSS2;GART
prerank,tRNA methylation (GO:0030488),-0.19595146790721069,-0.5787289366833006,0.9784366576819407,1.0,1.0,34/34,80.45%,TARBP1;GTPBP3;MTO1;THUMPD3;METTL1;BCDIN3D;DALRD3;TRMT61A;METTL2B;METTL2A;THUMPD2;TRMT13;TRMT44;FTSJ1;HSD17B10;TRMT5;TRDMT1;TRMT1;THADA;WDR6;TRMO;METTL6;TYW3;TRMT112;TRMT10A;TRMT1L;NSUN2;TRMT12;TRMT61B;TRMT10C;LCMT2;ALKBH8;NSUN6;PRORP
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.24402759385315861,0.578474545299207,0.9391891891891891,1.0,1.0,10/25,28.05%,DNAJB5;ERO1A;BAG1;HSPE1;DNAJB12;DNAJB1;GAK;HSPA1B;HSPA13;HSPA14
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),-0.2487500792860316,-0.5773185214036863,0.9527027027027027,1.0,1.0,5/13,24.98%,ANAPC15;LCMT1;GEN1;NDC80;XRCC3
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.2668499461962545,0.5759171596438798,0.921875,1.0,1.0,4/14,21.42%,NIFK;RPL7L1;URB1;RPL7
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.27384429892778467,0.5758260096480626,0.9291187739463601,1.0,1.0,3/12,23.51%,IL23A;CARD9;ZBTB1
prerank,regulation of exit from mitosis (GO:0007096),-0.1980302748430292,-0.5733743230833261,0.9969418960244648,1.0,1.0,5/38,10.87%,SIRT2;CDC14B;ANAPC5;RGCC;ANAPC15
prerank,regulation of steroid metabolic process (GO:0019218),0.2433016328812708,0.5732905295241549,0.9393939393939394,1.0,1.0,8/23,21.57%,PANK2;ABCG1;ASAH1;TTC39B;STAR;ABCB11;FMO5;RORC
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.23422958208814684,0.5722759521267642,0.9649122807017544,1.0,1.0,10/30,20.56%,DYRK1A;BCL2L1;DDIAS;SFRP2;TPT1;THOC1;KDM1A;PTTG1IP;THOC5;RPS3
prerank,regulation of mRNA metabolic process (GO:1903311),0.28504713045336394,0.5722299589360262,0.9160714285714285,1.0,1.0,4/11,23.96%,SRPK3;SLTM;CDK11B;IWS1
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.26657117311194856,0.5722205636336378,0.918825561312608,1.0,1.0,3/14,12.62%,GAS6;CARD16;GSTP1
prerank,organelle fusion (GO:0048284),-0.21611992773279853,-0.5721655054150504,0.9604938271604938,1.0,1.0,7/22,25.12%,MIGA2;CHCHD3;STX4;MIEF2;VPS11;BAX;GDAP1
prerank,autophagy of nucleus (GO:0044804),0.2658279705975004,0.5714212094831498,0.9290540540540541,1.0,1.0,4/16,18.71%,ULK1;ATG2A;ATG2B;ATG7
prerank,negative regulation of T cell proliferation (GO:0042130),0.23088596790103194,0.5706160845111824,0.9546925566343042,1.0,1.0,3/28,10.78%,PLA2G2D;BTN2A2;RC3H1
prerank,sulfur amino acid catabolic process (GO:0000098),-0.25713316980879797,-0.5700291194720308,0.9176201372997712,1.0,1.0,4/10,24.83%,CBS;BLMH;CTH;MTRR
prerank,tRNA wobble uridine modification (GO:0002098),-0.2397187166446914,-0.5699188508607307,0.9550561797752809,1.0,1.0,14/14,76.06%,GTPBP3;ELP4;MTO1;URM1;ELP1;TRMT9B;CTU1;CTU2;TRMU;ELP3;MOCS3;DPH3;KTI12;ALKBH8
prerank,acyl-CoA biosynthetic process (GO:0071616),0.25753972343643083,0.5696384563224086,0.9163763066202091,1.0,1.0,2/16,10.48%,FASN;SLC25A1
prerank,positive regulation of TORC1 signaling (GO:1904263),-0.2301487281608363,-0.5688011927105219,0.9575,1.0,1.0,6/16,26.16%,KLHL22;GPR137B;FLCN;GPR137C;PIP4P1;RRAGD
prerank,double-strand break repair via break-induced replication (GO:0000727),0.2749701801745244,0.5684844548551808,0.9552238805970149,1.0,1.0,12/12,72.52%,GINS2;MCM6;MUS81;MCM7;MCM2;MCM4;MCM5;CDC7;CDC45;MCM3;MCMDC2;GINS4
prerank,cellular response to copper ion (GO:0071280),-0.2296121783776225,-0.5681172662506293,0.9492753623188406,1.0,1.0,2/16,16.20%,SNCA;MT3
prerank,regulation of double-strand break repair (GO:2000779),0.22169514572287186,0.56804983579561,0.9760119940029985,1.0,1.0,9/39,22.18%,RNF169;WRAP53;ACTR2;SIRT6;SPIDR;MGMT;KDM1A;DEK;SIRT7
prerank,regulation of catabolic process (GO:0009894),0.24977330293661562,0.5667781085903504,0.9562289562289562,1.0,1.0,1/18,2.36%,NEDD4L
prerank,tRNA wobble base modification (GO:0002097),-0.2397187166446914,-0.5663681366404468,0.9636363636363636,1.0,1.0,14/14,76.06%,GTPBP3;ELP4;MTO1;ADAT2;URM1;TRMT9B;CTU1;CTU2;ALKBH1;ELP3;MOCS3;DPH3;KTI12;ALKBH8
prerank,protein import (GO:0017038),0.19773054085988398,0.5650237153441504,0.9921363040629095,1.0,1.0,24/84,23.47%,STAT3;IPO11;PPP1R10;PEX26;IPO8;NUP214;ABCD1;PRICKLE1;NUP133;PEX14;ALDH3A2;TNPO3;NUP153;RAB8B;TOMM22;PTTG1IP;E2F3;CSE1L;KPNB1;HIKESHI;EIF4ENIF1;APPL1;HSPA4;CLU
prerank,melanosome organization (GO:0032438),0.23706200823534623,0.5647662273891075,0.9485903814262023,1.0,1.0,5/26,17.00%,SHROOM2;RAB38;AP3B1;RAB32;BLOC1S5
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.26624820648769937,0.5637963689111856,0.9429590017825312,1.0,1.0,3/13,17.28%,SVIP;UBAC2;YOD1
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.2053405296176825,0.5635843777460573,0.9865671641791045,1.0,1.0,14/57,22.46%,TAOK2;BABAM2;BRCC3;CDK2;FOXN3;HUS1;NOP53;CHEK2;RAD17;PLK1;RINT1;TIPIN;BABAM1;TAOK1
prerank,purine-containing compound biosynthetic process (GO:0072522),0.2405322193843367,0.5630791376165836,0.9548611111111112,1.0,1.0,3/25,9.72%,GMPR;ADSL;HPRT1
prerank,positive regulation of phospholipid transport (GO:2001140),0.27825778812571894,0.5615304478569594,0.9332096474953617,1.0,1.0,1/10,5.76%,ABCA3
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.28122795185541005,0.5607008561924137,0.9262589928057554,1.0,1.0,2/10,12.16%,TFAP4;MUC1
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.25515844078174704,0.5593235727583811,0.955595026642984,1.0,1.0,2/16,9.98%,RPA1;RECQL
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.25542276160765426,0.5592634308840668,0.9519572953736655,1.0,1.0,5/16,18.19%,PIGQ;PIGG;PIGF;PIGL;PIGC
prerank,regulation of G0 to G1 transition (GO:0070316),0.2155463072635676,0.5586796361038068,0.9869753979739508,1.0,1.0,10/38,23.34%,DAB2IP;EPC1;MAX;RYBP;APAF1;PHC3;EHMT1;PHC1;UXT;BMI1
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.2595928199174147,0.5582898097064742,0.916,1.0,1.0,2/13,11.20%,GLRX3;MMS19
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.22257589851405105,-0.5581874083016186,0.9584295612009238,1.0,1.0,6/18,23.02%,COX16;COX19;COX17;COX18;FASTKD3;TIMM21
prerank,maintenance of protein localization in organelle (GO:0072595),0.2459179341001338,0.5579372169262582,0.948306595365419,1.0,1.0,3/19,14.49%,BCL3;TAF3;TOPORS
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.22602526939303952,-0.5569979032512274,0.9665871121718377,1.0,1.0,6/16,26.79%,HNRNPA2B1;RTEL1;TERF2;SLX4;ATM;SMG5
prerank,tetrahydrofolate metabolic process (GO:0046653),0.28181331581487146,0.5567162161667403,0.9059500959692899,1.0,1.0,1/10,5.80%,MTHFD1L
prerank,organelle disassembly (GO:1903008),0.22559572837192465,0.5562893515936297,0.9701726844583988,1.0,1.0,12/33,25.09%,ULK1;MCTS1;MRRF;MTIF3;ATG2A;ATG2B;VRK1;DENR;PLK3;RB1CC1;MTIF2;UFM1
prerank,regulation of histone deacetylation (GO:0031063),0.2627795349251717,0.5557680715023972,0.9335664335664335,1.0,1.0,4/13,22.92%,CTBP1;APLNR;SAP30BP;NIPBL
prerank,purine nucleotide biosynthetic process (GO:0006164),0.26880727098091756,0.5552874187232668,0.9307116104868914,1.0,1.0,4/12,19.61%,ADSL;HPRT1;GART;ADA
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.2749705856079044,0.5549520056524117,0.9194139194139194,1.0,1.0,3/11,15.66%,MBTPS2;ATF6;DDIT3
prerank,replication fork processing (GO:0031297),0.21783267732790557,0.5539070234899987,0.9761904761904762,1.0,1.0,3/38,8.20%,SAMHD1;MMS22L;PRIMPOL
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.26400417027936723,0.5527979863301536,0.9481765834932822,1.0,1.0,8/11,35.21%,FBLL1;TENT4B;EXOSC4;PARN;EXOSC5;EXOSC2;DKC1;EXOSC10
prerank,protein targeting to mitochondrion (GO:0006626),-0.1716460745816203,-0.5526004234558811,0.9967213114754099,1.0,1.0,16/52,28.94%,HSP90AA1;TOMM40;AIFM1;TIMM22;TIMM17B;GRPEL2;TSPO;TIMM8B;TIMM21;TIMM9;GDAP1;DNAJC15;TIMM10;PAM16;SAMM50;PMPCB
prerank,mitochondrial transcription (GO:0006390),-0.25222940186519793,-0.5524221894087745,0.9446902654867256,1.0,1.0,3/10,19.82%,TFAM;SLC25A33;POLRMT
prerank,steroid hormone biosynthetic process (GO:0120178),-0.19304165307919108,-0.5523879642014721,0.9859550561797753,1.0,1.0,6/29,22.74%,AKR1B1;FDX1;FDXR;TSPO;DHCR7;TSPOAP1
prerank,mitochondrion disassembly (GO:0061726),0.2213433077501791,0.5501971239420659,0.9753086419753086,1.0,1.0,8/34,18.71%,ULK1;CTSK;BNIP3;GABARAPL1;ATG2A;ATG2B;CISD2;ATG7
prerank,aerobic respiration (GO:0009060),-0.2147522578637232,-0.5493479481509027,0.9816091954022989,1.0,1.0,7/20,28.21%,SLC25A14;MTFR1L;SDHC;UQCRB;NDUFS7;MDH2;UQCR10
prerank,response to copper ion (GO:0046688),0.24015434450911044,0.5482202886300791,0.9510603588907015,1.0,1.0,2/20,13.27%,ATP7B;AOC1
prerank,regulation of centrosome duplication (GO:0010824),0.22530629150550946,0.5482062240552229,0.9701726844583988,1.0,1.0,11/30,26.73%,PLK2;CHMP2B;CHMP4B;NPM1;CEP295;CEP131;CEP120;PDCD6IP;CHMP3;CENPJ;CHMP4C
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.2734702296991231,0.5475550971249639,0.9372693726937269,1.0,1.0,4/12,20.63%,ANAPC7;RB1;CUL3;NSMCE2
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.2734702296991231,0.5475550971249639,0.9372693726937269,1.0,1.0,4/12,20.63%,ANAPC7;RB1;CUL3;NSMCE2
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.2734702296991231,0.5475550971249639,0.9372693726937269,1.0,1.0,4/12,20.63%,ANAPC7;RB1;CUL3;NSMCE2
prerank,cell differentiation in hindbrain (GO:0021533),-0.24624755160653633,-0.5470785221582011,0.9667405764966741,1.0,1.0,6/11,32.16%,GRID2;FAIM2;LHX1;KNDC1;CEND1;NOG
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.2269519026627842,-0.5458305622022984,0.9681818181818181,1.0,1.0,5/14,31.78%,U2AF2;PCBP4;SRSF6;C1QBP;SRSF9
prerank,inositol phosphate biosynthetic process (GO:0032958),-0.2395082114052338,-0.5418853057117481,0.9681818181818181,1.0,1.0,3/11,21.67%,FGF2;PPIP5K2;IP6K1
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.1852876579052897,0.5404083839354206,1.0,1.0,1.0,26/87,26.77%,IMMP2L;NDUFA8;NDUFA7;COA8;NDUFA10;OMA1;COA3;NDUFS2;SURF1;NDUFS4;SDHAF2;NDUFS6;SCO2;PET100;NDUFB9;COA5;UQCC3;NDUFC1;NUBPL;NDUFS8;NDUFB7;SCO1;ECSIT;SDHAF1;NDUFAF8;NDUFA6
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.26303013728766955,0.5403421124163297,0.9466666666666667,1.0,1.0,3/10,17.28%,SVIP;UBAC2;YOD1
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.24435172174061845,0.539859650160399,0.9471766848816029,1.0,1.0,4/15,21.65%,HUS1;CHEK2;RAD17;TIPIN
prerank,negative regulation of cell division (GO:0051782),-0.23460740777409517,-0.5397053798301068,0.9627329192546584,1.0,1.0,6/11,32.52%,ZFYVE19;VPS4A;SUSD2;BLM;MYC;E2F8
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),-0.20052608125282342,-0.538914339766756,0.9765013054830287,1.0,1.0,4/22,14.39%,EIF2AK3;SMARCA4;SMARCB1;WDR43
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.24015219240466532,0.5387601282354487,0.9609236234458259,1.0,1.0,7/20,23.47%,LONP1;HSP90AB1;CCT2;MKKS;PSMG2;HSPA4;CLU
prerank,protein methylation (GO:0006479),-0.17494594554942478,-0.5379671764526397,0.9876543209876543,1.0,1.0,17/40,38.13%,EHMT2;LCMT1;CARM1;VCPKMT;EEF1AKMT1;PRMT8;METTL21A;EEF2KMT;PRMT2;EEF1AKMT3;NTMT1;PRMT7;PRMT6;GSPT1;NSD1;PRMT1;EEF1AKMT2
prerank,prostanoid metabolic process (GO:0006692),0.2562319823019657,0.5377396833547903,0.955719557195572,1.0,1.0,2/13,12.62%,PTGS1;GSTP1
prerank,mitochondrial genome maintenance (GO:0000002),0.26165084855690035,0.5373849553068999,0.9504761904761905,1.0,1.0,3/11,13.74%,AKT3;LONP1;MEF2A
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.22739901887800915,0.5368773516308625,0.9730639730639731,1.0,1.0,6/25,17.21%,ATXN3;LONP1;OMA1;UGGT1;RNF5;CUL3
prerank,aerobic electron transport chain (GO:0019646),0.1905699997662721,0.5368295129385449,0.9931600547195623,1.0,1.0,17/68,24.79%,NDUFA8;CYCS;NDUFA7;NDUFA10;NDUFS2;COX6C;UQCRQ;NDUFS4;SDHAF2;NDUFS6;UQCRC1;NDUFB9;UQCC3;NDUFC1;NDUFS8;NDUFB7;COX6A1
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.23331427193768545,0.5367427857930469,0.9552980132450332,1.0,1.0,11/21,31.54%,RPA1;ERCC4;GTF2H4;CHD1L;GTF2H1;CUL4B;GTF2H5;RPA3;GTF2H2;XPA;RBX1
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.23331427193768545,0.5367427857930469,0.9552980132450332,1.0,1.0,11/21,31.54%,RPA1;ERCC4;GTF2H4;CHD1L;GTF2H1;CUL4B;GTF2H5;RPA3;GTF2H2;XPA;RBX1
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.18995420244750638,0.5357225582670455,0.9931787175989086,1.0,1.0,17/69,24.79%,NDUFA8;CYCS;NDUFA7;NDUFA10;NDUFS2;COX6C;UQCRQ;NDUFS4;SDHAF2;NDUFS6;UQCRC1;NDUFB9;UQCC3;NDUFC1;NDUFS8;NDUFB7;COX6A1
prerank,positive regulation of immunoglobulin production (GO:0002639),0.21497530873480508,0.5348697848022309,0.9857594936708861,1.0,1.0,7/31,21.98%,XBP1;SHLD1;MAD2L2;KMT5B;GPI;DNAJB9;RIF1
prerank,cellular response to pH (GO:0071467),0.24337480629075325,0.5345995350580087,0.9530201342281879,1.0,1.0,4/17,16.45%,RAB11FIP5;RAB11B;KCNK4;CHP1
prerank,mitochondrial RNA metabolic process (GO:0000959),-0.22271939892446152,-0.5340040429441506,0.9834123222748815,1.0,1.0,4/14,21.27%,TFAM;SLC25A33;POLRMT;FASTKD5
prerank,autophagy of mitochondrion (GO:0000422),0.2090200626648147,0.5334643225355062,0.9834087481146304,1.0,1.0,8/38,18.71%,ULK1;CTSK;BNIP3;GABARAPL1;ATG2A;ATG2B;CISD2;ATG7
prerank,mitotic DNA replication (GO:1902969),-0.24559984748853533,-0.5329353442768544,0.9620535714285714,1.0,1.0,6/10,36.23%,GINS3;GINS1;LIG1;MCMDC2;MCM3;CDC45
prerank,UV-damage excision repair (GO:0070914),0.2598211268674046,0.5325011103040683,0.9383177570093458,1.0,1.0,3/12,16.59%,POLA1;MC1R;ACTR5
prerank,positive regulation of rRNA processing (GO:2000234),0.2692128299046498,0.5318798154812232,0.9283088235294118,1.0,1.0,4/10,22.18%,RIOK1;HEATR1;RIOK2;SIRT7
prerank,respiratory chain complex IV assembly (GO:0008535),-0.20502692663866237,-0.5316912755922508,0.9807692307692307,1.0,1.0,6/21,23.02%,COX16;COX19;COX17;COX18;FASTKD3;TIMM21
prerank,negative regulation of DNA recombination at telomere (GO:0048239),-0.20609605624060778,-0.5293312309594114,0.97,1.0,1.0,6/19,26.60%,POLR2B;POLR2K;TERF2;POLR2I;POLR2D;POLR2H
prerank,regulation of DNA recombination at telomere (GO:0072695),-0.20609605624060778,-0.5293312309594114,0.97,1.0,1.0,6/19,26.60%,POLR2B;POLR2K;TERF2;POLR2I;POLR2D;POLR2H
prerank,regulation of DNA damage checkpoint (GO:2000001),-0.24345963760104794,-0.5291845007870875,0.9676025917926566,1.0,1.0,2/10,18.45%,DDX39B;CRY1
prerank,cellular response to misfolded protein (GO:0071218),0.2286543335851194,0.5278114491421634,0.9674657534246576,1.0,1.0,5/20,18.27%,ATXN3;UGGT1;RNF5;CUL3;DNAJB12
prerank,peptidyl-amino acid modification (GO:0018193),-0.24210166408944078,-0.5276384547199146,0.9744136460554371,1.0,1.0,4/10,35.67%,FKBP10;TTLL4;FKBP7;METAP1
prerank,snRNA 3'-end processing (GO:0034472),-0.1993424522131046,-0.5272833934119228,0.9724137931034482,1.0,1.0,4/19,20.42%,EXOSC7;EXOSC3;EXOSC9;INTS7
prerank,ncRNA catabolic process (GO:0034661),0.21276237390927016,0.5227322954935852,0.9798136645962733,1.0,1.0,9/28,26.27%,MTREX;NUDT16;TRIR;DIS3L;RBM7;SND1;TENT4B;DIS3;EXOSC4
prerank,regulation of glycogen metabolic process (GO:0070873),-0.22397694374512295,-0.5227320998330067,0.9816933638443935,1.0,1.0,3/12,20.01%,PPP1R3C;PPP1R3F;PPP1R3B
prerank,positive regulation of TOR signaling (GO:0032008),0.2041596357368482,0.5226268520845933,0.9789473684210527,1.0,1.0,7/40,16.42%,SIK3;RPTOR;RICTOR;LARS1;GAS6;PIH1D1;RHEB
prerank,regulation of cholesterol metabolic process (GO:0090181),0.23179490287689536,0.5223672085619108,0.9554794520547946,1.0,1.0,7/20,24.45%,LPCAT3;MBTPS2;TTC39B;FMO5;KPNB1;SEC14L2;LDLRAP1
prerank,negative regulation of histone modification (GO:0031057),-0.22185842912027998,-0.5196858764226628,0.9651162790697675,1.0,1.0,5/14,23.89%,THAP7;SNCA;AASS;SPHK2;TWIST1
prerank,negative regulation of protein transport (GO:0051224),0.21851520475770653,0.5193196142351048,0.9728867623604466,1.0,1.0,4/25,16.57%,PPM1F;SNX3;RHBDF2;NDFIP2
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.22400500211797422,-0.5192416937704776,0.9798206278026906,1.0,1.0,4/13,20.54%,FUT9;MDK;ZDHHC21;ITGB2
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.18932026689239764,0.5177925413702879,0.997093023255814,1.0,1.0,21/58,27.36%,BABAM2;HERC2;POLA1;BRCC3;CYREN;ERCC4;DCLRE1C;XRCC4;NSMCE2;UBE2V2;RIF1;BABAM1;NSD2;ERCC6;HMGB1;LIG4;POLL;SUMO1;UBE2N;RNF168;UIMC1
prerank,negative regulation of secretion (GO:0051048),-0.23562481529504606,-0.515523042264679,0.9730941704035875,1.0,1.0,5/10,29.63%,CD74;NR1H3;ERBB3;NRG1;EGF
prerank,peptidyl-methionine modification (GO:0018206),0.2426037425472986,0.5155049081979544,0.9696969696969697,1.0,1.0,3/12,22.78%,NAA16;NAA30;PDF
prerank,tryptophan metabolic process (GO:0006568),0.24613935969868175,0.5137641764330267,0.9502868068833652,1.0,1.0,11/11,75.40%,ATP7A;IL4I1;IDO2;ACMSD;IDO1;KMO;TDO2;AADAT;KYNU;HAAO;KYAT1
prerank,telomere capping (GO:0016233),0.2368676598386757,0.5124398064556894,0.9636363636363636,1.0,1.0,4/16,20.76%,ACD;TERF1;DCLRE1C;TEN1
prerank,cellular response to arsenic-containing substance (GO:0071243),-0.21062535607294852,-0.5118023608669288,0.9853658536585366,1.0,1.0,1/15,3.31%,CPEB2
prerank,"base-excision repair, AP site formation (GO:0006285)",0.2294685468019097,0.5106823070833564,0.9744897959183674,1.0,1.0,6/17,24.96%,ACD;UNG;MPG;TERF1;MBD4;NEIL2
prerank,male meiosis I (GO:0007141),-0.20947133856096062,-0.5089830523612879,0.9881516587677726,1.0,1.0,8/16,36.20%,FOXJ3;BRDT;HSF2BP;MYBL1;SYCP3;DDX4;TDRD9;SLC25A31
prerank,microtubule nucleation (GO:0007020),-0.19730849400364428,-0.5081134493248498,0.9883177570093458,1.0,1.0,6/20,31.47%,TUBGCP5;CCDC57;TPX2;CLASP1;GOLGA2;TPPP
prerank,negative regulation of immune effector process (GO:0002698),0.24729402676174114,0.5074283908146073,0.9632867132867133,1.0,1.0,5/13,24.38%,RPS19;RC3H1;HAVCR2;APPL1;CD47
prerank,piRNA metabolic process (GO:0034587),0.22602330843362792,0.5074055263592299,0.9767441860465116,1.0,1.0,3/19,17.51%,BTBD18;HENMT1;TEX15
prerank,maturation of LSU-rRNA (GO:0000470),0.21024723124020644,0.5054988072067547,0.9797979797979798,1.0,1.0,9/26,24.47%,RPF1;NIFK;EIF6;RPL7L1;MAK16;URB1;RPL7;MRPL1;LAS1L
prerank,regulation of transcription by RNA polymerase I (GO:0006356),-0.19540137443209865,-0.5042428838421618,0.9899497487437185,1.0,1.0,5/18,25.84%,EIF2AK3;WDR43;POLR2K;RASL11A;MAF1
prerank,regulation of biosynthetic process (GO:0009889),-0.22530443227467978,-0.5029778422011428,0.9758241758241758,1.0,1.0,4/11,31.28%,SNCA;SLC25A33;SPHK2;ALOX5
prerank,response to zinc ion (GO:0010043),-0.18448061808908034,-0.5018965437602447,0.9916666666666667,1.0,1.0,1/25,3.65%,P2RX4
prerank,interstrand cross-link repair (GO:0036297),-0.1547917296345199,-0.5011306322868377,0.9936305732484076,1.0,1.0,20/53,34.58%,NUCKS1;FANCI;FANCE;MSH6;NEIL3;ATR;SLX4;FANCA;UBC;XRCC3;CENPX;ERCC6L2;DCLRE1B;FANCB;RPA2;ERCC1;FAAP24;VCP;UBE2T;FANCF
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.1924934698371772,-0.5008685750542292,0.9857482185273159,1.0,1.0,3/17,17.37%,AFG1L;COX6B1;COX7B
prerank,RNA splicing (GO:0008380),0.17092731470985234,0.5005325084320289,0.9959839357429718,1.0,1.0,35/95,30.54%,RSRC1;PPP1R9B;MBNL1;SF3B4;RNPS1;HNRNPC;SMU1;DHX15;SNRNP25;SCAF11;PRPF4;SRSF10;FUS;PPP2R1A;LSM1;DDX47;PRPF3;TRA2B;DBR1;SNRPD3;SRSF4;PPIG;SLU7;PPP2CA;RP9;SYNCRIP;DHX8;SFPQ;PRPF18;SMNDC1;IVNS1ABP;SNRPD2;SNRPD1;SF3B2;SF3B1
prerank,positive regulation of lymphocyte activation (GO:0051251),0.20500306468071255,0.5005071759744063,0.996742671009772,1.0,1.0,3/28,10.01%,LCK;IL23A;CYRIB
prerank,positive regulation of monocyte chemotaxis (GO:0090026),-0.19739016648368923,-0.5004996809890421,0.9752252252252253,1.0,1.0,3/17,13.20%,CXCL12;SERPINE1;CREB3
prerank,isotype switching (GO:0045190),-0.22213559834861524,-0.49899082427868957,0.9733606557377049,1.0,1.0,2/10,17.55%,EXOSC3;MSH6
prerank,negative regulation of phagocytosis (GO:0050765),0.22383479994983754,0.49800430982053323,0.9679595278246206,1.0,1.0,6/17,24.38%,SNX3;RACK1;PLSCR1;APPL1;HMGB1;CD47
prerank,DNA replication checkpoint signaling (GO:0000076),0.22762720951985943,0.4977094451952806,0.9695945945945946,1.0,1.0,6/16,27.95%,CDT1;HUS1;RAD17;TIPIN;TICRR;TIMELESS
prerank,negative regulation of transposition (GO:0010529),0.22820399738724828,0.4950048251531812,0.9630872483221476,1.0,1.0,6/16,27.43%,BTBD18;SPOCD1;TEX15;SIRT7;SMYD5;TUT7
prerank,regulation of nuclear division (GO:0051783),0.2157650216358485,0.4946174473166886,0.9767441860465116,1.0,1.0,3/20,14.41%,CAV2;CDC25C;PDXP
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.21205525956771296,0.49182842487980677,0.985691573926868,1.0,1.0,7/22,23.64%,ZDHHC18;ZDHHC9;ZDHHC24;ZDHHC1;ZDHHC6;ZDHHC8;ZDHHC2
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.21205525956771296,0.49182842487980677,0.985691573926868,1.0,1.0,7/22,23.64%,ZDHHC18;ZDHHC9;ZDHHC24;ZDHHC1;ZDHHC6;ZDHHC8;ZDHHC2
prerank,cilium movement (GO:0003341),0.18836568396778955,0.4911926534993303,0.9928571428571429,1.0,1.0,6/48,13.46%,CFAP53;TEKT5;SPA17;CFAP73;DNAH17;CABYR
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.21442088124166536,0.4888443211863149,0.9738219895287958,1.0,1.0,2/19,10.61%,TIRAP;NMI
prerank,DNA modification (GO:0006304),0.21077075463109363,0.4881709563035243,0.9731993299832495,1.0,1.0,5/22,16.50%,PARP2;ACD;UNG;MPG;TERF1
prerank,positive regulation of translational initiation (GO:0045948),0.21026188532311765,0.4880980371909687,0.9831649831649831,1.0,1.0,18/18,79.00%,EIF2B5;UHMK1;DAZL;YTHDF3;YTHDF1;DDX3X;LARP1;RPS6KB2;KHDRBS1;CDC123;YTHDF2;CCL5;POLR2G;BOLL;POLR2D;MTOR;RPS6KB1;HABP4
prerank,eye photoreceptor cell development (GO:0042462),0.22327178861083086,0.48792249744010524,0.9483985765124555,1.0,1.0,3/15,15.49%,NRL;TOPORS;CEP290
prerank,phagosome acidification (GO:0090383),0.2091260048487395,0.48676343478430206,0.9844479004665629,1.0,1.0,6/26,20.72%,ATP6V0A1;RAB38;ATP6V1G2;RAB7A;ATP6V1F;ATP6V1D
prerank,rRNA methylation (GO:0031167),0.2103068400401253,0.4826577417295656,0.9803600654664485,1.0,1.0,4/22,15.17%,TFB2M;NSUN4;FBLL1;EMG1
prerank,inner dynein arm assembly (GO:0036159),-0.2105439675670837,-0.4817888141085031,0.979498861047836,1.0,1.0,7/11,43.79%,CCDC39;DNAAF5;DNAAF4;CFAP100;DNAAF1;DNAI3;DNAH1
prerank,axoneme assembly (GO:0035082),-0.1647059620363213,-0.4806878300170751,0.9947368421052631,1.0,1.0,9/31,28.54%,DNAI4;CCDC39;RSPH9;SPAG1;GAS8;DRC1;JHY;FOXJ1;TTC12
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.21556921412599644,0.47805869791242916,0.961082910321489,1.0,1.0,5/16,20.46%,RC3H1;ZFP36;ZFP36L1;DHX36;TRIM71
prerank,negative regulation of telomere maintenance (GO:0032205),-0.1964386207501196,-0.47590685499231433,0.9932279909706546,1.0,1.0,9/15,38.38%,RTEL1;RAD50;TERF2;SLX4;ATM;ERCC1;TNKS2;PARP1;NBN
prerank,glutathione derivative biosynthetic process (GO:1901687),0.20891185593320877,0.47432433630220144,0.9844559585492227,1.0,1.0,6/20,22.95%,GSTO2;GSTA4;GSTP1;ESD;MGST1;AKR1A1
prerank,glutathione derivative metabolic process (GO:1901685),0.20891185593320877,0.47432433630220144,0.9844559585492227,1.0,1.0,6/20,22.95%,GSTO2;GSTA4;GSTP1;ESD;MGST1;AKR1A1
prerank,pseudouridine synthesis (GO:0001522),-0.20379206428930188,-0.4734728489127074,0.9886363636363636,1.0,1.0,13/13,79.64%,PUS3;TRUB2;NHP2;GAR1;PUS1;DKC1;NOP10;PUS10;PUSL1;PUS7;RPUSD2;TRUB1;PUS7L
prerank,sensory perception of smell (GO:0007608),-0.21123666038920275,-0.4734717879816324,0.9935344827586207,1.0,1.0,11/11,78.90%,ADCY3;UBR3;BBS4;SYT10;BEST2;OMP;OBP2B;GFY;DRD2;SLC24A4;MKKS
prerank,DNA biosynthetic process (GO:0071897),0.2148194662480378,0.4712072430060373,0.9780033840947546,1.0,1.0,16/16,78.54%,POLA1;RFC3;PPIA;TYMS;POLL;POLD4;POLH;WRNIP1;POLD3;SIRT1;WRN;POLD2;POLD1;CDKN2D;TERT;POLE
prerank,negative regulation of histone acetylation (GO:0035067),0.22649311269841815,0.46969246965966904,0.9720767888307156,1.0,1.0,4/11,26.55%,CTBP1;TAF7;SET;SIN3A
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.23139323153560143,0.46959510410813937,0.9790209790209791,1.0,1.0,3/10,16.77%,FMR1;CALM1;CRHR1
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.15583994347920696,0.46921101374129576,1.0,1.0,1.0,33/125,25.66%,PLK2;AURKA;PCNT;DYNLL1;XPO1;DYNC1LI1;NEK6;AURKC;RPS27;NUP98;MAD1L1;NUP133;NDEL1;BUB3;NUP43;PPP1CC;CLIP1;BCCIP;SBDS;PLK1;KIF4A;KPNB1;KIF2A;TAOK1;DCTN6;CLASP2;KIF18A;MAP4;CENPN;TNKS;NUP85;NSL1;RCC2
prerank,positive regulation of interferon-alpha production (GO:0032727),0.20899379422092246,0.46919899820971867,0.9896013864818024,1.0,1.0,4/19,19.01%,RIPK2;IFIH1;STAT1;DHX36
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.2163129473816399,0.4678516590051262,0.9745916515426497,1.0,1.0,15/15,78.39%,CCT7;CCT2;RUVBL1;RUVBL2;CCT8;NOP10;CCT6A;DKC1;CCT4;NAF1;CCT3;CCT5;TCP1;NHP2;SHQ1
prerank,regulation of T cell differentiation (GO:0045580),0.18825573953513833,0.46773460147492396,0.9969230769230769,1.0,1.0,4/33,11.56%,XBP1;IL7;ZMIZ1;CBFB
prerank,microtubule-based transport (GO:0099111),0.2289591489298573,0.4672706210569066,0.9821428571428571,1.0,1.0,2/13,13.46%,SPA17;CABYR
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.2364863023102347,0.46621689878555156,0.9772727272727273,1.0,1.0,6/10,31.35%,ACD;DCLRE1C;RIF1;APEX1;TFIP11;DCLRE1A
prerank,regulation of DNA recombination (GO:0000018),0.18793782804206574,0.46429167541773697,0.9968798751950078,1.0,1.0,7/32,20.19%,IL7R;SIRT6;SPIDR;ALYREF;THOC1;KDM1A;MSH2
prerank,DNA duplex unwinding (GO:0032508),-0.1440105490083168,-0.46421876416590047,1.0,1.0,1.0,7/50,16.42%,ANXA1;RECQL5;RTEL1;RAD50;DDB2;DDB1;XPC
prerank,natural killer cell mediated cytotoxicity (GO:0042267),-0.18645621194977674,-0.46113512595544615,1.0,1.0,1.0,8/16,43.69%,PLEKHM2;RAET1E;VAMP2;CORO1A;TUBB4B;KIF5B;SLAMF7;KLRK1
prerank,mismatch repair (GO:0006298),0.19175655217422255,0.45942330005146254,0.9967105263157895,1.0,1.0,6/27,22.07%,RNASEH2A;RPA1;MCM9;PMS1;MSH2;MSH5
prerank,natural killer cell mediated immunity (GO:0002228),-0.18485939339541504,-0.45585049733859134,0.9931506849315068,1.0,1.0,2/15,17.97%,PLEKHM2;RAET1E
prerank,ncRNA 3'-end processing (GO:0043628),0.21371987692136296,0.4516190447483291,0.9842657342657343,1.0,1.0,4/14,24.10%,INTS12;INTS8;TOE1;INTS6L
prerank,rRNA modification (GO:0000154),0.19267688367466185,0.45099232290458696,0.9922118380062306,1.0,1.0,3/21,13.09%,TFB2M;NSUN4;FBLL1
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.21772978402812632,0.45057103321720754,0.9906015037593985,1.0,1.0,13/13,78.24%,CPSF1;CPSF6;CPSF2;TUT1;CSTF2T;CPSF4L;NUDT21;CPSF7;NCBP1;CSTF2;NCBP2;CPSF4;FIP1L1
prerank,termination of RNA polymerase II transcription (GO:0006369),0.1780864973598188,0.4496632215975248,0.9984496124031008,1.0,1.0,33/33,82.23%,WDR33;CPSF1;SETX;SNRPD3;CPSF2;PCF11;TTF2;CPSF3;LSM11;PAPOLA;CSTF3;CSTF2T;SNRPB;SCAF8;CLP1;LSM10;SLBP;SSU72;NUDT21;CPSF7;NCBP1;CSTF2;NCBP2;CSTF1;SNRPE;SYMPK;SNRPG;CPSF4;MAZ;MED18;FIP1L1;SNRPF;PABPN1
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.16704606988246432,0.44921266858039116,1.0,1.0,1.0,10/50,22.41%,CCNK;CDKN1B;HSP90AB1;CDC25C;CCNJ;CDC37;BCCIP;GTF2H1;CCNH;CCNA2
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.1648344745272944,-0.44915302858913136,0.9974160206718347,1.0,1.0,22/22,83.55%,DDB2;DDB1;XPC;CUL4A;UBC;GTF2H3;PARP1;ERCC2;RAD23B;UBB;ERCC3;UBA52;RPS27A;RBX1;XPA;GTF2H2;GTF2H5;CUL4B;GTF2H1;CHD1L;CETN2;GTF2H4
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.1895067412860922,0.44657201746905206,0.9935483870967742,1.0,1.0,8/26,21.00%,NEK6;ANAPC7;RB1;CUL3;CDK5RAP2;NSMCE2;PLK1;RIOK2
prerank,regulation of oxidoreductase activity (GO:0051341),0.20956108710320928,0.44381993679544035,0.9892665474060823,1.0,1.0,5/13,26.75%,ABL2;ATP7A;HDAC6;ECSIT;NOD2
prerank,androgen metabolic process (GO:0008209),0.19611112085048626,0.4434530253581436,0.9864176570458404,1.0,1.0,3/18,19.16%,SRD5A2;SRD5A1;HSD17B11
prerank,regulation of RNA export from nucleus (GO:0046831),-0.1944260464353897,-0.4418750755680476,0.9912663755458515,1.0,1.0,1/11,8.29%,AKAP8L
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.16178785017311906,0.44179331642767106,1.0,1.0,1.0,56/56,83.88%,NDUFA8;NDUFA7;NDUFA10;NDUFS2;NDUFS4;NDUFS6;NDUFB9;NDUFC1;NUBPL;NDUFS8;NDUFB7;ECSIT;NDUFAF8;NDUFA6;NDUFA2;ACAD9;NDUFA5;DMAC1;NDUFA3;NDUFB2;NDUFAB1;TMEM126B;NDUFAF4;NDUFS1;NDUFA13;NDUFB4;NDUFAF5;NDUFB6;NDUFB8;OXA1L;TMEM126A;NDUFS5;NDUFB5;NDUFS3;NDUFB3;BCS1L;NDUFB11;NDUFA1;NDUFAF2;FOXRED1;NDUFV2;TIMMDC1;NDUFAF3;NDUFB10;NDUFS7;NDUFA9;NDUFC2;TIMM21;NDUFAF1;NDUFV1;NDUFAF6;NDUFA11;NDUFA12;NDUFV3;DMAC2;NDUFAF7
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.16178785017311906,0.44179331642767106,1.0,1.0,1.0,56/56,83.88%,NDUFA8;NDUFA7;NDUFA10;NDUFS2;NDUFS4;NDUFS6;NDUFB9;NDUFC1;NUBPL;NDUFS8;NDUFB7;ECSIT;NDUFAF8;NDUFA6;NDUFA2;ACAD9;NDUFA5;DMAC1;NDUFA3;NDUFB2;NDUFAB1;TMEM126B;NDUFAF4;NDUFS1;NDUFA13;NDUFB4;NDUFAF5;NDUFB6;NDUFB8;OXA1L;TMEM126A;NDUFS5;NDUFB5;NDUFS3;NDUFB3;BCS1L;NDUFB11;NDUFA1;NDUFAF2;FOXRED1;NDUFV2;TIMMDC1;NDUFAF3;NDUFB10;NDUFS7;NDUFA9;NDUFC2;TIMM21;NDUFAF1;NDUFV1;NDUFAF6;NDUFA11;NDUFA12;NDUFV3;DMAC2;NDUFAF7
prerank,tRNA 5'-leader removal (GO:0001682),-0.19001311347386285,-0.4392651253623533,0.9931506849315068,1.0,1.0,7/13,34.04%,POP1;POP4;SSB;RPP25L;POP5;RPP40;RPP21
prerank,B cell activation involved in immune response (GO:0002312),-0.18696634856855854,-0.43673511609134064,0.9934924078091106,1.0,1.0,13/13,81.32%,EXOSC3;MSH6;FCGR2B;BATF;GPR183;CD19;GAPT;CD40LG;RNF8;RNF168;LIG4;MSH2;CD180
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.16099163862983393,0.4367339066361852,0.9971428571428571,1.0,1.0,14/53,24.92%,PSMA2;PSMA8;PSMA6;PSME1;PSMA4;PSMF1;PSMB7;PSMB1;PSMD2;PSMA5;BCKDK;PSMC3;PSMD3;PSMA3
prerank,histone methylation (GO:0016571),0.1812550577251338,0.4365470060804329,1.0,1.0,1.0,11/26,29.23%,SMYD3;FBLL1;EHMT1;SIRT7;SUV39H1;N6AMT1;CREBBP;PRMT5;EZH2;SMYD2;SMYD1
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.1985689795559471,0.43599572331473035,0.9928443649373881,1.0,1.0,3/16,12.92%,MEIOB;RMI1;ERCC4
prerank,serine family amino acid catabolic process (GO:0009071),-0.19710003821341435,-0.43458600383903206,0.9956616052060737,1.0,1.0,5/10,40.36%,CBS;GLDC;THNSL2;AMT;SHMT2
prerank,tRNA 5'-end processing (GO:0099116),0.20141472872143573,0.4315764898223352,0.9875666074600356,1.0,1.0,6/15,27.98%,RPP30;RPP25;PRORP;TRMT10C;RPP38;RPP14
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),-0.14865622695614272,-0.4284316847946832,1.0,1.0,1.0,10/29,33.80%,ACOT11;ACAT1;ACSF2;DBI;ACOT9;ACOT8;MLYCD;ACOT1;GPAT4;ACOT7
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),-0.14865622695614272,-0.4284316847946832,1.0,1.0,1.0,10/29,33.80%,ACOT11;ACAT1;ACSF2;DBI;ACOT9;ACOT8;MLYCD;ACOT1;GPAT4;ACOT7
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.21733767791589798,0.4265288531491518,0.9790076335877863,1.0,1.0,4/10,26.28%,HSP90AB1;FN1;CDH3;FURIN
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.20722754994473924,0.42385945140047937,0.9893428063943162,1.0,1.0,3/12,20.50%,HUS1;CHEK2;RAD17
prerank,regulation of cellular amine metabolic process (GO:0033238),0.15760627665944849,0.42374063930054995,1.0,1.0,1.0,13/50,24.92%,PSMA2;PSMA8;PSMA6;PSME1;PSMA4;PSMF1;PSMB7;PSMB1;PSMD2;PSMA5;PSMC3;PSMD3;PSMA3
prerank,DNA packaging (GO:0006323),0.18893350426034233,0.41567804614058196,0.9946714031971581,1.0,1.0,2/16,15.11%,HAT1;KAT6A
prerank,ATP synthesis coupled proton transport (GO:0015986),0.18514188187344427,0.41150252301693435,0.9931153184165232,1.0,1.0,6/17,28.62%,ATP5PD;VPS9D1;ATP5MC2;STOML2;ATP5F1B;ATP5F1C
prerank,"base-excision repair, gap-filling (GO:0006287)",0.1639820118049896,0.41132321905478475,0.9984076433121019,1.0,1.0,34/35,78.54%,RPA1;UNG;PARG;MPG;RFC3;MBD4;RFC5;POLL;RPA3;APEX1;RFC2;POLD4;RFC4;PNKP;PCNA;OGG1;POLD3;XRCC1;SMUG1;LIG3;PARP1;FEN1;RPA2;ADPRS;LIG1;NEIL1;POLD2;POLB;POLD1;NTHL1;TDG;POLG;MUTYH;POLE
prerank,negative regulation of inclusion body assembly (GO:0090084),0.20438139476492384,0.40728415727232814,0.9865900383141762,1.0,1.0,10/10,79.57%,DNAJB1;DNAJB6;HSPA1B;DNAJA4;DNAJB8;HSPA1A;SORL1;SACS;HSPA2;DNAJB2
prerank,peptidyl-lysine acetylation (GO:0018394),0.20080346494256485,0.40460144267511244,0.9943714821763602,0.9999561547796106,1.0,10/10,79.93%,KAT2B;CREBBP;KAT7;EP300;KAT2A;ESCO1;SIRT1;BLOC1S1;BAG6;KAT5
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.16548161434791092,0.4032820796439418,0.9968602825745683,0.9996446725467126,1.0,13/29,31.70%,RPA1;GTF2H4;CETN2;CHD1L;GTF2H1;CCNH;CUL4B;GTF2H5;RPA3;GTF2H2;XPA;RBX1;RPS27A
prerank,anterograde synaptic vesicle transport (GO:0048490),0.18554428335985662,0.401948169860063,0.9929701230228472,0.9989350574650059,1.0,3/15,17.00%,AP3B1;AP3S1;BLOC1S5
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.18554428335985662,0.401948169860063,0.9929701230228472,0.9989350574650059,1.0,3/15,17.00%,AP3B1;AP3S1;BLOC1S5
prerank,protein localization to microtubule organizing center (GO:1905508),-0.1643790053513521,-0.39914611423447,0.9976303317535545,1.0,1.0,4/15,25.30%,CEP192;PCM1;C2CD3;STIL
prerank,positive regulation of cilium assembly (GO:0045724),-0.1573973395262935,-0.3975983162563416,0.9976470588235294,1.0,1.0,7/18,35.59%,FUZ;HTT;ARHGAP35;SEPTIN9;CROCC;CCP110;KCTD17
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.17996860282574578,0.3958662719436759,0.9948275862068966,0.9989822657987643,1.0,16/16,82.02%,ATP5PD;ATP5MC2;STOML2;ATP5F1B;ATP5F1C;ATP5F1A;ATP5F1E;ATP5MF;ATP5MC1;ATP5F1D;ATP5MC3;DMAC2L;ATP5MG;ATP5ME;ATP5PF;ATP5PO
prerank,global genome nucleotide-excision repair (GO:0070911),0.1680047184422154,0.3945762821745474,1.0,0.9986704086764167,1.0,13/26,32.68%,ERCC4;GTF2H4;CETN2;CHD1L;GTF2H1;RNF111;CUL4B;GTF2H5;GTF2H2;XPA;RBX1;RPS27A;UBA52
prerank,N-terminal protein amino acid modification (GO:0031365),0.1797635069376231,0.38404351576628853,0.9928698752228164,0.9988796256992828,1.0,8/14,32.77%,NAA11;NAA16;NAA35;PDF;NAA50;METAP1D;AANAT;METAP2
prerank,tRNA modification (GO:0006400),-0.11280382071542415,-0.3758348633700561,1.0,1.0,1.0,19/62,35.37%,TARBP1;PUS3;GTPBP3;DUS2;MTO1;TPRKB;ELP5;THUMPD3;ANKRD16;SSB;METTL1;BCDIN3D;ADAT2;QTRT1;TRMT61A;AARS1;METTL2B;METTL2A;URM1
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),-0.1591335759881054,-0.35885580733696704,1.0,0.9997146675985603,1.0,4/12,30.70%,PLK5;TP53;PRKDC;RPA2
prerank,regulation of protein acetylation (GO:1901983),0.1743181968656987,0.3571302174198746,0.9981308411214953,0.9995397342067517,1.0,4/12,26.51%,CEP295;RAPGEF3;TAOK1;GSK3B
prerank,error-free translesion synthesis (GO:0070987),0.11941762063047298,0.27808620532813033,1.0,0.999986515783907,1.0,10/22,33.85%,RPA1;RFC3;RFC5;RPA3;RFC2;RPS27A;UBA52;POLDIP2;UFD1;POLH
